data_2l1m_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l1m _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo . . . . . 0 CA--C 1.532 0.406 0 CA-C-O 122.173 0.822 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -63.96 -26.98 68.83 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -167.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -70.05 -49.98 45.78 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.67 0.668 . . . . 0.0 110.761 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.5 t -78.25 -33.99 49.36 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.547 1.139 . . . . 0.0 112.357 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -59.78 -42.4 93.24 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.306 0.642 . . . . 0.0 109.947 172.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.9 tp -70.12 -45.43 66.89 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-O 118.708 -0.663 . . . . 0.0 111.868 173.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -48.05 -39.87 21.3 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 120.04 1.291 . . . . 0.0 113.207 174.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.6 m -60.07 -44.98 94.35 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.605 -0.684 . . . . 0.0 112.261 172.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.8 mm -66.34 -36.61 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.762 0.825 . . . . 0.0 110.691 175.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.9 mm -55.96 -53.87 33.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.434 0 CA-C-O 118.445 -0.788 . . . . 0.0 109.05 173.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -59.97 -29.0 68.14 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 118.845 0.748 . . . . 0.0 112.54 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 tptt -63.42 -46.2 87.45 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 118.624 -0.703 . . . . 0.0 112.815 172.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -101.41 11.4 39.22 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.549 0.924 0 C-N-CA 125.273 1.429 . . . . 0.0 113.698 -167.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 mptt . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 118.863 -0.589 . . . . 0.0 111.953 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -169.9 161.29 8.86 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -171.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -128.03 172.29 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.884 1.274 . . . . 0.0 111.732 174.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.2 mm -130.28 120.07 48.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 125.988 1.715 . . . . 0.0 108.375 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.02 153.78 51.15 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -81.34 108.49 15.0 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.599 0.714 . . . . 0.0 111.469 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.21 -15.82 62.48 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.239 1.015 . . . . 0.0 113.461 177.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -89.96 -2.13 58.1 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.705 1.602 . . . . 0.0 113.906 -172.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.27 140.14 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.105 1.362 . . . . 0.0 110.567 -174.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -59.46 -28.17 66.74 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -177.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -84.16 -3.55 58.21 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.017 1.327 . . . . 0.0 114.469 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.5 p 37.44 51.29 1.17 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 126.899 2.079 . . . . 0.0 114.417 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.77 150.18 24.33 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -167.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.4 t -79.96 89.96 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 127.843 2.457 . . . . 0.0 108.957 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.8 pt -70.0 -24.86 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.08 1.352 . . . . 0.0 112.446 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -154.78 159.71 40.8 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.151 0.98 . . . . 0.0 112.576 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 5.8 p -148.77 145.29 27.52 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.975 -1.078 . . . . 0.0 113.07 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -86.89 156.64 19.76 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 178.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.58 -27.65 67.87 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.621 0.769 . . . . 0.0 111.913 171.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.41 -50.49 52.6 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.331 -0.856 . . . . 0.0 113.03 170.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.57 -38.16 74.36 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 119.652 1.726 . . . . 0.0 110.593 173.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.6 t -60.22 -40.78 91.35 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.821 -0.55 . . . . 0.0 111.098 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -77.62 -26.31 50.48 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.649 0.78 . . . . 0.0 112.969 175.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.0 tp -63.92 -55.81 19.88 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.951 1.3 . . . . 0.0 111.29 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 77.1 m -95.96 -20.05 19.03 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.934 0.894 . . . . 0.0 113.067 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.4 20.21 76.71 Favored Glycine 0 CA--C 1.538 1.491 0 O-C-N 120.988 -1.07 . . . . 0.0 113.847 -174.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -84.87 -129.64 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.97 1.308 . . . . 0.0 110.313 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 41.6 t -159.87 150.12 18.66 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 127.589 2.356 . . . . 0.0 108.288 173.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.1 mtm180 -58.28 -35.28 71.55 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.124 -0.985 . . . . 0.0 112.328 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.42 -21.71 64.35 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -81.85 -20.79 38.23 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.207 1.403 . . . . 0.0 112.511 175.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -105.3 -17.06 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 7.6 mmt -49.89 108.0 0.19 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 125.519 1.528 . . . . 0.0 111.051 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 70.55 18.86 6.39 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.792 1.637 . . . . 0.0 113.793 171.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.12 159.11 76.29 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 123.843 0.857 . . . . 0.0 110.452 167.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -60.34 140.03 89.74 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.532 2.154 . . . . 0.0 111.857 169.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.7 t -67.47 -9.99 47.26 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.844 1.657 . . . . 0.0 113.469 176.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.7 m -62.81 100.17 0.19 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 127.672 2.389 . . . . 0.0 111.507 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 46.4 m -49.93 -23.48 1.99 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.088 1.755 . . . . 0.0 115.299 -176.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -46.99 -41.81 16.94 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.435 1.494 . . . . 0.0 112.863 169.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -63.1 -16.64 60.63 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.28 1.032 . . . . 0.0 113.551 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 pp -123.11 25.25 8.57 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.74 1.616 . . . . 0.0 113.653 173.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -65.01 151.56 45.67 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.109 -0.995 . . . . 0.0 112.181 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -125.6 -177.81 15.05 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.378 1.466 . . . . 0.0 113.694 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -64.65 -10.13 23.45 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.318 2.679 . . . . 0.0 116.293 -171.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -107.6 -7.39 16.49 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.825 1.65 . . . . 0.0 113.341 175.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.8 m -71.71 132.22 44.23 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.074 -1.016 . . . . 0.0 111.335 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -80.01 135.72 36.44 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.081 0.943 . . . . 0.0 110.105 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.3 mmt-85 -66.33 -39.79 89.47 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.737 -0.602 . . . . 0.0 110.658 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 49.5 ptt85 -53.76 -39.07 65.06 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.385 1.074 . . . . 0.0 113.463 171.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.03 -50.21 43.57 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.593 1.157 . . . . 0.0 110.234 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.23 -33.67 76.55 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.137 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.5 -54.98 11.57 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.478 1.111 . . . . 0.0 111.541 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -50.16 -40.14 45.72 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.862 0.865 . . . . 0.0 112.873 172.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.4 mt -65.48 -50.03 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 118.758 0.708 . . . . 0.0 111.018 174.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.09 -39.89 57.13 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.732 -0.651 . . . . 0.0 111.977 174.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -70.03 -37.71 75.69 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.449 0.7 . . . . 0.0 111.669 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.66 -34.02 76.95 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.328 -0.857 . . . . 0.0 111.317 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mt -83.15 -28.88 29.07 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.509 0.724 . . . . 0.0 111.664 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.19 -27.88 69.01 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.819 2.048 . . . . 0.0 111.016 168.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.0 17.36 9.64 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.245 1.402 . . . . 0.0 114.918 170.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.89 -49.93 74.24 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 118.642 1.221 . . . . 0.0 111.231 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -159.9 139.06 10.93 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.886 1.674 . . . . 0.0 111.392 169.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -74.02 101.45 3.87 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 169.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -144.04 140.05 29.32 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.82 1.248 . . . . 0.0 111.828 -168.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -77.49 135.03 38.2 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.506 1.123 . . . . 0.0 111.123 173.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -136.51 153.2 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.038 1.735 . . . . 0.0 108.553 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -79.93 160.07 26.11 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.857 0.863 . . . . 0.0 110.104 169.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -164.35 149.85 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 119.234 0.925 . . . . 0.0 111.448 169.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -88.89 145.33 25.61 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.431 0.692 . . . . 0.0 111.548 172.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -117.29 160.97 20.25 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.374 1.07 . . . . 0.0 110.999 173.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -125.64 140.04 53.06 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.466 0.65 . . . . 0.0 111.441 169.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -83.99 154.78 23.11 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.418 1.087 . . . . 0.0 112.591 175.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -53.95 -27.85 33.64 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.025 1.73 . . . . 0.0 113.089 171.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -71.42 -9.95 58.99 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.188 1.395 . . . . 0.0 114.181 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.76 18.24 33.06 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.249 1.404 . . . . 0.0 115.831 175.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 71.2 m -107.17 136.86 46.29 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 118.634 1.217 . . . . 0.0 111.717 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 29.5 t -126.21 135.0 51.08 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.858 1.263 . . . . 0.0 112.325 -175.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -149.96 139.98 22.01 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.55 1.14 . . . . 0.0 113.422 -168.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -102.54 125.56 49.3 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.408 1.883 . . . . 0.0 109.139 170.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 61.4 m -129.74 173.16 10.9 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.42 1.488 . . . . 0.0 110.082 173.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 30.4 tp -79.31 59.88 2.96 Favored 'General case' 0 CA--C 1.549 0.911 0 O-C-N 120.592 -1.317 . . . . 0.0 111.644 -176.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 45.7 t -63.41 142.9 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 126.062 1.745 . . . . 0.0 111.623 -173.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -108.81 69.98 0.73 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.203 1.001 . . . . 0.0 112.979 -167.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.8 t -81.25 70.02 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.732 1.213 . . . . 0.0 111.045 -168.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.8 p -121.51 126.53 26.45 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 124.133 0.973 . . . . 0.0 112.247 -175.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -88.93 -176.4 1.39 Allowed 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 123.846 3.031 . . . . 0.0 112.293 -173.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -117.03 133.59 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 123.178 1.465 . . . . 0.0 113.677 -175.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.46 160.78 30.43 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.092 2.157 . . . . 0.0 111.947 -173.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -89.92 -176.27 4.87 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.124 0.97 . . . . 0.0 112.092 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -62.48 -19.98 64.11 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -77.29 -19.97 55.71 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.011 1.324 . . . . 0.0 113.862 170.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.75 -0.13 64.74 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.23 1.395 . . . . 0.0 114.447 -176.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.25 131.38 35.29 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.372 1.086 . . . . 0.0 111.669 174.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.7 p -72.56 98.3 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.73 2.012 . . . . 0.0 111.078 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.7 -29.14 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 123.555 0.742 . . . . 0.0 111.731 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.9 148.6 50.12 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 124.115 1.912 . . . . 0.0 112.834 174.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -102.45 83.93 2.37 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 125.815 1.646 . . . . 0.0 106.766 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.6 mt -99.87 79.29 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 170.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.296 34.5 mt -83.0 86.01 7.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 123.226 1.488 . . . . 0.0 108.946 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -59.93 103.13 0.19 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 113.045 -1.889 . . . . 0.0 109.441 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -85.16 55.63 3.58 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 122.584 1.183 . . . . 0.0 110.885 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -79.83 106.75 12.09 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 123.653 1.692 . . . . 0.0 110.507 -176.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.54 120.32 12.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 125.73 1.612 . . . . 0.0 108.691 170.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.472 0.667 0 O-C-N 123.277 0.36 . . . . 0.0 110.076 175.113 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo . . . . . 0 CA--C 1.535 0.551 0 CA-C-O 122.282 0.868 . . . . 0.0 112.329 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -60.02 -28.8 68.03 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -165.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -66.65 -49.85 64.85 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.715 0.806 . . . . 0.0 110.53 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 t -79.2 -34.15 43.21 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.177 0.991 . . . . 0.0 112.428 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -58.41 -39.94 81.11 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.07 0.948 . . . . 0.0 110.458 170.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 44.5 tp -70.07 -45.72 66.44 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 118.813 -0.613 . . . . 0.0 111.999 170.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -46.5 -39.93 11.64 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.975 1.31 . . . . 0.0 112.936 174.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.6 m -58.97 -45.1 91.39 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 121.595 -0.691 . . . . 0.0 111.664 173.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.8 mm -66.1 -36.84 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.89 0.876 . . . . 0.0 110.543 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.2 mm -54.51 -55.79 13.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 CA-C-O 117.777 -1.106 . . . . 0.0 108.545 171.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -59.87 -29.99 68.69 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 120.108 1.322 . . . . 0.0 111.922 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.1 tptt -63.6 -40.64 97.46 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.582 1.153 . . . . 0.0 112.235 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -108.16 -0.14 21.19 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 116.034 1.864 . . . . 0.0 116.034 176.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.554 1.101 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -166.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -169.72 160.92 9.03 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -121.25 168.93 13.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 126.892 2.077 . . . . 0.0 111.387 170.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.8 mm -119.1 113.85 42.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 126.105 1.762 . . . . 0.0 106.617 170.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -119.09 148.98 42.44 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.922 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -80.87 113.21 18.92 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.946 0.898 . . . . 0.0 110.068 174.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.03 -12.4 60.32 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -100.01 -7.45 25.04 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.022 1.329 . . . . 0.0 114.041 -169.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 p -105.85 140.07 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.887 1.675 . . . . 0.0 111.285 -177.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.76 -30.73 70.19 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -174.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -77.35 -8.96 58.5 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.272 1.029 . . . . 0.0 113.592 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.8 m 48.63 39.01 12.51 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.746 1.618 . . . . 0.0 113.138 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.21 155.16 27.5 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -166.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.9 t -79.96 93.15 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 129.128 2.971 . . . . 0.0 108.192 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.4 pt -73.51 -23.62 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.174 1.39 . . . . 0.0 112.149 177.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -157.57 159.75 37.43 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.659 1.184 . . . . 0.0 112.014 175.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.3 p -141.68 151.12 42.73 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.821 -1.174 . . . . 0.0 114.125 -175.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -89.77 151.45 21.81 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.674 0.75 . . . . 0.0 111.653 166.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -65.92 -27.04 67.89 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.614 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.36 -50.07 48.72 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 121.156 -0.965 . . . . 0.0 112.778 172.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -29.86 66.96 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 118.845 1.323 . . . . 0.0 111.67 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.6 t -59.31 -39.83 84.29 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.597 -0.689 . . . . 0.0 110.466 170.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -77.75 -30.01 51.35 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 118.905 0.775 . . . . 0.0 112.857 174.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.4 tp -55.92 -52.1 65.3 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.15 1.38 . . . . 0.0 110.911 174.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 57.7 m -90.64 -20.85 22.06 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.16 9.98 84.41 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 126.557 2.027 . . . . 0.0 116.69 174.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -87.57 -120.25 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 119.558 1.679 . . . . 0.0 112.728 -175.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.1 t -159.86 138.63 10.68 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.772 1.629 . . . . 0.0 110.313 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -60.57 -32.64 71.72 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.328 1.051 . . . . 0.0 113.459 -175.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.14 -16.58 33.6 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.505 1.122 . . . . 0.0 113.645 174.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -97.1 -20.78 17.76 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.778 1.631 . . . . 0.0 112.46 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 m -89.92 -17.24 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 120.145 1.339 . . . . 0.0 113.134 -172.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 36.3 mmt -49.85 114.93 1.19 Allowed 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.221 1.009 . . . . 0.0 109.698 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 72.66 21.07 3.61 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.036 1.735 . . . . 0.0 114.355 171.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.05 154.03 88.65 Favored Pre-proline 0 N--CA 1.48 1.031 0 O-C-N 120.762 -1.211 . . . . 0.0 111.074 167.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.18 139.99 57.51 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.62 2.213 . . . . 0.0 111.645 173.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.8 t -69.95 -18.96 63.38 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.179 0.992 . . . . 0.0 112.991 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.0 m -61.39 100.1 0.12 Allowed 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 127.143 2.177 . . . . 0.0 111.614 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 68.3 m -50.44 -19.29 0.82 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 116.43 2.011 . . . . 0.0 116.43 -173.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -56.33 -36.31 68.59 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.036 -1.04 . . . . 0.0 111.635 172.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -57.58 -23.49 51.04 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.373 1.469 . . . . 0.0 113.391 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 pp -119.44 22.87 11.53 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.938 1.695 . . . . 0.0 113.162 176.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -63.25 147.1 51.96 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.379 -0.826 . . . . 0.0 111.993 173.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.72 -173.13 12.89 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 125.189 1.376 . . . . 0.0 113.219 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -62.35 -10.07 17.48 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 123.758 2.972 . . . . 0.0 116.406 -172.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -108.18 -9.34 15.57 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.902 1.681 . . . . 0.0 113.562 176.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.1 m -81.29 141.17 34.33 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.928 0.891 . . . . 0.0 112.153 -174.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -89.08 136.78 32.83 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 122.294 1.045 . . . . 0.0 111.512 171.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.4 mmm-85 -69.98 -39.69 75.78 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.363 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -53.23 -39.29 63.68 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 169.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.9 -52.84 54.31 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 122.221 1.01 . . . . 0.0 110.031 175.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.94 -33.86 77.03 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.882 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.02 -50.92 36.53 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.941 1.696 . . . . 0.0 112.271 176.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -50.2 -41.56 49.88 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.42 1.009 . . . . 0.0 112.306 169.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.7 mt -61.78 -49.9 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 O-C-N 121.653 -0.654 . . . . 0.0 111.001 171.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.07 -39.85 56.97 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.385 -0.817 . . . . 0.0 112.171 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -70.11 -34.88 73.67 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.695 0.798 . . . . 0.0 111.888 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.53 -31.45 69.67 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.656 -0.653 . . . . 0.0 111.744 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 mt -82.78 -32.24 27.84 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.537 0.735 . . . . 0.0 111.604 176.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.07 -33.1 74.72 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.868 2.067 . . . . 0.0 110.833 169.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.78 23.67 6.11 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.551 1.072 . . . . 0.0 115.031 168.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.75 -50.63 62.13 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.168 1.484 . . . . 0.0 110.218 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -151.77 143.41 23.6 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.389 2.276 . . . . 0.0 108.63 172.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -77.71 115.56 17.56 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.703 1.138 . . . . 0.0 108.188 169.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -138.96 137.73 36.67 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.592 1.157 . . . . 0.0 111.646 -168.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -87.03 129.63 34.81 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.177 1.791 . . . . 0.0 109.949 169.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.27 145.97 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.102 1.361 . . . . 0.0 109.355 -175.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -79.97 151.44 30.03 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.457 0.703 . . . . 0.0 109.846 170.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -163.0 147.13 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.06 0.944 . . . . 0.0 110.544 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -87.58 141.42 28.62 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.206 175.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -106.09 155.19 19.67 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.915 1.286 . . . . 0.0 111.231 169.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -121.83 138.29 54.44 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.796 0.838 . . . . 0.0 109.089 166.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -100.04 152.59 20.04 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.944 1.697 . . . . 0.0 110.504 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.92 -15.59 44.27 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 -171.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -78.28 -11.08 59.91 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.227 1.411 . . . . 0.0 113.72 171.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.86 2.53 56.15 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 126.203 1.859 . . . . 0.0 115.126 -174.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 55.3 m -74.77 128.21 35.01 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.866 1.833 . . . . 0.0 111.328 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 67.1 m -124.47 130.62 52.8 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.696 1.198 . . . . 0.0 111.443 -175.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -150.01 139.93 21.9 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.89 0.876 . . . . 0.0 113.013 -171.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -110.36 134.79 51.96 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.673 1.989 . . . . 0.0 109.3 172.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 2.1 m -138.95 171.64 14.02 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.502 1.521 . . . . 0.0 110.457 169.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 29.5 tp -76.88 59.87 1.68 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.199 0.999 . . . . 0.0 110.088 174.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.0 t -58.29 145.36 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.912 1.285 . . . . 0.0 110.516 -172.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -100.0 69.76 1.55 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.693 1.235 . . . . 0.0 111.277 -168.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.4 t -82.43 69.85 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.268 1.027 . . . . 0.0 110.526 -170.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.3 130.76 24.41 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.004 0.922 . . . . 0.0 110.948 -176.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -85.47 -169.72 0.64 Allowed 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 123.199 2.6 . . . . 0.0 111.888 -174.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.92 130.33 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-O 123.133 1.444 . . . . 0.0 113.947 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.4 mttm -112.82 162.4 15.83 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 127.655 2.382 . . . . 0.0 112.801 -175.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -93.17 -179.98 5.25 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.154 171.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.4 -21.69 65.57 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -70.63 -19.88 62.78 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.532 1.133 . . . . 0.0 113.727 169.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.51 0.32 59.44 Favored Glycine 0 CA--C 1.533 1.156 0 C-N-CA 126.112 1.815 . . . . 0.0 114.423 -176.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.75 139.39 30.61 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.64 1.22 . . . . 0.0 113.274 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.6 p -74.67 98.96 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.484 1.513 . . . . 0.0 109.856 -176.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.37 -30.01 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 118.345 -0.836 . . . . 0.0 110.833 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.9 mmt -136.59 150.04 48.37 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-O 123.85 1.786 . . . . 0.0 110.906 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -104.33 81.11 1.78 Allowed 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 125.564 1.545 . . . . 0.0 107.522 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 36.1 mt -100.44 70.74 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 O-C-N 120.481 -1.387 . . . . 0.0 109.211 172.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -77.25 85.72 3.69 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 123.44 1.591 . . . . 0.0 109.384 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -60.0 103.05 0.19 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 112.877 -1.965 . . . . 0.0 111.007 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -85.54 62.71 7.65 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.518 -1.364 . . . . 0.0 111.799 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -79.71 131.33 35.92 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.185 -0.947 . . . . 0.0 110.372 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 50.5 t -92.95 114.6 30.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 124.58 1.152 . . . . 0.0 108.118 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.472 0.675 0 CA-C-O 121.331 0.586 . . . . 0.0 112.094 -175.565 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo . . . . . 0 CA--C 1.533 0.436 0 CA-C-O 122.729 1.054 . . . . 0.0 111.855 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -65.8 -27.08 68.0 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.989 0.915 . . . . 0.0 113.257 -169.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -70.02 -49.99 45.88 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.023 0.529 . . . . 0.0 110.325 -176.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.5 t -74.13 -35.31 64.09 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.724 0.81 . . . . 0.0 112.509 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -58.24 -41.48 84.27 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.318 0.647 . . . . 0.0 109.909 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.1 tp -75.49 -45.04 40.74 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 118.619 -0.705 . . . . 0.0 112.427 174.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -47.66 -39.81 18.18 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.713 1.605 . . . . 0.0 113.151 175.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.7 m -60.02 -45.16 93.71 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.88 -0.513 . . . . 0.0 111.679 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.5 mm -68.95 -34.77 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.941 0.897 . . . . 0.0 110.931 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.8 mm -54.67 -56.5 10.15 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 171.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -60.8 -27.05 67.73 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 176.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -63.2 -43.1 99.12 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.465 0.706 . . . . 0.0 112.228 172.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -104.66 -0.01 27.98 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 . . . . . 0 N--CA 1.477 0.887 0 C-N-CA 125.504 1.522 . . . . 0.0 113.751 -167.499 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.2 mptt . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 118.95 -0.548 . . . . 0.0 111.567 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -169.81 162.36 9.47 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -169.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -122.93 168.96 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 128.039 2.536 . . . . 0.0 111.217 171.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.0 mm -128.24 124.81 63.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 C-N-CA 126.219 1.807 . . . . 0.0 108.378 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.06 154.46 49.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -177.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -77.77 108.27 10.88 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.402 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.01 -19.52 63.32 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -94.84 2.38 55.45 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.701 1.201 . . . . 0.0 113.989 -169.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.49 140.07 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.32 1.448 . . . . 0.0 110.508 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.97 -23.82 65.63 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -86.55 -7.39 58.41 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.344 1.458 . . . . 0.0 114.23 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.0 p 42.92 43.38 3.51 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 126.945 2.098 . . . . 0.0 115.293 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.53 149.9 32.98 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 -167.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.0 t -80.03 89.98 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 128.584 2.753 . . . . 0.0 109.08 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.7 pt -69.96 -24.54 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.993 1.317 . . . . 0.0 112.453 175.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -153.58 159.62 42.22 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.804 0.842 . . . . 0.0 112.86 173.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.0 p -143.21 143.26 31.69 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.289 -0.882 . . . . 0.0 112.687 -177.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -89.67 155.12 19.44 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 173.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -66.93 -19.92 65.81 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.869 -0.519 . . . . 0.0 112.257 174.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.65 -49.91 55.83 Favored Glycine 0 CA--C 1.535 1.283 0 O-C-N 121.33 -0.856 . . . . 0.0 112.212 169.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -56.75 -39.23 73.62 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 119.04 1.42 . . . . 0.0 110.903 172.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.3 t -60.14 -41.3 92.43 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.922 -0.486 . . . . 0.0 111.321 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -77.1 -30.09 55.2 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.679 0.791 . . . . 0.0 112.663 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.18 -53.8 43.59 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.721 1.609 . . . . 0.0 112.174 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 82.7 m -101.12 -19.97 15.53 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.876 1.271 . . . . 0.0 112.787 -173.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.95 11.87 84.75 Favored Glycine 0 CA--C 1.539 1.541 0 CA-C-O 118.715 -1.047 . . . . 0.0 115.502 176.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -90.71 -122.13 0.07 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.956 1.378 . . . . 0.0 111.401 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.4 t -159.89 150.16 18.67 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.929 1.292 . . . . 0.0 111.095 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.0 mtt-85 -50.04 -43.9 51.16 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.576 1.15 . . . . 0.0 111.189 169.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.81 -19.12 64.78 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.378 1.071 . . . . 0.0 113.824 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -86.48 -20.56 27.91 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.473 1.509 . . . . 0.0 112.81 174.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.7 m -102.11 -18.99 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 174.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 5.4 mmt -49.81 107.47 0.15 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.509 1.523 . . . . 0.0 111.46 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 71.47 18.06 5.56 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.818 1.647 . . . . 0.0 113.85 171.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.55 157.12 72.81 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.039 0.936 . . . . 0.0 111.09 167.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.51 140.17 92.43 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.873 3.049 . . . . 0.0 112.879 169.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.3 m -62.95 -13.79 39.19 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 172.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.3 m -65.98 99.92 0.54 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.396 1.478 . . . . 0.0 110.911 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 32.0 p -53.32 -17.56 1.9 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.878 1.671 . . . . 0.0 115.004 -176.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -48.5 -42.88 34.32 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.925 1.29 . . . . 0.0 111.742 168.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -64.42 -16.19 61.93 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 pp -122.99 23.02 9.45 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.32 1.848 . . . . 0.0 113.432 173.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.27 144.57 57.06 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.224 -0.922 . . . . 0.0 112.568 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.54 173.16 22.67 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.067 1.318 . . . . 0.0 113.479 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.14 -9.99 25.6 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.485 2.79 . . . . 0.0 113.825 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.27 -4.69 25.29 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.192 1.797 . . . . 0.0 113.617 174.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.5 m -80.5 143.19 33.51 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 119.329 0.968 . . . . 0.0 111.889 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.2 mm-40 -92.97 145.24 24.52 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 123.453 1.597 . . . . 0.0 114.097 175.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.473 ' HD2' ' H ' ' A' ' 76' ' ' ARG . 1.2 mpt_? -70.11 -42.45 72.67 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 113.463 -1.699 . . . . 0.0 110.874 -175.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -60.05 -38.85 84.0 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.584 1.154 . . . . 0.0 113.5 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.69 -53.01 57.93 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.044 0.938 . . . . 0.0 109.972 174.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.73 -34.6 78.57 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.551 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.96 -53.29 18.45 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.951 1.301 . . . . 0.0 111.94 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -50.13 -41.6 49.08 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.18 0.9 . . . . 0.0 112.13 171.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 47.7 mt -63.8 -49.79 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 O-C-N 121.834 -0.541 . . . . 0.0 111.493 174.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.87 -39.81 54.77 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.167 0.587 . . . . 0.0 111.912 174.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -67.61 -39.56 84.73 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.553 0.615 . . . . 0.0 111.705 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.45 -27.16 65.01 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.833 -0.542 . . . . 0.0 112.162 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 mt -88.57 -31.53 18.59 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.235 0.614 . . . . 0.0 111.388 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.43 -36.11 79.44 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.31 1.844 . . . . 0.0 109.845 168.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 113.71 22.42 5.39 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.828 1.204 . . . . 0.0 114.821 171.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.24 -50.0 74.84 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 118.374 1.087 . . . . 0.0 111.399 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -159.73 148.6 17.7 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.448 1.499 . . . . 0.0 112.243 170.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -70.97 111.24 6.2 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 167.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -148.07 136.64 21.61 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.41 1.084 . . . . 0.0 111.392 -174.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -84.03 133.59 34.66 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.269 1.428 . . . . 0.0 110.606 171.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.61 146.3 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.434 1.494 . . . . 0.0 109.143 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -80.0 153.9 28.55 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.996 0.918 . . . . 0.0 110.598 172.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -163.74 149.5 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.114 0.966 . . . . 0.0 111.428 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -90.47 145.32 25.0 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.483 174.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -116.64 162.28 17.89 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.632 1.173 . . . . 0.0 111.394 171.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -126.55 137.89 53.41 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.608 0.718 . . . . 0.0 110.59 167.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -92.83 157.59 16.31 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.288 1.835 . . . . 0.0 111.693 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -55.66 -30.55 61.21 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.103 1.761 . . . . 0.0 113.616 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.4 p30 -77.28 -9.89 59.09 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 175.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.51 -1.15 49.56 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 126.247 1.879 . . . . 0.0 115.298 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.4 m -70.1 130.86 43.25 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.35 1.575 . . . . 0.0 111.483 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 80.5 m -119.91 129.48 54.38 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.748 1.219 . . . . 0.0 110.969 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -151.03 140.01 21.01 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -172.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -110.83 131.77 54.77 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 127.19 2.196 . . . . 0.0 108.144 168.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 5.6 m -138.96 179.17 6.65 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.174 1.39 . . . . 0.0 110.93 170.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 76.9 mt -77.61 60.0 2.07 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.153 0.981 . . . . 0.0 110.763 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.6 t -60.57 142.29 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.739 1.215 . . . . 0.0 110.751 -173.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -102.91 69.72 1.06 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 122.076 0.941 . . . . 0.0 110.769 -168.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.5 t -83.56 69.76 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.835 0.826 . . . . 0.0 109.786 -169.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.47 134.31 24.83 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 124.745 1.218 . . . . 0.0 110.054 -174.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -87.55 -164.65 0.2 Allowed 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 123.083 2.522 . . . . 0.0 112.073 -172.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.7 m -124.93 132.94 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 122.922 1.344 . . . . 0.0 112.941 174.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -118.5 160.95 20.83 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.752 2.021 . . . . 0.0 111.794 -171.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -90.03 179.97 5.82 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.095 0.958 . . . . 0.0 111.976 172.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.72 -21.59 64.63 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -71.24 -19.92 62.31 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.615 1.166 . . . . 0.0 113.866 170.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.7 -1.87 60.12 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.791 1.662 . . . . 0.0 114.307 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -85.99 139.45 31.18 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.57 1.185 . . . . 0.0 113.25 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -74.41 100.02 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 125.828 1.651 . . . . 0.0 110.503 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.86 -30.06 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 118.194 -0.907 . . . . 0.0 111.367 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.8 mmt -136.27 148.33 47.95 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 123.517 1.627 . . . . 0.0 111.077 178.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -103.13 86.84 2.77 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.915 1.686 . . . . 0.0 108.088 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.8 mt -106.49 69.9 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 170.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.02 88.95 2.98 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.259 1.028 . . . . 0.0 108.748 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -59.82 107.03 0.55 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.151 1.381 . . . . 0.0 110.203 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -84.67 52.22 2.34 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 120.617 -1.302 . . . . 0.0 112.169 -176.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -79.89 106.9 12.25 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 123.793 1.759 . . . . 0.0 112.678 -176.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 22.3 t -64.17 112.52 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 125.802 1.641 . . . . 0.0 108.296 169.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.47 0.556 0 CA-C-O 120.832 0.348 . . . . 0.0 111.026 177.237 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo . . . . . 0 CA--C 1.535 0.558 0 CA-C-O 122.115 0.798 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -64.55 -26.59 68.48 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -168.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -69.97 -49.97 46.4 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.49 0.586 . . . . 0.0 110.585 -176.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.1 t -77.3 -33.41 55.68 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.133 0.973 . . . . 0.0 112.304 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -60.04 -41.02 91.35 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.667 -0.646 . . . . 0.0 110.184 172.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.2 tp -71.03 -45.11 64.5 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-O 118.696 -0.669 . . . . 0.0 112.041 172.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -47.68 -39.75 18.17 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.203 1.365 . . . . 0.0 113.279 173.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 90.2 m -60.16 -43.67 95.62 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.521 -0.737 . . . . 0.0 112.326 172.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.4 mm -68.59 -35.28 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.898 0.879 . . . . 0.0 110.938 175.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 26.2 mm -55.49 -54.5 24.83 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.483 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 171.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 55.5 mtm180 -60.32 -27.36 67.27 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.8 0.727 . . . . 0.0 112.959 176.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.3 tptt -65.09 -40.47 94.64 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 118.631 -0.7 . . . . 0.0 112.757 172.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -106.03 2.4 27.26 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 CA--C 1.551 1.001 0 C-N-CA 126.536 1.935 . . . . 0.0 114.266 -167.793 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.477 0.917 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -169.79 163.13 9.76 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -121.71 169.77 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.887 169.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.9 mm -123.2 114.65 42.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 126.069 1.747 . . . . 0.0 107.015 173.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.17 153.16 40.43 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.475 175.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -85.21 120.83 27.13 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.37 -9.62 59.34 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 46.0 mmm-85 -100.1 5.68 44.93 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.886 1.674 . . . . 0.0 114.246 -172.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.4 m -119.61 139.9 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 126.117 1.767 . . . . 0.0 111.73 -174.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.12 -24.4 65.01 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.85 0.86 . . . . 0.0 113.142 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.56 -12.3 59.95 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.169 1.388 . . . . 0.0 112.431 173.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.9 m 46.73 37.95 5.28 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.899 1.68 . . . . 0.0 112.782 -175.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.31 149.86 40.46 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -165.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.4 t -80.66 90.0 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 C-N-CA 128.667 2.787 . . . . 0.0 108.631 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.4 pt -69.95 -24.15 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.162 1.385 . . . . 0.0 112.207 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -155.62 159.82 39.93 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.802 1.241 . . . . 0.0 112.93 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.3 p -143.23 139.96 30.48 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.873 -1.142 . . . . 0.0 112.879 -175.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -83.73 157.98 21.94 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -61.26 -28.22 69.02 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.547 0.739 . . . . 0.0 111.429 171.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.58 -49.97 59.06 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.71 -1.05 . . . . 0.0 113.296 170.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.76 -40.6 69.52 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 120.064 1.932 . . . . 0.0 110.662 172.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.4 t -60.24 -40.65 90.98 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.625 0.37 . . . . 0.0 111.074 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -76.23 -29.62 57.61 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.965 0.906 . . . . 0.0 112.579 176.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.7 tp -64.28 -55.78 19.1 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.935 1.294 . . . . 0.0 111.733 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.1 m -99.59 -20.06 16.54 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.72 0.808 . . . . 0.0 112.794 -172.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.94 14.51 82.55 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-O 118.871 -0.96 . . . . 0.0 115.413 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -89.96 -128.79 0.08 Allowed 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 118.845 1.322 . . . . 0.0 111.762 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.9 t -159.95 150.19 18.6 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.635 1.974 . . . . 0.0 109.789 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.5 mtt85 -50.88 -40.37 56.27 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.329 1.052 . . . . 0.0 112.52 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.7 -21.2 62.63 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.351 1.06 . . . . 0.0 113.537 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -85.38 -20.96 29.08 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.638 1.575 . . . . 0.0 112.296 177.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -105.37 -20.03 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 5.8 mmt -49.97 107.76 0.17 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.845 1.658 . . . . 0.0 111.306 -174.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 70.24 18.4 6.89 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.383 1.473 . . . . 0.0 113.558 170.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.75 161.38 61.37 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 123.882 0.873 . . . . 0.0 110.553 167.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -56.19 140.06 86.79 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.992 2.461 . . . . 0.0 113.165 171.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 34.9 t -67.65 -10.05 48.76 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.128 1.371 . . . . 0.0 113.158 170.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -61.29 100.19 0.12 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 128.01 2.524 . . . . 0.0 110.866 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 33.8 m -50.03 -13.11 0.09 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.461 1.904 . . . . 0.0 115.903 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -52.79 -37.02 59.17 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.844 1.258 . . . . 0.0 111.776 167.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -55.83 -21.78 21.48 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.396 1.479 . . . . 0.0 113.343 171.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.13 20.03 14.6 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 127.611 2.364 . . . . 0.0 111.824 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -72.81 142.2 48.03 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.319 -1.488 . . . . 0.0 111.324 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.68 -170.11 11.99 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.665 1.602 . . . . 0.0 113.123 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -64.6 -10.13 23.29 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.29 2.66 . . . . 0.0 116.26 -170.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -110.07 -2.03 17.22 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.852 1.661 . . . . 0.0 114.415 175.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.0 m -78.53 137.83 38.1 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.704 1.138 . . . . 0.0 112.298 -175.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -82.58 132.22 35.2 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 122.636 1.208 . . . . 0.0 110.59 172.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.7 mmt85 -70.0 -39.9 75.61 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.185 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -56.87 -35.68 69.2 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.682 1.193 . . . . 0.0 113.599 169.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.48 -50.24 53.79 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.648 0.779 . . . . 0.0 110.907 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.32 -34.95 78.81 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.34 -53.01 27.03 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.832 1.253 . . . . 0.0 112.012 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -50.16 -40.8 47.69 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.39 0.996 . . . . 0.0 112.731 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 29.7 mt -63.82 -49.75 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 O-C-N 121.708 -0.62 . . . . 0.0 111.08 174.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.81 -39.94 59.6 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.565 0.621 . . . . 0.0 111.958 173.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -63.51 -39.82 95.43 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.243 0.617 . . . . 0.0 111.635 175.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.16 -28.75 66.7 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mt -84.07 -40.09 18.75 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 pp -66.02 -28.72 69.08 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 118.46 0.573 . . . . 0.0 112.212 169.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.75 18.91 8.55 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 119.031 -0.872 . . . . 0.0 113.965 169.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.27 -50.01 65.73 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 118.372 1.086 . . . . 0.0 110.303 169.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -162.69 129.97 3.68 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.924 1.689 . . . . 0.0 111.648 168.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -68.81 116.55 9.43 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.193 1.397 . . . . 0.0 108.633 172.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -151.73 142.93 23.29 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.851 1.26 . . . . 0.0 111.706 -169.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -83.72 130.69 34.96 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.449 1.5 . . . . 0.0 110.554 169.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.6 153.1 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.508 1.523 . . . . 0.0 109.077 -177.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -79.87 158.83 26.62 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.429 0.691 . . . . 0.0 109.477 170.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -166.71 150.16 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.437 1.095 . . . . 0.0 110.08 175.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -91.4 145.35 24.7 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.276 172.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -114.61 162.3 16.94 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.76 1.224 . . . . 0.0 111.276 172.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -132.13 140.06 48.65 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.831 0.852 . . . . 0.0 111.495 168.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.2 mtp-105 -88.68 166.66 13.94 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 125.296 1.439 . . . . 0.0 113.393 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -57.81 -33.25 68.39 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.04 2.136 . . . . 0.0 112.88 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -76.99 -9.86 58.98 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.814 1.246 . . . . 0.0 114.235 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.6 -1.3 59.99 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.573 1.559 . . . . 0.0 115.842 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.5 m -72.88 139.66 47.03 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.735 1.767 . . . . 0.0 111.139 176.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 29.3 p -136.01 140.05 43.59 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -178.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -150.89 142.02 23.13 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.378 1.071 . . . . 0.0 113.359 -172.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -102.61 135.21 44.67 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.419 1.888 . . . . 0.0 109.763 169.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.9 m -139.83 170.27 16.18 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.319 1.448 . . . . 0.0 110.246 167.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 28.7 tp -77.37 59.92 1.93 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.939 0.896 . . . . 0.0 109.603 172.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.1 t -57.1 147.65 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.959 1.303 . . . . 0.0 110.55 -172.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -99.84 69.68 1.58 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 122.951 1.358 . . . . 0.0 111.177 -169.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.3 t -83.3 69.86 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.571 1.149 . . . . 0.0 110.594 -169.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -121.9 129.03 25.32 Favored Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 123.57 0.748 . . . . 0.0 112.915 -174.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -88.15 -179.49 2.44 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.713 2.942 . . . . 0.0 112.669 -175.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.46 138.43 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 122.925 1.345 . . . . 0.0 114.018 -172.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -118.84 163.08 17.43 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 127.041 2.136 . . . . 0.0 112.38 -169.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -94.31 -179.98 5.1 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.204 1.002 . . . . 0.0 111.937 171.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.77 -21.35 64.49 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -71.41 -19.87 62.2 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.604 1.162 . . . . 0.0 113.893 170.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.12 5.61 60.67 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.6 1.571 . . . . 0.0 114.431 -176.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.89 139.58 30.38 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 118.362 1.081 . . . . 0.0 113.025 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.1 p -73.55 100.05 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.921 1.688 . . . . 0.0 110.641 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.12 -30.0 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.255 177.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 10.3 mmt -135.37 147.36 49.03 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 123.567 1.651 . . . . 0.0 111.347 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -103.95 79.97 1.7 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 126.477 1.911 . . . . 0.0 107.24 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.7 mt -99.96 73.14 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 122.398 1.094 . . . . 0.0 108.999 175.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.281 17.5 mt -77.89 86.62 4.11 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 122.752 1.263 . . . . 0.0 108.934 -178.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -59.84 103.18 0.19 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.094 1.757 . . . . 0.0 109.96 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -84.97 61.31 6.78 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 120.916 -1.115 . . . . 0.0 111.197 -177.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -79.75 128.27 33.21 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 121.949 0.881 . . . . 0.0 110.687 175.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.4 t -88.2 114.06 26.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 124.72 1.208 . . . . 0.0 108.128 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 121.084 0.468 . . . . 0.0 111.956 -175.723 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo . . . . . 0 CA--C 1.538 0.687 0 CA-C-O 122.278 0.866 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -64.74 -28.73 69.79 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -166.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -68.1 -49.82 58.77 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.287 0.635 . . . . 0.0 110.361 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 t -75.82 -35.43 60.02 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.932 0.893 . . . . 0.0 112.345 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -58.04 -41.82 84.08 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.509 0.724 . . . . 0.0 110.024 173.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.7 tp -73.12 -44.47 60.22 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 118.959 -0.543 . . . . 0.0 112.27 173.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -48.61 -39.91 25.61 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.798 1.181 . . . . 0.0 112.424 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.0 m -60.12 -42.89 95.73 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 121.52 -0.737 . . . . 0.0 112.434 173.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.7 mm -69.09 -30.59 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.228 1.011 . . . . 0.0 110.334 176.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.3 mm -60.02 -51.62 70.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 172.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.5 mmp_? -59.9 -30.08 68.78 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.728 1.149 . . . . 0.0 111.812 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -64.48 -45.55 86.89 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.789 0.836 . . . . 0.0 112.519 176.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -100.97 3.14 41.36 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 178.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 . . . . . 0 N--CA 1.476 0.856 0 C-N-CA 125.149 1.38 . . . . 0.0 113.313 -167.812 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 118.822 -0.608 . . . . 0.0 112.127 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -169.75 163.32 9.87 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 116.76 2.133 . . . . 0.0 116.76 -170.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -126.66 170.15 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 128.231 2.612 . . . . 0.0 110.682 174.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.6 mm -124.18 117.71 51.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 126.033 1.733 . . . . 0.0 107.727 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.81 153.94 40.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.661 1.219 . . . . 0.0 111.931 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -83.74 110.46 18.33 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.77 1.228 . . . . 0.0 110.292 176.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.84 -12.53 60.4 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -100.17 -5.21 28.11 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.81 1.244 . . . . 0.0 113.812 -169.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 p -109.24 140.0 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.715 1.606 . . . . 0.0 111.339 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.99 -23.95 67.69 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -175.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -85.29 -5.92 59.29 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.153 1.381 . . . . 0.0 113.723 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.0 p 44.27 32.86 0.74 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 128.005 2.522 . . . . 0.0 116.123 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.82 156.3 34.59 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 116.767 2.136 . . . . 0.0 116.767 -167.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.9 t -79.94 91.27 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.15 0 C-N-CA 129.354 3.061 . . . . 0.0 109.148 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.5 pt -69.93 -23.74 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 126.096 1.758 . . . . 0.0 112.991 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -155.9 159.94 39.73 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.768 1.227 . . . . 0.0 112.917 177.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.0 m -139.84 140.78 36.63 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.813 -1.179 . . . . 0.0 111.32 -169.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -93.31 153.46 18.55 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 169.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -65.18 -23.96 67.24 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 122.031 -0.418 . . . . 0.0 111.583 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.93 -50.0 46.27 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 119.191 -0.783 . . . . 0.0 112.515 169.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -39.55 83.35 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 119.454 1.627 . . . . 0.0 110.897 175.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 16.1 t -60.19 -40.8 91.27 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 121.665 -0.647 . . . . 0.0 110.758 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -78.67 -28.7 45.34 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.066 0.946 . . . . 0.0 112.473 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 52.8 tp -62.13 -55.78 25.44 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.786 1.234 . . . . 0.0 111.412 175.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 77.7 m -97.43 -20.2 17.94 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 -172.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.27 12.9 83.86 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-O 118.692 -1.06 . . . . 0.0 115.459 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -88.92 -124.3 0.05 Allowed 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 119.172 1.486 . . . . 0.0 111.095 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.9 t -159.97 150.16 18.52 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.312 1.845 . . . . 0.0 109.683 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -52.19 -37.52 55.07 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.429 -0.795 . . . . 0.0 112.432 171.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.0 -20.19 63.63 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -86.17 -20.84 28.0 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.599 1.56 . . . . 0.0 112.55 176.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.5 m -105.42 -17.37 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 125.229 1.412 . . . . 0.0 114.377 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 3.3 mmt -49.87 113.14 0.78 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.809 1.644 . . . . 0.0 111.223 -175.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 67.07 29.76 7.77 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.766 1.627 . . . . 0.0 112.378 169.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -106.74 154.0 40.38 Favored Pre-proline 0 N--CA 1.471 0.593 0 CA-C-O 117.283 -1.342 . . . . 0.0 112.606 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -48.64 135.25 27.5 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.576 2.85 . . . . 0.0 113.934 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 14.3 t -68.17 -9.79 49.43 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.296 1.038 . . . . 0.0 113.236 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.37 87.26 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.573 1.949 . . . . 0.0 110.848 175.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 26.2 p -54.48 -13.04 0.82 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.611 2.365 . . . . 0.0 114.733 -171.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.539 ' HA ' ' CG ' ' A' ' 70' ' ' HIS . 1.6 p30 -51.15 -22.9 2.81 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 167.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -53.49 -23.55 10.61 Favored 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 169.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.287 2.0 pp -123.14 24.0 9.0 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 170.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.539 ' CG ' ' HA ' ' A' ' 67' ' ' ASP . 1.8 m-70 -67.46 146.45 53.98 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.327 -1.483 . . . . 0.0 112.573 169.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.21 -178.95 23.37 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 124.955 1.264 . . . . 0.0 113.844 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.52 -9.99 24.59 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.591 2.861 . . . . 0.0 114.32 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -89.97 -10.15 46.11 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.009 1.324 . . . . 0.0 113.087 174.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.412 HG21 ' H ' ' A' ' 97' ' ' ALA . 3.0 m -84.16 143.63 29.52 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -168.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -84.55 138.36 32.79 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.651 1.215 . . . . 0.0 112.605 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.9 mmt85 -69.99 -39.99 75.58 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.51 -0.743 . . . . 0.0 111.208 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -57.59 -37.42 73.18 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.221 1.408 . . . . 0.0 113.822 170.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.9 -53.31 52.49 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.005 0.907 . . . . 0.0 110.055 173.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.86 -35.1 79.52 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.423 -0.808 . . . . 0.0 113.009 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.14 -54.1 20.42 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.173 1.389 . . . . 0.0 111.623 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -50.22 -40.83 48.65 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.212 0.914 . . . . 0.0 112.777 171.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.3 mt -63.74 -49.22 83.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 O-C-N 121.495 -0.753 . . . . 0.0 111.433 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.74 -39.99 59.43 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.346 0.521 . . . . 0.0 111.677 173.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -63.43 -39.96 95.88 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.347 0.659 . . . . 0.0 111.796 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.51 -30.3 69.08 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 176.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 mt -83.18 -35.52 25.42 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 pp -70.49 -27.87 64.54 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 118.326 0.512 . . . . 0.0 111.914 168.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.94 16.36 10.75 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.095 -0.836 . . . . 0.0 114.244 168.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.89 -49.82 65.12 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 118.265 1.033 . . . . 0.0 111.99 175.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -155.56 141.66 18.33 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.602 1.561 . . . . 0.0 111.649 171.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -79.31 110.15 14.32 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.199 -0.938 . . . . 0.0 109.164 170.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -155.88 145.27 20.87 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.312 1.045 . . . . 0.0 111.203 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -76.77 143.12 40.08 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.143 1.377 . . . . 0.0 111.638 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -136.49 145.32 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.995 0.918 . . . . 0.0 110.105 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -81.15 147.97 29.8 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.113 0.965 . . . . 0.0 109.99 170.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -158.46 156.93 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 110.27 -176.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.412 ' H ' HG21 ' A' ' 74' ' ' THR . . . -110.12 145.34 37.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.107 0.963 . . . . 0.0 112.41 175.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -130.61 156.14 45.37 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.821 1.248 . . . . 0.0 111.472 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -120.43 138.34 53.84 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.703 0.764 . . . . 0.0 111.913 168.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 28.3 mtp-105 -80.51 166.64 20.99 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.394 1.477 . . . . 0.0 112.847 177.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -56.56 -32.38 65.11 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.616 1.967 . . . . 0.0 113.109 175.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -78.25 -9.89 59.42 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 175.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.75 -1.09 58.04 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.693 1.616 . . . . 0.0 115.826 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 73.3 m -70.15 128.56 36.71 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 119.778 1.789 . . . . 0.0 111.036 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 45.5 t -128.65 125.61 38.43 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.717 1.207 . . . . 0.0 112.201 -170.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -150.96 149.68 29.9 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -171.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.01 125.27 46.04 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.596 1.958 . . . . 0.0 107.177 167.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 81.1 m -125.7 168.47 13.71 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.571 1.148 . . . . 0.0 110.31 169.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.25 59.89 2.93 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.652 -1.28 . . . . 0.0 110.244 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.0 t -63.06 147.48 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.811 1.244 . . . . 0.0 111.206 -172.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -103.58 69.74 1.0 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.724 0.774 . . . . 0.0 111.723 -168.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.4 t -83.22 69.75 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 121.339 -0.851 . . . . 0.0 110.965 -168.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.7 m -112.92 136.47 21.68 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 124.728 1.211 . . . . 0.0 110.368 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -86.13 -161.64 0.13 Allowed 'Trans proline' 0 CA--C 1.552 1.421 0 C-N-CA 123.105 2.536 . . . . 0.0 110.08 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.7 m -127.1 131.13 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-O 122.992 1.377 . . . . 0.0 113.062 172.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.1 pmtp? -122.01 160.04 25.75 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.947 2.099 . . . . 0.0 112.253 -176.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -90.07 -179.41 5.67 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.794 0.838 . . . . 0.0 111.499 178.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.88 -21.7 61.36 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -73.64 -19.91 60.72 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.713 1.205 . . . . 0.0 114.134 171.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.89 -4.28 63.07 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.47 1.51 . . . . 0.0 114.142 -176.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -79.84 129.25 34.32 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 118.26 1.03 . . . . 0.0 112.025 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.7 p -67.86 99.74 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 127.008 2.123 . . . . 0.0 110.509 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.97 -29.63 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.795 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.73 149.96 49.37 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 124.002 1.858 . . . . 0.0 111.713 174.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -103.01 80.03 1.82 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.149 -1.387 . . . . 0.0 107.797 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.0 mt -100.0 71.32 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 O-C-N 120.24 -1.537 . . . . 0.0 108.336 171.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -74.33 86.86 1.99 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 123.362 1.553 . . . . 0.0 109.453 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -59.85 103.08 0.18 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 112.847 -1.979 . . . . 0.0 110.326 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -87.15 53.35 2.79 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 120.543 -1.348 . . . . 0.0 111.937 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -79.86 106.96 12.27 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 123.569 1.652 . . . . 0.0 111.868 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 t -59.85 118.91 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.435 1.494 . . . . 0.0 108.89 169.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.471 0.611 0 C-N-CA 122.463 0.305 . . . . 0.0 110.603 170.569 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo . . . . . 0 CA--C 1.536 0.617 0 CA-C-O 122.381 0.909 . . . . 0.0 111.817 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -63.12 -29.05 70.49 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -164.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -70.02 -49.98 46.0 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.096 0.862 . . . . 0.0 110.72 -176.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 t -77.05 -35.51 56.75 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.685 1.194 . . . . 0.0 112.392 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -57.04 -45.68 82.98 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.284 0.634 . . . . 0.0 110.143 170.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.6 tp -69.95 -42.28 73.43 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 118.549 -0.738 . . . . 0.0 111.237 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -50.01 -39.85 42.69 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.125 1.33 . . . . 0.0 113.073 172.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 58.1 m -60.13 -42.24 94.4 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.348 0.659 . . . . 0.0 112.503 171.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.1 mm -68.49 -35.35 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 O-C-N 121.204 -0.935 . . . . 0.0 110.023 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.5 mm -56.5 -51.14 68.71 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 CA-C-O 117.903 -1.046 . . . . 0.0 108.713 170.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -27.71 66.69 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.145 1.339 . . . . 0.0 112.906 175.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -66.78 -43.92 82.73 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.563 1.145 . . . . 0.0 112.449 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -107.91 7.61 28.11 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 . . . . . 0 N--CA 1.48 1.035 0 C-N-CA 125.39 1.476 . . . . 0.0 114.504 -167.526 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 119.199 -0.429 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -169.76 163.11 9.83 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 -172.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -121.29 170.83 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.277 1.431 . . . . 0.0 111.512 170.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.0 mm -123.48 116.99 49.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 126.154 1.782 . . . . 0.0 107.428 172.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.5 149.97 50.36 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -76.42 106.67 8.19 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.511 0.672 . . . . 0.0 111.445 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.6 -13.17 60.97 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -91.64 0.91 57.46 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.855 1.662 . . . . 0.0 114.117 -173.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.77 140.12 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.438 1.495 . . . . 0.0 110.943 -173.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -59.78 -26.6 65.85 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.95 -8.65 59.69 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.674 1.19 . . . . 0.0 113.937 177.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 27.1 p 36.46 51.34 0.85 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.241 2.217 . . . . 0.0 115.631 175.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.03 160.2 14.5 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -168.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.2 t -79.85 89.97 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 129.028 2.931 . . . . 0.0 109.071 -171.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.4 pt -69.95 -24.27 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.241 1.416 . . . . 0.0 112.201 175.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -155.35 159.71 40.15 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.197 0.999 . . . . 0.0 111.836 172.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.4 p -142.22 149.07 39.17 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -177.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -86.44 149.99 24.6 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.623 0.725 . . . . 0.0 111.559 168.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -67.87 -24.93 65.29 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.597 176.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.39 -50.0 49.18 Favored Glycine 0 CA--C 1.534 1.239 0 O-C-N 120.903 -1.123 . . . . 0.0 112.941 170.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -29.85 66.79 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 118.965 1.383 . . . . 0.0 111.376 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 23.2 t -60.04 -39.78 87.1 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.186 0.994 . . . . 0.0 110.2 172.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -78.21 -29.99 48.64 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.328 -0.857 . . . . 0.0 112.403 174.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.8 tp -56.44 -53.9 51.99 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.371 1.068 . . . . 0.0 110.602 174.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.8 p -80.01 -27.91 39.5 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.2 12.78 75.59 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 125.531 1.539 . . . . 0.0 115.986 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -89.04 -121.47 0.05 Allowed 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 119.552 1.676 . . . . 0.0 112.899 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.4 t -159.9 144.36 14.78 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.346 1.858 . . . . 0.0 109.981 -176.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.2 ptm85 -64.69 -30.02 71.03 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 120.891 -1.131 . . . . 0.0 113.593 -173.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.47 -16.76 39.7 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.211 1.005 . . . . 0.0 113.361 172.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -89.94 -20.57 23.19 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.532 1.933 . . . . 0.0 112.225 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 m -96.23 -19.98 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-N 119.243 0.928 . . . . 0.0 113.331 -173.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 35.3 mmt -50.01 115.71 1.52 Allowed 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.522 1.129 . . . . 0.0 111.014 -170.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 67.66 29.49 6.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.696 1.598 . . . . 0.0 112.862 169.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -100.81 151.63 37.65 Favored Pre-proline 0 N--CA 1.477 0.882 0 CA-C-O 117.756 -1.116 . . . . 0.0 113.716 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -54.54 135.28 65.82 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.262 2.641 . . . . 0.0 113.171 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 49.6 t -68.73 -12.54 61.56 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 126.349 1.86 . . . . 0.0 112.894 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -63.61 100.11 0.26 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 126.708 2.003 . . . . 0.0 111.046 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 30.2 p -49.89 -19.42 0.68 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.397 1.879 . . . . 0.0 115.614 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -48.13 -43.94 31.62 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.755 1.222 . . . . 0.0 111.939 169.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -67.06 -11.48 57.22 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 pp -123.1 20.04 9.9 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.95 1.7 . . . . 0.0 113.523 172.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -60.8 144.38 52.67 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.312 -0.868 . . . . 0.0 113.241 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.97 172.05 19.51 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 125.216 1.389 . . . . 0.0 113.074 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -65.92 -10.17 25.91 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.448 2.099 . . . . 0.0 116.062 -172.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 77.5 mtm-85 -110.1 0.05 18.18 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.765 1.626 . . . . 0.0 114.91 171.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.9 m -67.58 136.68 54.85 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.976 1.262 . . . . 0.0 111.305 175.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -82.64 132.81 35.18 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.581 1.181 . . . . 0.0 110.636 175.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -67.65 -39.79 84.59 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.585 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -41.37 63.5 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.432 1.093 . . . . 0.0 113.397 169.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.78 -49.98 59.52 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 124.44 1.096 . . . . 0.0 110.211 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.25 -33.41 75.75 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.301 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.04 -51.14 34.53 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.302 1.441 . . . . 0.0 112.495 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -49.94 -43.42 49.89 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.779 1.232 . . . . 0.0 111.223 170.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.4 mt -64.06 -49.16 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 121.895 -0.503 . . . . 0.0 111.256 174.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.01 -39.87 56.82 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.575 -0.726 . . . . 0.0 112.175 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -69.06 -38.07 78.86 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.582 0.753 . . . . 0.0 111.379 176.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.6 -33.02 74.73 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.446 -0.784 . . . . 0.0 111.496 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mt -82.62 -29.66 29.98 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.417 0.687 . . . . 0.0 111.9 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.26 -28.75 69.56 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.338 2.255 . . . . 0.0 111.001 169.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.98 18.22 8.99 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.043 1.306 . . . . 0.0 114.799 169.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.55 -49.99 74.45 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.63 1.215 . . . . 0.0 111.024 177.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -163.0 144.35 9.82 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.364 1.865 . . . . 0.0 110.98 169.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -72.07 117.59 13.88 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 167.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.5 tpp180 -149.31 137.23 20.49 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.446 1.098 . . . . 0.0 111.161 -176.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -76.79 127.42 32.72 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.216 1.006 . . . . 0.0 109.958 169.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -129.05 154.46 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.423 1.489 . . . . 0.0 108.863 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -79.9 160.12 26.13 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.221 1.008 . . . . 0.0 110.302 169.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -166.59 152.85 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.133 0.973 . . . . 0.0 111.115 169.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -85.88 145.32 27.23 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.122 174.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -115.39 163.03 16.31 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.345 1.458 . . . . 0.0 111.506 169.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -135.38 140.09 44.72 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.089 0.471 . . . . 0.0 111.799 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 19.4 mmm-85 -74.19 140.12 44.9 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 168.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -13.8 2.82 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -171.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -72.61 -9.99 59.26 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.198 1.399 . . . . 0.0 113.829 170.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.64 4.43 26.55 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 126.332 1.92 . . . . 0.0 115.467 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 52.6 m -86.5 100.23 12.23 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 118.838 1.319 . . . . 0.0 111.631 -173.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 25.2 t -106.33 137.84 43.59 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.107 1.363 . . . . 0.0 113.924 -172.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -150.99 146.05 25.97 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.439 1.496 . . . . 0.0 113.184 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -100.04 125.45 46.1 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.927 1.691 . . . . 0.0 109.233 170.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 78.2 m -129.6 173.6 10.45 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.048 1.339 . . . . 0.0 110.51 171.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 70.9 mt -79.88 59.84 3.29 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.006 -1.059 . . . . 0.0 111.403 -175.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 47.1 t -62.42 141.83 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.584 1.554 . . . . 0.0 111.426 -172.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -105.26 69.95 0.87 Allowed 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 122.486 1.136 . . . . 0.0 112.554 -168.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.8 t -81.18 70.77 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.071 1.348 . . . . 0.0 111.43 -168.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.8 p -120.5 129.28 25.4 Favored Pre-proline 0 N--CA 1.484 1.249 0 CA-C-O 118.408 -0.806 . . . . 0.0 111.945 -176.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -88.18 -166.61 0.27 Allowed 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.972 3.114 . . . . 0.0 112.435 -173.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -126.29 131.37 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 122.991 1.377 . . . . 0.0 113.415 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -119.01 159.95 22.92 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.081 2.153 . . . . 0.0 111.507 -172.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -89.89 -179.96 5.84 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.02 0.928 . . . . 0.0 111.935 174.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.18 -21.72 64.06 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -72.23 -19.89 61.64 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.698 1.199 . . . . 0.0 113.916 170.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.46 0.9 60.84 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.588 1.566 . . . . 0.0 114.238 -176.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -87.93 139.16 30.8 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.538 1.169 . . . . 0.0 112.937 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.7 p -77.99 98.34 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 125.142 1.377 . . . . 0.0 110.872 -174.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.63 -29.97 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.002 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.8 mmt -136.2 148.04 47.92 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 123.502 1.62 . . . . 0.0 111.122 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.7 m-30 -105.15 87.59 2.67 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 125.767 1.627 . . . . 0.0 106.733 -178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 43.4 mt -103.83 73.76 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 122.574 1.178 . . . . 0.0 108.471 174.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.312 34.9 mt -80.62 84.06 6.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 123.208 1.48 . . . . 0.0 110.064 -176.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -59.87 104.74 0.32 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.018 2.127 . . . . 0.0 110.825 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -87.41 58.17 4.82 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 120.614 -1.304 . . . . 0.0 112.378 -175.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -79.79 106.89 12.14 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 124.772 2.225 . . . . 0.0 112.46 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 42.8 t -65.63 110.75 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 127.344 2.258 . . . . 0.0 109.218 174.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 179.477 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo . . . . . 0 CA--C 1.535 0.564 0 CA-C-O 122.446 0.936 . . . . 0.0 112.169 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -66.22 -26.52 67.41 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -169.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -69.99 -49.92 46.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.359 0.664 . . . . 0.0 110.39 -176.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.2 t -76.21 -34.53 59.27 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.04 0.936 . . . . 0.0 112.399 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -58.86 -41.77 87.81 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.693 -0.629 . . . . 0.0 110.29 172.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.5 tp -70.71 -45.52 64.8 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-O 118.76 -0.638 . . . . 0.0 112.072 173.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -47.47 -39.81 16.75 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.261 1.424 . . . . 0.0 113.213 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 85.5 m -60.09 -44.6 94.67 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.639 -0.663 . . . . 0.0 112.235 172.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.6 mm -67.31 -35.86 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.952 0.901 . . . . 0.0 110.661 175.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.9 mm -55.79 -54.38 26.98 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 CA-C-O 118.356 -0.83 . . . . 0.0 108.845 172.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 55.4 mtm180 -60.01 -28.44 67.73 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.115 0.871 . . . . 0.0 112.979 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.1 tttt -64.23 -41.16 97.13 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 172.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -105.77 2.99 28.35 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 N--CA 1.478 0.931 0 C-N-CA 126.6 1.96 . . . . 0.0 115.239 -167.14 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 118.988 -0.529 . . . . 0.0 112.15 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -169.79 161.31 9.08 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -171.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -120.08 172.15 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.548 1.539 . . . . 0.0 111.248 173.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.5 mm -130.01 117.79 42.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 125.621 1.568 . . . . 0.0 107.92 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.12 148.99 52.03 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -81.79 106.61 13.86 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.688 0.756 . . . . 0.0 110.539 174.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.23 -9.31 58.48 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -95.19 -5.79 43.14 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.639 1.176 . . . . 0.0 114.112 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.79 140.21 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.942 1.297 . . . . 0.0 109.952 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -56.1 -31.07 62.93 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -175.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -83.83 -9.1 59.01 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 73.7 m 45.33 51.18 9.59 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.045 1.738 . . . . 0.0 113.112 -177.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.23 153.08 22.27 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -167.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 67.5 t -80.07 90.04 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 127.957 2.503 . . . . 0.0 108.947 -178.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.7 pt -69.94 -24.21 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.648 1.179 . . . . 0.0 112.141 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -155.38 159.71 40.12 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.475 1.11 . . . . 0.0 112.237 175.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.436 ' HG ' ' CG2' ' A' ' 59' ' ' VAL . 27.4 p -139.88 150.94 45.23 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.925 -1.109 . . . . 0.0 112.76 175.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -83.66 156.13 22.81 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 175.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -61.15 -27.77 68.64 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.887 -0.508 . . . . 0.0 111.768 172.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.85 -51.62 44.06 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-O 118.99 -0.894 . . . . 0.0 112.727 169.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.42 -40.11 67.97 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.592 1.696 . . . . 0.0 110.404 174.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.1 t -60.27 -40.91 92.06 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.032 0.533 . . . . 0.0 111.725 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -75.7 -28.93 58.81 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.763 0.825 . . . . 0.0 112.453 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 50.7 tp -66.57 -55.71 14.18 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.206 1.402 . . . . 0.0 111.483 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 33.6 m -93.76 -20.9 19.68 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.092 0.957 . . . . 0.0 112.726 -173.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 72.25 11.57 75.63 Favored Glycine 0 CA--C 1.541 1.706 0 N-CA-C 116.027 1.171 . . . . 0.0 116.027 177.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -90.49 -118.15 0.07 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.239 1.519 . . . . 0.0 111.058 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.3 t -159.91 150.13 18.6 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.945 1.698 . . . . 0.0 110.518 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -55.06 -38.67 68.33 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.947 1.299 . . . . 0.0 112.148 178.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.1 -20.08 63.66 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.352 1.061 . . . . 0.0 113.61 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -82.35 -20.74 36.65 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.212 1.405 . . . . 0.0 112.123 175.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.436 ' CG2' ' HG ' ' A' ' 44' ' ' CYS . 15.6 m -105.36 -18.59 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 177.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 32.2 mmt -49.89 111.77 0.56 Allowed 'General case' 0 C--N 1.344 0.34 0 CA-C-N 119.637 1.108 . . . . 0.0 111.083 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 71.03 18.13 5.99 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.108 1.763 . . . . 0.0 113.652 170.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.49 162.07 70.01 Favored Pre-proline 0 N--CA 1.474 0.727 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.668 167.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -57.67 140.01 92.11 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.961 2.441 . . . . 0.0 112.648 170.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 32.4 t -67.56 -14.3 62.81 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.249 1.019 . . . . 0.0 112.617 171.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.0 m -64.65 100.1 0.36 Allowed 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 126.714 2.005 . . . . 0.0 110.585 176.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 29.6 p -51.58 -18.62 1.19 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.894 1.678 . . . . 0.0 115.402 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -48.71 -41.84 33.11 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.114 1.365 . . . . 0.0 111.375 169.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -56.29 -24.71 44.96 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.716 1.606 . . . . 0.0 113.355 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 pp -123.14 19.98 9.88 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.419 1.887 . . . . 0.0 114.084 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.76 150.46 47.84 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.916 -1.115 . . . . 0.0 113.375 -177.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -130.58 -173.07 13.27 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.799 1.19 . . . . 0.0 115.532 -169.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -68.95 -10.17 28.39 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.383 2.722 . . . . 0.0 115.876 -169.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.4 ttm-85 -109.98 -4.7 15.76 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.086 1.354 . . . . 0.0 113.284 171.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.2 m -75.43 136.64 40.71 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.451 1.023 . . . . 0.0 110.489 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -80.39 132.77 35.81 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 122.738 1.256 . . . . 0.0 109.675 171.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -68.24 -39.75 82.19 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.514 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -53.08 -38.95 62.97 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.488 1.115 . . . . 0.0 113.87 169.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.42 -50.28 53.92 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.357 1.063 . . . . 0.0 110.707 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.48 -33.88 76.91 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.03 -51.47 31.95 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.859 1.264 . . . . 0.0 112.435 177.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -50.07 -41.87 48.87 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.659 1.183 . . . . 0.0 111.916 170.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 34.3 mt -63.65 -49.62 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 O-C-N 121.745 -0.597 . . . . 0.0 111.077 173.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.63 -39.8 51.39 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.208 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -69.43 -36.78 76.99 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.601 0.76 . . . . 0.0 111.685 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.35 -31.09 70.24 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.503 -0.748 . . . . 0.0 111.547 177.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mt -82.59 -31.76 28.79 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.437 0.695 . . . . 0.0 111.342 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.44 -29.75 70.99 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.112 2.165 . . . . 0.0 111.311 169.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.95 20.22 7.71 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.907 1.241 . . . . 0.0 114.929 169.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.23 -50.04 74.69 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 118.857 1.328 . . . . 0.0 110.79 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -163.66 144.98 9.14 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.464 2.306 . . . . 0.0 109.34 168.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -84.9 122.26 28.93 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.984 -1.073 . . . . 0.0 108.728 170.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.8 tpp180 -154.64 150.11 27.32 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.019 1.328 . . . . 0.0 110.537 -169.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -76.73 135.29 39.03 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 171.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -129.42 154.2 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.953 1.301 . . . . 0.0 108.66 172.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -79.83 160.12 26.22 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.084 0.953 . . . . 0.0 109.642 169.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -168.46 150.55 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.362 0.983 . . . . 0.0 110.945 169.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.54 145.36 25.33 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.937 173.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -112.29 159.78 18.3 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.459 1.503 . . . . 0.0 111.771 169.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -132.79 140.01 47.8 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.434 0.694 . . . . 0.0 111.102 169.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -82.47 160.24 22.72 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.938 1.295 . . . . 0.0 113.282 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -54.31 -30.74 52.11 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.613 1.965 . . . . 0.0 113.125 170.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -76.81 -9.95 59.03 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.121 1.368 . . . . 0.0 113.985 175.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.31 4.66 56.24 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 125.755 1.645 . . . . 0.0 115.886 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 58.7 m -87.94 132.26 34.29 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.061 1.431 . . . . 0.0 111.642 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 27.0 p -124.28 140.01 53.36 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.654 1.182 . . . . 0.0 113.529 -174.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -151.0 140.06 21.08 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.306 1.442 . . . . 0.0 113.29 -170.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -110.16 136.12 49.88 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.916 2.086 . . . . 0.0 109.311 171.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.6 m -142.28 178.69 7.39 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.318 1.447 . . . . 0.0 111.653 170.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -78.15 59.85 2.32 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.48 1.112 . . . . 0.0 110.192 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.4 t -60.45 146.76 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.975 1.71 . . . . 0.0 111.572 -171.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -102.25 69.71 1.15 Allowed 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 122.437 1.113 . . . . 0.0 112.981 -167.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.0 t -83.44 69.93 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.761 0.824 . . . . 0.0 110.052 -169.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 49.1 t -118.7 123.73 28.91 Favored Pre-proline 0 N--CA 1.484 1.26 0 CA-C-O 118.074 -0.965 . . . . 0.0 111.945 -169.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -81.37 179.91 5.47 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.534 2.823 . . . . 0.0 114.577 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.4 133.05 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.191 1.396 . . . . 0.0 112.928 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -118.74 166.65 12.51 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.421 1.888 . . . . 0.0 112.509 -169.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -96.79 -179.99 4.77 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.995 0.918 . . . . 0.0 112.029 170.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.0 -21.42 64.85 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -71.01 -19.87 62.46 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.574 1.15 . . . . 0.0 113.785 170.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.71 4.29 60.56 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.699 1.619 . . . . 0.0 114.432 -176.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -91.13 138.84 31.29 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.443 1.122 . . . . 0.0 113.014 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.06 100.18 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 126.123 1.769 . . . . 0.0 110.784 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.93 -29.51 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 118.805 -0.616 . . . . 0.0 111.915 173.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.63 147.87 51.5 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 124.248 1.975 . . . . 0.0 113.465 173.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -100.09 84.85 2.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 113.204 -1.816 . . . . 0.0 107.344 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 39.4 mt -100.02 69.99 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 169.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.5 mt -80.5 87.18 5.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.352 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -59.78 104.13 0.26 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.711 -178.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -83.91 49.94 1.72 Allowed 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.406 -1.434 . . . . 0.0 111.778 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -82.26 106.89 14.51 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 123.799 1.761 . . . . 0.0 112.846 -177.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 41.3 t -58.28 113.02 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 127.119 2.168 . . . . 0.0 109.286 170.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.472 0.647 0 C-N-CA 123.111 0.564 . . . . 0.0 111.359 176.083 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo . . . . . 0 CA--C 1.535 0.537 0 CA-C-O 122.362 0.901 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -65.47 -26.49 67.96 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.774 1.028 . . . . 0.0 113.774 -168.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -69.98 -50.03 45.74 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.508 0.594 . . . . 0.0 110.493 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 t -77.0 -34.58 57.51 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.17 0.988 . . . . 0.0 112.378 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -59.17 -41.65 88.93 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.073 0.549 . . . . 0.0 110.165 172.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.6 tp -70.95 -45.25 64.48 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-O 118.654 -0.689 . . . . 0.0 112.04 173.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -47.83 -39.81 19.46 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 120.154 1.343 . . . . 0.0 113.146 174.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.6 m -60.01 -44.32 94.66 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.64 -0.663 . . . . 0.0 112.282 172.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.2 mm -67.94 -35.38 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.978 0.911 . . . . 0.0 110.837 175.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.2 mm -55.71 -54.53 25.11 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.462 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 172.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 -60.81 -27.51 68.1 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.125 0.875 . . . . 0.0 113.163 176.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -63.81 -42.14 97.75 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.436 0.694 . . . . 0.0 112.386 172.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -106.09 2.33 27.07 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 . . . . . 0 N--CA 1.479 0.976 0 C-N-CA 126.352 1.861 . . . . 0.0 114.639 -167.389 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? . . . . . 0 N--CA 1.476 0.86 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -169.79 162.37 9.51 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -173.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -119.98 172.23 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.337 1.455 . . . . 0.0 111.344 173.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.4 mm -127.08 118.44 50.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 125.764 1.626 . . . . 0.0 107.498 172.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.72 145.36 51.92 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -79.37 106.47 11.42 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.524 0.678 . . . . 0.0 110.684 176.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.52 -7.06 51.82 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -176.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -99.97 -4.68 29.59 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.91 1.284 . . . . 0.0 114.272 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.12 140.26 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.234 1.414 . . . . 0.0 110.243 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -55.06 -26.32 36.81 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -174.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -92.98 -10.32 36.75 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.944 1.298 . . . . 0.0 114.286 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 93.7 m 47.03 55.76 7.62 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.166 1.786 . . . . 0.0 113.259 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.97 157.8 16.61 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 -168.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.6 t -79.95 92.69 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 128.696 2.798 . . . . 0.0 108.728 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.0 pt -72.44 -24.76 22.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.21 1.404 . . . . 0.0 112.228 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -156.84 159.81 38.57 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.272 1.029 . . . . 0.0 112.359 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.4 p -139.94 151.94 45.96 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.094 -1.003 . . . . 0.0 113.368 -175.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -89.2 149.93 22.9 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.711 0.767 . . . . 0.0 111.672 167.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -65.09 -31.15 72.22 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.378 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.22 -50.83 38.6 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 119.451 -0.638 . . . . 0.0 112.812 172.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -29.85 66.9 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 119.258 1.529 . . . . 0.0 111.766 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 13.9 t -60.05 -40.03 88.01 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.542 -0.724 . . . . 0.0 110.962 171.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -80.19 -30.1 38.72 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 121.432 -0.793 . . . . 0.0 112.828 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.4 tp -54.93 -54.35 43.87 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.666 1.586 . . . . 0.0 110.111 172.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.3 m -80.0 -31.12 39.71 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 122.542 0.337 . . . . 0.0 111.624 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.93 17.22 63.67 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 125.438 1.494 . . . . 0.0 115.672 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -98.72 -118.88 0.14 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.073 1.349 . . . . 0.0 112.349 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.1 t -159.84 142.65 13.75 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.863 1.265 . . . . 0.0 111.499 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -59.61 -33.35 71.38 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.637 1.175 . . . . 0.0 113.07 -177.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.76 -16.63 42.24 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.628 1.171 . . . . 0.0 113.211 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -96.67 -20.76 18.04 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.505 1.522 . . . . 0.0 112.561 177.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 m -90.75 -20.04 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 CA-C-N 120.315 1.416 . . . . 0.0 113.378 -175.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 36.1 mmt -51.17 114.47 1.21 Allowed 'General case' 0 C--N 1.339 0.135 0 C-N-CA 124.283 1.033 . . . . 0.0 110.218 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 73.72 20.46 2.99 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.453 1.901 . . . . 0.0 114.769 173.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.98 152.95 95.77 Favored Pre-proline 0 N--CA 1.479 0.982 0 O-C-N 120.6 -1.313 . . . . 0.0 111.304 167.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -62.13 140.02 81.55 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.518 2.146 . . . . 0.0 110.714 170.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 18.9 t -65.19 -11.8 44.52 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.59 0.756 . . . . 0.0 112.879 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.06 87.69 0.11 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.91 1.684 . . . . 0.0 110.152 170.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 22.7 p -50.86 -13.08 0.12 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.229 2.212 . . . . 0.0 114.802 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.476 ' HA ' ' CD2' ' A' ' 70' ' ' HIS . 22.8 t70 -46.45 -31.84 2.93 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.088 1.355 . . . . 0.0 112.505 167.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -55.47 -22.15 19.52 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 174.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 pp -122.96 20.82 9.95 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.528 1.931 . . . . 0.0 114.593 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.476 ' CD2' ' HA ' ' A' ' 67' ' ' ASP . 2.1 m-70 -69.42 151.57 45.95 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 120.753 -1.217 . . . . 0.0 113.652 174.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -124.34 -173.37 13.81 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.715 1.626 . . . . 0.0 114.461 -172.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.71 -10.04 27.93 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.601 2.867 . . . . 0.0 115.24 -171.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.4 tpt85 -94.72 -10.05 32.85 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.68 1.192 . . . . 0.0 113.21 171.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.0 m -83.17 138.41 33.66 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -169.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -93.2 138.04 31.97 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.744 1.259 . . . . 0.0 111.71 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.6 mmm-85 -69.26 -39.79 78.2 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.773 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.3 ptt-85 -52.18 -39.47 60.12 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 169.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.22 -51.4 61.15 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 122.053 0.93 . . . . 0.0 109.971 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.84 -35.77 79.23 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.02 -52.09 26.94 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 126.171 1.789 . . . . 0.0 111.345 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -50.07 -40.76 46.39 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.589 1.086 . . . . 0.0 112.906 169.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 40.6 mt -63.46 -50.24 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 119.183 -0.437 . . . . 0.0 111.343 173.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.74 -39.89 59.27 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.713 0.688 . . . . 0.0 111.904 174.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -63.46 -39.06 93.45 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.517 0.727 . . . . 0.0 111.716 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.01 -29.5 68.52 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 174.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mt -82.44 -38.9 23.33 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 pp -68.99 -29.65 67.89 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 169.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.85 18.27 9.02 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.927 -0.929 . . . . 0.0 114.042 169.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.6 -49.88 69.38 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 118.77 1.285 . . . . 0.0 110.664 173.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -158.49 134.18 8.9 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.584 1.954 . . . . 0.0 109.777 167.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -74.54 120.47 20.14 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.143 -0.973 . . . . 0.0 108.454 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -143.3 136.78 28.31 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.397 1.079 . . . . 0.0 111.685 -168.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -81.37 130.19 34.93 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.469 1.108 . . . . 0.0 109.384 169.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -136.58 145.63 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.611 1.165 . . . . 0.0 109.333 -174.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.95 150.75 30.39 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.876 0.871 . . . . 0.0 109.714 169.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -162.01 146.56 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.614 1.165 . . . . 0.0 110.083 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -91.06 145.46 24.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.051 0.541 . . . . 0.0 112.263 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -122.26 157.75 30.99 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.539 1.136 . . . . 0.0 111.633 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -120.9 140.07 52.33 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.31 0.644 . . . . 0.0 110.415 167.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -95.52 162.28 13.71 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.246 1.418 . . . . 0.0 111.656 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -57.78 -29.09 64.57 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.359 1.864 . . . . 0.0 113.189 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -74.24 -9.95 59.12 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.82 1.248 . . . . 0.0 113.859 175.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.93 6.73 56.92 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.602 1.572 . . . . 0.0 115.561 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 63.4 m -87.51 137.99 31.86 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 118.812 1.306 . . . . 0.0 111.247 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 44.0 t -134.13 128.04 33.3 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.176 0.99 . . . . 0.0 112.598 -177.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -151.05 155.52 39.17 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -174.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -99.91 131.66 45.74 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.668 1.987 . . . . 0.0 109.736 169.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 56.8 m -135.13 168.07 19.82 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.643 1.577 . . . . 0.0 110.256 169.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.07 59.94 3.44 Favored 'General case' 0 CA--C 1.548 0.869 0 O-C-N 121.038 -1.039 . . . . 0.0 111.128 -175.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.8 t -59.85 147.88 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.261 1.424 . . . . 0.0 111.716 -171.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -105.19 69.67 0.86 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 122.475 1.131 . . . . 0.0 111.812 -168.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 19.9 t -82.54 69.96 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.213 1.005 . . . . 0.0 110.695 -169.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.6 p -117.26 130.0 24.94 Favored Pre-proline 0 N--CA 1.485 1.285 0 C-N-CA 124.202 1.001 . . . . 0.0 112.973 -171.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -82.21 -177.57 3.57 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 124.828 3.686 . . . . 0.0 114.488 -173.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.7 m -123.69 124.72 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-O 123.08 1.419 . . . . 0.0 112.802 171.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -109.73 165.61 11.56 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.33 2.252 . . . . 0.0 112.27 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -95.17 179.91 5.03 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 114.781 -1.1 . . . . 0.0 112.244 170.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.65 -21.4 65.67 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -70.19 -19.93 63.15 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.575 1.15 . . . . 0.0 113.677 169.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.36 2.2 59.03 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 126.048 1.785 . . . . 0.0 114.489 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.03 139.59 30.49 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 118.506 1.153 . . . . 0.0 113.324 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.8 p -71.26 100.14 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 125.395 1.478 . . . . 0.0 110.542 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.54 -29.97 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.091 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.037 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 10.1 mmt -136.46 143.63 43.97 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 123.705 1.717 . . . . 0.0 111.081 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -100.15 87.69 3.52 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 125.381 1.472 . . . . 0.0 107.756 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 36.4 mt -102.27 69.92 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 169.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.9 mt -79.94 87.72 5.35 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 122.284 1.04 . . . . 0.0 109.55 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -59.84 109.03 0.84 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.002 1.321 . . . . 0.0 110.643 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -87.43 49.98 1.92 Allowed 'General case' 0 CA--C 1.533 0.315 0 O-C-N 120.571 -1.331 . . . . 0.0 111.75 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -79.85 106.97 12.26 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 123.838 1.78 . . . . 0.0 111.536 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 20.1 t -60.13 119.93 5.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 126.718 2.007 . . . . 0.0 109.179 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 120.761 0.315 . . . . 0.0 111.078 175.054 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 CA--C 1.534 0.513 0 CA-C-O 122.594 0.998 . . . . 0.0 112.107 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -66.57 -26.61 67.2 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.118 0.967 . . . . 0.0 113.208 -170.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -70.05 -49.86 47.0 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.526 0.73 . . . . 0.0 110.419 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 t -75.83 -33.87 60.08 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.954 0.902 . . . . 0.0 112.385 178.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -59.41 -41.17 88.84 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.743 -0.598 . . . . 0.0 110.438 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.6 tp -70.28 -44.84 67.56 Favored 'General case' 0 C--O 1.22 -0.447 0 CA-C-O 118.927 -0.559 . . . . 0.0 111.907 171.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -48.07 -39.7 20.93 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 120.003 1.274 . . . . 0.0 113.556 174.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.2 m -60.03 -42.58 94.68 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 121.704 -0.622 . . . . 0.0 112.289 172.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.5 mm -69.29 -34.15 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 O-C-N 121.113 -0.992 . . . . 0.0 110.857 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.9 mm -55.7 -54.32 27.42 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 169.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.92 -23.96 63.95 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.629 1.104 . . . . 0.0 113.436 175.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -68.62 -43.84 75.52 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.146 0.885 . . . . 0.0 112.495 171.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -102.75 0.26 32.63 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 . . . . . 0 CA--C 1.548 0.897 0 C-N-CA 127.044 2.137 . . . . 0.0 114.141 -168.684 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -169.77 163.38 9.83 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.499 1.519 . . . . 0.0 113.935 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -120.9 170.48 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.849 1.26 . . . . 0.0 112.129 171.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.0 mm -120.66 114.44 43.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 168.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.07 152.82 43.82 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.653 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -85.86 119.39 26.13 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.8 -11.69 59.91 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.538 0.735 . . . . 0.0 112.891 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -100.05 -1.51 36.74 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.186 1.394 . . . . 0.0 114.185 -171.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.8 m -104.27 140.14 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 127.053 2.141 . . . . 0.0 111.58 -177.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -64.59 -27.86 69.24 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.395 1.078 . . . . 0.0 113.11 -174.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -84.47 -6.89 59.42 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.431 1.092 . . . . 0.0 113.28 173.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 46.7 m 49.47 39.89 17.74 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.781 1.632 . . . . 0.0 112.666 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.41 149.93 43.83 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -166.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.4 t -80.01 90.03 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 129.323 3.049 . . . . 0.0 108.511 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.3 pt -69.98 -21.87 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.949 1.3 . . . . 0.0 112.343 178.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -158.99 159.71 35.13 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.051 1.34 . . . . 0.0 111.711 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.415 ' HG ' ' CG2' ' A' ' 59' ' ' VAL . 27.4 p -139.98 148.3 41.7 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 120.77 -1.206 . . . . 0.0 113.876 -176.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -82.56 151.33 26.46 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.489 0.662 . . . . 0.0 110.704 166.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -66.48 -28.67 68.76 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.512 175.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.1 -50.79 54.05 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 121.267 -0.896 . . . . 0.0 112.867 173.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -29.85 66.92 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.202 1.501 . . . . 0.0 110.581 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.6 t -60.04 -39.77 87.09 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.555 0.742 . . . . 0.0 110.266 173.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -78.15 -27.92 48.22 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.016 0.926 . . . . 0.0 112.534 173.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.7 tp -60.65 -49.39 77.7 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.471 1.108 . . . . 0.0 111.462 175.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 26.9 p -79.97 -27.4 39.72 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 169.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.2 24.52 61.2 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 125.168 1.366 . . . . 0.0 114.515 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.3 m-30 -90.21 -129.96 0.09 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.154 1.382 . . . . 0.0 111.887 -177.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.7 t -159.9 150.16 18.65 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.604 2.362 . . . . 0.0 109.013 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 67.6 mtp85 -56.27 -43.05 78.4 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 121.059 -1.026 . . . . 0.0 112.112 -171.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.4 -18.12 63.37 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.741 1.216 . . . . 0.0 113.69 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -86.84 -20.72 27.08 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.116 1.766 . . . . 0.0 112.178 176.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.415 ' CG2' ' HG ' ' A' ' 44' ' ' CYS . 16.4 m -103.57 -20.2 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -177.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 33.8 mmt -50.0 113.64 0.9 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 124.084 0.954 . . . . 0.0 110.709 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 71.47 20.47 4.84 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.03 1.732 . . . . 0.0 113.744 169.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.52 160.12 75.68 Favored Pre-proline 0 N--CA 1.475 0.808 0 CA-C-O 118.145 -0.931 . . . . 0.0 111.557 167.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.09 140.05 91.63 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.732 2.288 . . . . 0.0 113.073 173.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 37.8 t -63.95 -17.7 63.52 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.592 1.157 . . . . 0.0 112.384 170.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.7 m -64.83 89.45 0.07 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.471 1.908 . . . . 0.0 110.795 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 26.8 p -52.95 -13.29 0.42 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.655 1.982 . . . . 0.0 115.127 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -46.35 -37.79 7.97 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.456 1.502 . . . . 0.0 111.416 166.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.83 -23.08 63.07 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.25 3.0 pp -123.13 28.15 7.28 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.205 1.802 . . . . 0.0 113.729 174.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.43 148.71 47.8 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.913 -1.117 . . . . 0.0 113.27 172.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.85 173.77 22.87 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.714 1.626 . . . . 0.0 114.603 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.56 -10.11 27.24 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.308 2.672 . . . . 0.0 114.152 -174.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -110.04 0.02 18.25 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.165 1.386 . . . . 0.0 113.879 170.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.6 m -71.42 139.0 49.53 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.726 1.148 . . . . 0.0 111.384 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -79.96 129.94 34.89 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 123.099 1.428 . . . . 0.0 109.59 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -70.16 -39.7 75.16 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.398 -176.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -56.63 -36.75 69.85 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 170.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.55 -51.7 53.6 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 122.029 0.919 . . . . 0.0 110.324 174.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.0 -33.27 75.66 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.449 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.01 -50.16 44.3 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.321 1.449 . . . . 0.0 112.18 177.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -49.99 -41.06 46.19 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.563 1.074 . . . . 0.0 112.09 169.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 20.9 mt -64.07 -49.68 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 118.518 0.599 . . . . 0.0 111.937 172.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.12 -39.83 44.27 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.453 0.57 . . . . 0.0 112.022 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -68.43 -39.35 81.56 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.376 0.67 . . . . 0.0 111.764 176.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.15 -27.75 65.83 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.836 -0.54 . . . . 0.0 112.157 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mt -88.02 -34.77 17.9 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.302 0.641 . . . . 0.0 110.538 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.58 -37.63 73.49 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.275 1.83 . . . . 0.0 110.142 168.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 117.46 22.43 4.07 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.691 1.139 . . . . 0.0 114.962 170.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.08 -50.0 75.03 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 118.644 1.222 . . . . 0.0 111.036 174.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -162.74 143.85 9.97 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.173 1.789 . . . . 0.0 111.145 169.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.45 118.4 13.21 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 168.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.9 tpp180 -151.75 138.35 18.73 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.61 1.164 . . . . 0.0 111.685 -173.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -80.63 128.72 33.94 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.693 1.197 . . . . 0.0 110.091 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.34 148.94 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.319 1.447 . . . . 0.0 108.813 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -79.94 157.13 26.96 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.061 0.944 . . . . 0.0 110.399 171.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -164.11 149.13 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.994 0.918 . . . . 0.0 110.629 171.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.36 145.39 28.25 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.726 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -117.0 156.2 27.89 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.523 1.129 . . . . 0.0 111.155 175.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -122.75 140.17 53.18 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.173 0.511 . . . . 0.0 110.263 168.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -91.01 146.32 23.95 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.769 1.228 . . . . 0.0 109.687 175.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -49.86 -30.51 10.09 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 126.728 2.011 . . . . 0.0 114.577 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -75.67 -9.82 58.92 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 109.91 28.11 4.32 Favored Glycine 0 CA--C 1.536 1.397 0 N-CA-C 115.905 1.122 . . . . 0.0 115.905 169.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.6 m -119.02 138.54 52.76 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.529 1.132 . . . . 0.0 111.229 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 32.0 p -135.99 140.03 43.61 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -150.93 148.62 28.63 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.837 1.255 . . . . 0.0 113.723 -173.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -99.98 120.94 40.6 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.471 1.509 . . . . 0.0 108.296 167.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 75.3 m -122.74 163.49 20.08 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.465 1.506 . . . . 0.0 109.579 174.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 67.4 mt -79.99 59.85 3.36 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.211 -0.931 . . . . 0.0 111.25 -175.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.5 m -65.2 144.82 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.6 1.96 . . . . 0.0 111.69 -173.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -107.68 69.85 0.76 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 122.42 1.105 . . . . 0.0 112.394 -167.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.8 t -81.37 69.92 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.762 1.225 . . . . 0.0 111.452 -168.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.49 131.99 24.32 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 124.317 1.047 . . . . 0.0 112.364 -175.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -86.18 -170.65 0.71 Allowed 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 123.544 2.83 . . . . 0.0 112.911 -172.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -123.17 129.85 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 122.868 1.318 . . . . 0.0 112.688 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -117.64 159.86 22.23 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.006 2.122 . . . . 0.0 111.277 -174.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -89.88 -179.8 5.81 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.947 0.899 . . . . 0.0 111.923 175.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.17 -21.77 64.09 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -72.45 -19.91 61.49 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.656 1.182 . . . . 0.0 113.884 170.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.54 0.55 60.89 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.622 1.582 . . . . 0.0 114.203 -176.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -87.35 139.39 30.6 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.465 1.132 . . . . 0.0 112.927 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.8 p -77.63 100.0 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 125.449 1.5 . . . . 0.0 111.114 -175.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.25 -30.0 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.71 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.89 150.0 49.19 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 123.997 1.856 . . . . 0.0 113.053 173.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -103.73 84.07 2.22 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 126.166 1.786 . . . . 0.0 107.475 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 44.3 mt -99.97 70.01 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 122.855 1.312 . . . . 0.0 108.697 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.277 22.0 mt -78.74 85.4 4.75 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 122.998 1.38 . . . . 0.0 110.051 -177.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -59.89 105.71 0.42 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.456 1.902 . . . . 0.0 110.143 175.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -86.13 53.97 2.98 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.559 -1.338 . . . . 0.0 110.017 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -79.76 106.66 11.94 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 124.168 1.937 . . . . 0.0 111.241 -168.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.7 t -61.19 112.34 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 113.452 -1.704 . . . . 0.0 108.242 177.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.467 0.381 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 175.789 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo . . . . . 0 CA--C 1.535 0.554 0 CA-C-O 122.164 0.818 . . . . 0.0 111.434 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -63.74 -27.5 69.24 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -168.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -70.01 -50.03 45.51 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.614 0.643 . . . . 0.0 110.473 -175.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.4 t -77.27 -34.4 55.72 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.433 1.093 . . . . 0.0 112.373 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -58.82 -41.98 88.11 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.036 0.534 . . . . 0.0 110.161 172.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.45 -44.18 68.32 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 118.82 -0.609 . . . . 0.0 112.07 172.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -48.92 -39.99 28.36 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.865 1.211 . . . . 0.0 112.316 175.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.0 m -60.18 -43.1 96.11 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.399 -0.813 . . . . 0.0 112.718 172.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.8 mm -67.94 -35.76 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 O-C-N 121.306 -0.871 . . . . 0.0 110.389 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.4 mm -55.72 -54.57 24.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 172.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -24.36 64.25 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.568 1.147 . . . . 0.0 113.383 177.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -69.44 -44.65 70.85 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.616 1.166 . . . . 0.0 113.557 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -105.54 4.15 30.12 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 . . . . . 0 N--CA 1.477 0.893 0 C-N-CA 126.473 1.909 . . . . 0.0 115.169 -167.69 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -169.93 160.18 8.23 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 -172.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 pp -119.92 166.07 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 127.637 2.375 . . . . 0.0 111.052 173.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.8 mm -130.78 118.04 40.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 125.206 1.402 . . . . 0.0 108.206 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.09 156.36 44.66 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -78.88 129.58 34.71 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 169.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.65 -11.87 52.76 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 169.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -94.37 0.4 55.47 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.949 1.7 . . . . 0.0 114.05 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.7 m -109.52 138.89 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 125.692 1.597 . . . . 0.0 111.153 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -63.86 -28.01 69.55 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.822 0.849 . . . . 0.0 112.941 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -81.92 -5.95 58.7 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.49 1.116 . . . . 0.0 113.671 175.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.0 p 45.06 37.41 2.5 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 127.028 2.131 . . . . 0.0 113.709 -175.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.05 150.01 40.86 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -167.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 64.7 t -79.99 90.91 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 129.454 3.102 . . . . 0.0 108.787 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.6 pt -69.99 -23.81 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.116 1.366 . . . . 0.0 112.267 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -156.41 159.72 38.97 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.346 1.058 . . . . 0.0 112.157 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.491 ' HG ' ' CG2' ' A' ' 59' ' ' VAL . 27.5 p -143.64 155.79 44.36 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 120.76 -1.212 . . . . 0.0 112.812 172.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -92.29 156.89 16.96 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -58.41 -29.05 65.79 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.708 0.803 . . . . 0.0 111.578 172.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.09 -49.83 41.66 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.416 1.008 . . . . 0.0 113.34 168.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.97 -38.48 76.11 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 119.343 1.572 . . . . 0.0 110.421 174.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.8 t -60.21 -39.86 88.11 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.881 -0.512 . . . . 0.0 111.051 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -74.71 -28.3 60.74 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 121.247 -0.908 . . . . 0.0 112.833 175.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.5 tp -66.85 -55.81 13.15 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.761 1.224 . . . . 0.0 111.594 177.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 64.2 m -98.77 -19.89 17.2 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.526 1.131 . . . . 0.0 113.054 -172.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.78 10.0 83.2 Favored Glycine 0 CA--C 1.541 1.696 0 N-CA-C 116.143 1.217 . . . . 0.0 116.143 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -89.21 -116.86 0.06 Allowed 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 119.072 1.436 . . . . 0.0 111.451 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.7 t -160.02 150.08 18.36 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.229 1.411 . . . . 0.0 110.948 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.9 mtp-105 -55.36 -40.78 71.7 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.402 1.081 . . . . 0.0 111.623 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.52 -19.15 63.33 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.489 1.116 . . . . 0.0 113.766 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -85.67 -20.65 29.1 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.966 1.307 . . . . 0.0 112.712 174.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.491 ' CG2' ' HG ' ' A' ' 44' ' ' CYS . 15.7 m -100.97 -20.05 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 174.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 30.2 mmt -49.91 113.24 0.8 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.423 1.089 . . . . 0.0 111.089 -177.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 71.49 15.74 6.08 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.839 1.656 . . . . 0.0 113.977 170.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.83 160.16 74.82 Favored Pre-proline 0 N--CA 1.475 0.803 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.414 167.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.03 140.1 85.92 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.801 2.334 . . . . 0.0 111.834 169.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.4 t -69.39 -12.58 61.77 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.807 0.843 . . . . 0.0 113.091 177.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.7 m -64.76 97.86 0.24 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.373 1.869 . . . . 0.0 110.731 177.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 31.8 p -52.67 -15.05 0.61 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.075 1.75 . . . . 0.0 115.134 -177.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -47.36 -38.98 14.06 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.746 1.219 . . . . 0.0 111.854 168.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.07 -19.76 63.27 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 pp -123.0 24.91 8.78 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.428 1.891 . . . . 0.0 113.045 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.53 145.67 53.69 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.308 -0.87 . . . . 0.0 112.419 174.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -110.8 178.97 19.98 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.532 1.539 . . . . 0.0 113.558 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.05 -10.07 27.73 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.493 2.795 . . . . 0.0 114.208 -177.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.25 -10.09 24.54 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.649 1.579 . . . . 0.0 112.582 172.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.46 HG23 ' H ' ' A' ' 97' ' ' ALA . 2.9 m -80.24 138.37 36.8 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.717 -1.239 . . . . 0.0 111.541 -175.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -87.64 135.26 33.44 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.384 1.088 . . . . 0.0 110.709 174.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.4 mmm-85 -66.26 -39.68 89.62 Favored 'General case' 0 C--O 1.219 -0.536 0 O-C-N 121.43 -0.794 . . . . 0.0 111.074 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -53.68 -38.34 64.1 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 171.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.38 -52.35 47.68 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.942 0.877 . . . . 0.0 110.027 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.55 -33.79 76.73 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.554 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.01 -52.19 26.16 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.859 1.664 . . . . 0.0 112.314 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -50.13 -42.02 49.88 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.455 1.025 . . . . 0.0 112.287 170.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 48.9 mt -62.94 -49.34 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 O-C-N 121.876 -0.515 . . . . 0.0 111.052 173.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.27 -39.93 57.8 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.592 -0.718 . . . . 0.0 112.114 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -68.68 -37.67 79.77 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.636 0.774 . . . . 0.0 111.477 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.37 -33.0 74.73 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.436 -0.79 . . . . 0.0 111.311 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 mt -82.06 -29.83 31.68 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.469 0.707 . . . . 0.0 112.119 177.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.3 -28.75 69.54 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.216 2.206 . . . . 0.0 110.766 168.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.95 17.66 9.44 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.196 1.379 . . . . 0.0 114.905 169.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.4 -50.04 67.01 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.648 1.224 . . . . 0.0 111.182 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -150.59 141.36 22.76 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.658 1.583 . . . . 0.0 111.621 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -79.59 104.02 9.9 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 166.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.7 tpt85 -145.11 136.79 25.43 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.242 1.017 . . . . 0.0 111.433 -171.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -82.02 133.04 35.26 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.572 1.549 . . . . 0.0 109.632 169.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.22 146.42 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.406 1.483 . . . . 0.0 108.9 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.01 153.86 28.57 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.644 0.778 . . . . 0.0 110.404 172.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -161.33 158.57 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.728 1.211 . . . . 0.0 110.537 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.46 ' H ' HG23 ' A' ' 74' ' ' THR . . . -100.09 145.44 27.95 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.671 0.789 . . . . 0.0 112.181 174.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -115.91 158.61 22.75 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.561 1.145 . . . . 0.0 111.041 169.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -127.44 137.46 52.71 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.519 0.728 . . . . 0.0 110.241 168.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -81.26 159.7 24.44 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.191 0.997 . . . . 0.0 112.611 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -55.43 -29.05 57.89 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.786 1.635 . . . . 0.0 112.979 171.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -80.02 -9.9 59.73 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.022 1.329 . . . . 0.0 113.774 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.37 0.69 53.74 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 126.106 1.813 . . . . 0.0 115.822 178.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.0 m -78.23 128.0 33.09 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.108 1.454 . . . . 0.0 111.741 -178.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 61.5 m -115.7 137.93 51.6 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.742 1.217 . . . . 0.0 112.317 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -151.03 139.92 20.92 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.25 121.37 41.83 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 127.091 2.156 . . . . 0.0 108.341 169.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 89.0 m -129.37 177.47 7.16 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.429 1.492 . . . . 0.0 110.218 169.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 25.0 tp -78.36 59.92 2.45 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.688 -1.258 . . . . 0.0 110.821 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 49.8 t -55.82 146.06 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.129 1.372 . . . . 0.0 111.194 -172.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -100.03 69.81 1.55 Allowed 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 122.948 1.356 . . . . 0.0 112.047 -167.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.3 t -83.84 69.84 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.37 1.068 . . . . 0.0 110.62 -169.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.77 134.99 23.52 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 124.989 1.316 . . . . 0.0 110.512 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -88.5 -166.41 0.26 Allowed 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 123.517 2.811 . . . . 0.0 113.153 -170.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.65 131.08 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-O 122.927 1.346 . . . . 0.0 113.628 173.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -116.99 160.25 21.23 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.18 2.192 . . . . 0.0 111.744 -173.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -90.02 179.99 5.82 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.065 0.946 . . . . 0.0 112.081 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.99 -21.46 64.87 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -71.2 -19.9 62.34 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.575 1.15 . . . . 0.0 113.819 170.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.08 3.55 60.35 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.599 1.571 . . . . 0.0 114.337 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.06 139.8 30.28 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.585 1.193 . . . . 0.0 113.053 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.2 p -74.34 99.95 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.868 1.667 . . . . 0.0 110.914 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.0 -29.63 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.565 0.746 . . . . 0.0 111.792 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.97 149.14 52.26 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 124.251 1.977 . . . . 0.0 112.626 173.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.2 m-30 -105.01 79.99 1.57 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.27 -1.787 . . . . 0.0 106.886 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 44.3 mt -100.59 70.41 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 169.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.09 89.23 3.6 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.923 0.868 . . . . 0.0 108.822 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -59.86 106.44 0.49 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.663 1.185 . . . . 0.0 110.797 -177.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -84.02 53.21 2.52 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.546 -1.346 . . . . 0.0 112.52 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -79.73 127.2 31.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 122.196 0.998 . . . . 0.0 111.109 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 65.6 t -81.14 117.76 27.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 125.169 1.388 . . . . 0.0 108.327 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.477 0.903 0 CA-C-O 121.416 0.626 . . . . 0.0 112.642 -178.691 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo . . . . . 0 CA--C 1.536 0.612 0 CA-C-O 122.388 0.912 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -65.47 -26.94 68.16 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -167.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -68.76 -49.99 54.15 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.672 0.789 . . . . 0.0 110.299 -178.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 t -74.55 -35.76 63.1 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.716 0.806 . . . . 0.0 112.114 178.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.06 -39.98 83.72 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.498 0.719 . . . . 0.0 110.423 174.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.2 tp -69.99 -45.83 66.46 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.984 0.514 . . . . 0.0 111.869 170.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -47.61 -39.78 17.78 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.974 1.261 . . . . 0.0 113.742 175.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 92.8 m -60.03 -41.69 92.77 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 121.579 -0.701 . . . . 0.0 112.371 172.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.2 mm -68.66 -35.29 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 O-C-N 121.154 -0.966 . . . . 0.0 110.219 174.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.5 mm -56.54 -51.65 62.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 CA-C-O 117.765 -1.112 . . . . 0.0 108.865 170.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -29.02 67.94 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.932 1.242 . . . . 0.0 112.255 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.9 tttp -66.69 -42.79 85.92 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.336 1.054 . . . . 0.0 113.055 174.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -103.65 1.91 32.55 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 . . . . . 0 N--CA 1.476 0.874 0 C-N-CA 126.183 1.793 . . . . 0.0 114.804 -167.875 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.483 1.207 0 CA-C-O 118.794 -0.622 . . . . 0.0 112.241 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -169.79 159.64 8.14 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 -175.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 pp -120.04 172.87 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 126.022 1.729 . . . . 0.0 111.036 174.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.5 mm -131.64 119.72 43.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 125.999 1.72 . . . . 0.0 107.781 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -137.49 152.33 49.41 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -175.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -76.91 107.92 9.58 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.6 174.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.07 -17.42 63.24 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -95.67 2.61 54.14 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.119 1.367 . . . . 0.0 114.034 -169.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.18 140.23 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.797 1.639 . . . . 0.0 110.109 -177.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -57.53 -28.37 63.42 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.18 -14.81 59.31 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.847 1.259 . . . . 0.0 113.982 178.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 82.7 m 43.87 50.67 6.97 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.5 1.52 . . . . 0.0 113.377 -177.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.51 150.02 21.95 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -166.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 98.3 t -79.84 90.0 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 128.011 2.524 . . . . 0.0 109.387 -175.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.5 pt -70.02 -23.75 25.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.837 1.255 . . . . 0.0 112.223 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -155.74 159.83 39.8 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.449 1.099 . . . . 0.0 112.329 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.402 ' HG ' ' CG2' ' A' ' 59' ' ' VAL . 27.4 p -140.01 154.69 47.2 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.809 -1.182 . . . . 0.0 113.227 173.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -85.94 153.48 22.16 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 174.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -63.29 -24.1 67.71 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.673 173.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.73 -49.99 45.07 Favored Glycine 0 CA--C 1.532 1.138 0 O-C-N 121.308 -0.87 . . . . 0.0 112.249 168.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -37.25 78.59 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 119.208 1.504 . . . . 0.0 110.852 175.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.2 t -60.09 -39.97 87.97 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.538 -0.726 . . . . 0.0 110.896 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -73.93 -30.04 62.35 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.541 0.736 . . . . 0.0 112.327 175.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.4 tp -64.72 -55.67 18.5 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.274 1.029 . . . . 0.0 112.18 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 78.1 m -97.68 -20.71 17.45 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -172.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.21 15.15 81.3 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-O 118.735 -1.036 . . . . 0.0 115.633 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -88.85 -124.26 0.05 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 119.129 1.465 . . . . 0.0 111.316 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.3 m -159.92 150.09 18.57 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.903 2.081 . . . . 0.0 109.719 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -57.07 -36.19 70.26 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.21 -20.68 59.84 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.886 1.274 . . . . 0.0 113.613 174.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -83.15 -20.89 33.9 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.743 1.617 . . . . 0.0 112.279 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.402 ' CG2' ' HG ' ' A' ' 44' ' ' CYS . 15.6 m -104.46 -19.29 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 177.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 33.4 mmt -49.99 115.4 1.39 Allowed 'General case' 0 C--N 1.343 0.286 0 CA-C-O 122.172 0.986 . . . . 0.0 110.877 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 72.2 17.67 4.93 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.713 2.005 . . . . 0.0 113.703 169.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.57 154.48 81.38 Favored Pre-proline 0 N--CA 1.473 0.697 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.339 167.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -65.41 140.16 62.42 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.983 3.122 . . . . 0.0 112.043 171.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 96.0 m -62.18 -10.0 9.31 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.4 m -65.24 96.47 0.22 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.198 1.799 . . . . 0.0 110.763 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 61.6 m -50.37 -20.01 0.99 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.629 1.972 . . . . 0.0 115.789 -171.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -46.56 -39.48 11.08 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.059 1.344 . . . . 0.0 112.395 169.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -60.98 -20.17 62.03 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 pp -122.98 23.73 9.21 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.885 1.674 . . . . 0.0 113.229 176.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -64.57 147.18 53.4 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.354 -0.842 . . . . 0.0 112.338 175.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.72 -169.69 11.88 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 125.574 1.559 . . . . 0.0 113.989 -176.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -64.68 -10.13 23.53 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.533 2.822 . . . . 0.0 116.378 -170.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.4 mmm-85 -104.96 -10.1 17.48 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.466 1.506 . . . . 0.0 113.601 174.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.9 m -79.21 133.09 36.69 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.228 0.922 . . . . 0.0 111.608 -169.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -85.2 137.03 33.26 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 122.409 1.1 . . . . 0.0 110.683 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -69.48 -39.69 77.53 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.948 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.9 ptt-85 -53.64 -40.31 65.74 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 169.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.4 -50.66 62.71 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.029 0.931 . . . . 0.0 110.261 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.82 -33.85 76.98 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.457 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.98 -51.89 28.82 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.239 1.416 . . . . 0.0 112.098 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -49.97 -41.91 47.69 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.594 1.158 . . . . 0.0 111.799 170.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.7 mt -64.38 -49.13 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 121.824 -0.547 . . . . 0.0 111.602 173.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.49 -39.94 49.7 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.859 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -70.3 -38.78 75.04 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.758 0.823 . . . . 0.0 111.734 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.42 -32.69 73.74 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.455 -0.778 . . . . 0.0 111.399 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mt -86.94 -27.98 23.01 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.814 0.846 . . . . 0.0 111.521 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.98 -30.19 70.76 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.579 1.952 . . . . 0.0 110.658 168.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.94 22.52 6.56 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.725 1.155 . . . . 0.0 114.319 170.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.33 -49.95 75.36 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.405 1.102 . . . . 0.0 109.81 171.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -166.95 141.36 3.93 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.786 2.435 . . . . 0.0 109.534 167.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -72.67 120.52 18.4 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.897 -1.127 . . . . 0.0 108.485 169.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 26.2 tpp180 -157.56 140.3 14.92 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.542 1.537 . . . . 0.0 110.243 -168.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -81.57 137.36 35.53 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.714 0.806 . . . . 0.0 111.628 175.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.0 t -137.83 150.09 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 126.55 1.94 . . . . 0.0 108.183 177.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -79.97 158.37 26.59 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.073 0.949 . . . . 0.0 110.573 171.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -164.29 152.56 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.526 1.13 . . . . 0.0 110.269 171.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -85.88 145.35 27.21 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.008 176.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -117.31 162.04 18.55 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.822 1.249 . . . . 0.0 111.771 176.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -131.15 140.01 49.88 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.017 0.927 . . . . 0.0 111.5 168.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 24.5 mtp-105 -86.29 166.63 15.5 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.553 1.541 . . . . 0.0 113.088 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -58.15 -30.94 66.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.93 2.092 . . . . 0.0 112.839 174.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -78.06 -9.87 59.35 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.876 1.27 . . . . 0.0 114.047 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.65 -0.8 61.37 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 125.701 1.62 . . . . 0.0 116.003 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.0 t -76.46 140.87 41.43 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.799 1.799 . . . . 0.0 111.39 176.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 23.7 p -137.51 137.25 38.45 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -174.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -151.05 148.4 28.29 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.87 1.268 . . . . 0.0 114.256 -172.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -102.6 125.06 49.2 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.52 1.528 . . . . 0.0 108.337 167.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 67.7 m -128.11 166.27 18.79 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.264 1.426 . . . . 0.0 109.867 172.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 mp -80.05 59.81 3.39 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.071 -1.018 . . . . 0.0 110.238 -176.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 18.2 m -67.66 148.02 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.294 1.838 . . . . 0.0 111.623 -169.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -109.34 69.72 0.71 Allowed 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 122.545 1.164 . . . . 0.0 113.397 -166.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.8 t -80.62 69.8 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 125.093 1.357 . . . . 0.0 110.003 -171.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.7 p -123.79 130.79 24.31 Favored Pre-proline 0 N--CA 1.484 1.259 0 C-N-CA 124.922 1.289 . . . . 0.0 112.535 -169.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -83.05 179.92 4.85 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.237 1.958 . . . . 0.0 113.34 -174.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -123.18 135.62 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 123.089 1.424 . . . . 0.0 112.334 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.09 165.03 22.03 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.779 2.032 . . . . 0.0 112.152 -169.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -89.99 -177.04 5.09 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.139 1.376 . . . . 0.0 111.958 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.8 -19.96 65.41 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -80.04 -19.85 46.67 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.683 1.193 . . . . 0.0 113.087 170.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.35 8.98 59.52 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.345 1.45 . . . . 0.0 114.147 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -84.59 129.25 34.87 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.347 1.574 . . . . 0.0 110.802 175.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.29 99.99 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 125.82 1.648 . . . . 0.0 110.279 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.8 -29.96 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 118.402 -0.809 . . . . 0.0 111.263 176.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.6 mmt -138.0 148.5 45.22 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 123.835 1.779 . . . . 0.0 111.911 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -101.44 87.07 3.1 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 126.613 1.965 . . . . 0.0 108.307 175.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 40.9 mt -100.72 70.82 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 169.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.3 mt -78.65 84.92 4.72 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.801 0.81 . . . . 0.0 109.672 -174.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -59.9 109.74 1.01 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.072 1.349 . . . . 0.0 110.885 -176.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -85.2 49.86 1.83 Allowed 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.215 -1.553 . . . . 0.0 110.857 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -85.54 106.88 17.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 123.468 1.604 . . . . 0.0 113.412 -168.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.0 t -55.16 114.3 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 113.624 -1.625 . . . . 0.0 109.02 171.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.465 0.315 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 171.178 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo . . . . . 0 CA--C 1.536 0.577 0 CA-C-O 121.963 0.735 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -64.36 -26.87 68.66 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -167.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -69.31 -49.86 51.98 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.28 0.632 . . . . 0.0 110.303 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 t -78.69 -32.71 47.16 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.393 1.077 . . . . 0.0 112.883 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -55.26 -44.64 75.77 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.276 1.03 . . . . 0.0 109.594 168.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.7 tp -72.21 -45.22 61.17 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 118.594 -0.717 . . . . 0.0 112.135 175.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -46.73 -39.99 12.62 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.527 1.531 . . . . 0.0 113.349 173.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.4 m -60.0 -45.9 91.22 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.468 173.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.1 mm -68.1 -36.14 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.859 0.864 . . . . 0.0 111.235 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.3 mm -53.28 -57.65 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 172.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -63.43 -24.72 67.96 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.614 0.765 . . . . 0.0 112.946 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.7 tptt -61.63 -45.09 95.56 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 118.347 -0.835 . . . . 0.0 111.974 170.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -103.97 -0.18 29.22 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 116.177 1.918 . . . . 0.0 116.177 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 . . . . . 0 N--CA 1.477 0.895 0 C-N-CA 126.318 1.847 . . . . 0.0 115.736 -168.48 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 ptpp? . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -169.79 167.22 9.42 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.686 1.594 . . . . 0.0 114.212 -177.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 pp -120.04 169.41 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.722 1.209 . . . . 0.0 111.12 167.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.6 mm -125.54 117.94 50.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 126.058 1.743 . . . . 0.0 107.11 171.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.36 147.66 50.64 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -81.01 106.55 13.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.648 0.737 . . . . 0.0 110.644 175.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.88 -6.48 51.01 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 53.1 mmm-85 -100.05 1.85 42.75 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.798 1.639 . . . . 0.0 114.133 -177.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -108.96 140.22 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.381 1.473 . . . . 0.0 109.974 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -55.7 -29.92 60.22 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -175.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -83.89 -12.67 55.15 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 95.9 m 42.99 58.8 3.13 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.497 1.919 . . . . 0.0 113.518 -177.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.0 156.97 16.12 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -168.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.3 t -79.9 89.94 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 128.272 2.629 . . . . 0.0 108.858 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.7 pt -70.48 -25.39 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.857 1.263 . . . . 0.0 112.185 176.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -156.76 159.79 38.64 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.916 0.886 . . . . 0.0 112.701 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.427 ' HG ' ' CG2' ' A' ' 59' ' ' VAL . 7.9 p -145.34 147.58 32.46 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.209 -0.932 . . . . 0.0 113.289 -169.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -86.26 152.4 22.81 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.503 0.668 . . . . 0.0 112.537 169.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -61.98 -36.06 80.33 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.215 0.606 . . . . 0.0 111.252 171.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.0 -49.94 53.31 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 121.292 -0.88 . . . . 0.0 112.911 175.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -29.94 66.93 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 118.939 1.37 . . . . 0.0 110.823 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.9 t -60.18 -40.03 88.59 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.007 -1.058 . . . . 0.0 111.181 172.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -78.74 -30.02 45.55 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.977 0.911 . . . . 0.0 112.385 175.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.3 tp -55.17 -52.72 62.4 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.886 1.274 . . . . 0.0 110.244 171.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 57.5 m -80.03 -29.17 39.27 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.15 0.5 . . . . 0.0 112.316 176.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.29 26.07 58.13 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 125.376 1.465 . . . . 0.0 114.143 -173.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 16.1 m-30 -94.7 -130.11 0.14 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.881 1.272 . . . . 0.0 111.865 -173.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.0 t -159.88 140.38 11.98 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 127.117 2.167 . . . . 0.0 108.741 175.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.8 mtm105 -64.75 -31.33 72.51 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 120.92 -1.113 . . . . 0.0 113.246 -171.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.81 -16.66 29.98 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.023 0.929 . . . . 0.0 113.403 172.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -95.6 -20.82 18.67 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.476 1.91 . . . . 0.0 112.14 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.427 ' CG2' ' HG ' ' A' ' 44' ' ' CYS . 3.1 m -89.89 -18.12 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-N 119.489 1.04 . . . . 0.0 112.694 -174.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 33.6 mmt -49.73 115.42 1.36 Allowed 'General case' 0 C--N 1.341 0.204 0 C-N-CA 125.041 1.336 . . . . 0.0 110.486 -172.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 69.0 21.03 7.58 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.283 1.433 . . . . 0.0 113.62 169.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.72 155.1 93.87 Favored Pre-proline 0 N--CA 1.475 0.794 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.528 167.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.12 140.04 93.23 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.47 2.113 . . . . 0.0 111.649 169.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 37.4 t -64.36 -17.66 63.93 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.62 1.168 . . . . 0.0 112.914 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.6 m -62.61 99.98 0.17 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 127.09 2.156 . . . . 0.0 111.232 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 28.0 p -55.14 -14.17 1.54 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.446 1.498 . . . . 0.0 114.918 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -49.33 -40.06 33.82 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.778 1.231 . . . . 0.0 111.587 168.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -66.73 -11.0 52.77 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 pp -123.04 20.52 9.92 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.14 1.776 . . . . 0.0 113.744 170.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -63.74 144.38 57.08 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.136 -0.978 . . . . 0.0 113.084 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -109.15 175.87 19.36 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.691 1.615 . . . . 0.0 113.754 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.56 -10.05 27.89 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.445 2.763 . . . . 0.0 114.629 -175.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -103.14 -7.63 21.12 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.206 1.402 . . . . 0.0 113.696 170.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.0 m -70.85 134.58 47.44 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.536 1.062 . . . . 0.0 110.355 178.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -81.97 137.39 35.14 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.643 0.735 . . . . 0.0 110.2 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -66.35 -39.85 89.43 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.697 -0.627 . . . . 0.0 110.855 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.5 ptt-85 -55.59 -41.18 73.04 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.802 0.841 . . . . 0.0 113.008 171.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.56 -51.35 63.23 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.766 0.826 . . . . 0.0 110.364 177.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.44 -33.65 76.19 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.247 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.06 -52.77 21.25 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.762 1.225 . . . . 0.0 111.983 177.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -50.0 -42.18 48.64 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.719 1.208 . . . . 0.0 111.859 171.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 54.3 mt -63.8 -51.04 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 121.878 -0.514 . . . . 0.0 110.897 174.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.37 -39.9 58.1 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 118.604 -0.713 . . . . 0.0 112.116 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -69.09 -36.58 77.73 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.64 0.776 . . . . 0.0 111.601 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.49 -30.11 68.87 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.684 -0.635 . . . . 0.0 111.673 177.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mt -83.59 -31.33 26.36 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.565 0.746 . . . . 0.0 111.445 176.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.77 -30.08 71.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.249 2.22 . . . . 0.0 111.484 169.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.05 19.92 7.83 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.797 1.189 . . . . 0.0 114.953 169.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.89 -50.01 73.93 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 118.868 1.334 . . . . 0.0 110.5 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -162.8 141.47 8.63 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.608 2.363 . . . . 0.0 108.934 168.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -78.73 120.47 23.42 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.987 -1.071 . . . . 0.0 108.654 170.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.9 tpp180 -152.19 136.62 16.79 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.311 1.444 . . . . 0.0 109.857 -169.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -79.61 134.44 36.45 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.302 0.641 . . . . 0.0 110.578 173.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.29 148.2 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.645 1.578 . . . . 0.0 109.126 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -79.87 155.73 27.67 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.108 0.963 . . . . 0.0 110.381 172.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -163.39 149.75 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.357 1.063 . . . . 0.0 110.858 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -87.14 145.37 26.46 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.844 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -112.3 145.69 39.55 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.032 1.333 . . . . 0.0 111.675 169.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.66 132.27 53.81 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.535 0.734 . . . . 0.0 109.394 167.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 28.7 mtp-105 -100.04 153.35 19.28 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.738 1.615 . . . . 0.0 112.881 -168.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -58.9 -29.44 67.05 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.688 1.195 . . . . 0.0 112.287 171.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -72.27 -10.03 59.25 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.471 1.508 . . . . 0.0 113.878 175.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.49 0.87 55.53 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.49 1.519 . . . . 0.0 115.397 177.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.51 148.72 47.92 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.85 1.325 . . . . 0.0 111.273 174.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 34.3 t -152.0 110.62 3.79 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.245 0.93 . . . . 0.0 111.421 175.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -151.0 151.75 32.52 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -173.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -102.2 126.43 49.17 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.421 1.889 . . . . 0.0 108.989 168.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 73.5 m -130.29 171.47 12.88 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.94 1.296 . . . . 0.0 110.618 170.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 mp -79.96 59.85 3.34 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 120.947 -1.095 . . . . 0.0 110.921 -175.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.0 t -61.28 140.68 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.179 1.391 . . . . 0.0 111.932 -170.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -101.59 69.78 1.24 Allowed 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 123.109 1.433 . . . . 0.0 112.447 -169.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.8 t -78.18 69.97 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.271 1.828 . . . . 0.0 111.481 -173.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.4 p -120.86 131.19 24.54 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.085 -1.009 . . . . 0.0 113.56 -171.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -85.58 -178.9 3.18 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 125.028 3.819 . . . . 0.0 115.578 -169.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.9 m -123.69 131.36 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-O 122.844 1.307 . . . . 0.0 113.048 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -115.4 163.05 16.29 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.876 2.07 . . . . 0.0 111.82 -171.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -95.64 -179.96 4.92 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.269 1.028 . . . . 0.0 112.009 172.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -61.82 -19.99 63.15 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -177.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -71.37 -21.59 62.0 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.529 1.132 . . . . 0.0 113.57 170.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.75 5.25 57.7 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 125.581 1.562 . . . . 0.0 114.695 -174.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -97.51 142.24 29.59 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.852 1.326 . . . . 0.0 113.581 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.7 p -71.12 100.16 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.955 1.702 . . . . 0.0 111.089 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.45 -29.25 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 118.631 -0.7 . . . . 0.0 111.68 174.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.35 147.59 51.83 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 124.277 1.989 . . . . 0.0 113.236 172.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -99.2 86.03 3.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 112.994 -1.912 . . . . 0.0 107.284 173.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 36.3 mt -101.43 70.0 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 122.834 1.302 . . . . 0.0 108.631 170.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.253 17.7 mt -80.27 83.57 6.09 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.118 -177.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -59.8 103.09 0.18 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.429 1.892 . . . . 0.0 110.443 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -83.32 57.41 3.98 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.679 -1.263 . . . . 0.0 112.593 -174.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -79.74 106.93 12.13 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 124.576 2.132 . . . . 0.0 112.265 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.1 t -61.19 110.39 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 C-N-CA 127.24 2.216 . . . . 0.0 109.051 170.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 120.805 0.336 . . . . 0.0 111.699 -179.753 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo . . . . . 0 CA--C 1.534 0.477 0 CA-C-O 122.614 1.006 . . . . 0.0 111.947 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -66.13 -26.65 67.54 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.106 0.962 . . . . 0.0 113.332 -169.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -70.06 -49.9 46.44 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.339 0.656 . . . . 0.0 110.399 -176.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 t -76.13 -33.92 59.42 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.992 0.917 . . . . 0.0 112.32 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -59.96 -40.79 90.23 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.196 0.599 . . . . 0.0 110.328 173.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.3 tp -70.64 -45.68 64.71 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 118.781 -0.628 . . . . 0.0 111.759 171.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.9 -39.78 19.95 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.04 1.291 . . . . 0.0 113.475 175.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 86.6 m -60.12 -42.09 94.04 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.701 -0.624 . . . . 0.0 112.434 172.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.1 mm -68.79 -35.18 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 121.112 -0.993 . . . . 0.0 110.454 174.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.9 mm -56.83 -50.89 73.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 CA-C-O 117.673 -1.156 . . . . 0.0 108.668 170.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.79 -27.76 66.85 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.527 1.512 . . . . 0.0 113.15 174.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -65.82 -42.03 91.11 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.832 0.853 . . . . 0.0 112.361 173.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -107.11 2.43 24.9 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 . . . . . 0 N--CA 1.478 0.948 0 C-N-CA 126.378 1.871 . . . . 0.0 114.311 -168.098 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 110.515 -0.18 . . . . 0.0 110.515 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -169.84 159.1 7.73 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 122.498 1.142 . . . . 0.0 112.899 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -123.91 171.56 12.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.755 173.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.4 mm -127.06 117.25 47.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 125.99 1.716 . . . . 0.0 106.772 174.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.12 148.83 50.6 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -80.74 106.45 12.76 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.388 0.614 . . . . 0.0 110.829 175.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.26 -6.48 53.27 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -96.1 -1.43 48.63 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.579 1.551 . . . . 0.0 113.797 -178.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -110.42 140.18 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.32 1.448 . . . . 0.0 109.951 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -57.4 -23.45 49.38 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -174.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -90.41 -10.53 43.5 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.381 1.472 . . . . 0.0 114.447 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 80.9 m 44.32 54.0 6.45 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.326 1.85 . . . . 0.0 114.663 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.03 158.52 15.77 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -168.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.8 t -79.93 89.97 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 128.624 2.769 . . . . 0.0 109.592 -172.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.4 pt -70.0 -24.46 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.256 1.422 . . . . 0.0 112.393 176.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -153.6 159.6 42.19 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.046 0.938 . . . . 0.0 112.276 174.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 10.0 p -147.27 142.54 27.3 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.038 -1.039 . . . . 0.0 113.268 -173.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -84.78 153.61 22.89 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -61.86 -29.82 70.44 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.757 0.423 . . . . 0.0 111.399 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.36 -49.92 43.01 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 123.945 0.783 . . . . 0.0 112.747 169.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -38.39 81.43 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 119.52 1.66 . . . . 0.0 110.644 175.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.6 t -60.18 -39.9 88.1 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.594 -0.691 . . . . 0.0 110.566 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -74.81 -30.02 61.28 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.339 0.655 . . . . 0.0 112.238 175.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 66.3 tp -63.83 -55.74 20.69 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.245 1.018 . . . . 0.0 111.83 177.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 59.9 m -95.68 -20.01 19.25 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.291 0.636 . . . . 0.0 112.661 -174.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.53 10.05 86.48 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-O 118.339 -1.256 . . . . 0.0 115.549 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -87.97 -121.73 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 119.46 1.63 . . . . 0.0 111.217 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.1 t -159.98 150.22 18.56 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.535 1.934 . . . . 0.0 109.96 -176.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -50.0 -41.13 46.41 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.259 1.024 . . . . 0.0 112.099 172.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.07 -19.94 63.47 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.321 1.048 . . . . 0.0 113.532 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -84.72 -20.71 30.73 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.635 1.574 . . . . 0.0 112.311 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -105.4 -18.84 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 125.66 1.584 . . . . 0.0 115.127 175.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 7.0 mmt -49.81 112.08 0.6 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.402 1.481 . . . . 0.0 111.647 -174.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 67.3 30.82 6.87 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.358 1.863 . . . . 0.0 112.745 171.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -106.75 154.85 39.87 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-O 117.599 -1.191 . . . . 0.0 112.984 177.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.86 137.59 60.75 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.282 2.654 . . . . 0.0 114.124 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 49.4 t -70.11 -9.94 57.14 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 125.427 1.491 . . . . 0.0 113.616 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.0 m -66.33 100.01 0.6 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 127.044 2.138 . . . . 0.0 111.671 -176.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 32.5 m -50.05 -13.2 0.1 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 127.031 2.132 . . . . 0.0 116.478 -176.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -53.7 -35.18 60.85 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.071 0.948 . . . . 0.0 111.607 168.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.9 -10.39 20.61 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 174.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.02 19.95 10.78 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.936 2.494 . . . . 0.0 111.08 178.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.52 138.43 45.03 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.589 -1.32 . . . . 0.0 111.905 177.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.72 -169.31 11.78 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.518 1.532 . . . . 0.0 113.57 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -61.23 -10.01 14.31 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 124.253 3.302 . . . . 0.0 117.049 -174.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -107.75 -10.01 15.68 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.943 1.297 . . . . 0.0 113.522 174.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.2 m -82.12 138.35 34.78 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.098 0.863 . . . . 0.0 112.109 -170.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -91.47 134.06 34.96 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 122.32 1.057 . . . . 0.0 110.75 176.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.5 mmm-85 -66.9 -39.71 87.51 Favored 'General case' 0 C--O 1.222 -0.394 0 O-C-N 121.65 -0.657 . . . . 0.0 110.593 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 46.7 ptt85 -51.39 -38.62 54.33 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 170.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.07 -50.71 38.32 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.523 1.129 . . . . 0.0 110.294 177.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.37 -33.85 76.43 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.465 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.06 -53.14 18.81 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.663 1.585 . . . . 0.0 112.22 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -50.14 -41.04 48.13 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.323 0.965 . . . . 0.0 112.514 170.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.8 mt -63.0 -49.69 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 121.684 -0.635 . . . . 0.0 111.368 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.3 -39.95 57.95 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.47 0.577 . . . . 0.0 111.944 174.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -62.97 -40.55 98.05 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.423 0.689 . . . . 0.0 111.723 175.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.49 -31.94 72.43 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 176.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 mt -84.16 -35.9 23.25 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -175.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 pp -69.63 -28.19 65.71 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.455 0.57 . . . . 0.0 111.693 168.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.88 14.77 13.02 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 119.078 -0.846 . . . . 0.0 113.986 168.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.69 -49.88 75.05 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 118.333 1.066 . . . . 0.0 111.216 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -160.3 129.99 5.18 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.859 1.264 . . . . 0.0 112.797 169.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -79.77 124.81 28.94 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.233 1.813 . . . . 0.0 109.084 173.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.1 ttp-105 -159.88 165.08 32.93 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.465 1.506 . . . . 0.0 110.999 171.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -76.73 137.07 39.11 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.7 0.8 . . . . 0.0 110.173 170.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.62 152.36 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.958 1.303 . . . . 0.0 108.917 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -79.89 160.04 26.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.325 0.65 . . . . 0.0 109.609 169.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -165.85 147.65 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.156 0.889 . . . . 0.0 110.64 168.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -90.39 145.43 24.95 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.009 173.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -118.17 157.2 27.39 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.0 0.92 . . . . 0.0 111.505 173.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -121.14 140.07 52.49 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.467 1.107 . . . . 0.0 110.443 169.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 24.7 mtp-105 -89.81 160.18 16.64 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.573 1.149 . . . . 0.0 111.379 175.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -21.23 65.01 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 172.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -75.24 -10.02 59.08 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.642 1.577 . . . . 0.0 113.61 172.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.81 6.75 67.1 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.384 1.468 . . . . 0.0 115.223 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.8 t -78.94 134.18 36.87 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 118.813 1.306 . . . . 0.0 110.817 175.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 60.8 m -131.61 128.95 40.23 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.635 1.174 . . . . 0.0 111.707 -172.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -151.04 142.72 23.68 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -174.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -109.57 129.94 55.54 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.06 2.144 . . . . 0.0 108.504 168.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 2.2 m -135.84 178.81 6.76 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.368 1.467 . . . . 0.0 111.605 172.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.5 mt -76.69 59.94 1.62 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.416 1.086 . . . . 0.0 111.129 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 36.4 t -61.28 145.16 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.936 1.295 . . . . 0.0 111.406 -173.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -104.16 69.68 0.94 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 122.274 1.035 . . . . 0.0 112.11 -168.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.0 t -83.5 69.91 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.744 0.817 . . . . 0.0 110.476 -169.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 44.8 t -117.12 123.33 30.2 Favored Pre-proline 0 N--CA 1.483 1.213 0 CA-C-O 117.723 -1.132 . . . . 0.0 110.603 -174.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -87.26 -170.36 0.59 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.479 2.786 . . . . 0.0 113.084 -175.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -123.53 126.78 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 123.018 1.39 . . . . 0.0 113.213 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.6 mtmt -112.26 161.12 16.95 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.588 2.355 . . . . 0.0 112.415 -176.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -92.23 179.98 5.41 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.663 -1.153 . . . . 0.0 112.19 172.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.41 -21.69 65.58 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -71.23 -19.89 62.32 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.558 1.143 . . . . 0.0 113.753 170.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.96 4.25 60.23 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.641 1.591 . . . . 0.0 114.322 -176.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -93.19 140.75 29.18 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.462 1.131 . . . . 0.0 113.132 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.14 100.01 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.486 1.514 . . . . 0.0 110.696 -174.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.56 -29.08 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 123.768 0.827 . . . . 0.0 111.795 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.88 148.45 52.29 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 124.111 1.91 . . . . 0.0 112.555 169.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -100.81 85.13 2.83 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.258 -1.792 . . . . 0.0 107.045 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 40.2 mt -99.98 70.04 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 122.86 1.314 . . . . 0.0 108.678 170.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.317 34.7 mt -78.59 88.55 4.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 123.356 1.55 . . . . 0.0 109.843 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -59.88 103.13 0.19 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.501 1.921 . . . . 0.0 110.139 173.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -87.19 50.99 2.12 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 120.683 -1.261 . . . . 0.0 111.85 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -79.97 106.86 12.3 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 124.182 1.944 . . . . 0.0 112.066 -176.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 32.6 t -64.43 114.3 2.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 126.813 2.045 . . . . 0.0 108.694 171.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.475 0.777 0 C-N-CA 122.633 0.373 . . . . 0.0 110.637 176.282 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo . . . . . 0 CA--C 1.536 0.578 0 CA-C-O 122.226 0.844 . . . . 0.0 112.449 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -59.97 -27.25 66.68 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 115.103 1.519 . . . . 0.0 115.103 -165.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -69.99 -49.86 47.34 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.851 0.751 . . . . 0.0 110.407 -176.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 t -76.71 -36.2 57.35 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.1 0.96 . . . . 0.0 112.225 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -57.93 -39.99 79.38 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.951 0.9 . . . . 0.0 110.506 172.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.1 tp -71.49 -44.78 64.09 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.047 0.539 . . . . 0.0 112.266 170.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -47.87 -39.93 20.14 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 120.004 1.275 . . . . 0.0 113.583 176.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.1 m -60.08 -42.6 94.93 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 172.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.1 mm -69.0 -33.96 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.077 0.951 . . . . 0.0 110.436 176.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.5 mm -56.97 -53.7 39.56 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-O 118.202 -0.904 . . . . 0.0 108.714 169.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -25.15 64.9 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.551 1.069 . . . . 0.0 112.924 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.4 tttt -68.8 -45.09 72.17 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.303 1.041 . . . . 0.0 113.443 171.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -100.07 0.28 40.5 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 . . . . . 0 CA--C 1.549 0.94 0 C-N-CA 127.3 2.24 . . . . 0.0 113.53 -169.455 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -169.72 162.49 9.69 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 123.339 1.542 . . . . 0.0 114.455 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 pp -128.35 170.25 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 127.238 2.215 . . . . 0.0 111.15 172.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.5 mm -127.23 120.05 54.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 126.389 1.876 . . . . 0.0 107.293 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.38 149.16 48.4 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 123.829 0.852 . . . . 0.0 112.553 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -81.14 108.82 15.12 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.519 0.676 . . . . 0.0 110.746 172.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.92 -15.73 63.11 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -100.07 3.02 43.79 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.947 1.299 . . . . 0.0 114.116 -169.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.71 140.13 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.36 1.464 . . . . 0.0 110.726 -176.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -60.09 -27.04 66.67 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -176.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -83.46 -10.22 58.51 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.771 1.229 . . . . 0.0 114.204 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 24.9 m 45.56 47.82 11.18 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.28 1.832 . . . . 0.0 113.449 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.97 152.25 26.81 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -167.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.7 t -79.98 90.0 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 127.914 2.486 . . . . 0.0 108.758 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.8 pt -70.03 -24.78 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.731 1.212 . . . . 0.0 112.462 178.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -153.7 159.62 42.07 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.015 0.926 . . . . 0.0 112.484 174.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.2 p -147.85 145.73 28.82 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.111 -0.993 . . . . 0.0 113.077 -175.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -93.03 159.46 15.3 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -64.01 -23.62 67.4 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.531 -0.731 . . . . 0.0 112.384 175.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.74 -50.03 62.91 Favored Glycine 0 CA--C 1.537 1.413 0 CA-C-O 119.015 -0.881 . . . . 0.0 112.669 169.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -38.33 68.74 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.529 1.665 . . . . 0.0 109.787 172.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.7 t -60.25 -39.98 88.65 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.808 -0.558 . . . . 0.0 111.128 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -74.99 -30.03 61.05 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 175.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.8 tp -64.85 -54.57 28.93 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.683 1.593 . . . . 0.0 112.193 178.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 84.0 m -92.8 -22.58 19.24 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.126 0.971 . . . . 0.0 112.431 -178.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.5 10.04 85.84 Favored Glycine 0 CA--C 1.539 1.573 0 N-CA-C 115.758 1.063 . . . . 0.0 115.758 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -93.94 -116.71 0.1 Allowed 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 118.735 1.267 . . . . 0.0 111.68 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.3 t -159.9 150.12 18.62 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.532 1.533 . . . . 0.0 110.719 -177.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.7 mtm180 -57.63 -36.36 71.72 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.662 1.185 . . . . 0.0 112.426 177.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.32 -20.77 63.32 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.182 0.993 . . . . 0.0 113.503 174.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -84.4 -20.77 31.33 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.118 1.367 . . . . 0.0 112.268 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.5 m -105.39 -11.83 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 10.4 mmt -49.86 107.37 0.15 Allowed 'General case' 0 C--N 1.34 0.191 0 C-N-CA 125.078 1.351 . . . . 0.0 110.427 176.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 68.13 22.43 8.31 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.729 1.612 . . . . 0.0 113.224 172.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.58 161.75 57.98 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 124.887 1.275 . . . . 0.0 110.682 168.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -60.45 137.42 74.04 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.7 2.267 . . . . 0.0 113.032 175.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 23.5 t -70.04 -19.83 63.28 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.509 1.124 . . . . 0.0 112.756 170.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -60.36 100.13 0.09 Allowed 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 127.927 2.491 . . . . 0.0 111.222 178.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 54.7 m -49.98 -13.25 0.1 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.829 2.052 . . . . 0.0 116.35 -176.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -55.11 -39.45 69.39 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.979 1.311 . . . . 0.0 111.26 167.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -58.38 -20.12 41.38 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.57 1.548 . . . . 0.0 113.094 172.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.14 20.0 18.85 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 127.498 2.319 . . . . 0.0 112.169 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -56.37 136.98 53.42 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.657 -1.277 . . . . 0.0 113.482 174.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -130.58 177.2 18.49 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 126.343 1.925 . . . . 0.0 111.687 168.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -64.21 -10.13 22.36 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.524 2.816 . . . . 0.0 115.603 -176.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -104.11 -9.95 18.35 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.739 1.615 . . . . 0.0 113.369 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.4 m -76.63 139.42 40.59 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.297 0.953 . . . . 0.0 111.996 -173.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -84.23 129.91 34.86 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 123.126 1.441 . . . . 0.0 109.847 175.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -70.19 -39.91 74.94 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.14 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -59.53 -35.69 74.68 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.27 1.428 . . . . 0.0 113.919 170.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.27 -50.78 64.45 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.427 0.691 . . . . 0.0 110.604 173.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.03 -33.37 75.89 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.22 -52.3 42.74 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.513 1.125 . . . . 0.0 112.192 176.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -50.16 -42.12 50.38 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.053 0.941 . . . . 0.0 112.66 170.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 35.8 mt -63.61 -48.69 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 O-C-N 121.588 -0.695 . . . . 0.0 111.021 174.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.03 -39.82 56.77 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.526 0.603 . . . . 0.0 111.831 173.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -67.84 -38.24 82.92 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.586 0.63 . . . . 0.0 111.952 175.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.99 -26.85 64.28 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.267 0.627 . . . . 0.0 112.565 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 mt -87.74 -33.63 18.63 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.304 0.642 . . . . 0.0 110.95 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -37.68 81.38 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.197 1.799 . . . . 0.0 110.009 169.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.02 26.37 4.98 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.796 1.189 . . . . 0.0 114.724 171.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.73 -49.93 74.45 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 118.685 1.242 . . . . 0.0 111.204 173.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -159.0 148.85 19.12 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.066 2.146 . . . . 0.0 109.52 169.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -81.31 117.79 22.09 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.998 -1.063 . . . . 0.0 108.567 172.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 -144.85 136.67 25.69 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.355 1.062 . . . . 0.0 111.623 -169.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -83.22 132.06 35.07 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.429 1.492 . . . . 0.0 110.053 171.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -136.41 151.11 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.444 1.498 . . . . 0.0 109.043 -177.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.73 157.09 27.23 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.275 0.63 . . . . 0.0 109.652 170.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -165.71 148.47 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.073 0.949 . . . . 0.0 110.675 176.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -87.11 145.32 26.49 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.585 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -112.65 160.45 17.88 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.213 1.405 . . . . 0.0 110.634 169.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -125.3 140.1 53.12 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.781 0.8 . . . . 0.0 111.079 169.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 17.6 tpp85 -84.39 150.38 25.38 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.147 1.779 . . . . 0.0 109.921 176.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -55.02 -28.98 56.32 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.992 1.717 . . . . 0.0 113.578 175.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -75.71 -9.95 59.02 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.025 1.33 . . . . 0.0 114.1 175.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.81 -0.04 39.21 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 126.205 1.86 . . . . 0.0 115.576 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 45.2 m -78.8 126.44 30.72 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 119.068 1.434 . . . . 0.0 111.566 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 67.4 m -114.83 134.52 55.06 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.244 1.017 . . . . 0.0 111.667 -176.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -149.97 139.95 21.96 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.979 0.912 . . . . 0.0 112.978 -170.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -115.76 136.23 53.26 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.493 1.917 . . . . 0.0 110.104 176.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.7 m -139.34 169.54 17.57 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.757 1.623 . . . . 0.0 109.931 168.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.4 tt -78.54 60.01 2.57 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 121.849 0.833 . . . . 0.0 109.31 172.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.1 t -52.99 149.2 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.962 1.705 . . . . 0.0 110.645 -174.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -99.79 69.74 1.6 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 123.172 1.463 . . . . 0.0 110.811 -168.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.8 t -83.2 69.95 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.677 1.191 . . . . 0.0 110.255 -170.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.85 131.24 24.23 Favored Pre-proline 0 N--CA 1.478 0.932 0 C-N-CA 124.05 0.94 . . . . 0.0 110.712 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -85.1 -168.67 0.53 Allowed 'Trans proline' 0 CA--C 1.551 1.348 0 C-N-CA 123.109 2.539 . . . . 0.0 111.481 -174.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.52 129.52 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-O 123.026 1.394 . . . . 0.0 113.656 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -112.1 162.16 15.73 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.666 2.386 . . . . 0.0 112.838 -176.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -92.85 179.96 5.31 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.499 1.12 . . . . 0.0 112.207 171.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.42 -21.69 65.6 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -70.85 -19.92 62.59 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.563 1.145 . . . . 0.0 113.738 169.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.6 -0.02 59.44 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.007 1.765 . . . . 0.0 114.358 -176.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.6 139.98 30.0 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.609 1.204 . . . . 0.0 113.246 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.7 p -75.97 99.96 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 125.515 1.526 . . . . 0.0 110.216 -175.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.04 -28.9 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.641 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.71 149.99 50.55 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 124.012 1.863 . . . . 0.0 111.922 173.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -104.02 80.22 1.71 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.857 -1.52 . . . . 0.0 107.843 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.6 mt -99.98 71.15 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 120.611 -1.305 . . . . 0.0 108.789 171.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -76.91 85.19 3.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 123.41 1.576 . . . . 0.0 108.878 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -59.91 103.8 0.24 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 112.958 -1.928 . . . . 0.0 109.931 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -85.81 59.12 5.44 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 120.69 -1.256 . . . . 0.0 111.784 -177.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -79.77 126.58 31.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 122.163 0.983 . . . . 0.0 110.908 175.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.5 t -81.99 113.2 20.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 125.225 1.41 . . . . 0.0 108.403 -178.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.474 0.749 0 CA-C-O 121.092 0.473 . . . . 0.0 112.077 -176.76 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo . . . . . 0 CA--C 1.537 0.628 0 CA-C-O 122.403 0.918 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -65.62 -27.13 68.18 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -167.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -69.17 -49.86 52.94 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.519 0.727 . . . . 0.0 110.385 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 t -75.52 -34.02 60.76 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.835 0.854 . . . . 0.0 112.405 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -59.92 -41.07 90.94 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.577 -0.702 . . . . 0.0 110.157 172.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.2 tp -70.85 -45.58 64.22 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.076 172.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -47.43 -39.83 16.55 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.238 1.415 . . . . 0.0 113.217 173.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 90.7 m -60.11 -44.02 95.15 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.615 -0.678 . . . . 0.0 112.205 172.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.5 mm -67.81 -35.7 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.834 0.854 . . . . 0.0 110.868 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.4 mm -55.62 -54.44 25.79 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 52.7 mtm180 -60.16 -29.38 68.63 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 118.981 0.809 . . . . 0.0 112.809 176.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.4 tptt -62.82 -42.42 99.72 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 118.676 -0.678 . . . . 0.0 112.265 173.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -104.51 1.64 30.06 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 178.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 . . . . . 0 N--CA 1.478 0.931 0 C-N-CA 125.834 1.654 . . . . 0.0 113.894 -167.717 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 119.342 -0.361 . . . . 0.0 111.82 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -169.77 155.4 5.83 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 123.975 1.845 . . . . 0.0 115.074 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -119.9 165.45 15.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 128.025 2.53 . . . . 0.0 110.167 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.8 mm -127.58 113.71 32.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.52 155.91 39.86 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.884 0.85 . . . . 0.0 112.142 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.9 t-20 -85.72 122.3 29.62 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 176.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.46 -9.18 59.77 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -100.03 6.09 45.06 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.974 1.31 . . . . 0.0 113.477 -173.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.8 m -114.08 139.16 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 126.728 2.011 . . . . 0.0 111.378 -177.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.52 -23.26 65.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.133 0.973 . . . . 0.0 113.456 -175.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -90.8 0.56 57.42 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.538 1.535 . . . . 0.0 113.399 174.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 27.8 p 42.08 46.92 3.8 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.969 1.707 . . . . 0.0 113.098 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.1 149.8 31.97 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -167.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.2 t -81.71 92.37 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 128.762 2.825 . . . . 0.0 109.009 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.6 pt -70.43 -23.14 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 126.195 1.798 . . . . 0.0 112.692 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -158.19 159.73 36.42 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.448 1.499 . . . . 0.0 112.592 174.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.5 p -147.08 154.4 41.12 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.406 -1.434 . . . . 0.0 113.322 173.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -96.23 157.46 15.89 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -59.36 -28.97 67.34 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.186 0.994 . . . . 0.0 112.006 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.86 -50.04 39.42 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.04 0.828 . . . . 0.0 112.918 169.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.92 -35.54 78.71 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 119.321 1.561 . . . . 0.0 110.706 176.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.0 t -60.04 -39.87 87.43 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.171 -0.956 . . . . 0.0 110.548 176.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -75.85 -25.69 56.46 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 174.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 53.4 tp -64.86 -55.74 17.64 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.089 0.956 . . . . 0.0 111.806 175.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.5 m -94.82 -21.15 18.88 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -174.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.73 22.6 78.14 Favored Glycine 0 CA--C 1.539 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 113.564 -169.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.6 m-30 -91.49 -130.1 0.1 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.288 1.435 . . . . 0.0 110.979 -176.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.5 t -162.11 150.17 14.67 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.794 2.438 . . . . 0.0 109.045 177.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.7 ttp180 -50.14 -40.88 47.69 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.751 0.82 . . . . 0.0 111.907 170.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.77 -20.81 63.98 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -87.41 -20.69 26.3 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.335 1.454 . . . . 0.0 113.069 175.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -104.73 -16.33 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 176.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.4 mmt -49.92 110.34 0.38 Allowed 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.424 1.489 . . . . 0.0 111.388 -177.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 71.13 17.05 6.18 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.472 1.509 . . . . 0.0 113.764 171.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.43 160.81 63.99 Favored Pre-proline 0 N--CA 1.475 0.812 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.397 166.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -58.48 140.08 93.2 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.539 2.159 . . . . 0.0 111.639 169.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.4 p -64.69 -10.0 23.92 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 169.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.0 m -64.49 93.42 0.1 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.218 1.807 . . . . 0.0 111.683 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 28.4 p -53.13 -14.27 0.62 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.337 1.855 . . . . 0.0 115.34 -176.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -48.13 -40.04 22.43 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.098 0.959 . . . . 0.0 111.565 167.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.85 -19.96 63.17 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 pp -123.1 23.8 9.1 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.476 1.91 . . . . 0.0 113.052 176.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -60.87 140.01 57.81 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.086 -1.009 . . . . 0.0 112.826 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -95.18 171.45 29.71 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.828 1.204 . . . . 0.0 113.325 175.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.0 -10.05 27.19 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.495 2.797 . . . . 0.0 114.446 -177.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -91.55 -9.27 44.9 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.492 1.917 . . . . 0.0 113.442 174.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.6 m -78.02 139.86 39.13 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.984 0.914 . . . . 0.0 112.428 -173.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -85.34 131.68 34.37 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.743 1.259 . . . . 0.0 109.946 168.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.6 mmm-85 -65.79 -39.66 91.18 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.866 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.22 -41.83 50.52 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 169.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.66 -51.23 61.15 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.311 1.044 . . . . 0.0 110.122 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.26 -33.81 76.66 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.729 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.04 -51.39 32.5 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.022 1.729 . . . . 0.0 112.662 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -50.01 -43.89 50.86 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.686 1.194 . . . . 0.0 111.062 170.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 51.2 mt -62.91 -49.52 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.118 174.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.08 -39.86 57.04 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-O 118.248 -0.882 . . . . 0.0 112.179 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -69.0 -38.51 79.3 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.895 0.77 . . . . 0.0 111.466 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.18 -34.85 78.97 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.557 -0.714 . . . . 0.0 111.949 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.0 mt -84.87 -24.66 28.43 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.393 0.677 . . . . 0.0 111.674 177.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.78 -30.04 70.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.788 2.035 . . . . 0.0 110.062 168.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.07 17.93 9.16 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.063 1.316 . . . . 0.0 114.84 169.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.94 -50.13 65.48 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.845 1.323 . . . . 0.0 111.126 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -151.94 141.54 21.75 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.843 1.657 . . . . 0.0 111.312 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -74.61 114.52 13.11 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 166.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -149.28 137.26 20.55 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.951 0.9 . . . . 0.0 111.557 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -84.84 130.44 34.66 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.585 1.554 . . . . 0.0 110.196 169.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.6 153.64 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.525 1.53 . . . . 0.0 108.896 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -79.88 160.04 26.19 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.278 1.031 . . . . 0.0 109.812 169.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -169.75 151.92 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.584 1.154 . . . . 0.0 111.129 173.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.48 145.42 25.31 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 174.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -115.15 162.07 17.54 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.968 1.707 . . . . 0.0 111.722 168.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -136.51 140.18 42.82 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.232 0.613 . . . . 0.0 110.792 168.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -84.69 152.43 23.76 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.332 1.053 . . . . 0.0 112.658 177.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -55.1 -25.14 29.51 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.968 1.707 . . . . 0.0 112.974 169.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.54 -11.12 60.72 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.395 1.478 . . . . 0.0 113.949 174.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.61 41.33 5.11 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.843 1.211 . . . . 0.0 114.833 175.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.0 t -136.71 141.71 43.07 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.499 1.12 . . . . 0.0 111.629 176.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 23.9 p -129.82 139.62 51.19 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.423 1.489 . . . . 0.0 113.508 -171.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -150.23 139.94 21.71 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.899 1.279 . . . . 0.0 113.457 -168.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -108.44 134.34 51.36 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.918 2.087 . . . . 0.0 108.667 169.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.9 m -140.0 179.11 6.8 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.292 1.437 . . . . 0.0 111.559 171.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.2 mp -78.23 60.0 2.4 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.652 1.181 . . . . 0.0 109.904 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 16.6 t -63.2 145.58 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.587 1.155 . . . . 0.0 111.261 -171.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -107.63 69.74 0.75 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.615 1.198 . . . . 0.0 112.055 -168.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.6 t -84.05 69.86 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.016 0.927 . . . . 0.0 110.886 -169.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.17 136.12 26.07 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 124.611 1.164 . . . . 0.0 111.253 -174.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -86.88 -169.17 0.48 Allowed 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 123.603 2.869 . . . . 0.0 113.361 -172.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -126.47 132.33 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-O 122.835 1.302 . . . . 0.0 113.689 175.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -111.87 166.62 11.05 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 127.042 2.137 . . . . 0.0 112.389 -174.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -97.23 179.95 4.72 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.272 169.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.78 -21.21 65.7 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -70.11 -19.85 63.21 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.583 1.153 . . . . 0.0 113.68 169.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.6 6.5 59.58 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.811 1.672 . . . . 0.0 114.458 -176.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -97.13 141.76 29.87 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.54 1.17 . . . . 0.0 113.594 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.8 100.01 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 126.0 1.72 . . . . 0.0 110.615 -176.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.02 -29.6 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.113 177.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.53 149.98 51.68 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 124.288 1.994 . . . . 0.0 112.646 173.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -104.52 79.89 1.62 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 113.222 -1.808 . . . . 0.0 107.41 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.1 mt -99.91 69.95 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 170.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.66 88.25 4.57 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.985 0.898 . . . . 0.0 108.828 -178.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -59.85 104.22 0.27 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.767 1.227 . . . . 0.0 111.419 -174.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -82.81 53.61 2.45 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.18 -1.575 . . . . 0.0 112.163 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -79.94 106.84 12.26 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 124.076 1.893 . . . . 0.0 112.782 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.1 t -64.77 111.81 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 127.002 2.121 . . . . 0.0 108.738 170.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.472 0.649 0 C-N-CA 122.758 0.423 . . . . 0.0 110.551 176.99 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo . . . . . 0 CA--C 1.536 0.592 0 CA-C-O 122.785 1.077 . . . . 0.0 112.737 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -59.91 -27.41 66.72 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -163.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -67.84 -49.95 59.35 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.731 0.696 . . . . 0.0 110.143 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.6 t -79.77 -35.19 39.02 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.59 1.156 . . . . 0.0 112.679 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -57.97 -39.88 79.25 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.567 1.147 . . . . 0.0 110.243 171.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.8 tp -74.84 -45.49 42.87 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 118.885 -0.579 . . . . 0.0 112.468 170.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -47.8 -39.82 19.31 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.845 1.258 . . . . 0.0 112.628 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 91.3 m -60.07 -42.58 94.84 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.538 -0.726 . . . . 0.0 111.875 175.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.4 mm -68.5 -33.66 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 123.839 0.856 . . . . 0.0 110.194 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.3 mm -59.33 -52.99 54.32 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.517 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 173.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -59.88 -29.21 68.16 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.477 1.111 . . . . 0.0 111.673 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -67.21 -42.11 84.63 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.813 1.245 . . . . 0.0 113.167 175.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -102.84 -0.01 31.96 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 CA--C 1.549 0.915 0 C-N-CA 124.711 1.204 . . . . 0.0 113.391 -166.311 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -169.81 162.99 9.7 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 123.312 1.529 . . . . 0.0 115.094 -171.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -126.57 168.93 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 127.951 2.501 . . . . 0.0 111.203 173.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.5 mm -129.99 120.08 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 126.224 1.81 . . . . 0.0 108.165 178.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.5 155.23 48.96 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -78.58 114.68 17.71 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.977 169.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.03 -17.47 58.78 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -178.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 -96.14 5.93 49.96 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.794 1.238 . . . . 0.0 113.831 -170.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.98 140.16 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.744 1.618 . . . . 0.0 110.694 -175.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -58.19 -29.46 65.67 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.054 0.942 . . . . 0.0 113.187 -176.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -82.73 -5.81 59.08 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.5 p 39.08 45.76 1.08 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.678 1.991 . . . . 0.0 114.646 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.02 149.96 26.63 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 -166.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.1 t -79.94 97.22 2.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 128.907 2.883 . . . . 0.0 108.221 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.6 pt -76.67 -24.02 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.556 1.542 . . . . 0.0 111.735 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -153.6 159.44 42.14 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.963 0.905 . . . . 0.0 112.398 171.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 9.1 p -149.29 143.58 25.93 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.971 -1.08 . . . . 0.0 112.901 -174.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -88.79 157.7 18.4 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 -178.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.48 -31.18 67.6 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.533 -0.729 . . . . 0.0 111.706 169.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.91 -49.81 57.21 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.052 0.834 . . . . 0.0 113.249 169.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -58.32 -37.67 75.58 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 119.05 1.425 . . . . 0.0 109.337 176.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.1 t -60.01 -40.28 88.74 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.108 0.563 . . . . 0.0 111.549 177.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -71.06 -30.29 66.4 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.323 -0.86 . . . . 0.0 112.524 173.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.4 tp -70.12 -44.95 67.91 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.103 1.361 . . . . 0.0 114.196 -177.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 2.2 t -99.57 -24.08 14.86 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.634 0.773 . . . . 0.0 111.869 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.11 10.73 86.0 Favored Glycine 0 CA--C 1.541 1.672 0 O-C-N 120.928 -1.107 . . . . 0.0 115.825 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -94.24 -114.71 0.11 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 118.975 1.387 . . . . 0.0 111.911 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.9 t -159.99 148.97 17.49 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.946 1.299 . . . . 0.0 111.818 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 86.7 mtm-85 -53.74 -41.44 67.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.819 1.248 . . . . 0.0 111.811 171.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.79 -19.52 62.6 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.613 1.165 . . . . 0.0 113.355 177.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -88.37 -20.67 25.01 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.037 1.335 . . . . 0.0 112.911 175.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.7 m -103.67 -3.55 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 35.6 mmt -49.93 114.48 1.09 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.136 0.88 . . . . 0.0 109.804 172.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 70.57 23.93 4.61 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.856 1.662 . . . . 0.0 112.885 172.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -101.32 152.06 37.88 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 124.523 1.129 . . . . 0.0 112.342 -176.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.26 140.07 57.4 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.168 2.579 . . . . 0.0 113.227 -174.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.4 m -67.31 -13.25 61.82 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 173.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.7 m -68.17 100.04 0.97 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.416 1.086 . . . . 0.0 110.853 -176.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 30.4 p -54.56 -13.35 0.94 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.607 1.963 . . . . 0.0 116.123 -173.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -55.85 -36.59 67.7 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.877 -1.14 . . . . 0.0 111.267 169.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -54.7 -24.86 23.91 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.272 1.429 . . . . 0.0 113.509 173.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 pp -123.1 27.71 7.49 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.985 1.714 . . . . 0.0 113.029 177.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -62.63 145.79 53.67 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.231 -0.918 . . . . 0.0 111.984 172.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -127.43 -176.72 14.57 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 125.3 1.429 . . . . 0.0 113.157 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -66.51 -10.14 26.71 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.726 2.284 . . . . 0.0 116.512 -169.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.5 ttm105 -110.08 -2.75 16.81 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.768 1.627 . . . . 0.0 113.865 173.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.7 m -78.52 140.35 38.56 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.053 -1.029 . . . . 0.0 112.047 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -90.22 133.05 35.16 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 123.221 1.486 . . . . 0.0 111.65 172.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.7 mmm-85 -69.19 -39.79 78.45 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.302 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -55.57 -38.5 69.44 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.875 0.761 . . . . 0.0 112.956 171.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.8 -51.21 60.91 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 122.119 0.961 . . . . 0.0 109.88 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.44 -33.52 76.07 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.837 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.01 -50.01 45.78 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.01 1.724 . . . . 0.0 112.798 177.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -50.17 -42.93 51.99 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.251 1.021 . . . . 0.0 111.372 169.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.4 mt -62.62 -47.71 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 121.798 -0.564 . . . . 0.0 111.605 172.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.28 -39.96 46.9 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.661 -0.685 . . . . 0.0 112.193 174.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -69.01 -38.27 79.14 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.652 0.781 . . . . 0.0 111.551 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.1 -33.17 75.18 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.374 -0.828 . . . . 0.0 111.571 177.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mt -81.59 -29.99 33.15 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.668 0.787 . . . . 0.0 111.987 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.83 -28.72 69.19 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.393 2.277 . . . . 0.0 111.125 169.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.98 17.94 9.21 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.972 1.272 . . . . 0.0 114.873 169.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.36 -49.99 75.39 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.554 1.177 . . . . 0.0 111.495 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -161.39 152.63 18.64 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.517 1.527 . . . . 0.0 112.246 171.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -77.65 110.68 12.69 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 168.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.5 tpp180 -151.0 139.03 20.03 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.461 1.104 . . . . 0.0 110.949 -174.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -76.76 137.19 39.15 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.724 0.81 . . . . 0.0 110.342 170.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.11 148.75 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.772 1.229 . . . . 0.0 109.072 173.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.93 155.48 27.7 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.824 0.85 . . . . 0.0 110.294 171.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -164.29 151.21 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 119.228 0.922 . . . . 0.0 111.146 173.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -88.22 145.36 25.92 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.092 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -118.04 143.71 46.19 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.504 1.121 . . . . 0.0 112.161 172.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -109.99 140.15 44.32 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.422 0.689 . . . . 0.0 111.336 173.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.6 mmt-85 -81.8 141.16 33.73 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 168.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -49.97 -26.95 4.71 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.994 2.117 . . . . 0.0 113.607 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -64.35 -17.39 63.66 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.316 1.446 . . . . 0.0 114.086 174.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.41 41.26 1.65 Allowed Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.463 1.506 . . . . 0.0 115.453 172.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.3 t -141.97 138.49 31.95 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 118.756 1.278 . . . . 0.0 112.217 175.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 28.9 t -128.9 138.8 52.22 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.483 1.513 . . . . 0.0 113.277 -172.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -150.95 151.33 31.97 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -100.9 127.99 47.13 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 127.917 2.487 . . . . 0.0 109.956 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 41.6 m -132.76 177.92 7.26 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.567 1.547 . . . . 0.0 111.134 171.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -80.05 59.92 3.42 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.415 1.086 . . . . 0.0 110.846 -177.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.5 t -62.16 141.69 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.716 1.606 . . . . 0.0 111.658 -172.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -102.61 69.83 1.11 Allowed 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 122.231 1.015 . . . . 0.0 112.175 -168.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.7 t -83.25 69.84 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 121.391 -0.818 . . . . 0.0 110.726 -168.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.5 t -117.92 127.26 26.74 Favored Pre-proline 0 N--CA 1.473 0.718 0 CA-C-O 117.801 -1.095 . . . . 0.0 109.363 -176.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -82.32 -170.09 0.88 Allowed 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.212 2.608 . . . . 0.0 112.434 -177.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -119.89 127.24 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-O 122.865 1.317 . . . . 0.0 112.548 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -121.06 160.02 24.49 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 127.012 2.125 . . . . 0.0 111.909 -176.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -89.87 -179.53 5.75 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.807 0.843 . . . . 0.0 111.556 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -60.02 -21.61 61.55 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -73.68 -19.94 60.69 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.803 1.241 . . . . 0.0 114.156 171.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.92 -4.27 63.0 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.529 1.538 . . . . 0.0 114.073 -176.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -79.77 129.38 34.43 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.308 1.054 . . . . 0.0 111.973 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.67 99.99 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 127.215 2.206 . . . . 0.0 110.536 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.54 -30.04 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 123.397 0.679 . . . . 0.0 111.983 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.52 149.99 50.73 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 124.215 1.96 . . . . 0.0 112.642 174.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.8 m-30 -103.84 80.76 1.8 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.408 -1.724 . . . . 0.0 107.662 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.4 mt -101.18 71.32 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 169.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.02 90.39 3.03 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 122.32 1.057 . . . . 0.0 108.803 175.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -59.97 95.16 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.112 1.365 . . . . 0.0 110.553 176.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -80.99 51.85 1.65 Allowed 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.544 -1.348 . . . . 0.0 112.636 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -79.86 106.81 12.16 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 124.296 1.998 . . . . 0.0 112.681 -176.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 41.2 t -62.49 113.75 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 127.377 2.271 . . . . 0.0 108.917 170.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 120.957 0.408 . . . . 0.0 111.316 177.511 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo . . . . . 0 CA--C 1.534 0.502 0 CA-C-O 122.737 1.057 . . . . 0.0 112.233 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -66.34 -27.17 67.68 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.184 0.993 . . . . 0.0 113.095 -171.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -70.09 -49.85 46.79 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.273 0.629 . . . . 0.0 110.415 -177.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 t -75.61 -34.7 60.61 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.028 0.931 . . . . 0.0 112.377 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -57.93 -42.72 85.45 Favored 'General case' 0 C--N 1.341 0.238 0 O-C-N 121.859 -0.526 . . . . 0.0 110.296 171.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.3 tp -70.02 -44.65 68.85 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 118.869 -0.586 . . . . 0.0 112.062 173.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -48.45 -40.01 24.79 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.882 1.219 . . . . 0.0 112.389 175.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.1 m -60.19 -43.09 96.2 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 121.486 -0.759 . . . . 0.0 112.502 172.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.2 mm -67.7 -35.67 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 123.962 0.905 . . . . 0.0 110.783 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.5 mm -56.21 -54.97 21.42 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 172.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -26.75 66.22 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.469 1.108 . . . . 0.0 112.978 176.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -65.31 -46.56 79.88 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 118.155 -0.926 . . . . 0.0 112.193 172.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -104.04 0.0 29.3 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 . . . . . 0 N--CA 1.477 0.893 0 N-CA-C 116.72 2.119 . . . . 0.0 116.72 -165.593 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.7 mptt . . . . . 0 N--CA 1.478 0.973 0 CA-C-O 119.101 -0.476 . . . . 0.0 111.419 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -169.69 162.1 9.59 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -171.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.6 pp -123.3 169.13 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 127.754 2.422 . . . . 0.0 111.864 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.7 mm -127.74 119.07 50.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 126.365 1.866 . . . . 0.0 108.06 174.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.32 154.6 46.71 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 -177.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -77.38 106.69 9.3 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.287 172.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.81 -15.87 61.17 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -96.09 5.94 49.97 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.918 1.287 . . . . 0.0 114.057 -171.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.99 140.19 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.087 1.755 . . . . 0.0 110.912 -173.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -59.92 -23.56 63.61 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -176.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -76.03 -20.78 57.5 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.238 1.015 . . . . 0.0 113.578 174.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 15.6 m 45.1 42.85 7.04 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.017 1.727 . . . . 0.0 113.991 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.05 164.12 12.13 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 117.282 2.327 . . . . 0.0 117.282 -166.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 67.6 t -79.78 96.97 2.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 128.633 2.773 . . . . 0.0 108.419 -170.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.7 pt -78.76 -24.44 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.637 1.575 . . . . 0.0 111.47 173.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -153.79 159.68 41.98 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.952 0.901 . . . . 0.0 111.424 171.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 25.0 p -144.21 151.39 39.41 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.167 -0.958 . . . . 0.0 112.84 -173.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -87.8 153.27 21.47 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.721 0.772 . . . . 0.0 112.381 168.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -62.81 -32.87 74.14 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.305 0.642 . . . . 0.0 111.254 173.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.94 -50.04 56.41 Favored Glycine 0 CA--C 1.532 1.113 0 O-C-N 121.346 -0.846 . . . . 0.0 112.794 175.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -29.87 66.97 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 118.857 1.328 . . . . 0.0 111.56 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.7 t -59.97 -39.94 87.36 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.344 -0.848 . . . . 0.0 110.877 171.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -77.05 -30.13 55.46 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.435 -0.791 . . . . 0.0 112.387 174.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.6 tp -57.36 -55.72 31.1 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.277 1.431 . . . . 0.0 110.838 175.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.9 p -79.98 -28.08 39.57 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 175.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.53 9.96 74.42 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.913 1.72 . . . . 0.0 115.919 178.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -86.04 -121.83 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 119.547 1.674 . . . . 0.0 112.603 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.3 t -159.88 142.88 13.87 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.12 1.768 . . . . 0.0 110.036 -176.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -63.7 -33.97 76.82 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 121.168 -0.957 . . . . 0.0 112.178 -173.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.87 -16.65 43.99 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.578 1.151 . . . . 0.0 113.778 173.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -94.04 -20.56 19.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.211 2.204 . . . . 0.0 112.602 177.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 m -89.9 -20.05 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-N 120.254 1.388 . . . . 0.0 112.823 -173.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 35.1 mmt -49.98 118.57 2.98 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.587 1.155 . . . . 0.0 110.263 -174.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 72.56 20.33 3.9 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.825 1.65 . . . . 0.0 114.098 170.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -89.92 150.93 44.64 Favored Pre-proline 0 N--CA 1.484 1.231 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 169.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -64.24 140.02 68.91 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 124.062 3.174 . . . . 0.0 113.165 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 76.9 m -70.08 -12.36 61.55 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 169.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.1 m -59.08 100.09 0.06 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 126.888 2.075 . . . . 0.0 110.304 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 54.4 m -53.64 -13.21 0.61 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 -170.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -54.25 -38.31 65.63 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.399 1.08 . . . . 0.0 111.359 167.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -59.89 -20.36 56.82 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.457 1.503 . . . . 0.0 112.918 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.55 20.03 14.98 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 127.377 2.271 . . . . 0.0 111.52 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.05 149.2 45.09 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.629 -1.294 . . . . 0.0 112.826 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.7 -172.41 12.66 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.573 1.559 . . . . 0.0 112.45 172.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.35 -9.99 24.28 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.412 2.741 . . . . 0.0 114.781 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -96.46 -10.1 28.23 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.14 1.376 . . . . 0.0 113.555 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.3 m -82.83 139.72 33.33 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 119.237 0.926 . . . . 0.0 112.181 -170.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -95.74 143.65 26.81 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 122.684 1.23 . . . . 0.0 112.139 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.79 -39.88 79.92 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.93 -176.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -57.94 -40.71 81.16 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.259 1.024 . . . . 0.0 112.912 174.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.73 -52.19 58.38 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.368 1.067 . . . . 0.0 110.039 176.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.88 -34.79 79.23 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.07 -54.82 11.42 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.69 1.196 . . . . 0.0 111.563 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -50.15 -40.06 45.29 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.243 1.017 . . . . 0.0 112.405 172.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 49.6 mt -64.42 -50.61 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 O-C-N 121.704 -0.623 . . . . 0.0 111.442 173.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.1 -39.93 57.26 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 118.481 -0.771 . . . . 0.0 111.806 175.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -70.63 -37.16 73.76 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.617 0.767 . . . . 0.0 111.852 176.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.34 -33.41 74.25 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.484 -0.76 . . . . 0.0 111.243 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 mt -81.67 -31.96 32.01 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.287 0.635 . . . . 0.0 111.571 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.94 -29.25 70.65 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.494 1.918 . . . . 0.0 111.518 169.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.99 18.44 8.81 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.912 1.244 . . . . 0.0 114.929 169.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.95 -49.9 75.57 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 118.623 1.211 . . . . 0.0 111.424 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -156.75 146.2 20.56 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.535 1.934 . . . . 0.0 110.232 171.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -74.83 113.63 12.33 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 169.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -143.31 136.28 27.79 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.331 -167.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -87.72 129.86 35.01 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.424 1.49 . . . . 0.0 109.535 169.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.1 t -136.09 142.88 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.348 1.459 . . . . 0.0 108.705 -175.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -80.03 150.43 30.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.635 0.774 . . . . 0.0 110.093 172.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -161.57 148.88 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.255 1.022 . . . . 0.0 110.843 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.04 145.36 25.53 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.3 173.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -119.48 157.55 28.06 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.373 1.069 . . . . 0.0 111.165 175.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -113.93 140.06 48.7 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.834 0.854 . . . . 0.0 109.836 167.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -93.94 150.33 20.46 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.154 1.381 . . . . 0.0 109.585 170.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -17.64 60.73 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -171.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -73.1 -10.03 59.36 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.036 1.334 . . . . 0.0 113.659 172.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.0 9.31 37.34 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.693 1.616 . . . . 0.0 115.442 176.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 63.8 m -91.44 133.16 35.72 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.851 1.326 . . . . 0.0 111.198 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 49.6 t -134.44 129.37 35.17 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.827 0.851 . . . . 0.0 112.86 -176.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -151.01 153.35 34.98 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -173.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -100.04 135.35 41.61 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.772 2.029 . . . . 0.0 110.435 173.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 2.1 m -139.24 170.0 16.75 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.524 1.529 . . . . 0.0 110.706 168.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 31.1 tp -78.33 60.79 2.63 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.796 1.238 . . . . 0.0 110.69 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.7 t -60.79 145.23 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.691 1.196 . . . . 0.0 111.206 -174.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -104.1 69.69 0.95 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 122.493 1.139 . . . . 0.0 111.195 -169.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.1 t -82.76 69.81 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.022 0.929 . . . . 0.0 110.228 -169.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.89 132.46 23.91 Favored Pre-proline 0 N--CA 1.483 1.183 0 C-N-CA 124.26 1.024 . . . . 0.0 111.88 -171.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -88.54 -174.28 1.04 Allowed 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 123.595 2.863 . . . . 0.0 113.797 -171.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.85 129.26 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-O 122.854 1.311 . . . . 0.0 113.658 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -107.72 170.56 7.91 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 127.001 2.12 . . . . 0.0 112.31 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -104.13 179.91 4.14 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 113.666 -1.606 . . . . 0.0 112.346 169.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.25 -19.95 65.01 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -69.34 -19.96 63.86 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.458 1.103 . . . . 0.0 113.681 170.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.95 18.69 49.94 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.468 1.032 . . . . 0.0 113.842 -173.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -110.86 142.4 42.95 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.317 1.047 . . . . 0.0 113.448 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.6 p -74.99 100.06 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.946 1.698 . . . . 0.0 110.814 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.13 -28.94 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 123.303 0.641 . . . . 0.0 111.993 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.33 149.88 50.9 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-O 124.24 1.971 . . . . 0.0 112.654 174.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.8 m-30 -104.87 82.62 1.9 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.222 -1.808 . . . . 0.0 107.337 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.8 mt -100.83 69.88 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 170.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.49 88.93 5.61 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.99 0.9 . . . . 0.0 108.696 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -59.89 108.86 0.82 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.637 1.175 . . . . 0.0 110.712 -176.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -84.17 52.53 2.35 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 120.407 -1.433 . . . . 0.0 112.196 -176.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -79.93 106.89 12.29 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 123.998 1.856 . . . . 0.0 112.294 -178.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 37.0 t -64.74 112.42 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 C-N-CA 126.308 1.843 . . . . 0.0 108.633 171.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.471 0.599 0 C-N-CA 122.842 0.457 . . . . 0.0 110.041 175.198 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo . . . . . 0 CA--C 1.535 0.54 0 CA-C-O 122.459 0.941 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -66.38 -26.79 67.43 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -168.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -68.32 -49.92 57.04 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.719 0.808 . . . . 0.0 110.272 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 t -74.35 -36.43 63.61 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.751 0.821 . . . . 0.0 112.307 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -57.9 -40.02 79.31 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.27 0.628 . . . . 0.0 110.541 173.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.5 tp -71.19 -44.28 65.77 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 118.957 -0.544 . . . . 0.0 112.4 171.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -47.51 -39.9 17.33 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.951 1.3 . . . . 0.0 112.743 175.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 57.0 m -60.14 -42.27 94.47 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 121.193 -0.942 . . . . 0.0 112.549 172.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.8 mm -70.09 -33.31 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.311 1.045 . . . . 0.0 110.785 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.9 mm -56.43 -55.62 18.14 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.426 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 169.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -23.74 63.71 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.303 1.041 . . . . 0.0 113.354 177.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.2 tptp -68.96 -45.49 70.58 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.166 0.986 . . . . 0.0 112.989 171.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -102.45 -0.08 32.98 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 . . . . . 0 N--CA 1.475 0.803 0 C-N-CA 127.256 2.222 . . . . 0.0 116.544 -167.128 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -169.78 159.25 7.92 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 123.189 1.471 . . . . 0.0 114.916 -175.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -120.03 169.01 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 127.574 2.35 . . . . 0.0 111.208 172.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.0 mm -125.25 120.07 57.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 125.957 1.703 . . . . 0.0 107.365 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.0 152.56 48.48 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 178.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -77.31 110.72 12.27 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.301 0.572 . . . . 0.0 111.53 173.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.21 -15.51 61.94 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -99.92 4.63 45.1 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.536 1.309 . . . . 0.0 114.536 -169.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -119.73 140.05 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.422 1.489 . . . . 0.0 110.882 -175.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.4 -23.17 65.62 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -175.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -83.37 -14.52 52.63 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.899 1.28 . . . . 0.0 113.725 175.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.1 m 43.3 54.4 5.14 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.52 1.928 . . . . 0.0 113.528 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.84 154.71 17.59 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -168.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 80.8 t -79.95 90.01 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 128.111 2.565 . . . . 0.0 108.799 -176.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.7 pt -70.11 -23.79 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.698 1.199 . . . . 0.0 112.376 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -155.55 159.66 39.88 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.858 0.863 . . . . 0.0 112.258 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 18.5 p -142.96 139.96 30.89 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 121.342 -0.848 . . . . 0.0 113.069 -173.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -81.82 152.41 26.93 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.724 0.773 . . . . 0.0 112.748 170.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -61.97 -32.26 72.69 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.509 0.724 . . . . 0.0 111.252 175.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.45 -52.55 32.39 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 121.46 -0.775 . . . . 0.0 112.975 172.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.13 -29.73 66.73 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 119.21 1.505 . . . . 0.0 111.136 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.7 t -58.79 -39.82 82.22 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.528 -0.732 . . . . 0.0 110.619 171.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -79.23 -28.31 42.47 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.688 0.795 . . . . 0.0 113.056 174.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.2 tp -57.87 -53.09 62.15 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.051 1.341 . . . . 0.0 110.85 174.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 79.8 m -90.04 -20.01 23.73 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 177.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.71 34.01 40.55 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 124.312 0.958 . . . . 0.0 114.737 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -99.01 -130.18 0.21 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.564 1.146 . . . . 0.0 112.357 -176.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.7 m -159.84 142.88 13.92 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 128.669 2.787 . . . . 0.0 108.143 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -63.98 -40.11 95.65 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 120.922 -1.111 . . . . 0.0 112.934 -169.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.38 -18.04 56.88 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.522 1.129 . . . . 0.0 113.528 174.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -90.21 -20.72 22.7 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.183 1.393 . . . . 0.0 112.179 178.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.7 m -92.7 -14.49 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 CA-C-N 119.31 0.959 . . . . 0.0 113.546 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 35.5 mmt -49.87 114.01 0.98 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.915 1.286 . . . . 0.0 110.467 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 70.15 21.77 5.85 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.88 1.672 . . . . 0.0 113.74 169.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.34 158.84 86.14 Favored Pre-proline 0 N--CA 1.474 0.768 0 O-C-N 121.345 -0.847 . . . . 0.0 111.138 167.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.51 132.99 49.08 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.593 2.196 . . . . 0.0 112.209 171.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 4.6 t -69.99 -23.68 63.19 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.76 1.224 . . . . 0.0 112.548 174.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.0 m -57.04 100.14 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 128.092 2.557 . . . . 0.0 111.792 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 57.7 m -50.04 -21.74 1.35 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -174.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -52.67 -39.19 61.65 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.242 1.017 . . . . 0.0 112.014 171.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -56.14 -24.41 40.85 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.785 1.634 . . . . 0.0 113.4 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 pp -123.08 25.0 8.7 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.048 1.739 . . . . 0.0 113.284 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -63.5 147.26 51.85 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.37 -0.831 . . . . 0.0 112.613 176.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.5 -174.6 13.7 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 125.69 1.615 . . . . 0.0 113.709 -176.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -67.91 -4.38 12.28 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.995 3.13 . . . . 0.0 116.098 -170.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 78.9 mmt-85 -110.26 -10.05 14.64 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 119.609 1.095 . . . . 0.0 113.519 169.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.8 m -73.94 134.98 43.22 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.23 0.923 . . . . 0.0 110.812 -173.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -85.38 137.46 32.92 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.84 0.829 . . . . 0.0 110.029 173.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.0 mmm-85 -67.36 -39.67 85.73 Favored 'General case' 0 C--O 1.219 -0.517 0 O-C-N 121.402 -0.811 . . . . 0.0 111.084 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.1 ptt-85 -53.6 -38.63 64.15 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 169.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.85 -52.15 52.84 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 122.04 0.924 . . . . 0.0 110.079 175.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.42 -33.8 76.8 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.618 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.12 -51.85 28.33 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.783 1.633 . . . . 0.0 112.057 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -50.17 -41.62 49.53 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.456 1.025 . . . . 0.0 112.341 169.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 46.2 mt -62.94 -50.03 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 O-C-N 121.769 -0.582 . . . . 0.0 111.047 172.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.08 -39.79 56.89 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.374 -0.822 . . . . 0.0 112.173 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -69.84 -37.95 76.35 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.589 0.755 . . . . 0.0 111.473 176.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.23 -32.88 74.22 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.536 -0.727 . . . . 0.0 111.075 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mt -81.35 -33.47 32.39 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.452 0.701 . . . . 0.0 111.693 176.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.05 -28.47 69.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.791 2.036 . . . . 0.0 111.28 169.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.09 17.6 9.41 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.007 1.289 . . . . 0.0 114.84 169.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.85 -49.91 75.55 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 118.526 1.163 . . . . 0.0 111.439 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -161.56 151.65 17.14 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.695 1.598 . . . . 0.0 111.926 171.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -72.18 112.98 8.73 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 167.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.5 tpp180 -148.26 135.97 20.78 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.268 1.027 . . . . 0.0 111.431 -176.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -83.87 131.95 34.83 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.403 1.481 . . . . 0.0 110.204 169.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.7 t -134.93 146.12 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.353 1.461 . . . . 0.0 109.074 -176.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -80.05 152.5 29.36 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.773 0.829 . . . . 0.0 110.011 171.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -163.25 148.71 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.42 1.088 . . . . 0.0 110.813 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.8 145.38 25.22 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.665 174.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -117.18 154.14 31.61 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.677 1.191 . . . . 0.0 111.088 172.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -123.9 140.05 53.36 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.535 0.734 . . . . 0.0 110.811 169.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -83.11 162.12 21.42 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.953 1.301 . . . . 0.0 113.28 177.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -50.05 -35.28 24.42 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.469 1.908 . . . . 0.0 113.417 171.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -81.75 -9.91 59.51 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.56 1.144 . . . . 0.0 113.946 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.96 2.07 48.86 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.789 1.661 . . . . 0.0 115.382 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.5 m -74.66 125.11 27.99 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.936 1.368 . . . . 0.0 110.717 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 19.1 t -127.9 132.75 49.28 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.208 1.003 . . . . 0.0 112.589 -170.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -151.06 139.98 20.95 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.57 1.148 . . . . 0.0 113.825 -169.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -104.81 128.75 53.08 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.405 1.882 . . . . 0.0 109.033 168.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 62.3 m -134.99 172.66 12.69 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.422 1.489 . . . . 0.0 110.018 169.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 28.6 tp -79.98 59.88 3.37 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.983 -1.073 . . . . 0.0 110.81 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.7 t -58.42 146.28 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.253 1.421 . . . . 0.0 111.662 -171.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -100.87 69.72 1.35 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 122.608 1.194 . . . . 0.0 111.622 -168.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.7 t -83.32 69.86 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.229 1.011 . . . . 0.0 110.389 -169.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.0 p -119.51 133.47 23.8 Favored Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 124.689 1.195 . . . . 0.0 111.441 -173.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -88.79 -171.34 0.57 Allowed 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 123.761 2.974 . . . . 0.0 113.55 -171.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.7 m -127.81 127.19 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-O 122.811 1.291 . . . . 0.0 113.573 174.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -114.12 165.07 13.02 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 127.273 2.229 . . . . 0.0 112.202 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -94.22 179.99 5.12 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.654 174.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.65 -20.62 63.61 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -71.39 -19.87 62.21 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.546 1.139 . . . . 0.0 114.025 171.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.95 0.96 58.6 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 124.815 1.197 . . . . 0.0 114.127 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.21 126.25 37.21 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.485 1.114 . . . . 0.0 112.025 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.7 p -59.95 99.8 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 128.214 2.605 . . . . 0.0 109.796 171.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.22 -30.06 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.975 177.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.9 mmt -135.46 148.37 49.23 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 124.167 1.937 . . . . 0.0 111.128 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.8 m-30 -104.85 80.39 1.63 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.934 1.694 . . . . 0.0 106.749 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.0 mt -100.05 69.85 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 171.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.87 90.14 4.7 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -59.81 109.05 0.84 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.515 1.126 . . . . 0.0 110.857 -176.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -84.46 49.98 1.79 Allowed 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.233 -1.542 . . . . 0.0 112.515 -177.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -79.84 107.05 12.32 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 123.685 1.707 . . . . 0.0 111.98 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.3 t -57.94 115.82 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 127.166 2.186 . . . . 0.0 109.44 170.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.475 0.801 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 176.757 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo . . . . . 0 CA--C 1.537 0.652 0 CA-C-O 122.708 1.045 . . . . 0.0 113.149 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -68.48 -25.22 64.86 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.485 -0.76 . . . . 0.0 112.855 -169.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -66.7 -49.85 64.74 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.07 0.948 . . . . 0.0 110.384 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 t -75.71 -35.8 60.17 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.829 0.852 . . . . 0.0 112.347 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -57.8 -40.69 80.5 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.138 0.575 . . . . 0.0 110.388 172.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.1 tp -72.54 -43.63 63.25 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 118.607 -0.711 . . . . 0.0 112.289 172.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -48.58 -39.97 25.66 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 120.077 1.308 . . . . 0.0 112.164 175.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 78.9 m -60.12 -42.64 95.21 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 121.607 -0.683 . . . . 0.0 112.732 173.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.1 mm -69.95 -32.74 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.219 1.008 . . . . 0.0 111.011 176.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.7 mm -57.08 -55.8 18.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 170.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -25.33 64.98 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 176.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.1 tptt -68.58 -42.19 78.61 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.087 0.955 . . . . 0.0 112.271 172.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -114.99 16.39 17.14 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 -175.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 -166.914 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -169.78 162.45 9.55 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -172.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 pp -129.25 170.66 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 127.323 2.249 . . . . 0.0 111.347 175.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.1 mm -126.21 114.45 38.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 126.368 1.867 . . . . 0.0 107.388 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.5 150.26 41.85 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 124.325 1.05 . . . . 0.0 111.614 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -81.72 114.03 20.11 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.391 1.076 . . . . 0.0 110.37 176.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.82 4.16 45.55 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 175.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -100.19 -3.38 31.74 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.397 1.479 . . . . 0.0 113.936 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 p -118.15 139.29 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.83 1.652 . . . . 0.0 111.501 -176.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -62.15 -26.39 68.3 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.926 0.89 . . . . 0.0 112.937 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -77.53 -8.88 58.48 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.824 1.25 . . . . 0.0 113.93 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.0 p 43.62 35.4 0.99 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 126.991 2.116 . . . . 0.0 114.877 -176.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.71 154.87 29.73 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -167.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 98.9 t -79.99 89.99 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 129.143 2.977 . . . . 0.0 109.02 -175.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.0 pt -69.94 -24.25 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.462 1.505 . . . . 0.0 112.392 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -153.92 159.66 41.82 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.281 1.033 . . . . 0.0 112.224 171.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.4 ' HG ' ' CG2' ' A' ' 59' ' ' VAL . 18.6 p -143.77 147.35 34.05 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.817 -1.177 . . . . 0.0 112.798 -177.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -89.74 156.86 18.24 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 176.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -58.81 -27.4 65.04 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.277 0.631 . . . . 0.0 111.626 169.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.7 -56.64 12.84 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 119.218 -0.768 . . . . 0.0 112.465 169.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -53.19 -39.49 63.69 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.4 1.6 . . . . 0.0 111.371 174.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.3 t -60.14 -40.06 88.47 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.901 -0.5 . . . . 0.0 111.308 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -78.56 -25.86 45.49 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.978 0.911 . . . . 0.0 112.979 176.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 36.2 tp -66.26 -55.74 14.66 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.877 1.271 . . . . 0.0 111.213 176.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 78.4 m -93.35 -22.06 19.18 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.638 0.775 . . . . 0.0 113.084 -176.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.22 20.07 79.82 Favored Glycine 0 CA--C 1.539 1.586 0 O-C-N 121.034 -1.041 . . . . 0.0 113.855 -171.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -87.47 -130.02 0.06 Allowed 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 118.493 1.147 . . . . 0.0 110.839 -176.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.0 t -160.66 150.16 17.31 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 127.862 2.465 . . . . 0.0 108.846 176.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.08 -38.87 54.29 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 121.466 -0.771 . . . . 0.0 112.624 172.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.51 -19.99 64.16 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.56 1.144 . . . . 0.0 113.737 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -86.76 -20.73 27.19 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.267 1.427 . . . . 0.0 113.189 174.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.4 ' CG2' ' HG ' ' A' ' 44' ' ' CYS . 15.6 m -105.41 -18.49 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 176.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.5 mmt -49.84 111.41 0.51 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.491 1.517 . . . . 0.0 111.248 -172.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 66.83 30.67 7.76 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.823 1.649 . . . . 0.0 112.544 170.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -107.21 154.4 40.52 Favored Pre-proline 0 N--CA 1.471 0.61 0 CA-C-O 117.321 -1.323 . . . . 0.0 112.594 176.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -50.59 134.82 40.56 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.267 2.645 . . . . 0.0 113.95 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 52.7 t -66.68 -17.86 65.07 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.727 1.211 . . . . 0.0 112.981 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.2 m -61.88 99.99 0.14 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.211 1.804 . . . . 0.0 111.859 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 27.8 p -54.08 -15.69 1.59 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -175.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -52.85 -38.74 61.85 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.991 0.917 . . . . 0.0 111.523 170.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -64.78 -15.19 61.32 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 pp -123.06 25.38 8.54 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.118 1.767 . . . . 0.0 113.358 172.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -62.34 148.33 45.52 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.197 -0.94 . . . . 0.0 112.62 176.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.96 -179.75 16.04 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 125.126 1.346 . . . . 0.0 114.09 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -63.5 -10.01 20.17 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.572 2.848 . . . . 0.0 116.629 -174.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -110.03 -2.27 17.13 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.412 1.485 . . . . 0.0 114.15 173.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.2 m -80.8 139.99 35.72 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.348 0.976 . . . . 0.0 111.944 -177.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -87.27 135.61 33.25 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 122.493 1.139 . . . . 0.0 111.407 171.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.8 mmm-85 -69.79 -39.74 76.43 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 118.573 -0.727 . . . . 0.0 110.965 176.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.2 ptp85 -54.13 -38.37 65.37 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 169.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.23 -52.81 52.21 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 122.111 0.958 . . . . 0.0 110.05 174.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.24 -32.71 74.52 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.695 -178.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.1 -50.22 43.03 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.17 1.788 . . . . 0.0 112.559 176.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -50.11 -42.61 50.7 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.659 1.118 . . . . 0.0 111.975 169.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 43.0 mt -61.31 -48.83 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.857 -0.527 . . . . 0.0 111.271 173.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.56 -39.88 58.69 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.131 0.572 . . . . 0.0 111.957 174.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -62.63 -40.81 98.18 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.556 0.742 . . . . 0.0 111.284 175.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.01 -29.13 68.05 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 175.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mt -86.55 -32.48 20.67 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.1 pp -71.48 -30.3 65.83 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.618 -0.676 . . . . 0.0 111.227 167.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.83 20.06 7.85 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 118.988 -0.896 . . . . 0.0 113.823 168.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.27 -50.0 68.28 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 118.486 1.143 . . . . 0.0 111.179 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -167.27 150.21 6.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.938 2.095 . . . . 0.0 110.566 169.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -86.84 130.15 34.59 Favored 'General case' 0 C--O 1.238 0.471 0 O-C-N 121.21 -0.931 . . . . 0.0 109.166 -178.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.06 150.54 27.36 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.092 0.957 . . . . 0.0 112.351 174.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -76.77 138.44 39.91 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.275 1.03 . . . . 0.0 109.339 168.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -139.24 144.75 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.332 1.053 . . . . 0.0 109.525 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -80.01 152.62 29.35 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.905 0.882 . . . . 0.0 110.04 171.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -163.46 148.05 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.235 1.014 . . . . 0.0 111.028 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -90.76 145.37 24.85 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.888 0.475 . . . . 0.0 112.247 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -117.51 162.56 17.78 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.767 1.227 . . . . 0.0 111.93 172.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -127.94 136.46 51.36 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.604 0.761 . . . . 0.0 111.531 168.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.7 mmt85 -71.08 152.22 43.72 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.446 1.498 . . . . 0.0 111.624 173.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -54.88 -30.57 58.29 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.788 1.235 . . . . 0.0 112.341 168.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -76.21 -9.95 59.03 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.568 1.547 . . . . 0.0 114.271 175.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.8 10.23 47.16 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.296 1.427 . . . . 0.0 116.313 174.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.3 m -87.61 135.12 33.49 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 119.14 1.47 . . . . 0.0 111.578 176.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 59.3 m -123.24 133.18 54.22 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.467 1.107 . . . . 0.0 112.243 -171.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -150.9 140.47 21.59 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -176.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -102.58 127.46 49.65 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.004 1.722 . . . . 0.0 108.465 168.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 60.9 m -128.45 168.49 15.56 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.435 1.094 . . . . 0.0 110.579 171.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 73.2 mt -79.99 59.85 3.36 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.876 -1.14 . . . . 0.0 110.199 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.3 t -59.06 146.37 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.531 1.532 . . . . 0.0 112.208 -168.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -100.05 69.69 1.53 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 122.56 1.172 . . . . 0.0 112.31 -168.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.9 t -84.67 69.85 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 121.372 -0.83 . . . . 0.0 111.346 -168.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.2 t -111.25 129.2 24.28 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 124.504 1.121 . . . . 0.0 109.464 -178.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -82.96 -168.67 0.61 Allowed 'Trans proline' 0 CA--C 1.553 1.427 0 C-N-CA 123.121 2.548 . . . . 0.0 111.298 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -127.17 128.9 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-O 123.124 1.44 . . . . 0.0 113.945 175.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -111.7 162.2 15.46 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.675 2.39 . . . . 0.0 112.818 -175.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -94.46 -178.95 4.74 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.475 172.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -61.57 -22.18 64.96 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -71.89 -19.98 61.86 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.641 1.177 . . . . 0.0 113.829 170.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.32 -0.03 59.85 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 126.017 1.77 . . . . 0.0 114.372 -176.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.4 140.01 29.94 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.541 1.171 . . . . 0.0 113.146 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.3 p -73.95 98.89 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.668 1.587 . . . . 0.0 109.8 -176.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.96 -30.03 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 118.397 -0.811 . . . . 0.0 111.059 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.7 mmt -135.96 149.91 49.07 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-O 123.455 1.597 . . . . 0.0 110.452 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.2 m-30 -105.61 81.09 1.63 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -175.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.9 mt -99.95 69.99 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 120.206 -1.559 . . . . 0.0 108.295 173.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -73.96 87.64 1.83 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 123.405 1.574 . . . . 0.0 109.398 176.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -59.89 96.54 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 112.845 -1.98 . . . . 0.0 109.862 176.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -83.4 52.76 2.3 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.454 -1.403 . . . . 0.0 111.881 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -79.84 127.08 31.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 122.065 0.936 . . . . 0.0 111.992 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 t -69.36 123.56 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.423 1.089 . . . . 0.0 109.016 172.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 169.25 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo . . . . . 0 CA--C 1.536 0.604 0 CA-C-O 122.3 0.875 . . . . 0.0 112.031 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -63.87 -27.16 68.97 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -168.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -68.45 -50.0 55.72 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.754 0.822 . . . . 0.0 110.371 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 t -75.67 -33.9 60.43 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.835 0.854 . . . . 0.0 112.488 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -59.9 -40.35 88.47 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.454 0.702 . . . . 0.0 110.185 172.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.4 tp -71.6 -45.99 60.55 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-O 118.824 -0.607 . . . . 0.0 112.161 172.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -46.86 -39.75 12.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.587 1.555 . . . . 0.0 113.353 173.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 90.3 m -60.01 -44.77 94.35 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.546 -0.721 . . . . 0.0 112.025 172.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.1 mm -67.3 -35.54 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.881 0.872 . . . . 0.0 110.756 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.4 mm -55.78 -54.95 20.66 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 172.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 -59.96 -28.43 67.65 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.981 0.809 . . . . 0.0 113.038 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.7 tttt -64.27 -41.69 96.79 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 172.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -103.51 1.01 31.76 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 . . . . . 0 N--CA 1.477 0.894 0 C-N-CA 126.872 2.069 . . . . 0.0 114.16 -168.612 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.6 mttp . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -169.72 161.5 9.28 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.392 1.477 . . . . 0.0 113.374 176.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -125.01 167.92 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 126.845 2.058 . . . . 0.0 111.636 170.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.6 mm -125.74 122.43 62.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 125.846 1.658 . . . . 0.0 107.882 173.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.41 152.78 49.43 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 178.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -77.91 106.72 9.95 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 121.561 0.696 . . . . 0.0 111.191 172.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.71 -14.98 61.23 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -94.97 4.14 54.14 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.808 1.243 . . . . 0.0 114.163 -172.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -117.73 140.09 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.482 1.513 . . . . 0.0 110.647 -176.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.34 -26.05 66.28 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -177.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.83 -8.95 59.85 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.223 1.409 . . . . 0.0 114.001 177.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.5 p 35.34 56.12 0.84 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 127.043 2.137 . . . . 0.0 114.214 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.93 153.14 17.92 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -167.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.0 t -79.97 89.97 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 128.64 2.776 . . . . 0.0 108.895 -176.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.5 pt -70.82 -24.64 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.642 1.177 . . . . 0.0 112.2 176.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -154.9 159.77 40.7 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 177.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 25.5 p -142.29 146.8 35.46 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -172.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -92.01 154.1 19.0 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.549 0.69 . . . . 0.0 112.595 167.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -62.9 -33.56 75.57 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.265 0.626 . . . . 0.0 111.14 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.95 -49.95 56.78 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 121.69 -0.631 . . . . 0.0 113.155 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.02 -29.86 67.01 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 119.41 1.605 . . . . 0.0 111.141 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.8 t -59.19 -39.87 83.92 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 120.78 -1.2 . . . . 0.0 110.429 171.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -79.49 -24.79 42.07 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.285 1.034 . . . . 0.0 112.935 173.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.4 tp -59.33 -50.33 74.39 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.438 1.095 . . . . 0.0 110.398 172.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.1 m -86.68 -23.71 25.51 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 175.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.59 31.72 60.37 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 124.481 1.038 . . . . 0.0 114.197 -175.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 17.7 m-30 -95.99 -130.16 0.16 Allowed 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 118.379 1.09 . . . . 0.0 112.146 -175.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.4 t -160.06 149.96 18.19 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 128.026 2.53 . . . . 0.0 108.578 174.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -61.3 -35.35 77.09 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 120.699 -1.251 . . . . 0.0 113.234 -173.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.42 -16.67 48.92 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.436 1.094 . . . . 0.0 113.26 175.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -93.66 -20.86 19.77 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.422 1.889 . . . . 0.0 111.99 178.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 m -95.83 -19.99 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 119.762 1.164 . . . . 0.0 113.296 -174.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 34.3 mmt -50.01 112.97 0.75 Allowed 'General case' 0 C--N 1.342 0.248 0 C-N-CA 124.683 1.193 . . . . 0.0 110.889 -173.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 68.74 21.99 7.56 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.193 1.397 . . . . 0.0 113.549 169.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.3 158.79 86.92 Favored Pre-proline 0 N--CA 1.475 0.785 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.687 167.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.78 140.01 93.23 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.117 1.878 . . . . 0.0 111.481 169.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 3.9 t -69.62 -14.69 62.96 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.043 1.337 . . . . 0.0 112.747 177.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.28 99.8 0.31 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 127.82 2.448 . . . . 0.0 110.544 176.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 30.4 p -55.23 -14.86 1.93 Allowed 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.638 -1.165 . . . . 0.0 113.652 174.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -47.15 -42.82 20.28 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.442 1.497 . . . . 0.0 111.828 167.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -66.81 -12.66 59.77 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 pp -123.05 23.62 9.2 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.282 1.833 . . . . 0.0 113.428 171.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.12 146.85 53.52 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.036 -1.04 . . . . 0.0 112.912 177.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -123.19 -177.43 15.14 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.309 1.433 . . . . 0.0 114.547 -173.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -66.78 -10.15 27.18 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.009 2.473 . . . . 0.0 116.218 -172.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -110.07 -5.34 15.42 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.702 1.201 . . . . 0.0 113.898 170.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.468 HG22 ' H ' ' A' ' 97' ' ' ALA . 3.6 m -71.23 134.1 46.62 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.889 1.222 . . . . 0.0 110.076 177.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -79.88 134.59 36.31 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 122.263 1.03 . . . . 0.0 109.072 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -66.3 -39.71 89.51 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.342 -0.849 . . . . 0.0 110.105 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.8 ptt-85 -55.34 -38.91 69.38 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.559 1.144 . . . . 0.0 113.909 169.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.16 -52.84 60.79 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.987 0.915 . . . . 0.0 110.482 174.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.05 -34.45 78.45 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.181 -178.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.09 -52.81 24.53 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.599 1.16 . . . . 0.0 112.194 176.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -50.18 -40.01 45.59 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.378 0.99 . . . . 0.0 112.921 171.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 46.2 mt -63.62 -49.27 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 121.453 -0.779 . . . . 0.0 111.365 173.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.75 -39.88 59.3 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.777 0.717 . . . . 0.0 111.763 173.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -63.29 -39.76 95.48 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.319 0.648 . . . . 0.0 111.542 175.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.04 -29.7 68.74 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.3 mt -82.79 -34.97 26.87 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.9 pp -70.66 -27.2 63.85 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.976 -0.453 . . . . 0.0 112.056 167.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.93 17.48 9.6 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.315 -0.714 . . . . 0.0 114.2 169.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -51.61 -49.88 61.32 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 118.087 0.944 . . . . 0.0 112.042 173.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -157.01 142.74 17.66 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.52 1.928 . . . . 0.0 110.644 170.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -75.81 118.19 18.35 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.71 -1.244 . . . . 0.0 108.017 169.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -146.23 135.62 22.94 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.851 0.86 . . . . 0.0 112.474 -167.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -86.88 130.0 34.65 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.043 1.337 . . . . 0.0 109.518 168.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.71 144.28 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.21 1.404 . . . . 0.0 109.081 -175.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -79.88 150.62 30.54 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.522 0.729 . . . . 0.0 109.891 171.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -160.86 159.98 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.367 1.067 . . . . 0.0 110.32 -177.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.468 ' H ' HG22 ' A' ' 74' ' ' THR . . . -102.09 145.31 29.52 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.807 171.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -112.4 152.59 28.47 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.862 1.665 . . . . 0.0 110.645 169.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -127.06 139.56 52.91 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.44 0.638 . . . . 0.0 110.289 167.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -84.9 158.55 20.54 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.786 1.234 . . . . 0.0 112.927 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -54.68 -30.44 55.63 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.574 1.55 . . . . 0.0 112.853 169.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -75.45 -9.94 59.02 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.115 1.366 . . . . 0.0 113.998 175.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.08 3.82 55.6 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.76 1.647 . . . . 0.0 115.763 176.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 54.2 m -84.57 128.24 34.49 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 119.169 1.484 . . . . 0.0 111.347 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 46.9 t -124.43 129.88 51.47 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.065 1.346 . . . . 0.0 112.005 -173.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -150.91 139.96 21.07 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.399 1.079 . . . . 0.0 113.764 -169.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.0 134.87 49.51 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.711 2.404 . . . . 0.0 109.121 172.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 4.5 m -139.04 173.1 11.91 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.66 1.584 . . . . 0.0 110.281 168.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 26.6 tp -76.95 59.84 1.7 Allowed 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.019 -1.051 . . . . 0.0 109.995 173.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.7 t -59.81 146.98 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.955 1.302 . . . . 0.0 110.8 -172.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -100.0 69.72 1.55 Allowed 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 122.802 1.287 . . . . 0.0 112.584 -168.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.1 t -84.19 69.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.343 1.057 . . . . 0.0 110.89 -169.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.2 p -117.88 134.07 23.31 Favored Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 124.038 0.935 . . . . 0.0 111.887 -173.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -86.81 -173.22 1.1 Allowed 'Trans proline' 0 CA--C 1.546 1.089 0 C-N-CA 123.472 2.781 . . . . 0.0 113.445 -172.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.16 127.12 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-O 122.972 1.368 . . . . 0.0 113.483 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -110.62 162.07 15.1 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.634 2.374 . . . . 0.0 112.63 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -92.81 179.97 5.31 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.735 -1.121 . . . . 0.0 112.156 171.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.67 -21.4 65.69 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -70.84 -19.87 62.61 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.481 1.112 . . . . 0.0 113.737 169.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.69 0.09 59.27 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 126.007 1.765 . . . . 0.0 114.406 -176.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.74 139.64 30.36 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.69 1.245 . . . . 0.0 113.292 -178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.8 p -74.53 100.1 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 125.582 1.553 . . . . 0.0 110.565 -176.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.26 -29.98 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.34 0.656 . . . . 0.0 111.837 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.27 149.99 50.97 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 124.273 1.987 . . . . 0.0 112.732 173.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.3 m-30 -104.45 82.05 1.88 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.155 -1.839 . . . . 0.0 107.048 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.3 mt -102.06 69.88 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 171.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.19 86.56 5.59 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.899 0.857 . . . . 0.0 108.858 -178.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -59.94 104.21 0.28 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.544 1.138 . . . . 0.0 110.94 -175.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -83.85 58.13 4.5 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.277 -1.514 . . . . 0.0 111.729 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -79.79 124.95 29.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 122.626 1.203 . . . . 0.0 110.914 176.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 55.9 t -81.99 113.34 21.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 125.048 1.339 . . . . 0.0 108.27 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.474 0.727 0 CA-C-O 120.836 0.351 . . . . 0.0 111.635 -177.964 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 118.757 -0.639 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -66.88 -27.74 43.3 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.129 2.553 . . . . 0.0 115.196 -175.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.1 p -149.54 156.79 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.771 1.628 . . . . 0.0 110.676 -177.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 30.9 ptt-85 -78.16 52.45 1.1 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.902 1.681 . . . . 0.0 114.401 -176.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -122.92 149.95 43.57 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.794 2.037 . . . . 0.0 111.42 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.29 -54.79 3.98 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.982 1.277 . . . . 0.0 113.351 -177.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 44.0 p-80 -88.17 157.5 18.8 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.535 1.134 . . . . 0.0 112.124 170.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.1 t -130.02 136.09 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.99 1.316 . . . . 0.0 109.246 171.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.43 159.96 69.45 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.091 0.956 . . . . 0.0 111.881 173.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -57.64 105.41 0.2 Allowed 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.678 2.252 . . . . 0.0 110.648 170.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -63.96 -26.98 68.83 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -167.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -70.05 -49.98 45.78 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.67 0.668 . . . . 0.0 110.761 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.5 t -78.25 -33.99 49.36 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.547 1.139 . . . . 0.0 112.357 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -59.78 -42.4 93.24 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.306 0.642 . . . . 0.0 109.947 172.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.9 tp -70.12 -45.43 66.89 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-O 118.708 -0.663 . . . . 0.0 111.868 173.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -48.05 -39.87 21.3 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 120.04 1.291 . . . . 0.0 113.207 174.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.6 m -60.07 -44.98 94.35 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.605 -0.684 . . . . 0.0 112.261 172.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.8 mm -66.34 -36.61 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.762 0.825 . . . . 0.0 110.691 175.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.9 mm -55.96 -53.87 33.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.434 0 CA-C-O 118.445 -0.788 . . . . 0.0 109.05 173.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -59.97 -29.0 68.14 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 118.845 0.748 . . . . 0.0 112.54 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 tptt -63.42 -46.2 87.45 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 118.624 -0.703 . . . . 0.0 112.815 172.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -101.41 11.4 39.22 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.05 -29.09 68.3 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.273 1.429 . . . . 0.0 113.698 -167.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.4 15.04 56.44 Favored Glycine 0 CA--C 1.536 1.391 0 N-CA-C 118.02 1.968 . . . . 0.0 118.02 166.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -121.71 -44.08 2.34 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.358 1.463 . . . . 0.0 111.663 -174.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 71.4 m -113.93 -25.24 8.67 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.085 1.754 . . . . 0.0 111.816 168.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.1 mmt-85 -100.06 156.37 17.21 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.265 1.426 . . . . 0.0 112.63 173.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -134.02 145.35 49.37 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.976 1.71 . . . . 0.0 111.953 -168.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -169.9 161.29 8.86 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -171.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -128.03 172.29 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.884 1.274 . . . . 0.0 111.732 174.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.2 mm -130.28 120.07 48.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 125.988 1.715 . . . . 0.0 108.375 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.02 153.78 51.15 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -81.34 108.49 15.0 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.599 0.714 . . . . 0.0 111.469 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.21 -15.82 62.48 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.239 1.015 . . . . 0.0 113.461 177.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -89.96 -2.13 58.1 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.705 1.602 . . . . 0.0 113.906 -172.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.27 140.14 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.105 1.362 . . . . 0.0 110.567 -174.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -59.46 -28.17 66.74 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -177.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -84.16 -3.55 58.21 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.017 1.327 . . . . 0.0 114.469 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.5 p 37.44 51.29 1.17 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 126.899 2.079 . . . . 0.0 114.417 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.77 150.18 24.33 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -167.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.4 t -79.96 89.96 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 127.843 2.457 . . . . 0.0 108.957 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.8 pt -70.0 -24.86 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.08 1.352 . . . . 0.0 112.446 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -154.78 159.71 40.8 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.151 0.98 . . . . 0.0 112.576 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 5.8 p -148.77 145.29 27.52 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.975 -1.078 . . . . 0.0 113.07 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -86.89 156.64 19.76 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 178.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.58 -27.65 67.87 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.621 0.769 . . . . 0.0 111.913 171.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.41 -50.49 52.6 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.331 -0.856 . . . . 0.0 113.03 170.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.57 -38.16 74.36 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 119.652 1.726 . . . . 0.0 110.593 173.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.6 t -60.22 -40.78 91.35 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.821 -0.55 . . . . 0.0 111.098 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -77.62 -26.31 50.48 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.649 0.78 . . . . 0.0 112.969 175.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.0 tp -63.92 -55.81 19.88 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.951 1.3 . . . . 0.0 111.29 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 77.1 m -95.96 -20.05 19.03 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.934 0.894 . . . . 0.0 113.067 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.4 20.21 76.71 Favored Glycine 0 CA--C 1.538 1.491 0 O-C-N 120.988 -1.07 . . . . 0.0 113.847 -174.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -84.87 -129.64 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.97 1.308 . . . . 0.0 110.313 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 41.6 t -159.87 150.12 18.66 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 127.589 2.356 . . . . 0.0 108.288 173.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.1 mtm180 -58.28 -35.28 71.55 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.124 -0.985 . . . . 0.0 112.328 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.42 -21.71 64.35 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -81.85 -20.79 38.23 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.207 1.403 . . . . 0.0 112.511 175.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -105.3 -17.06 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 7.6 mmt -49.89 108.0 0.19 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 125.519 1.528 . . . . 0.0 111.051 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 70.55 18.86 6.39 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.792 1.637 . . . . 0.0 113.793 171.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.12 159.11 76.29 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 123.843 0.857 . . . . 0.0 110.452 167.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -60.34 140.03 89.74 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.532 2.154 . . . . 0.0 111.857 169.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.7 t -67.47 -9.99 47.26 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.844 1.657 . . . . 0.0 113.469 176.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.7 m -62.81 100.17 0.19 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 127.672 2.389 . . . . 0.0 111.507 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 46.4 m -49.93 -23.48 1.99 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.088 1.755 . . . . 0.0 115.299 -176.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -46.99 -41.81 16.94 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.435 1.494 . . . . 0.0 112.863 169.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -63.1 -16.64 60.63 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.28 1.032 . . . . 0.0 113.551 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 pp -123.11 25.25 8.57 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.74 1.616 . . . . 0.0 113.653 173.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -65.01 151.56 45.67 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.109 -0.995 . . . . 0.0 112.181 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -125.6 -177.81 15.05 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.378 1.466 . . . . 0.0 113.694 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -64.65 -10.13 23.45 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.318 2.679 . . . . 0.0 116.293 -171.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -107.6 -7.39 16.49 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.825 1.65 . . . . 0.0 113.341 175.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.8 m -71.71 132.22 44.23 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.074 -1.016 . . . . 0.0 111.335 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -80.01 135.72 36.44 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.081 0.943 . . . . 0.0 110.105 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.3 mmt-85 -66.33 -39.79 89.47 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.737 -0.602 . . . . 0.0 110.658 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 49.5 ptt85 -53.76 -39.07 65.06 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.385 1.074 . . . . 0.0 113.463 171.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.03 -50.21 43.57 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.593 1.157 . . . . 0.0 110.234 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.23 -33.67 76.55 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.137 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.5 -54.98 11.57 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.478 1.111 . . . . 0.0 111.541 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -50.16 -40.14 45.72 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.862 0.865 . . . . 0.0 112.873 172.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.4 mt -65.48 -50.03 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 118.758 0.708 . . . . 0.0 111.018 174.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.09 -39.89 57.13 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.732 -0.651 . . . . 0.0 111.977 174.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -70.03 -37.71 75.69 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.449 0.7 . . . . 0.0 111.669 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.66 -34.02 76.95 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.328 -0.857 . . . . 0.0 111.317 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mt -83.15 -28.88 29.07 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.509 0.724 . . . . 0.0 111.664 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.19 -27.88 69.01 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.819 2.048 . . . . 0.0 111.016 168.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.0 17.36 9.64 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.245 1.402 . . . . 0.0 114.918 170.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.89 -49.93 74.24 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 118.642 1.221 . . . . 0.0 111.231 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -159.9 139.06 10.93 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.886 1.674 . . . . 0.0 111.392 169.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -74.02 101.45 3.87 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 169.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -144.04 140.05 29.32 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.82 1.248 . . . . 0.0 111.828 -168.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -77.49 135.03 38.2 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.506 1.123 . . . . 0.0 111.123 173.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -136.51 153.2 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.038 1.735 . . . . 0.0 108.553 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -79.93 160.07 26.11 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.857 0.863 . . . . 0.0 110.104 169.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -164.35 149.85 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 119.234 0.925 . . . . 0.0 111.448 169.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -88.89 145.33 25.61 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.431 0.692 . . . . 0.0 111.548 172.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -117.29 160.97 20.25 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.374 1.07 . . . . 0.0 110.999 173.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -125.64 140.04 53.06 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.466 0.65 . . . . 0.0 111.441 169.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -83.99 154.78 23.11 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.418 1.087 . . . . 0.0 112.591 175.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -53.95 -27.85 33.64 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.025 1.73 . . . . 0.0 113.089 171.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -71.42 -9.95 58.99 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.188 1.395 . . . . 0.0 114.181 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.76 18.24 33.06 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.249 1.404 . . . . 0.0 115.831 175.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 71.2 m -107.17 136.86 46.29 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 118.634 1.217 . . . . 0.0 111.717 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 29.5 t -126.21 135.0 51.08 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.858 1.263 . . . . 0.0 112.325 -175.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -149.96 139.98 22.01 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.55 1.14 . . . . 0.0 113.422 -168.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -102.54 125.56 49.3 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.408 1.883 . . . . 0.0 109.139 170.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 61.4 m -129.74 173.16 10.9 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.42 1.488 . . . . 0.0 110.082 173.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 30.4 tp -79.31 59.88 2.96 Favored 'General case' 0 CA--C 1.549 0.911 0 O-C-N 120.592 -1.317 . . . . 0.0 111.644 -176.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 45.7 t -63.41 142.9 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 126.062 1.745 . . . . 0.0 111.623 -173.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -108.81 69.98 0.73 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.203 1.001 . . . . 0.0 112.979 -167.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.8 t -81.25 70.02 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.732 1.213 . . . . 0.0 111.045 -168.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.8 p -121.51 126.53 26.45 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 124.133 0.973 . . . . 0.0 112.247 -175.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -88.93 -176.4 1.39 Allowed 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 123.846 3.031 . . . . 0.0 112.293 -173.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -117.03 133.59 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 123.178 1.465 . . . . 0.0 113.677 -175.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.46 160.78 30.43 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.092 2.157 . . . . 0.0 111.947 -173.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -89.92 -176.27 4.87 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.124 0.97 . . . . 0.0 112.092 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -62.48 -19.98 64.11 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -77.29 -19.97 55.71 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.011 1.324 . . . . 0.0 113.862 170.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.75 -0.13 64.74 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.23 1.395 . . . . 0.0 114.447 -176.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.25 131.38 35.29 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.372 1.086 . . . . 0.0 111.669 174.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.7 p -72.56 98.3 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.73 2.012 . . . . 0.0 111.078 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.7 -29.14 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 123.555 0.742 . . . . 0.0 111.731 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.9 148.6 50.12 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 124.115 1.912 . . . . 0.0 112.834 174.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -102.45 83.93 2.37 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 125.815 1.646 . . . . 0.0 106.766 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.6 mt -99.87 79.29 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 170.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.296 34.5 mt -83.0 86.01 7.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 123.226 1.488 . . . . 0.0 108.946 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -59.93 103.13 0.19 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 113.045 -1.889 . . . . 0.0 109.441 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -85.16 55.63 3.58 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 122.584 1.183 . . . . 0.0 110.885 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -79.83 106.75 12.09 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 123.653 1.692 . . . . 0.0 110.507 -176.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.54 120.32 12.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 125.73 1.612 . . . . 0.0 108.691 170.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.2 146.74 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 O-C-N 123.277 0.36 . . . . 0.0 110.076 175.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 87.9 mtp -142.11 152.36 43.18 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.111 1.364 . . . . 0.0 111.145 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -74.46 153.2 39.27 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.241 1.017 . . . . 0.0 112.646 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 C--O 1.253 1.255 0 C-N-CA 125.363 1.465 . . . . 0.0 112.439 177.799 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.8 ttp . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 118.612 -0.709 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -59.32 151.92 64.38 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.459 2.773 . . . . 0.0 113.901 176.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.0 p -148.95 150.86 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.437 1.495 . . . . 0.0 110.878 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -71.91 134.04 45.79 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.76 0.824 . . . . 0.0 110.644 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -153.21 170.09 21.41 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.981 1.712 . . . . 0.0 112.25 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.32 8.27 58.69 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 125.138 1.352 . . . . 0.0 116.38 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -134.71 141.21 46.46 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.319 1.559 . . . . 0.0 112.746 -175.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.2 t -119.33 140.87 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.292 1.437 . . . . 0.0 109.527 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.58 160.76 9.37 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 123.943 0.897 . . . . 0.0 111.786 171.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -42.15 110.09 0.14 Allowed 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 124.57 3.513 . . . . 0.0 112.329 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -60.02 -28.8 68.03 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -165.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -66.65 -49.85 64.85 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.715 0.806 . . . . 0.0 110.53 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 t -79.2 -34.15 43.21 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.177 0.991 . . . . 0.0 112.428 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -58.41 -39.94 81.11 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.07 0.948 . . . . 0.0 110.458 170.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 44.5 tp -70.07 -45.72 66.44 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 118.813 -0.613 . . . . 0.0 111.999 170.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -46.5 -39.93 11.64 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.975 1.31 . . . . 0.0 112.936 174.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.6 m -58.97 -45.1 91.39 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 121.595 -0.691 . . . . 0.0 111.664 173.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.8 mm -66.1 -36.84 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.89 0.876 . . . . 0.0 110.543 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.2 mm -54.51 -55.79 13.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 CA-C-O 117.777 -1.106 . . . . 0.0 108.545 171.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -59.87 -29.99 68.69 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 120.108 1.322 . . . . 0.0 111.922 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.1 tptt -63.6 -40.64 97.46 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.582 1.153 . . . . 0.0 112.235 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -108.16 -0.14 21.19 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 116.034 1.864 . . . . 0.0 116.034 176.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.17 -29.19 68.51 Favored 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -166.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.66 -1.68 69.11 Favored Glycine 0 CA--C 1.54 1.627 0 N-CA-C 117.75 1.86 . . . . 0.0 117.75 169.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -122.13 -32.17 3.74 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.075 1.75 . . . . 0.0 111.492 169.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.4 m -64.2 -29.98 71.06 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.707 0.803 . . . . 0.0 110.478 167.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -76.35 149.93 36.92 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.395 1.478 . . . . 0.0 112.924 169.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -139.95 153.37 46.89 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 128.872 2.869 . . . . 0.0 108.892 170.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -169.72 160.92 9.03 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -121.25 168.93 13.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 126.892 2.077 . . . . 0.0 111.387 170.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.8 mm -119.1 113.85 42.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 126.105 1.762 . . . . 0.0 106.617 170.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -119.09 148.98 42.44 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.922 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -80.87 113.21 18.92 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.946 0.898 . . . . 0.0 110.068 174.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.03 -12.4 60.32 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -100.01 -7.45 25.04 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.022 1.329 . . . . 0.0 114.041 -169.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 p -105.85 140.07 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.887 1.675 . . . . 0.0 111.285 -177.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.76 -30.73 70.19 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -174.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -77.35 -8.96 58.5 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.272 1.029 . . . . 0.0 113.592 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.8 m 48.63 39.01 12.51 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.746 1.618 . . . . 0.0 113.138 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.21 155.16 27.5 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -166.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.9 t -79.96 93.15 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 129.128 2.971 . . . . 0.0 108.192 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.4 pt -73.51 -23.62 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.174 1.39 . . . . 0.0 112.149 177.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -157.57 159.75 37.43 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.659 1.184 . . . . 0.0 112.014 175.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.3 p -141.68 151.12 42.73 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.821 -1.174 . . . . 0.0 114.125 -175.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -89.77 151.45 21.81 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.674 0.75 . . . . 0.0 111.653 166.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -65.92 -27.04 67.89 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.614 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.36 -50.07 48.72 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 121.156 -0.965 . . . . 0.0 112.778 172.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -29.86 66.96 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 118.845 1.323 . . . . 0.0 111.67 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.6 t -59.31 -39.83 84.29 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.597 -0.689 . . . . 0.0 110.466 170.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -77.75 -30.01 51.35 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 118.905 0.775 . . . . 0.0 112.857 174.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.4 tp -55.92 -52.1 65.3 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.15 1.38 . . . . 0.0 110.911 174.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 57.7 m -90.64 -20.85 22.06 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.16 9.98 84.41 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 126.557 2.027 . . . . 0.0 116.69 174.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -87.57 -120.25 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 119.558 1.679 . . . . 0.0 112.728 -175.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.1 t -159.86 138.63 10.68 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.772 1.629 . . . . 0.0 110.313 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -60.57 -32.64 71.72 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.328 1.051 . . . . 0.0 113.459 -175.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.14 -16.58 33.6 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.505 1.122 . . . . 0.0 113.645 174.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -97.1 -20.78 17.76 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.778 1.631 . . . . 0.0 112.46 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 m -89.92 -17.24 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 120.145 1.339 . . . . 0.0 113.134 -172.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 36.3 mmt -49.85 114.93 1.19 Allowed 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.221 1.009 . . . . 0.0 109.698 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 72.66 21.07 3.61 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.036 1.735 . . . . 0.0 114.355 171.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.05 154.03 88.65 Favored Pre-proline 0 N--CA 1.48 1.031 0 O-C-N 120.762 -1.211 . . . . 0.0 111.074 167.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.18 139.99 57.51 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.62 2.213 . . . . 0.0 111.645 173.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.8 t -69.95 -18.96 63.38 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.179 0.992 . . . . 0.0 112.991 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.0 m -61.39 100.1 0.12 Allowed 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 127.143 2.177 . . . . 0.0 111.614 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 68.3 m -50.44 -19.29 0.82 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 116.43 2.011 . . . . 0.0 116.43 -173.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -56.33 -36.31 68.59 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.036 -1.04 . . . . 0.0 111.635 172.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -57.58 -23.49 51.04 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.373 1.469 . . . . 0.0 113.391 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 pp -119.44 22.87 11.53 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.938 1.695 . . . . 0.0 113.162 176.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -63.25 147.1 51.96 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.379 -0.826 . . . . 0.0 111.993 173.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.72 -173.13 12.89 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 125.189 1.376 . . . . 0.0 113.219 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -62.35 -10.07 17.48 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 123.758 2.972 . . . . 0.0 116.406 -172.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -108.18 -9.34 15.57 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.902 1.681 . . . . 0.0 113.562 176.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.1 m -81.29 141.17 34.33 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.928 0.891 . . . . 0.0 112.153 -174.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -89.08 136.78 32.83 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 122.294 1.045 . . . . 0.0 111.512 171.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.4 mmm-85 -69.98 -39.69 75.78 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.363 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -53.23 -39.29 63.68 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 169.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.9 -52.84 54.31 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 122.221 1.01 . . . . 0.0 110.031 175.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.94 -33.86 77.03 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.882 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.02 -50.92 36.53 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.941 1.696 . . . . 0.0 112.271 176.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -50.2 -41.56 49.88 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.42 1.009 . . . . 0.0 112.306 169.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.7 mt -61.78 -49.9 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 O-C-N 121.653 -0.654 . . . . 0.0 111.001 171.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.07 -39.85 56.97 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.385 -0.817 . . . . 0.0 112.171 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -70.11 -34.88 73.67 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.695 0.798 . . . . 0.0 111.888 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.53 -31.45 69.67 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.656 -0.653 . . . . 0.0 111.744 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 mt -82.78 -32.24 27.84 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.537 0.735 . . . . 0.0 111.604 176.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.07 -33.1 74.72 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.868 2.067 . . . . 0.0 110.833 169.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.78 23.67 6.11 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.551 1.072 . . . . 0.0 115.031 168.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.75 -50.63 62.13 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.168 1.484 . . . . 0.0 110.218 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -151.77 143.41 23.6 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.389 2.276 . . . . 0.0 108.63 172.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -77.71 115.56 17.56 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.703 1.138 . . . . 0.0 108.188 169.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -138.96 137.73 36.67 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.592 1.157 . . . . 0.0 111.646 -168.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -87.03 129.63 34.81 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.177 1.791 . . . . 0.0 109.949 169.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.27 145.97 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.102 1.361 . . . . 0.0 109.355 -175.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -79.97 151.44 30.03 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.457 0.703 . . . . 0.0 109.846 170.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -163.0 147.13 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.06 0.944 . . . . 0.0 110.544 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -87.58 141.42 28.62 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.206 175.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -106.09 155.19 19.67 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.915 1.286 . . . . 0.0 111.231 169.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -121.83 138.29 54.44 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.796 0.838 . . . . 0.0 109.089 166.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -100.04 152.59 20.04 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.944 1.697 . . . . 0.0 110.504 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.92 -15.59 44.27 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 -171.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -78.28 -11.08 59.91 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.227 1.411 . . . . 0.0 113.72 171.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.86 2.53 56.15 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 126.203 1.859 . . . . 0.0 115.126 -174.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 55.3 m -74.77 128.21 35.01 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.866 1.833 . . . . 0.0 111.328 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 67.1 m -124.47 130.62 52.8 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.696 1.198 . . . . 0.0 111.443 -175.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -150.01 139.93 21.9 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.89 0.876 . . . . 0.0 113.013 -171.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -110.36 134.79 51.96 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.673 1.989 . . . . 0.0 109.3 172.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 2.1 m -138.95 171.64 14.02 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.502 1.521 . . . . 0.0 110.457 169.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 29.5 tp -76.88 59.87 1.68 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.199 0.999 . . . . 0.0 110.088 174.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.0 t -58.29 145.36 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.912 1.285 . . . . 0.0 110.516 -172.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -100.0 69.76 1.55 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.693 1.235 . . . . 0.0 111.277 -168.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.4 t -82.43 69.85 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.268 1.027 . . . . 0.0 110.526 -170.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.3 130.76 24.41 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.004 0.922 . . . . 0.0 110.948 -176.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -85.47 -169.72 0.64 Allowed 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 123.199 2.6 . . . . 0.0 111.888 -174.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.92 130.33 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-O 123.133 1.444 . . . . 0.0 113.947 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.4 mttm -112.82 162.4 15.83 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 127.655 2.382 . . . . 0.0 112.801 -175.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -93.17 -179.98 5.25 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.154 171.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.4 -21.69 65.57 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -70.63 -19.88 62.78 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.532 1.133 . . . . 0.0 113.727 169.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.51 0.32 59.44 Favored Glycine 0 CA--C 1.533 1.156 0 C-N-CA 126.112 1.815 . . . . 0.0 114.423 -176.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.75 139.39 30.61 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.64 1.22 . . . . 0.0 113.274 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.6 p -74.67 98.96 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.484 1.513 . . . . 0.0 109.856 -176.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.37 -30.01 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 118.345 -0.836 . . . . 0.0 110.833 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.9 mmt -136.59 150.04 48.37 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-O 123.85 1.786 . . . . 0.0 110.906 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -104.33 81.11 1.78 Allowed 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 125.564 1.545 . . . . 0.0 107.522 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 36.1 mt -100.44 70.74 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 O-C-N 120.481 -1.387 . . . . 0.0 109.211 172.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -77.25 85.72 3.69 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 123.44 1.591 . . . . 0.0 109.384 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -60.0 103.05 0.19 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 112.877 -1.965 . . . . 0.0 111.007 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -85.54 62.71 7.65 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.518 -1.364 . . . . 0.0 111.799 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -79.71 131.33 35.92 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.185 -0.947 . . . . 0.0 110.372 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 50.5 t -92.95 114.6 30.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 124.58 1.152 . . . . 0.0 108.118 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.34 136.9 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-O 121.331 0.586 . . . . 0.0 112.094 -175.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 28.1 ptm -127.93 164.78 21.55 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.088 1.755 . . . . 0.0 111.329 173.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.07 153.58 43.51 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 45.0 mttm . . . . . 0 C--O 1.253 1.277 0 C-N-CA 126.019 1.728 . . . . 0.0 112.16 176.566 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.3 mtm . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 119.037 -0.506 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -69.11 156.56 64.66 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.439 2.759 . . . . 0.0 112.514 176.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.2 t -134.53 140.87 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.554 1.542 . . . . 0.0 109.875 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -65.52 145.74 55.73 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.351 1.061 . . . . 0.0 111.938 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.26 145.01 24.76 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.813 1.245 . . . . 0.0 109.981 172.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.76 -147.28 46.42 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 123.226 0.441 . . . . 0.0 112.274 -169.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -73.95 158.99 33.4 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.143 0.977 . . . . 0.0 112.843 175.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.0 t -78.97 121.26 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.702 0.801 . . . . 0.0 109.782 174.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.02 159.93 82.4 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.154 0.982 . . . . 0.0 111.489 173.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.61 103.5 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.68 2.253 . . . . 0.0 111.855 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -65.8 -27.08 68.0 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.989 0.915 . . . . 0.0 113.257 -169.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -70.02 -49.99 45.88 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.023 0.529 . . . . 0.0 110.325 -176.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.5 t -74.13 -35.31 64.09 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.724 0.81 . . . . 0.0 112.509 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -58.24 -41.48 84.27 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.318 0.647 . . . . 0.0 109.909 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.1 tp -75.49 -45.04 40.74 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 118.619 -0.705 . . . . 0.0 112.427 174.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -47.66 -39.81 18.18 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.713 1.605 . . . . 0.0 113.151 175.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.7 m -60.02 -45.16 93.71 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.88 -0.513 . . . . 0.0 111.679 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.5 mm -68.95 -34.77 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.941 0.897 . . . . 0.0 110.931 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.8 mm -54.67 -56.5 10.15 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 171.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -60.8 -27.05 67.73 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 176.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -63.2 -43.1 99.12 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.465 0.706 . . . . 0.0 112.228 172.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -104.66 -0.01 27.98 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -59.74 -29.24 68.01 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.504 1.522 . . . . 0.0 113.751 -167.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.29 -0.02 69.88 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 125.276 1.417 . . . . 0.0 115.731 -176.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -114.61 -47.13 2.92 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.2 1.5 . . . . 0.0 112.969 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.9 m -78.98 3.06 18.26 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 175.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -120.06 151.07 39.56 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.522 1.529 . . . . 0.0 113.303 -173.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -134.46 143.23 47.39 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.349 1.859 . . . . 0.0 111.567 -167.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -169.81 162.36 9.47 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -169.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -122.93 168.96 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 128.039 2.536 . . . . 0.0 111.217 171.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.0 mm -128.24 124.81 63.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 C-N-CA 126.219 1.807 . . . . 0.0 108.378 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.06 154.46 49.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -177.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -77.77 108.27 10.88 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.402 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.01 -19.52 63.32 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -94.84 2.38 55.45 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.701 1.201 . . . . 0.0 113.989 -169.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.49 140.07 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.32 1.448 . . . . 0.0 110.508 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.97 -23.82 65.63 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -86.55 -7.39 58.41 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.344 1.458 . . . . 0.0 114.23 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.0 p 42.92 43.38 3.51 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 126.945 2.098 . . . . 0.0 115.293 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.53 149.9 32.98 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 -167.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.0 t -80.03 89.98 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 128.584 2.753 . . . . 0.0 109.08 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.7 pt -69.96 -24.54 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.993 1.317 . . . . 0.0 112.453 175.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -153.58 159.62 42.22 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.804 0.842 . . . . 0.0 112.86 173.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.0 p -143.21 143.26 31.69 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.289 -0.882 . . . . 0.0 112.687 -177.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -89.67 155.12 19.44 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 173.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -66.93 -19.92 65.81 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.869 -0.519 . . . . 0.0 112.257 174.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.65 -49.91 55.83 Favored Glycine 0 CA--C 1.535 1.283 0 O-C-N 121.33 -0.856 . . . . 0.0 112.212 169.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -56.75 -39.23 73.62 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 119.04 1.42 . . . . 0.0 110.903 172.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.3 t -60.14 -41.3 92.43 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.922 -0.486 . . . . 0.0 111.321 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -77.1 -30.09 55.2 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.679 0.791 . . . . 0.0 112.663 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.18 -53.8 43.59 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.721 1.609 . . . . 0.0 112.174 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 82.7 m -101.12 -19.97 15.53 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.876 1.271 . . . . 0.0 112.787 -173.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.95 11.87 84.75 Favored Glycine 0 CA--C 1.539 1.541 0 CA-C-O 118.715 -1.047 . . . . 0.0 115.502 176.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -90.71 -122.13 0.07 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.956 1.378 . . . . 0.0 111.401 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.4 t -159.89 150.16 18.67 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.929 1.292 . . . . 0.0 111.095 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.0 mtt-85 -50.04 -43.9 51.16 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.576 1.15 . . . . 0.0 111.189 169.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.81 -19.12 64.78 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.378 1.071 . . . . 0.0 113.824 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -86.48 -20.56 27.91 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.473 1.509 . . . . 0.0 112.81 174.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.7 m -102.11 -18.99 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 174.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 5.4 mmt -49.81 107.47 0.15 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.509 1.523 . . . . 0.0 111.46 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 71.47 18.06 5.56 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.818 1.647 . . . . 0.0 113.85 171.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.55 157.12 72.81 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.039 0.936 . . . . 0.0 111.09 167.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.51 140.17 92.43 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.873 3.049 . . . . 0.0 112.879 169.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.3 m -62.95 -13.79 39.19 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 172.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.3 m -65.98 99.92 0.54 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.396 1.478 . . . . 0.0 110.911 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 32.0 p -53.32 -17.56 1.9 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.878 1.671 . . . . 0.0 115.004 -176.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -48.5 -42.88 34.32 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.925 1.29 . . . . 0.0 111.742 168.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -64.42 -16.19 61.93 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 pp -122.99 23.02 9.45 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.32 1.848 . . . . 0.0 113.432 173.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.27 144.57 57.06 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.224 -0.922 . . . . 0.0 112.568 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.54 173.16 22.67 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.067 1.318 . . . . 0.0 113.479 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.14 -9.99 25.6 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.485 2.79 . . . . 0.0 113.825 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.27 -4.69 25.29 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.192 1.797 . . . . 0.0 113.617 174.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.5 m -80.5 143.19 33.51 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 119.329 0.968 . . . . 0.0 111.889 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.2 mm-40 -92.97 145.24 24.52 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 123.453 1.597 . . . . 0.0 114.097 175.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.473 ' HD2' ' H ' ' A' ' 76' ' ' ARG . 1.2 mpt_? -70.11 -42.45 72.67 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 113.463 -1.699 . . . . 0.0 110.874 -175.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -60.05 -38.85 84.0 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.584 1.154 . . . . 0.0 113.5 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.69 -53.01 57.93 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.044 0.938 . . . . 0.0 109.972 174.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.73 -34.6 78.57 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.551 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.96 -53.29 18.45 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.951 1.301 . . . . 0.0 111.94 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -50.13 -41.6 49.08 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.18 0.9 . . . . 0.0 112.13 171.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 47.7 mt -63.8 -49.79 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 O-C-N 121.834 -0.541 . . . . 0.0 111.493 174.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.87 -39.81 54.77 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.167 0.587 . . . . 0.0 111.912 174.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -67.61 -39.56 84.73 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.553 0.615 . . . . 0.0 111.705 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.45 -27.16 65.01 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.833 -0.542 . . . . 0.0 112.162 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 mt -88.57 -31.53 18.59 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.235 0.614 . . . . 0.0 111.388 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.43 -36.11 79.44 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.31 1.844 . . . . 0.0 109.845 168.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 113.71 22.42 5.39 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.828 1.204 . . . . 0.0 114.821 171.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.24 -50.0 74.84 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 118.374 1.087 . . . . 0.0 111.399 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -159.73 148.6 17.7 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.448 1.499 . . . . 0.0 112.243 170.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -70.97 111.24 6.2 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 167.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -148.07 136.64 21.61 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.41 1.084 . . . . 0.0 111.392 -174.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -84.03 133.59 34.66 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.269 1.428 . . . . 0.0 110.606 171.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.61 146.3 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.434 1.494 . . . . 0.0 109.143 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -80.0 153.9 28.55 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.996 0.918 . . . . 0.0 110.598 172.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -163.74 149.5 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.114 0.966 . . . . 0.0 111.428 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -90.47 145.32 25.0 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.483 174.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -116.64 162.28 17.89 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.632 1.173 . . . . 0.0 111.394 171.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -126.55 137.89 53.41 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.608 0.718 . . . . 0.0 110.59 167.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -92.83 157.59 16.31 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.288 1.835 . . . . 0.0 111.693 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -55.66 -30.55 61.21 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.103 1.761 . . . . 0.0 113.616 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.4 p30 -77.28 -9.89 59.09 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 175.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.51 -1.15 49.56 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 126.247 1.879 . . . . 0.0 115.298 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.4 m -70.1 130.86 43.25 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.35 1.575 . . . . 0.0 111.483 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 80.5 m -119.91 129.48 54.38 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.748 1.219 . . . . 0.0 110.969 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -151.03 140.01 21.01 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -172.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -110.83 131.77 54.77 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 127.19 2.196 . . . . 0.0 108.144 168.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 5.6 m -138.96 179.17 6.65 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.174 1.39 . . . . 0.0 110.93 170.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 76.9 mt -77.61 60.0 2.07 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.153 0.981 . . . . 0.0 110.763 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.6 t -60.57 142.29 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.739 1.215 . . . . 0.0 110.751 -173.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -102.91 69.72 1.06 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 122.076 0.941 . . . . 0.0 110.769 -168.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.5 t -83.56 69.76 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.835 0.826 . . . . 0.0 109.786 -169.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.47 134.31 24.83 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 124.745 1.218 . . . . 0.0 110.054 -174.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -87.55 -164.65 0.2 Allowed 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 123.083 2.522 . . . . 0.0 112.073 -172.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.7 m -124.93 132.94 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 122.922 1.344 . . . . 0.0 112.941 174.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -118.5 160.95 20.83 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.752 2.021 . . . . 0.0 111.794 -171.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -90.03 179.97 5.82 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.095 0.958 . . . . 0.0 111.976 172.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.72 -21.59 64.63 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -71.24 -19.92 62.31 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.615 1.166 . . . . 0.0 113.866 170.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.7 -1.87 60.12 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.791 1.662 . . . . 0.0 114.307 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -85.99 139.45 31.18 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.57 1.185 . . . . 0.0 113.25 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -74.41 100.02 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 125.828 1.651 . . . . 0.0 110.503 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.86 -30.06 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 118.194 -0.907 . . . . 0.0 111.367 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.8 mmt -136.27 148.33 47.95 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 123.517 1.627 . . . . 0.0 111.077 178.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -103.13 86.84 2.77 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.915 1.686 . . . . 0.0 108.088 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.8 mt -106.49 69.9 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 170.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.02 88.95 2.98 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.259 1.028 . . . . 0.0 108.748 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -59.82 107.03 0.55 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.151 1.381 . . . . 0.0 110.203 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -84.67 52.22 2.34 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 120.617 -1.302 . . . . 0.0 112.169 -176.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -79.89 106.9 12.25 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 123.793 1.759 . . . . 0.0 112.678 -176.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 22.3 t -64.17 112.52 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 125.802 1.641 . . . . 0.0 108.296 169.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.45 140.9 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.832 0.348 . . . . 0.0 111.026 177.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 27.9 ptm -136.33 173.4 11.75 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.645 1.578 . . . . 0.0 112.198 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.91 154.95 32.28 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.808 1.243 . . . . 0.0 113.737 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt . . . . . 0 C--O 1.253 1.283 0 C-N-CA 126.02 1.728 . . . . 0.0 112.517 -175.214 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.0 mtt . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 119.224 -0.417 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -69.44 170.6 15.81 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.371 2.714 . . . . 0.0 111.673 169.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.0 t -63.52 130.03 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.567 0.747 . . . . 0.0 110.182 176.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 -93.57 20.04 7.82 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.268 1.427 . . . . 0.0 113.98 -171.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.18 155.6 46.76 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.705 2.002 . . . . 0.0 111.667 -176.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.81 3.16 83.64 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 125.024 1.297 . . . . 0.0 115.567 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -143.79 173.33 11.78 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.832 1.653 . . . . 0.0 112.058 176.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.7 p -129.97 151.43 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.58 1.552 . . . . 0.0 110.982 175.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.66 159.97 57.03 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 123.83 0.852 . . . . 0.0 111.696 171.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -58.57 107.97 0.37 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.103 2.536 . . . . 0.0 111.197 173.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -64.55 -26.59 68.48 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -168.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -69.97 -49.97 46.4 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.49 0.586 . . . . 0.0 110.585 -176.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.1 t -77.3 -33.41 55.68 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.133 0.973 . . . . 0.0 112.304 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -60.04 -41.02 91.35 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.667 -0.646 . . . . 0.0 110.184 172.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.2 tp -71.03 -45.11 64.5 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-O 118.696 -0.669 . . . . 0.0 112.041 172.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -47.68 -39.75 18.17 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.203 1.365 . . . . 0.0 113.279 173.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 90.2 m -60.16 -43.67 95.62 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.521 -0.737 . . . . 0.0 112.326 172.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.4 mm -68.59 -35.28 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.898 0.879 . . . . 0.0 110.938 175.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 26.2 mm -55.49 -54.5 24.83 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.483 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 171.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 55.5 mtm180 -60.32 -27.36 67.27 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.8 0.727 . . . . 0.0 112.959 176.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.3 tptt -65.09 -40.47 94.64 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 118.631 -0.7 . . . . 0.0 112.757 172.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -106.03 2.4 27.26 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -55.64 -29.0 58.5 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.536 1.935 . . . . 0.0 114.266 -167.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.82 -1.63 68.59 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.695 1.617 . . . . 0.0 116.4 169.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -119.84 -13.14 9.1 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.597 1.559 . . . . 0.0 112.106 168.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.9 p -76.12 8.51 3.19 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 128.016 2.526 . . . . 0.0 115.054 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.82 163.86 4.2 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.335 1.454 . . . . 0.0 113.682 178.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.96 146.1 28.02 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.972 2.109 . . . . 0.0 115.173 -167.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -169.79 163.13 9.76 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -121.71 169.77 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.887 169.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.9 mm -123.2 114.65 42.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 126.069 1.747 . . . . 0.0 107.015 173.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.17 153.16 40.43 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.475 175.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -85.21 120.83 27.13 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.37 -9.62 59.34 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 46.0 mmm-85 -100.1 5.68 44.93 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.886 1.674 . . . . 0.0 114.246 -172.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.4 m -119.61 139.9 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 126.117 1.767 . . . . 0.0 111.73 -174.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.12 -24.4 65.01 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.85 0.86 . . . . 0.0 113.142 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.56 -12.3 59.95 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.169 1.388 . . . . 0.0 112.431 173.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.9 m 46.73 37.95 5.28 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.899 1.68 . . . . 0.0 112.782 -175.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.31 149.86 40.46 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -165.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.4 t -80.66 90.0 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 C-N-CA 128.667 2.787 . . . . 0.0 108.631 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.4 pt -69.95 -24.15 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.162 1.385 . . . . 0.0 112.207 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -155.62 159.82 39.93 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.802 1.241 . . . . 0.0 112.93 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.3 p -143.23 139.96 30.48 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.873 -1.142 . . . . 0.0 112.879 -175.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -83.73 157.98 21.94 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -61.26 -28.22 69.02 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.547 0.739 . . . . 0.0 111.429 171.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.58 -49.97 59.06 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.71 -1.05 . . . . 0.0 113.296 170.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.76 -40.6 69.52 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 120.064 1.932 . . . . 0.0 110.662 172.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.4 t -60.24 -40.65 90.98 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.625 0.37 . . . . 0.0 111.074 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -76.23 -29.62 57.61 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.965 0.906 . . . . 0.0 112.579 176.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.7 tp -64.28 -55.78 19.1 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.935 1.294 . . . . 0.0 111.733 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.1 m -99.59 -20.06 16.54 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.72 0.808 . . . . 0.0 112.794 -172.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.94 14.51 82.55 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-O 118.871 -0.96 . . . . 0.0 115.413 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -89.96 -128.79 0.08 Allowed 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 118.845 1.322 . . . . 0.0 111.762 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.9 t -159.95 150.19 18.6 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.635 1.974 . . . . 0.0 109.789 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.5 mtt85 -50.88 -40.37 56.27 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.329 1.052 . . . . 0.0 112.52 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.7 -21.2 62.63 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.351 1.06 . . . . 0.0 113.537 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -85.38 -20.96 29.08 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.638 1.575 . . . . 0.0 112.296 177.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -105.37 -20.03 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 5.8 mmt -49.97 107.76 0.17 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.845 1.658 . . . . 0.0 111.306 -174.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 70.24 18.4 6.89 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.383 1.473 . . . . 0.0 113.558 170.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.75 161.38 61.37 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 123.882 0.873 . . . . 0.0 110.553 167.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -56.19 140.06 86.79 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.992 2.461 . . . . 0.0 113.165 171.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 34.9 t -67.65 -10.05 48.76 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.128 1.371 . . . . 0.0 113.158 170.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -61.29 100.19 0.12 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 128.01 2.524 . . . . 0.0 110.866 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 33.8 m -50.03 -13.11 0.09 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.461 1.904 . . . . 0.0 115.903 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -52.79 -37.02 59.17 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.844 1.258 . . . . 0.0 111.776 167.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -55.83 -21.78 21.48 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.396 1.479 . . . . 0.0 113.343 171.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.13 20.03 14.6 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 127.611 2.364 . . . . 0.0 111.824 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -72.81 142.2 48.03 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.319 -1.488 . . . . 0.0 111.324 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.68 -170.11 11.99 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.665 1.602 . . . . 0.0 113.123 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -64.6 -10.13 23.29 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.29 2.66 . . . . 0.0 116.26 -170.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -110.07 -2.03 17.22 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.852 1.661 . . . . 0.0 114.415 175.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.0 m -78.53 137.83 38.1 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.704 1.138 . . . . 0.0 112.298 -175.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -82.58 132.22 35.2 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 122.636 1.208 . . . . 0.0 110.59 172.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.7 mmt85 -70.0 -39.9 75.61 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.185 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -56.87 -35.68 69.2 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.682 1.193 . . . . 0.0 113.599 169.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.48 -50.24 53.79 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.648 0.779 . . . . 0.0 110.907 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.32 -34.95 78.81 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.34 -53.01 27.03 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.832 1.253 . . . . 0.0 112.012 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -50.16 -40.8 47.69 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.39 0.996 . . . . 0.0 112.731 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 29.7 mt -63.82 -49.75 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 O-C-N 121.708 -0.62 . . . . 0.0 111.08 174.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.81 -39.94 59.6 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.565 0.621 . . . . 0.0 111.958 173.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -63.51 -39.82 95.43 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.243 0.617 . . . . 0.0 111.635 175.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.16 -28.75 66.7 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mt -84.07 -40.09 18.75 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 pp -66.02 -28.72 69.08 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 118.46 0.573 . . . . 0.0 112.212 169.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.75 18.91 8.55 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 119.031 -0.872 . . . . 0.0 113.965 169.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.27 -50.01 65.73 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 118.372 1.086 . . . . 0.0 110.303 169.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -162.69 129.97 3.68 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.924 1.689 . . . . 0.0 111.648 168.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -68.81 116.55 9.43 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.193 1.397 . . . . 0.0 108.633 172.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -151.73 142.93 23.29 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.851 1.26 . . . . 0.0 111.706 -169.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -83.72 130.69 34.96 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.449 1.5 . . . . 0.0 110.554 169.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.6 153.1 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.508 1.523 . . . . 0.0 109.077 -177.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -79.87 158.83 26.62 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.429 0.691 . . . . 0.0 109.477 170.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -166.71 150.16 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.437 1.095 . . . . 0.0 110.08 175.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -91.4 145.35 24.7 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.276 172.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -114.61 162.3 16.94 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.76 1.224 . . . . 0.0 111.276 172.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -132.13 140.06 48.65 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.831 0.852 . . . . 0.0 111.495 168.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.2 mtp-105 -88.68 166.66 13.94 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 125.296 1.439 . . . . 0.0 113.393 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -57.81 -33.25 68.39 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.04 2.136 . . . . 0.0 112.88 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -76.99 -9.86 58.98 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.814 1.246 . . . . 0.0 114.235 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.6 -1.3 59.99 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.573 1.559 . . . . 0.0 115.842 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.5 m -72.88 139.66 47.03 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.735 1.767 . . . . 0.0 111.139 176.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 29.3 p -136.01 140.05 43.59 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -178.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -150.89 142.02 23.13 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.378 1.071 . . . . 0.0 113.359 -172.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -102.61 135.21 44.67 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.419 1.888 . . . . 0.0 109.763 169.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.9 m -139.83 170.27 16.18 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.319 1.448 . . . . 0.0 110.246 167.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 28.7 tp -77.37 59.92 1.93 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.939 0.896 . . . . 0.0 109.603 172.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.1 t -57.1 147.65 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.959 1.303 . . . . 0.0 110.55 -172.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -99.84 69.68 1.58 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 122.951 1.358 . . . . 0.0 111.177 -169.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.3 t -83.3 69.86 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.571 1.149 . . . . 0.0 110.594 -169.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -121.9 129.03 25.32 Favored Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 123.57 0.748 . . . . 0.0 112.915 -174.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -88.15 -179.49 2.44 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.713 2.942 . . . . 0.0 112.669 -175.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.46 138.43 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 122.925 1.345 . . . . 0.0 114.018 -172.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -118.84 163.08 17.43 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 127.041 2.136 . . . . 0.0 112.38 -169.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -94.31 -179.98 5.1 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.204 1.002 . . . . 0.0 111.937 171.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.77 -21.35 64.49 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -71.41 -19.87 62.2 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.604 1.162 . . . . 0.0 113.893 170.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.12 5.61 60.67 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.6 1.571 . . . . 0.0 114.431 -176.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.89 139.58 30.38 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 118.362 1.081 . . . . 0.0 113.025 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.1 p -73.55 100.05 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.921 1.688 . . . . 0.0 110.641 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.12 -30.0 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.255 177.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 10.3 mmt -135.37 147.36 49.03 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 123.567 1.651 . . . . 0.0 111.347 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -103.95 79.97 1.7 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 126.477 1.911 . . . . 0.0 107.24 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.7 mt -99.96 73.14 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 122.398 1.094 . . . . 0.0 108.999 175.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.281 17.5 mt -77.89 86.62 4.11 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 122.752 1.263 . . . . 0.0 108.934 -178.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -59.84 103.18 0.19 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.094 1.757 . . . . 0.0 109.96 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -84.97 61.31 6.78 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 120.916 -1.115 . . . . 0.0 111.197 -177.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -79.75 128.27 33.21 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 121.949 0.881 . . . . 0.0 110.687 175.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.4 t -88.2 114.06 26.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 124.72 1.208 . . . . 0.0 108.128 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.37 135.8 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 121.084 0.468 . . . . 0.0 111.956 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 94.9 mtp -101.74 149.66 23.93 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.774 1.63 . . . . 0.0 110.97 174.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -69.63 152.19 45.02 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.773 1.229 . . . . 0.0 112.554 175.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? . . . . . 0 C--O 1.253 1.274 0 C-N-CA 125.088 1.355 . . . . 0.0 113.69 177.44 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 118.742 -0.647 . . . . 0.0 110.387 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -70.47 153.81 65.37 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.289 2.659 . . . . 0.0 112.584 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 45.4 t -137.46 139.66 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.552 1.541 . . . . 0.0 109.852 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -81.72 74.73 8.7 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.745 1.218 . . . . 0.0 110.766 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -132.32 163.13 29.34 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 127.148 2.179 . . . . 0.0 112.32 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.51 -26.29 3.11 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 125.31 1.433 . . . . 0.0 114.107 -171.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -143.72 151.19 39.72 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.088 2.155 . . . . 0.0 109.691 169.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.1 p -129.99 136.9 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.477 1.111 . . . . 0.0 111.074 175.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.63 160.95 69.95 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.641 0.776 . . . . 0.0 110.988 169.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -51.57 109.96 0.38 Allowed 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.205 2.603 . . . . 0.0 110.905 169.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -64.74 -28.73 69.79 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -166.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -68.1 -49.82 58.77 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.287 0.635 . . . . 0.0 110.361 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 t -75.82 -35.43 60.02 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.932 0.893 . . . . 0.0 112.345 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -58.04 -41.82 84.08 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.509 0.724 . . . . 0.0 110.024 173.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.7 tp -73.12 -44.47 60.22 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 118.959 -0.543 . . . . 0.0 112.27 173.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -48.61 -39.91 25.61 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.798 1.181 . . . . 0.0 112.424 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.0 m -60.12 -42.89 95.73 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 121.52 -0.737 . . . . 0.0 112.434 173.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.7 mm -69.09 -30.59 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.228 1.011 . . . . 0.0 110.334 176.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.3 mm -60.02 -51.62 70.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 172.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.5 mmp_? -59.9 -30.08 68.78 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.728 1.149 . . . . 0.0 111.812 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -64.48 -45.55 86.89 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.789 0.836 . . . . 0.0 112.519 176.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -100.97 3.14 41.36 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 178.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -57.35 -29.09 63.72 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.149 1.38 . . . . 0.0 113.313 -167.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.05 8.86 85.06 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.667 1.127 . . . . 0.0 115.701 171.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -125.31 -58.09 1.46 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.402 1.101 . . . . 0.0 112.029 174.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 62.2 p -70.84 -30.25 66.6 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.712 -0.618 . . . . 0.0 112.25 174.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.8 mmt85 -117.84 149.95 39.97 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 127.176 2.191 . . . . 0.0 109.39 169.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.12 150.18 51.5 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.354 1.462 . . . . 0.0 112.127 -167.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -169.75 163.32 9.87 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 116.76 2.133 . . . . 0.0 116.76 -170.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -126.66 170.15 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 128.231 2.612 . . . . 0.0 110.682 174.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.6 mm -124.18 117.71 51.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 126.033 1.733 . . . . 0.0 107.727 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.81 153.94 40.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.661 1.219 . . . . 0.0 111.931 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -83.74 110.46 18.33 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.77 1.228 . . . . 0.0 110.292 176.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.84 -12.53 60.4 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -100.17 -5.21 28.11 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.81 1.244 . . . . 0.0 113.812 -169.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 p -109.24 140.0 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.715 1.606 . . . . 0.0 111.339 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.99 -23.95 67.69 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -175.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -85.29 -5.92 59.29 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.153 1.381 . . . . 0.0 113.723 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.0 p 44.27 32.86 0.74 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 128.005 2.522 . . . . 0.0 116.123 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.82 156.3 34.59 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 116.767 2.136 . . . . 0.0 116.767 -167.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.9 t -79.94 91.27 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.15 0 C-N-CA 129.354 3.061 . . . . 0.0 109.148 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.5 pt -69.93 -23.74 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 126.096 1.758 . . . . 0.0 112.991 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -155.9 159.94 39.73 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.768 1.227 . . . . 0.0 112.917 177.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.0 m -139.84 140.78 36.63 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.813 -1.179 . . . . 0.0 111.32 -169.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -93.31 153.46 18.55 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 169.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -65.18 -23.96 67.24 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 122.031 -0.418 . . . . 0.0 111.583 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.93 -50.0 46.27 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 119.191 -0.783 . . . . 0.0 112.515 169.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -39.55 83.35 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 119.454 1.627 . . . . 0.0 110.897 175.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 16.1 t -60.19 -40.8 91.27 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 121.665 -0.647 . . . . 0.0 110.758 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -78.67 -28.7 45.34 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.066 0.946 . . . . 0.0 112.473 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 52.8 tp -62.13 -55.78 25.44 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.786 1.234 . . . . 0.0 111.412 175.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 77.7 m -97.43 -20.2 17.94 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 -172.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.27 12.9 83.86 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-O 118.692 -1.06 . . . . 0.0 115.459 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -88.92 -124.3 0.05 Allowed 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 119.172 1.486 . . . . 0.0 111.095 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.9 t -159.97 150.16 18.52 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.312 1.845 . . . . 0.0 109.683 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -52.19 -37.52 55.07 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.429 -0.795 . . . . 0.0 112.432 171.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.0 -20.19 63.63 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -86.17 -20.84 28.0 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.599 1.56 . . . . 0.0 112.55 176.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.5 m -105.42 -17.37 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 125.229 1.412 . . . . 0.0 114.377 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 3.3 mmt -49.87 113.14 0.78 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.809 1.644 . . . . 0.0 111.223 -175.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 67.07 29.76 7.77 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.766 1.627 . . . . 0.0 112.378 169.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -106.74 154.0 40.38 Favored Pre-proline 0 N--CA 1.471 0.593 0 CA-C-O 117.283 -1.342 . . . . 0.0 112.606 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -48.64 135.25 27.5 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.576 2.85 . . . . 0.0 113.934 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 14.3 t -68.17 -9.79 49.43 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.296 1.038 . . . . 0.0 113.236 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.37 87.26 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.573 1.949 . . . . 0.0 110.848 175.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 26.2 p -54.48 -13.04 0.82 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.611 2.365 . . . . 0.0 114.733 -171.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.539 ' HA ' ' CG ' ' A' ' 70' ' ' HIS . 1.6 p30 -51.15 -22.9 2.81 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 167.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -53.49 -23.55 10.61 Favored 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 169.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.287 2.0 pp -123.14 24.0 9.0 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 170.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.539 ' CG ' ' HA ' ' A' ' 67' ' ' ASP . 1.8 m-70 -67.46 146.45 53.98 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.327 -1.483 . . . . 0.0 112.573 169.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.21 -178.95 23.37 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 124.955 1.264 . . . . 0.0 113.844 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.52 -9.99 24.59 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.591 2.861 . . . . 0.0 114.32 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -89.97 -10.15 46.11 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.009 1.324 . . . . 0.0 113.087 174.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.412 HG21 ' H ' ' A' ' 97' ' ' ALA . 3.0 m -84.16 143.63 29.52 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -168.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -84.55 138.36 32.79 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.651 1.215 . . . . 0.0 112.605 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.9 mmt85 -69.99 -39.99 75.58 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.51 -0.743 . . . . 0.0 111.208 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -57.59 -37.42 73.18 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.221 1.408 . . . . 0.0 113.822 170.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.9 -53.31 52.49 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.005 0.907 . . . . 0.0 110.055 173.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.86 -35.1 79.52 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.423 -0.808 . . . . 0.0 113.009 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.14 -54.1 20.42 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.173 1.389 . . . . 0.0 111.623 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -50.22 -40.83 48.65 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.212 0.914 . . . . 0.0 112.777 171.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.3 mt -63.74 -49.22 83.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 O-C-N 121.495 -0.753 . . . . 0.0 111.433 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.74 -39.99 59.43 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.346 0.521 . . . . 0.0 111.677 173.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -63.43 -39.96 95.88 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.347 0.659 . . . . 0.0 111.796 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.51 -30.3 69.08 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 176.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 mt -83.18 -35.52 25.42 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 pp -70.49 -27.87 64.54 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 118.326 0.512 . . . . 0.0 111.914 168.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.94 16.36 10.75 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.095 -0.836 . . . . 0.0 114.244 168.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.89 -49.82 65.12 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 118.265 1.033 . . . . 0.0 111.99 175.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -155.56 141.66 18.33 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.602 1.561 . . . . 0.0 111.649 171.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -79.31 110.15 14.32 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.199 -0.938 . . . . 0.0 109.164 170.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -155.88 145.27 20.87 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.312 1.045 . . . . 0.0 111.203 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -76.77 143.12 40.08 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.143 1.377 . . . . 0.0 111.638 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -136.49 145.32 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.995 0.918 . . . . 0.0 110.105 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -81.15 147.97 29.8 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.113 0.965 . . . . 0.0 109.99 170.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -158.46 156.93 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 110.27 -176.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.412 ' H ' HG21 ' A' ' 74' ' ' THR . . . -110.12 145.34 37.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.107 0.963 . . . . 0.0 112.41 175.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -130.61 156.14 45.37 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.821 1.248 . . . . 0.0 111.472 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -120.43 138.34 53.84 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.703 0.764 . . . . 0.0 111.913 168.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 28.3 mtp-105 -80.51 166.64 20.99 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.394 1.477 . . . . 0.0 112.847 177.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -56.56 -32.38 65.11 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.616 1.967 . . . . 0.0 113.109 175.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -78.25 -9.89 59.42 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 175.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.75 -1.09 58.04 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.693 1.616 . . . . 0.0 115.826 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 73.3 m -70.15 128.56 36.71 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 119.778 1.789 . . . . 0.0 111.036 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 45.5 t -128.65 125.61 38.43 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.717 1.207 . . . . 0.0 112.201 -170.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -150.96 149.68 29.9 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -171.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.01 125.27 46.04 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.596 1.958 . . . . 0.0 107.177 167.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 81.1 m -125.7 168.47 13.71 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.571 1.148 . . . . 0.0 110.31 169.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.25 59.89 2.93 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.652 -1.28 . . . . 0.0 110.244 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.0 t -63.06 147.48 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.811 1.244 . . . . 0.0 111.206 -172.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -103.58 69.74 1.0 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.724 0.774 . . . . 0.0 111.723 -168.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.4 t -83.22 69.75 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 121.339 -0.851 . . . . 0.0 110.965 -168.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.7 m -112.92 136.47 21.68 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 124.728 1.211 . . . . 0.0 110.368 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -86.13 -161.64 0.13 Allowed 'Trans proline' 0 CA--C 1.552 1.421 0 C-N-CA 123.105 2.536 . . . . 0.0 110.08 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.7 m -127.1 131.13 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-O 122.992 1.377 . . . . 0.0 113.062 172.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.1 pmtp? -122.01 160.04 25.75 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.947 2.099 . . . . 0.0 112.253 -176.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -90.07 -179.41 5.67 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.794 0.838 . . . . 0.0 111.499 178.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.88 -21.7 61.36 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -73.64 -19.91 60.72 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.713 1.205 . . . . 0.0 114.134 171.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.89 -4.28 63.07 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.47 1.51 . . . . 0.0 114.142 -176.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -79.84 129.25 34.32 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 118.26 1.03 . . . . 0.0 112.025 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.7 p -67.86 99.74 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 127.008 2.123 . . . . 0.0 110.509 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.97 -29.63 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.795 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.73 149.96 49.37 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 124.002 1.858 . . . . 0.0 111.713 174.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -103.01 80.03 1.82 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.149 -1.387 . . . . 0.0 107.797 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.0 mt -100.0 71.32 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 O-C-N 120.24 -1.537 . . . . 0.0 108.336 171.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -74.33 86.86 1.99 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 123.362 1.553 . . . . 0.0 109.453 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -59.85 103.08 0.18 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 112.847 -1.979 . . . . 0.0 110.326 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -87.15 53.35 2.79 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 120.543 -1.348 . . . . 0.0 111.937 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -79.86 106.96 12.27 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 123.569 1.652 . . . . 0.0 111.868 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 t -59.85 118.91 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.435 1.494 . . . . 0.0 108.89 169.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.38 145.99 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 122.463 0.305 . . . . 0.0 110.603 170.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 78.3 mtm -142.74 155.17 44.82 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.675 1.59 . . . . 0.0 111.012 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -73.06 151.81 41.53 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.163 0.985 . . . . 0.0 112.616 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 C--O 1.252 1.213 0 C-N-CA 125.405 1.482 . . . . 0.0 112.102 178.143 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.287 51.8 tpp . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 116.871 -1.537 . . . . 0.0 113.132 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.51 135.6 54.13 Favored 'Trans proline' 0 C--N 1.356 0.948 0 CA-C-N 122.542 1.943 . . . . 0.0 113.45 -175.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.51 149.43 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.143 0.977 . . . . 0.0 112.652 -174.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -75.32 144.53 42.36 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.213 1.005 . . . . 0.0 111.362 176.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.64 148.73 25.83 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.781 1.633 . . . . 0.0 112.081 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.94 -24.17 60.37 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 124.187 0.899 . . . . 0.0 114.569 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -143.85 154.08 43.01 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.069 1.748 . . . . 0.0 110.781 175.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.57 110.02 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 122.051 0.929 . . . . 0.0 112.175 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.7 160.38 80.03 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.438 1.095 . . . . 0.0 110.163 168.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -44.99 110.11 0.21 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 124.161 3.241 . . . . 0.0 111.817 174.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -63.12 -29.05 70.49 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -164.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -70.02 -49.98 46.0 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.096 0.862 . . . . 0.0 110.72 -176.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 t -77.05 -35.51 56.75 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.685 1.194 . . . . 0.0 112.392 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -57.04 -45.68 82.98 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.284 0.634 . . . . 0.0 110.143 170.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.6 tp -69.95 -42.28 73.43 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 118.549 -0.738 . . . . 0.0 111.237 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -50.01 -39.85 42.69 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.125 1.33 . . . . 0.0 113.073 172.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 58.1 m -60.13 -42.24 94.4 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.348 0.659 . . . . 0.0 112.503 171.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.1 mm -68.49 -35.35 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 O-C-N 121.204 -0.935 . . . . 0.0 110.023 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.5 mm -56.5 -51.14 68.71 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 CA-C-O 117.903 -1.046 . . . . 0.0 108.713 170.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -27.71 66.69 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.145 1.339 . . . . 0.0 112.906 175.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -66.78 -43.92 82.73 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.563 1.145 . . . . 0.0 112.449 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -107.91 7.61 28.11 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -55.49 -29.0 58.01 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.39 1.476 . . . . 0.0 114.504 -167.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.52 33.85 41.92 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 115.605 1.002 . . . . 0.0 115.605 169.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -61.66 -17.78 56.85 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 118.897 1.348 . . . . 0.0 113.895 175.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.6 p -89.3 19.81 4.16 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.177 2.191 . . . . 0.0 113.994 173.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 mmt85 -51.98 149.93 4.67 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.053 1.741 . . . . 0.0 114.644 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.1 151.81 45.63 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 128.171 2.588 . . . . 0.0 110.907 173.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -169.76 163.11 9.83 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 -172.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -121.29 170.83 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.277 1.431 . . . . 0.0 111.512 170.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.0 mm -123.48 116.99 49.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 126.154 1.782 . . . . 0.0 107.428 172.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.5 149.97 50.36 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -76.42 106.67 8.19 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.511 0.672 . . . . 0.0 111.445 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.6 -13.17 60.97 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -91.64 0.91 57.46 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.855 1.662 . . . . 0.0 114.117 -173.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.77 140.12 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.438 1.495 . . . . 0.0 110.943 -173.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -59.78 -26.6 65.85 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.95 -8.65 59.69 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.674 1.19 . . . . 0.0 113.937 177.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 27.1 p 36.46 51.34 0.85 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.241 2.217 . . . . 0.0 115.631 175.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.03 160.2 14.5 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -168.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.2 t -79.85 89.97 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 129.028 2.931 . . . . 0.0 109.071 -171.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.4 pt -69.95 -24.27 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.241 1.416 . . . . 0.0 112.201 175.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -155.35 159.71 40.15 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.197 0.999 . . . . 0.0 111.836 172.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.4 p -142.22 149.07 39.17 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -177.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -86.44 149.99 24.6 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.623 0.725 . . . . 0.0 111.559 168.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -67.87 -24.93 65.29 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.597 176.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.39 -50.0 49.18 Favored Glycine 0 CA--C 1.534 1.239 0 O-C-N 120.903 -1.123 . . . . 0.0 112.941 170.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -29.85 66.79 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 118.965 1.383 . . . . 0.0 111.376 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 23.2 t -60.04 -39.78 87.1 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.186 0.994 . . . . 0.0 110.2 172.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -78.21 -29.99 48.64 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.328 -0.857 . . . . 0.0 112.403 174.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.8 tp -56.44 -53.9 51.99 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.371 1.068 . . . . 0.0 110.602 174.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.8 p -80.01 -27.91 39.5 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.2 12.78 75.59 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 125.531 1.539 . . . . 0.0 115.986 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -89.04 -121.47 0.05 Allowed 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 119.552 1.676 . . . . 0.0 112.899 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.4 t -159.9 144.36 14.78 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.346 1.858 . . . . 0.0 109.981 -176.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.2 ptm85 -64.69 -30.02 71.03 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 120.891 -1.131 . . . . 0.0 113.593 -173.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.47 -16.76 39.7 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.211 1.005 . . . . 0.0 113.361 172.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -89.94 -20.57 23.19 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.532 1.933 . . . . 0.0 112.225 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 m -96.23 -19.98 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-N 119.243 0.928 . . . . 0.0 113.331 -173.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 35.3 mmt -50.01 115.71 1.52 Allowed 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.522 1.129 . . . . 0.0 111.014 -170.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 67.66 29.49 6.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.696 1.598 . . . . 0.0 112.862 169.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -100.81 151.63 37.65 Favored Pre-proline 0 N--CA 1.477 0.882 0 CA-C-O 117.756 -1.116 . . . . 0.0 113.716 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -54.54 135.28 65.82 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.262 2.641 . . . . 0.0 113.171 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 49.6 t -68.73 -12.54 61.56 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 126.349 1.86 . . . . 0.0 112.894 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -63.61 100.11 0.26 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 126.708 2.003 . . . . 0.0 111.046 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 30.2 p -49.89 -19.42 0.68 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.397 1.879 . . . . 0.0 115.614 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -48.13 -43.94 31.62 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.755 1.222 . . . . 0.0 111.939 169.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -67.06 -11.48 57.22 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 pp -123.1 20.04 9.9 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.95 1.7 . . . . 0.0 113.523 172.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -60.8 144.38 52.67 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.312 -0.868 . . . . 0.0 113.241 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.97 172.05 19.51 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 125.216 1.389 . . . . 0.0 113.074 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -65.92 -10.17 25.91 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.448 2.099 . . . . 0.0 116.062 -172.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 77.5 mtm-85 -110.1 0.05 18.18 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.765 1.626 . . . . 0.0 114.91 171.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.9 m -67.58 136.68 54.85 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.976 1.262 . . . . 0.0 111.305 175.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -82.64 132.81 35.18 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.581 1.181 . . . . 0.0 110.636 175.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -67.65 -39.79 84.59 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.585 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -41.37 63.5 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.432 1.093 . . . . 0.0 113.397 169.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.78 -49.98 59.52 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 124.44 1.096 . . . . 0.0 110.211 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.25 -33.41 75.75 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.301 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.04 -51.14 34.53 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.302 1.441 . . . . 0.0 112.495 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -49.94 -43.42 49.89 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.779 1.232 . . . . 0.0 111.223 170.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.4 mt -64.06 -49.16 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 121.895 -0.503 . . . . 0.0 111.256 174.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.01 -39.87 56.82 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.575 -0.726 . . . . 0.0 112.175 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -69.06 -38.07 78.86 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.582 0.753 . . . . 0.0 111.379 176.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.6 -33.02 74.73 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.446 -0.784 . . . . 0.0 111.496 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mt -82.62 -29.66 29.98 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.417 0.687 . . . . 0.0 111.9 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.26 -28.75 69.56 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.338 2.255 . . . . 0.0 111.001 169.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.98 18.22 8.99 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.043 1.306 . . . . 0.0 114.799 169.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.55 -49.99 74.45 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.63 1.215 . . . . 0.0 111.024 177.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -163.0 144.35 9.82 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.364 1.865 . . . . 0.0 110.98 169.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -72.07 117.59 13.88 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 167.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.5 tpp180 -149.31 137.23 20.49 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.446 1.098 . . . . 0.0 111.161 -176.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -76.79 127.42 32.72 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.216 1.006 . . . . 0.0 109.958 169.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -129.05 154.46 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.423 1.489 . . . . 0.0 108.863 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -79.9 160.12 26.13 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.221 1.008 . . . . 0.0 110.302 169.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -166.59 152.85 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.133 0.973 . . . . 0.0 111.115 169.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -85.88 145.32 27.23 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.122 174.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -115.39 163.03 16.31 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.345 1.458 . . . . 0.0 111.506 169.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -135.38 140.09 44.72 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.089 0.471 . . . . 0.0 111.799 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 19.4 mmm-85 -74.19 140.12 44.9 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 168.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -13.8 2.82 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -171.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -72.61 -9.99 59.26 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.198 1.399 . . . . 0.0 113.829 170.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.64 4.43 26.55 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 126.332 1.92 . . . . 0.0 115.467 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 52.6 m -86.5 100.23 12.23 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 118.838 1.319 . . . . 0.0 111.631 -173.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 25.2 t -106.33 137.84 43.59 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.107 1.363 . . . . 0.0 113.924 -172.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -150.99 146.05 25.97 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.439 1.496 . . . . 0.0 113.184 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -100.04 125.45 46.1 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.927 1.691 . . . . 0.0 109.233 170.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 78.2 m -129.6 173.6 10.45 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.048 1.339 . . . . 0.0 110.51 171.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 70.9 mt -79.88 59.84 3.29 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.006 -1.059 . . . . 0.0 111.403 -175.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 47.1 t -62.42 141.83 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.584 1.554 . . . . 0.0 111.426 -172.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -105.26 69.95 0.87 Allowed 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 122.486 1.136 . . . . 0.0 112.554 -168.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.8 t -81.18 70.77 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.071 1.348 . . . . 0.0 111.43 -168.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.8 p -120.5 129.28 25.4 Favored Pre-proline 0 N--CA 1.484 1.249 0 CA-C-O 118.408 -0.806 . . . . 0.0 111.945 -176.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -88.18 -166.61 0.27 Allowed 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.972 3.114 . . . . 0.0 112.435 -173.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -126.29 131.37 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 122.991 1.377 . . . . 0.0 113.415 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -119.01 159.95 22.92 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.081 2.153 . . . . 0.0 111.507 -172.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -89.89 -179.96 5.84 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.02 0.928 . . . . 0.0 111.935 174.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.18 -21.72 64.06 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -72.23 -19.89 61.64 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.698 1.199 . . . . 0.0 113.916 170.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.46 0.9 60.84 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.588 1.566 . . . . 0.0 114.238 -176.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -87.93 139.16 30.8 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.538 1.169 . . . . 0.0 112.937 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.7 p -77.99 98.34 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 125.142 1.377 . . . . 0.0 110.872 -174.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.63 -29.97 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.002 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.8 mmt -136.2 148.04 47.92 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 123.502 1.62 . . . . 0.0 111.122 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.7 m-30 -105.15 87.59 2.67 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 125.767 1.627 . . . . 0.0 106.733 -178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 43.4 mt -103.83 73.76 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 122.574 1.178 . . . . 0.0 108.471 174.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.312 34.9 mt -80.62 84.06 6.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 123.208 1.48 . . . . 0.0 110.064 -176.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -59.87 104.74 0.32 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.018 2.127 . . . . 0.0 110.825 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -87.41 58.17 4.82 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 120.614 -1.304 . . . . 0.0 112.378 -175.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -79.79 106.89 12.14 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 124.772 2.225 . . . . 0.0 112.46 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 42.8 t -65.63 110.75 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 127.344 2.258 . . . . 0.0 109.218 174.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p -140.37 137.89 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 71.0 mtm -142.87 158.12 43.93 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.001 1.72 . . . . 0.0 110.731 169.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -75.19 147.96 39.96 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.923 -0.486 . . . . 0.0 111.705 169.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.109 0 C-N-CA 126.063 1.745 . . . . 0.0 112.778 -175.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 119.2 -0.429 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.86 -13.9 15.76 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.289 2.659 . . . . 0.0 114.325 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.0 m -73.91 20.0 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 125.696 1.598 . . . . 0.0 114.928 -175.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 54.8 ptt85 -93.81 19.76 8.46 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 126.472 1.909 . . . . 0.0 113.822 176.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 42.4 ptt85 -152.83 60.97 0.79 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 127.916 2.486 . . . . 0.0 109.76 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.39 -171.54 43.38 Favored Glycine 0 CA--C 1.538 1.492 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.044 -168.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -71.82 138.53 48.37 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.506 -0.997 . . . . 0.0 111.938 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.4 t -130.1 142.82 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.711 1.604 . . . . 0.0 109.034 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.43 159.89 28.53 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 123.515 0.726 . . . . 0.0 112.097 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.05 106.34 0.65 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.091 2.528 . . . . 0.0 112.169 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -66.22 -26.52 67.41 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -169.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -69.99 -49.92 46.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.359 0.664 . . . . 0.0 110.39 -176.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.2 t -76.21 -34.53 59.27 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.04 0.936 . . . . 0.0 112.399 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -58.86 -41.77 87.81 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.693 -0.629 . . . . 0.0 110.29 172.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.5 tp -70.71 -45.52 64.8 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-O 118.76 -0.638 . . . . 0.0 112.072 173.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -47.47 -39.81 16.75 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.261 1.424 . . . . 0.0 113.213 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 85.5 m -60.09 -44.6 94.67 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.639 -0.663 . . . . 0.0 112.235 172.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.6 mm -67.31 -35.86 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.952 0.901 . . . . 0.0 110.661 175.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.9 mm -55.79 -54.38 26.98 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 CA-C-O 118.356 -0.83 . . . . 0.0 108.845 172.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 55.4 mtm180 -60.01 -28.44 67.73 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.115 0.871 . . . . 0.0 112.979 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.1 tttt -64.23 -41.16 97.13 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 172.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -105.77 2.99 28.35 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -55.25 -29.02 57.25 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.6 1.96 . . . . 0.0 115.239 -167.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.34 55.44 6.17 Favored Glycine 0 CA--C 1.532 1.127 0 O-C-N 121.558 -0.714 . . . . 0.0 112.9 177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -65.0 -6.31 8.29 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 -171.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 63.3 p -72.61 -19.08 61.53 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.719 1.208 . . . . 0.0 112.989 168.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 -82.79 153.43 25.23 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.144 1.778 . . . . 0.0 111.177 175.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.27 148.67 33.66 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.739 1.616 . . . . 0.0 112.15 -169.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -169.79 161.31 9.08 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -171.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -120.08 172.15 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.548 1.539 . . . . 0.0 111.248 173.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.5 mm -130.01 117.79 42.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 125.621 1.568 . . . . 0.0 107.92 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.12 148.99 52.03 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -81.79 106.61 13.86 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.688 0.756 . . . . 0.0 110.539 174.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.23 -9.31 58.48 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -95.19 -5.79 43.14 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.639 1.176 . . . . 0.0 114.112 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.79 140.21 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.942 1.297 . . . . 0.0 109.952 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -56.1 -31.07 62.93 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -175.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -83.83 -9.1 59.01 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 73.7 m 45.33 51.18 9.59 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.045 1.738 . . . . 0.0 113.112 -177.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.23 153.08 22.27 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -167.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 67.5 t -80.07 90.04 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 127.957 2.503 . . . . 0.0 108.947 -178.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.7 pt -69.94 -24.21 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.648 1.179 . . . . 0.0 112.141 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -155.38 159.71 40.12 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.475 1.11 . . . . 0.0 112.237 175.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.436 ' HG ' ' CG2' ' A' ' 59' ' ' VAL . 27.4 p -139.88 150.94 45.23 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.925 -1.109 . . . . 0.0 112.76 175.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -83.66 156.13 22.81 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 175.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -61.15 -27.77 68.64 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.887 -0.508 . . . . 0.0 111.768 172.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.85 -51.62 44.06 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-O 118.99 -0.894 . . . . 0.0 112.727 169.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.42 -40.11 67.97 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.592 1.696 . . . . 0.0 110.404 174.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.1 t -60.27 -40.91 92.06 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.032 0.533 . . . . 0.0 111.725 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -75.7 -28.93 58.81 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.763 0.825 . . . . 0.0 112.453 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 50.7 tp -66.57 -55.71 14.18 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.206 1.402 . . . . 0.0 111.483 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 33.6 m -93.76 -20.9 19.68 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.092 0.957 . . . . 0.0 112.726 -173.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 72.25 11.57 75.63 Favored Glycine 0 CA--C 1.541 1.706 0 N-CA-C 116.027 1.171 . . . . 0.0 116.027 177.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -90.49 -118.15 0.07 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.239 1.519 . . . . 0.0 111.058 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.3 t -159.91 150.13 18.6 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.945 1.698 . . . . 0.0 110.518 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -55.06 -38.67 68.33 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.947 1.299 . . . . 0.0 112.148 178.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.1 -20.08 63.66 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.352 1.061 . . . . 0.0 113.61 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -82.35 -20.74 36.65 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.212 1.405 . . . . 0.0 112.123 175.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.436 ' CG2' ' HG ' ' A' ' 44' ' ' CYS . 15.6 m -105.36 -18.59 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 177.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 32.2 mmt -49.89 111.77 0.56 Allowed 'General case' 0 C--N 1.344 0.34 0 CA-C-N 119.637 1.108 . . . . 0.0 111.083 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 71.03 18.13 5.99 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.108 1.763 . . . . 0.0 113.652 170.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.49 162.07 70.01 Favored Pre-proline 0 N--CA 1.474 0.727 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.668 167.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -57.67 140.01 92.11 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.961 2.441 . . . . 0.0 112.648 170.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 32.4 t -67.56 -14.3 62.81 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.249 1.019 . . . . 0.0 112.617 171.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.0 m -64.65 100.1 0.36 Allowed 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 126.714 2.005 . . . . 0.0 110.585 176.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 29.6 p -51.58 -18.62 1.19 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.894 1.678 . . . . 0.0 115.402 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -48.71 -41.84 33.11 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.114 1.365 . . . . 0.0 111.375 169.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -56.29 -24.71 44.96 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.716 1.606 . . . . 0.0 113.355 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 pp -123.14 19.98 9.88 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.419 1.887 . . . . 0.0 114.084 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.76 150.46 47.84 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.916 -1.115 . . . . 0.0 113.375 -177.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -130.58 -173.07 13.27 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.799 1.19 . . . . 0.0 115.532 -169.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -68.95 -10.17 28.39 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.383 2.722 . . . . 0.0 115.876 -169.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.4 ttm-85 -109.98 -4.7 15.76 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.086 1.354 . . . . 0.0 113.284 171.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.2 m -75.43 136.64 40.71 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.451 1.023 . . . . 0.0 110.489 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -80.39 132.77 35.81 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 122.738 1.256 . . . . 0.0 109.675 171.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -68.24 -39.75 82.19 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.514 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -53.08 -38.95 62.97 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.488 1.115 . . . . 0.0 113.87 169.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.42 -50.28 53.92 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.357 1.063 . . . . 0.0 110.707 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.48 -33.88 76.91 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.03 -51.47 31.95 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.859 1.264 . . . . 0.0 112.435 177.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -50.07 -41.87 48.87 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.659 1.183 . . . . 0.0 111.916 170.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 34.3 mt -63.65 -49.62 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 O-C-N 121.745 -0.597 . . . . 0.0 111.077 173.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.63 -39.8 51.39 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.208 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -69.43 -36.78 76.99 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.601 0.76 . . . . 0.0 111.685 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.35 -31.09 70.24 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.503 -0.748 . . . . 0.0 111.547 177.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mt -82.59 -31.76 28.79 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.437 0.695 . . . . 0.0 111.342 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.44 -29.75 70.99 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.112 2.165 . . . . 0.0 111.311 169.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.95 20.22 7.71 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.907 1.241 . . . . 0.0 114.929 169.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.23 -50.04 74.69 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 118.857 1.328 . . . . 0.0 110.79 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -163.66 144.98 9.14 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.464 2.306 . . . . 0.0 109.34 168.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -84.9 122.26 28.93 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.984 -1.073 . . . . 0.0 108.728 170.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.8 tpp180 -154.64 150.11 27.32 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.019 1.328 . . . . 0.0 110.537 -169.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -76.73 135.29 39.03 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 171.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -129.42 154.2 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.953 1.301 . . . . 0.0 108.66 172.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -79.83 160.12 26.22 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.084 0.953 . . . . 0.0 109.642 169.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -168.46 150.55 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.362 0.983 . . . . 0.0 110.945 169.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.54 145.36 25.33 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.937 173.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -112.29 159.78 18.3 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.459 1.503 . . . . 0.0 111.771 169.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -132.79 140.01 47.8 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.434 0.694 . . . . 0.0 111.102 169.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -82.47 160.24 22.72 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.938 1.295 . . . . 0.0 113.282 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -54.31 -30.74 52.11 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.613 1.965 . . . . 0.0 113.125 170.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -76.81 -9.95 59.03 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.121 1.368 . . . . 0.0 113.985 175.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.31 4.66 56.24 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 125.755 1.645 . . . . 0.0 115.886 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 58.7 m -87.94 132.26 34.29 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.061 1.431 . . . . 0.0 111.642 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 27.0 p -124.28 140.01 53.36 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.654 1.182 . . . . 0.0 113.529 -174.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -151.0 140.06 21.08 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.306 1.442 . . . . 0.0 113.29 -170.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -110.16 136.12 49.88 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.916 2.086 . . . . 0.0 109.311 171.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.6 m -142.28 178.69 7.39 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.318 1.447 . . . . 0.0 111.653 170.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -78.15 59.85 2.32 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.48 1.112 . . . . 0.0 110.192 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.4 t -60.45 146.76 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.975 1.71 . . . . 0.0 111.572 -171.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -102.25 69.71 1.15 Allowed 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 122.437 1.113 . . . . 0.0 112.981 -167.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.0 t -83.44 69.93 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.761 0.824 . . . . 0.0 110.052 -169.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 49.1 t -118.7 123.73 28.91 Favored Pre-proline 0 N--CA 1.484 1.26 0 CA-C-O 118.074 -0.965 . . . . 0.0 111.945 -169.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -81.37 179.91 5.47 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.534 2.823 . . . . 0.0 114.577 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.4 133.05 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.191 1.396 . . . . 0.0 112.928 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -118.74 166.65 12.51 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.421 1.888 . . . . 0.0 112.509 -169.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -96.79 -179.99 4.77 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.995 0.918 . . . . 0.0 112.029 170.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.0 -21.42 64.85 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -71.01 -19.87 62.46 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.574 1.15 . . . . 0.0 113.785 170.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.71 4.29 60.56 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.699 1.619 . . . . 0.0 114.432 -176.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -91.13 138.84 31.29 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.443 1.122 . . . . 0.0 113.014 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.06 100.18 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 126.123 1.769 . . . . 0.0 110.784 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.93 -29.51 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 118.805 -0.616 . . . . 0.0 111.915 173.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.63 147.87 51.5 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 124.248 1.975 . . . . 0.0 113.465 173.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -100.09 84.85 2.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 113.204 -1.816 . . . . 0.0 107.344 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 39.4 mt -100.02 69.99 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 169.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.5 mt -80.5 87.18 5.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.352 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -59.78 104.13 0.26 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.711 -178.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -83.91 49.94 1.72 Allowed 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.406 -1.434 . . . . 0.0 111.778 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -82.26 106.89 14.51 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 123.799 1.761 . . . . 0.0 112.846 -177.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 41.3 t -58.28 113.02 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 127.119 2.168 . . . . 0.0 109.286 170.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p -140.47 141.46 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 123.111 0.564 . . . . 0.0 111.359 176.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 20.5 ptp -139.01 155.43 47.99 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.467 1.507 . . . . 0.0 111.382 172.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -74.09 143.93 45.19 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.887 0.875 . . . . 0.0 111.868 173.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt . . . . . 0 C--O 1.254 1.329 0 C-N-CA 126.28 1.832 . . . . 0.0 111.827 -177.618 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 mmt . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -69.27 159.21 54.64 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.531 2.821 . . . . 0.0 112.641 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.9 m -135.22 158.06 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 125.764 1.625 . . . . 0.0 111.661 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -78.05 58.67 2.03 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.205 1.402 . . . . 0.0 113.795 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 61.4 ttt-85 -58.82 133.81 56.32 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.632 1.173 . . . . 0.0 111.404 176.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.75 9.63 86.76 Favored Glycine 0 CA--C 1.54 1.654 0 N-CA-C 115.592 0.997 . . . . 0.0 115.592 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -64.68 145.6 55.96 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.033 1.416 . . . . 0.0 112.349 175.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -82.01 123.43 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.155 0.982 . . . . 0.0 110.839 -175.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.36 159.89 37.05 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 124.612 1.165 . . . . 0.0 112.316 174.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -58.78 106.8 0.3 Allowed 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.141 2.56 . . . . 0.0 111.682 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -65.47 -26.49 67.96 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.774 1.028 . . . . 0.0 113.774 -168.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -69.98 -50.03 45.74 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.508 0.594 . . . . 0.0 110.493 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 t -77.0 -34.58 57.51 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.17 0.988 . . . . 0.0 112.378 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -59.17 -41.65 88.93 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.073 0.549 . . . . 0.0 110.165 172.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.6 tp -70.95 -45.25 64.48 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-O 118.654 -0.689 . . . . 0.0 112.04 173.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -47.83 -39.81 19.46 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 120.154 1.343 . . . . 0.0 113.146 174.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.6 m -60.01 -44.32 94.66 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.64 -0.663 . . . . 0.0 112.282 172.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.2 mm -67.94 -35.38 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.978 0.911 . . . . 0.0 110.837 175.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.2 mm -55.71 -54.53 25.11 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.462 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 172.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 -60.81 -27.51 68.1 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.125 0.875 . . . . 0.0 113.163 176.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -63.81 -42.14 97.75 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.436 0.694 . . . . 0.0 112.386 172.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -106.09 2.33 27.07 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -55.06 -29.17 56.94 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.352 1.861 . . . . 0.0 114.639 -167.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.64 55.43 11.77 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.159 0.885 . . . . 0.0 113.444 172.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -62.02 -4.21 1.54 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.945 2.098 . . . . 0.0 115.116 -169.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 72.6 p -74.87 15.2 0.41 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.125 1.77 . . . . 0.0 113.072 167.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.8 mtt180 -51.91 155.62 1.73 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.143 1.377 . . . . 0.0 113.216 173.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -113.26 138.43 50.02 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.916 1.287 . . . . 0.0 112.383 -166.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -169.79 162.37 9.51 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -173.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -119.98 172.23 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.337 1.455 . . . . 0.0 111.344 173.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.4 mm -127.08 118.44 50.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 125.764 1.626 . . . . 0.0 107.498 172.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.72 145.36 51.92 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -79.37 106.47 11.42 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.524 0.678 . . . . 0.0 110.684 176.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.52 -7.06 51.82 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -176.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -99.97 -4.68 29.59 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.91 1.284 . . . . 0.0 114.272 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.12 140.26 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.234 1.414 . . . . 0.0 110.243 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -55.06 -26.32 36.81 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -174.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -92.98 -10.32 36.75 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.944 1.298 . . . . 0.0 114.286 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 93.7 m 47.03 55.76 7.62 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.166 1.786 . . . . 0.0 113.259 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.97 157.8 16.61 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 -168.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.6 t -79.95 92.69 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 128.696 2.798 . . . . 0.0 108.728 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.0 pt -72.44 -24.76 22.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.21 1.404 . . . . 0.0 112.228 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -156.84 159.81 38.57 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.272 1.029 . . . . 0.0 112.359 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.4 p -139.94 151.94 45.96 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.094 -1.003 . . . . 0.0 113.368 -175.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -89.2 149.93 22.9 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.711 0.767 . . . . 0.0 111.672 167.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -65.09 -31.15 72.22 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.378 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.22 -50.83 38.6 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 119.451 -0.638 . . . . 0.0 112.812 172.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -29.85 66.9 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 119.258 1.529 . . . . 0.0 111.766 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 13.9 t -60.05 -40.03 88.01 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.542 -0.724 . . . . 0.0 110.962 171.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -80.19 -30.1 38.72 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 121.432 -0.793 . . . . 0.0 112.828 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.4 tp -54.93 -54.35 43.87 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.666 1.586 . . . . 0.0 110.111 172.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.3 m -80.0 -31.12 39.71 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 122.542 0.337 . . . . 0.0 111.624 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.93 17.22 63.67 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 125.438 1.494 . . . . 0.0 115.672 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -98.72 -118.88 0.14 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.073 1.349 . . . . 0.0 112.349 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.1 t -159.84 142.65 13.75 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.863 1.265 . . . . 0.0 111.499 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -59.61 -33.35 71.38 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.637 1.175 . . . . 0.0 113.07 -177.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.76 -16.63 42.24 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.628 1.171 . . . . 0.0 113.211 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -96.67 -20.76 18.04 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.505 1.522 . . . . 0.0 112.561 177.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 m -90.75 -20.04 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 CA-C-N 120.315 1.416 . . . . 0.0 113.378 -175.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 36.1 mmt -51.17 114.47 1.21 Allowed 'General case' 0 C--N 1.339 0.135 0 C-N-CA 124.283 1.033 . . . . 0.0 110.218 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 73.72 20.46 2.99 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.453 1.901 . . . . 0.0 114.769 173.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.98 152.95 95.77 Favored Pre-proline 0 N--CA 1.479 0.982 0 O-C-N 120.6 -1.313 . . . . 0.0 111.304 167.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -62.13 140.02 81.55 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.518 2.146 . . . . 0.0 110.714 170.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 18.9 t -65.19 -11.8 44.52 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.59 0.756 . . . . 0.0 112.879 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.06 87.69 0.11 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.91 1.684 . . . . 0.0 110.152 170.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 22.7 p -50.86 -13.08 0.12 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.229 2.212 . . . . 0.0 114.802 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.476 ' HA ' ' CD2' ' A' ' 70' ' ' HIS . 22.8 t70 -46.45 -31.84 2.93 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.088 1.355 . . . . 0.0 112.505 167.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -55.47 -22.15 19.52 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 174.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 pp -122.96 20.82 9.95 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.528 1.931 . . . . 0.0 114.593 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.476 ' CD2' ' HA ' ' A' ' 67' ' ' ASP . 2.1 m-70 -69.42 151.57 45.95 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 120.753 -1.217 . . . . 0.0 113.652 174.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -124.34 -173.37 13.81 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.715 1.626 . . . . 0.0 114.461 -172.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.71 -10.04 27.93 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.601 2.867 . . . . 0.0 115.24 -171.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.4 tpt85 -94.72 -10.05 32.85 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.68 1.192 . . . . 0.0 113.21 171.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.0 m -83.17 138.41 33.66 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -169.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -93.2 138.04 31.97 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.744 1.259 . . . . 0.0 111.71 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.6 mmm-85 -69.26 -39.79 78.2 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.773 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.3 ptt-85 -52.18 -39.47 60.12 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 169.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.22 -51.4 61.15 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 122.053 0.93 . . . . 0.0 109.971 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.84 -35.77 79.23 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.02 -52.09 26.94 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 126.171 1.789 . . . . 0.0 111.345 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -50.07 -40.76 46.39 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.589 1.086 . . . . 0.0 112.906 169.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 40.6 mt -63.46 -50.24 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 119.183 -0.437 . . . . 0.0 111.343 173.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.74 -39.89 59.27 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.713 0.688 . . . . 0.0 111.904 174.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -63.46 -39.06 93.45 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.517 0.727 . . . . 0.0 111.716 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.01 -29.5 68.52 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 174.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mt -82.44 -38.9 23.33 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 pp -68.99 -29.65 67.89 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 169.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.85 18.27 9.02 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.927 -0.929 . . . . 0.0 114.042 169.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.6 -49.88 69.38 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 118.77 1.285 . . . . 0.0 110.664 173.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -158.49 134.18 8.9 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.584 1.954 . . . . 0.0 109.777 167.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -74.54 120.47 20.14 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.143 -0.973 . . . . 0.0 108.454 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -143.3 136.78 28.31 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.397 1.079 . . . . 0.0 111.685 -168.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -81.37 130.19 34.93 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.469 1.108 . . . . 0.0 109.384 169.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -136.58 145.63 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.611 1.165 . . . . 0.0 109.333 -174.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.95 150.75 30.39 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.876 0.871 . . . . 0.0 109.714 169.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -162.01 146.56 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.614 1.165 . . . . 0.0 110.083 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -91.06 145.46 24.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.051 0.541 . . . . 0.0 112.263 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -122.26 157.75 30.99 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.539 1.136 . . . . 0.0 111.633 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -120.9 140.07 52.33 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.31 0.644 . . . . 0.0 110.415 167.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -95.52 162.28 13.71 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.246 1.418 . . . . 0.0 111.656 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -57.78 -29.09 64.57 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.359 1.864 . . . . 0.0 113.189 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -74.24 -9.95 59.12 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.82 1.248 . . . . 0.0 113.859 175.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.93 6.73 56.92 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.602 1.572 . . . . 0.0 115.561 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 63.4 m -87.51 137.99 31.86 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 118.812 1.306 . . . . 0.0 111.247 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 44.0 t -134.13 128.04 33.3 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.176 0.99 . . . . 0.0 112.598 -177.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -151.05 155.52 39.17 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -174.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -99.91 131.66 45.74 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.668 1.987 . . . . 0.0 109.736 169.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 56.8 m -135.13 168.07 19.82 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.643 1.577 . . . . 0.0 110.256 169.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.07 59.94 3.44 Favored 'General case' 0 CA--C 1.548 0.869 0 O-C-N 121.038 -1.039 . . . . 0.0 111.128 -175.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.8 t -59.85 147.88 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.261 1.424 . . . . 0.0 111.716 -171.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -105.19 69.67 0.86 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 122.475 1.131 . . . . 0.0 111.812 -168.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 19.9 t -82.54 69.96 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.213 1.005 . . . . 0.0 110.695 -169.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.6 p -117.26 130.0 24.94 Favored Pre-proline 0 N--CA 1.485 1.285 0 C-N-CA 124.202 1.001 . . . . 0.0 112.973 -171.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -82.21 -177.57 3.57 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 124.828 3.686 . . . . 0.0 114.488 -173.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.7 m -123.69 124.72 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-O 123.08 1.419 . . . . 0.0 112.802 171.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -109.73 165.61 11.56 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.33 2.252 . . . . 0.0 112.27 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -95.17 179.91 5.03 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 114.781 -1.1 . . . . 0.0 112.244 170.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.65 -21.4 65.67 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -70.19 -19.93 63.15 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.575 1.15 . . . . 0.0 113.677 169.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.36 2.2 59.03 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 126.048 1.785 . . . . 0.0 114.489 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.03 139.59 30.49 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 118.506 1.153 . . . . 0.0 113.324 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.8 p -71.26 100.14 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 125.395 1.478 . . . . 0.0 110.542 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.54 -29.97 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.091 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.037 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 10.1 mmt -136.46 143.63 43.97 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 123.705 1.717 . . . . 0.0 111.081 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -100.15 87.69 3.52 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 125.381 1.472 . . . . 0.0 107.756 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 36.4 mt -102.27 69.92 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 169.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.9 mt -79.94 87.72 5.35 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 122.284 1.04 . . . . 0.0 109.55 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -59.84 109.03 0.84 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.002 1.321 . . . . 0.0 110.643 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -87.43 49.98 1.92 Allowed 'General case' 0 CA--C 1.533 0.315 0 O-C-N 120.571 -1.331 . . . . 0.0 111.75 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -79.85 106.97 12.26 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 123.838 1.78 . . . . 0.0 111.536 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 20.1 t -60.13 119.93 5.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 126.718 2.007 . . . . 0.0 109.179 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.34 145.63 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 120.761 0.315 . . . . 0.0 111.078 175.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 91.8 mtp -129.77 153.72 47.93 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.974 1.71 . . . . 0.0 110.801 173.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.9 154.86 40.39 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.092 0.957 . . . . 0.0 113.066 175.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt . . . . . 0 C--O 1.253 1.27 0 C-N-CA 126.388 1.875 . . . . 0.0 111.787 -177.697 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 119.088 -0.482 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.56 169.22 22.8 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 123.973 3.115 . . . . 0.0 113.157 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . 0.288 33.0 m 50.03 33.61 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 127.291 2.236 . . . . 0.0 115.96 170.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 36.0 mtp-105 -70.49 152.64 43.79 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.639 1.176 . . . . 0.0 112.416 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -73.83 165.51 24.99 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.231 1.412 . . . . 0.0 113.079 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -150.47 167.9 30.31 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.264 1.412 . . . . 0.0 112.996 176.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -143.75 149.49 37.19 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.263 1.425 . . . . 0.0 112.202 -175.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.2 t -130.04 135.81 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.704 1.602 . . . . 0.0 109.243 173.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.63 159.83 57.92 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.554 0.742 . . . . 0.0 112.188 177.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.57 104.5 0.79 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.888 2.392 . . . . 0.0 112.107 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -66.57 -26.61 67.2 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.118 0.967 . . . . 0.0 113.208 -170.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -70.05 -49.86 47.0 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.526 0.73 . . . . 0.0 110.419 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 t -75.83 -33.87 60.08 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.954 0.902 . . . . 0.0 112.385 178.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -59.41 -41.17 88.84 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.743 -0.598 . . . . 0.0 110.438 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.6 tp -70.28 -44.84 67.56 Favored 'General case' 0 C--O 1.22 -0.447 0 CA-C-O 118.927 -0.559 . . . . 0.0 111.907 171.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -48.07 -39.7 20.93 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 120.003 1.274 . . . . 0.0 113.556 174.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.2 m -60.03 -42.58 94.68 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 121.704 -0.622 . . . . 0.0 112.289 172.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.5 mm -69.29 -34.15 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 O-C-N 121.113 -0.992 . . . . 0.0 110.857 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.9 mm -55.7 -54.32 27.42 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 169.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.92 -23.96 63.95 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.629 1.104 . . . . 0.0 113.436 175.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -68.62 -43.84 75.52 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.146 0.885 . . . . 0.0 112.495 171.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -102.75 0.26 32.63 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -56.59 -29.12 61.75 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.044 2.137 . . . . 0.0 114.141 -168.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.37 -1.65 60.06 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 125.869 1.7 . . . . 0.0 116.041 176.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -104.16 -25.43 12.93 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.616 1.566 . . . . 0.0 111.407 169.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.5 p -75.6 26.9 0.11 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 129.708 3.203 . . . . 0.0 114.513 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.39 168.84 3.26 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.618 1.167 . . . . 0.0 112.984 176.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -63.89 133.84 54.05 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.882 1.673 . . . . 0.0 113.902 -167.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -169.77 163.38 9.83 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.499 1.519 . . . . 0.0 113.935 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -120.9 170.48 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.849 1.26 . . . . 0.0 112.129 171.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.0 mm -120.66 114.44 43.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 168.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.07 152.82 43.82 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.653 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -85.86 119.39 26.13 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.8 -11.69 59.91 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.538 0.735 . . . . 0.0 112.891 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -100.05 -1.51 36.74 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.186 1.394 . . . . 0.0 114.185 -171.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.8 m -104.27 140.14 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 127.053 2.141 . . . . 0.0 111.58 -177.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -64.59 -27.86 69.24 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.395 1.078 . . . . 0.0 113.11 -174.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -84.47 -6.89 59.42 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.431 1.092 . . . . 0.0 113.28 173.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 46.7 m 49.47 39.89 17.74 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.781 1.632 . . . . 0.0 112.666 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.41 149.93 43.83 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -166.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.4 t -80.01 90.03 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 129.323 3.049 . . . . 0.0 108.511 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.3 pt -69.98 -21.87 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.949 1.3 . . . . 0.0 112.343 178.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -158.99 159.71 35.13 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.051 1.34 . . . . 0.0 111.711 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.415 ' HG ' ' CG2' ' A' ' 59' ' ' VAL . 27.4 p -139.98 148.3 41.7 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 120.77 -1.206 . . . . 0.0 113.876 -176.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -82.56 151.33 26.46 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.489 0.662 . . . . 0.0 110.704 166.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -66.48 -28.67 68.76 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.512 175.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.1 -50.79 54.05 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 121.267 -0.896 . . . . 0.0 112.867 173.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -29.85 66.92 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.202 1.501 . . . . 0.0 110.581 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.6 t -60.04 -39.77 87.09 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.555 0.742 . . . . 0.0 110.266 173.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -78.15 -27.92 48.22 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.016 0.926 . . . . 0.0 112.534 173.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.7 tp -60.65 -49.39 77.7 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.471 1.108 . . . . 0.0 111.462 175.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 26.9 p -79.97 -27.4 39.72 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 169.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.2 24.52 61.2 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 125.168 1.366 . . . . 0.0 114.515 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.3 m-30 -90.21 -129.96 0.09 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.154 1.382 . . . . 0.0 111.887 -177.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.7 t -159.9 150.16 18.65 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.604 2.362 . . . . 0.0 109.013 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 67.6 mtp85 -56.27 -43.05 78.4 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 121.059 -1.026 . . . . 0.0 112.112 -171.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.4 -18.12 63.37 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.741 1.216 . . . . 0.0 113.69 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -86.84 -20.72 27.08 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.116 1.766 . . . . 0.0 112.178 176.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.415 ' CG2' ' HG ' ' A' ' 44' ' ' CYS . 16.4 m -103.57 -20.2 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -177.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 33.8 mmt -50.0 113.64 0.9 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 124.084 0.954 . . . . 0.0 110.709 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 71.47 20.47 4.84 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.03 1.732 . . . . 0.0 113.744 169.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.52 160.12 75.68 Favored Pre-proline 0 N--CA 1.475 0.808 0 CA-C-O 118.145 -0.931 . . . . 0.0 111.557 167.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.09 140.05 91.63 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.732 2.288 . . . . 0.0 113.073 173.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 37.8 t -63.95 -17.7 63.52 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.592 1.157 . . . . 0.0 112.384 170.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.7 m -64.83 89.45 0.07 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.471 1.908 . . . . 0.0 110.795 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 26.8 p -52.95 -13.29 0.42 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.655 1.982 . . . . 0.0 115.127 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -46.35 -37.79 7.97 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.456 1.502 . . . . 0.0 111.416 166.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.83 -23.08 63.07 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.25 3.0 pp -123.13 28.15 7.28 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.205 1.802 . . . . 0.0 113.729 174.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.43 148.71 47.8 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.913 -1.117 . . . . 0.0 113.27 172.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.85 173.77 22.87 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.714 1.626 . . . . 0.0 114.603 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.56 -10.11 27.24 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.308 2.672 . . . . 0.0 114.152 -174.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -110.04 0.02 18.25 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.165 1.386 . . . . 0.0 113.879 170.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.6 m -71.42 139.0 49.53 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.726 1.148 . . . . 0.0 111.384 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -79.96 129.94 34.89 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 123.099 1.428 . . . . 0.0 109.59 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -70.16 -39.7 75.16 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.398 -176.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -56.63 -36.75 69.85 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 170.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.55 -51.7 53.6 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 122.029 0.919 . . . . 0.0 110.324 174.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.0 -33.27 75.66 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.449 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.01 -50.16 44.3 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.321 1.449 . . . . 0.0 112.18 177.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -49.99 -41.06 46.19 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.563 1.074 . . . . 0.0 112.09 169.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 20.9 mt -64.07 -49.68 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 118.518 0.599 . . . . 0.0 111.937 172.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.12 -39.83 44.27 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.453 0.57 . . . . 0.0 112.022 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -68.43 -39.35 81.56 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.376 0.67 . . . . 0.0 111.764 176.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.15 -27.75 65.83 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.836 -0.54 . . . . 0.0 112.157 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mt -88.02 -34.77 17.9 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.302 0.641 . . . . 0.0 110.538 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.58 -37.63 73.49 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.275 1.83 . . . . 0.0 110.142 168.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 117.46 22.43 4.07 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.691 1.139 . . . . 0.0 114.962 170.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.08 -50.0 75.03 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 118.644 1.222 . . . . 0.0 111.036 174.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -162.74 143.85 9.97 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.173 1.789 . . . . 0.0 111.145 169.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.45 118.4 13.21 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 168.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.9 tpp180 -151.75 138.35 18.73 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.61 1.164 . . . . 0.0 111.685 -173.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -80.63 128.72 33.94 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.693 1.197 . . . . 0.0 110.091 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.34 148.94 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.319 1.447 . . . . 0.0 108.813 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -79.94 157.13 26.96 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.061 0.944 . . . . 0.0 110.399 171.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -164.11 149.13 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.994 0.918 . . . . 0.0 110.629 171.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.36 145.39 28.25 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.726 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -117.0 156.2 27.89 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.523 1.129 . . . . 0.0 111.155 175.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -122.75 140.17 53.18 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.173 0.511 . . . . 0.0 110.263 168.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -91.01 146.32 23.95 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.769 1.228 . . . . 0.0 109.687 175.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -49.86 -30.51 10.09 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 126.728 2.011 . . . . 0.0 114.577 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -75.67 -9.82 58.92 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 109.91 28.11 4.32 Favored Glycine 0 CA--C 1.536 1.397 0 N-CA-C 115.905 1.122 . . . . 0.0 115.905 169.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.6 m -119.02 138.54 52.76 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.529 1.132 . . . . 0.0 111.229 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 32.0 p -135.99 140.03 43.61 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -150.93 148.62 28.63 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.837 1.255 . . . . 0.0 113.723 -173.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -99.98 120.94 40.6 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.471 1.509 . . . . 0.0 108.296 167.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 75.3 m -122.74 163.49 20.08 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.465 1.506 . . . . 0.0 109.579 174.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 67.4 mt -79.99 59.85 3.36 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.211 -0.931 . . . . 0.0 111.25 -175.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.5 m -65.2 144.82 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.6 1.96 . . . . 0.0 111.69 -173.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -107.68 69.85 0.76 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 122.42 1.105 . . . . 0.0 112.394 -167.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.8 t -81.37 69.92 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.762 1.225 . . . . 0.0 111.452 -168.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.49 131.99 24.32 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 124.317 1.047 . . . . 0.0 112.364 -175.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -86.18 -170.65 0.71 Allowed 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 123.544 2.83 . . . . 0.0 112.911 -172.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -123.17 129.85 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 122.868 1.318 . . . . 0.0 112.688 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -117.64 159.86 22.23 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.006 2.122 . . . . 0.0 111.277 -174.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -89.88 -179.8 5.81 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.947 0.899 . . . . 0.0 111.923 175.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.17 -21.77 64.09 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -72.45 -19.91 61.49 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.656 1.182 . . . . 0.0 113.884 170.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.54 0.55 60.89 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.622 1.582 . . . . 0.0 114.203 -176.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -87.35 139.39 30.6 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.465 1.132 . . . . 0.0 112.927 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.8 p -77.63 100.0 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 125.449 1.5 . . . . 0.0 111.114 -175.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.25 -30.0 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.71 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.89 150.0 49.19 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 123.997 1.856 . . . . 0.0 113.053 173.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -103.73 84.07 2.22 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 126.166 1.786 . . . . 0.0 107.475 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 44.3 mt -99.97 70.01 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 122.855 1.312 . . . . 0.0 108.697 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.277 22.0 mt -78.74 85.4 4.75 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 122.998 1.38 . . . . 0.0 110.051 -177.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -59.89 105.71 0.42 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.456 1.902 . . . . 0.0 110.143 175.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -86.13 53.97 2.98 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.559 -1.338 . . . . 0.0 110.017 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -79.76 106.66 11.94 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 124.168 1.937 . . . . 0.0 111.241 -168.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.7 t -61.19 112.34 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 113.452 -1.704 . . . . 0.0 108.242 177.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.32 142.05 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 175.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 78.6 mtm -141.35 147.43 38.06 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.01 1.324 . . . . 0.0 111.552 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -70.74 153.55 42.68 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.686 1.194 . . . . 0.0 112.956 176.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 60.9 mttp . . . . . 0 C--O 1.252 1.221 0 C-N-CA 125.939 1.696 . . . . 0.0 112.295 -169.11 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 119.042 -0.504 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -59.81 154.45 49.63 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.634 2.89 . . . . 0.0 113.121 170.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.6 t -72.79 129.37 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.655 0.782 . . . . 0.0 110.622 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 25.1 ptt-85 -135.52 19.9 3.34 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.669 1.588 . . . . 0.0 114.428 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 -49.87 136.75 17.68 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.265 1.826 . . . . 0.0 113.091 -170.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.49 7.85 64.69 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 124.691 1.138 . . . . 0.0 114.403 -170.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -64.93 155.99 32.58 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.115 1.366 . . . . 0.0 112.973 173.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.3 m -79.34 146.81 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.324 1.45 . . . . 0.0 112.638 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.22 159.94 74.1 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 124.065 0.946 . . . . 0.0 111.274 169.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -58.91 108.38 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.283 2.655 . . . . 0.0 111.434 174.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -63.74 -27.5 69.24 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -168.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -70.01 -50.03 45.51 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.614 0.643 . . . . 0.0 110.473 -175.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.4 t -77.27 -34.4 55.72 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.433 1.093 . . . . 0.0 112.373 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -58.82 -41.98 88.11 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.036 0.534 . . . . 0.0 110.161 172.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.45 -44.18 68.32 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 118.82 -0.609 . . . . 0.0 112.07 172.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -48.92 -39.99 28.36 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.865 1.211 . . . . 0.0 112.316 175.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.0 m -60.18 -43.1 96.11 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.399 -0.813 . . . . 0.0 112.718 172.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.8 mm -67.94 -35.76 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 O-C-N 121.306 -0.871 . . . . 0.0 110.389 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.4 mm -55.72 -54.57 24.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 172.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -24.36 64.25 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.568 1.147 . . . . 0.0 113.383 177.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -69.44 -44.65 70.85 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.616 1.166 . . . . 0.0 113.557 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -105.54 4.15 30.12 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -54.37 -29.08 47.23 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.473 1.909 . . . . 0.0 115.169 -167.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.01 -1.62 31.25 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.433 1.492 . . . . 0.0 116.651 170.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -105.66 -5.69 19.82 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.584 1.554 . . . . 0.0 113.181 -174.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 63.6 p -93.73 16.4 14.08 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.01 2.124 . . . . 0.0 113.463 174.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.8 mtt85 -69.19 156.88 37.98 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.074 1.75 . . . . 0.0 114.75 -173.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.1 147.73 40.69 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.308 1.843 . . . . 0.0 113.577 -169.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -169.93 160.18 8.23 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 -172.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 pp -119.92 166.07 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 127.637 2.375 . . . . 0.0 111.052 173.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.8 mm -130.78 118.04 40.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 125.206 1.402 . . . . 0.0 108.206 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.09 156.36 44.66 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -78.88 129.58 34.71 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 169.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.65 -11.87 52.76 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 169.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -94.37 0.4 55.47 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.949 1.7 . . . . 0.0 114.05 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.7 m -109.52 138.89 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 125.692 1.597 . . . . 0.0 111.153 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -63.86 -28.01 69.55 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.822 0.849 . . . . 0.0 112.941 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -81.92 -5.95 58.7 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.49 1.116 . . . . 0.0 113.671 175.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.0 p 45.06 37.41 2.5 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 127.028 2.131 . . . . 0.0 113.709 -175.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.05 150.01 40.86 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -167.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 64.7 t -79.99 90.91 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 129.454 3.102 . . . . 0.0 108.787 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.6 pt -69.99 -23.81 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.116 1.366 . . . . 0.0 112.267 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -156.41 159.72 38.97 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.346 1.058 . . . . 0.0 112.157 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.491 ' HG ' ' CG2' ' A' ' 59' ' ' VAL . 27.5 p -143.64 155.79 44.36 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 120.76 -1.212 . . . . 0.0 112.812 172.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -92.29 156.89 16.96 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -58.41 -29.05 65.79 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.708 0.803 . . . . 0.0 111.578 172.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.09 -49.83 41.66 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.416 1.008 . . . . 0.0 113.34 168.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.97 -38.48 76.11 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 119.343 1.572 . . . . 0.0 110.421 174.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.8 t -60.21 -39.86 88.11 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.881 -0.512 . . . . 0.0 111.051 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -74.71 -28.3 60.74 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 121.247 -0.908 . . . . 0.0 112.833 175.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.5 tp -66.85 -55.81 13.15 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.761 1.224 . . . . 0.0 111.594 177.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 64.2 m -98.77 -19.89 17.2 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.526 1.131 . . . . 0.0 113.054 -172.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.78 10.0 83.2 Favored Glycine 0 CA--C 1.541 1.696 0 N-CA-C 116.143 1.217 . . . . 0.0 116.143 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -89.21 -116.86 0.06 Allowed 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 119.072 1.436 . . . . 0.0 111.451 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.7 t -160.02 150.08 18.36 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.229 1.411 . . . . 0.0 110.948 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.9 mtp-105 -55.36 -40.78 71.7 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.402 1.081 . . . . 0.0 111.623 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.52 -19.15 63.33 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.489 1.116 . . . . 0.0 113.766 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -85.67 -20.65 29.1 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.966 1.307 . . . . 0.0 112.712 174.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.491 ' CG2' ' HG ' ' A' ' 44' ' ' CYS . 15.7 m -100.97 -20.05 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 174.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 30.2 mmt -49.91 113.24 0.8 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.423 1.089 . . . . 0.0 111.089 -177.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 71.49 15.74 6.08 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.839 1.656 . . . . 0.0 113.977 170.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.83 160.16 74.82 Favored Pre-proline 0 N--CA 1.475 0.803 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.414 167.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.03 140.1 85.92 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.801 2.334 . . . . 0.0 111.834 169.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.4 t -69.39 -12.58 61.77 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.807 0.843 . . . . 0.0 113.091 177.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.7 m -64.76 97.86 0.24 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.373 1.869 . . . . 0.0 110.731 177.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 31.8 p -52.67 -15.05 0.61 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.075 1.75 . . . . 0.0 115.134 -177.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -47.36 -38.98 14.06 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.746 1.219 . . . . 0.0 111.854 168.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.07 -19.76 63.27 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 pp -123.0 24.91 8.78 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.428 1.891 . . . . 0.0 113.045 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.53 145.67 53.69 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.308 -0.87 . . . . 0.0 112.419 174.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -110.8 178.97 19.98 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.532 1.539 . . . . 0.0 113.558 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.05 -10.07 27.73 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.493 2.795 . . . . 0.0 114.208 -177.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.25 -10.09 24.54 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.649 1.579 . . . . 0.0 112.582 172.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.46 HG23 ' H ' ' A' ' 97' ' ' ALA . 2.9 m -80.24 138.37 36.8 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.717 -1.239 . . . . 0.0 111.541 -175.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -87.64 135.26 33.44 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.384 1.088 . . . . 0.0 110.709 174.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.4 mmm-85 -66.26 -39.68 89.62 Favored 'General case' 0 C--O 1.219 -0.536 0 O-C-N 121.43 -0.794 . . . . 0.0 111.074 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -53.68 -38.34 64.1 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 171.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.38 -52.35 47.68 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.942 0.877 . . . . 0.0 110.027 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.55 -33.79 76.73 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.554 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.01 -52.19 26.16 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.859 1.664 . . . . 0.0 112.314 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -50.13 -42.02 49.88 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.455 1.025 . . . . 0.0 112.287 170.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 48.9 mt -62.94 -49.34 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 O-C-N 121.876 -0.515 . . . . 0.0 111.052 173.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.27 -39.93 57.8 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.592 -0.718 . . . . 0.0 112.114 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -68.68 -37.67 79.77 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.636 0.774 . . . . 0.0 111.477 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.37 -33.0 74.73 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.436 -0.79 . . . . 0.0 111.311 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 mt -82.06 -29.83 31.68 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.469 0.707 . . . . 0.0 112.119 177.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.3 -28.75 69.54 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.216 2.206 . . . . 0.0 110.766 168.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.95 17.66 9.44 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.196 1.379 . . . . 0.0 114.905 169.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.4 -50.04 67.01 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.648 1.224 . . . . 0.0 111.182 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -150.59 141.36 22.76 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.658 1.583 . . . . 0.0 111.621 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -79.59 104.02 9.9 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 166.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.7 tpt85 -145.11 136.79 25.43 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.242 1.017 . . . . 0.0 111.433 -171.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -82.02 133.04 35.26 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.572 1.549 . . . . 0.0 109.632 169.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.22 146.42 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.406 1.483 . . . . 0.0 108.9 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.01 153.86 28.57 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.644 0.778 . . . . 0.0 110.404 172.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -161.33 158.57 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.728 1.211 . . . . 0.0 110.537 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.46 ' H ' HG23 ' A' ' 74' ' ' THR . . . -100.09 145.44 27.95 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.671 0.789 . . . . 0.0 112.181 174.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -115.91 158.61 22.75 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.561 1.145 . . . . 0.0 111.041 169.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -127.44 137.46 52.71 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.519 0.728 . . . . 0.0 110.241 168.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -81.26 159.7 24.44 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.191 0.997 . . . . 0.0 112.611 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -55.43 -29.05 57.89 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.786 1.635 . . . . 0.0 112.979 171.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -80.02 -9.9 59.73 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.022 1.329 . . . . 0.0 113.774 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.37 0.69 53.74 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 126.106 1.813 . . . . 0.0 115.822 178.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.0 m -78.23 128.0 33.09 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.108 1.454 . . . . 0.0 111.741 -178.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 61.5 m -115.7 137.93 51.6 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.742 1.217 . . . . 0.0 112.317 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -151.03 139.92 20.92 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.25 121.37 41.83 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 127.091 2.156 . . . . 0.0 108.341 169.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 89.0 m -129.37 177.47 7.16 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.429 1.492 . . . . 0.0 110.218 169.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 25.0 tp -78.36 59.92 2.45 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.688 -1.258 . . . . 0.0 110.821 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 49.8 t -55.82 146.06 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.129 1.372 . . . . 0.0 111.194 -172.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -100.03 69.81 1.55 Allowed 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 122.948 1.356 . . . . 0.0 112.047 -167.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.3 t -83.84 69.84 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.37 1.068 . . . . 0.0 110.62 -169.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.77 134.99 23.52 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 124.989 1.316 . . . . 0.0 110.512 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -88.5 -166.41 0.26 Allowed 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 123.517 2.811 . . . . 0.0 113.153 -170.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.65 131.08 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-O 122.927 1.346 . . . . 0.0 113.628 173.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -116.99 160.25 21.23 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.18 2.192 . . . . 0.0 111.744 -173.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -90.02 179.99 5.82 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.065 0.946 . . . . 0.0 112.081 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.99 -21.46 64.87 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -71.2 -19.9 62.34 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.575 1.15 . . . . 0.0 113.819 170.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.08 3.55 60.35 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.599 1.571 . . . . 0.0 114.337 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.06 139.8 30.28 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.585 1.193 . . . . 0.0 113.053 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.2 p -74.34 99.95 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.868 1.667 . . . . 0.0 110.914 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.0 -29.63 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.565 0.746 . . . . 0.0 111.792 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.97 149.14 52.26 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 124.251 1.977 . . . . 0.0 112.626 173.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.2 m-30 -105.01 79.99 1.57 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.27 -1.787 . . . . 0.0 106.886 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 44.3 mt -100.59 70.41 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 169.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.09 89.23 3.6 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.923 0.868 . . . . 0.0 108.822 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -59.86 106.44 0.49 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.663 1.185 . . . . 0.0 110.797 -177.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -84.02 53.21 2.52 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.546 -1.346 . . . . 0.0 112.52 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -79.73 127.2 31.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 122.196 0.998 . . . . 0.0 111.109 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 65.6 t -81.14 117.76 27.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 125.169 1.388 . . . . 0.0 108.327 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.36 140.56 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-O 121.416 0.626 . . . . 0.0 112.642 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 28.5 ptm -133.12 172.48 12.59 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.611 1.964 . . . . 0.0 110.783 174.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.74 135.1 57.48 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.697 0.799 . . . . 0.0 112.043 177.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 86.1 tttt . . . . . 0 C--O 1.253 1.266 0 C-N-CA 125.891 1.676 . . . . 0.0 112.627 -176.456 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -60.05 155.76 43.04 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.735 2.956 . . . . 0.0 114.155 177.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 46.7 t -74.17 136.54 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.277 1.031 . . . . 0.0 110.426 176.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 94.1 mtm-85 -70.63 153.23 43.06 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.484 1.114 . . . . 0.0 112.652 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -137.96 147.96 44.77 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.12 1.768 . . . . 0.0 110.828 173.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.85 9.59 62.96 Favored Glycine 0 CA--C 1.54 1.629 0 C-N-CA 124.499 1.047 . . . . 0.0 115.499 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 -84.18 162.35 20.24 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.258 1.823 . . . . 0.0 113.065 -178.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.4 t -79.46 137.08 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.106 0.962 . . . . 0.0 109.346 172.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.09 159.88 19.15 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.924 0.89 . . . . 0.0 111.997 173.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -52.39 110.01 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.688 2.925 . . . . 0.0 111.858 174.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -65.47 -26.94 68.16 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -167.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -68.76 -49.99 54.15 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.672 0.789 . . . . 0.0 110.299 -178.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 t -74.55 -35.76 63.1 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.716 0.806 . . . . 0.0 112.114 178.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.06 -39.98 83.72 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.498 0.719 . . . . 0.0 110.423 174.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.2 tp -69.99 -45.83 66.46 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.984 0.514 . . . . 0.0 111.869 170.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -47.61 -39.78 17.78 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.974 1.261 . . . . 0.0 113.742 175.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 92.8 m -60.03 -41.69 92.77 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 121.579 -0.701 . . . . 0.0 112.371 172.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.2 mm -68.66 -35.29 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 O-C-N 121.154 -0.966 . . . . 0.0 110.219 174.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.5 mm -56.54 -51.65 62.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 CA-C-O 117.765 -1.112 . . . . 0.0 108.865 170.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -29.02 67.94 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.932 1.242 . . . . 0.0 112.255 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.9 tttp -66.69 -42.79 85.92 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.336 1.054 . . . . 0.0 113.055 174.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -103.65 1.91 32.55 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -56.0 -29.02 59.71 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.183 1.793 . . . . 0.0 114.804 -167.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.42 55.41 3.98 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 121.246 -0.909 . . . . 0.0 111.998 -175.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -71.48 7.07 1.52 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.297 2.239 . . . . 0.0 114.039 -173.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.3 p -73.36 13.85 0.4 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.067 1.747 . . . . 0.0 112.528 167.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -53.27 149.86 6.83 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.789 1.636 . . . . 0.0 112.276 169.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.15 147.68 29.78 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 127.157 2.183 . . . . 0.0 112.241 -172.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -169.79 159.64 8.14 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 -175.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 pp -120.04 172.87 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 126.022 1.729 . . . . 0.0 111.036 174.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.5 mm -131.64 119.72 43.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 125.999 1.72 . . . . 0.0 107.781 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -137.49 152.33 49.41 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -175.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -76.91 107.92 9.58 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.6 174.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.07 -17.42 63.24 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -95.67 2.61 54.14 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.119 1.367 . . . . 0.0 114.034 -169.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.18 140.23 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.797 1.639 . . . . 0.0 110.109 -177.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -57.53 -28.37 63.42 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.18 -14.81 59.31 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.847 1.259 . . . . 0.0 113.982 178.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 82.7 m 43.87 50.67 6.97 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.5 1.52 . . . . 0.0 113.377 -177.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.51 150.02 21.95 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -166.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 98.3 t -79.84 90.0 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 128.011 2.524 . . . . 0.0 109.387 -175.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.5 pt -70.02 -23.75 25.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.837 1.255 . . . . 0.0 112.223 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -155.74 159.83 39.8 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.449 1.099 . . . . 0.0 112.329 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.402 ' HG ' ' CG2' ' A' ' 59' ' ' VAL . 27.4 p -140.01 154.69 47.2 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.809 -1.182 . . . . 0.0 113.227 173.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -85.94 153.48 22.16 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 174.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -63.29 -24.1 67.71 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.673 173.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.73 -49.99 45.07 Favored Glycine 0 CA--C 1.532 1.138 0 O-C-N 121.308 -0.87 . . . . 0.0 112.249 168.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -37.25 78.59 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 119.208 1.504 . . . . 0.0 110.852 175.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.2 t -60.09 -39.97 87.97 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.538 -0.726 . . . . 0.0 110.896 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -73.93 -30.04 62.35 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.541 0.736 . . . . 0.0 112.327 175.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.4 tp -64.72 -55.67 18.5 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.274 1.029 . . . . 0.0 112.18 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 78.1 m -97.68 -20.71 17.45 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -172.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.21 15.15 81.3 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-O 118.735 -1.036 . . . . 0.0 115.633 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -88.85 -124.26 0.05 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 119.129 1.465 . . . . 0.0 111.316 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.3 m -159.92 150.09 18.57 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.903 2.081 . . . . 0.0 109.719 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -57.07 -36.19 70.26 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.21 -20.68 59.84 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.886 1.274 . . . . 0.0 113.613 174.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -83.15 -20.89 33.9 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.743 1.617 . . . . 0.0 112.279 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.402 ' CG2' ' HG ' ' A' ' 44' ' ' CYS . 15.6 m -104.46 -19.29 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 177.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 33.4 mmt -49.99 115.4 1.39 Allowed 'General case' 0 C--N 1.343 0.286 0 CA-C-O 122.172 0.986 . . . . 0.0 110.877 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 72.2 17.67 4.93 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.713 2.005 . . . . 0.0 113.703 169.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.57 154.48 81.38 Favored Pre-proline 0 N--CA 1.473 0.697 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.339 167.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -65.41 140.16 62.42 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.983 3.122 . . . . 0.0 112.043 171.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 96.0 m -62.18 -10.0 9.31 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.4 m -65.24 96.47 0.22 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.198 1.799 . . . . 0.0 110.763 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 61.6 m -50.37 -20.01 0.99 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.629 1.972 . . . . 0.0 115.789 -171.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -46.56 -39.48 11.08 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.059 1.344 . . . . 0.0 112.395 169.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -60.98 -20.17 62.03 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 pp -122.98 23.73 9.21 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.885 1.674 . . . . 0.0 113.229 176.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -64.57 147.18 53.4 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.354 -0.842 . . . . 0.0 112.338 175.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.72 -169.69 11.88 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 125.574 1.559 . . . . 0.0 113.989 -176.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -64.68 -10.13 23.53 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.533 2.822 . . . . 0.0 116.378 -170.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.4 mmm-85 -104.96 -10.1 17.48 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.466 1.506 . . . . 0.0 113.601 174.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.9 m -79.21 133.09 36.69 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.228 0.922 . . . . 0.0 111.608 -169.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -85.2 137.03 33.26 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 122.409 1.1 . . . . 0.0 110.683 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -69.48 -39.69 77.53 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.948 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.9 ptt-85 -53.64 -40.31 65.74 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 169.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.4 -50.66 62.71 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.029 0.931 . . . . 0.0 110.261 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.82 -33.85 76.98 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.457 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.98 -51.89 28.82 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.239 1.416 . . . . 0.0 112.098 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -49.97 -41.91 47.69 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.594 1.158 . . . . 0.0 111.799 170.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.7 mt -64.38 -49.13 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 121.824 -0.547 . . . . 0.0 111.602 173.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.49 -39.94 49.7 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.859 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -70.3 -38.78 75.04 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.758 0.823 . . . . 0.0 111.734 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.42 -32.69 73.74 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.455 -0.778 . . . . 0.0 111.399 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mt -86.94 -27.98 23.01 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.814 0.846 . . . . 0.0 111.521 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.98 -30.19 70.76 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.579 1.952 . . . . 0.0 110.658 168.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.94 22.52 6.56 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.725 1.155 . . . . 0.0 114.319 170.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.33 -49.95 75.36 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.405 1.102 . . . . 0.0 109.81 171.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -166.95 141.36 3.93 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.786 2.435 . . . . 0.0 109.534 167.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -72.67 120.52 18.4 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.897 -1.127 . . . . 0.0 108.485 169.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 26.2 tpp180 -157.56 140.3 14.92 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.542 1.537 . . . . 0.0 110.243 -168.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -81.57 137.36 35.53 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.714 0.806 . . . . 0.0 111.628 175.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.0 t -137.83 150.09 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 126.55 1.94 . . . . 0.0 108.183 177.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -79.97 158.37 26.59 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.073 0.949 . . . . 0.0 110.573 171.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -164.29 152.56 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.526 1.13 . . . . 0.0 110.269 171.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -85.88 145.35 27.21 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.008 176.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -117.31 162.04 18.55 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.822 1.249 . . . . 0.0 111.771 176.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -131.15 140.01 49.88 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.017 0.927 . . . . 0.0 111.5 168.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 24.5 mtp-105 -86.29 166.63 15.5 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.553 1.541 . . . . 0.0 113.088 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -58.15 -30.94 66.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.93 2.092 . . . . 0.0 112.839 174.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -78.06 -9.87 59.35 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.876 1.27 . . . . 0.0 114.047 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.65 -0.8 61.37 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 125.701 1.62 . . . . 0.0 116.003 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.0 t -76.46 140.87 41.43 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.799 1.799 . . . . 0.0 111.39 176.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 23.7 p -137.51 137.25 38.45 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -174.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -151.05 148.4 28.29 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.87 1.268 . . . . 0.0 114.256 -172.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -102.6 125.06 49.2 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.52 1.528 . . . . 0.0 108.337 167.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 67.7 m -128.11 166.27 18.79 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.264 1.426 . . . . 0.0 109.867 172.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 mp -80.05 59.81 3.39 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.071 -1.018 . . . . 0.0 110.238 -176.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 18.2 m -67.66 148.02 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.294 1.838 . . . . 0.0 111.623 -169.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -109.34 69.72 0.71 Allowed 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 122.545 1.164 . . . . 0.0 113.397 -166.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.8 t -80.62 69.8 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 125.093 1.357 . . . . 0.0 110.003 -171.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.7 p -123.79 130.79 24.31 Favored Pre-proline 0 N--CA 1.484 1.259 0 C-N-CA 124.922 1.289 . . . . 0.0 112.535 -169.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -83.05 179.92 4.85 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.237 1.958 . . . . 0.0 113.34 -174.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -123.18 135.62 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 123.089 1.424 . . . . 0.0 112.334 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.09 165.03 22.03 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.779 2.032 . . . . 0.0 112.152 -169.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -89.99 -177.04 5.09 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.139 1.376 . . . . 0.0 111.958 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.8 -19.96 65.41 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -80.04 -19.85 46.67 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.683 1.193 . . . . 0.0 113.087 170.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.35 8.98 59.52 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.345 1.45 . . . . 0.0 114.147 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -84.59 129.25 34.87 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.347 1.574 . . . . 0.0 110.802 175.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.29 99.99 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 125.82 1.648 . . . . 0.0 110.279 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.8 -29.96 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 118.402 -0.809 . . . . 0.0 111.263 176.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.6 mmt -138.0 148.5 45.22 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 123.835 1.779 . . . . 0.0 111.911 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -101.44 87.07 3.1 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 126.613 1.965 . . . . 0.0 108.307 175.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 40.9 mt -100.72 70.82 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 169.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.3 mt -78.65 84.92 4.72 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.801 0.81 . . . . 0.0 109.672 -174.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -59.9 109.74 1.01 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.072 1.349 . . . . 0.0 110.885 -176.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -85.2 49.86 1.83 Allowed 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.215 -1.553 . . . . 0.0 110.857 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -85.54 106.88 17.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 123.468 1.604 . . . . 0.0 113.412 -168.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.0 t -55.16 114.3 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 113.624 -1.625 . . . . 0.0 109.02 171.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p -140.39 144.58 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 171.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 84.7 mtp -142.79 153.86 43.66 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.602 1.161 . . . . 0.0 111.329 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -73.85 153.43 39.9 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.212 1.005 . . . . 0.0 112.659 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 65.3 pttt . . . . . 0 C--O 1.254 1.299 0 C-N-CA 125.116 1.366 . . . . 0.0 113.732 178.035 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 119.115 -0.469 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.26 168.53 23.91 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.719 2.946 . . . . 0.0 112.812 177.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.3 m -66.63 157.14 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.29 1.036 . . . . 0.0 112.171 172.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -66.69 158.4 30.21 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.738 1.215 . . . . 0.0 113.152 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -123.52 146.48 48.06 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.556 1.942 . . . . 0.0 109.944 169.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.28 24.8 73.59 Favored Glycine 0 CA--C 1.54 1.639 0 C-N-CA 123.411 0.529 . . . . 0.0 113.912 -171.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -117.51 148.2 42.07 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.708 2.003 . . . . 0.0 111.718 -173.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.6 t -126.33 117.77 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.989 1.315 . . . . 0.0 107.624 169.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.06 159.93 52.06 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.401 0.68 . . . . 0.0 111.119 174.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.08 107.5 0.26 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.898 2.398 . . . . 0.0 111.159 174.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -64.36 -26.87 68.66 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -167.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -69.31 -49.86 51.98 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.28 0.632 . . . . 0.0 110.303 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 t -78.69 -32.71 47.16 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.393 1.077 . . . . 0.0 112.883 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -55.26 -44.64 75.77 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.276 1.03 . . . . 0.0 109.594 168.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.7 tp -72.21 -45.22 61.17 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 118.594 -0.717 . . . . 0.0 112.135 175.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -46.73 -39.99 12.62 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.527 1.531 . . . . 0.0 113.349 173.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.4 m -60.0 -45.9 91.22 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.468 173.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.1 mm -68.1 -36.14 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.859 0.864 . . . . 0.0 111.235 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.3 mm -53.28 -57.65 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 172.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -63.43 -24.72 67.96 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.614 0.765 . . . . 0.0 112.946 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.7 tptt -61.63 -45.09 95.56 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 118.347 -0.835 . . . . 0.0 111.974 170.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -103.97 -0.18 29.22 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 116.177 1.918 . . . . 0.0 116.177 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -60.02 -29.12 68.28 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.318 1.847 . . . . 0.0 115.736 -168.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.25 55.46 0.91 Allowed Glycine 0 CA--C 1.539 1.555 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -164.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -84.15 4.48 30.29 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 128.284 2.633 . . . . 0.0 114.615 -168.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.6 m -57.65 -4.1 0.24 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.833 2.053 . . . . 0.0 114.204 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.7 174.36 6.05 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.412 0.685 . . . . 0.0 112.609 168.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 ptpp? -59.35 137.81 57.86 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.71 1.604 . . . . 0.0 114.814 -173.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -169.79 167.22 9.42 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.686 1.594 . . . . 0.0 114.212 -177.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 pp -120.04 169.41 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.722 1.209 . . . . 0.0 111.12 167.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.6 mm -125.54 117.94 50.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 126.058 1.743 . . . . 0.0 107.11 171.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.36 147.66 50.64 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -81.01 106.55 13.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.648 0.737 . . . . 0.0 110.644 175.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.88 -6.48 51.01 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 53.1 mmm-85 -100.05 1.85 42.75 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.798 1.639 . . . . 0.0 114.133 -177.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -108.96 140.22 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.381 1.473 . . . . 0.0 109.974 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -55.7 -29.92 60.22 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -175.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -83.89 -12.67 55.15 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 95.9 m 42.99 58.8 3.13 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.497 1.919 . . . . 0.0 113.518 -177.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.0 156.97 16.12 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -168.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.3 t -79.9 89.94 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 128.272 2.629 . . . . 0.0 108.858 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.7 pt -70.48 -25.39 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.857 1.263 . . . . 0.0 112.185 176.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -156.76 159.79 38.64 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.916 0.886 . . . . 0.0 112.701 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.427 ' HG ' ' CG2' ' A' ' 59' ' ' VAL . 7.9 p -145.34 147.58 32.46 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.209 -0.932 . . . . 0.0 113.289 -169.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -86.26 152.4 22.81 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.503 0.668 . . . . 0.0 112.537 169.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -61.98 -36.06 80.33 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.215 0.606 . . . . 0.0 111.252 171.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.0 -49.94 53.31 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 121.292 -0.88 . . . . 0.0 112.911 175.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -29.94 66.93 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 118.939 1.37 . . . . 0.0 110.823 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.9 t -60.18 -40.03 88.59 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.007 -1.058 . . . . 0.0 111.181 172.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -78.74 -30.02 45.55 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.977 0.911 . . . . 0.0 112.385 175.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.3 tp -55.17 -52.72 62.4 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.886 1.274 . . . . 0.0 110.244 171.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 57.5 m -80.03 -29.17 39.27 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.15 0.5 . . . . 0.0 112.316 176.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.29 26.07 58.13 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 125.376 1.465 . . . . 0.0 114.143 -173.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 16.1 m-30 -94.7 -130.11 0.14 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.881 1.272 . . . . 0.0 111.865 -173.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.0 t -159.88 140.38 11.98 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 127.117 2.167 . . . . 0.0 108.741 175.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.8 mtm105 -64.75 -31.33 72.51 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 120.92 -1.113 . . . . 0.0 113.246 -171.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.81 -16.66 29.98 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.023 0.929 . . . . 0.0 113.403 172.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -95.6 -20.82 18.67 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.476 1.91 . . . . 0.0 112.14 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.427 ' CG2' ' HG ' ' A' ' 44' ' ' CYS . 3.1 m -89.89 -18.12 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-N 119.489 1.04 . . . . 0.0 112.694 -174.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 33.6 mmt -49.73 115.42 1.36 Allowed 'General case' 0 C--N 1.341 0.204 0 C-N-CA 125.041 1.336 . . . . 0.0 110.486 -172.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 69.0 21.03 7.58 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.283 1.433 . . . . 0.0 113.62 169.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.72 155.1 93.87 Favored Pre-proline 0 N--CA 1.475 0.794 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.528 167.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.12 140.04 93.23 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.47 2.113 . . . . 0.0 111.649 169.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 37.4 t -64.36 -17.66 63.93 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.62 1.168 . . . . 0.0 112.914 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.6 m -62.61 99.98 0.17 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 127.09 2.156 . . . . 0.0 111.232 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 28.0 p -55.14 -14.17 1.54 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.446 1.498 . . . . 0.0 114.918 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -49.33 -40.06 33.82 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.778 1.231 . . . . 0.0 111.587 168.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -66.73 -11.0 52.77 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 pp -123.04 20.52 9.92 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.14 1.776 . . . . 0.0 113.744 170.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -63.74 144.38 57.08 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.136 -0.978 . . . . 0.0 113.084 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -109.15 175.87 19.36 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.691 1.615 . . . . 0.0 113.754 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.56 -10.05 27.89 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.445 2.763 . . . . 0.0 114.629 -175.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -103.14 -7.63 21.12 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.206 1.402 . . . . 0.0 113.696 170.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.0 m -70.85 134.58 47.44 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.536 1.062 . . . . 0.0 110.355 178.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -81.97 137.39 35.14 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.643 0.735 . . . . 0.0 110.2 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -66.35 -39.85 89.43 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.697 -0.627 . . . . 0.0 110.855 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.5 ptt-85 -55.59 -41.18 73.04 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.802 0.841 . . . . 0.0 113.008 171.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.56 -51.35 63.23 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.766 0.826 . . . . 0.0 110.364 177.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.44 -33.65 76.19 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.247 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.06 -52.77 21.25 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.762 1.225 . . . . 0.0 111.983 177.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -50.0 -42.18 48.64 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.719 1.208 . . . . 0.0 111.859 171.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 54.3 mt -63.8 -51.04 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 121.878 -0.514 . . . . 0.0 110.897 174.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.37 -39.9 58.1 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 118.604 -0.713 . . . . 0.0 112.116 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -69.09 -36.58 77.73 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.64 0.776 . . . . 0.0 111.601 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.49 -30.11 68.87 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.684 -0.635 . . . . 0.0 111.673 177.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mt -83.59 -31.33 26.36 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.565 0.746 . . . . 0.0 111.445 176.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.77 -30.08 71.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.249 2.22 . . . . 0.0 111.484 169.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.05 19.92 7.83 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.797 1.189 . . . . 0.0 114.953 169.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.89 -50.01 73.93 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 118.868 1.334 . . . . 0.0 110.5 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -162.8 141.47 8.63 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.608 2.363 . . . . 0.0 108.934 168.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -78.73 120.47 23.42 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.987 -1.071 . . . . 0.0 108.654 170.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.9 tpp180 -152.19 136.62 16.79 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.311 1.444 . . . . 0.0 109.857 -169.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -79.61 134.44 36.45 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.302 0.641 . . . . 0.0 110.578 173.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.29 148.2 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.645 1.578 . . . . 0.0 109.126 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -79.87 155.73 27.67 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.108 0.963 . . . . 0.0 110.381 172.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -163.39 149.75 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.357 1.063 . . . . 0.0 110.858 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -87.14 145.37 26.46 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.844 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -112.3 145.69 39.55 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.032 1.333 . . . . 0.0 111.675 169.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.66 132.27 53.81 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.535 0.734 . . . . 0.0 109.394 167.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 28.7 mtp-105 -100.04 153.35 19.28 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.738 1.615 . . . . 0.0 112.881 -168.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -58.9 -29.44 67.05 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.688 1.195 . . . . 0.0 112.287 171.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -72.27 -10.03 59.25 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.471 1.508 . . . . 0.0 113.878 175.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.49 0.87 55.53 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.49 1.519 . . . . 0.0 115.397 177.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.51 148.72 47.92 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.85 1.325 . . . . 0.0 111.273 174.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 34.3 t -152.0 110.62 3.79 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.245 0.93 . . . . 0.0 111.421 175.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -151.0 151.75 32.52 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -173.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -102.2 126.43 49.17 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.421 1.889 . . . . 0.0 108.989 168.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 73.5 m -130.29 171.47 12.88 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.94 1.296 . . . . 0.0 110.618 170.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 mp -79.96 59.85 3.34 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 120.947 -1.095 . . . . 0.0 110.921 -175.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.0 t -61.28 140.68 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.179 1.391 . . . . 0.0 111.932 -170.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -101.59 69.78 1.24 Allowed 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 123.109 1.433 . . . . 0.0 112.447 -169.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.8 t -78.18 69.97 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.271 1.828 . . . . 0.0 111.481 -173.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.4 p -120.86 131.19 24.54 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.085 -1.009 . . . . 0.0 113.56 -171.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -85.58 -178.9 3.18 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 125.028 3.819 . . . . 0.0 115.578 -169.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.9 m -123.69 131.36 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-O 122.844 1.307 . . . . 0.0 113.048 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -115.4 163.05 16.29 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.876 2.07 . . . . 0.0 111.82 -171.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -95.64 -179.96 4.92 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.269 1.028 . . . . 0.0 112.009 172.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -61.82 -19.99 63.15 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -177.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -71.37 -21.59 62.0 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.529 1.132 . . . . 0.0 113.57 170.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.75 5.25 57.7 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 125.581 1.562 . . . . 0.0 114.695 -174.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -97.51 142.24 29.59 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.852 1.326 . . . . 0.0 113.581 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.7 p -71.12 100.16 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.955 1.702 . . . . 0.0 111.089 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.45 -29.25 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 118.631 -0.7 . . . . 0.0 111.68 174.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.35 147.59 51.83 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 124.277 1.989 . . . . 0.0 113.236 172.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -99.2 86.03 3.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 112.994 -1.912 . . . . 0.0 107.284 173.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 36.3 mt -101.43 70.0 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 122.834 1.302 . . . . 0.0 108.631 170.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.253 17.7 mt -80.27 83.57 6.09 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.118 -177.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -59.8 103.09 0.18 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.429 1.892 . . . . 0.0 110.443 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -83.32 57.41 3.98 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.679 -1.263 . . . . 0.0 112.593 -174.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -79.74 106.93 12.13 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 124.576 2.132 . . . . 0.0 112.265 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.1 t -61.19 110.39 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 C-N-CA 127.24 2.216 . . . . 0.0 109.051 170.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p -140.43 140.39 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 120.805 0.336 . . . . 0.0 111.699 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 85.2 mtp -139.3 151.67 46.61 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.336 1.454 . . . . 0.0 110.897 169.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -72.53 150.19 43.41 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.037 0.935 . . . . 0.0 112.499 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 C--O 1.252 1.197 0 C-N-CA 126.537 1.935 . . . . 0.0 111.895 -177.531 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 ttp . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 118.433 -0.794 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -63.31 -29.57 72.82 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.127 2.551 . . . . 0.0 115.073 -177.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . 0.322 6.6 p 45.75 40.36 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 127.089 2.156 . . . . 0.0 114.472 172.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 56.68 25.21 9.82 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 127.003 2.121 . . . . 0.0 115.271 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -72.67 155.79 39.63 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.953 1.301 . . . . 0.0 112.082 174.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.17 -164.25 52.18 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.416 1.008 . . . . 0.0 114.178 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -143.84 148.32 35.34 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.267 1.427 . . . . 0.0 111.704 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.6 t -130.1 135.39 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.505 1.522 . . . . 0.0 109.437 174.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.99 159.9 60.54 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 123.677 0.791 . . . . 0.0 112.102 176.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.37 105.15 0.57 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.904 2.403 . . . . 0.0 111.947 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -66.13 -26.65 67.54 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.106 0.962 . . . . 0.0 113.332 -169.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -70.06 -49.9 46.44 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.339 0.656 . . . . 0.0 110.399 -176.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 t -76.13 -33.92 59.42 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.992 0.917 . . . . 0.0 112.32 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -59.96 -40.79 90.23 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.196 0.599 . . . . 0.0 110.328 173.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.3 tp -70.64 -45.68 64.71 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 118.781 -0.628 . . . . 0.0 111.759 171.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.9 -39.78 19.95 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.04 1.291 . . . . 0.0 113.475 175.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 86.6 m -60.12 -42.09 94.04 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.701 -0.624 . . . . 0.0 112.434 172.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.1 mm -68.79 -35.18 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 121.112 -0.993 . . . . 0.0 110.454 174.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.9 mm -56.83 -50.89 73.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 CA-C-O 117.673 -1.156 . . . . 0.0 108.668 170.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.79 -27.76 66.85 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.527 1.512 . . . . 0.0 113.15 174.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -65.82 -42.03 91.11 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.832 0.853 . . . . 0.0 112.361 173.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -107.11 2.43 24.9 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -57.27 -29.16 63.62 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.378 1.871 . . . . 0.0 114.311 -168.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.67 -1.7 5.35 Favored Glycine 0 CA--C 1.544 1.858 0 C-N-CA 125.711 1.624 . . . . 0.0 116.257 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -100.79 0.2 38.32 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.978 1.711 . . . . 0.0 112.738 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.5 m -75.1 -10.59 59.62 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.531 1.532 . . . . 0.0 113.094 173.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -63.21 157.75 21.78 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.339 1.456 . . . . 0.0 111.736 170.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.06 132.65 35.89 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.129 0.971 . . . . 0.0 110.515 -174.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -169.84 159.1 7.73 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 122.498 1.142 . . . . 0.0 112.899 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -123.91 171.56 12.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.755 173.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.4 mm -127.06 117.25 47.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 125.99 1.716 . . . . 0.0 106.772 174.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.12 148.83 50.6 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -80.74 106.45 12.76 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.388 0.614 . . . . 0.0 110.829 175.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.26 -6.48 53.27 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -96.1 -1.43 48.63 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.579 1.551 . . . . 0.0 113.797 -178.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -110.42 140.18 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.32 1.448 . . . . 0.0 109.951 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -57.4 -23.45 49.38 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -174.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -90.41 -10.53 43.5 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.381 1.472 . . . . 0.0 114.447 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 80.9 m 44.32 54.0 6.45 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.326 1.85 . . . . 0.0 114.663 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.03 158.52 15.77 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -168.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.8 t -79.93 89.97 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 128.624 2.769 . . . . 0.0 109.592 -172.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.4 pt -70.0 -24.46 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.256 1.422 . . . . 0.0 112.393 176.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -153.6 159.6 42.19 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.046 0.938 . . . . 0.0 112.276 174.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 10.0 p -147.27 142.54 27.3 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.038 -1.039 . . . . 0.0 113.268 -173.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -84.78 153.61 22.89 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -61.86 -29.82 70.44 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.757 0.423 . . . . 0.0 111.399 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.36 -49.92 43.01 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 123.945 0.783 . . . . 0.0 112.747 169.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -38.39 81.43 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 119.52 1.66 . . . . 0.0 110.644 175.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.6 t -60.18 -39.9 88.1 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.594 -0.691 . . . . 0.0 110.566 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -74.81 -30.02 61.28 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.339 0.655 . . . . 0.0 112.238 175.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 66.3 tp -63.83 -55.74 20.69 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.245 1.018 . . . . 0.0 111.83 177.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 59.9 m -95.68 -20.01 19.25 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.291 0.636 . . . . 0.0 112.661 -174.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.53 10.05 86.48 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-O 118.339 -1.256 . . . . 0.0 115.549 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -87.97 -121.73 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 119.46 1.63 . . . . 0.0 111.217 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.1 t -159.98 150.22 18.56 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.535 1.934 . . . . 0.0 109.96 -176.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -50.0 -41.13 46.41 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.259 1.024 . . . . 0.0 112.099 172.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.07 -19.94 63.47 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.321 1.048 . . . . 0.0 113.532 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -84.72 -20.71 30.73 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.635 1.574 . . . . 0.0 112.311 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -105.4 -18.84 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 125.66 1.584 . . . . 0.0 115.127 175.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 7.0 mmt -49.81 112.08 0.6 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.402 1.481 . . . . 0.0 111.647 -174.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 67.3 30.82 6.87 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.358 1.863 . . . . 0.0 112.745 171.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -106.75 154.85 39.87 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-O 117.599 -1.191 . . . . 0.0 112.984 177.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.86 137.59 60.75 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.282 2.654 . . . . 0.0 114.124 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 49.4 t -70.11 -9.94 57.14 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 125.427 1.491 . . . . 0.0 113.616 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.0 m -66.33 100.01 0.6 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 127.044 2.138 . . . . 0.0 111.671 -176.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 32.5 m -50.05 -13.2 0.1 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 127.031 2.132 . . . . 0.0 116.478 -176.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -53.7 -35.18 60.85 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.071 0.948 . . . . 0.0 111.607 168.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.9 -10.39 20.61 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 174.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.02 19.95 10.78 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.936 2.494 . . . . 0.0 111.08 178.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.52 138.43 45.03 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.589 -1.32 . . . . 0.0 111.905 177.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.72 -169.31 11.78 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.518 1.532 . . . . 0.0 113.57 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -61.23 -10.01 14.31 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 124.253 3.302 . . . . 0.0 117.049 -174.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -107.75 -10.01 15.68 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.943 1.297 . . . . 0.0 113.522 174.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.2 m -82.12 138.35 34.78 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.098 0.863 . . . . 0.0 112.109 -170.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -91.47 134.06 34.96 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 122.32 1.057 . . . . 0.0 110.75 176.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.5 mmm-85 -66.9 -39.71 87.51 Favored 'General case' 0 C--O 1.222 -0.394 0 O-C-N 121.65 -0.657 . . . . 0.0 110.593 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 46.7 ptt85 -51.39 -38.62 54.33 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 170.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.07 -50.71 38.32 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.523 1.129 . . . . 0.0 110.294 177.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.37 -33.85 76.43 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.465 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.06 -53.14 18.81 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.663 1.585 . . . . 0.0 112.22 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -50.14 -41.04 48.13 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.323 0.965 . . . . 0.0 112.514 170.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.8 mt -63.0 -49.69 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 121.684 -0.635 . . . . 0.0 111.368 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.3 -39.95 57.95 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.47 0.577 . . . . 0.0 111.944 174.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -62.97 -40.55 98.05 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.423 0.689 . . . . 0.0 111.723 175.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.49 -31.94 72.43 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 176.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 mt -84.16 -35.9 23.25 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -175.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 pp -69.63 -28.19 65.71 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.455 0.57 . . . . 0.0 111.693 168.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.88 14.77 13.02 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 119.078 -0.846 . . . . 0.0 113.986 168.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.69 -49.88 75.05 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 118.333 1.066 . . . . 0.0 111.216 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -160.3 129.99 5.18 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.859 1.264 . . . . 0.0 112.797 169.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -79.77 124.81 28.94 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.233 1.813 . . . . 0.0 109.084 173.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.1 ttp-105 -159.88 165.08 32.93 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.465 1.506 . . . . 0.0 110.999 171.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -76.73 137.07 39.11 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.7 0.8 . . . . 0.0 110.173 170.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.62 152.36 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.958 1.303 . . . . 0.0 108.917 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -79.89 160.04 26.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.325 0.65 . . . . 0.0 109.609 169.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -165.85 147.65 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.156 0.889 . . . . 0.0 110.64 168.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -90.39 145.43 24.95 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.009 173.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -118.17 157.2 27.39 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.0 0.92 . . . . 0.0 111.505 173.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -121.14 140.07 52.49 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.467 1.107 . . . . 0.0 110.443 169.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 24.7 mtp-105 -89.81 160.18 16.64 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.573 1.149 . . . . 0.0 111.379 175.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -21.23 65.01 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 172.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -75.24 -10.02 59.08 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.642 1.577 . . . . 0.0 113.61 172.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.81 6.75 67.1 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.384 1.468 . . . . 0.0 115.223 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.8 t -78.94 134.18 36.87 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 118.813 1.306 . . . . 0.0 110.817 175.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 60.8 m -131.61 128.95 40.23 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.635 1.174 . . . . 0.0 111.707 -172.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -151.04 142.72 23.68 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -174.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -109.57 129.94 55.54 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.06 2.144 . . . . 0.0 108.504 168.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 2.2 m -135.84 178.81 6.76 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.368 1.467 . . . . 0.0 111.605 172.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.5 mt -76.69 59.94 1.62 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.416 1.086 . . . . 0.0 111.129 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 36.4 t -61.28 145.16 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.936 1.295 . . . . 0.0 111.406 -173.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -104.16 69.68 0.94 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 122.274 1.035 . . . . 0.0 112.11 -168.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.0 t -83.5 69.91 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.744 0.817 . . . . 0.0 110.476 -169.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 44.8 t -117.12 123.33 30.2 Favored Pre-proline 0 N--CA 1.483 1.213 0 CA-C-O 117.723 -1.132 . . . . 0.0 110.603 -174.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -87.26 -170.36 0.59 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.479 2.786 . . . . 0.0 113.084 -175.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -123.53 126.78 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 123.018 1.39 . . . . 0.0 113.213 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.6 mtmt -112.26 161.12 16.95 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.588 2.355 . . . . 0.0 112.415 -176.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -92.23 179.98 5.41 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.663 -1.153 . . . . 0.0 112.19 172.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.41 -21.69 65.58 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -71.23 -19.89 62.32 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.558 1.143 . . . . 0.0 113.753 170.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.96 4.25 60.23 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.641 1.591 . . . . 0.0 114.322 -176.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -93.19 140.75 29.18 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.462 1.131 . . . . 0.0 113.132 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.14 100.01 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.486 1.514 . . . . 0.0 110.696 -174.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.56 -29.08 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 123.768 0.827 . . . . 0.0 111.795 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.88 148.45 52.29 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 124.111 1.91 . . . . 0.0 112.555 169.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -100.81 85.13 2.83 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.258 -1.792 . . . . 0.0 107.045 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 40.2 mt -99.98 70.04 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 122.86 1.314 . . . . 0.0 108.678 170.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.317 34.7 mt -78.59 88.55 4.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 123.356 1.55 . . . . 0.0 109.843 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -59.88 103.13 0.19 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.501 1.921 . . . . 0.0 110.139 173.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -87.19 50.99 2.12 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 120.683 -1.261 . . . . 0.0 111.85 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -79.97 106.86 12.3 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 124.182 1.944 . . . . 0.0 112.066 -176.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 32.6 t -64.43 114.3 2.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 126.813 2.045 . . . . 0.0 108.694 171.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p -140.39 136.23 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 122.633 0.373 . . . . 0.0 110.637 176.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 97.1 mtp -80.06 165.12 22.84 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 122.725 1.25 . . . . 0.0 112.444 -173.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.79 149.21 50.53 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.459 1.504 . . . . 0.0 112.625 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.7 tptt . . . . . 0 C--O 1.251 1.179 0 C-N-CA 125.886 1.674 . . . . 0.0 111.487 179.872 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 118.91 -0.567 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -70.43 162.23 43.15 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.445 2.763 . . . . 0.0 112.76 176.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.64 155.98 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.328 1.051 . . . . 0.0 112.317 174.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 81.4 mtt85 -129.69 153.94 47.65 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.626 1.571 . . . . 0.0 111.782 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -147.85 163.37 36.96 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.063 1.745 . . . . 0.0 112.537 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.28 -173.37 52.98 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.529 1.061 . . . . 0.0 114.559 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -76.96 159.59 29.83 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.327 1.451 . . . . 0.0 113.271 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.3 p -82.3 146.88 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.494 1.118 . . . . 0.0 111.047 171.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.9 159.96 17.7 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 124.168 0.987 . . . . 0.0 111.403 169.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -43.9 110.05 0.18 Allowed 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 124.503 3.468 . . . . 0.0 112.449 175.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -59.97 -27.25 66.68 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 115.103 1.519 . . . . 0.0 115.103 -165.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -69.99 -49.86 47.34 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.851 0.751 . . . . 0.0 110.407 -176.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 t -76.71 -36.2 57.35 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.1 0.96 . . . . 0.0 112.225 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -57.93 -39.99 79.38 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.951 0.9 . . . . 0.0 110.506 172.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.1 tp -71.49 -44.78 64.09 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.047 0.539 . . . . 0.0 112.266 170.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -47.87 -39.93 20.14 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 120.004 1.275 . . . . 0.0 113.583 176.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.1 m -60.08 -42.6 94.93 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 172.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.1 mm -69.0 -33.96 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.077 0.951 . . . . 0.0 110.436 176.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.5 mm -56.97 -53.7 39.56 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-O 118.202 -0.904 . . . . 0.0 108.714 169.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -25.15 64.9 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.551 1.069 . . . . 0.0 112.924 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.4 tttt -68.8 -45.09 72.17 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.303 1.041 . . . . 0.0 113.443 171.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -100.07 0.28 40.5 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -53.67 -29.02 36.72 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.3 2.24 . . . . 0.0 113.53 -169.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.21 55.52 0.91 Allowed Glycine 0 CA--C 1.531 1.032 0 C-N-CA 125.381 1.467 . . . . 0.0 112.48 -169.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -59.73 -17.17 32.71 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 120.884 -1.363 . . . . 0.0 112.719 174.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.8 p -78.05 -11.31 59.9 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.892 2.077 . . . . 0.0 115.195 178.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . 0.343 0.0 OUTLIER -72.89 167.68 20.49 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 120.753 1.615 . . . . 0.0 112.143 174.132 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.51 144.78 54.49 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.615 1.566 . . . . 0.0 114.868 -167.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -169.72 162.49 9.69 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 123.339 1.542 . . . . 0.0 114.455 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 pp -128.35 170.25 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 127.238 2.215 . . . . 0.0 111.15 172.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.5 mm -127.23 120.05 54.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 126.389 1.876 . . . . 0.0 107.293 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.38 149.16 48.4 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 123.829 0.852 . . . . 0.0 112.553 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -81.14 108.82 15.12 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.519 0.676 . . . . 0.0 110.746 172.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.92 -15.73 63.11 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -100.07 3.02 43.79 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.947 1.299 . . . . 0.0 114.116 -169.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.71 140.13 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.36 1.464 . . . . 0.0 110.726 -176.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -60.09 -27.04 66.67 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -176.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -83.46 -10.22 58.51 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.771 1.229 . . . . 0.0 114.204 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 24.9 m 45.56 47.82 11.18 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.28 1.832 . . . . 0.0 113.449 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.97 152.25 26.81 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -167.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.7 t -79.98 90.0 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 127.914 2.486 . . . . 0.0 108.758 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.8 pt -70.03 -24.78 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.731 1.212 . . . . 0.0 112.462 178.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -153.7 159.62 42.07 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.015 0.926 . . . . 0.0 112.484 174.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.2 p -147.85 145.73 28.82 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.111 -0.993 . . . . 0.0 113.077 -175.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -93.03 159.46 15.3 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -64.01 -23.62 67.4 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.531 -0.731 . . . . 0.0 112.384 175.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.74 -50.03 62.91 Favored Glycine 0 CA--C 1.537 1.413 0 CA-C-O 119.015 -0.881 . . . . 0.0 112.669 169.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -38.33 68.74 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.529 1.665 . . . . 0.0 109.787 172.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.7 t -60.25 -39.98 88.65 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.808 -0.558 . . . . 0.0 111.128 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -74.99 -30.03 61.05 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 175.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.8 tp -64.85 -54.57 28.93 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.683 1.593 . . . . 0.0 112.193 178.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 84.0 m -92.8 -22.58 19.24 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.126 0.971 . . . . 0.0 112.431 -178.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.5 10.04 85.84 Favored Glycine 0 CA--C 1.539 1.573 0 N-CA-C 115.758 1.063 . . . . 0.0 115.758 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -93.94 -116.71 0.1 Allowed 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 118.735 1.267 . . . . 0.0 111.68 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.3 t -159.9 150.12 18.62 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.532 1.533 . . . . 0.0 110.719 -177.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.7 mtm180 -57.63 -36.36 71.72 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.662 1.185 . . . . 0.0 112.426 177.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.32 -20.77 63.32 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.182 0.993 . . . . 0.0 113.503 174.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -84.4 -20.77 31.33 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.118 1.367 . . . . 0.0 112.268 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.5 m -105.39 -11.83 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 10.4 mmt -49.86 107.37 0.15 Allowed 'General case' 0 C--N 1.34 0.191 0 C-N-CA 125.078 1.351 . . . . 0.0 110.427 176.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 68.13 22.43 8.31 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.729 1.612 . . . . 0.0 113.224 172.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.58 161.75 57.98 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 124.887 1.275 . . . . 0.0 110.682 168.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -60.45 137.42 74.04 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.7 2.267 . . . . 0.0 113.032 175.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 23.5 t -70.04 -19.83 63.28 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.509 1.124 . . . . 0.0 112.756 170.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -60.36 100.13 0.09 Allowed 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 127.927 2.491 . . . . 0.0 111.222 178.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 54.7 m -49.98 -13.25 0.1 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.829 2.052 . . . . 0.0 116.35 -176.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -55.11 -39.45 69.39 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.979 1.311 . . . . 0.0 111.26 167.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -58.38 -20.12 41.38 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.57 1.548 . . . . 0.0 113.094 172.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.14 20.0 18.85 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 127.498 2.319 . . . . 0.0 112.169 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -56.37 136.98 53.42 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.657 -1.277 . . . . 0.0 113.482 174.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -130.58 177.2 18.49 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 126.343 1.925 . . . . 0.0 111.687 168.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -64.21 -10.13 22.36 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.524 2.816 . . . . 0.0 115.603 -176.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -104.11 -9.95 18.35 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.739 1.615 . . . . 0.0 113.369 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.4 m -76.63 139.42 40.59 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.297 0.953 . . . . 0.0 111.996 -173.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -84.23 129.91 34.86 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 123.126 1.441 . . . . 0.0 109.847 175.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -70.19 -39.91 74.94 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.14 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -59.53 -35.69 74.68 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.27 1.428 . . . . 0.0 113.919 170.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.27 -50.78 64.45 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.427 0.691 . . . . 0.0 110.604 173.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.03 -33.37 75.89 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.22 -52.3 42.74 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.513 1.125 . . . . 0.0 112.192 176.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -50.16 -42.12 50.38 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.053 0.941 . . . . 0.0 112.66 170.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 35.8 mt -63.61 -48.69 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 O-C-N 121.588 -0.695 . . . . 0.0 111.021 174.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.03 -39.82 56.77 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.526 0.603 . . . . 0.0 111.831 173.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -67.84 -38.24 82.92 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.586 0.63 . . . . 0.0 111.952 175.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.99 -26.85 64.28 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.267 0.627 . . . . 0.0 112.565 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 mt -87.74 -33.63 18.63 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.304 0.642 . . . . 0.0 110.95 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -37.68 81.38 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.197 1.799 . . . . 0.0 110.009 169.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.02 26.37 4.98 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.796 1.189 . . . . 0.0 114.724 171.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.73 -49.93 74.45 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 118.685 1.242 . . . . 0.0 111.204 173.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -159.0 148.85 19.12 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.066 2.146 . . . . 0.0 109.52 169.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -81.31 117.79 22.09 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.998 -1.063 . . . . 0.0 108.567 172.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 -144.85 136.67 25.69 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.355 1.062 . . . . 0.0 111.623 -169.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -83.22 132.06 35.07 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.429 1.492 . . . . 0.0 110.053 171.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -136.41 151.11 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.444 1.498 . . . . 0.0 109.043 -177.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.73 157.09 27.23 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.275 0.63 . . . . 0.0 109.652 170.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -165.71 148.47 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.073 0.949 . . . . 0.0 110.675 176.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -87.11 145.32 26.49 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.585 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -112.65 160.45 17.88 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.213 1.405 . . . . 0.0 110.634 169.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -125.3 140.1 53.12 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.781 0.8 . . . . 0.0 111.079 169.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 17.6 tpp85 -84.39 150.38 25.38 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.147 1.779 . . . . 0.0 109.921 176.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -55.02 -28.98 56.32 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.992 1.717 . . . . 0.0 113.578 175.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -75.71 -9.95 59.02 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.025 1.33 . . . . 0.0 114.1 175.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.81 -0.04 39.21 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 126.205 1.86 . . . . 0.0 115.576 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 45.2 m -78.8 126.44 30.72 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 119.068 1.434 . . . . 0.0 111.566 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 67.4 m -114.83 134.52 55.06 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.244 1.017 . . . . 0.0 111.667 -176.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -149.97 139.95 21.96 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.979 0.912 . . . . 0.0 112.978 -170.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -115.76 136.23 53.26 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.493 1.917 . . . . 0.0 110.104 176.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.7 m -139.34 169.54 17.57 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.757 1.623 . . . . 0.0 109.931 168.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.4 tt -78.54 60.01 2.57 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 121.849 0.833 . . . . 0.0 109.31 172.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.1 t -52.99 149.2 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.962 1.705 . . . . 0.0 110.645 -174.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -99.79 69.74 1.6 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 123.172 1.463 . . . . 0.0 110.811 -168.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.8 t -83.2 69.95 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.677 1.191 . . . . 0.0 110.255 -170.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.85 131.24 24.23 Favored Pre-proline 0 N--CA 1.478 0.932 0 C-N-CA 124.05 0.94 . . . . 0.0 110.712 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -85.1 -168.67 0.53 Allowed 'Trans proline' 0 CA--C 1.551 1.348 0 C-N-CA 123.109 2.539 . . . . 0.0 111.481 -174.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.52 129.52 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-O 123.026 1.394 . . . . 0.0 113.656 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -112.1 162.16 15.73 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.666 2.386 . . . . 0.0 112.838 -176.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -92.85 179.96 5.31 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.499 1.12 . . . . 0.0 112.207 171.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.42 -21.69 65.6 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -70.85 -19.92 62.59 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.563 1.145 . . . . 0.0 113.738 169.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.6 -0.02 59.44 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.007 1.765 . . . . 0.0 114.358 -176.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.6 139.98 30.0 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.609 1.204 . . . . 0.0 113.246 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.7 p -75.97 99.96 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 125.515 1.526 . . . . 0.0 110.216 -175.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.04 -28.9 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.641 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.71 149.99 50.55 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 124.012 1.863 . . . . 0.0 111.922 173.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -104.02 80.22 1.71 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.857 -1.52 . . . . 0.0 107.843 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.6 mt -99.98 71.15 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 120.611 -1.305 . . . . 0.0 108.789 171.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -76.91 85.19 3.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 123.41 1.576 . . . . 0.0 108.878 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -59.91 103.8 0.24 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 112.958 -1.928 . . . . 0.0 109.931 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -85.81 59.12 5.44 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 120.69 -1.256 . . . . 0.0 111.784 -177.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -79.77 126.58 31.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 122.163 0.983 . . . . 0.0 110.908 175.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.5 t -81.99 113.2 20.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 125.225 1.41 . . . . 0.0 108.403 -178.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p -140.35 137.4 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.092 0.473 . . . . 0.0 112.077 -176.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 21.2 ptp -137.4 158.66 43.92 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.653 1.581 . . . . 0.0 111.306 171.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -72.23 151.74 42.67 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.178 0.991 . . . . 0.0 112.656 177.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 65.4 pttt . . . . . 0 C--O 1.253 1.258 0 C-N-CA 125.183 1.393 . . . . 0.0 113.802 177.91 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 118.771 -0.633 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.98 158.29 55.76 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.219 2.613 . . . . 0.0 112.61 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.8 m -96.08 19.97 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 125.204 1.402 . . . . 0.0 113.653 -178.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -71.97 144.63 48.81 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.14 1.376 . . . . 0.0 111.922 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -150.48 160.11 44.01 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.954 1.702 . . . . 0.0 112.465 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.59 177.91 39.2 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.726 1.155 . . . . 0.0 114.757 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -87.08 161.44 18.13 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.565 1.546 . . . . 0.0 113.0 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.3 t -82.03 138.17 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.268 1.027 . . . . 0.0 109.409 172.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.62 159.93 22.06 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.753 0.821 . . . . 0.0 112.075 173.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -52.97 110.05 0.43 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.629 2.886 . . . . 0.0 111.703 174.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -65.62 -27.13 68.18 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -167.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -69.17 -49.86 52.94 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.519 0.727 . . . . 0.0 110.385 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 t -75.52 -34.02 60.76 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.835 0.854 . . . . 0.0 112.405 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -59.92 -41.07 90.94 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.577 -0.702 . . . . 0.0 110.157 172.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.2 tp -70.85 -45.58 64.22 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.076 172.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -47.43 -39.83 16.55 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.238 1.415 . . . . 0.0 113.217 173.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 90.7 m -60.11 -44.02 95.15 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.615 -0.678 . . . . 0.0 112.205 172.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.5 mm -67.81 -35.7 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.834 0.854 . . . . 0.0 110.868 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.4 mm -55.62 -54.44 25.79 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 52.7 mtm180 -60.16 -29.38 68.63 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 118.981 0.809 . . . . 0.0 112.809 176.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.4 tptt -62.82 -42.42 99.72 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 118.676 -0.678 . . . . 0.0 112.265 173.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -104.51 1.64 30.06 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 178.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -57.77 -29.04 64.51 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.834 1.654 . . . . 0.0 113.894 -167.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.85 55.42 4.49 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -168.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -55.67 -26.88 47.02 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.836 1.654 . . . . 0.0 114.953 -168.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.7 m -67.53 -19.78 65.34 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.2 1.0 . . . . 0.0 113.415 175.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.8 mmt85 -92.55 150.0 21.01 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.368 1.867 . . . . 0.0 110.902 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.19 146.9 38.49 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.845 1.658 . . . . 0.0 111.82 -171.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -169.77 155.4 5.83 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 123.975 1.845 . . . . 0.0 115.074 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -119.9 165.45 15.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 128.025 2.53 . . . . 0.0 110.167 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.8 mm -127.58 113.71 32.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.52 155.91 39.86 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.884 0.85 . . . . 0.0 112.142 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.9 t-20 -85.72 122.3 29.62 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 176.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.46 -9.18 59.77 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -100.03 6.09 45.06 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.974 1.31 . . . . 0.0 113.477 -173.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.8 m -114.08 139.16 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 126.728 2.011 . . . . 0.0 111.378 -177.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.52 -23.26 65.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.133 0.973 . . . . 0.0 113.456 -175.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -90.8 0.56 57.42 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.538 1.535 . . . . 0.0 113.399 174.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 27.8 p 42.08 46.92 3.8 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.969 1.707 . . . . 0.0 113.098 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.1 149.8 31.97 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -167.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.2 t -81.71 92.37 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 128.762 2.825 . . . . 0.0 109.009 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.6 pt -70.43 -23.14 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 126.195 1.798 . . . . 0.0 112.692 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -158.19 159.73 36.42 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.448 1.499 . . . . 0.0 112.592 174.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.5 p -147.08 154.4 41.12 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.406 -1.434 . . . . 0.0 113.322 173.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -96.23 157.46 15.89 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -59.36 -28.97 67.34 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.186 0.994 . . . . 0.0 112.006 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.86 -50.04 39.42 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.04 0.828 . . . . 0.0 112.918 169.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.92 -35.54 78.71 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 119.321 1.561 . . . . 0.0 110.706 176.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.0 t -60.04 -39.87 87.43 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.171 -0.956 . . . . 0.0 110.548 176.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -75.85 -25.69 56.46 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 174.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 53.4 tp -64.86 -55.74 17.64 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.089 0.956 . . . . 0.0 111.806 175.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.5 m -94.82 -21.15 18.88 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -174.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.73 22.6 78.14 Favored Glycine 0 CA--C 1.539 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 113.564 -169.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.6 m-30 -91.49 -130.1 0.1 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.288 1.435 . . . . 0.0 110.979 -176.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.5 t -162.11 150.17 14.67 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.794 2.438 . . . . 0.0 109.045 177.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.7 ttp180 -50.14 -40.88 47.69 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.751 0.82 . . . . 0.0 111.907 170.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.77 -20.81 63.98 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -87.41 -20.69 26.3 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.335 1.454 . . . . 0.0 113.069 175.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -104.73 -16.33 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 176.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.4 mmt -49.92 110.34 0.38 Allowed 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.424 1.489 . . . . 0.0 111.388 -177.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 71.13 17.05 6.18 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.472 1.509 . . . . 0.0 113.764 171.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.43 160.81 63.99 Favored Pre-proline 0 N--CA 1.475 0.812 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.397 166.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -58.48 140.08 93.2 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.539 2.159 . . . . 0.0 111.639 169.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.4 p -64.69 -10.0 23.92 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 169.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.0 m -64.49 93.42 0.1 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.218 1.807 . . . . 0.0 111.683 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 28.4 p -53.13 -14.27 0.62 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.337 1.855 . . . . 0.0 115.34 -176.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -48.13 -40.04 22.43 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.098 0.959 . . . . 0.0 111.565 167.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.85 -19.96 63.17 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 pp -123.1 23.8 9.1 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.476 1.91 . . . . 0.0 113.052 176.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -60.87 140.01 57.81 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.086 -1.009 . . . . 0.0 112.826 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -95.18 171.45 29.71 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.828 1.204 . . . . 0.0 113.325 175.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.0 -10.05 27.19 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.495 2.797 . . . . 0.0 114.446 -177.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -91.55 -9.27 44.9 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.492 1.917 . . . . 0.0 113.442 174.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.6 m -78.02 139.86 39.13 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.984 0.914 . . . . 0.0 112.428 -173.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -85.34 131.68 34.37 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.743 1.259 . . . . 0.0 109.946 168.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.6 mmm-85 -65.79 -39.66 91.18 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.866 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.22 -41.83 50.52 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 169.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.66 -51.23 61.15 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.311 1.044 . . . . 0.0 110.122 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.26 -33.81 76.66 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.729 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.04 -51.39 32.5 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.022 1.729 . . . . 0.0 112.662 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -50.01 -43.89 50.86 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.686 1.194 . . . . 0.0 111.062 170.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 51.2 mt -62.91 -49.52 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.118 174.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.08 -39.86 57.04 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-O 118.248 -0.882 . . . . 0.0 112.179 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -69.0 -38.51 79.3 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.895 0.77 . . . . 0.0 111.466 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.18 -34.85 78.97 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.557 -0.714 . . . . 0.0 111.949 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.0 mt -84.87 -24.66 28.43 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.393 0.677 . . . . 0.0 111.674 177.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.78 -30.04 70.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.788 2.035 . . . . 0.0 110.062 168.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.07 17.93 9.16 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.063 1.316 . . . . 0.0 114.84 169.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.94 -50.13 65.48 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.845 1.323 . . . . 0.0 111.126 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -151.94 141.54 21.75 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.843 1.657 . . . . 0.0 111.312 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -74.61 114.52 13.11 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 166.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -149.28 137.26 20.55 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.951 0.9 . . . . 0.0 111.557 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -84.84 130.44 34.66 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.585 1.554 . . . . 0.0 110.196 169.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.6 153.64 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.525 1.53 . . . . 0.0 108.896 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -79.88 160.04 26.19 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.278 1.031 . . . . 0.0 109.812 169.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -169.75 151.92 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.584 1.154 . . . . 0.0 111.129 173.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.48 145.42 25.31 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 174.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -115.15 162.07 17.54 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.968 1.707 . . . . 0.0 111.722 168.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -136.51 140.18 42.82 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.232 0.613 . . . . 0.0 110.792 168.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -84.69 152.43 23.76 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.332 1.053 . . . . 0.0 112.658 177.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -55.1 -25.14 29.51 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.968 1.707 . . . . 0.0 112.974 169.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.54 -11.12 60.72 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.395 1.478 . . . . 0.0 113.949 174.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.61 41.33 5.11 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.843 1.211 . . . . 0.0 114.833 175.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.0 t -136.71 141.71 43.07 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.499 1.12 . . . . 0.0 111.629 176.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 23.9 p -129.82 139.62 51.19 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.423 1.489 . . . . 0.0 113.508 -171.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -150.23 139.94 21.71 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.899 1.279 . . . . 0.0 113.457 -168.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -108.44 134.34 51.36 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.918 2.087 . . . . 0.0 108.667 169.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.9 m -140.0 179.11 6.8 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.292 1.437 . . . . 0.0 111.559 171.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.2 mp -78.23 60.0 2.4 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.652 1.181 . . . . 0.0 109.904 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 16.6 t -63.2 145.58 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.587 1.155 . . . . 0.0 111.261 -171.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -107.63 69.74 0.75 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.615 1.198 . . . . 0.0 112.055 -168.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.6 t -84.05 69.86 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.016 0.927 . . . . 0.0 110.886 -169.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.17 136.12 26.07 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 124.611 1.164 . . . . 0.0 111.253 -174.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -86.88 -169.17 0.48 Allowed 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 123.603 2.869 . . . . 0.0 113.361 -172.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -126.47 132.33 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-O 122.835 1.302 . . . . 0.0 113.689 175.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -111.87 166.62 11.05 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 127.042 2.137 . . . . 0.0 112.389 -174.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -97.23 179.95 4.72 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.272 169.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.78 -21.21 65.7 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -70.11 -19.85 63.21 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.583 1.153 . . . . 0.0 113.68 169.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.6 6.5 59.58 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.811 1.672 . . . . 0.0 114.458 -176.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -97.13 141.76 29.87 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.54 1.17 . . . . 0.0 113.594 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.8 100.01 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 126.0 1.72 . . . . 0.0 110.615 -176.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.02 -29.6 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.113 177.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.53 149.98 51.68 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 124.288 1.994 . . . . 0.0 112.646 173.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -104.52 79.89 1.62 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 113.222 -1.808 . . . . 0.0 107.41 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.1 mt -99.91 69.95 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 170.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.66 88.25 4.57 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.985 0.898 . . . . 0.0 108.828 -178.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -59.85 104.22 0.27 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.767 1.227 . . . . 0.0 111.419 -174.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -82.81 53.61 2.45 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.18 -1.575 . . . . 0.0 112.163 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -79.94 106.84 12.26 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 124.076 1.893 . . . . 0.0 112.782 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.1 t -64.77 111.81 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 127.002 2.121 . . . . 0.0 108.738 170.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p -140.42 137.6 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 122.758 0.423 . . . . 0.0 110.551 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 77.4 mtm -85.6 159.07 19.95 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.83 1.252 . . . . 0.0 111.761 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -70.8 156.77 39.13 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.885 1.274 . . . . 0.0 113.197 175.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 62.0 tttp . . . . . 0 C--O 1.252 1.232 0 C-N-CA 125.95 1.7 . . . . 0.0 111.461 179.838 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.2 mtm . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 119.062 -0.494 . . . . 0.0 110.529 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.06 154.82 71.67 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.369 2.712 . . . . 0.0 112.76 177.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.8 m -74.31 156.15 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.466 1.107 . . . . 0.0 112.619 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -130.68 147.73 52.38 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.499 1.52 . . . . 0.0 110.755 172.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.38 140.64 22.24 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.346 1.459 . . . . 0.0 112.683 177.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.94 -17.95 55.22 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 124.853 1.216 . . . . 0.0 113.754 169.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -71.9 149.75 44.84 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.826 1.25 . . . . 0.0 112.006 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.3 t -79.93 109.86 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.927 0.891 . . . . 0.0 110.947 -176.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.96 170.0 11.32 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 125.444 1.498 . . . . 0.0 109.497 167.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -32.93 110.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 124.851 3.701 . . . . 0.0 112.737 171.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -59.91 -27.41 66.72 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -163.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -67.84 -49.95 59.35 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.731 0.696 . . . . 0.0 110.143 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.6 t -79.77 -35.19 39.02 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.59 1.156 . . . . 0.0 112.679 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -57.97 -39.88 79.25 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.567 1.147 . . . . 0.0 110.243 171.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.8 tp -74.84 -45.49 42.87 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 118.885 -0.579 . . . . 0.0 112.468 170.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -47.8 -39.82 19.31 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.845 1.258 . . . . 0.0 112.628 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 91.3 m -60.07 -42.58 94.84 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.538 -0.726 . . . . 0.0 111.875 175.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.4 mm -68.5 -33.66 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 123.839 0.856 . . . . 0.0 110.194 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.3 mm -59.33 -52.99 54.32 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.517 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 173.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -59.88 -29.21 68.16 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.477 1.111 . . . . 0.0 111.673 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -67.21 -42.11 84.63 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.813 1.245 . . . . 0.0 113.167 175.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -102.84 -0.01 31.96 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -59.88 -29.34 68.26 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.711 1.204 . . . . 0.0 113.391 -166.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.6 -1.72 2.18 Favored Glycine 0 CA--C 1.544 1.849 0 C-N-CA 126.438 1.971 . . . . 0.0 116.794 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -133.61 -10.63 2.77 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.247 1.419 . . . . 0.0 114.451 -172.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.9 p -78.83 -15.8 57.92 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.1 mmt85 -78.8 160.42 27.39 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.71 1.604 . . . . 0.0 113.841 -168.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.15 150.25 44.0 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.494 1.918 . . . . 0.0 112.878 -175.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -169.81 162.99 9.7 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 123.312 1.529 . . . . 0.0 115.094 -171.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -126.57 168.93 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 127.951 2.501 . . . . 0.0 111.203 173.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.5 mm -129.99 120.08 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 126.224 1.81 . . . . 0.0 108.165 178.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.5 155.23 48.96 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -78.58 114.68 17.71 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.977 169.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.03 -17.47 58.78 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -178.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 -96.14 5.93 49.96 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.794 1.238 . . . . 0.0 113.831 -170.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.98 140.16 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.744 1.618 . . . . 0.0 110.694 -175.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -58.19 -29.46 65.67 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.054 0.942 . . . . 0.0 113.187 -176.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -82.73 -5.81 59.08 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.5 p 39.08 45.76 1.08 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.678 1.991 . . . . 0.0 114.646 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.02 149.96 26.63 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 -166.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.1 t -79.94 97.22 2.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 128.907 2.883 . . . . 0.0 108.221 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.6 pt -76.67 -24.02 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.556 1.542 . . . . 0.0 111.735 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -153.6 159.44 42.14 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.963 0.905 . . . . 0.0 112.398 171.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 9.1 p -149.29 143.58 25.93 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.971 -1.08 . . . . 0.0 112.901 -174.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -88.79 157.7 18.4 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 -178.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.48 -31.18 67.6 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.533 -0.729 . . . . 0.0 111.706 169.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.91 -49.81 57.21 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.052 0.834 . . . . 0.0 113.249 169.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -58.32 -37.67 75.58 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 119.05 1.425 . . . . 0.0 109.337 176.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.1 t -60.01 -40.28 88.74 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.108 0.563 . . . . 0.0 111.549 177.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -71.06 -30.29 66.4 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.323 -0.86 . . . . 0.0 112.524 173.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.4 tp -70.12 -44.95 67.91 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.103 1.361 . . . . 0.0 114.196 -177.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 2.2 t -99.57 -24.08 14.86 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.634 0.773 . . . . 0.0 111.869 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.11 10.73 86.0 Favored Glycine 0 CA--C 1.541 1.672 0 O-C-N 120.928 -1.107 . . . . 0.0 115.825 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -94.24 -114.71 0.11 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 118.975 1.387 . . . . 0.0 111.911 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.9 t -159.99 148.97 17.49 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.946 1.299 . . . . 0.0 111.818 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 86.7 mtm-85 -53.74 -41.44 67.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.819 1.248 . . . . 0.0 111.811 171.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.79 -19.52 62.6 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.613 1.165 . . . . 0.0 113.355 177.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -88.37 -20.67 25.01 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.037 1.335 . . . . 0.0 112.911 175.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.7 m -103.67 -3.55 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 35.6 mmt -49.93 114.48 1.09 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.136 0.88 . . . . 0.0 109.804 172.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 70.57 23.93 4.61 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.856 1.662 . . . . 0.0 112.885 172.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -101.32 152.06 37.88 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 124.523 1.129 . . . . 0.0 112.342 -176.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.26 140.07 57.4 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.168 2.579 . . . . 0.0 113.227 -174.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.4 m -67.31 -13.25 61.82 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 173.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.7 m -68.17 100.04 0.97 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.416 1.086 . . . . 0.0 110.853 -176.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 30.4 p -54.56 -13.35 0.94 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.607 1.963 . . . . 0.0 116.123 -173.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -55.85 -36.59 67.7 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.877 -1.14 . . . . 0.0 111.267 169.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -54.7 -24.86 23.91 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.272 1.429 . . . . 0.0 113.509 173.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 pp -123.1 27.71 7.49 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.985 1.714 . . . . 0.0 113.029 177.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -62.63 145.79 53.67 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.231 -0.918 . . . . 0.0 111.984 172.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -127.43 -176.72 14.57 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 125.3 1.429 . . . . 0.0 113.157 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -66.51 -10.14 26.71 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.726 2.284 . . . . 0.0 116.512 -169.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.5 ttm105 -110.08 -2.75 16.81 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.768 1.627 . . . . 0.0 113.865 173.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.7 m -78.52 140.35 38.56 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.053 -1.029 . . . . 0.0 112.047 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -90.22 133.05 35.16 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 123.221 1.486 . . . . 0.0 111.65 172.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.7 mmm-85 -69.19 -39.79 78.45 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.302 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -55.57 -38.5 69.44 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.875 0.761 . . . . 0.0 112.956 171.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.8 -51.21 60.91 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 122.119 0.961 . . . . 0.0 109.88 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.44 -33.52 76.07 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.837 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.01 -50.01 45.78 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.01 1.724 . . . . 0.0 112.798 177.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -50.17 -42.93 51.99 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.251 1.021 . . . . 0.0 111.372 169.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.4 mt -62.62 -47.71 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 121.798 -0.564 . . . . 0.0 111.605 172.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.28 -39.96 46.9 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.661 -0.685 . . . . 0.0 112.193 174.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -69.01 -38.27 79.14 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.652 0.781 . . . . 0.0 111.551 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.1 -33.17 75.18 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.374 -0.828 . . . . 0.0 111.571 177.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mt -81.59 -29.99 33.15 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.668 0.787 . . . . 0.0 111.987 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.83 -28.72 69.19 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.393 2.277 . . . . 0.0 111.125 169.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.98 17.94 9.21 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.972 1.272 . . . . 0.0 114.873 169.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.36 -49.99 75.39 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.554 1.177 . . . . 0.0 111.495 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -161.39 152.63 18.64 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.517 1.527 . . . . 0.0 112.246 171.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -77.65 110.68 12.69 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 168.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.5 tpp180 -151.0 139.03 20.03 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.461 1.104 . . . . 0.0 110.949 -174.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -76.76 137.19 39.15 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.724 0.81 . . . . 0.0 110.342 170.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.11 148.75 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.772 1.229 . . . . 0.0 109.072 173.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.93 155.48 27.7 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.824 0.85 . . . . 0.0 110.294 171.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -164.29 151.21 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 119.228 0.922 . . . . 0.0 111.146 173.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -88.22 145.36 25.92 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.092 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -118.04 143.71 46.19 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.504 1.121 . . . . 0.0 112.161 172.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -109.99 140.15 44.32 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.422 0.689 . . . . 0.0 111.336 173.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.6 mmt-85 -81.8 141.16 33.73 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 168.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -49.97 -26.95 4.71 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.994 2.117 . . . . 0.0 113.607 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -64.35 -17.39 63.66 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.316 1.446 . . . . 0.0 114.086 174.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.41 41.26 1.65 Allowed Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.463 1.506 . . . . 0.0 115.453 172.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.3 t -141.97 138.49 31.95 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 118.756 1.278 . . . . 0.0 112.217 175.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 28.9 t -128.9 138.8 52.22 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.483 1.513 . . . . 0.0 113.277 -172.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -150.95 151.33 31.97 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -100.9 127.99 47.13 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 127.917 2.487 . . . . 0.0 109.956 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 41.6 m -132.76 177.92 7.26 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.567 1.547 . . . . 0.0 111.134 171.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -80.05 59.92 3.42 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.415 1.086 . . . . 0.0 110.846 -177.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.5 t -62.16 141.69 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.716 1.606 . . . . 0.0 111.658 -172.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -102.61 69.83 1.11 Allowed 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 122.231 1.015 . . . . 0.0 112.175 -168.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.7 t -83.25 69.84 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 121.391 -0.818 . . . . 0.0 110.726 -168.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.5 t -117.92 127.26 26.74 Favored Pre-proline 0 N--CA 1.473 0.718 0 CA-C-O 117.801 -1.095 . . . . 0.0 109.363 -176.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -82.32 -170.09 0.88 Allowed 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.212 2.608 . . . . 0.0 112.434 -177.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -119.89 127.24 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-O 122.865 1.317 . . . . 0.0 112.548 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -121.06 160.02 24.49 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 127.012 2.125 . . . . 0.0 111.909 -176.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -89.87 -179.53 5.75 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.807 0.843 . . . . 0.0 111.556 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -60.02 -21.61 61.55 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -73.68 -19.94 60.69 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.803 1.241 . . . . 0.0 114.156 171.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.92 -4.27 63.0 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.529 1.538 . . . . 0.0 114.073 -176.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -79.77 129.38 34.43 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.308 1.054 . . . . 0.0 111.973 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.67 99.99 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 127.215 2.206 . . . . 0.0 110.536 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.54 -30.04 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 123.397 0.679 . . . . 0.0 111.983 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.52 149.99 50.73 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 124.215 1.96 . . . . 0.0 112.642 174.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.8 m-30 -103.84 80.76 1.8 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.408 -1.724 . . . . 0.0 107.662 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.4 mt -101.18 71.32 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 169.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.02 90.39 3.03 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 122.32 1.057 . . . . 0.0 108.803 175.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -59.97 95.16 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.112 1.365 . . . . 0.0 110.553 176.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -80.99 51.85 1.65 Allowed 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.544 -1.348 . . . . 0.0 112.636 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -79.86 106.81 12.16 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 124.296 1.998 . . . . 0.0 112.681 -176.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 41.2 t -62.49 113.75 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 127.377 2.271 . . . . 0.0 108.917 170.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.35 138.48 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 120.957 0.408 . . . . 0.0 111.316 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 28.6 ptm -92.69 178.55 5.76 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.021 1.728 . . . . 0.0 112.777 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -121.11 152.09 39.11 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.133 1.773 . . . . 0.0 112.44 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 22.5 pttp . . . . . 0 C--O 1.25 1.083 0 C-N-CA 125.252 1.421 . . . . 0.0 113.568 -174.416 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 119.098 -0.477 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -69.1 157.66 60.82 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.479 2.786 . . . . 0.0 112.607 177.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.9 m -135.14 156.78 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.837 1.655 . . . . 0.0 111.899 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -145.35 164.31 31.85 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.628 1.571 . . . . 0.0 113.033 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 21.1 ttp180 -71.73 146.4 48.17 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.147 1.379 . . . . 0.0 111.132 171.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.1 -174.0 26.34 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.368 0.985 . . . . 0.0 114.376 174.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -74.12 142.26 45.56 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.75 -0.853 . . . . 0.0 112.177 175.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.5 t -130.04 135.83 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.643 1.577 . . . . 0.0 109.014 173.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.37 159.86 63.32 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 123.696 0.798 . . . . 0.0 112.139 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.13 103.58 0.77 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.818 2.346 . . . . 0.0 112.233 -178.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -66.34 -27.17 67.68 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.184 0.993 . . . . 0.0 113.095 -171.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -70.09 -49.85 46.79 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.273 0.629 . . . . 0.0 110.415 -177.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 t -75.61 -34.7 60.61 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.028 0.931 . . . . 0.0 112.377 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -57.93 -42.72 85.45 Favored 'General case' 0 C--N 1.341 0.238 0 O-C-N 121.859 -0.526 . . . . 0.0 110.296 171.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.3 tp -70.02 -44.65 68.85 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 118.869 -0.586 . . . . 0.0 112.062 173.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -48.45 -40.01 24.79 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.882 1.219 . . . . 0.0 112.389 175.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.1 m -60.19 -43.09 96.2 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 121.486 -0.759 . . . . 0.0 112.502 172.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.2 mm -67.7 -35.67 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 123.962 0.905 . . . . 0.0 110.783 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.5 mm -56.21 -54.97 21.42 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 172.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -26.75 66.22 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.469 1.108 . . . . 0.0 112.978 176.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -65.31 -46.56 79.88 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 118.155 -0.926 . . . . 0.0 112.193 172.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -104.04 0.0 29.3 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -53.72 -29.16 38.04 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 116.72 2.119 . . . . 0.0 116.72 -165.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.58 -1.8 1.01 Allowed Glycine 0 CA--C 1.544 1.845 0 C-N-CA 126.098 1.809 . . . . 0.0 117.579 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -112.19 -26.01 9.02 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.303 1.551 . . . . 0.0 113.555 -170.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 65.3 m -89.28 16.3 7.62 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.821 1.248 . . . . 0.0 112.651 169.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.7 mmt-85 -89.67 163.58 15.07 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.226 1.81 . . . . 0.0 112.767 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -122.0 145.26 48.3 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.594 1.957 . . . . 0.0 111.419 -169.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -169.69 162.1 9.59 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -171.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.6 pp -123.3 169.13 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 127.754 2.422 . . . . 0.0 111.864 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.7 mm -127.74 119.07 50.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 126.365 1.866 . . . . 0.0 108.06 174.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.32 154.6 46.71 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 -177.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -77.38 106.69 9.3 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.287 172.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.81 -15.87 61.17 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -96.09 5.94 49.97 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.918 1.287 . . . . 0.0 114.057 -171.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.99 140.19 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.087 1.755 . . . . 0.0 110.912 -173.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -59.92 -23.56 63.61 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -176.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -76.03 -20.78 57.5 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.238 1.015 . . . . 0.0 113.578 174.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 15.6 m 45.1 42.85 7.04 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.017 1.727 . . . . 0.0 113.991 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.05 164.12 12.13 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 117.282 2.327 . . . . 0.0 117.282 -166.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 67.6 t -79.78 96.97 2.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 128.633 2.773 . . . . 0.0 108.419 -170.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.7 pt -78.76 -24.44 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.637 1.575 . . . . 0.0 111.47 173.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -153.79 159.68 41.98 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.952 0.901 . . . . 0.0 111.424 171.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 25.0 p -144.21 151.39 39.41 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.167 -0.958 . . . . 0.0 112.84 -173.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -87.8 153.27 21.47 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.721 0.772 . . . . 0.0 112.381 168.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -62.81 -32.87 74.14 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.305 0.642 . . . . 0.0 111.254 173.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.94 -50.04 56.41 Favored Glycine 0 CA--C 1.532 1.113 0 O-C-N 121.346 -0.846 . . . . 0.0 112.794 175.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -29.87 66.97 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 118.857 1.328 . . . . 0.0 111.56 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.7 t -59.97 -39.94 87.36 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.344 -0.848 . . . . 0.0 110.877 171.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -77.05 -30.13 55.46 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.435 -0.791 . . . . 0.0 112.387 174.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.6 tp -57.36 -55.72 31.1 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.277 1.431 . . . . 0.0 110.838 175.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.9 p -79.98 -28.08 39.57 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 175.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.53 9.96 74.42 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.913 1.72 . . . . 0.0 115.919 178.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -86.04 -121.83 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 119.547 1.674 . . . . 0.0 112.603 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.3 t -159.88 142.88 13.87 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.12 1.768 . . . . 0.0 110.036 -176.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -63.7 -33.97 76.82 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 121.168 -0.957 . . . . 0.0 112.178 -173.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.87 -16.65 43.99 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.578 1.151 . . . . 0.0 113.778 173.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -94.04 -20.56 19.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.211 2.204 . . . . 0.0 112.602 177.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 m -89.9 -20.05 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-N 120.254 1.388 . . . . 0.0 112.823 -173.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 35.1 mmt -49.98 118.57 2.98 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.587 1.155 . . . . 0.0 110.263 -174.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 72.56 20.33 3.9 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.825 1.65 . . . . 0.0 114.098 170.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -89.92 150.93 44.64 Favored Pre-proline 0 N--CA 1.484 1.231 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 169.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -64.24 140.02 68.91 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 124.062 3.174 . . . . 0.0 113.165 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 76.9 m -70.08 -12.36 61.55 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 169.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.1 m -59.08 100.09 0.06 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 126.888 2.075 . . . . 0.0 110.304 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 54.4 m -53.64 -13.21 0.61 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 -170.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -54.25 -38.31 65.63 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.399 1.08 . . . . 0.0 111.359 167.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -59.89 -20.36 56.82 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.457 1.503 . . . . 0.0 112.918 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.55 20.03 14.98 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 127.377 2.271 . . . . 0.0 111.52 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.05 149.2 45.09 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.629 -1.294 . . . . 0.0 112.826 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.7 -172.41 12.66 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.573 1.559 . . . . 0.0 112.45 172.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.35 -9.99 24.28 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.412 2.741 . . . . 0.0 114.781 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -96.46 -10.1 28.23 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.14 1.376 . . . . 0.0 113.555 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.3 m -82.83 139.72 33.33 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 119.237 0.926 . . . . 0.0 112.181 -170.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -95.74 143.65 26.81 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 122.684 1.23 . . . . 0.0 112.139 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.79 -39.88 79.92 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.93 -176.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -57.94 -40.71 81.16 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.259 1.024 . . . . 0.0 112.912 174.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.73 -52.19 58.38 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.368 1.067 . . . . 0.0 110.039 176.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.88 -34.79 79.23 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.07 -54.82 11.42 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.69 1.196 . . . . 0.0 111.563 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -50.15 -40.06 45.29 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.243 1.017 . . . . 0.0 112.405 172.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 49.6 mt -64.42 -50.61 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 O-C-N 121.704 -0.623 . . . . 0.0 111.442 173.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.1 -39.93 57.26 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 118.481 -0.771 . . . . 0.0 111.806 175.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -70.63 -37.16 73.76 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.617 0.767 . . . . 0.0 111.852 176.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.34 -33.41 74.25 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.484 -0.76 . . . . 0.0 111.243 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 mt -81.67 -31.96 32.01 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.287 0.635 . . . . 0.0 111.571 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.94 -29.25 70.65 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.494 1.918 . . . . 0.0 111.518 169.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.99 18.44 8.81 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.912 1.244 . . . . 0.0 114.929 169.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.95 -49.9 75.57 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 118.623 1.211 . . . . 0.0 111.424 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -156.75 146.2 20.56 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.535 1.934 . . . . 0.0 110.232 171.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -74.83 113.63 12.33 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 169.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -143.31 136.28 27.79 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.331 -167.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -87.72 129.86 35.01 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.424 1.49 . . . . 0.0 109.535 169.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.1 t -136.09 142.88 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.348 1.459 . . . . 0.0 108.705 -175.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -80.03 150.43 30.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.635 0.774 . . . . 0.0 110.093 172.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -161.57 148.88 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.255 1.022 . . . . 0.0 110.843 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.04 145.36 25.53 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.3 173.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -119.48 157.55 28.06 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.373 1.069 . . . . 0.0 111.165 175.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -113.93 140.06 48.7 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.834 0.854 . . . . 0.0 109.836 167.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -93.94 150.33 20.46 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.154 1.381 . . . . 0.0 109.585 170.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -17.64 60.73 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -171.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -73.1 -10.03 59.36 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.036 1.334 . . . . 0.0 113.659 172.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.0 9.31 37.34 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.693 1.616 . . . . 0.0 115.442 176.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 63.8 m -91.44 133.16 35.72 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.851 1.326 . . . . 0.0 111.198 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 49.6 t -134.44 129.37 35.17 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.827 0.851 . . . . 0.0 112.86 -176.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -151.01 153.35 34.98 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -173.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -100.04 135.35 41.61 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.772 2.029 . . . . 0.0 110.435 173.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 2.1 m -139.24 170.0 16.75 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.524 1.529 . . . . 0.0 110.706 168.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 31.1 tp -78.33 60.79 2.63 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.796 1.238 . . . . 0.0 110.69 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.7 t -60.79 145.23 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.691 1.196 . . . . 0.0 111.206 -174.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -104.1 69.69 0.95 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 122.493 1.139 . . . . 0.0 111.195 -169.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.1 t -82.76 69.81 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.022 0.929 . . . . 0.0 110.228 -169.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.89 132.46 23.91 Favored Pre-proline 0 N--CA 1.483 1.183 0 C-N-CA 124.26 1.024 . . . . 0.0 111.88 -171.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -88.54 -174.28 1.04 Allowed 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 123.595 2.863 . . . . 0.0 113.797 -171.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.85 129.26 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-O 122.854 1.311 . . . . 0.0 113.658 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -107.72 170.56 7.91 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 127.001 2.12 . . . . 0.0 112.31 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -104.13 179.91 4.14 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 113.666 -1.606 . . . . 0.0 112.346 169.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.25 -19.95 65.01 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -69.34 -19.96 63.86 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.458 1.103 . . . . 0.0 113.681 170.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.95 18.69 49.94 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.468 1.032 . . . . 0.0 113.842 -173.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -110.86 142.4 42.95 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.317 1.047 . . . . 0.0 113.448 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.6 p -74.99 100.06 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.946 1.698 . . . . 0.0 110.814 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.13 -28.94 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 123.303 0.641 . . . . 0.0 111.993 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.33 149.88 50.9 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-O 124.24 1.971 . . . . 0.0 112.654 174.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.8 m-30 -104.87 82.62 1.9 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.222 -1.808 . . . . 0.0 107.337 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.8 mt -100.83 69.88 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 170.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.49 88.93 5.61 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.99 0.9 . . . . 0.0 108.696 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -59.89 108.86 0.82 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.637 1.175 . . . . 0.0 110.712 -176.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -84.17 52.53 2.35 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 120.407 -1.433 . . . . 0.0 112.196 -176.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -79.93 106.89 12.29 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 123.998 1.856 . . . . 0.0 112.294 -178.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 37.0 t -64.74 112.42 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 C-N-CA 126.308 1.843 . . . . 0.0 108.633 171.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p -140.36 138.79 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 122.842 0.457 . . . . 0.0 110.041 175.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.2 ptp -83.99 178.77 7.73 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.73 1.212 . . . . 0.0 112.47 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -59.67 157.7 11.41 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.893 1.277 . . . . 0.0 112.498 175.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 86.3 tttt . . . . . 0 C--O 1.254 1.307 0 C-N-CA 125.626 1.57 . . . . 0.0 113.731 -172.127 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.955 -0.545 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.64 -17.81 7.1 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 123.341 2.694 . . . . 0.0 115.199 -174.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.8 t -130.48 152.92 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 125.663 1.585 . . . . 0.0 111.086 -169.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 57.45 43.46 22.97 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.576 1.95 . . . . 0.0 114.007 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.8 ppt_? -139.94 154.13 47.12 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.033 1.733 . . . . 0.0 111.969 169.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.21 5.72 59.58 Favored Glycine 0 CA--C 1.541 1.71 0 C-N-CA 124.514 1.055 . . . . 0.0 115.419 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 55.1 p-80 -84.91 162.47 19.44 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.282 1.833 . . . . 0.0 112.79 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.2 t -75.1 130.89 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.707 0.803 . . . . 0.0 109.335 172.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.03 159.92 24.64 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 123.62 0.768 . . . . 0.0 111.942 174.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -52.97 110.0 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.525 2.816 . . . . 0.0 111.774 174.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -66.38 -26.79 67.43 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -168.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -68.32 -49.92 57.04 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.719 0.808 . . . . 0.0 110.272 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 t -74.35 -36.43 63.61 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.751 0.821 . . . . 0.0 112.307 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -57.9 -40.02 79.31 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.27 0.628 . . . . 0.0 110.541 173.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.5 tp -71.19 -44.28 65.77 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 118.957 -0.544 . . . . 0.0 112.4 171.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -47.51 -39.9 17.33 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.951 1.3 . . . . 0.0 112.743 175.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 57.0 m -60.14 -42.27 94.47 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 121.193 -0.942 . . . . 0.0 112.549 172.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.8 mm -70.09 -33.31 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.311 1.045 . . . . 0.0 110.785 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.9 mm -56.43 -55.62 18.14 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.426 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 169.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -23.74 63.71 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.303 1.041 . . . . 0.0 113.354 177.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.2 tptp -68.96 -45.49 70.58 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.166 0.986 . . . . 0.0 112.989 171.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -102.45 -0.08 32.98 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -51.57 -28.97 15.51 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 127.256 2.222 . . . . 0.0 116.544 -167.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.5 55.53 6.7 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 118.951 0.796 . . . . 0.0 112.449 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -63.6 9.34 0.06 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.606 2.362 . . . . 0.0 116.521 -169.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.2 p -75.56 5.87 5.45 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.241 1.416 . . . . 0.0 111.695 165.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.8 mtt180 -53.62 158.47 1.85 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.154 1.782 . . . . 0.0 112.518 170.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -114.38 145.14 42.19 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.515 1.126 . . . . 0.0 112.601 -168.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -169.78 159.25 7.92 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 123.189 1.471 . . . . 0.0 114.916 -175.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -120.03 169.01 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 127.574 2.35 . . . . 0.0 111.208 172.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.0 mm -125.25 120.07 57.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 125.957 1.703 . . . . 0.0 107.365 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.0 152.56 48.48 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 178.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -77.31 110.72 12.27 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.301 0.572 . . . . 0.0 111.53 173.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.21 -15.51 61.94 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -99.92 4.63 45.1 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.536 1.309 . . . . 0.0 114.536 -169.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -119.73 140.05 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.422 1.489 . . . . 0.0 110.882 -175.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.4 -23.17 65.62 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -175.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -83.37 -14.52 52.63 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.899 1.28 . . . . 0.0 113.725 175.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.1 m 43.3 54.4 5.14 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.52 1.928 . . . . 0.0 113.528 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.84 154.71 17.59 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -168.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 80.8 t -79.95 90.01 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 128.111 2.565 . . . . 0.0 108.799 -176.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.7 pt -70.11 -23.79 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.698 1.199 . . . . 0.0 112.376 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -155.55 159.66 39.88 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.858 0.863 . . . . 0.0 112.258 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 18.5 p -142.96 139.96 30.89 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 121.342 -0.848 . . . . 0.0 113.069 -173.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -81.82 152.41 26.93 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.724 0.773 . . . . 0.0 112.748 170.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -61.97 -32.26 72.69 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.509 0.724 . . . . 0.0 111.252 175.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.45 -52.55 32.39 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 121.46 -0.775 . . . . 0.0 112.975 172.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.13 -29.73 66.73 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 119.21 1.505 . . . . 0.0 111.136 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.7 t -58.79 -39.82 82.22 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.528 -0.732 . . . . 0.0 110.619 171.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -79.23 -28.31 42.47 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.688 0.795 . . . . 0.0 113.056 174.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.2 tp -57.87 -53.09 62.15 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.051 1.341 . . . . 0.0 110.85 174.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 79.8 m -90.04 -20.01 23.73 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 177.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.71 34.01 40.55 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 124.312 0.958 . . . . 0.0 114.737 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -99.01 -130.18 0.21 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.564 1.146 . . . . 0.0 112.357 -176.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.7 m -159.84 142.88 13.92 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 128.669 2.787 . . . . 0.0 108.143 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -63.98 -40.11 95.65 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 120.922 -1.111 . . . . 0.0 112.934 -169.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.38 -18.04 56.88 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.522 1.129 . . . . 0.0 113.528 174.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -90.21 -20.72 22.7 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.183 1.393 . . . . 0.0 112.179 178.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.7 m -92.7 -14.49 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 CA-C-N 119.31 0.959 . . . . 0.0 113.546 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 35.5 mmt -49.87 114.01 0.98 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.915 1.286 . . . . 0.0 110.467 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 70.15 21.77 5.85 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.88 1.672 . . . . 0.0 113.74 169.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.34 158.84 86.14 Favored Pre-proline 0 N--CA 1.474 0.768 0 O-C-N 121.345 -0.847 . . . . 0.0 111.138 167.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.51 132.99 49.08 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.593 2.196 . . . . 0.0 112.209 171.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 4.6 t -69.99 -23.68 63.19 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.76 1.224 . . . . 0.0 112.548 174.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.0 m -57.04 100.14 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 128.092 2.557 . . . . 0.0 111.792 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 57.7 m -50.04 -21.74 1.35 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -174.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -52.67 -39.19 61.65 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.242 1.017 . . . . 0.0 112.014 171.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -56.14 -24.41 40.85 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.785 1.634 . . . . 0.0 113.4 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 pp -123.08 25.0 8.7 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.048 1.739 . . . . 0.0 113.284 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -63.5 147.26 51.85 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.37 -0.831 . . . . 0.0 112.613 176.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.5 -174.6 13.7 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 125.69 1.615 . . . . 0.0 113.709 -176.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -67.91 -4.38 12.28 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.995 3.13 . . . . 0.0 116.098 -170.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 78.9 mmt-85 -110.26 -10.05 14.64 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 119.609 1.095 . . . . 0.0 113.519 169.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.8 m -73.94 134.98 43.22 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.23 0.923 . . . . 0.0 110.812 -173.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -85.38 137.46 32.92 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.84 0.829 . . . . 0.0 110.029 173.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.0 mmm-85 -67.36 -39.67 85.73 Favored 'General case' 0 C--O 1.219 -0.517 0 O-C-N 121.402 -0.811 . . . . 0.0 111.084 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.1 ptt-85 -53.6 -38.63 64.15 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 169.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.85 -52.15 52.84 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 122.04 0.924 . . . . 0.0 110.079 175.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.42 -33.8 76.8 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.618 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.12 -51.85 28.33 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.783 1.633 . . . . 0.0 112.057 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -50.17 -41.62 49.53 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.456 1.025 . . . . 0.0 112.341 169.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 46.2 mt -62.94 -50.03 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 O-C-N 121.769 -0.582 . . . . 0.0 111.047 172.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.08 -39.79 56.89 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.374 -0.822 . . . . 0.0 112.173 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -69.84 -37.95 76.35 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.589 0.755 . . . . 0.0 111.473 176.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.23 -32.88 74.22 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.536 -0.727 . . . . 0.0 111.075 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mt -81.35 -33.47 32.39 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.452 0.701 . . . . 0.0 111.693 176.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.05 -28.47 69.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.791 2.036 . . . . 0.0 111.28 169.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.09 17.6 9.41 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.007 1.289 . . . . 0.0 114.84 169.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.85 -49.91 75.55 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 118.526 1.163 . . . . 0.0 111.439 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -161.56 151.65 17.14 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.695 1.598 . . . . 0.0 111.926 171.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -72.18 112.98 8.73 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 167.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.5 tpp180 -148.26 135.97 20.78 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.268 1.027 . . . . 0.0 111.431 -176.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -83.87 131.95 34.83 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.403 1.481 . . . . 0.0 110.204 169.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.7 t -134.93 146.12 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.353 1.461 . . . . 0.0 109.074 -176.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -80.05 152.5 29.36 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.773 0.829 . . . . 0.0 110.011 171.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -163.25 148.71 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.42 1.088 . . . . 0.0 110.813 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.8 145.38 25.22 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.665 174.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -117.18 154.14 31.61 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.677 1.191 . . . . 0.0 111.088 172.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -123.9 140.05 53.36 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.535 0.734 . . . . 0.0 110.811 169.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -83.11 162.12 21.42 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.953 1.301 . . . . 0.0 113.28 177.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -50.05 -35.28 24.42 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.469 1.908 . . . . 0.0 113.417 171.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -81.75 -9.91 59.51 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.56 1.144 . . . . 0.0 113.946 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.96 2.07 48.86 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.789 1.661 . . . . 0.0 115.382 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.5 m -74.66 125.11 27.99 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.936 1.368 . . . . 0.0 110.717 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 19.1 t -127.9 132.75 49.28 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.208 1.003 . . . . 0.0 112.589 -170.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -151.06 139.98 20.95 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.57 1.148 . . . . 0.0 113.825 -169.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -104.81 128.75 53.08 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.405 1.882 . . . . 0.0 109.033 168.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 62.3 m -134.99 172.66 12.69 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.422 1.489 . . . . 0.0 110.018 169.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 28.6 tp -79.98 59.88 3.37 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.983 -1.073 . . . . 0.0 110.81 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.7 t -58.42 146.28 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.253 1.421 . . . . 0.0 111.662 -171.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -100.87 69.72 1.35 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 122.608 1.194 . . . . 0.0 111.622 -168.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.7 t -83.32 69.86 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.229 1.011 . . . . 0.0 110.389 -169.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.0 p -119.51 133.47 23.8 Favored Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 124.689 1.195 . . . . 0.0 111.441 -173.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -88.79 -171.34 0.57 Allowed 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 123.761 2.974 . . . . 0.0 113.55 -171.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.7 m -127.81 127.19 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-O 122.811 1.291 . . . . 0.0 113.573 174.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -114.12 165.07 13.02 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 127.273 2.229 . . . . 0.0 112.202 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -94.22 179.99 5.12 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.654 174.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.65 -20.62 63.61 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -71.39 -19.87 62.21 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.546 1.139 . . . . 0.0 114.025 171.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.95 0.96 58.6 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 124.815 1.197 . . . . 0.0 114.127 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.21 126.25 37.21 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.485 1.114 . . . . 0.0 112.025 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.7 p -59.95 99.8 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 128.214 2.605 . . . . 0.0 109.796 171.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.22 -30.06 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.975 177.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.9 mmt -135.46 148.37 49.23 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 124.167 1.937 . . . . 0.0 111.128 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.8 m-30 -104.85 80.39 1.63 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.934 1.694 . . . . 0.0 106.749 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.0 mt -100.05 69.85 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 171.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.87 90.14 4.7 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -59.81 109.05 0.84 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.515 1.126 . . . . 0.0 110.857 -176.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -84.46 49.98 1.79 Allowed 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.233 -1.542 . . . . 0.0 112.515 -177.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -79.84 107.05 12.32 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 123.685 1.707 . . . . 0.0 111.98 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.3 t -57.94 115.82 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 127.166 2.186 . . . . 0.0 109.44 170.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.47 144.12 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 176.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 78.5 mtm -137.0 154.87 50.3 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.062 1.745 . . . . 0.0 110.834 169.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -73.77 157.06 37.13 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.133 0.973 . . . . 0.0 113.28 176.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.8 tptt . . . . . 0 C--O 1.252 1.211 0 C-N-CA 125.912 1.685 . . . . 0.0 111.381 179.773 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.3 mtm . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -69.14 157.67 60.7 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.435 2.757 . . . . 0.0 112.634 177.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.8 t -133.06 137.96 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.609 1.563 . . . . 0.0 109.847 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -88.82 19.93 3.8 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -173.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.8 161.65 42.24 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 127.098 2.159 . . . . 0.0 112.385 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.74 143.32 9.0 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.35 1.452 . . . . 0.0 111.986 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -143.9 162.65 35.58 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.505 1.522 . . . . 0.0 112.705 -170.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.75 142.47 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.649 1.18 . . . . 0.0 109.476 171.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.19 159.87 13.77 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 123.813 0.845 . . . . 0.0 112.193 174.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -54.46 110.1 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.671 2.914 . . . . 0.0 113.149 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -68.48 -25.22 64.86 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.485 -0.76 . . . . 0.0 112.855 -169.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -66.7 -49.85 64.74 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.07 0.948 . . . . 0.0 110.384 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 t -75.71 -35.8 60.17 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.829 0.852 . . . . 0.0 112.347 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -57.8 -40.69 80.5 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.138 0.575 . . . . 0.0 110.388 172.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.1 tp -72.54 -43.63 63.25 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 118.607 -0.711 . . . . 0.0 112.289 172.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -48.58 -39.97 25.66 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 120.077 1.308 . . . . 0.0 112.164 175.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 78.9 m -60.12 -42.64 95.21 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 121.607 -0.683 . . . . 0.0 112.732 173.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.1 mm -69.95 -32.74 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.219 1.008 . . . . 0.0 111.011 176.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.7 mm -57.08 -55.8 18.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 170.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -25.33 64.98 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 176.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.1 tptt -68.58 -42.19 78.61 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.087 0.955 . . . . 0.0 112.271 172.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -114.99 16.39 17.14 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 -175.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -60.08 -29.05 68.31 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 -166.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.54 55.47 28.68 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 119.019 0.827 . . . . 0.0 113.188 172.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -58.07 -6.71 0.64 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 116.858 2.17 . . . . 0.0 116.858 -168.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.8 m -69.88 -18.76 63.43 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 120.927 -1.108 . . . . 0.0 112.323 167.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -78.1 154.58 31.18 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.787 2.035 . . . . 0.0 110.904 172.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -111.82 149.08 32.27 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.482 1.513 . . . . 0.0 113.496 -168.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -169.78 162.45 9.55 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -172.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 pp -129.25 170.66 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 127.323 2.249 . . . . 0.0 111.347 175.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.1 mm -126.21 114.45 38.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 126.368 1.867 . . . . 0.0 107.388 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.5 150.26 41.85 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 124.325 1.05 . . . . 0.0 111.614 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -81.72 114.03 20.11 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.391 1.076 . . . . 0.0 110.37 176.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.82 4.16 45.55 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 175.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -100.19 -3.38 31.74 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.397 1.479 . . . . 0.0 113.936 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 p -118.15 139.29 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.83 1.652 . . . . 0.0 111.501 -176.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -62.15 -26.39 68.3 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.926 0.89 . . . . 0.0 112.937 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -77.53 -8.88 58.48 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.824 1.25 . . . . 0.0 113.93 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.0 p 43.62 35.4 0.99 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 126.991 2.116 . . . . 0.0 114.877 -176.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.71 154.87 29.73 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -167.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 98.9 t -79.99 89.99 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 129.143 2.977 . . . . 0.0 109.02 -175.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.0 pt -69.94 -24.25 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.462 1.505 . . . . 0.0 112.392 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -153.92 159.66 41.82 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.281 1.033 . . . . 0.0 112.224 171.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.4 ' HG ' ' CG2' ' A' ' 59' ' ' VAL . 18.6 p -143.77 147.35 34.05 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.817 -1.177 . . . . 0.0 112.798 -177.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -89.74 156.86 18.24 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 176.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -58.81 -27.4 65.04 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.277 0.631 . . . . 0.0 111.626 169.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.7 -56.64 12.84 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 119.218 -0.768 . . . . 0.0 112.465 169.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -53.19 -39.49 63.69 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.4 1.6 . . . . 0.0 111.371 174.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.3 t -60.14 -40.06 88.47 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.901 -0.5 . . . . 0.0 111.308 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -78.56 -25.86 45.49 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.978 0.911 . . . . 0.0 112.979 176.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 36.2 tp -66.26 -55.74 14.66 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.877 1.271 . . . . 0.0 111.213 176.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 78.4 m -93.35 -22.06 19.18 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.638 0.775 . . . . 0.0 113.084 -176.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.22 20.07 79.82 Favored Glycine 0 CA--C 1.539 1.586 0 O-C-N 121.034 -1.041 . . . . 0.0 113.855 -171.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -87.47 -130.02 0.06 Allowed 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 118.493 1.147 . . . . 0.0 110.839 -176.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.0 t -160.66 150.16 17.31 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 127.862 2.465 . . . . 0.0 108.846 176.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.08 -38.87 54.29 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 121.466 -0.771 . . . . 0.0 112.624 172.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.51 -19.99 64.16 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.56 1.144 . . . . 0.0 113.737 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -86.76 -20.73 27.19 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.267 1.427 . . . . 0.0 113.189 174.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.4 ' CG2' ' HG ' ' A' ' 44' ' ' CYS . 15.6 m -105.41 -18.49 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 176.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.5 mmt -49.84 111.41 0.51 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.491 1.517 . . . . 0.0 111.248 -172.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 66.83 30.67 7.76 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.823 1.649 . . . . 0.0 112.544 170.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -107.21 154.4 40.52 Favored Pre-proline 0 N--CA 1.471 0.61 0 CA-C-O 117.321 -1.323 . . . . 0.0 112.594 176.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -50.59 134.82 40.56 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.267 2.645 . . . . 0.0 113.95 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 52.7 t -66.68 -17.86 65.07 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.727 1.211 . . . . 0.0 112.981 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.2 m -61.88 99.99 0.14 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.211 1.804 . . . . 0.0 111.859 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 27.8 p -54.08 -15.69 1.59 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -175.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -52.85 -38.74 61.85 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.991 0.917 . . . . 0.0 111.523 170.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -64.78 -15.19 61.32 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 pp -123.06 25.38 8.54 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.118 1.767 . . . . 0.0 113.358 172.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -62.34 148.33 45.52 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.197 -0.94 . . . . 0.0 112.62 176.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.96 -179.75 16.04 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 125.126 1.346 . . . . 0.0 114.09 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -63.5 -10.01 20.17 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.572 2.848 . . . . 0.0 116.629 -174.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -110.03 -2.27 17.13 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.412 1.485 . . . . 0.0 114.15 173.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.2 m -80.8 139.99 35.72 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.348 0.976 . . . . 0.0 111.944 -177.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -87.27 135.61 33.25 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 122.493 1.139 . . . . 0.0 111.407 171.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.8 mmm-85 -69.79 -39.74 76.43 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 118.573 -0.727 . . . . 0.0 110.965 176.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.2 ptp85 -54.13 -38.37 65.37 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 169.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.23 -52.81 52.21 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 122.111 0.958 . . . . 0.0 110.05 174.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.24 -32.71 74.52 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.695 -178.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.1 -50.22 43.03 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.17 1.788 . . . . 0.0 112.559 176.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -50.11 -42.61 50.7 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.659 1.118 . . . . 0.0 111.975 169.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 43.0 mt -61.31 -48.83 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.857 -0.527 . . . . 0.0 111.271 173.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.56 -39.88 58.69 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.131 0.572 . . . . 0.0 111.957 174.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -62.63 -40.81 98.18 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.556 0.742 . . . . 0.0 111.284 175.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.01 -29.13 68.05 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 175.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mt -86.55 -32.48 20.67 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.1 pp -71.48 -30.3 65.83 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.618 -0.676 . . . . 0.0 111.227 167.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.83 20.06 7.85 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 118.988 -0.896 . . . . 0.0 113.823 168.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.27 -50.0 68.28 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 118.486 1.143 . . . . 0.0 111.179 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -167.27 150.21 6.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.938 2.095 . . . . 0.0 110.566 169.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -86.84 130.15 34.59 Favored 'General case' 0 C--O 1.238 0.471 0 O-C-N 121.21 -0.931 . . . . 0.0 109.166 -178.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.06 150.54 27.36 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.092 0.957 . . . . 0.0 112.351 174.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -76.77 138.44 39.91 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.275 1.03 . . . . 0.0 109.339 168.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -139.24 144.75 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.332 1.053 . . . . 0.0 109.525 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -80.01 152.62 29.35 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.905 0.882 . . . . 0.0 110.04 171.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -163.46 148.05 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.235 1.014 . . . . 0.0 111.028 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -90.76 145.37 24.85 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.888 0.475 . . . . 0.0 112.247 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -117.51 162.56 17.78 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.767 1.227 . . . . 0.0 111.93 172.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -127.94 136.46 51.36 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.604 0.761 . . . . 0.0 111.531 168.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.7 mmt85 -71.08 152.22 43.72 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.446 1.498 . . . . 0.0 111.624 173.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -54.88 -30.57 58.29 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.788 1.235 . . . . 0.0 112.341 168.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -76.21 -9.95 59.03 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.568 1.547 . . . . 0.0 114.271 175.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.8 10.23 47.16 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.296 1.427 . . . . 0.0 116.313 174.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.3 m -87.61 135.12 33.49 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 119.14 1.47 . . . . 0.0 111.578 176.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 59.3 m -123.24 133.18 54.22 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.467 1.107 . . . . 0.0 112.243 -171.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -150.9 140.47 21.59 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -176.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -102.58 127.46 49.65 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.004 1.722 . . . . 0.0 108.465 168.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 60.9 m -128.45 168.49 15.56 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.435 1.094 . . . . 0.0 110.579 171.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 73.2 mt -79.99 59.85 3.36 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.876 -1.14 . . . . 0.0 110.199 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.3 t -59.06 146.37 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.531 1.532 . . . . 0.0 112.208 -168.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -100.05 69.69 1.53 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 122.56 1.172 . . . . 0.0 112.31 -168.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.9 t -84.67 69.85 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 121.372 -0.83 . . . . 0.0 111.346 -168.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.2 t -111.25 129.2 24.28 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 124.504 1.121 . . . . 0.0 109.464 -178.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -82.96 -168.67 0.61 Allowed 'Trans proline' 0 CA--C 1.553 1.427 0 C-N-CA 123.121 2.548 . . . . 0.0 111.298 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -127.17 128.9 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-O 123.124 1.44 . . . . 0.0 113.945 175.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -111.7 162.2 15.46 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.675 2.39 . . . . 0.0 112.818 -175.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -94.46 -178.95 4.74 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.475 172.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -61.57 -22.18 64.96 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -71.89 -19.98 61.86 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.641 1.177 . . . . 0.0 113.829 170.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.32 -0.03 59.85 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 126.017 1.77 . . . . 0.0 114.372 -176.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.4 140.01 29.94 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.541 1.171 . . . . 0.0 113.146 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.3 p -73.95 98.89 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.668 1.587 . . . . 0.0 109.8 -176.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.96 -30.03 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 118.397 -0.811 . . . . 0.0 111.059 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.7 mmt -135.96 149.91 49.07 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-O 123.455 1.597 . . . . 0.0 110.452 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.2 m-30 -105.61 81.09 1.63 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -175.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.9 mt -99.95 69.99 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 120.206 -1.559 . . . . 0.0 108.295 173.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -73.96 87.64 1.83 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 123.405 1.574 . . . . 0.0 109.398 176.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -59.89 96.54 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 112.845 -1.98 . . . . 0.0 109.862 176.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -83.4 52.76 2.3 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.454 -1.403 . . . . 0.0 111.881 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -79.84 127.08 31.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 122.065 0.936 . . . . 0.0 111.992 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 t -69.36 123.56 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.423 1.089 . . . . 0.0 109.016 172.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.46 145.24 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 169.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.2 ptp -142.87 157.66 44.38 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.858 1.263 . . . . 0.0 111.865 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -76.18 145.93 39.5 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.374 0.67 . . . . 0.0 111.68 169.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt . . . . . 0 C--O 1.253 1.278 0 C-N-CA 125.973 1.709 . . . . 0.0 111.784 -174.494 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.4 ttm . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 118.775 -0.631 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -71.07 -22.92 25.54 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.27 2.647 . . . . 0.0 114.098 -175.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.0 m -119.56 154.4 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 126.321 1.848 . . . . 0.0 111.308 173.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.9 ptp85 -157.13 162.95 39.39 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.327 1.451 . . . . 0.0 112.776 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -81.59 146.92 29.86 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.335 1.054 . . . . 0.0 110.941 168.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.97 -155.97 48.02 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 123.612 0.625 . . . . 0.0 113.725 -175.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -77.85 162.43 26.87 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.13 1.372 . . . . 0.0 113.462 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.9 p -90.15 148.69 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.874 1.269 . . . . 0.0 110.956 170.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.36 159.93 27.55 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 123.531 0.732 . . . . 0.0 111.561 169.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -51.6 110.16 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.803 3.002 . . . . 0.0 112.031 174.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -63.87 -27.16 68.97 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -168.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -68.45 -50.0 55.72 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.754 0.822 . . . . 0.0 110.371 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 t -75.67 -33.9 60.43 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.835 0.854 . . . . 0.0 112.488 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -59.9 -40.35 88.47 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.454 0.702 . . . . 0.0 110.185 172.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.4 tp -71.6 -45.99 60.55 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-O 118.824 -0.607 . . . . 0.0 112.161 172.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -46.86 -39.75 12.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.587 1.555 . . . . 0.0 113.353 173.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 90.3 m -60.01 -44.77 94.35 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.546 -0.721 . . . . 0.0 112.025 172.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.1 mm -67.3 -35.54 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.881 0.872 . . . . 0.0 110.756 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.4 mm -55.78 -54.95 20.66 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 172.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 -59.96 -28.43 67.65 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.981 0.809 . . . . 0.0 113.038 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.7 tttt -64.27 -41.69 96.79 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 172.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -103.51 1.01 31.76 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -57.43 -26.96 61.96 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.872 2.069 . . . . 0.0 114.16 -168.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.71 42.9 30.49 Favored Glycine 0 CA--C 1.532 1.147 0 O-C-N 121.284 -0.885 . . . . 0.0 113.066 -178.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -63.39 -10.18 15.69 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.875 1.67 . . . . 0.0 113.421 -173.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 51.1 p -61.66 -8.56 4.69 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.938 1.695 . . . . 0.0 114.774 171.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . 0.369 0.0 OUTLIER -69.21 -175.24 0.74 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 119.777 1.171 . . . . 0.0 113.591 169.287 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -62.1 130.5 45.76 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.764 1.626 . . . . 0.0 113.181 -167.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -169.72 161.5 9.28 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.392 1.477 . . . . 0.0 113.374 176.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -125.01 167.92 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 126.845 2.058 . . . . 0.0 111.636 170.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.6 mm -125.74 122.43 62.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 125.846 1.658 . . . . 0.0 107.882 173.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.41 152.78 49.43 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 178.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -77.91 106.72 9.95 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 121.561 0.696 . . . . 0.0 111.191 172.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.71 -14.98 61.23 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -94.97 4.14 54.14 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.808 1.243 . . . . 0.0 114.163 -172.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -117.73 140.09 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.482 1.513 . . . . 0.0 110.647 -176.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.34 -26.05 66.28 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -177.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.83 -8.95 59.85 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.223 1.409 . . . . 0.0 114.001 177.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.5 p 35.34 56.12 0.84 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 127.043 2.137 . . . . 0.0 114.214 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.93 153.14 17.92 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -167.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.0 t -79.97 89.97 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 128.64 2.776 . . . . 0.0 108.895 -176.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.5 pt -70.82 -24.64 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.642 1.177 . . . . 0.0 112.2 176.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -154.9 159.77 40.7 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 177.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 25.5 p -142.29 146.8 35.46 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -172.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -92.01 154.1 19.0 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.549 0.69 . . . . 0.0 112.595 167.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -62.9 -33.56 75.57 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.265 0.626 . . . . 0.0 111.14 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.95 -49.95 56.78 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 121.69 -0.631 . . . . 0.0 113.155 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.02 -29.86 67.01 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 119.41 1.605 . . . . 0.0 111.141 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.8 t -59.19 -39.87 83.92 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 120.78 -1.2 . . . . 0.0 110.429 171.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -79.49 -24.79 42.07 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.285 1.034 . . . . 0.0 112.935 173.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.4 tp -59.33 -50.33 74.39 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.438 1.095 . . . . 0.0 110.398 172.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.1 m -86.68 -23.71 25.51 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 175.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.59 31.72 60.37 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 124.481 1.038 . . . . 0.0 114.197 -175.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 17.7 m-30 -95.99 -130.16 0.16 Allowed 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 118.379 1.09 . . . . 0.0 112.146 -175.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.4 t -160.06 149.96 18.19 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 128.026 2.53 . . . . 0.0 108.578 174.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -61.3 -35.35 77.09 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 120.699 -1.251 . . . . 0.0 113.234 -173.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.42 -16.67 48.92 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.436 1.094 . . . . 0.0 113.26 175.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -93.66 -20.86 19.77 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.422 1.889 . . . . 0.0 111.99 178.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 m -95.83 -19.99 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 119.762 1.164 . . . . 0.0 113.296 -174.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 34.3 mmt -50.01 112.97 0.75 Allowed 'General case' 0 C--N 1.342 0.248 0 C-N-CA 124.683 1.193 . . . . 0.0 110.889 -173.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 68.74 21.99 7.56 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.193 1.397 . . . . 0.0 113.549 169.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.3 158.79 86.92 Favored Pre-proline 0 N--CA 1.475 0.785 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.687 167.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.78 140.01 93.23 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.117 1.878 . . . . 0.0 111.481 169.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 3.9 t -69.62 -14.69 62.96 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.043 1.337 . . . . 0.0 112.747 177.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.28 99.8 0.31 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 127.82 2.448 . . . . 0.0 110.544 176.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 30.4 p -55.23 -14.86 1.93 Allowed 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.638 -1.165 . . . . 0.0 113.652 174.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -47.15 -42.82 20.28 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.442 1.497 . . . . 0.0 111.828 167.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -66.81 -12.66 59.77 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 pp -123.05 23.62 9.2 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.282 1.833 . . . . 0.0 113.428 171.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.12 146.85 53.52 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.036 -1.04 . . . . 0.0 112.912 177.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -123.19 -177.43 15.14 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.309 1.433 . . . . 0.0 114.547 -173.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -66.78 -10.15 27.18 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.009 2.473 . . . . 0.0 116.218 -172.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -110.07 -5.34 15.42 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.702 1.201 . . . . 0.0 113.898 170.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.468 HG22 ' H ' ' A' ' 97' ' ' ALA . 3.6 m -71.23 134.1 46.62 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.889 1.222 . . . . 0.0 110.076 177.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -79.88 134.59 36.31 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 122.263 1.03 . . . . 0.0 109.072 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -66.3 -39.71 89.51 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.342 -0.849 . . . . 0.0 110.105 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.8 ptt-85 -55.34 -38.91 69.38 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.559 1.144 . . . . 0.0 113.909 169.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.16 -52.84 60.79 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.987 0.915 . . . . 0.0 110.482 174.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.05 -34.45 78.45 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.181 -178.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.09 -52.81 24.53 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.599 1.16 . . . . 0.0 112.194 176.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -50.18 -40.01 45.59 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.378 0.99 . . . . 0.0 112.921 171.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 46.2 mt -63.62 -49.27 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 121.453 -0.779 . . . . 0.0 111.365 173.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.75 -39.88 59.3 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.777 0.717 . . . . 0.0 111.763 173.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -63.29 -39.76 95.48 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.319 0.648 . . . . 0.0 111.542 175.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.04 -29.7 68.74 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.3 mt -82.79 -34.97 26.87 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.9 pp -70.66 -27.2 63.85 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.976 -0.453 . . . . 0.0 112.056 167.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.93 17.48 9.6 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.315 -0.714 . . . . 0.0 114.2 169.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -51.61 -49.88 61.32 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 118.087 0.944 . . . . 0.0 112.042 173.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -157.01 142.74 17.66 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.52 1.928 . . . . 0.0 110.644 170.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -75.81 118.19 18.35 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.71 -1.244 . . . . 0.0 108.017 169.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -146.23 135.62 22.94 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.851 0.86 . . . . 0.0 112.474 -167.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -86.88 130.0 34.65 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.043 1.337 . . . . 0.0 109.518 168.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.71 144.28 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.21 1.404 . . . . 0.0 109.081 -175.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -79.88 150.62 30.54 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.522 0.729 . . . . 0.0 109.891 171.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -160.86 159.98 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.367 1.067 . . . . 0.0 110.32 -177.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.468 ' H ' HG22 ' A' ' 74' ' ' THR . . . -102.09 145.31 29.52 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.807 171.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -112.4 152.59 28.47 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.862 1.665 . . . . 0.0 110.645 169.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -127.06 139.56 52.91 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.44 0.638 . . . . 0.0 110.289 167.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -84.9 158.55 20.54 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.786 1.234 . . . . 0.0 112.927 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -54.68 -30.44 55.63 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.574 1.55 . . . . 0.0 112.853 169.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -75.45 -9.94 59.02 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.115 1.366 . . . . 0.0 113.998 175.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.08 3.82 55.6 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.76 1.647 . . . . 0.0 115.763 176.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 54.2 m -84.57 128.24 34.49 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 119.169 1.484 . . . . 0.0 111.347 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 46.9 t -124.43 129.88 51.47 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.065 1.346 . . . . 0.0 112.005 -173.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -150.91 139.96 21.07 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.399 1.079 . . . . 0.0 113.764 -169.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.0 134.87 49.51 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.711 2.404 . . . . 0.0 109.121 172.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 4.5 m -139.04 173.1 11.91 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.66 1.584 . . . . 0.0 110.281 168.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 26.6 tp -76.95 59.84 1.7 Allowed 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.019 -1.051 . . . . 0.0 109.995 173.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.7 t -59.81 146.98 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.955 1.302 . . . . 0.0 110.8 -172.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -100.0 69.72 1.55 Allowed 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 122.802 1.287 . . . . 0.0 112.584 -168.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.1 t -84.19 69.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.343 1.057 . . . . 0.0 110.89 -169.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.2 p -117.88 134.07 23.31 Favored Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 124.038 0.935 . . . . 0.0 111.887 -173.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -86.81 -173.22 1.1 Allowed 'Trans proline' 0 CA--C 1.546 1.089 0 C-N-CA 123.472 2.781 . . . . 0.0 113.445 -172.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.16 127.12 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-O 122.972 1.368 . . . . 0.0 113.483 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -110.62 162.07 15.1 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.634 2.374 . . . . 0.0 112.63 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -92.81 179.97 5.31 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.735 -1.121 . . . . 0.0 112.156 171.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.67 -21.4 65.69 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -70.84 -19.87 62.61 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.481 1.112 . . . . 0.0 113.737 169.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.69 0.09 59.27 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 126.007 1.765 . . . . 0.0 114.406 -176.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.74 139.64 30.36 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.69 1.245 . . . . 0.0 113.292 -178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.8 p -74.53 100.1 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 125.582 1.553 . . . . 0.0 110.565 -176.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.26 -29.98 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.34 0.656 . . . . 0.0 111.837 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.27 149.99 50.97 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 124.273 1.987 . . . . 0.0 112.732 173.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.3 m-30 -104.45 82.05 1.88 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.155 -1.839 . . . . 0.0 107.048 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.3 mt -102.06 69.88 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 171.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.19 86.56 5.59 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.899 0.857 . . . . 0.0 108.858 -178.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -59.94 104.21 0.28 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.544 1.138 . . . . 0.0 110.94 -175.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -83.85 58.13 4.5 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.277 -1.514 . . . . 0.0 111.729 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -79.79 124.95 29.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 122.626 1.203 . . . . 0.0 110.914 176.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 55.9 t -81.99 113.34 21.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 125.048 1.339 . . . . 0.0 108.27 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.6 p -140.38 135.99 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 120.836 0.351 . . . . 0.0 111.635 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 27.8 ptm -142.82 158.74 43.33 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.34 1.456 . . . . 0.0 111.722 173.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -72.54 149.63 43.89 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.951 0.9 . . . . 0.0 112.202 173.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 87.1 tttt . . . . . 0 C--O 1.252 1.204 0 C-N-CA 125.792 1.637 . . . . 0.0 111.505 179.86 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo . . . . . 0 CA--C 1.532 0.406 0 CA-C-O 122.173 0.822 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -63.96 -26.98 68.83 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -167.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -70.05 -49.98 45.78 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.67 0.668 . . . . 0.0 110.761 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.5 t -78.25 -33.99 49.36 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.547 1.139 . . . . 0.0 112.357 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -59.78 -42.4 93.24 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.306 0.642 . . . . 0.0 109.947 172.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.9 tp -70.12 -45.43 66.89 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-O 118.708 -0.663 . . . . 0.0 111.868 173.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -48.05 -39.87 21.3 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 120.04 1.291 . . . . 0.0 113.207 174.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.6 m -60.07 -44.98 94.35 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.605 -0.684 . . . . 0.0 112.261 172.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.8 mm -66.34 -36.61 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.762 0.825 . . . . 0.0 110.691 175.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.9 mm -55.96 -53.87 33.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.434 0 CA-C-O 118.445 -0.788 . . . . 0.0 109.05 173.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -59.97 -29.0 68.14 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 118.845 0.748 . . . . 0.0 112.54 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 tptt -63.42 -46.2 87.45 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 118.624 -0.703 . . . . 0.0 112.815 172.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -101.41 11.4 39.22 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.549 0.924 0 C-N-CA 125.273 1.429 . . . . 0.0 113.698 -167.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 mptt . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 118.863 -0.589 . . . . 0.0 111.953 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -169.9 161.29 8.86 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -171.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -128.03 172.29 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.884 1.274 . . . . 0.0 111.732 174.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.2 mm -130.28 120.07 48.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 125.988 1.715 . . . . 0.0 108.375 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.02 153.78 51.15 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -81.34 108.49 15.0 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.599 0.714 . . . . 0.0 111.469 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.21 -15.82 62.48 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.239 1.015 . . . . 0.0 113.461 177.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -89.96 -2.13 58.1 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.705 1.602 . . . . 0.0 113.906 -172.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.27 140.14 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.105 1.362 . . . . 0.0 110.567 -174.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -59.46 -28.17 66.74 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -177.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -84.16 -3.55 58.21 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.017 1.327 . . . . 0.0 114.469 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.5 p 37.44 51.29 1.17 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 126.899 2.079 . . . . 0.0 114.417 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.77 150.18 24.33 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -167.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.4 t -79.96 89.96 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 127.843 2.457 . . . . 0.0 108.957 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.8 pt -70.0 -24.86 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.08 1.352 . . . . 0.0 112.446 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -154.78 159.71 40.8 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.151 0.98 . . . . 0.0 112.576 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 5.8 p -148.77 145.29 27.52 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.975 -1.078 . . . . 0.0 113.07 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -86.89 156.64 19.76 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 178.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.58 -27.65 67.87 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.621 0.769 . . . . 0.0 111.913 171.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.41 -50.49 52.6 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.331 -0.856 . . . . 0.0 113.03 170.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.57 -38.16 74.36 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 119.652 1.726 . . . . 0.0 110.593 173.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.6 t -60.22 -40.78 91.35 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.821 -0.55 . . . . 0.0 111.098 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -77.62 -26.31 50.48 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.649 0.78 . . . . 0.0 112.969 175.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.0 tp -63.92 -55.81 19.88 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.951 1.3 . . . . 0.0 111.29 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 77.1 m -95.96 -20.05 19.03 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.934 0.894 . . . . 0.0 113.067 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.4 20.21 76.71 Favored Glycine 0 CA--C 1.538 1.491 0 O-C-N 120.988 -1.07 . . . . 0.0 113.847 -174.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -84.87 -129.64 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.97 1.308 . . . . 0.0 110.313 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 41.6 t -159.87 150.12 18.66 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 127.589 2.356 . . . . 0.0 108.288 173.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.1 mtm180 -58.28 -35.28 71.55 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.124 -0.985 . . . . 0.0 112.328 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.42 -21.71 64.35 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -81.85 -20.79 38.23 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.207 1.403 . . . . 0.0 112.511 175.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -105.3 -17.06 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 7.6 mmt -49.89 108.0 0.19 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 125.519 1.528 . . . . 0.0 111.051 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 70.55 18.86 6.39 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.792 1.637 . . . . 0.0 113.793 171.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.12 159.11 76.29 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 123.843 0.857 . . . . 0.0 110.452 167.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -60.34 140.03 89.74 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.532 2.154 . . . . 0.0 111.857 169.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.7 t -67.47 -9.99 47.26 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.844 1.657 . . . . 0.0 113.469 176.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.7 m -62.81 100.17 0.19 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 127.672 2.389 . . . . 0.0 111.507 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 46.4 m -49.93 -23.48 1.99 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.088 1.755 . . . . 0.0 115.299 -176.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -46.99 -41.81 16.94 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.435 1.494 . . . . 0.0 112.863 169.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -63.1 -16.64 60.63 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.28 1.032 . . . . 0.0 113.551 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 pp -123.11 25.25 8.57 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.74 1.616 . . . . 0.0 113.653 173.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -65.01 151.56 45.67 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.109 -0.995 . . . . 0.0 112.181 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -125.6 -177.81 15.05 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.378 1.466 . . . . 0.0 113.694 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -64.65 -10.13 23.45 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.318 2.679 . . . . 0.0 116.293 -171.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -107.6 -7.39 16.49 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.825 1.65 . . . . 0.0 113.341 175.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.526 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 3.8 m -71.71 132.22 44.23 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.074 -1.016 . . . . 0.0 111.335 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -80.01 135.72 36.44 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.081 0.943 . . . . 0.0 110.105 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.3 mmt-85 -66.33 -39.79 89.47 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.737 -0.602 . . . . 0.0 110.658 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 49.5 ptt85 -53.76 -39.07 65.06 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.385 1.074 . . . . 0.0 113.463 171.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.03 -50.21 43.57 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.593 1.157 . . . . 0.0 110.234 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.23 -33.67 76.55 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.137 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.5 -54.98 11.57 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.478 1.111 . . . . 0.0 111.541 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -50.16 -40.14 45.72 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.862 0.865 . . . . 0.0 112.873 172.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.4 mt -65.48 -50.03 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 118.758 0.708 . . . . 0.0 111.018 174.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.09 -39.89 57.13 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.732 -0.651 . . . . 0.0 111.977 174.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -70.03 -37.71 75.69 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.449 0.7 . . . . 0.0 111.669 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.66 -34.02 76.95 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.328 -0.857 . . . . 0.0 111.317 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mt -83.15 -28.88 29.07 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.509 0.724 . . . . 0.0 111.664 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.19 -27.88 69.01 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.819 2.048 . . . . 0.0 111.016 168.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.0 17.36 9.64 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.245 1.402 . . . . 0.0 114.918 170.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.89 -49.93 74.24 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 118.642 1.221 . . . . 0.0 111.231 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -159.9 139.06 10.93 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.886 1.674 . . . . 0.0 111.392 169.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -74.02 101.45 3.87 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 169.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -144.04 140.05 29.32 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.82 1.248 . . . . 0.0 111.828 -168.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -77.49 135.03 38.2 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.506 1.123 . . . . 0.0 111.123 173.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -136.51 153.2 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.038 1.735 . . . . 0.0 108.553 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -79.93 160.07 26.11 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.857 0.863 . . . . 0.0 110.104 169.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.51 HD13 ' CZ ' ' A' ' 98' ' ' PHE . 0.3 OUTLIER -164.35 149.85 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 119.234 0.925 . . . . 0.0 111.448 169.853 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.526 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -88.89 145.33 25.61 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.431 0.692 . . . . 0.0 111.548 172.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.51 ' CZ ' HD13 ' A' ' 96' ' ' ILE . 40.9 m-85 -117.29 160.97 20.25 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.374 1.07 . . . . 0.0 110.999 173.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -125.64 140.04 53.06 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.466 0.65 . . . . 0.0 111.441 169.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -83.99 154.78 23.11 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.418 1.087 . . . . 0.0 112.591 175.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -53.95 -27.85 33.64 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.025 1.73 . . . . 0.0 113.089 171.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -71.42 -9.95 58.99 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.188 1.395 . . . . 0.0 114.181 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.76 18.24 33.06 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.249 1.404 . . . . 0.0 115.831 175.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 71.2 m -107.17 136.86 46.29 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 118.634 1.217 . . . . 0.0 111.717 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 29.5 t -126.21 135.0 51.08 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.858 1.263 . . . . 0.0 112.325 -175.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -149.96 139.98 22.01 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.55 1.14 . . . . 0.0 113.422 -168.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -102.54 125.56 49.3 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.408 1.883 . . . . 0.0 109.139 170.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 61.4 m -129.74 173.16 10.9 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.42 1.488 . . . . 0.0 110.082 173.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 30.4 tp -79.31 59.88 2.96 Favored 'General case' 0 CA--C 1.549 0.911 0 O-C-N 120.592 -1.317 . . . . 0.0 111.644 -176.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 45.7 t -63.41 142.9 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 126.062 1.745 . . . . 0.0 111.623 -173.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -108.81 69.98 0.73 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.203 1.001 . . . . 0.0 112.979 -167.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.8 t -81.25 70.02 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.732 1.213 . . . . 0.0 111.045 -168.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.8 p -121.51 126.53 26.45 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 124.133 0.973 . . . . 0.0 112.247 -175.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -88.93 -176.4 1.39 Allowed 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 123.846 3.031 . . . . 0.0 112.293 -173.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -117.03 133.59 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 123.178 1.465 . . . . 0.0 113.677 -175.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.46 160.78 30.43 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.092 2.157 . . . . 0.0 111.947 -173.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -89.92 -176.27 4.87 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.124 0.97 . . . . 0.0 112.092 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -62.48 -19.98 64.11 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -77.29 -19.97 55.71 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.011 1.324 . . . . 0.0 113.862 170.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.75 -0.13 64.74 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.23 1.395 . . . . 0.0 114.447 -176.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.25 131.38 35.29 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.372 1.086 . . . . 0.0 111.669 174.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.7 p -72.56 98.3 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.73 2.012 . . . . 0.0 111.078 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.7 -29.14 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 123.555 0.742 . . . . 0.0 111.731 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.9 148.6 50.12 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 124.115 1.912 . . . . 0.0 112.834 174.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -102.45 83.93 2.37 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 125.815 1.646 . . . . 0.0 106.766 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.6 mt -99.87 79.29 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 170.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.296 34.5 mt -83.0 86.01 7.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 123.226 1.488 . . . . 0.0 108.946 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -59.93 103.13 0.19 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 113.045 -1.889 . . . . 0.0 109.441 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -85.16 55.63 3.58 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 122.584 1.183 . . . . 0.0 110.885 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -79.83 106.75 12.09 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 123.653 1.692 . . . . 0.0 110.507 -176.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.54 120.32 12.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 125.73 1.612 . . . . 0.0 108.691 170.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.472 0.667 0 O-C-N 123.277 0.36 . . . . 0.0 110.076 175.113 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo . . . . . 0 CA--C 1.535 0.551 0 CA-C-O 122.282 0.868 . . . . 0.0 112.329 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -60.02 -28.8 68.03 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -165.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -66.65 -49.85 64.85 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.715 0.806 . . . . 0.0 110.53 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 t -79.2 -34.15 43.21 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.177 0.991 . . . . 0.0 112.428 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -58.41 -39.94 81.11 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.07 0.948 . . . . 0.0 110.458 170.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 44.5 tp -70.07 -45.72 66.44 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 118.813 -0.613 . . . . 0.0 111.999 170.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -46.5 -39.93 11.64 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.975 1.31 . . . . 0.0 112.936 174.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.6 m -58.97 -45.1 91.39 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 121.595 -0.691 . . . . 0.0 111.664 173.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.8 mm -66.1 -36.84 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.89 0.876 . . . . 0.0 110.543 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.2 mm -54.51 -55.79 13.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 CA-C-O 117.777 -1.106 . . . . 0.0 108.545 171.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -59.87 -29.99 68.69 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 120.108 1.322 . . . . 0.0 111.922 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.1 tptt -63.6 -40.64 97.46 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.582 1.153 . . . . 0.0 112.235 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -108.16 -0.14 21.19 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 116.034 1.864 . . . . 0.0 116.034 176.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.554 1.101 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -166.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -169.72 160.92 9.03 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -121.25 168.93 13.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 126.892 2.077 . . . . 0.0 111.387 170.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.8 mm -119.1 113.85 42.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 126.105 1.762 . . . . 0.0 106.617 170.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -119.09 148.98 42.44 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.922 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -80.87 113.21 18.92 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.946 0.898 . . . . 0.0 110.068 174.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.03 -12.4 60.32 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -100.01 -7.45 25.04 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.022 1.329 . . . . 0.0 114.041 -169.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 p -105.85 140.07 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.887 1.675 . . . . 0.0 111.285 -177.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.76 -30.73 70.19 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -174.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -77.35 -8.96 58.5 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.272 1.029 . . . . 0.0 113.592 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.8 m 48.63 39.01 12.51 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.746 1.618 . . . . 0.0 113.138 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.21 155.16 27.5 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -166.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.9 t -79.96 93.15 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 129.128 2.971 . . . . 0.0 108.192 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.4 pt -73.51 -23.62 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.174 1.39 . . . . 0.0 112.149 177.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -157.57 159.75 37.43 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.659 1.184 . . . . 0.0 112.014 175.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.3 p -141.68 151.12 42.73 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.821 -1.174 . . . . 0.0 114.125 -175.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -89.77 151.45 21.81 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.674 0.75 . . . . 0.0 111.653 166.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -65.92 -27.04 67.89 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.614 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.36 -50.07 48.72 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 121.156 -0.965 . . . . 0.0 112.778 172.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -29.86 66.96 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 118.845 1.323 . . . . 0.0 111.67 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.6 t -59.31 -39.83 84.29 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.597 -0.689 . . . . 0.0 110.466 170.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -77.75 -30.01 51.35 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 118.905 0.775 . . . . 0.0 112.857 174.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.4 tp -55.92 -52.1 65.3 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.15 1.38 . . . . 0.0 110.911 174.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 57.7 m -90.64 -20.85 22.06 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.16 9.98 84.41 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 126.557 2.027 . . . . 0.0 116.69 174.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -87.57 -120.25 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 119.558 1.679 . . . . 0.0 112.728 -175.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.1 t -159.86 138.63 10.68 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.772 1.629 . . . . 0.0 110.313 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -60.57 -32.64 71.72 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.328 1.051 . . . . 0.0 113.459 -175.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.14 -16.58 33.6 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.505 1.122 . . . . 0.0 113.645 174.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -97.1 -20.78 17.76 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.778 1.631 . . . . 0.0 112.46 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 m -89.92 -17.24 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 120.145 1.339 . . . . 0.0 113.134 -172.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 36.3 mmt -49.85 114.93 1.19 Allowed 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.221 1.009 . . . . 0.0 109.698 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 72.66 21.07 3.61 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.036 1.735 . . . . 0.0 114.355 171.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.05 154.03 88.65 Favored Pre-proline 0 N--CA 1.48 1.031 0 O-C-N 120.762 -1.211 . . . . 0.0 111.074 167.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.18 139.99 57.51 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.62 2.213 . . . . 0.0 111.645 173.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.8 t -69.95 -18.96 63.38 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.179 0.992 . . . . 0.0 112.991 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.0 m -61.39 100.1 0.12 Allowed 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 127.143 2.177 . . . . 0.0 111.614 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 68.3 m -50.44 -19.29 0.82 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 116.43 2.011 . . . . 0.0 116.43 -173.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -56.33 -36.31 68.59 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.036 -1.04 . . . . 0.0 111.635 172.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -57.58 -23.49 51.04 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.373 1.469 . . . . 0.0 113.391 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 pp -119.44 22.87 11.53 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.938 1.695 . . . . 0.0 113.162 176.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -63.25 147.1 51.96 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.379 -0.826 . . . . 0.0 111.993 173.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.72 -173.13 12.89 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 125.189 1.376 . . . . 0.0 113.219 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -62.35 -10.07 17.48 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 123.758 2.972 . . . . 0.0 116.406 -172.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -108.18 -9.34 15.57 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.902 1.681 . . . . 0.0 113.562 176.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.438 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 3.1 m -81.29 141.17 34.33 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.928 0.891 . . . . 0.0 112.153 -174.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -89.08 136.78 32.83 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 122.294 1.045 . . . . 0.0 111.512 171.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.4 mmm-85 -69.98 -39.69 75.78 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.363 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -53.23 -39.29 63.68 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 169.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.9 -52.84 54.31 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 122.221 1.01 . . . . 0.0 110.031 175.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.94 -33.86 77.03 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.882 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.02 -50.92 36.53 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.941 1.696 . . . . 0.0 112.271 176.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -50.2 -41.56 49.88 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.42 1.009 . . . . 0.0 112.306 169.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.7 mt -61.78 -49.9 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 O-C-N 121.653 -0.654 . . . . 0.0 111.001 171.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.07 -39.85 56.97 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.385 -0.817 . . . . 0.0 112.171 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -70.11 -34.88 73.67 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.695 0.798 . . . . 0.0 111.888 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.53 -31.45 69.67 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.656 -0.653 . . . . 0.0 111.744 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 mt -82.78 -32.24 27.84 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.537 0.735 . . . . 0.0 111.604 176.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.07 -33.1 74.72 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.868 2.067 . . . . 0.0 110.833 169.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.78 23.67 6.11 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.551 1.072 . . . . 0.0 115.031 168.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.75 -50.63 62.13 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.168 1.484 . . . . 0.0 110.218 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -151.77 143.41 23.6 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.389 2.276 . . . . 0.0 108.63 172.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -77.71 115.56 17.56 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.703 1.138 . . . . 0.0 108.188 169.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -138.96 137.73 36.67 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.592 1.157 . . . . 0.0 111.646 -168.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -87.03 129.63 34.81 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.177 1.791 . . . . 0.0 109.949 169.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.27 145.97 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.102 1.361 . . . . 0.0 109.355 -175.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -79.97 151.44 30.03 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.457 0.703 . . . . 0.0 109.846 170.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -163.0 147.13 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.06 0.944 . . . . 0.0 110.544 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.438 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -87.58 141.42 28.62 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.206 175.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -106.09 155.19 19.67 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.915 1.286 . . . . 0.0 111.231 169.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -121.83 138.29 54.44 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.796 0.838 . . . . 0.0 109.089 166.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -100.04 152.59 20.04 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.944 1.697 . . . . 0.0 110.504 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.92 -15.59 44.27 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 -171.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -78.28 -11.08 59.91 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.227 1.411 . . . . 0.0 113.72 171.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.86 2.53 56.15 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 126.203 1.859 . . . . 0.0 115.126 -174.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 55.3 m -74.77 128.21 35.01 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.866 1.833 . . . . 0.0 111.328 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 67.1 m -124.47 130.62 52.8 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.696 1.198 . . . . 0.0 111.443 -175.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -150.01 139.93 21.9 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.89 0.876 . . . . 0.0 113.013 -171.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.464 HD13 ' N ' ' A' ' 108' ' ' CYS . 2.2 tm? -110.36 134.79 51.96 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.673 1.989 . . . . 0.0 109.3 172.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.464 ' N ' HD13 ' A' ' 107' ' ' LEU . 2.1 m -138.95 171.64 14.02 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.502 1.521 . . . . 0.0 110.457 169.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 29.5 tp -76.88 59.87 1.68 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.199 0.999 . . . . 0.0 110.088 174.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.0 t -58.29 145.36 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.912 1.285 . . . . 0.0 110.516 -172.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -100.0 69.76 1.55 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.693 1.235 . . . . 0.0 111.277 -168.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.4 t -82.43 69.85 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.268 1.027 . . . . 0.0 110.526 -170.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.3 130.76 24.41 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.004 0.922 . . . . 0.0 110.948 -176.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -85.47 -169.72 0.64 Allowed 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 123.199 2.6 . . . . 0.0 111.888 -174.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.92 130.33 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-O 123.133 1.444 . . . . 0.0 113.947 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.4 mttm -112.82 162.4 15.83 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 127.655 2.382 . . . . 0.0 112.801 -175.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -93.17 -179.98 5.25 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.154 171.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.4 -21.69 65.57 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -70.63 -19.88 62.78 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.532 1.133 . . . . 0.0 113.727 169.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.51 0.32 59.44 Favored Glycine 0 CA--C 1.533 1.156 0 C-N-CA 126.112 1.815 . . . . 0.0 114.423 -176.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.75 139.39 30.61 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.64 1.22 . . . . 0.0 113.274 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.6 p -74.67 98.96 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.484 1.513 . . . . 0.0 109.856 -176.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.37 -30.01 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 118.345 -0.836 . . . . 0.0 110.833 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.9 mmt -136.59 150.04 48.37 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-O 123.85 1.786 . . . . 0.0 110.906 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -104.33 81.11 1.78 Allowed 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 125.564 1.545 . . . . 0.0 107.522 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 36.1 mt -100.44 70.74 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 O-C-N 120.481 -1.387 . . . . 0.0 109.211 172.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 127' ' ' LEU . 1.9 mm? -77.25 85.72 3.69 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 123.44 1.591 . . . . 0.0 109.384 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -60.0 103.05 0.19 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 112.877 -1.965 . . . . 0.0 111.007 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -85.54 62.71 7.65 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.518 -1.364 . . . . 0.0 111.799 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -79.71 131.33 35.92 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.185 -0.947 . . . . 0.0 110.372 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 50.5 t -92.95 114.6 30.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 124.58 1.152 . . . . 0.0 108.118 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.472 0.675 0 CA-C-O 121.331 0.586 . . . . 0.0 112.094 -175.565 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo . . . . . 0 CA--C 1.533 0.436 0 CA-C-O 122.729 1.054 . . . . 0.0 111.855 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -65.8 -27.08 68.0 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.989 0.915 . . . . 0.0 113.257 -169.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -70.02 -49.99 45.88 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.023 0.529 . . . . 0.0 110.325 -176.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.5 t -74.13 -35.31 64.09 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.724 0.81 . . . . 0.0 112.509 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -58.24 -41.48 84.27 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.318 0.647 . . . . 0.0 109.909 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.1 tp -75.49 -45.04 40.74 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 118.619 -0.705 . . . . 0.0 112.427 174.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -47.66 -39.81 18.18 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.713 1.605 . . . . 0.0 113.151 175.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.7 m -60.02 -45.16 93.71 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.88 -0.513 . . . . 0.0 111.679 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.5 mm -68.95 -34.77 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.941 0.897 . . . . 0.0 110.931 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.8 mm -54.67 -56.5 10.15 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 171.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -60.8 -27.05 67.73 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 176.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -63.2 -43.1 99.12 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.465 0.706 . . . . 0.0 112.228 172.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -104.66 -0.01 27.98 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 . . . . . 0 N--CA 1.477 0.887 0 C-N-CA 125.504 1.522 . . . . 0.0 113.751 -167.499 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.2 mptt . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 118.95 -0.548 . . . . 0.0 111.567 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -169.81 162.36 9.47 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -169.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -122.93 168.96 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 128.039 2.536 . . . . 0.0 111.217 171.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.0 mm -128.24 124.81 63.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 C-N-CA 126.219 1.807 . . . . 0.0 108.378 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.06 154.46 49.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -177.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -77.77 108.27 10.88 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.402 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.01 -19.52 63.32 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -94.84 2.38 55.45 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.701 1.201 . . . . 0.0 113.989 -169.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.49 140.07 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.32 1.448 . . . . 0.0 110.508 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.97 -23.82 65.63 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -86.55 -7.39 58.41 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.344 1.458 . . . . 0.0 114.23 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.0 p 42.92 43.38 3.51 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 126.945 2.098 . . . . 0.0 115.293 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.53 149.9 32.98 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 -167.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.0 t -80.03 89.98 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 128.584 2.753 . . . . 0.0 109.08 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.7 pt -69.96 -24.54 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.993 1.317 . . . . 0.0 112.453 175.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -153.58 159.62 42.22 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.804 0.842 . . . . 0.0 112.86 173.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.0 p -143.21 143.26 31.69 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.289 -0.882 . . . . 0.0 112.687 -177.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -89.67 155.12 19.44 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 173.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -66.93 -19.92 65.81 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.869 -0.519 . . . . 0.0 112.257 174.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.65 -49.91 55.83 Favored Glycine 0 CA--C 1.535 1.283 0 O-C-N 121.33 -0.856 . . . . 0.0 112.212 169.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -56.75 -39.23 73.62 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 119.04 1.42 . . . . 0.0 110.903 172.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.3 t -60.14 -41.3 92.43 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.922 -0.486 . . . . 0.0 111.321 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -77.1 -30.09 55.2 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.679 0.791 . . . . 0.0 112.663 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.18 -53.8 43.59 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.721 1.609 . . . . 0.0 112.174 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 82.7 m -101.12 -19.97 15.53 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.876 1.271 . . . . 0.0 112.787 -173.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.95 11.87 84.75 Favored Glycine 0 CA--C 1.539 1.541 0 CA-C-O 118.715 -1.047 . . . . 0.0 115.502 176.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -90.71 -122.13 0.07 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.956 1.378 . . . . 0.0 111.401 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.4 t -159.89 150.16 18.67 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.929 1.292 . . . . 0.0 111.095 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.0 mtt-85 -50.04 -43.9 51.16 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.576 1.15 . . . . 0.0 111.189 169.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.81 -19.12 64.78 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.378 1.071 . . . . 0.0 113.824 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -86.48 -20.56 27.91 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.473 1.509 . . . . 0.0 112.81 174.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.7 m -102.11 -18.99 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 174.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 5.4 mmt -49.81 107.47 0.15 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.509 1.523 . . . . 0.0 111.46 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 71.47 18.06 5.56 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.818 1.647 . . . . 0.0 113.85 171.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.55 157.12 72.81 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.039 0.936 . . . . 0.0 111.09 167.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.51 140.17 92.43 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.873 3.049 . . . . 0.0 112.879 169.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.3 m -62.95 -13.79 39.19 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 172.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.3 m -65.98 99.92 0.54 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.396 1.478 . . . . 0.0 110.911 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 32.0 p -53.32 -17.56 1.9 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.878 1.671 . . . . 0.0 115.004 -176.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -48.5 -42.88 34.32 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.925 1.29 . . . . 0.0 111.742 168.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -64.42 -16.19 61.93 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 pp -122.99 23.02 9.45 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.32 1.848 . . . . 0.0 113.432 173.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.27 144.57 57.06 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.224 -0.922 . . . . 0.0 112.568 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.54 173.16 22.67 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.067 1.318 . . . . 0.0 113.479 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.14 -9.99 25.6 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.485 2.79 . . . . 0.0 113.825 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.27 -4.69 25.29 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.192 1.797 . . . . 0.0 113.617 174.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.468 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 5.5 m -80.5 143.19 33.51 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 119.329 0.968 . . . . 0.0 111.889 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.2 mm-40 -92.97 145.24 24.52 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 123.453 1.597 . . . . 0.0 114.097 175.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.486 ' H ' ' HD2' ' A' ' 76' ' ' ARG . 1.2 mpt_? -70.11 -42.45 72.67 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 113.463 -1.699 . . . . 0.0 110.874 -175.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -60.05 -38.85 84.0 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.584 1.154 . . . . 0.0 113.5 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.42 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -63.69 -53.01 57.93 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.044 0.938 . . . . 0.0 109.972 174.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.73 -34.6 78.57 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.551 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.96 -53.29 18.45 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.951 1.301 . . . . 0.0 111.94 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -50.13 -41.6 49.08 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.18 0.9 . . . . 0.0 112.13 171.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 47.7 mt -63.8 -49.79 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 O-C-N 121.834 -0.541 . . . . 0.0 111.493 174.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.87 -39.81 54.77 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.167 0.587 . . . . 0.0 111.912 174.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -67.61 -39.56 84.73 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.553 0.615 . . . . 0.0 111.705 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.45 -27.16 65.01 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.833 -0.542 . . . . 0.0 112.162 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 mt -88.57 -31.53 18.59 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.235 0.614 . . . . 0.0 111.388 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.43 -36.11 79.44 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.31 1.844 . . . . 0.0 109.845 168.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 113.71 22.42 5.39 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.828 1.204 . . . . 0.0 114.821 171.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.24 -50.0 74.84 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 118.374 1.087 . . . . 0.0 111.399 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -159.73 148.6 17.7 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.448 1.499 . . . . 0.0 112.243 170.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -70.97 111.24 6.2 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 167.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -148.07 136.64 21.61 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.41 1.084 . . . . 0.0 111.392 -174.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -84.03 133.59 34.66 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.269 1.428 . . . . 0.0 110.606 171.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.61 146.3 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.434 1.494 . . . . 0.0 109.143 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -80.0 153.9 28.55 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.996 0.918 . . . . 0.0 110.598 172.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.42 HG23 ' HB1' ' A' ' 78' ' ' ALA . 0.6 OUTLIER -163.74 149.5 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.114 0.966 . . . . 0.0 111.428 179.177 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.468 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -90.47 145.32 25.0 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.483 174.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -116.64 162.28 17.89 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.632 1.173 . . . . 0.0 111.394 171.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -126.55 137.89 53.41 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.608 0.718 . . . . 0.0 110.59 167.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -92.83 157.59 16.31 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.288 1.835 . . . . 0.0 111.693 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -55.66 -30.55 61.21 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.103 1.761 . . . . 0.0 113.616 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.4 p30 -77.28 -9.89 59.09 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 175.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.51 -1.15 49.56 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 126.247 1.879 . . . . 0.0 115.298 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.4 m -70.1 130.86 43.25 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.35 1.575 . . . . 0.0 111.483 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 80.5 m -119.91 129.48 54.38 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.748 1.219 . . . . 0.0 110.969 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -151.03 140.01 21.01 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -172.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.436 HD13 ' N ' ' A' ' 108' ' ' CYS . 1.6 tm? -110.83 131.77 54.77 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 127.19 2.196 . . . . 0.0 108.144 168.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.436 ' N ' HD13 ' A' ' 107' ' ' LEU . 5.6 m -138.96 179.17 6.65 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.174 1.39 . . . . 0.0 110.93 170.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 76.9 mt -77.61 60.0 2.07 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.153 0.981 . . . . 0.0 110.763 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.6 t -60.57 142.29 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.739 1.215 . . . . 0.0 110.751 -173.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -102.91 69.72 1.06 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 122.076 0.941 . . . . 0.0 110.769 -168.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.5 t -83.56 69.76 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.835 0.826 . . . . 0.0 109.786 -169.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.47 134.31 24.83 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 124.745 1.218 . . . . 0.0 110.054 -174.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -87.55 -164.65 0.2 Allowed 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 123.083 2.522 . . . . 0.0 112.073 -172.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.7 m -124.93 132.94 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 122.922 1.344 . . . . 0.0 112.941 174.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -118.5 160.95 20.83 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.752 2.021 . . . . 0.0 111.794 -171.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -90.03 179.97 5.82 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.095 0.958 . . . . 0.0 111.976 172.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.72 -21.59 64.63 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -71.24 -19.92 62.31 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.615 1.166 . . . . 0.0 113.866 170.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.7 -1.87 60.12 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.791 1.662 . . . . 0.0 114.307 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -85.99 139.45 31.18 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.57 1.185 . . . . 0.0 113.25 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -74.41 100.02 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 125.828 1.651 . . . . 0.0 110.503 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.86 -30.06 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 118.194 -0.907 . . . . 0.0 111.367 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.8 mmt -136.27 148.33 47.95 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 123.517 1.627 . . . . 0.0 111.077 178.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -103.13 86.84 2.77 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.915 1.686 . . . . 0.0 108.088 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.8 mt -106.49 69.9 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 170.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.02 88.95 2.98 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.259 1.028 . . . . 0.0 108.748 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -59.82 107.03 0.55 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.151 1.381 . . . . 0.0 110.203 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -84.67 52.22 2.34 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 120.617 -1.302 . . . . 0.0 112.169 -176.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -79.89 106.9 12.25 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 123.793 1.759 . . . . 0.0 112.678 -176.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 22.3 t -64.17 112.52 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 125.802 1.641 . . . . 0.0 108.296 169.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.47 0.556 0 CA-C-O 120.832 0.348 . . . . 0.0 111.026 177.237 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo . . . . . 0 CA--C 1.535 0.558 0 CA-C-O 122.115 0.798 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -64.55 -26.59 68.48 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -168.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -69.97 -49.97 46.4 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.49 0.586 . . . . 0.0 110.585 -176.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.1 t -77.3 -33.41 55.68 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.133 0.973 . . . . 0.0 112.304 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -60.04 -41.02 91.35 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.667 -0.646 . . . . 0.0 110.184 172.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.2 tp -71.03 -45.11 64.5 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-O 118.696 -0.669 . . . . 0.0 112.041 172.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -47.68 -39.75 18.17 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.203 1.365 . . . . 0.0 113.279 173.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 90.2 m -60.16 -43.67 95.62 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.521 -0.737 . . . . 0.0 112.326 172.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.4 mm -68.59 -35.28 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.898 0.879 . . . . 0.0 110.938 175.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 26.2 mm -55.49 -54.5 24.83 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.483 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 171.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 55.5 mtm180 -60.32 -27.36 67.27 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.8 0.727 . . . . 0.0 112.959 176.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.3 tptt -65.09 -40.47 94.64 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 118.631 -0.7 . . . . 0.0 112.757 172.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -106.03 2.4 27.26 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 CA--C 1.551 1.001 0 C-N-CA 126.536 1.935 . . . . 0.0 114.266 -167.793 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.477 0.917 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -169.79 163.13 9.76 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -121.71 169.77 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.887 169.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.9 mm -123.2 114.65 42.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 126.069 1.747 . . . . 0.0 107.015 173.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.17 153.16 40.43 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.475 175.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -85.21 120.83 27.13 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.37 -9.62 59.34 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 46.0 mmm-85 -100.1 5.68 44.93 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.886 1.674 . . . . 0.0 114.246 -172.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.4 m -119.61 139.9 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 126.117 1.767 . . . . 0.0 111.73 -174.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.12 -24.4 65.01 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.85 0.86 . . . . 0.0 113.142 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.56 -12.3 59.95 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.169 1.388 . . . . 0.0 112.431 173.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.9 m 46.73 37.95 5.28 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.899 1.68 . . . . 0.0 112.782 -175.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.31 149.86 40.46 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -165.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.4 t -80.66 90.0 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 C-N-CA 128.667 2.787 . . . . 0.0 108.631 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.4 pt -69.95 -24.15 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.162 1.385 . . . . 0.0 112.207 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -155.62 159.82 39.93 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.802 1.241 . . . . 0.0 112.93 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.3 p -143.23 139.96 30.48 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.873 -1.142 . . . . 0.0 112.879 -175.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -83.73 157.98 21.94 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -61.26 -28.22 69.02 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.547 0.739 . . . . 0.0 111.429 171.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.58 -49.97 59.06 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.71 -1.05 . . . . 0.0 113.296 170.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.76 -40.6 69.52 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 120.064 1.932 . . . . 0.0 110.662 172.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.4 t -60.24 -40.65 90.98 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.625 0.37 . . . . 0.0 111.074 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -76.23 -29.62 57.61 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.965 0.906 . . . . 0.0 112.579 176.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.7 tp -64.28 -55.78 19.1 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.935 1.294 . . . . 0.0 111.733 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.1 m -99.59 -20.06 16.54 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.72 0.808 . . . . 0.0 112.794 -172.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.94 14.51 82.55 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-O 118.871 -0.96 . . . . 0.0 115.413 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -89.96 -128.79 0.08 Allowed 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 118.845 1.322 . . . . 0.0 111.762 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.9 t -159.95 150.19 18.6 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.635 1.974 . . . . 0.0 109.789 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.5 mtt85 -50.88 -40.37 56.27 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.329 1.052 . . . . 0.0 112.52 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.7 -21.2 62.63 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.351 1.06 . . . . 0.0 113.537 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -85.38 -20.96 29.08 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.638 1.575 . . . . 0.0 112.296 177.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -105.37 -20.03 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 5.8 mmt -49.97 107.76 0.17 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.845 1.658 . . . . 0.0 111.306 -174.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 70.24 18.4 6.89 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.383 1.473 . . . . 0.0 113.558 170.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.75 161.38 61.37 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 123.882 0.873 . . . . 0.0 110.553 167.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -56.19 140.06 86.79 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.992 2.461 . . . . 0.0 113.165 171.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 34.9 t -67.65 -10.05 48.76 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.128 1.371 . . . . 0.0 113.158 170.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -61.29 100.19 0.12 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 128.01 2.524 . . . . 0.0 110.866 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 33.8 m -50.03 -13.11 0.09 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.461 1.904 . . . . 0.0 115.903 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -52.79 -37.02 59.17 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.844 1.258 . . . . 0.0 111.776 167.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -55.83 -21.78 21.48 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.396 1.479 . . . . 0.0 113.343 171.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.13 20.03 14.6 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 127.611 2.364 . . . . 0.0 111.824 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -72.81 142.2 48.03 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.319 -1.488 . . . . 0.0 111.324 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.68 -170.11 11.99 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.665 1.602 . . . . 0.0 113.123 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -64.6 -10.13 23.29 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.29 2.66 . . . . 0.0 116.26 -170.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -110.07 -2.03 17.22 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.852 1.661 . . . . 0.0 114.415 175.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.503 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 6.0 m -78.53 137.83 38.1 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.704 1.138 . . . . 0.0 112.298 -175.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -82.58 132.22 35.2 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 122.636 1.208 . . . . 0.0 110.59 172.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.7 mmt85 -70.0 -39.9 75.61 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.185 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -56.87 -35.68 69.2 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.682 1.193 . . . . 0.0 113.599 169.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.48 -50.24 53.79 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.648 0.779 . . . . 0.0 110.907 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.32 -34.95 78.81 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.34 -53.01 27.03 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.832 1.253 . . . . 0.0 112.012 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -50.16 -40.8 47.69 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.39 0.996 . . . . 0.0 112.731 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 29.7 mt -63.82 -49.75 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 O-C-N 121.708 -0.62 . . . . 0.0 111.08 174.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.81 -39.94 59.6 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.565 0.621 . . . . 0.0 111.958 173.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -63.51 -39.82 95.43 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.243 0.617 . . . . 0.0 111.635 175.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.16 -28.75 66.7 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mt -84.07 -40.09 18.75 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 pp -66.02 -28.72 69.08 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 118.46 0.573 . . . . 0.0 112.212 169.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.75 18.91 8.55 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 119.031 -0.872 . . . . 0.0 113.965 169.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.27 -50.01 65.73 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 118.372 1.086 . . . . 0.0 110.303 169.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -162.69 129.97 3.68 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.924 1.689 . . . . 0.0 111.648 168.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -68.81 116.55 9.43 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.193 1.397 . . . . 0.0 108.633 172.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -151.73 142.93 23.29 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.851 1.26 . . . . 0.0 111.706 -169.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -83.72 130.69 34.96 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.449 1.5 . . . . 0.0 110.554 169.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.6 153.1 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.508 1.523 . . . . 0.0 109.077 -177.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -79.87 158.83 26.62 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.429 0.691 . . . . 0.0 109.477 170.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -166.71 150.16 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.437 1.095 . . . . 0.0 110.08 175.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.503 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -91.4 145.35 24.7 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.276 172.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -114.61 162.3 16.94 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.76 1.224 . . . . 0.0 111.276 172.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -132.13 140.06 48.65 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.831 0.852 . . . . 0.0 111.495 168.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.2 mtp-105 -88.68 166.66 13.94 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 125.296 1.439 . . . . 0.0 113.393 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -57.81 -33.25 68.39 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.04 2.136 . . . . 0.0 112.88 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -76.99 -9.86 58.98 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.814 1.246 . . . . 0.0 114.235 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.6 -1.3 59.99 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.573 1.559 . . . . 0.0 115.842 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.5 m -72.88 139.66 47.03 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.735 1.767 . . . . 0.0 111.139 176.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 29.3 p -136.01 140.05 43.59 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -178.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -150.89 142.02 23.13 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.378 1.071 . . . . 0.0 113.359 -172.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.499 HD13 ' N ' ' A' ' 108' ' ' CYS . 2.2 tm? -102.61 135.21 44.67 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.419 1.888 . . . . 0.0 109.763 169.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.499 ' N ' HD13 ' A' ' 107' ' ' LEU . 1.9 m -139.83 170.27 16.18 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.319 1.448 . . . . 0.0 110.246 167.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 28.7 tp -77.37 59.92 1.93 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.939 0.896 . . . . 0.0 109.603 172.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.1 t -57.1 147.65 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.959 1.303 . . . . 0.0 110.55 -172.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -99.84 69.68 1.58 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 122.951 1.358 . . . . 0.0 111.177 -169.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.3 t -83.3 69.86 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.571 1.149 . . . . 0.0 110.594 -169.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -121.9 129.03 25.32 Favored Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 123.57 0.748 . . . . 0.0 112.915 -174.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -88.15 -179.49 2.44 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.713 2.942 . . . . 0.0 112.669 -175.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.46 138.43 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 122.925 1.345 . . . . 0.0 114.018 -172.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -118.84 163.08 17.43 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 127.041 2.136 . . . . 0.0 112.38 -169.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -94.31 -179.98 5.1 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.204 1.002 . . . . 0.0 111.937 171.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.77 -21.35 64.49 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -71.41 -19.87 62.2 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.604 1.162 . . . . 0.0 113.893 170.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.12 5.61 60.67 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.6 1.571 . . . . 0.0 114.431 -176.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.89 139.58 30.38 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 118.362 1.081 . . . . 0.0 113.025 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.1 p -73.55 100.05 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.921 1.688 . . . . 0.0 110.641 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.12 -30.0 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.255 177.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 10.3 mmt -135.37 147.36 49.03 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 123.567 1.651 . . . . 0.0 111.347 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -103.95 79.97 1.7 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 126.477 1.911 . . . . 0.0 107.24 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.7 mt -99.96 73.14 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 122.398 1.094 . . . . 0.0 108.999 175.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.281 17.5 mt -77.89 86.62 4.11 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 122.752 1.263 . . . . 0.0 108.934 -178.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -59.84 103.18 0.19 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.094 1.757 . . . . 0.0 109.96 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -84.97 61.31 6.78 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 120.916 -1.115 . . . . 0.0 111.197 -177.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -79.75 128.27 33.21 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 121.949 0.881 . . . . 0.0 110.687 175.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.4 t -88.2 114.06 26.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 124.72 1.208 . . . . 0.0 108.128 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 121.084 0.468 . . . . 0.0 111.956 -175.723 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo . . . . . 0 CA--C 1.538 0.687 0 CA-C-O 122.278 0.866 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -64.74 -28.73 69.79 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -166.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -68.1 -49.82 58.77 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.287 0.635 . . . . 0.0 110.361 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 t -75.82 -35.43 60.02 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.932 0.893 . . . . 0.0 112.345 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -58.04 -41.82 84.08 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.509 0.724 . . . . 0.0 110.024 173.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.7 tp -73.12 -44.47 60.22 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 118.959 -0.543 . . . . 0.0 112.27 173.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -48.61 -39.91 25.61 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.798 1.181 . . . . 0.0 112.424 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.0 m -60.12 -42.89 95.73 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 121.52 -0.737 . . . . 0.0 112.434 173.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.7 mm -69.09 -30.59 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.228 1.011 . . . . 0.0 110.334 176.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.3 mm -60.02 -51.62 70.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 172.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.5 mmp_? -59.9 -30.08 68.78 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.728 1.149 . . . . 0.0 111.812 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -64.48 -45.55 86.89 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.789 0.836 . . . . 0.0 112.519 176.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -100.97 3.14 41.36 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 178.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 . . . . . 0 N--CA 1.476 0.856 0 C-N-CA 125.149 1.38 . . . . 0.0 113.313 -167.812 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 118.822 -0.608 . . . . 0.0 112.127 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -169.75 163.32 9.87 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 116.76 2.133 . . . . 0.0 116.76 -170.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -126.66 170.15 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 128.231 2.612 . . . . 0.0 110.682 174.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.6 mm -124.18 117.71 51.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 126.033 1.733 . . . . 0.0 107.727 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.81 153.94 40.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.661 1.219 . . . . 0.0 111.931 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -83.74 110.46 18.33 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.77 1.228 . . . . 0.0 110.292 176.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.84 -12.53 60.4 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -100.17 -5.21 28.11 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.81 1.244 . . . . 0.0 113.812 -169.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 p -109.24 140.0 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.715 1.606 . . . . 0.0 111.339 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.99 -23.95 67.69 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -175.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -85.29 -5.92 59.29 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.153 1.381 . . . . 0.0 113.723 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.0 p 44.27 32.86 0.74 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 128.005 2.522 . . . . 0.0 116.123 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.82 156.3 34.59 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 116.767 2.136 . . . . 0.0 116.767 -167.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.9 t -79.94 91.27 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.15 0 C-N-CA 129.354 3.061 . . . . 0.0 109.148 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.5 pt -69.93 -23.74 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 126.096 1.758 . . . . 0.0 112.991 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -155.9 159.94 39.73 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.768 1.227 . . . . 0.0 112.917 177.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.46 ' SG ' HG23 ' A' ' 59' ' ' VAL . 4.0 m -139.84 140.78 36.63 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.813 -1.179 . . . . 0.0 111.32 -169.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -93.31 153.46 18.55 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 169.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -65.18 -23.96 67.24 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 122.031 -0.418 . . . . 0.0 111.583 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.93 -50.0 46.27 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 119.191 -0.783 . . . . 0.0 112.515 169.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -39.55 83.35 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 119.454 1.627 . . . . 0.0 110.897 175.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 16.1 t -60.19 -40.8 91.27 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 121.665 -0.647 . . . . 0.0 110.758 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -78.67 -28.7 45.34 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.066 0.946 . . . . 0.0 112.473 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 52.8 tp -62.13 -55.78 25.44 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.786 1.234 . . . . 0.0 111.412 175.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 77.7 m -97.43 -20.2 17.94 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 -172.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.27 12.9 83.86 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-O 118.692 -1.06 . . . . 0.0 115.459 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -88.92 -124.3 0.05 Allowed 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 119.172 1.486 . . . . 0.0 111.095 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.9 t -159.97 150.16 18.52 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.312 1.845 . . . . 0.0 109.683 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -52.19 -37.52 55.07 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.429 -0.795 . . . . 0.0 112.432 171.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.0 -20.19 63.63 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -86.17 -20.84 28.0 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.599 1.56 . . . . 0.0 112.55 176.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.46 HG23 ' SG ' ' A' ' 44' ' ' CYS . 15.5 m -105.42 -17.37 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 125.229 1.412 . . . . 0.0 114.377 176.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 3.3 mmt -49.87 113.14 0.78 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.809 1.644 . . . . 0.0 111.223 -175.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 67.07 29.76 7.77 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.766 1.627 . . . . 0.0 112.378 169.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -106.74 154.0 40.38 Favored Pre-proline 0 N--CA 1.471 0.593 0 CA-C-O 117.283 -1.342 . . . . 0.0 112.606 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -48.64 135.25 27.5 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.576 2.85 . . . . 0.0 113.934 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 14.3 t -68.17 -9.79 49.43 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.296 1.038 . . . . 0.0 113.236 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.37 87.26 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.573 1.949 . . . . 0.0 110.848 175.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 26.2 p -54.48 -13.04 0.82 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.611 2.365 . . . . 0.0 114.733 -171.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.554 ' HA ' ' CG ' ' A' ' 70' ' ' HIS . 1.6 p30 -51.15 -22.9 2.81 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 167.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -53.49 -23.55 10.61 Favored 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 169.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.287 2.0 pp -123.14 24.0 9.0 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 170.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.554 ' CG ' ' HA ' ' A' ' 67' ' ' ASP . 1.8 m-70 -67.46 146.45 53.98 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.327 -1.483 . . . . 0.0 112.573 169.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.21 -178.95 23.37 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 124.955 1.264 . . . . 0.0 113.844 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.52 -9.99 24.59 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.591 2.861 . . . . 0.0 114.32 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -89.97 -10.15 46.11 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.009 1.324 . . . . 0.0 113.087 174.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.67 HG23 ' H ' ' A' ' 97' ' ' ALA . 3.0 m -84.16 143.63 29.52 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -168.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -84.55 138.36 32.79 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.651 1.215 . . . . 0.0 112.605 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.9 mmt85 -69.99 -39.99 75.58 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.51 -0.743 . . . . 0.0 111.208 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -57.59 -37.42 73.18 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.221 1.408 . . . . 0.0 113.822 170.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.9 -53.31 52.49 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.005 0.907 . . . . 0.0 110.055 173.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.86 -35.1 79.52 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.423 -0.808 . . . . 0.0 113.009 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.14 -54.1 20.42 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.173 1.389 . . . . 0.0 111.623 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -50.22 -40.83 48.65 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.212 0.914 . . . . 0.0 112.777 171.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.3 mt -63.74 -49.22 83.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 O-C-N 121.495 -0.753 . . . . 0.0 111.433 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.74 -39.99 59.43 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.346 0.521 . . . . 0.0 111.677 173.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -63.43 -39.96 95.88 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.347 0.659 . . . . 0.0 111.796 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.51 -30.3 69.08 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 176.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 mt -83.18 -35.52 25.42 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 pp -70.49 -27.87 64.54 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 118.326 0.512 . . . . 0.0 111.914 168.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.94 16.36 10.75 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.095 -0.836 . . . . 0.0 114.244 168.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.89 -49.82 65.12 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 118.265 1.033 . . . . 0.0 111.99 175.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -155.56 141.66 18.33 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.602 1.561 . . . . 0.0 111.649 171.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -79.31 110.15 14.32 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.199 -0.938 . . . . 0.0 109.164 170.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -155.88 145.27 20.87 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.312 1.045 . . . . 0.0 111.203 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -76.77 143.12 40.08 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.143 1.377 . . . . 0.0 111.638 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -136.49 145.32 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.995 0.918 . . . . 0.0 110.105 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -81.15 147.97 29.8 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.113 0.965 . . . . 0.0 109.99 170.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -158.46 156.93 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 110.27 -176.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.67 ' H ' HG23 ' A' ' 74' ' ' THR . . . -110.12 145.34 37.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.107 0.963 . . . . 0.0 112.41 175.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -130.61 156.14 45.37 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.821 1.248 . . . . 0.0 111.472 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -120.43 138.34 53.84 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.703 0.764 . . . . 0.0 111.913 168.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 28.3 mtp-105 -80.51 166.64 20.99 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.394 1.477 . . . . 0.0 112.847 177.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -56.56 -32.38 65.11 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.616 1.967 . . . . 0.0 113.109 175.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -78.25 -9.89 59.42 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 175.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.75 -1.09 58.04 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.693 1.616 . . . . 0.0 115.826 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 73.3 m -70.15 128.56 36.71 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 119.778 1.789 . . . . 0.0 111.036 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 45.5 t -128.65 125.61 38.43 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.717 1.207 . . . . 0.0 112.201 -170.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -150.96 149.68 29.9 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -171.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.01 125.27 46.04 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.596 1.958 . . . . 0.0 107.177 167.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.406 ' SG ' HG13 ' A' ' 131' ' ' VAL . 81.1 m -125.7 168.47 13.71 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.571 1.148 . . . . 0.0 110.31 169.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.25 59.89 2.93 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.652 -1.28 . . . . 0.0 110.244 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.0 t -63.06 147.48 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.811 1.244 . . . . 0.0 111.206 -172.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -103.58 69.74 1.0 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.724 0.774 . . . . 0.0 111.723 -168.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.4 t -83.22 69.75 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 121.339 -0.851 . . . . 0.0 110.965 -168.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.7 m -112.92 136.47 21.68 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 124.728 1.211 . . . . 0.0 110.368 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -86.13 -161.64 0.13 Allowed 'Trans proline' 0 CA--C 1.552 1.421 0 C-N-CA 123.105 2.536 . . . . 0.0 110.08 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.7 m -127.1 131.13 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-O 122.992 1.377 . . . . 0.0 113.062 172.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.1 pmtp? -122.01 160.04 25.75 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.947 2.099 . . . . 0.0 112.253 -176.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -90.07 -179.41 5.67 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.794 0.838 . . . . 0.0 111.499 178.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.88 -21.7 61.36 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -73.64 -19.91 60.72 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.713 1.205 . . . . 0.0 114.134 171.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.89 -4.28 63.07 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.47 1.51 . . . . 0.0 114.142 -176.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -79.84 129.25 34.32 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 118.26 1.03 . . . . 0.0 112.025 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.7 p -67.86 99.74 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 127.008 2.123 . . . . 0.0 110.509 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.97 -29.63 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.795 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.73 149.96 49.37 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 124.002 1.858 . . . . 0.0 111.713 174.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -103.01 80.03 1.82 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.149 -1.387 . . . . 0.0 107.797 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.0 mt -100.0 71.32 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 O-C-N 120.24 -1.537 . . . . 0.0 108.336 171.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.41 HD22 ' N ' ' A' ' 127' ' ' LEU . 1.8 mm? -74.33 86.86 1.99 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 123.362 1.553 . . . . 0.0 109.453 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -59.85 103.08 0.18 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 112.847 -1.979 . . . . 0.0 110.326 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -87.15 53.35 2.79 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 120.543 -1.348 . . . . 0.0 111.937 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -79.86 106.96 12.27 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 123.569 1.652 . . . . 0.0 111.868 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.406 HG13 ' SG ' ' A' ' 108' ' ' CYS . 3.4 t -59.85 118.91 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.435 1.494 . . . . 0.0 108.89 169.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.471 0.611 0 C-N-CA 122.463 0.305 . . . . 0.0 110.603 170.569 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo . . . . . 0 CA--C 1.536 0.617 0 CA-C-O 122.381 0.909 . . . . 0.0 111.817 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -63.12 -29.05 70.49 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -164.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -70.02 -49.98 46.0 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.096 0.862 . . . . 0.0 110.72 -176.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 t -77.05 -35.51 56.75 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.685 1.194 . . . . 0.0 112.392 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -57.04 -45.68 82.98 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.284 0.634 . . . . 0.0 110.143 170.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.6 tp -69.95 -42.28 73.43 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 118.549 -0.738 . . . . 0.0 111.237 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -50.01 -39.85 42.69 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.125 1.33 . . . . 0.0 113.073 172.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 58.1 m -60.13 -42.24 94.4 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.348 0.659 . . . . 0.0 112.503 171.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.1 mm -68.49 -35.35 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 O-C-N 121.204 -0.935 . . . . 0.0 110.023 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.5 mm -56.5 -51.14 68.71 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 CA-C-O 117.903 -1.046 . . . . 0.0 108.713 170.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -27.71 66.69 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.145 1.339 . . . . 0.0 112.906 175.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -66.78 -43.92 82.73 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.563 1.145 . . . . 0.0 112.449 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -107.91 7.61 28.11 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 . . . . . 0 N--CA 1.48 1.035 0 C-N-CA 125.39 1.476 . . . . 0.0 114.504 -167.526 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 119.199 -0.429 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -169.76 163.11 9.83 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 -172.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -121.29 170.83 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.277 1.431 . . . . 0.0 111.512 170.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.0 mm -123.48 116.99 49.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 126.154 1.782 . . . . 0.0 107.428 172.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.5 149.97 50.36 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -76.42 106.67 8.19 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.511 0.672 . . . . 0.0 111.445 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.6 -13.17 60.97 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -91.64 0.91 57.46 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.855 1.662 . . . . 0.0 114.117 -173.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.77 140.12 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.438 1.495 . . . . 0.0 110.943 -173.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -59.78 -26.6 65.85 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.95 -8.65 59.69 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.674 1.19 . . . . 0.0 113.937 177.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 27.1 p 36.46 51.34 0.85 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.241 2.217 . . . . 0.0 115.631 175.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.03 160.2 14.5 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -168.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.2 t -79.85 89.97 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 129.028 2.931 . . . . 0.0 109.071 -171.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.4 pt -69.95 -24.27 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.241 1.416 . . . . 0.0 112.201 175.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -155.35 159.71 40.15 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.197 0.999 . . . . 0.0 111.836 172.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.4 p -142.22 149.07 39.17 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -177.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -86.44 149.99 24.6 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.623 0.725 . . . . 0.0 111.559 168.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -67.87 -24.93 65.29 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.597 176.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.39 -50.0 49.18 Favored Glycine 0 CA--C 1.534 1.239 0 O-C-N 120.903 -1.123 . . . . 0.0 112.941 170.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -29.85 66.79 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 118.965 1.383 . . . . 0.0 111.376 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 23.2 t -60.04 -39.78 87.1 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.186 0.994 . . . . 0.0 110.2 172.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -78.21 -29.99 48.64 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.328 -0.857 . . . . 0.0 112.403 174.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.8 tp -56.44 -53.9 51.99 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.371 1.068 . . . . 0.0 110.602 174.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.8 p -80.01 -27.91 39.5 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.2 12.78 75.59 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 125.531 1.539 . . . . 0.0 115.986 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -89.04 -121.47 0.05 Allowed 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 119.552 1.676 . . . . 0.0 112.899 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.4 t -159.9 144.36 14.78 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.346 1.858 . . . . 0.0 109.981 -176.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.2 ptm85 -64.69 -30.02 71.03 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 120.891 -1.131 . . . . 0.0 113.593 -173.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.47 -16.76 39.7 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.211 1.005 . . . . 0.0 113.361 172.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -89.94 -20.57 23.19 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.532 1.933 . . . . 0.0 112.225 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 m -96.23 -19.98 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-N 119.243 0.928 . . . . 0.0 113.331 -173.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 35.3 mmt -50.01 115.71 1.52 Allowed 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.522 1.129 . . . . 0.0 111.014 -170.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 67.66 29.49 6.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.696 1.598 . . . . 0.0 112.862 169.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -100.81 151.63 37.65 Favored Pre-proline 0 N--CA 1.477 0.882 0 CA-C-O 117.756 -1.116 . . . . 0.0 113.716 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -54.54 135.28 65.82 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.262 2.641 . . . . 0.0 113.171 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 49.6 t -68.73 -12.54 61.56 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 126.349 1.86 . . . . 0.0 112.894 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -63.61 100.11 0.26 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 126.708 2.003 . . . . 0.0 111.046 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 30.2 p -49.89 -19.42 0.68 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.397 1.879 . . . . 0.0 115.614 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -48.13 -43.94 31.62 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.755 1.222 . . . . 0.0 111.939 169.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -67.06 -11.48 57.22 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 pp -123.1 20.04 9.9 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.95 1.7 . . . . 0.0 113.523 172.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -60.8 144.38 52.67 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.312 -0.868 . . . . 0.0 113.241 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.97 172.05 19.51 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 125.216 1.389 . . . . 0.0 113.074 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -65.92 -10.17 25.91 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.448 2.099 . . . . 0.0 116.062 -172.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 77.5 mtm-85 -110.1 0.05 18.18 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.765 1.626 . . . . 0.0 114.91 171.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 6.9 m -67.58 136.68 54.85 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.976 1.262 . . . . 0.0 111.305 175.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -82.64 132.81 35.18 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.581 1.181 . . . . 0.0 110.636 175.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -67.65 -39.79 84.59 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.585 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -41.37 63.5 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.432 1.093 . . . . 0.0 113.397 169.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.403 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -67.78 -49.98 59.52 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 124.44 1.096 . . . . 0.0 110.211 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.25 -33.41 75.75 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.301 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.04 -51.14 34.53 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.302 1.441 . . . . 0.0 112.495 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -49.94 -43.42 49.89 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.779 1.232 . . . . 0.0 111.223 170.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.4 mt -64.06 -49.16 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 121.895 -0.503 . . . . 0.0 111.256 174.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.01 -39.87 56.82 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.575 -0.726 . . . . 0.0 112.175 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -69.06 -38.07 78.86 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.582 0.753 . . . . 0.0 111.379 176.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.6 -33.02 74.73 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.446 -0.784 . . . . 0.0 111.496 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mt -82.62 -29.66 29.98 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.417 0.687 . . . . 0.0 111.9 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.26 -28.75 69.56 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.338 2.255 . . . . 0.0 111.001 169.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.98 18.22 8.99 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.043 1.306 . . . . 0.0 114.799 169.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.55 -49.99 74.45 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.63 1.215 . . . . 0.0 111.024 177.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -163.0 144.35 9.82 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.364 1.865 . . . . 0.0 110.98 169.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -72.07 117.59 13.88 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 167.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.5 tpp180 -149.31 137.23 20.49 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.446 1.098 . . . . 0.0 111.161 -176.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -76.79 127.42 32.72 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.216 1.006 . . . . 0.0 109.958 169.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -129.05 154.46 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.423 1.489 . . . . 0.0 108.863 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -79.9 160.12 26.13 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.221 1.008 . . . . 0.0 110.302 169.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.403 HG23 ' HB1' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -166.59 152.85 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.133 0.973 . . . . 0.0 111.115 169.759 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -85.88 145.32 27.23 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.122 174.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -115.39 163.03 16.31 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.345 1.458 . . . . 0.0 111.506 169.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -135.38 140.09 44.72 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.089 0.471 . . . . 0.0 111.799 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 19.4 mmm-85 -74.19 140.12 44.9 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 168.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -13.8 2.82 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -171.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -72.61 -9.99 59.26 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.198 1.399 . . . . 0.0 113.829 170.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.64 4.43 26.55 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 126.332 1.92 . . . . 0.0 115.467 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 52.6 m -86.5 100.23 12.23 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 118.838 1.319 . . . . 0.0 111.631 -173.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 25.2 t -106.33 137.84 43.59 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.107 1.363 . . . . 0.0 113.924 -172.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -150.99 146.05 25.97 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.439 1.496 . . . . 0.0 113.184 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -100.04 125.45 46.1 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.927 1.691 . . . . 0.0 109.233 170.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 78.2 m -129.6 173.6 10.45 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.048 1.339 . . . . 0.0 110.51 171.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 70.9 mt -79.88 59.84 3.29 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.006 -1.059 . . . . 0.0 111.403 -175.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 47.1 t -62.42 141.83 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.584 1.554 . . . . 0.0 111.426 -172.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -105.26 69.95 0.87 Allowed 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 122.486 1.136 . . . . 0.0 112.554 -168.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.8 t -81.18 70.77 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.071 1.348 . . . . 0.0 111.43 -168.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.8 p -120.5 129.28 25.4 Favored Pre-proline 0 N--CA 1.484 1.249 0 CA-C-O 118.408 -0.806 . . . . 0.0 111.945 -176.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -88.18 -166.61 0.27 Allowed 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.972 3.114 . . . . 0.0 112.435 -173.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -126.29 131.37 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 122.991 1.377 . . . . 0.0 113.415 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -119.01 159.95 22.92 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.081 2.153 . . . . 0.0 111.507 -172.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -89.89 -179.96 5.84 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.02 0.928 . . . . 0.0 111.935 174.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.18 -21.72 64.06 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -72.23 -19.89 61.64 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.698 1.199 . . . . 0.0 113.916 170.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.46 0.9 60.84 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.588 1.566 . . . . 0.0 114.238 -176.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -87.93 139.16 30.8 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.538 1.169 . . . . 0.0 112.937 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.7 p -77.99 98.34 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 125.142 1.377 . . . . 0.0 110.872 -174.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.63 -29.97 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.002 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.8 mmt -136.2 148.04 47.92 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 123.502 1.62 . . . . 0.0 111.122 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.7 m-30 -105.15 87.59 2.67 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 125.767 1.627 . . . . 0.0 106.733 -178.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 43.4 mt -103.83 73.76 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 122.574 1.178 . . . . 0.0 108.471 174.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.312 34.9 mt -80.62 84.06 6.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 123.208 1.48 . . . . 0.0 110.064 -176.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -59.87 104.74 0.32 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.018 2.127 . . . . 0.0 110.825 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -87.41 58.17 4.82 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 120.614 -1.304 . . . . 0.0 112.378 -175.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -79.79 106.89 12.14 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 124.772 2.225 . . . . 0.0 112.46 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 42.8 t -65.63 110.75 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 127.344 2.258 . . . . 0.0 109.218 174.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 179.477 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo . . . . . 0 CA--C 1.535 0.564 0 CA-C-O 122.446 0.936 . . . . 0.0 112.169 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -66.22 -26.52 67.41 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -169.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -69.99 -49.92 46.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.359 0.664 . . . . 0.0 110.39 -176.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.2 t -76.21 -34.53 59.27 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.04 0.936 . . . . 0.0 112.399 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -58.86 -41.77 87.81 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.693 -0.629 . . . . 0.0 110.29 172.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.5 tp -70.71 -45.52 64.8 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-O 118.76 -0.638 . . . . 0.0 112.072 173.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -47.47 -39.81 16.75 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.261 1.424 . . . . 0.0 113.213 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 85.5 m -60.09 -44.6 94.67 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.639 -0.663 . . . . 0.0 112.235 172.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.6 mm -67.31 -35.86 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.952 0.901 . . . . 0.0 110.661 175.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.9 mm -55.79 -54.38 26.98 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 CA-C-O 118.356 -0.83 . . . . 0.0 108.845 172.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 55.4 mtm180 -60.01 -28.44 67.73 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.115 0.871 . . . . 0.0 112.979 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.1 tttt -64.23 -41.16 97.13 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 172.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -105.77 2.99 28.35 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 N--CA 1.478 0.931 0 C-N-CA 126.6 1.96 . . . . 0.0 115.239 -167.14 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 118.988 -0.529 . . . . 0.0 112.15 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -169.79 161.31 9.08 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -171.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -120.08 172.15 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.548 1.539 . . . . 0.0 111.248 173.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.5 mm -130.01 117.79 42.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 125.621 1.568 . . . . 0.0 107.92 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.12 148.99 52.03 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -81.79 106.61 13.86 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.688 0.756 . . . . 0.0 110.539 174.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.23 -9.31 58.48 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -95.19 -5.79 43.14 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.639 1.176 . . . . 0.0 114.112 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.79 140.21 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.942 1.297 . . . . 0.0 109.952 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -56.1 -31.07 62.93 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -175.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -83.83 -9.1 59.01 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 73.7 m 45.33 51.18 9.59 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.045 1.738 . . . . 0.0 113.112 -177.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.23 153.08 22.27 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -167.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 67.5 t -80.07 90.04 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 127.957 2.503 . . . . 0.0 108.947 -178.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.7 pt -69.94 -24.21 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.648 1.179 . . . . 0.0 112.141 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -155.38 159.71 40.12 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.475 1.11 . . . . 0.0 112.237 175.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.4 p -139.88 150.94 45.23 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.925 -1.109 . . . . 0.0 112.76 175.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -83.66 156.13 22.81 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 175.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -61.15 -27.77 68.64 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.887 -0.508 . . . . 0.0 111.768 172.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.85 -51.62 44.06 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-O 118.99 -0.894 . . . . 0.0 112.727 169.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.42 -40.11 67.97 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.592 1.696 . . . . 0.0 110.404 174.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.1 t -60.27 -40.91 92.06 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.032 0.533 . . . . 0.0 111.725 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -75.7 -28.93 58.81 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.763 0.825 . . . . 0.0 112.453 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 50.7 tp -66.57 -55.71 14.18 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.206 1.402 . . . . 0.0 111.483 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 33.6 m -93.76 -20.9 19.68 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.092 0.957 . . . . 0.0 112.726 -173.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 72.25 11.57 75.63 Favored Glycine 0 CA--C 1.541 1.706 0 N-CA-C 116.027 1.171 . . . . 0.0 116.027 177.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -90.49 -118.15 0.07 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.239 1.519 . . . . 0.0 111.058 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.3 t -159.91 150.13 18.6 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.945 1.698 . . . . 0.0 110.518 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -55.06 -38.67 68.33 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.947 1.299 . . . . 0.0 112.148 178.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.1 -20.08 63.66 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.352 1.061 . . . . 0.0 113.61 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -82.35 -20.74 36.65 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.212 1.405 . . . . 0.0 112.123 175.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -105.36 -18.59 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 32.2 mmt -49.89 111.77 0.56 Allowed 'General case' 0 C--N 1.344 0.34 0 CA-C-N 119.637 1.108 . . . . 0.0 111.083 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 71.03 18.13 5.99 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.108 1.763 . . . . 0.0 113.652 170.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.49 162.07 70.01 Favored Pre-proline 0 N--CA 1.474 0.727 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.668 167.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -57.67 140.01 92.11 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.961 2.441 . . . . 0.0 112.648 170.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 32.4 t -67.56 -14.3 62.81 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.249 1.019 . . . . 0.0 112.617 171.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.0 m -64.65 100.1 0.36 Allowed 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 126.714 2.005 . . . . 0.0 110.585 176.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 29.6 p -51.58 -18.62 1.19 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.894 1.678 . . . . 0.0 115.402 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -48.71 -41.84 33.11 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.114 1.365 . . . . 0.0 111.375 169.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -56.29 -24.71 44.96 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.716 1.606 . . . . 0.0 113.355 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 pp -123.14 19.98 9.88 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.419 1.887 . . . . 0.0 114.084 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.76 150.46 47.84 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.916 -1.115 . . . . 0.0 113.375 -177.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -130.58 -173.07 13.27 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.799 1.19 . . . . 0.0 115.532 -169.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -68.95 -10.17 28.39 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.383 2.722 . . . . 0.0 115.876 -169.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.4 ttm-85 -109.98 -4.7 15.76 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.086 1.354 . . . . 0.0 113.284 171.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.535 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 3.2 m -75.43 136.64 40.71 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.451 1.023 . . . . 0.0 110.489 -177.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -80.39 132.77 35.81 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 122.738 1.256 . . . . 0.0 109.675 171.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -68.24 -39.75 82.19 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.514 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -53.08 -38.95 62.97 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.488 1.115 . . . . 0.0 113.87 169.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.42 -50.28 53.92 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.357 1.063 . . . . 0.0 110.707 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.48 -33.88 76.91 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.03 -51.47 31.95 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.859 1.264 . . . . 0.0 112.435 177.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -50.07 -41.87 48.87 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.659 1.183 . . . . 0.0 111.916 170.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 34.3 mt -63.65 -49.62 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 O-C-N 121.745 -0.597 . . . . 0.0 111.077 173.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.63 -39.8 51.39 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.208 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -69.43 -36.78 76.99 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.601 0.76 . . . . 0.0 111.685 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.35 -31.09 70.24 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.503 -0.748 . . . . 0.0 111.547 177.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mt -82.59 -31.76 28.79 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.437 0.695 . . . . 0.0 111.342 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.44 -29.75 70.99 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.112 2.165 . . . . 0.0 111.311 169.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.95 20.22 7.71 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.907 1.241 . . . . 0.0 114.929 169.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.23 -50.04 74.69 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 118.857 1.328 . . . . 0.0 110.79 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -163.66 144.98 9.14 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.464 2.306 . . . . 0.0 109.34 168.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -84.9 122.26 28.93 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.984 -1.073 . . . . 0.0 108.728 170.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.8 tpp180 -154.64 150.11 27.32 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.019 1.328 . . . . 0.0 110.537 -169.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -76.73 135.29 39.03 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 171.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -129.42 154.2 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.953 1.301 . . . . 0.0 108.66 172.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -79.83 160.12 26.22 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.084 0.953 . . . . 0.0 109.642 169.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -168.46 150.55 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.362 0.983 . . . . 0.0 110.945 169.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.535 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -89.54 145.36 25.33 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.937 173.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -112.29 159.78 18.3 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.459 1.503 . . . . 0.0 111.771 169.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -132.79 140.01 47.8 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.434 0.694 . . . . 0.0 111.102 169.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -82.47 160.24 22.72 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.938 1.295 . . . . 0.0 113.282 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -54.31 -30.74 52.11 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.613 1.965 . . . . 0.0 113.125 170.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -76.81 -9.95 59.03 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.121 1.368 . . . . 0.0 113.985 175.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.31 4.66 56.24 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 125.755 1.645 . . . . 0.0 115.886 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 58.7 m -87.94 132.26 34.29 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.061 1.431 . . . . 0.0 111.642 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 27.0 p -124.28 140.01 53.36 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.654 1.182 . . . . 0.0 113.529 -174.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -151.0 140.06 21.08 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.306 1.442 . . . . 0.0 113.29 -170.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.476 HD13 ' N ' ' A' ' 108' ' ' CYS . 2.0 tm? -110.16 136.12 49.88 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.916 2.086 . . . . 0.0 109.311 171.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.476 ' N ' HD13 ' A' ' 107' ' ' LEU . 1.6 m -142.28 178.69 7.39 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.318 1.447 . . . . 0.0 111.653 170.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -78.15 59.85 2.32 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.48 1.112 . . . . 0.0 110.192 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.4 t -60.45 146.76 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.975 1.71 . . . . 0.0 111.572 -171.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -102.25 69.71 1.15 Allowed 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 122.437 1.113 . . . . 0.0 112.981 -167.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.0 t -83.44 69.93 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.761 0.824 . . . . 0.0 110.052 -169.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 49.1 t -118.7 123.73 28.91 Favored Pre-proline 0 N--CA 1.484 1.26 0 CA-C-O 118.074 -0.965 . . . . 0.0 111.945 -169.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -81.37 179.91 5.47 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.534 2.823 . . . . 0.0 114.577 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.4 133.05 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.191 1.396 . . . . 0.0 112.928 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -118.74 166.65 12.51 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.421 1.888 . . . . 0.0 112.509 -169.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -96.79 -179.99 4.77 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.995 0.918 . . . . 0.0 112.029 170.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.0 -21.42 64.85 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -71.01 -19.87 62.46 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.574 1.15 . . . . 0.0 113.785 170.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.71 4.29 60.56 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.699 1.619 . . . . 0.0 114.432 -176.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -91.13 138.84 31.29 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.443 1.122 . . . . 0.0 113.014 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.06 100.18 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 126.123 1.769 . . . . 0.0 110.784 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.93 -29.51 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 118.805 -0.616 . . . . 0.0 111.915 173.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.63 147.87 51.5 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 124.248 1.975 . . . . 0.0 113.465 173.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -100.09 84.85 2.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 113.204 -1.816 . . . . 0.0 107.344 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 39.4 mt -100.02 69.99 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 169.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.5 mt -80.5 87.18 5.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.352 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -59.78 104.13 0.26 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.711 -178.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -83.91 49.94 1.72 Allowed 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.406 -1.434 . . . . 0.0 111.778 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -82.26 106.89 14.51 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 123.799 1.761 . . . . 0.0 112.846 -177.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 41.3 t -58.28 113.02 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 127.119 2.168 . . . . 0.0 109.286 170.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.472 0.647 0 C-N-CA 123.111 0.564 . . . . 0.0 111.359 176.083 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo . . . . . 0 CA--C 1.535 0.537 0 CA-C-O 122.362 0.901 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -65.47 -26.49 67.96 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.774 1.028 . . . . 0.0 113.774 -168.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -69.98 -50.03 45.74 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.508 0.594 . . . . 0.0 110.493 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 t -77.0 -34.58 57.51 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.17 0.988 . . . . 0.0 112.378 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -59.17 -41.65 88.93 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.073 0.549 . . . . 0.0 110.165 172.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.6 tp -70.95 -45.25 64.48 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-O 118.654 -0.689 . . . . 0.0 112.04 173.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -47.83 -39.81 19.46 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 120.154 1.343 . . . . 0.0 113.146 174.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.6 m -60.01 -44.32 94.66 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.64 -0.663 . . . . 0.0 112.282 172.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.2 mm -67.94 -35.38 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.978 0.911 . . . . 0.0 110.837 175.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.2 mm -55.71 -54.53 25.11 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.462 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 172.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 -60.81 -27.51 68.1 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.125 0.875 . . . . 0.0 113.163 176.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -63.81 -42.14 97.75 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.436 0.694 . . . . 0.0 112.386 172.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -106.09 2.33 27.07 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 . . . . . 0 N--CA 1.479 0.976 0 C-N-CA 126.352 1.861 . . . . 0.0 114.639 -167.389 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? . . . . . 0 N--CA 1.476 0.86 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -169.79 162.37 9.51 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -173.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -119.98 172.23 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.337 1.455 . . . . 0.0 111.344 173.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.4 mm -127.08 118.44 50.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 125.764 1.626 . . . . 0.0 107.498 172.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.72 145.36 51.92 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -79.37 106.47 11.42 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.524 0.678 . . . . 0.0 110.684 176.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.52 -7.06 51.82 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -176.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -99.97 -4.68 29.59 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.91 1.284 . . . . 0.0 114.272 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.12 140.26 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.234 1.414 . . . . 0.0 110.243 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -55.06 -26.32 36.81 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -174.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -92.98 -10.32 36.75 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.944 1.298 . . . . 0.0 114.286 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 93.7 m 47.03 55.76 7.62 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.166 1.786 . . . . 0.0 113.259 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.97 157.8 16.61 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 -168.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.6 t -79.95 92.69 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 128.696 2.798 . . . . 0.0 108.728 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.0 pt -72.44 -24.76 22.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.21 1.404 . . . . 0.0 112.228 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -156.84 159.81 38.57 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.272 1.029 . . . . 0.0 112.359 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.4 p -139.94 151.94 45.96 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.094 -1.003 . . . . 0.0 113.368 -175.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -89.2 149.93 22.9 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.711 0.767 . . . . 0.0 111.672 167.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -65.09 -31.15 72.22 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.378 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.22 -50.83 38.6 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 119.451 -0.638 . . . . 0.0 112.812 172.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -29.85 66.9 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 119.258 1.529 . . . . 0.0 111.766 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 13.9 t -60.05 -40.03 88.01 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.542 -0.724 . . . . 0.0 110.962 171.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -80.19 -30.1 38.72 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 121.432 -0.793 . . . . 0.0 112.828 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.4 tp -54.93 -54.35 43.87 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.666 1.586 . . . . 0.0 110.111 172.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.3 m -80.0 -31.12 39.71 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 122.542 0.337 . . . . 0.0 111.624 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.93 17.22 63.67 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 125.438 1.494 . . . . 0.0 115.672 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -98.72 -118.88 0.14 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.073 1.349 . . . . 0.0 112.349 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.1 t -159.84 142.65 13.75 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.863 1.265 . . . . 0.0 111.499 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -59.61 -33.35 71.38 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.637 1.175 . . . . 0.0 113.07 -177.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.76 -16.63 42.24 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.628 1.171 . . . . 0.0 113.211 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -96.67 -20.76 18.04 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.505 1.522 . . . . 0.0 112.561 177.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 m -90.75 -20.04 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 CA-C-N 120.315 1.416 . . . . 0.0 113.378 -175.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 36.1 mmt -51.17 114.47 1.21 Allowed 'General case' 0 C--N 1.339 0.135 0 C-N-CA 124.283 1.033 . . . . 0.0 110.218 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 73.72 20.46 2.99 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.453 1.901 . . . . 0.0 114.769 173.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.98 152.95 95.77 Favored Pre-proline 0 N--CA 1.479 0.982 0 O-C-N 120.6 -1.313 . . . . 0.0 111.304 167.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -62.13 140.02 81.55 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.518 2.146 . . . . 0.0 110.714 170.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 18.9 t -65.19 -11.8 44.52 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.59 0.756 . . . . 0.0 112.879 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.06 87.69 0.11 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.91 1.684 . . . . 0.0 110.152 170.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 22.7 p -50.86 -13.08 0.12 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.229 2.212 . . . . 0.0 114.802 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.483 ' HA ' ' CG ' ' A' ' 70' ' ' HIS . 22.8 t70 -46.45 -31.84 2.93 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.088 1.355 . . . . 0.0 112.505 167.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -55.47 -22.15 19.52 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 174.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 pp -122.96 20.82 9.95 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.528 1.931 . . . . 0.0 114.593 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.561 ' CG ' HG21 ' A' ' 74' ' ' THR . 36.9 m170 -69.42 151.57 45.95 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 120.753 -1.217 . . . . 0.0 113.652 174.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -124.34 -173.37 13.81 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.715 1.626 . . . . 0.0 114.461 -172.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.71 -10.04 27.93 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.601 2.867 . . . . 0.0 115.24 -171.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.4 tpt85 -94.72 -10.05 32.85 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.68 1.192 . . . . 0.0 113.21 171.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.561 HG21 ' CG ' ' A' ' 70' ' ' HIS . 2.0 m -83.17 138.41 33.66 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -169.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -93.2 138.04 31.97 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.744 1.259 . . . . 0.0 111.71 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.6 mmm-85 -69.26 -39.79 78.2 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.773 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.3 ptt-85 -52.18 -39.47 60.12 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 169.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.41 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -65.22 -51.4 61.15 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 122.053 0.93 . . . . 0.0 109.971 174.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.84 -35.77 79.23 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.02 -52.09 26.94 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 126.171 1.789 . . . . 0.0 111.345 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -50.07 -40.76 46.39 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.589 1.086 . . . . 0.0 112.906 169.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 40.6 mt -63.46 -50.24 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 119.183 -0.437 . . . . 0.0 111.343 173.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.74 -39.89 59.27 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.713 0.688 . . . . 0.0 111.904 174.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -63.46 -39.06 93.45 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.517 0.727 . . . . 0.0 111.716 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.01 -29.5 68.52 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 174.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mt -82.44 -38.9 23.33 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 pp -68.99 -29.65 67.89 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 169.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.85 18.27 9.02 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.927 -0.929 . . . . 0.0 114.042 169.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.6 -49.88 69.38 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 118.77 1.285 . . . . 0.0 110.664 173.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -158.49 134.18 8.9 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.584 1.954 . . . . 0.0 109.777 167.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -74.54 120.47 20.14 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.143 -0.973 . . . . 0.0 108.454 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -143.3 136.78 28.31 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.397 1.079 . . . . 0.0 111.685 -168.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -81.37 130.19 34.93 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.469 1.108 . . . . 0.0 109.384 169.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -136.58 145.63 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.611 1.165 . . . . 0.0 109.333 -174.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.95 150.75 30.39 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.876 0.871 . . . . 0.0 109.714 169.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.41 HG23 ' HB1' ' A' ' 78' ' ' ALA . 0.6 OUTLIER -162.01 146.56 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.614 1.165 . . . . 0.0 110.083 -179.113 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.471 ' H ' HG23 ' A' ' 74' ' ' THR . . . -91.06 145.46 24.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.051 0.541 . . . . 0.0 112.263 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -122.26 157.75 30.99 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.539 1.136 . . . . 0.0 111.633 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -120.9 140.07 52.33 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.31 0.644 . . . . 0.0 110.415 167.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -95.52 162.28 13.71 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.246 1.418 . . . . 0.0 111.656 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -57.78 -29.09 64.57 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.359 1.864 . . . . 0.0 113.189 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -74.24 -9.95 59.12 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.82 1.248 . . . . 0.0 113.859 175.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.93 6.73 56.92 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.602 1.572 . . . . 0.0 115.561 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 63.4 m -87.51 137.99 31.86 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 118.812 1.306 . . . . 0.0 111.247 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 44.0 t -134.13 128.04 33.3 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.176 0.99 . . . . 0.0 112.598 -177.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -151.05 155.52 39.17 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -174.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.413 HD13 ' N ' ' A' ' 108' ' ' CYS . 1.9 tm? -99.91 131.66 45.74 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.668 1.987 . . . . 0.0 109.736 169.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.413 ' N ' HD13 ' A' ' 107' ' ' LEU . 56.8 m -135.13 168.07 19.82 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.643 1.577 . . . . 0.0 110.256 169.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.07 59.94 3.44 Favored 'General case' 0 CA--C 1.548 0.869 0 O-C-N 121.038 -1.039 . . . . 0.0 111.128 -175.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.8 t -59.85 147.88 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.261 1.424 . . . . 0.0 111.716 -171.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -105.19 69.67 0.86 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 122.475 1.131 . . . . 0.0 111.812 -168.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 19.9 t -82.54 69.96 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.213 1.005 . . . . 0.0 110.695 -169.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.6 p -117.26 130.0 24.94 Favored Pre-proline 0 N--CA 1.485 1.285 0 C-N-CA 124.202 1.001 . . . . 0.0 112.973 -171.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -82.21 -177.57 3.57 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 124.828 3.686 . . . . 0.0 114.488 -173.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.425 HG23 ' HB2' ' A' ' 124' ' ' MET . 15.7 m -123.69 124.72 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-O 123.08 1.419 . . . . 0.0 112.802 171.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -109.73 165.61 11.56 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.33 2.252 . . . . 0.0 112.27 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -95.17 179.91 5.03 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 114.781 -1.1 . . . . 0.0 112.244 170.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.65 -21.4 65.67 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -70.19 -19.93 63.15 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.575 1.15 . . . . 0.0 113.677 169.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.36 2.2 59.03 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 126.048 1.785 . . . . 0.0 114.489 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.03 139.59 30.49 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 118.506 1.153 . . . . 0.0 113.324 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.8 p -71.26 100.14 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 125.395 1.478 . . . . 0.0 110.542 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.54 -29.97 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.091 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.037 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.425 ' HB2' HG23 ' A' ' 115' ' ' VAL . 10.1 mmt -136.46 143.63 43.97 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 123.705 1.717 . . . . 0.0 111.081 177.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -100.15 87.69 3.52 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 125.381 1.472 . . . . 0.0 107.756 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 36.4 mt -102.27 69.92 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 169.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.9 mt -79.94 87.72 5.35 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 122.284 1.04 . . . . 0.0 109.55 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -59.84 109.03 0.84 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.002 1.321 . . . . 0.0 110.643 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -87.43 49.98 1.92 Allowed 'General case' 0 CA--C 1.533 0.315 0 O-C-N 120.571 -1.331 . . . . 0.0 111.75 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -79.85 106.97 12.26 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 123.838 1.78 . . . . 0.0 111.536 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 20.1 t -60.13 119.93 5.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 126.718 2.007 . . . . 0.0 109.179 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 120.761 0.315 . . . . 0.0 111.078 175.054 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 CA--C 1.534 0.513 0 CA-C-O 122.594 0.998 . . . . 0.0 112.107 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -66.57 -26.61 67.2 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.118 0.967 . . . . 0.0 113.208 -170.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -70.05 -49.86 47.0 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.526 0.73 . . . . 0.0 110.419 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 t -75.83 -33.87 60.08 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.954 0.902 . . . . 0.0 112.385 178.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -59.41 -41.17 88.84 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.743 -0.598 . . . . 0.0 110.438 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.6 tp -70.28 -44.84 67.56 Favored 'General case' 0 C--O 1.22 -0.447 0 CA-C-O 118.927 -0.559 . . . . 0.0 111.907 171.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -48.07 -39.7 20.93 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 120.003 1.274 . . . . 0.0 113.556 174.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.2 m -60.03 -42.58 94.68 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 121.704 -0.622 . . . . 0.0 112.289 172.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.5 mm -69.29 -34.15 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 O-C-N 121.113 -0.992 . . . . 0.0 110.857 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.9 mm -55.7 -54.32 27.42 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 169.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.92 -23.96 63.95 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.629 1.104 . . . . 0.0 113.436 175.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -68.62 -43.84 75.52 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.146 0.885 . . . . 0.0 112.495 171.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -102.75 0.26 32.63 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 . . . . . 0 CA--C 1.548 0.897 0 C-N-CA 127.044 2.137 . . . . 0.0 114.141 -168.684 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -169.77 163.38 9.83 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.499 1.519 . . . . 0.0 113.935 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -120.9 170.48 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.849 1.26 . . . . 0.0 112.129 171.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.0 mm -120.66 114.44 43.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 168.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.07 152.82 43.82 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.653 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -85.86 119.39 26.13 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.8 -11.69 59.91 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.538 0.735 . . . . 0.0 112.891 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -100.05 -1.51 36.74 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.186 1.394 . . . . 0.0 114.185 -171.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.8 m -104.27 140.14 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 127.053 2.141 . . . . 0.0 111.58 -177.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -64.59 -27.86 69.24 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.395 1.078 . . . . 0.0 113.11 -174.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -84.47 -6.89 59.42 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.431 1.092 . . . . 0.0 113.28 173.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 46.7 m 49.47 39.89 17.74 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.781 1.632 . . . . 0.0 112.666 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.41 149.93 43.83 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -166.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.4 t -80.01 90.03 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 129.323 3.049 . . . . 0.0 108.511 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.3 pt -69.98 -21.87 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.949 1.3 . . . . 0.0 112.343 178.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -158.99 159.71 35.13 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.051 1.34 . . . . 0.0 111.711 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.4 p -139.98 148.3 41.7 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 120.77 -1.206 . . . . 0.0 113.876 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -82.56 151.33 26.46 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.489 0.662 . . . . 0.0 110.704 166.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -66.48 -28.67 68.76 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.512 175.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.1 -50.79 54.05 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 121.267 -0.896 . . . . 0.0 112.867 173.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -29.85 66.92 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.202 1.501 . . . . 0.0 110.581 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.6 t -60.04 -39.77 87.09 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.555 0.742 . . . . 0.0 110.266 173.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -78.15 -27.92 48.22 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.016 0.926 . . . . 0.0 112.534 173.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.7 tp -60.65 -49.39 77.7 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.471 1.108 . . . . 0.0 111.462 175.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 26.9 p -79.97 -27.4 39.72 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 169.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.2 24.52 61.2 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 125.168 1.366 . . . . 0.0 114.515 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.3 m-30 -90.21 -129.96 0.09 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.154 1.382 . . . . 0.0 111.887 -177.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.7 t -159.9 150.16 18.65 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.604 2.362 . . . . 0.0 109.013 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 67.6 mtp85 -56.27 -43.05 78.4 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 121.059 -1.026 . . . . 0.0 112.112 -171.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.4 -18.12 63.37 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.741 1.216 . . . . 0.0 113.69 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -86.84 -20.72 27.08 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.116 1.766 . . . . 0.0 112.178 176.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.4 m -103.57 -20.2 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -177.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 33.8 mmt -50.0 113.64 0.9 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 124.084 0.954 . . . . 0.0 110.709 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 71.47 20.47 4.84 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.03 1.732 . . . . 0.0 113.744 169.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.52 160.12 75.68 Favored Pre-proline 0 N--CA 1.475 0.808 0 CA-C-O 118.145 -0.931 . . . . 0.0 111.557 167.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.09 140.05 91.63 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.732 2.288 . . . . 0.0 113.073 173.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 37.8 t -63.95 -17.7 63.52 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.592 1.157 . . . . 0.0 112.384 170.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.7 m -64.83 89.45 0.07 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.471 1.908 . . . . 0.0 110.795 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 26.8 p -52.95 -13.29 0.42 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.655 1.982 . . . . 0.0 115.127 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -46.35 -37.79 7.97 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.456 1.502 . . . . 0.0 111.416 166.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.83 -23.08 63.07 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.25 3.0 pp -123.13 28.15 7.28 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.205 1.802 . . . . 0.0 113.729 174.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.43 148.71 47.8 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.913 -1.117 . . . . 0.0 113.27 172.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.85 173.77 22.87 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.714 1.626 . . . . 0.0 114.603 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.56 -10.11 27.24 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.308 2.672 . . . . 0.0 114.152 -174.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -110.04 0.02 18.25 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.165 1.386 . . . . 0.0 113.879 170.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.525 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 18.6 m -71.42 139.0 49.53 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.726 1.148 . . . . 0.0 111.384 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -79.96 129.94 34.89 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 123.099 1.428 . . . . 0.0 109.59 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -70.16 -39.7 75.16 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.398 -176.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -56.63 -36.75 69.85 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 170.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.419 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -66.55 -51.7 53.6 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 122.029 0.919 . . . . 0.0 110.324 174.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.0 -33.27 75.66 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.449 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.01 -50.16 44.3 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.321 1.449 . . . . 0.0 112.18 177.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -49.99 -41.06 46.19 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.563 1.074 . . . . 0.0 112.09 169.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 20.9 mt -64.07 -49.68 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 118.518 0.599 . . . . 0.0 111.937 172.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.12 -39.83 44.27 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.453 0.57 . . . . 0.0 112.022 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -68.43 -39.35 81.56 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.376 0.67 . . . . 0.0 111.764 176.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.15 -27.75 65.83 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.836 -0.54 . . . . 0.0 112.157 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mt -88.02 -34.77 17.9 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.302 0.641 . . . . 0.0 110.538 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.58 -37.63 73.49 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.275 1.83 . . . . 0.0 110.142 168.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 117.46 22.43 4.07 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.691 1.139 . . . . 0.0 114.962 170.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.08 -50.0 75.03 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 118.644 1.222 . . . . 0.0 111.036 174.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -162.74 143.85 9.97 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.173 1.789 . . . . 0.0 111.145 169.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.45 118.4 13.21 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 168.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.9 tpp180 -151.75 138.35 18.73 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.61 1.164 . . . . 0.0 111.685 -173.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -80.63 128.72 33.94 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.693 1.197 . . . . 0.0 110.091 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.34 148.94 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.319 1.447 . . . . 0.0 108.813 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -79.94 157.13 26.96 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.061 0.944 . . . . 0.0 110.399 171.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.579 HD11 HG21 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -164.11 149.13 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.994 0.918 . . . . 0.0 110.629 171.679 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.525 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -84.36 145.39 28.25 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.726 176.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -117.0 156.2 27.89 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.523 1.129 . . . . 0.0 111.155 175.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -122.75 140.17 53.18 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.173 0.511 . . . . 0.0 110.263 168.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -91.01 146.32 23.95 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.769 1.228 . . . . 0.0 109.687 175.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -49.86 -30.51 10.09 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 126.728 2.011 . . . . 0.0 114.577 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -75.67 -9.82 58.92 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 109.91 28.11 4.32 Favored Glycine 0 CA--C 1.536 1.397 0 N-CA-C 115.905 1.122 . . . . 0.0 115.905 169.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.6 m -119.02 138.54 52.76 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.529 1.132 . . . . 0.0 111.229 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 32.0 p -135.99 140.03 43.61 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -150.93 148.62 28.63 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.837 1.255 . . . . 0.0 113.723 -173.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -99.98 120.94 40.6 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.471 1.509 . . . . 0.0 108.296 167.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 75.3 m -122.74 163.49 20.08 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.465 1.506 . . . . 0.0 109.579 174.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 67.4 mt -79.99 59.85 3.36 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.211 -0.931 . . . . 0.0 111.25 -175.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.555 HG21 HD12 ' A' ' 96' ' ' ILE . 14.5 m -65.2 144.82 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.6 1.96 . . . . 0.0 111.69 -173.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -107.68 69.85 0.76 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 122.42 1.105 . . . . 0.0 112.394 -167.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.579 HG21 HD11 ' A' ' 96' ' ' ILE . 12.8 t -81.37 69.92 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.762 1.225 . . . . 0.0 111.452 -168.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.49 131.99 24.32 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 124.317 1.047 . . . . 0.0 112.364 -175.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -86.18 -170.65 0.71 Allowed 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 123.544 2.83 . . . . 0.0 112.911 -172.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -123.17 129.85 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 122.868 1.318 . . . . 0.0 112.688 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -117.64 159.86 22.23 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.006 2.122 . . . . 0.0 111.277 -174.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -89.88 -179.8 5.81 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.947 0.899 . . . . 0.0 111.923 175.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.17 -21.77 64.09 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -72.45 -19.91 61.49 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.656 1.182 . . . . 0.0 113.884 170.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.54 0.55 60.89 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.622 1.582 . . . . 0.0 114.203 -176.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -87.35 139.39 30.6 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.465 1.132 . . . . 0.0 112.927 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.8 p -77.63 100.0 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 125.449 1.5 . . . . 0.0 111.114 -175.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.25 -30.0 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.71 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.89 150.0 49.19 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 123.997 1.856 . . . . 0.0 113.053 173.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -103.73 84.07 2.22 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 126.166 1.786 . . . . 0.0 107.475 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 44.3 mt -99.97 70.01 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 122.855 1.312 . . . . 0.0 108.697 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.277 22.0 mt -78.74 85.4 4.75 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 122.998 1.38 . . . . 0.0 110.051 -177.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -59.89 105.71 0.42 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.456 1.902 . . . . 0.0 110.143 175.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -86.13 53.97 2.98 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.559 -1.338 . . . . 0.0 110.017 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -79.76 106.66 11.94 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 124.168 1.937 . . . . 0.0 111.241 -168.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.7 t -61.19 112.34 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 113.452 -1.704 . . . . 0.0 108.242 177.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.467 0.381 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 175.789 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo . . . . . 0 CA--C 1.535 0.554 0 CA-C-O 122.164 0.818 . . . . 0.0 111.434 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -63.74 -27.5 69.24 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -168.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -70.01 -50.03 45.51 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.614 0.643 . . . . 0.0 110.473 -175.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.4 t -77.27 -34.4 55.72 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.433 1.093 . . . . 0.0 112.373 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -58.82 -41.98 88.11 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.036 0.534 . . . . 0.0 110.161 172.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.45 -44.18 68.32 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 118.82 -0.609 . . . . 0.0 112.07 172.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -48.92 -39.99 28.36 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.865 1.211 . . . . 0.0 112.316 175.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.0 m -60.18 -43.1 96.11 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.399 -0.813 . . . . 0.0 112.718 172.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.8 mm -67.94 -35.76 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 O-C-N 121.306 -0.871 . . . . 0.0 110.389 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.4 mm -55.72 -54.57 24.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 172.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -24.36 64.25 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.568 1.147 . . . . 0.0 113.383 177.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -69.44 -44.65 70.85 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.616 1.166 . . . . 0.0 113.557 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -105.54 4.15 30.12 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 . . . . . 0 N--CA 1.477 0.893 0 C-N-CA 126.473 1.909 . . . . 0.0 115.169 -167.69 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -169.93 160.18 8.23 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 -172.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 pp -119.92 166.07 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 127.637 2.375 . . . . 0.0 111.052 173.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.8 mm -130.78 118.04 40.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 125.206 1.402 . . . . 0.0 108.206 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.09 156.36 44.66 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -78.88 129.58 34.71 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 169.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.65 -11.87 52.76 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 169.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -94.37 0.4 55.47 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.949 1.7 . . . . 0.0 114.05 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.7 m -109.52 138.89 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 125.692 1.597 . . . . 0.0 111.153 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -63.86 -28.01 69.55 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.822 0.849 . . . . 0.0 112.941 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -81.92 -5.95 58.7 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.49 1.116 . . . . 0.0 113.671 175.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.0 p 45.06 37.41 2.5 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 127.028 2.131 . . . . 0.0 113.709 -175.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.05 150.01 40.86 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -167.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 64.7 t -79.99 90.91 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 129.454 3.102 . . . . 0.0 108.787 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.6 pt -69.99 -23.81 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.116 1.366 . . . . 0.0 112.267 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -156.41 159.72 38.97 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.346 1.058 . . . . 0.0 112.157 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.5 p -143.64 155.79 44.36 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 120.76 -1.212 . . . . 0.0 112.812 172.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -92.29 156.89 16.96 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -58.41 -29.05 65.79 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.708 0.803 . . . . 0.0 111.578 172.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.09 -49.83 41.66 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.416 1.008 . . . . 0.0 113.34 168.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.97 -38.48 76.11 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 119.343 1.572 . . . . 0.0 110.421 174.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.8 t -60.21 -39.86 88.11 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.881 -0.512 . . . . 0.0 111.051 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -74.71 -28.3 60.74 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 121.247 -0.908 . . . . 0.0 112.833 175.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.5 tp -66.85 -55.81 13.15 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.761 1.224 . . . . 0.0 111.594 177.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 64.2 m -98.77 -19.89 17.2 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.526 1.131 . . . . 0.0 113.054 -172.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.78 10.0 83.2 Favored Glycine 0 CA--C 1.541 1.696 0 N-CA-C 116.143 1.217 . . . . 0.0 116.143 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -89.21 -116.86 0.06 Allowed 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 119.072 1.436 . . . . 0.0 111.451 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.7 t -160.02 150.08 18.36 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.229 1.411 . . . . 0.0 110.948 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.9 mtp-105 -55.36 -40.78 71.7 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.402 1.081 . . . . 0.0 111.623 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.52 -19.15 63.33 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.489 1.116 . . . . 0.0 113.766 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -85.67 -20.65 29.1 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.966 1.307 . . . . 0.0 112.712 174.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.7 m -100.97 -20.05 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 174.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 30.2 mmt -49.91 113.24 0.8 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.423 1.089 . . . . 0.0 111.089 -177.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 71.49 15.74 6.08 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.839 1.656 . . . . 0.0 113.977 170.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.83 160.16 74.82 Favored Pre-proline 0 N--CA 1.475 0.803 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.414 167.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.03 140.1 85.92 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.801 2.334 . . . . 0.0 111.834 169.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.4 t -69.39 -12.58 61.77 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.807 0.843 . . . . 0.0 113.091 177.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.7 m -64.76 97.86 0.24 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.373 1.869 . . . . 0.0 110.731 177.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 31.8 p -52.67 -15.05 0.61 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.075 1.75 . . . . 0.0 115.134 -177.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -47.36 -38.98 14.06 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.746 1.219 . . . . 0.0 111.854 168.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.07 -19.76 63.27 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 pp -123.0 24.91 8.78 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.428 1.891 . . . . 0.0 113.045 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.53 145.67 53.69 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.308 -0.87 . . . . 0.0 112.419 174.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -110.8 178.97 19.98 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.532 1.539 . . . . 0.0 113.558 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.05 -10.07 27.73 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.493 2.795 . . . . 0.0 114.208 -177.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.25 -10.09 24.54 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.649 1.579 . . . . 0.0 112.582 172.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 97' ' ' ALA . 2.9 m -80.24 138.37 36.8 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.717 -1.239 . . . . 0.0 111.541 -175.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -87.64 135.26 33.44 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.384 1.088 . . . . 0.0 110.709 174.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.4 mmm-85 -66.26 -39.68 89.62 Favored 'General case' 0 C--O 1.219 -0.536 0 O-C-N 121.43 -0.794 . . . . 0.0 111.074 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -53.68 -38.34 64.1 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 171.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.38 -52.35 47.68 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.942 0.877 . . . . 0.0 110.027 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.55 -33.79 76.73 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.554 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.01 -52.19 26.16 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.859 1.664 . . . . 0.0 112.314 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -50.13 -42.02 49.88 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.455 1.025 . . . . 0.0 112.287 170.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 48.9 mt -62.94 -49.34 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 O-C-N 121.876 -0.515 . . . . 0.0 111.052 173.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.27 -39.93 57.8 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.592 -0.718 . . . . 0.0 112.114 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -68.68 -37.67 79.77 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.636 0.774 . . . . 0.0 111.477 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.37 -33.0 74.73 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.436 -0.79 . . . . 0.0 111.311 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 mt -82.06 -29.83 31.68 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.469 0.707 . . . . 0.0 112.119 177.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.3 -28.75 69.54 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.216 2.206 . . . . 0.0 110.766 168.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.95 17.66 9.44 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.196 1.379 . . . . 0.0 114.905 169.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.4 -50.04 67.01 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.648 1.224 . . . . 0.0 111.182 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -150.59 141.36 22.76 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.658 1.583 . . . . 0.0 111.621 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -79.59 104.02 9.9 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 166.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.7 tpt85 -145.11 136.79 25.43 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.242 1.017 . . . . 0.0 111.433 -171.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -82.02 133.04 35.26 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.572 1.549 . . . . 0.0 109.632 169.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.22 146.42 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.406 1.483 . . . . 0.0 108.9 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.01 153.86 28.57 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.644 0.778 . . . . 0.0 110.404 172.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -161.33 158.57 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.728 1.211 . . . . 0.0 110.537 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.516 ' H ' HG23 ' A' ' 74' ' ' THR . . . -100.09 145.44 27.95 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.671 0.789 . . . . 0.0 112.181 174.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -115.91 158.61 22.75 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.561 1.145 . . . . 0.0 111.041 169.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -127.44 137.46 52.71 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.519 0.728 . . . . 0.0 110.241 168.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -81.26 159.7 24.44 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.191 0.997 . . . . 0.0 112.611 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -55.43 -29.05 57.89 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.786 1.635 . . . . 0.0 112.979 171.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -80.02 -9.9 59.73 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.022 1.329 . . . . 0.0 113.774 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.37 0.69 53.74 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 126.106 1.813 . . . . 0.0 115.822 178.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.0 m -78.23 128.0 33.09 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.108 1.454 . . . . 0.0 111.741 -178.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 61.5 m -115.7 137.93 51.6 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.742 1.217 . . . . 0.0 112.317 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -151.03 139.92 20.92 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.429 ' HB2' ' HB2' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -116.25 121.37 41.83 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 127.091 2.156 . . . . 0.0 108.341 169.123 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 89.0 m -129.37 177.47 7.16 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.429 1.492 . . . . 0.0 110.218 169.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 25.0 tp -78.36 59.92 2.45 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.688 -1.258 . . . . 0.0 110.821 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 49.8 t -55.82 146.06 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.129 1.372 . . . . 0.0 111.194 -172.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -100.03 69.81 1.55 Allowed 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 122.948 1.356 . . . . 0.0 112.047 -167.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.3 t -83.84 69.84 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.37 1.068 . . . . 0.0 110.62 -169.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.77 134.99 23.52 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 124.989 1.316 . . . . 0.0 110.512 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -88.5 -166.41 0.26 Allowed 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 123.517 2.811 . . . . 0.0 113.153 -170.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.65 131.08 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-O 122.927 1.346 . . . . 0.0 113.628 173.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -116.99 160.25 21.23 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.18 2.192 . . . . 0.0 111.744 -173.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -90.02 179.99 5.82 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.065 0.946 . . . . 0.0 112.081 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.99 -21.46 64.87 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -71.2 -19.9 62.34 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.575 1.15 . . . . 0.0 113.819 170.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.08 3.55 60.35 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.599 1.571 . . . . 0.0 114.337 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.06 139.8 30.28 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.585 1.193 . . . . 0.0 113.053 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.2 p -74.34 99.95 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.868 1.667 . . . . 0.0 110.914 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.0 -29.63 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.565 0.746 . . . . 0.0 111.792 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.97 149.14 52.26 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 124.251 1.977 . . . . 0.0 112.626 173.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.2 m-30 -105.01 79.99 1.57 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.27 -1.787 . . . . 0.0 106.886 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 44.3 mt -100.59 70.41 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 169.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.09 89.23 3.6 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.923 0.868 . . . . 0.0 108.822 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -59.86 106.44 0.49 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.663 1.185 . . . . 0.0 110.797 -177.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -84.02 53.21 2.52 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.546 -1.346 . . . . 0.0 112.52 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -79.73 127.2 31.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 122.196 0.998 . . . . 0.0 111.109 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 65.6 t -81.14 117.76 27.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 125.169 1.388 . . . . 0.0 108.327 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.477 0.903 0 CA-C-O 121.416 0.626 . . . . 0.0 112.642 -178.691 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo . . . . . 0 CA--C 1.536 0.612 0 CA-C-O 122.388 0.912 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -65.47 -26.94 68.16 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -167.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -68.76 -49.99 54.15 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.672 0.789 . . . . 0.0 110.299 -178.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 t -74.55 -35.76 63.1 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.716 0.806 . . . . 0.0 112.114 178.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.06 -39.98 83.72 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.498 0.719 . . . . 0.0 110.423 174.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.2 tp -69.99 -45.83 66.46 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.984 0.514 . . . . 0.0 111.869 170.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -47.61 -39.78 17.78 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.974 1.261 . . . . 0.0 113.742 175.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 92.8 m -60.03 -41.69 92.77 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 121.579 -0.701 . . . . 0.0 112.371 172.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.2 mm -68.66 -35.29 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 O-C-N 121.154 -0.966 . . . . 0.0 110.219 174.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.5 mm -56.54 -51.65 62.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 CA-C-O 117.765 -1.112 . . . . 0.0 108.865 170.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -29.02 67.94 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.932 1.242 . . . . 0.0 112.255 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.9 tttp -66.69 -42.79 85.92 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.336 1.054 . . . . 0.0 113.055 174.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -103.65 1.91 32.55 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 . . . . . 0 N--CA 1.476 0.874 0 C-N-CA 126.183 1.793 . . . . 0.0 114.804 -167.875 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.483 1.207 0 CA-C-O 118.794 -0.622 . . . . 0.0 112.241 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -169.79 159.64 8.14 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 -175.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 pp -120.04 172.87 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 126.022 1.729 . . . . 0.0 111.036 174.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.5 mm -131.64 119.72 43.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 125.999 1.72 . . . . 0.0 107.781 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -137.49 152.33 49.41 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -175.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -76.91 107.92 9.58 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.6 174.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.07 -17.42 63.24 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -95.67 2.61 54.14 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.119 1.367 . . . . 0.0 114.034 -169.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.18 140.23 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.797 1.639 . . . . 0.0 110.109 -177.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -57.53 -28.37 63.42 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.18 -14.81 59.31 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.847 1.259 . . . . 0.0 113.982 178.12 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 82.7 m 43.87 50.67 6.97 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.5 1.52 . . . . 0.0 113.377 -177.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.51 150.02 21.95 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -166.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 98.3 t -79.84 90.0 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 128.011 2.524 . . . . 0.0 109.387 -175.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.5 pt -70.02 -23.75 25.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.837 1.255 . . . . 0.0 112.223 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -155.74 159.83 39.8 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.449 1.099 . . . . 0.0 112.329 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.4 p -140.01 154.69 47.2 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.809 -1.182 . . . . 0.0 113.227 173.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -85.94 153.48 22.16 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 174.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -63.29 -24.1 67.71 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.673 173.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.73 -49.99 45.07 Favored Glycine 0 CA--C 1.532 1.138 0 O-C-N 121.308 -0.87 . . . . 0.0 112.249 168.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -37.25 78.59 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 119.208 1.504 . . . . 0.0 110.852 175.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.2 t -60.09 -39.97 87.97 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.538 -0.726 . . . . 0.0 110.896 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -73.93 -30.04 62.35 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.541 0.736 . . . . 0.0 112.327 175.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.4 tp -64.72 -55.67 18.5 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.274 1.029 . . . . 0.0 112.18 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 78.1 m -97.68 -20.71 17.45 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -172.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.21 15.15 81.3 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-O 118.735 -1.036 . . . . 0.0 115.633 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -88.85 -124.26 0.05 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 119.129 1.465 . . . . 0.0 111.316 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.3 m -159.92 150.09 18.57 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.903 2.081 . . . . 0.0 109.719 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -57.07 -36.19 70.26 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.21 -20.68 59.84 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.886 1.274 . . . . 0.0 113.613 174.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -83.15 -20.89 33.9 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.743 1.617 . . . . 0.0 112.279 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -104.46 -19.29 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 177.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 33.4 mmt -49.99 115.4 1.39 Allowed 'General case' 0 C--N 1.343 0.286 0 CA-C-O 122.172 0.986 . . . . 0.0 110.877 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 72.2 17.67 4.93 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.713 2.005 . . . . 0.0 113.703 169.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.57 154.48 81.38 Favored Pre-proline 0 N--CA 1.473 0.697 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.339 167.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -65.41 140.16 62.42 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.983 3.122 . . . . 0.0 112.043 171.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 96.0 m -62.18 -10.0 9.31 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.4 m -65.24 96.47 0.22 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.198 1.799 . . . . 0.0 110.763 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 61.6 m -50.37 -20.01 0.99 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.629 1.972 . . . . 0.0 115.789 -171.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -46.56 -39.48 11.08 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.059 1.344 . . . . 0.0 112.395 169.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -60.98 -20.17 62.03 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 pp -122.98 23.73 9.21 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.885 1.674 . . . . 0.0 113.229 176.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -64.57 147.18 53.4 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.354 -0.842 . . . . 0.0 112.338 175.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.72 -169.69 11.88 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 125.574 1.559 . . . . 0.0 113.989 -176.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -64.68 -10.13 23.53 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.533 2.822 . . . . 0.0 116.378 -170.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.4 mmm-85 -104.96 -10.1 17.48 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.466 1.506 . . . . 0.0 113.601 174.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.469 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 2.9 m -79.21 133.09 36.69 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.228 0.922 . . . . 0.0 111.608 -169.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -85.2 137.03 33.26 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 122.409 1.1 . . . . 0.0 110.683 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -69.48 -39.69 77.53 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.948 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.9 ptt-85 -53.64 -40.31 65.74 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 169.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.4 -50.66 62.71 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.029 0.931 . . . . 0.0 110.261 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.82 -33.85 76.98 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.457 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.98 -51.89 28.82 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.239 1.416 . . . . 0.0 112.098 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -49.97 -41.91 47.69 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.594 1.158 . . . . 0.0 111.799 170.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.7 mt -64.38 -49.13 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 121.824 -0.547 . . . . 0.0 111.602 173.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.49 -39.94 49.7 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.859 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -70.3 -38.78 75.04 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.758 0.823 . . . . 0.0 111.734 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.42 -32.69 73.74 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.455 -0.778 . . . . 0.0 111.399 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mt -86.94 -27.98 23.01 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.814 0.846 . . . . 0.0 111.521 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.98 -30.19 70.76 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.579 1.952 . . . . 0.0 110.658 168.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.94 22.52 6.56 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.725 1.155 . . . . 0.0 114.319 170.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.33 -49.95 75.36 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.405 1.102 . . . . 0.0 109.81 171.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -166.95 141.36 3.93 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.786 2.435 . . . . 0.0 109.534 167.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -72.67 120.52 18.4 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.897 -1.127 . . . . 0.0 108.485 169.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 26.2 tpp180 -157.56 140.3 14.92 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.542 1.537 . . . . 0.0 110.243 -168.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -81.57 137.36 35.53 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.714 0.806 . . . . 0.0 111.628 175.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.0 t -137.83 150.09 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 126.55 1.94 . . . . 0.0 108.183 177.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -79.97 158.37 26.59 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.073 0.949 . . . . 0.0 110.573 171.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.52 HD11 HG21 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -164.29 152.56 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.526 1.13 . . . . 0.0 110.269 171.637 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.469 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -85.88 145.35 27.21 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.008 176.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.511 ' CE1' HD13 ' A' ' 96' ' ' ILE . 22.2 m-85 -117.31 162.04 18.55 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.822 1.249 . . . . 0.0 111.771 176.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -131.15 140.01 49.88 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.017 0.927 . . . . 0.0 111.5 168.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 24.5 mtp-105 -86.29 166.63 15.5 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.553 1.541 . . . . 0.0 113.088 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -58.15 -30.94 66.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.93 2.092 . . . . 0.0 112.839 174.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -78.06 -9.87 59.35 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.876 1.27 . . . . 0.0 114.047 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.65 -0.8 61.37 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 125.701 1.62 . . . . 0.0 116.003 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.0 t -76.46 140.87 41.43 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.799 1.799 . . . . 0.0 111.39 176.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 23.7 p -137.51 137.25 38.45 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -174.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -151.05 148.4 28.29 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.87 1.268 . . . . 0.0 114.256 -172.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -102.6 125.06 49.2 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.52 1.528 . . . . 0.0 108.337 167.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 67.7 m -128.11 166.27 18.79 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.264 1.426 . . . . 0.0 109.867 172.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 mp -80.05 59.81 3.39 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.071 -1.018 . . . . 0.0 110.238 -176.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.472 HG21 HD12 ' A' ' 96' ' ' ILE . 18.2 m -67.66 148.02 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.294 1.838 . . . . 0.0 111.623 -169.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -109.34 69.72 0.71 Allowed 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 122.545 1.164 . . . . 0.0 113.397 -166.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.52 HG21 HD11 ' A' ' 96' ' ' ILE . 10.8 t -80.62 69.8 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 125.093 1.357 . . . . 0.0 110.003 -171.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.7 p -123.79 130.79 24.31 Favored Pre-proline 0 N--CA 1.484 1.259 0 C-N-CA 124.922 1.289 . . . . 0.0 112.535 -169.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -83.05 179.92 4.85 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.237 1.958 . . . . 0.0 113.34 -174.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -123.18 135.62 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 123.089 1.424 . . . . 0.0 112.334 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.09 165.03 22.03 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.779 2.032 . . . . 0.0 112.152 -169.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -89.99 -177.04 5.09 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.139 1.376 . . . . 0.0 111.958 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.8 -19.96 65.41 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -80.04 -19.85 46.67 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.683 1.193 . . . . 0.0 113.087 170.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.35 8.98 59.52 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.345 1.45 . . . . 0.0 114.147 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -84.59 129.25 34.87 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.347 1.574 . . . . 0.0 110.802 175.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.29 99.99 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 125.82 1.648 . . . . 0.0 110.279 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.8 -29.96 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 118.402 -0.809 . . . . 0.0 111.263 176.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.6 mmt -138.0 148.5 45.22 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 123.835 1.779 . . . . 0.0 111.911 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -101.44 87.07 3.1 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 126.613 1.965 . . . . 0.0 108.307 175.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 40.9 mt -100.72 70.82 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 169.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.3 mt -78.65 84.92 4.72 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.801 0.81 . . . . 0.0 109.672 -174.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -59.9 109.74 1.01 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.072 1.349 . . . . 0.0 110.885 -176.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -85.2 49.86 1.83 Allowed 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.215 -1.553 . . . . 0.0 110.857 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -85.54 106.88 17.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 123.468 1.604 . . . . 0.0 113.412 -168.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.0 t -55.16 114.3 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 113.624 -1.625 . . . . 0.0 109.02 171.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.465 0.315 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 171.178 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo . . . . . 0 CA--C 1.536 0.577 0 CA-C-O 121.963 0.735 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -64.36 -26.87 68.66 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -167.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -69.31 -49.86 51.98 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.28 0.632 . . . . 0.0 110.303 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 t -78.69 -32.71 47.16 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.393 1.077 . . . . 0.0 112.883 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -55.26 -44.64 75.77 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.276 1.03 . . . . 0.0 109.594 168.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.7 tp -72.21 -45.22 61.17 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 118.594 -0.717 . . . . 0.0 112.135 175.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -46.73 -39.99 12.62 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.527 1.531 . . . . 0.0 113.349 173.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.4 m -60.0 -45.9 91.22 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.468 173.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.1 mm -68.1 -36.14 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.859 0.864 . . . . 0.0 111.235 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.3 mm -53.28 -57.65 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 172.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -63.43 -24.72 67.96 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.614 0.765 . . . . 0.0 112.946 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.7 tptt -61.63 -45.09 95.56 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 118.347 -0.835 . . . . 0.0 111.974 170.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -103.97 -0.18 29.22 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 116.177 1.918 . . . . 0.0 116.177 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 . . . . . 0 N--CA 1.477 0.895 0 C-N-CA 126.318 1.847 . . . . 0.0 115.736 -168.48 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 ptpp? . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -169.79 167.22 9.42 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.686 1.594 . . . . 0.0 114.212 -177.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 pp -120.04 169.41 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.722 1.209 . . . . 0.0 111.12 167.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.6 mm -125.54 117.94 50.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 126.058 1.743 . . . . 0.0 107.11 171.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.36 147.66 50.64 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -81.01 106.55 13.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.648 0.737 . . . . 0.0 110.644 175.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.88 -6.48 51.01 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 53.1 mmm-85 -100.05 1.85 42.75 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.798 1.639 . . . . 0.0 114.133 -177.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -108.96 140.22 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.381 1.473 . . . . 0.0 109.974 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -55.7 -29.92 60.22 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -175.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -83.89 -12.67 55.15 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 95.9 m 42.99 58.8 3.13 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.497 1.919 . . . . 0.0 113.518 -177.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.0 156.97 16.12 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -168.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.3 t -79.9 89.94 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 128.272 2.629 . . . . 0.0 108.858 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.7 pt -70.48 -25.39 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.857 1.263 . . . . 0.0 112.185 176.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -156.76 159.79 38.64 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.916 0.886 . . . . 0.0 112.701 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 7.9 p -145.34 147.58 32.46 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.209 -0.932 . . . . 0.0 113.289 -169.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -86.26 152.4 22.81 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.503 0.668 . . . . 0.0 112.537 169.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -61.98 -36.06 80.33 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.215 0.606 . . . . 0.0 111.252 171.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.0 -49.94 53.31 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 121.292 -0.88 . . . . 0.0 112.911 175.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -29.94 66.93 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 118.939 1.37 . . . . 0.0 110.823 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.9 t -60.18 -40.03 88.59 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.007 -1.058 . . . . 0.0 111.181 172.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -78.74 -30.02 45.55 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.977 0.911 . . . . 0.0 112.385 175.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.3 tp -55.17 -52.72 62.4 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.886 1.274 . . . . 0.0 110.244 171.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 57.5 m -80.03 -29.17 39.27 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.15 0.5 . . . . 0.0 112.316 176.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.29 26.07 58.13 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 125.376 1.465 . . . . 0.0 114.143 -173.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 16.1 m-30 -94.7 -130.11 0.14 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.881 1.272 . . . . 0.0 111.865 -173.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.0 t -159.88 140.38 11.98 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 127.117 2.167 . . . . 0.0 108.741 175.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.8 mtm105 -64.75 -31.33 72.51 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 120.92 -1.113 . . . . 0.0 113.246 -171.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.81 -16.66 29.98 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.023 0.929 . . . . 0.0 113.403 172.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -95.6 -20.82 18.67 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.476 1.91 . . . . 0.0 112.14 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.1 m -89.89 -18.12 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-N 119.489 1.04 . . . . 0.0 112.694 -174.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 33.6 mmt -49.73 115.42 1.36 Allowed 'General case' 0 C--N 1.341 0.204 0 C-N-CA 125.041 1.336 . . . . 0.0 110.486 -172.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 69.0 21.03 7.58 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.283 1.433 . . . . 0.0 113.62 169.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.72 155.1 93.87 Favored Pre-proline 0 N--CA 1.475 0.794 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.528 167.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.12 140.04 93.23 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.47 2.113 . . . . 0.0 111.649 169.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 37.4 t -64.36 -17.66 63.93 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.62 1.168 . . . . 0.0 112.914 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.6 m -62.61 99.98 0.17 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 127.09 2.156 . . . . 0.0 111.232 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 28.0 p -55.14 -14.17 1.54 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.446 1.498 . . . . 0.0 114.918 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -49.33 -40.06 33.82 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.778 1.231 . . . . 0.0 111.587 168.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -66.73 -11.0 52.77 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 pp -123.04 20.52 9.92 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.14 1.776 . . . . 0.0 113.744 170.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -63.74 144.38 57.08 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.136 -0.978 . . . . 0.0 113.084 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -109.15 175.87 19.36 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.691 1.615 . . . . 0.0 113.754 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.56 -10.05 27.89 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.445 2.763 . . . . 0.0 114.629 -175.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -103.14 -7.63 21.12 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.206 1.402 . . . . 0.0 113.696 170.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.472 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 5.0 m -70.85 134.58 47.44 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.536 1.062 . . . . 0.0 110.355 178.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -81.97 137.39 35.14 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.643 0.735 . . . . 0.0 110.2 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -66.35 -39.85 89.43 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.697 -0.627 . . . . 0.0 110.855 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.5 ptt-85 -55.59 -41.18 73.04 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.802 0.841 . . . . 0.0 113.008 171.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.429 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -64.56 -51.35 63.23 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.766 0.826 . . . . 0.0 110.364 177.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.44 -33.65 76.19 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.247 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.06 -52.77 21.25 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.762 1.225 . . . . 0.0 111.983 177.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -50.0 -42.18 48.64 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.719 1.208 . . . . 0.0 111.859 171.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 54.3 mt -63.8 -51.04 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 121.878 -0.514 . . . . 0.0 110.897 174.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.37 -39.9 58.1 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 118.604 -0.713 . . . . 0.0 112.116 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -69.09 -36.58 77.73 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.64 0.776 . . . . 0.0 111.601 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.49 -30.11 68.87 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.684 -0.635 . . . . 0.0 111.673 177.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mt -83.59 -31.33 26.36 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.565 0.746 . . . . 0.0 111.445 176.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.77 -30.08 71.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.249 2.22 . . . . 0.0 111.484 169.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.05 19.92 7.83 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.797 1.189 . . . . 0.0 114.953 169.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.89 -50.01 73.93 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 118.868 1.334 . . . . 0.0 110.5 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -162.8 141.47 8.63 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.608 2.363 . . . . 0.0 108.934 168.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -78.73 120.47 23.42 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.987 -1.071 . . . . 0.0 108.654 170.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.9 tpp180 -152.19 136.62 16.79 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.311 1.444 . . . . 0.0 109.857 -169.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -79.61 134.44 36.45 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.302 0.641 . . . . 0.0 110.578 173.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.29 148.2 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.645 1.578 . . . . 0.0 109.126 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -79.87 155.73 27.67 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.108 0.963 . . . . 0.0 110.381 172.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.429 HG23 ' HB1' ' A' ' 78' ' ' ALA . 0.7 OUTLIER -163.39 149.75 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.357 1.063 . . . . 0.0 110.858 179.749 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -87.14 145.37 26.46 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.844 176.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -112.3 145.69 39.55 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.032 1.333 . . . . 0.0 111.675 169.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.66 132.27 53.81 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.535 0.734 . . . . 0.0 109.394 167.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 28.7 mtp-105 -100.04 153.35 19.28 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.738 1.615 . . . . 0.0 112.881 -168.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -58.9 -29.44 67.05 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.688 1.195 . . . . 0.0 112.287 171.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -72.27 -10.03 59.25 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.471 1.508 . . . . 0.0 113.878 175.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.49 0.87 55.53 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.49 1.519 . . . . 0.0 115.397 177.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.51 148.72 47.92 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.85 1.325 . . . . 0.0 111.273 174.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 34.3 t -152.0 110.62 3.79 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.245 0.93 . . . . 0.0 111.421 175.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -151.0 151.75 32.52 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -173.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -102.2 126.43 49.17 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.421 1.889 . . . . 0.0 108.989 168.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 73.5 m -130.29 171.47 12.88 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.94 1.296 . . . . 0.0 110.618 170.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 mp -79.96 59.85 3.34 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 120.947 -1.095 . . . . 0.0 110.921 -175.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.0 t -61.28 140.68 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.179 1.391 . . . . 0.0 111.932 -170.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -101.59 69.78 1.24 Allowed 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 123.109 1.433 . . . . 0.0 112.447 -169.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.8 t -78.18 69.97 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.271 1.828 . . . . 0.0 111.481 -173.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.4 p -120.86 131.19 24.54 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.085 -1.009 . . . . 0.0 113.56 -171.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -85.58 -178.9 3.18 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 125.028 3.819 . . . . 0.0 115.578 -169.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.9 m -123.69 131.36 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-O 122.844 1.307 . . . . 0.0 113.048 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -115.4 163.05 16.29 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.876 2.07 . . . . 0.0 111.82 -171.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -95.64 -179.96 4.92 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.269 1.028 . . . . 0.0 112.009 172.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -61.82 -19.99 63.15 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -177.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -71.37 -21.59 62.0 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.529 1.132 . . . . 0.0 113.57 170.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.75 5.25 57.7 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 125.581 1.562 . . . . 0.0 114.695 -174.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -97.51 142.24 29.59 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.852 1.326 . . . . 0.0 113.581 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.7 p -71.12 100.16 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.955 1.702 . . . . 0.0 111.089 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.45 -29.25 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 118.631 -0.7 . . . . 0.0 111.68 174.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.35 147.59 51.83 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 124.277 1.989 . . . . 0.0 113.236 172.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -99.2 86.03 3.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 112.994 -1.912 . . . . 0.0 107.284 173.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 36.3 mt -101.43 70.0 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 122.834 1.302 . . . . 0.0 108.631 170.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.253 17.7 mt -80.27 83.57 6.09 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.118 -177.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -59.8 103.09 0.18 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.429 1.892 . . . . 0.0 110.443 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -83.32 57.41 3.98 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.679 -1.263 . . . . 0.0 112.593 -174.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -79.74 106.93 12.13 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 124.576 2.132 . . . . 0.0 112.265 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.1 t -61.19 110.39 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 C-N-CA 127.24 2.216 . . . . 0.0 109.051 170.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 120.805 0.336 . . . . 0.0 111.699 -179.753 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo . . . . . 0 CA--C 1.534 0.477 0 CA-C-O 122.614 1.006 . . . . 0.0 111.947 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -66.13 -26.65 67.54 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.106 0.962 . . . . 0.0 113.332 -169.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -70.06 -49.9 46.44 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.339 0.656 . . . . 0.0 110.399 -176.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 t -76.13 -33.92 59.42 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.992 0.917 . . . . 0.0 112.32 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -59.96 -40.79 90.23 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.196 0.599 . . . . 0.0 110.328 173.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.3 tp -70.64 -45.68 64.71 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 118.781 -0.628 . . . . 0.0 111.759 171.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.9 -39.78 19.95 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.04 1.291 . . . . 0.0 113.475 175.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 86.6 m -60.12 -42.09 94.04 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.701 -0.624 . . . . 0.0 112.434 172.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.1 mm -68.79 -35.18 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 121.112 -0.993 . . . . 0.0 110.454 174.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.9 mm -56.83 -50.89 73.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 CA-C-O 117.673 -1.156 . . . . 0.0 108.668 170.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.79 -27.76 66.85 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.527 1.512 . . . . 0.0 113.15 174.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -65.82 -42.03 91.11 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.832 0.853 . . . . 0.0 112.361 173.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -107.11 2.43 24.9 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 . . . . . 0 N--CA 1.478 0.948 0 C-N-CA 126.378 1.871 . . . . 0.0 114.311 -168.098 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 110.515 -0.18 . . . . 0.0 110.515 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -169.84 159.1 7.73 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 122.498 1.142 . . . . 0.0 112.899 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -123.91 171.56 12.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.755 173.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.4 mm -127.06 117.25 47.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 125.99 1.716 . . . . 0.0 106.772 174.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.12 148.83 50.6 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -80.74 106.45 12.76 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.388 0.614 . . . . 0.0 110.829 175.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.26 -6.48 53.27 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -96.1 -1.43 48.63 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.579 1.551 . . . . 0.0 113.797 -178.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -110.42 140.18 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.32 1.448 . . . . 0.0 109.951 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -57.4 -23.45 49.38 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -174.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -90.41 -10.53 43.5 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.381 1.472 . . . . 0.0 114.447 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 80.9 m 44.32 54.0 6.45 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.326 1.85 . . . . 0.0 114.663 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.03 158.52 15.77 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -168.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.8 t -79.93 89.97 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 128.624 2.769 . . . . 0.0 109.592 -172.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.4 pt -70.0 -24.46 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.256 1.422 . . . . 0.0 112.393 176.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -153.6 159.6 42.19 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.046 0.938 . . . . 0.0 112.276 174.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 10.0 p -147.27 142.54 27.3 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.038 -1.039 . . . . 0.0 113.268 -173.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -84.78 153.61 22.89 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -61.86 -29.82 70.44 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.757 0.423 . . . . 0.0 111.399 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.36 -49.92 43.01 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 123.945 0.783 . . . . 0.0 112.747 169.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -38.39 81.43 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 119.52 1.66 . . . . 0.0 110.644 175.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.6 t -60.18 -39.9 88.1 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.594 -0.691 . . . . 0.0 110.566 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -74.81 -30.02 61.28 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.339 0.655 . . . . 0.0 112.238 175.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 66.3 tp -63.83 -55.74 20.69 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.245 1.018 . . . . 0.0 111.83 177.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 59.9 m -95.68 -20.01 19.25 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.291 0.636 . . . . 0.0 112.661 -174.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.53 10.05 86.48 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-O 118.339 -1.256 . . . . 0.0 115.549 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -87.97 -121.73 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 119.46 1.63 . . . . 0.0 111.217 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.1 t -159.98 150.22 18.56 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.535 1.934 . . . . 0.0 109.96 -176.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -50.0 -41.13 46.41 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.259 1.024 . . . . 0.0 112.099 172.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.07 -19.94 63.47 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.321 1.048 . . . . 0.0 113.532 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -84.72 -20.71 30.73 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.635 1.574 . . . . 0.0 112.311 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -105.4 -18.84 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 125.66 1.584 . . . . 0.0 115.127 175.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 7.0 mmt -49.81 112.08 0.6 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.402 1.481 . . . . 0.0 111.647 -174.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 67.3 30.82 6.87 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.358 1.863 . . . . 0.0 112.745 171.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -106.75 154.85 39.87 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-O 117.599 -1.191 . . . . 0.0 112.984 177.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.86 137.59 60.75 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.282 2.654 . . . . 0.0 114.124 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 49.4 t -70.11 -9.94 57.14 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 125.427 1.491 . . . . 0.0 113.616 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.0 m -66.33 100.01 0.6 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 127.044 2.138 . . . . 0.0 111.671 -176.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 32.5 m -50.05 -13.2 0.1 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 127.031 2.132 . . . . 0.0 116.478 -176.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -53.7 -35.18 60.85 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.071 0.948 . . . . 0.0 111.607 168.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.9 -10.39 20.61 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 174.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.02 19.95 10.78 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.936 2.494 . . . . 0.0 111.08 178.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.52 138.43 45.03 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.589 -1.32 . . . . 0.0 111.905 177.024 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.72 -169.31 11.78 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.518 1.532 . . . . 0.0 113.57 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -61.23 -10.01 14.31 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 124.253 3.302 . . . . 0.0 117.049 -174.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -107.75 -10.01 15.68 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.943 1.297 . . . . 0.0 113.522 174.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.511 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 3.2 m -82.12 138.35 34.78 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.098 0.863 . . . . 0.0 112.109 -170.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -91.47 134.06 34.96 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 122.32 1.057 . . . . 0.0 110.75 176.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.5 mmm-85 -66.9 -39.71 87.51 Favored 'General case' 0 C--O 1.222 -0.394 0 O-C-N 121.65 -0.657 . . . . 0.0 110.593 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 46.7 ptt85 -51.39 -38.62 54.33 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 170.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.07 -50.71 38.32 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.523 1.129 . . . . 0.0 110.294 177.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.37 -33.85 76.43 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.465 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.06 -53.14 18.81 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.663 1.585 . . . . 0.0 112.22 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -50.14 -41.04 48.13 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.323 0.965 . . . . 0.0 112.514 170.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.8 mt -63.0 -49.69 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 121.684 -0.635 . . . . 0.0 111.368 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.3 -39.95 57.95 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.47 0.577 . . . . 0.0 111.944 174.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -62.97 -40.55 98.05 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.423 0.689 . . . . 0.0 111.723 175.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.49 -31.94 72.43 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 176.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 mt -84.16 -35.9 23.25 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -175.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 pp -69.63 -28.19 65.71 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.455 0.57 . . . . 0.0 111.693 168.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.88 14.77 13.02 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 119.078 -0.846 . . . . 0.0 113.986 168.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.69 -49.88 75.05 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 118.333 1.066 . . . . 0.0 111.216 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -160.3 129.99 5.18 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.859 1.264 . . . . 0.0 112.797 169.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -79.77 124.81 28.94 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.233 1.813 . . . . 0.0 109.084 173.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.1 ttp-105 -159.88 165.08 32.93 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.465 1.506 . . . . 0.0 110.999 171.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -76.73 137.07 39.11 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.7 0.8 . . . . 0.0 110.173 170.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.62 152.36 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.958 1.303 . . . . 0.0 108.917 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -79.89 160.04 26.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.325 0.65 . . . . 0.0 109.609 169.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.511 HD13 ' CZ ' ' A' ' 98' ' ' PHE . 0.2 OUTLIER -165.85 147.65 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.156 0.889 . . . . 0.0 110.64 168.948 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.511 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -90.39 145.43 24.95 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.009 173.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.511 ' CZ ' HD13 ' A' ' 96' ' ' ILE . 54.9 m-85 -118.17 157.2 27.39 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.0 0.92 . . . . 0.0 111.505 173.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -121.14 140.07 52.49 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.467 1.107 . . . . 0.0 110.443 169.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 24.7 mtp-105 -89.81 160.18 16.64 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.573 1.149 . . . . 0.0 111.379 175.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -21.23 65.01 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 172.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -75.24 -10.02 59.08 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.642 1.577 . . . . 0.0 113.61 172.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.81 6.75 67.1 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.384 1.468 . . . . 0.0 115.223 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.8 t -78.94 134.18 36.87 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 118.813 1.306 . . . . 0.0 110.817 175.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 60.8 m -131.61 128.95 40.23 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.635 1.174 . . . . 0.0 111.707 -172.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -151.04 142.72 23.68 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -174.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.429 HD13 ' N ' ' A' ' 108' ' ' CYS . 1.6 tm? -109.57 129.94 55.54 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.06 2.144 . . . . 0.0 108.504 168.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.429 ' N ' HD13 ' A' ' 107' ' ' LEU . 2.2 m -135.84 178.81 6.76 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.368 1.467 . . . . 0.0 111.605 172.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.5 mt -76.69 59.94 1.62 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.416 1.086 . . . . 0.0 111.129 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 36.4 t -61.28 145.16 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.936 1.295 . . . . 0.0 111.406 -173.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -104.16 69.68 0.94 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 122.274 1.035 . . . . 0.0 112.11 -168.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.0 t -83.5 69.91 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.744 0.817 . . . . 0.0 110.476 -169.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 44.8 t -117.12 123.33 30.2 Favored Pre-proline 0 N--CA 1.483 1.213 0 CA-C-O 117.723 -1.132 . . . . 0.0 110.603 -174.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -87.26 -170.36 0.59 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.479 2.786 . . . . 0.0 113.084 -175.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -123.53 126.78 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 123.018 1.39 . . . . 0.0 113.213 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.6 mtmt -112.26 161.12 16.95 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.588 2.355 . . . . 0.0 112.415 -176.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -92.23 179.98 5.41 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.663 -1.153 . . . . 0.0 112.19 172.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.41 -21.69 65.58 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -71.23 -19.89 62.32 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.558 1.143 . . . . 0.0 113.753 170.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.96 4.25 60.23 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.641 1.591 . . . . 0.0 114.322 -176.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -93.19 140.75 29.18 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.462 1.131 . . . . 0.0 113.132 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.14 100.01 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.486 1.514 . . . . 0.0 110.696 -174.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.56 -29.08 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 123.768 0.827 . . . . 0.0 111.795 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.88 148.45 52.29 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 124.111 1.91 . . . . 0.0 112.555 169.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -100.81 85.13 2.83 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.258 -1.792 . . . . 0.0 107.045 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 40.2 mt -99.98 70.04 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 122.86 1.314 . . . . 0.0 108.678 170.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.317 34.7 mt -78.59 88.55 4.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 123.356 1.55 . . . . 0.0 109.843 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -59.88 103.13 0.19 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.501 1.921 . . . . 0.0 110.139 173.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -87.19 50.99 2.12 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 120.683 -1.261 . . . . 0.0 111.85 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -79.97 106.86 12.3 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 124.182 1.944 . . . . 0.0 112.066 -176.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 32.6 t -64.43 114.3 2.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 126.813 2.045 . . . . 0.0 108.694 171.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.475 0.777 0 C-N-CA 122.633 0.373 . . . . 0.0 110.637 176.282 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo . . . . . 0 CA--C 1.536 0.578 0 CA-C-O 122.226 0.844 . . . . 0.0 112.449 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -59.97 -27.25 66.68 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 115.103 1.519 . . . . 0.0 115.103 -165.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -69.99 -49.86 47.34 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.851 0.751 . . . . 0.0 110.407 -176.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 t -76.71 -36.2 57.35 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.1 0.96 . . . . 0.0 112.225 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -57.93 -39.99 79.38 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.951 0.9 . . . . 0.0 110.506 172.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.1 tp -71.49 -44.78 64.09 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.047 0.539 . . . . 0.0 112.266 170.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -47.87 -39.93 20.14 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 120.004 1.275 . . . . 0.0 113.583 176.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.1 m -60.08 -42.6 94.93 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 172.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.1 mm -69.0 -33.96 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.077 0.951 . . . . 0.0 110.436 176.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.5 mm -56.97 -53.7 39.56 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-O 118.202 -0.904 . . . . 0.0 108.714 169.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -25.15 64.9 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.551 1.069 . . . . 0.0 112.924 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.4 tttt -68.8 -45.09 72.17 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.303 1.041 . . . . 0.0 113.443 171.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -100.07 0.28 40.5 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 . . . . . 0 CA--C 1.549 0.94 0 C-N-CA 127.3 2.24 . . . . 0.0 113.53 -169.455 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -169.72 162.49 9.69 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 123.339 1.542 . . . . 0.0 114.455 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 pp -128.35 170.25 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 127.238 2.215 . . . . 0.0 111.15 172.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.5 mm -127.23 120.05 54.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 126.389 1.876 . . . . 0.0 107.293 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.423 ' HB3' ' HB3' ' A' ' 125' ' ' PHE . . . -125.38 149.16 48.4 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 123.829 0.852 . . . . 0.0 112.553 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -81.14 108.82 15.12 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.519 0.676 . . . . 0.0 110.746 172.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.92 -15.73 63.11 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -100.07 3.02 43.79 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.947 1.299 . . . . 0.0 114.116 -169.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.71 140.13 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.36 1.464 . . . . 0.0 110.726 -176.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -60.09 -27.04 66.67 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -176.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -83.46 -10.22 58.51 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.771 1.229 . . . . 0.0 114.204 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 24.9 m 45.56 47.82 11.18 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.28 1.832 . . . . 0.0 113.449 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.97 152.25 26.81 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -167.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.7 t -79.98 90.0 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 127.914 2.486 . . . . 0.0 108.758 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.8 pt -70.03 -24.78 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.731 1.212 . . . . 0.0 112.462 178.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -153.7 159.62 42.07 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.015 0.926 . . . . 0.0 112.484 174.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.2 p -147.85 145.73 28.82 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.111 -0.993 . . . . 0.0 113.077 -175.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -93.03 159.46 15.3 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -64.01 -23.62 67.4 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.531 -0.731 . . . . 0.0 112.384 175.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.74 -50.03 62.91 Favored Glycine 0 CA--C 1.537 1.413 0 CA-C-O 119.015 -0.881 . . . . 0.0 112.669 169.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -38.33 68.74 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.529 1.665 . . . . 0.0 109.787 172.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.7 t -60.25 -39.98 88.65 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.808 -0.558 . . . . 0.0 111.128 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -74.99 -30.03 61.05 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 175.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.8 tp -64.85 -54.57 28.93 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.683 1.593 . . . . 0.0 112.193 178.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 84.0 m -92.8 -22.58 19.24 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.126 0.971 . . . . 0.0 112.431 -178.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.5 10.04 85.84 Favored Glycine 0 CA--C 1.539 1.573 0 N-CA-C 115.758 1.063 . . . . 0.0 115.758 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -93.94 -116.71 0.1 Allowed 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 118.735 1.267 . . . . 0.0 111.68 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.3 t -159.9 150.12 18.62 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.532 1.533 . . . . 0.0 110.719 -177.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.7 mtm180 -57.63 -36.36 71.72 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.662 1.185 . . . . 0.0 112.426 177.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.32 -20.77 63.32 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.182 0.993 . . . . 0.0 113.503 174.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -84.4 -20.77 31.33 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.118 1.367 . . . . 0.0 112.268 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.5 m -105.39 -11.83 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 10.4 mmt -49.86 107.37 0.15 Allowed 'General case' 0 C--N 1.34 0.191 0 C-N-CA 125.078 1.351 . . . . 0.0 110.427 176.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 68.13 22.43 8.31 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.729 1.612 . . . . 0.0 113.224 172.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.58 161.75 57.98 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 124.887 1.275 . . . . 0.0 110.682 168.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -60.45 137.42 74.04 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.7 2.267 . . . . 0.0 113.032 175.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 23.5 t -70.04 -19.83 63.28 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.509 1.124 . . . . 0.0 112.756 170.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -60.36 100.13 0.09 Allowed 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 127.927 2.491 . . . . 0.0 111.222 178.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 54.7 m -49.98 -13.25 0.1 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.829 2.052 . . . . 0.0 116.35 -176.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -55.11 -39.45 69.39 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.979 1.311 . . . . 0.0 111.26 167.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -58.38 -20.12 41.38 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.57 1.548 . . . . 0.0 113.094 172.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.14 20.0 18.85 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 127.498 2.319 . . . . 0.0 112.169 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -56.37 136.98 53.42 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.657 -1.277 . . . . 0.0 113.482 174.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -130.58 177.2 18.49 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 126.343 1.925 . . . . 0.0 111.687 168.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -64.21 -10.13 22.36 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.524 2.816 . . . . 0.0 115.603 -176.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -104.11 -9.95 18.35 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.739 1.615 . . . . 0.0 113.369 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.571 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 3.4 m -76.63 139.42 40.59 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.297 0.953 . . . . 0.0 111.996 -173.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -84.23 129.91 34.86 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 123.126 1.441 . . . . 0.0 109.847 175.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -70.19 -39.91 74.94 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.14 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -59.53 -35.69 74.68 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.27 1.428 . . . . 0.0 113.919 170.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.27 -50.78 64.45 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.427 0.691 . . . . 0.0 110.604 173.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.03 -33.37 75.89 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.22 -52.3 42.74 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.513 1.125 . . . . 0.0 112.192 176.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -50.16 -42.12 50.38 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.053 0.941 . . . . 0.0 112.66 170.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 35.8 mt -63.61 -48.69 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 O-C-N 121.588 -0.695 . . . . 0.0 111.021 174.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.03 -39.82 56.77 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.526 0.603 . . . . 0.0 111.831 173.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -67.84 -38.24 82.92 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.586 0.63 . . . . 0.0 111.952 175.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.99 -26.85 64.28 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.267 0.627 . . . . 0.0 112.565 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 mt -87.74 -33.63 18.63 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.304 0.642 . . . . 0.0 110.95 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -37.68 81.38 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.197 1.799 . . . . 0.0 110.009 169.144 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.02 26.37 4.98 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.796 1.189 . . . . 0.0 114.724 171.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.73 -49.93 74.45 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 118.685 1.242 . . . . 0.0 111.204 173.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -159.0 148.85 19.12 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.066 2.146 . . . . 0.0 109.52 169.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -81.31 117.79 22.09 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.998 -1.063 . . . . 0.0 108.567 172.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 -144.85 136.67 25.69 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.355 1.062 . . . . 0.0 111.623 -169.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -83.22 132.06 35.07 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.429 1.492 . . . . 0.0 110.053 171.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -136.41 151.11 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.444 1.498 . . . . 0.0 109.043 -177.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.73 157.09 27.23 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.275 0.63 . . . . 0.0 109.652 170.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -165.71 148.47 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.073 0.949 . . . . 0.0 110.675 176.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.571 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -87.11 145.32 26.49 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.585 175.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -112.65 160.45 17.88 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.213 1.405 . . . . 0.0 110.634 169.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -125.3 140.1 53.12 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.781 0.8 . . . . 0.0 111.079 169.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 17.6 tpp85 -84.39 150.38 25.38 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.147 1.779 . . . . 0.0 109.921 176.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -55.02 -28.98 56.32 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.992 1.717 . . . . 0.0 113.578 175.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -75.71 -9.95 59.02 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.025 1.33 . . . . 0.0 114.1 175.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.81 -0.04 39.21 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 126.205 1.86 . . . . 0.0 115.576 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 45.2 m -78.8 126.44 30.72 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 119.068 1.434 . . . . 0.0 111.566 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 67.4 m -114.83 134.52 55.06 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.244 1.017 . . . . 0.0 111.667 -176.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -149.97 139.95 21.96 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.979 0.912 . . . . 0.0 112.978 -170.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.477 HD13 ' N ' ' A' ' 108' ' ' CYS . 2.2 tm? -115.76 136.23 53.26 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.493 1.917 . . . . 0.0 110.104 176.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.477 ' N ' HD13 ' A' ' 107' ' ' LEU . 1.7 m -139.34 169.54 17.57 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.757 1.623 . . . . 0.0 109.931 168.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.4 tt -78.54 60.01 2.57 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 121.849 0.833 . . . . 0.0 109.31 172.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.1 t -52.99 149.2 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.962 1.705 . . . . 0.0 110.645 -174.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -99.79 69.74 1.6 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 123.172 1.463 . . . . 0.0 110.811 -168.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.8 t -83.2 69.95 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.677 1.191 . . . . 0.0 110.255 -170.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.85 131.24 24.23 Favored Pre-proline 0 N--CA 1.478 0.932 0 C-N-CA 124.05 0.94 . . . . 0.0 110.712 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -85.1 -168.67 0.53 Allowed 'Trans proline' 0 CA--C 1.551 1.348 0 C-N-CA 123.109 2.539 . . . . 0.0 111.481 -174.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.52 129.52 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-O 123.026 1.394 . . . . 0.0 113.656 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -112.1 162.16 15.73 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.666 2.386 . . . . 0.0 112.838 -176.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -92.85 179.96 5.31 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.499 1.12 . . . . 0.0 112.207 171.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.42 -21.69 65.6 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -70.85 -19.92 62.59 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.563 1.145 . . . . 0.0 113.738 169.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.6 -0.02 59.44 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.007 1.765 . . . . 0.0 114.358 -176.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.6 139.98 30.0 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.609 1.204 . . . . 0.0 113.246 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.7 p -75.97 99.96 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 125.515 1.526 . . . . 0.0 110.216 -175.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.04 -28.9 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.641 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.71 149.99 50.55 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 124.012 1.863 . . . . 0.0 111.922 173.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.423 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 2.3 m-30 -104.02 80.22 1.71 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.857 -1.52 . . . . 0.0 107.843 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.6 mt -99.98 71.15 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 120.611 -1.305 . . . . 0.0 108.789 171.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.419 HD22 ' N ' ' A' ' 127' ' ' LEU . 2.0 mm? -76.91 85.19 3.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 123.41 1.576 . . . . 0.0 108.878 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -59.91 103.8 0.24 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 112.958 -1.928 . . . . 0.0 109.931 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -85.81 59.12 5.44 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 120.69 -1.256 . . . . 0.0 111.784 -177.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -79.77 126.58 31.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 122.163 0.983 . . . . 0.0 110.908 175.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.5 t -81.99 113.2 20.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 125.225 1.41 . . . . 0.0 108.403 -178.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.474 0.749 0 CA-C-O 121.092 0.473 . . . . 0.0 112.077 -176.76 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo . . . . . 0 CA--C 1.537 0.628 0 CA-C-O 122.403 0.918 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -65.62 -27.13 68.18 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -167.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -69.17 -49.86 52.94 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.519 0.727 . . . . 0.0 110.385 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 t -75.52 -34.02 60.76 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.835 0.854 . . . . 0.0 112.405 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -59.92 -41.07 90.94 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.577 -0.702 . . . . 0.0 110.157 172.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.2 tp -70.85 -45.58 64.22 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.076 172.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -47.43 -39.83 16.55 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.238 1.415 . . . . 0.0 113.217 173.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 90.7 m -60.11 -44.02 95.15 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.615 -0.678 . . . . 0.0 112.205 172.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.5 mm -67.81 -35.7 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.834 0.854 . . . . 0.0 110.868 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.4 mm -55.62 -54.44 25.79 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 52.7 mtm180 -60.16 -29.38 68.63 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 118.981 0.809 . . . . 0.0 112.809 176.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.4 tptt -62.82 -42.42 99.72 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 118.676 -0.678 . . . . 0.0 112.265 173.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -104.51 1.64 30.06 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 178.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 . . . . . 0 N--CA 1.478 0.931 0 C-N-CA 125.834 1.654 . . . . 0.0 113.894 -167.717 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 119.342 -0.361 . . . . 0.0 111.82 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -169.77 155.4 5.83 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 123.975 1.845 . . . . 0.0 115.074 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -119.9 165.45 15.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 128.025 2.53 . . . . 0.0 110.167 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.8 mm -127.58 113.71 32.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.52 155.91 39.86 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.884 0.85 . . . . 0.0 112.142 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.9 t-20 -85.72 122.3 29.62 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 176.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.46 -9.18 59.77 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -100.03 6.09 45.06 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.974 1.31 . . . . 0.0 113.477 -173.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.8 m -114.08 139.16 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 126.728 2.011 . . . . 0.0 111.378 -177.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.52 -23.26 65.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.133 0.973 . . . . 0.0 113.456 -175.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -90.8 0.56 57.42 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.538 1.535 . . . . 0.0 113.399 174.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 27.8 p 42.08 46.92 3.8 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.969 1.707 . . . . 0.0 113.098 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.1 149.8 31.97 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -167.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.2 t -81.71 92.37 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 128.762 2.825 . . . . 0.0 109.009 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.6 pt -70.43 -23.14 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 126.195 1.798 . . . . 0.0 112.692 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -158.19 159.73 36.42 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.448 1.499 . . . . 0.0 112.592 174.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.5 p -147.08 154.4 41.12 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.406 -1.434 . . . . 0.0 113.322 173.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -96.23 157.46 15.89 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -59.36 -28.97 67.34 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.186 0.994 . . . . 0.0 112.006 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.86 -50.04 39.42 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.04 0.828 . . . . 0.0 112.918 169.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.92 -35.54 78.71 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 119.321 1.561 . . . . 0.0 110.706 176.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.0 t -60.04 -39.87 87.43 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.171 -0.956 . . . . 0.0 110.548 176.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -75.85 -25.69 56.46 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 174.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 53.4 tp -64.86 -55.74 17.64 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.089 0.956 . . . . 0.0 111.806 175.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.5 m -94.82 -21.15 18.88 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -174.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.73 22.6 78.14 Favored Glycine 0 CA--C 1.539 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 113.564 -169.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.6 m-30 -91.49 -130.1 0.1 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.288 1.435 . . . . 0.0 110.979 -176.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.5 t -162.11 150.17 14.67 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.794 2.438 . . . . 0.0 109.045 177.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.7 ttp180 -50.14 -40.88 47.69 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.751 0.82 . . . . 0.0 111.907 170.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.77 -20.81 63.98 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -87.41 -20.69 26.3 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.335 1.454 . . . . 0.0 113.069 175.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -104.73 -16.33 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 176.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.4 mmt -49.92 110.34 0.38 Allowed 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.424 1.489 . . . . 0.0 111.388 -177.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 71.13 17.05 6.18 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.472 1.509 . . . . 0.0 113.764 171.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.43 160.81 63.99 Favored Pre-proline 0 N--CA 1.475 0.812 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.397 166.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -58.48 140.08 93.2 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.539 2.159 . . . . 0.0 111.639 169.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.504 ' SG ' HD13 ' A' ' 86' ' ' LEU . 1.4 p -64.69 -10.0 23.92 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 169.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.0 m -64.49 93.42 0.1 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.218 1.807 . . . . 0.0 111.683 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 28.4 p -53.13 -14.27 0.62 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.337 1.855 . . . . 0.0 115.34 -176.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -48.13 -40.04 22.43 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.098 0.959 . . . . 0.0 111.565 167.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.85 -19.96 63.17 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 pp -123.1 23.8 9.1 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.476 1.91 . . . . 0.0 113.052 176.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -60.87 140.01 57.81 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.086 -1.009 . . . . 0.0 112.826 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -95.18 171.45 29.71 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.828 1.204 . . . . 0.0 113.325 175.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.0 -10.05 27.19 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.495 2.797 . . . . 0.0 114.446 -177.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -91.55 -9.27 44.9 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.492 1.917 . . . . 0.0 113.442 174.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.6 m -78.02 139.86 39.13 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.984 0.914 . . . . 0.0 112.428 -173.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -85.34 131.68 34.37 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.743 1.259 . . . . 0.0 109.946 168.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.6 mmm-85 -65.79 -39.66 91.18 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.866 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.22 -41.83 50.52 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 169.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.66 -51.23 61.15 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.311 1.044 . . . . 0.0 110.122 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.26 -33.81 76.66 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.729 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.04 -51.39 32.5 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.022 1.729 . . . . 0.0 112.662 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -50.01 -43.89 50.86 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.686 1.194 . . . . 0.0 111.062 170.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 51.2 mt -62.91 -49.52 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.118 174.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.08 -39.86 57.04 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-O 118.248 -0.882 . . . . 0.0 112.179 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -69.0 -38.51 79.3 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.895 0.77 . . . . 0.0 111.466 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.18 -34.85 78.97 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.557 -0.714 . . . . 0.0 111.949 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.504 HD13 ' SG ' ' A' ' 64' ' ' CYS . 3.0 mt -84.87 -24.66 28.43 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.393 0.677 . . . . 0.0 111.674 177.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.78 -30.04 70.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.788 2.035 . . . . 0.0 110.062 168.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.07 17.93 9.16 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.063 1.316 . . . . 0.0 114.84 169.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.94 -50.13 65.48 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.845 1.323 . . . . 0.0 111.126 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -151.94 141.54 21.75 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.843 1.657 . . . . 0.0 111.312 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -74.61 114.52 13.11 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 166.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -149.28 137.26 20.55 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.951 0.9 . . . . 0.0 111.557 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -84.84 130.44 34.66 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.585 1.554 . . . . 0.0 110.196 169.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.6 153.64 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.525 1.53 . . . . 0.0 108.896 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -79.88 160.04 26.19 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.278 1.031 . . . . 0.0 109.812 169.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -169.75 151.92 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.584 1.154 . . . . 0.0 111.129 173.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.48 145.42 25.31 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 174.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -115.15 162.07 17.54 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.968 1.707 . . . . 0.0 111.722 168.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -136.51 140.18 42.82 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.232 0.613 . . . . 0.0 110.792 168.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -84.69 152.43 23.76 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.332 1.053 . . . . 0.0 112.658 177.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -55.1 -25.14 29.51 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.968 1.707 . . . . 0.0 112.974 169.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.54 -11.12 60.72 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.395 1.478 . . . . 0.0 113.949 174.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.61 41.33 5.11 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.843 1.211 . . . . 0.0 114.833 175.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.0 t -136.71 141.71 43.07 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.499 1.12 . . . . 0.0 111.629 176.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 23.9 p -129.82 139.62 51.19 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.423 1.489 . . . . 0.0 113.508 -171.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -150.23 139.94 21.71 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.899 1.279 . . . . 0.0 113.457 -168.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.462 HD13 ' N ' ' A' ' 108' ' ' CYS . 1.6 tm? -108.44 134.34 51.36 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.918 2.087 . . . . 0.0 108.667 169.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.462 ' N ' HD13 ' A' ' 107' ' ' LEU . 1.9 m -140.0 179.11 6.8 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.292 1.437 . . . . 0.0 111.559 171.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.2 mp -78.23 60.0 2.4 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.652 1.181 . . . . 0.0 109.904 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 16.6 t -63.2 145.58 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.587 1.155 . . . . 0.0 111.261 -171.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -107.63 69.74 0.75 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.615 1.198 . . . . 0.0 112.055 -168.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.6 t -84.05 69.86 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.016 0.927 . . . . 0.0 110.886 -169.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.17 136.12 26.07 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 124.611 1.164 . . . . 0.0 111.253 -174.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -86.88 -169.17 0.48 Allowed 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 123.603 2.869 . . . . 0.0 113.361 -172.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -126.47 132.33 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-O 122.835 1.302 . . . . 0.0 113.689 175.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -111.87 166.62 11.05 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 127.042 2.137 . . . . 0.0 112.389 -174.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -97.23 179.95 4.72 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.272 169.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.78 -21.21 65.7 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -70.11 -19.85 63.21 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.583 1.153 . . . . 0.0 113.68 169.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.6 6.5 59.58 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.811 1.672 . . . . 0.0 114.458 -176.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -97.13 141.76 29.87 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.54 1.17 . . . . 0.0 113.594 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.8 100.01 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 126.0 1.72 . . . . 0.0 110.615 -176.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.02 -29.6 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.113 177.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.53 149.98 51.68 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 124.288 1.994 . . . . 0.0 112.646 173.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -104.52 79.89 1.62 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 113.222 -1.808 . . . . 0.0 107.41 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.1 mt -99.91 69.95 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 170.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.66 88.25 4.57 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.985 0.898 . . . . 0.0 108.828 -178.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -59.85 104.22 0.27 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.767 1.227 . . . . 0.0 111.419 -174.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -82.81 53.61 2.45 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.18 -1.575 . . . . 0.0 112.163 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -79.94 106.84 12.26 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 124.076 1.893 . . . . 0.0 112.782 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.1 t -64.77 111.81 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 127.002 2.121 . . . . 0.0 108.738 170.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.472 0.649 0 C-N-CA 122.758 0.423 . . . . 0.0 110.551 176.99 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo . . . . . 0 CA--C 1.536 0.592 0 CA-C-O 122.785 1.077 . . . . 0.0 112.737 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -59.91 -27.41 66.72 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -163.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -67.84 -49.95 59.35 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.731 0.696 . . . . 0.0 110.143 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.6 t -79.77 -35.19 39.02 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.59 1.156 . . . . 0.0 112.679 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -57.97 -39.88 79.25 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.567 1.147 . . . . 0.0 110.243 171.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.8 tp -74.84 -45.49 42.87 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 118.885 -0.579 . . . . 0.0 112.468 170.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -47.8 -39.82 19.31 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.845 1.258 . . . . 0.0 112.628 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 91.3 m -60.07 -42.58 94.84 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.538 -0.726 . . . . 0.0 111.875 175.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.4 mm -68.5 -33.66 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 123.839 0.856 . . . . 0.0 110.194 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.3 mm -59.33 -52.99 54.32 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.517 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 173.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -59.88 -29.21 68.16 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.477 1.111 . . . . 0.0 111.673 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -67.21 -42.11 84.63 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.813 1.245 . . . . 0.0 113.167 175.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -102.84 -0.01 31.96 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 CA--C 1.549 0.915 0 C-N-CA 124.711 1.204 . . . . 0.0 113.391 -166.311 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -169.81 162.99 9.7 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 123.312 1.529 . . . . 0.0 115.094 -171.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -126.57 168.93 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 127.951 2.501 . . . . 0.0 111.203 173.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.5 mm -129.99 120.08 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 126.224 1.81 . . . . 0.0 108.165 178.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.5 155.23 48.96 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -78.58 114.68 17.71 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.977 169.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.03 -17.47 58.78 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -178.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 -96.14 5.93 49.96 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.794 1.238 . . . . 0.0 113.831 -170.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.98 140.16 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.744 1.618 . . . . 0.0 110.694 -175.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -58.19 -29.46 65.67 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.054 0.942 . . . . 0.0 113.187 -176.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -82.73 -5.81 59.08 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.5 p 39.08 45.76 1.08 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.678 1.991 . . . . 0.0 114.646 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.02 149.96 26.63 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 -166.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.1 t -79.94 97.22 2.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 128.907 2.883 . . . . 0.0 108.221 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.6 pt -76.67 -24.02 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.556 1.542 . . . . 0.0 111.735 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -153.6 159.44 42.14 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.963 0.905 . . . . 0.0 112.398 171.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 9.1 p -149.29 143.58 25.93 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.971 -1.08 . . . . 0.0 112.901 -174.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -88.79 157.7 18.4 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 -178.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.48 -31.18 67.6 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.533 -0.729 . . . . 0.0 111.706 169.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.91 -49.81 57.21 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.052 0.834 . . . . 0.0 113.249 169.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -58.32 -37.67 75.58 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 119.05 1.425 . . . . 0.0 109.337 176.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.1 t -60.01 -40.28 88.74 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.108 0.563 . . . . 0.0 111.549 177.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -71.06 -30.29 66.4 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.323 -0.86 . . . . 0.0 112.524 173.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.4 tp -70.12 -44.95 67.91 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.103 1.361 . . . . 0.0 114.196 -177.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 2.2 t -99.57 -24.08 14.86 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.634 0.773 . . . . 0.0 111.869 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.11 10.73 86.0 Favored Glycine 0 CA--C 1.541 1.672 0 O-C-N 120.928 -1.107 . . . . 0.0 115.825 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -94.24 -114.71 0.11 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 118.975 1.387 . . . . 0.0 111.911 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.9 t -159.99 148.97 17.49 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.946 1.299 . . . . 0.0 111.818 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 86.7 mtm-85 -53.74 -41.44 67.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.819 1.248 . . . . 0.0 111.811 171.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.79 -19.52 62.6 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.613 1.165 . . . . 0.0 113.355 177.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -88.37 -20.67 25.01 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.037 1.335 . . . . 0.0 112.911 175.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.7 m -103.67 -3.55 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 35.6 mmt -49.93 114.48 1.09 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.136 0.88 . . . . 0.0 109.804 172.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 70.57 23.93 4.61 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.856 1.662 . . . . 0.0 112.885 172.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -101.32 152.06 37.88 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 124.523 1.129 . . . . 0.0 112.342 -176.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.26 140.07 57.4 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.168 2.579 . . . . 0.0 113.227 -174.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.4 m -67.31 -13.25 61.82 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 173.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.7 m -68.17 100.04 0.97 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.416 1.086 . . . . 0.0 110.853 -176.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 30.4 p -54.56 -13.35 0.94 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.607 1.963 . . . . 0.0 116.123 -173.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -55.85 -36.59 67.7 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.877 -1.14 . . . . 0.0 111.267 169.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -54.7 -24.86 23.91 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.272 1.429 . . . . 0.0 113.509 173.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 pp -123.1 27.71 7.49 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.985 1.714 . . . . 0.0 113.029 177.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -62.63 145.79 53.67 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.231 -0.918 . . . . 0.0 111.984 172.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -127.43 -176.72 14.57 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 125.3 1.429 . . . . 0.0 113.157 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -66.51 -10.14 26.71 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.726 2.284 . . . . 0.0 116.512 -169.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.5 ttm105 -110.08 -2.75 16.81 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.768 1.627 . . . . 0.0 113.865 173.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.486 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 3.7 m -78.52 140.35 38.56 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.053 -1.029 . . . . 0.0 112.047 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -90.22 133.05 35.16 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 123.221 1.486 . . . . 0.0 111.65 172.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.7 mmm-85 -69.19 -39.79 78.45 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.302 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -55.57 -38.5 69.44 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.875 0.761 . . . . 0.0 112.956 171.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.412 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -65.8 -51.21 60.91 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 122.119 0.961 . . . . 0.0 109.88 177.037 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.44 -33.52 76.07 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.837 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.01 -50.01 45.78 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.01 1.724 . . . . 0.0 112.798 177.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -50.17 -42.93 51.99 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.251 1.021 . . . . 0.0 111.372 169.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.4 mt -62.62 -47.71 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 121.798 -0.564 . . . . 0.0 111.605 172.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.28 -39.96 46.9 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.661 -0.685 . . . . 0.0 112.193 174.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -69.01 -38.27 79.14 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.652 0.781 . . . . 0.0 111.551 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.1 -33.17 75.18 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.374 -0.828 . . . . 0.0 111.571 177.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mt -81.59 -29.99 33.15 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.668 0.787 . . . . 0.0 111.987 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.83 -28.72 69.19 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.393 2.277 . . . . 0.0 111.125 169.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.98 17.94 9.21 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.972 1.272 . . . . 0.0 114.873 169.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.36 -49.99 75.39 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.554 1.177 . . . . 0.0 111.495 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -161.39 152.63 18.64 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.517 1.527 . . . . 0.0 112.246 171.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -77.65 110.68 12.69 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 168.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.5 tpp180 -151.0 139.03 20.03 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.461 1.104 . . . . 0.0 110.949 -174.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -76.76 137.19 39.15 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.724 0.81 . . . . 0.0 110.342 170.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.11 148.75 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.772 1.229 . . . . 0.0 109.072 173.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.93 155.48 27.7 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.824 0.85 . . . . 0.0 110.294 171.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.412 HG23 ' HB1' ' A' ' 78' ' ' ALA . 0.3 OUTLIER -164.29 151.21 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 119.228 0.922 . . . . 0.0 111.146 173.169 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.486 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -88.22 145.36 25.92 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.092 176.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -118.04 143.71 46.19 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.504 1.121 . . . . 0.0 112.161 172.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -109.99 140.15 44.32 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.422 0.689 . . . . 0.0 111.336 173.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.6 mmt-85 -81.8 141.16 33.73 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 168.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -49.97 -26.95 4.71 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.994 2.117 . . . . 0.0 113.607 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -64.35 -17.39 63.66 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.316 1.446 . . . . 0.0 114.086 174.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.41 41.26 1.65 Allowed Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.463 1.506 . . . . 0.0 115.453 172.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.3 t -141.97 138.49 31.95 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 118.756 1.278 . . . . 0.0 112.217 175.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 28.9 t -128.9 138.8 52.22 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.483 1.513 . . . . 0.0 113.277 -172.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -150.95 151.33 31.97 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -100.9 127.99 47.13 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 127.917 2.487 . . . . 0.0 109.956 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 41.6 m -132.76 177.92 7.26 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.567 1.547 . . . . 0.0 111.134 171.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -80.05 59.92 3.42 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.415 1.086 . . . . 0.0 110.846 -177.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.5 t -62.16 141.69 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.716 1.606 . . . . 0.0 111.658 -172.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -102.61 69.83 1.11 Allowed 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 122.231 1.015 . . . . 0.0 112.175 -168.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.7 t -83.25 69.84 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 121.391 -0.818 . . . . 0.0 110.726 -168.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.5 t -117.92 127.26 26.74 Favored Pre-proline 0 N--CA 1.473 0.718 0 CA-C-O 117.801 -1.095 . . . . 0.0 109.363 -176.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.488 ' HB3' HD11 ' A' ' 127' ' ' LEU . 60.2 Cg_endo -82.32 -170.09 0.88 Allowed 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.212 2.608 . . . . 0.0 112.434 -177.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -119.89 127.24 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-O 122.865 1.317 . . . . 0.0 112.548 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -121.06 160.02 24.49 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 127.012 2.125 . . . . 0.0 111.909 -176.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -89.87 -179.53 5.75 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.807 0.843 . . . . 0.0 111.556 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -60.02 -21.61 61.55 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -73.68 -19.94 60.69 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.803 1.241 . . . . 0.0 114.156 171.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.92 -4.27 63.0 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.529 1.538 . . . . 0.0 114.073 -176.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -79.77 129.38 34.43 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.308 1.054 . . . . 0.0 111.973 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.67 99.99 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 127.215 2.206 . . . . 0.0 110.536 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.54 -30.04 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 123.397 0.679 . . . . 0.0 111.983 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.52 149.99 50.73 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 124.215 1.96 . . . . 0.0 112.642 174.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.8 m-30 -103.84 80.76 1.8 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.408 -1.724 . . . . 0.0 107.662 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.4 mt -101.18 71.32 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 169.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.488 HD11 ' HB3' ' A' ' 114' ' ' PRO . 0.6 OUTLIER -76.02 90.39 3.03 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 122.32 1.057 . . . . 0.0 108.803 175.519 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -59.97 95.16 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.112 1.365 . . . . 0.0 110.553 176.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -80.99 51.85 1.65 Allowed 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.544 -1.348 . . . . 0.0 112.636 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -79.86 106.81 12.16 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 124.296 1.998 . . . . 0.0 112.681 -176.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 41.2 t -62.49 113.75 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 127.377 2.271 . . . . 0.0 108.917 170.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 120.957 0.408 . . . . 0.0 111.316 177.511 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo . . . . . 0 CA--C 1.534 0.502 0 CA-C-O 122.737 1.057 . . . . 0.0 112.233 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -66.34 -27.17 67.68 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.184 0.993 . . . . 0.0 113.095 -171.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -70.09 -49.85 46.79 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.273 0.629 . . . . 0.0 110.415 -177.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 t -75.61 -34.7 60.61 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.028 0.931 . . . . 0.0 112.377 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -57.93 -42.72 85.45 Favored 'General case' 0 C--N 1.341 0.238 0 O-C-N 121.859 -0.526 . . . . 0.0 110.296 171.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.3 tp -70.02 -44.65 68.85 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 118.869 -0.586 . . . . 0.0 112.062 173.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -48.45 -40.01 24.79 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.882 1.219 . . . . 0.0 112.389 175.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.1 m -60.19 -43.09 96.2 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 121.486 -0.759 . . . . 0.0 112.502 172.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.2 mm -67.7 -35.67 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 123.962 0.905 . . . . 0.0 110.783 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.5 mm -56.21 -54.97 21.42 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 172.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -26.75 66.22 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.469 1.108 . . . . 0.0 112.978 176.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -65.31 -46.56 79.88 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 118.155 -0.926 . . . . 0.0 112.193 172.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -104.04 0.0 29.3 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 . . . . . 0 N--CA 1.477 0.893 0 N-CA-C 116.72 2.119 . . . . 0.0 116.72 -165.593 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.7 mptt . . . . . 0 N--CA 1.478 0.973 0 CA-C-O 119.101 -0.476 . . . . 0.0 111.419 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -169.69 162.1 9.59 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -171.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.6 pp -123.3 169.13 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 127.754 2.422 . . . . 0.0 111.864 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.7 mm -127.74 119.07 50.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 126.365 1.866 . . . . 0.0 108.06 174.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.32 154.6 46.71 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 -177.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -77.38 106.69 9.3 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.287 172.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.81 -15.87 61.17 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -96.09 5.94 49.97 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.918 1.287 . . . . 0.0 114.057 -171.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.99 140.19 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.087 1.755 . . . . 0.0 110.912 -173.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -59.92 -23.56 63.61 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -176.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -76.03 -20.78 57.5 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.238 1.015 . . . . 0.0 113.578 174.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 15.6 m 45.1 42.85 7.04 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.017 1.727 . . . . 0.0 113.991 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.05 164.12 12.13 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 117.282 2.327 . . . . 0.0 117.282 -166.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 67.6 t -79.78 96.97 2.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 128.633 2.773 . . . . 0.0 108.419 -170.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.7 pt -78.76 -24.44 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.637 1.575 . . . . 0.0 111.47 173.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -153.79 159.68 41.98 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.952 0.901 . . . . 0.0 111.424 171.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 25.0 p -144.21 151.39 39.41 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.167 -0.958 . . . . 0.0 112.84 -173.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -87.8 153.27 21.47 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.721 0.772 . . . . 0.0 112.381 168.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -62.81 -32.87 74.14 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.305 0.642 . . . . 0.0 111.254 173.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.94 -50.04 56.41 Favored Glycine 0 CA--C 1.532 1.113 0 O-C-N 121.346 -0.846 . . . . 0.0 112.794 175.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -29.87 66.97 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 118.857 1.328 . . . . 0.0 111.56 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.7 t -59.97 -39.94 87.36 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.344 -0.848 . . . . 0.0 110.877 171.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -77.05 -30.13 55.46 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.435 -0.791 . . . . 0.0 112.387 174.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.6 tp -57.36 -55.72 31.1 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.277 1.431 . . . . 0.0 110.838 175.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.9 p -79.98 -28.08 39.57 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 175.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.53 9.96 74.42 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.913 1.72 . . . . 0.0 115.919 178.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -86.04 -121.83 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 119.547 1.674 . . . . 0.0 112.603 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.3 t -159.88 142.88 13.87 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.12 1.768 . . . . 0.0 110.036 -176.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -63.7 -33.97 76.82 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 121.168 -0.957 . . . . 0.0 112.178 -173.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.87 -16.65 43.99 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.578 1.151 . . . . 0.0 113.778 173.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -94.04 -20.56 19.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.211 2.204 . . . . 0.0 112.602 177.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 m -89.9 -20.05 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-N 120.254 1.388 . . . . 0.0 112.823 -173.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 35.1 mmt -49.98 118.57 2.98 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.587 1.155 . . . . 0.0 110.263 -174.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 72.56 20.33 3.9 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.825 1.65 . . . . 0.0 114.098 170.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -89.92 150.93 44.64 Favored Pre-proline 0 N--CA 1.484 1.231 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 169.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -64.24 140.02 68.91 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 124.062 3.174 . . . . 0.0 113.165 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 76.9 m -70.08 -12.36 61.55 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 169.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.1 m -59.08 100.09 0.06 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 126.888 2.075 . . . . 0.0 110.304 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 54.4 m -53.64 -13.21 0.61 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 -170.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -54.25 -38.31 65.63 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.399 1.08 . . . . 0.0 111.359 167.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -59.89 -20.36 56.82 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.457 1.503 . . . . 0.0 112.918 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.55 20.03 14.98 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 127.377 2.271 . . . . 0.0 111.52 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.05 149.2 45.09 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.629 -1.294 . . . . 0.0 112.826 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.7 -172.41 12.66 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.573 1.559 . . . . 0.0 112.45 172.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.35 -9.99 24.28 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.412 2.741 . . . . 0.0 114.781 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -96.46 -10.1 28.23 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.14 1.376 . . . . 0.0 113.555 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.3 m -82.83 139.72 33.33 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 119.237 0.926 . . . . 0.0 112.181 -170.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -95.74 143.65 26.81 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 122.684 1.23 . . . . 0.0 112.139 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.4 ' HD2' ' H ' ' A' ' 76' ' ' ARG . 0.4 OUTLIER -68.79 -39.88 79.92 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.93 -176.834 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -57.94 -40.71 81.16 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.259 1.024 . . . . 0.0 112.912 174.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.424 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -64.73 -52.19 58.38 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.368 1.067 . . . . 0.0 110.039 176.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.88 -34.79 79.23 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.07 -54.82 11.42 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.69 1.196 . . . . 0.0 111.563 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -50.15 -40.06 45.29 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.243 1.017 . . . . 0.0 112.405 172.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 49.6 mt -64.42 -50.61 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 O-C-N 121.704 -0.623 . . . . 0.0 111.442 173.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.1 -39.93 57.26 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 118.481 -0.771 . . . . 0.0 111.806 175.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -70.63 -37.16 73.76 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.617 0.767 . . . . 0.0 111.852 176.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.34 -33.41 74.25 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.484 -0.76 . . . . 0.0 111.243 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 mt -81.67 -31.96 32.01 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.287 0.635 . . . . 0.0 111.571 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.94 -29.25 70.65 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.494 1.918 . . . . 0.0 111.518 169.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.99 18.44 8.81 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.912 1.244 . . . . 0.0 114.929 169.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.95 -49.9 75.57 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 118.623 1.211 . . . . 0.0 111.424 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -156.75 146.2 20.56 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.535 1.934 . . . . 0.0 110.232 171.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -74.83 113.63 12.33 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 169.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -143.31 136.28 27.79 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.331 -167.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -87.72 129.86 35.01 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.424 1.49 . . . . 0.0 109.535 169.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.1 t -136.09 142.88 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.348 1.459 . . . . 0.0 108.705 -175.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -80.03 150.43 30.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.635 0.774 . . . . 0.0 110.093 172.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.424 HG23 ' HB1' ' A' ' 78' ' ' ALA . 0.6 OUTLIER -161.57 148.88 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.255 1.022 . . . . 0.0 110.843 -179.031 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.04 145.36 25.53 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.3 173.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -119.48 157.55 28.06 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.373 1.069 . . . . 0.0 111.165 175.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -113.93 140.06 48.7 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.834 0.854 . . . . 0.0 109.836 167.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -93.94 150.33 20.46 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.154 1.381 . . . . 0.0 109.585 170.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -17.64 60.73 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -171.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -73.1 -10.03 59.36 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.036 1.334 . . . . 0.0 113.659 172.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.0 9.31 37.34 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.693 1.616 . . . . 0.0 115.442 176.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 63.8 m -91.44 133.16 35.72 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.851 1.326 . . . . 0.0 111.198 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 49.6 t -134.44 129.37 35.17 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.827 0.851 . . . . 0.0 112.86 -176.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -151.01 153.35 34.98 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -173.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.443 HD13 ' N ' ' A' ' 108' ' ' CYS . 2.5 tm? -100.04 135.35 41.61 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.772 2.029 . . . . 0.0 110.435 173.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.443 ' N ' HD13 ' A' ' 107' ' ' LEU . 2.1 m -139.24 170.0 16.75 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.524 1.529 . . . . 0.0 110.706 168.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 31.1 tp -78.33 60.79 2.63 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.796 1.238 . . . . 0.0 110.69 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.7 t -60.79 145.23 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.691 1.196 . . . . 0.0 111.206 -174.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -104.1 69.69 0.95 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 122.493 1.139 . . . . 0.0 111.195 -169.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.1 t -82.76 69.81 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.022 0.929 . . . . 0.0 110.228 -169.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.89 132.46 23.91 Favored Pre-proline 0 N--CA 1.483 1.183 0 C-N-CA 124.26 1.024 . . . . 0.0 111.88 -171.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -88.54 -174.28 1.04 Allowed 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 123.595 2.863 . . . . 0.0 113.797 -171.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.85 129.26 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-O 122.854 1.311 . . . . 0.0 113.658 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -107.72 170.56 7.91 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 127.001 2.12 . . . . 0.0 112.31 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -104.13 179.91 4.14 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 113.666 -1.606 . . . . 0.0 112.346 169.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.25 -19.95 65.01 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -69.34 -19.96 63.86 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.458 1.103 . . . . 0.0 113.681 170.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.95 18.69 49.94 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.468 1.032 . . . . 0.0 113.842 -173.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -110.86 142.4 42.95 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.317 1.047 . . . . 0.0 113.448 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.6 p -74.99 100.06 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.946 1.698 . . . . 0.0 110.814 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.13 -28.94 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 123.303 0.641 . . . . 0.0 111.993 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.33 149.88 50.9 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-O 124.24 1.971 . . . . 0.0 112.654 174.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.8 m-30 -104.87 82.62 1.9 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.222 -1.808 . . . . 0.0 107.337 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.8 mt -100.83 69.88 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 170.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.49 88.93 5.61 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.99 0.9 . . . . 0.0 108.696 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -59.89 108.86 0.82 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.637 1.175 . . . . 0.0 110.712 -176.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -84.17 52.53 2.35 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 120.407 -1.433 . . . . 0.0 112.196 -176.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -79.93 106.89 12.29 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 123.998 1.856 . . . . 0.0 112.294 -178.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 37.0 t -64.74 112.42 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 C-N-CA 126.308 1.843 . . . . 0.0 108.633 171.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.471 0.599 0 C-N-CA 122.842 0.457 . . . . 0.0 110.041 175.198 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo . . . . . 0 CA--C 1.535 0.54 0 CA-C-O 122.459 0.941 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -66.38 -26.79 67.43 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -168.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -68.32 -49.92 57.04 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.719 0.808 . . . . 0.0 110.272 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 t -74.35 -36.43 63.61 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.751 0.821 . . . . 0.0 112.307 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -57.9 -40.02 79.31 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.27 0.628 . . . . 0.0 110.541 173.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.5 tp -71.19 -44.28 65.77 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 118.957 -0.544 . . . . 0.0 112.4 171.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -47.51 -39.9 17.33 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.951 1.3 . . . . 0.0 112.743 175.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 57.0 m -60.14 -42.27 94.47 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 121.193 -0.942 . . . . 0.0 112.549 172.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.8 mm -70.09 -33.31 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.311 1.045 . . . . 0.0 110.785 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.9 mm -56.43 -55.62 18.14 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.426 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 169.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -23.74 63.71 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.303 1.041 . . . . 0.0 113.354 177.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.2 tptp -68.96 -45.49 70.58 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.166 0.986 . . . . 0.0 112.989 171.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -102.45 -0.08 32.98 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 . . . . . 0 N--CA 1.475 0.803 0 C-N-CA 127.256 2.222 . . . . 0.0 116.544 -167.128 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -169.78 159.25 7.92 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 123.189 1.471 . . . . 0.0 114.916 -175.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -120.03 169.01 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 127.574 2.35 . . . . 0.0 111.208 172.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.0 mm -125.25 120.07 57.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 125.957 1.703 . . . . 0.0 107.365 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.0 152.56 48.48 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 178.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -77.31 110.72 12.27 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.301 0.572 . . . . 0.0 111.53 173.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.21 -15.51 61.94 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -99.92 4.63 45.1 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.536 1.309 . . . . 0.0 114.536 -169.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -119.73 140.05 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.422 1.489 . . . . 0.0 110.882 -175.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.4 -23.17 65.62 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -175.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -83.37 -14.52 52.63 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.899 1.28 . . . . 0.0 113.725 175.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.1 m 43.3 54.4 5.14 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.52 1.928 . . . . 0.0 113.528 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.84 154.71 17.59 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -168.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 80.8 t -79.95 90.01 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 128.111 2.565 . . . . 0.0 108.799 -176.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.7 pt -70.11 -23.79 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.698 1.199 . . . . 0.0 112.376 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -155.55 159.66 39.88 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.858 0.863 . . . . 0.0 112.258 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 18.5 p -142.96 139.96 30.89 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 121.342 -0.848 . . . . 0.0 113.069 -173.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -81.82 152.41 26.93 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.724 0.773 . . . . 0.0 112.748 170.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -61.97 -32.26 72.69 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.509 0.724 . . . . 0.0 111.252 175.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.45 -52.55 32.39 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 121.46 -0.775 . . . . 0.0 112.975 172.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.13 -29.73 66.73 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 119.21 1.505 . . . . 0.0 111.136 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.7 t -58.79 -39.82 82.22 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.528 -0.732 . . . . 0.0 110.619 171.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -79.23 -28.31 42.47 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.688 0.795 . . . . 0.0 113.056 174.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.2 tp -57.87 -53.09 62.15 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.051 1.341 . . . . 0.0 110.85 174.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 79.8 m -90.04 -20.01 23.73 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 177.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.71 34.01 40.55 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 124.312 0.958 . . . . 0.0 114.737 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -99.01 -130.18 0.21 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.564 1.146 . . . . 0.0 112.357 -176.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.7 m -159.84 142.88 13.92 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 128.669 2.787 . . . . 0.0 108.143 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -63.98 -40.11 95.65 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 120.922 -1.111 . . . . 0.0 112.934 -169.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.38 -18.04 56.88 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.522 1.129 . . . . 0.0 113.528 174.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -90.21 -20.72 22.7 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.183 1.393 . . . . 0.0 112.179 178.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.7 m -92.7 -14.49 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 CA-C-N 119.31 0.959 . . . . 0.0 113.546 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 35.5 mmt -49.87 114.01 0.98 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.915 1.286 . . . . 0.0 110.467 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 70.15 21.77 5.85 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.88 1.672 . . . . 0.0 113.74 169.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.34 158.84 86.14 Favored Pre-proline 0 N--CA 1.474 0.768 0 O-C-N 121.345 -0.847 . . . . 0.0 111.138 167.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.51 132.99 49.08 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.593 2.196 . . . . 0.0 112.209 171.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 4.6 t -69.99 -23.68 63.19 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.76 1.224 . . . . 0.0 112.548 174.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.0 m -57.04 100.14 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 128.092 2.557 . . . . 0.0 111.792 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 57.7 m -50.04 -21.74 1.35 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -174.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -52.67 -39.19 61.65 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.242 1.017 . . . . 0.0 112.014 171.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -56.14 -24.41 40.85 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.785 1.634 . . . . 0.0 113.4 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 pp -123.08 25.0 8.7 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.048 1.739 . . . . 0.0 113.284 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -63.5 147.26 51.85 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.37 -0.831 . . . . 0.0 112.613 176.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.5 -174.6 13.7 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 125.69 1.615 . . . . 0.0 113.709 -176.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -67.91 -4.38 12.28 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.995 3.13 . . . . 0.0 116.098 -170.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 78.9 mmt-85 -110.26 -10.05 14.64 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 119.609 1.095 . . . . 0.0 113.519 169.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.8 m -73.94 134.98 43.22 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.23 0.923 . . . . 0.0 110.812 -173.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -85.38 137.46 32.92 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.84 0.829 . . . . 0.0 110.029 173.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.0 mmm-85 -67.36 -39.67 85.73 Favored 'General case' 0 C--O 1.219 -0.517 0 O-C-N 121.402 -0.811 . . . . 0.0 111.084 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.1 ptt-85 -53.6 -38.63 64.15 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 169.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.85 -52.15 52.84 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 122.04 0.924 . . . . 0.0 110.079 175.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.42 -33.8 76.8 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.618 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.12 -51.85 28.33 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.783 1.633 . . . . 0.0 112.057 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -50.17 -41.62 49.53 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.456 1.025 . . . . 0.0 112.341 169.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 46.2 mt -62.94 -50.03 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 O-C-N 121.769 -0.582 . . . . 0.0 111.047 172.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.08 -39.79 56.89 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.374 -0.822 . . . . 0.0 112.173 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -69.84 -37.95 76.35 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.589 0.755 . . . . 0.0 111.473 176.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.23 -32.88 74.22 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.536 -0.727 . . . . 0.0 111.075 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mt -81.35 -33.47 32.39 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.452 0.701 . . . . 0.0 111.693 176.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.05 -28.47 69.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.791 2.036 . . . . 0.0 111.28 169.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.09 17.6 9.41 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.007 1.289 . . . . 0.0 114.84 169.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.85 -49.91 75.55 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 118.526 1.163 . . . . 0.0 111.439 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -161.56 151.65 17.14 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.695 1.598 . . . . 0.0 111.926 171.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -72.18 112.98 8.73 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 167.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.5 tpp180 -148.26 135.97 20.78 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.268 1.027 . . . . 0.0 111.431 -176.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -83.87 131.95 34.83 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.403 1.481 . . . . 0.0 110.204 169.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.7 t -134.93 146.12 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.353 1.461 . . . . 0.0 109.074 -176.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -80.05 152.5 29.36 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.773 0.829 . . . . 0.0 110.011 171.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -163.25 148.71 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.42 1.088 . . . . 0.0 110.813 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.8 145.38 25.22 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.665 174.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -117.18 154.14 31.61 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.677 1.191 . . . . 0.0 111.088 172.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -123.9 140.05 53.36 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.535 0.734 . . . . 0.0 110.811 169.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -83.11 162.12 21.42 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.953 1.301 . . . . 0.0 113.28 177.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -50.05 -35.28 24.42 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.469 1.908 . . . . 0.0 113.417 171.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -81.75 -9.91 59.51 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.56 1.144 . . . . 0.0 113.946 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.96 2.07 48.86 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.789 1.661 . . . . 0.0 115.382 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.5 m -74.66 125.11 27.99 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.936 1.368 . . . . 0.0 110.717 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 19.1 t -127.9 132.75 49.28 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.208 1.003 . . . . 0.0 112.589 -170.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -151.06 139.98 20.95 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.57 1.148 . . . . 0.0 113.825 -169.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.419 HD13 ' N ' ' A' ' 108' ' ' CYS . 1.9 tm? -104.81 128.75 53.08 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.405 1.882 . . . . 0.0 109.033 168.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.419 ' N ' HD13 ' A' ' 107' ' ' LEU . 62.3 m -134.99 172.66 12.69 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.422 1.489 . . . . 0.0 110.018 169.082 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 28.6 tp -79.98 59.88 3.37 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.983 -1.073 . . . . 0.0 110.81 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.7 t -58.42 146.28 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.253 1.421 . . . . 0.0 111.662 -171.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -100.87 69.72 1.35 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 122.608 1.194 . . . . 0.0 111.622 -168.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.7 t -83.32 69.86 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.229 1.011 . . . . 0.0 110.389 -169.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.0 p -119.51 133.47 23.8 Favored Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 124.689 1.195 . . . . 0.0 111.441 -173.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -88.79 -171.34 0.57 Allowed 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 123.761 2.974 . . . . 0.0 113.55 -171.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.7 m -127.81 127.19 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-O 122.811 1.291 . . . . 0.0 113.573 174.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -114.12 165.07 13.02 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 127.273 2.229 . . . . 0.0 112.202 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -94.22 179.99 5.12 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.654 174.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.65 -20.62 63.61 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -71.39 -19.87 62.21 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.546 1.139 . . . . 0.0 114.025 171.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.95 0.96 58.6 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 124.815 1.197 . . . . 0.0 114.127 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.21 126.25 37.21 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.485 1.114 . . . . 0.0 112.025 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.7 p -59.95 99.8 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 128.214 2.605 . . . . 0.0 109.796 171.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.22 -30.06 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.975 177.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.9 mmt -135.46 148.37 49.23 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 124.167 1.937 . . . . 0.0 111.128 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.8 m-30 -104.85 80.39 1.63 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.934 1.694 . . . . 0.0 106.749 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.0 mt -100.05 69.85 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 171.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.87 90.14 4.7 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -59.81 109.05 0.84 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.515 1.126 . . . . 0.0 110.857 -176.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -84.46 49.98 1.79 Allowed 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.233 -1.542 . . . . 0.0 112.515 -177.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -79.84 107.05 12.32 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 123.685 1.707 . . . . 0.0 111.98 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.3 t -57.94 115.82 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 127.166 2.186 . . . . 0.0 109.44 170.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.475 0.801 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 176.757 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo . . . . . 0 CA--C 1.537 0.652 0 CA-C-O 122.708 1.045 . . . . 0.0 113.149 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -68.48 -25.22 64.86 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.485 -0.76 . . . . 0.0 112.855 -169.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -66.7 -49.85 64.74 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.07 0.948 . . . . 0.0 110.384 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 t -75.71 -35.8 60.17 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.829 0.852 . . . . 0.0 112.347 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -57.8 -40.69 80.5 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.138 0.575 . . . . 0.0 110.388 172.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.1 tp -72.54 -43.63 63.25 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 118.607 -0.711 . . . . 0.0 112.289 172.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -48.58 -39.97 25.66 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 120.077 1.308 . . . . 0.0 112.164 175.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 78.9 m -60.12 -42.64 95.21 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 121.607 -0.683 . . . . 0.0 112.732 173.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.1 mm -69.95 -32.74 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.219 1.008 . . . . 0.0 111.011 176.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.7 mm -57.08 -55.8 18.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 170.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -25.33 64.98 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 176.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.1 tptt -68.58 -42.19 78.61 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.087 0.955 . . . . 0.0 112.271 172.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -114.99 16.39 17.14 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 -175.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 -166.914 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -169.78 162.45 9.55 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -172.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 pp -129.25 170.66 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 127.323 2.249 . . . . 0.0 111.347 175.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.1 mm -126.21 114.45 38.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 126.368 1.867 . . . . 0.0 107.388 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.5 150.26 41.85 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 124.325 1.05 . . . . 0.0 111.614 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -81.72 114.03 20.11 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.391 1.076 . . . . 0.0 110.37 176.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.82 4.16 45.55 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 175.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -100.19 -3.38 31.74 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.397 1.479 . . . . 0.0 113.936 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 p -118.15 139.29 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.83 1.652 . . . . 0.0 111.501 -176.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -62.15 -26.39 68.3 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.926 0.89 . . . . 0.0 112.937 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -77.53 -8.88 58.48 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.824 1.25 . . . . 0.0 113.93 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.0 p 43.62 35.4 0.99 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 126.991 2.116 . . . . 0.0 114.877 -176.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.71 154.87 29.73 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -167.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 98.9 t -79.99 89.99 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 129.143 2.977 . . . . 0.0 109.02 -175.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.0 pt -69.94 -24.25 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.462 1.505 . . . . 0.0 112.392 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -153.92 159.66 41.82 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.281 1.033 . . . . 0.0 112.224 171.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 18.6 p -143.77 147.35 34.05 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.817 -1.177 . . . . 0.0 112.798 -177.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -89.74 156.86 18.24 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 176.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -58.81 -27.4 65.04 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.277 0.631 . . . . 0.0 111.626 169.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.7 -56.64 12.84 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 119.218 -0.768 . . . . 0.0 112.465 169.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -53.19 -39.49 63.69 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.4 1.6 . . . . 0.0 111.371 174.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.3 t -60.14 -40.06 88.47 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.901 -0.5 . . . . 0.0 111.308 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -78.56 -25.86 45.49 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.978 0.911 . . . . 0.0 112.979 176.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 36.2 tp -66.26 -55.74 14.66 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.877 1.271 . . . . 0.0 111.213 176.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 78.4 m -93.35 -22.06 19.18 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.638 0.775 . . . . 0.0 113.084 -176.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.22 20.07 79.82 Favored Glycine 0 CA--C 1.539 1.586 0 O-C-N 121.034 -1.041 . . . . 0.0 113.855 -171.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -87.47 -130.02 0.06 Allowed 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 118.493 1.147 . . . . 0.0 110.839 -176.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.0 t -160.66 150.16 17.31 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 127.862 2.465 . . . . 0.0 108.846 176.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.08 -38.87 54.29 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 121.466 -0.771 . . . . 0.0 112.624 172.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.51 -19.99 64.16 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.56 1.144 . . . . 0.0 113.737 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -86.76 -20.73 27.19 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.267 1.427 . . . . 0.0 113.189 174.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -105.41 -18.49 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 176.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.5 mmt -49.84 111.41 0.51 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.491 1.517 . . . . 0.0 111.248 -172.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 66.83 30.67 7.76 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.823 1.649 . . . . 0.0 112.544 170.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -107.21 154.4 40.52 Favored Pre-proline 0 N--CA 1.471 0.61 0 CA-C-O 117.321 -1.323 . . . . 0.0 112.594 176.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -50.59 134.82 40.56 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.267 2.645 . . . . 0.0 113.95 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 52.7 t -66.68 -17.86 65.07 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.727 1.211 . . . . 0.0 112.981 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.2 m -61.88 99.99 0.14 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.211 1.804 . . . . 0.0 111.859 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 27.8 p -54.08 -15.69 1.59 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -175.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -52.85 -38.74 61.85 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.991 0.917 . . . . 0.0 111.523 170.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -64.78 -15.19 61.32 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 pp -123.06 25.38 8.54 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.118 1.767 . . . . 0.0 113.358 172.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -62.34 148.33 45.52 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.197 -0.94 . . . . 0.0 112.62 176.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.96 -179.75 16.04 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 125.126 1.346 . . . . 0.0 114.09 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -63.5 -10.01 20.17 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.572 2.848 . . . . 0.0 116.629 -174.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -110.03 -2.27 17.13 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.412 1.485 . . . . 0.0 114.15 173.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.509 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 3.2 m -80.8 139.99 35.72 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.348 0.976 . . . . 0.0 111.944 -177.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -87.27 135.61 33.25 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 122.493 1.139 . . . . 0.0 111.407 171.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.8 mmm-85 -69.79 -39.74 76.43 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 118.573 -0.727 . . . . 0.0 110.965 176.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.2 ptp85 -54.13 -38.37 65.37 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 169.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.406 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -65.23 -52.81 52.21 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 122.111 0.958 . . . . 0.0 110.05 174.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.24 -32.71 74.52 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.695 -178.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.1 -50.22 43.03 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.17 1.788 . . . . 0.0 112.559 176.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -50.11 -42.61 50.7 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.659 1.118 . . . . 0.0 111.975 169.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 43.0 mt -61.31 -48.83 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.857 -0.527 . . . . 0.0 111.271 173.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.56 -39.88 58.69 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.131 0.572 . . . . 0.0 111.957 174.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -62.63 -40.81 98.18 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.556 0.742 . . . . 0.0 111.284 175.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.01 -29.13 68.05 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 175.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mt -86.55 -32.48 20.67 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.1 pp -71.48 -30.3 65.83 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.618 -0.676 . . . . 0.0 111.227 167.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.83 20.06 7.85 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 118.988 -0.896 . . . . 0.0 113.823 168.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.27 -50.0 68.28 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 118.486 1.143 . . . . 0.0 111.179 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -167.27 150.21 6.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.938 2.095 . . . . 0.0 110.566 169.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -86.84 130.15 34.59 Favored 'General case' 0 C--O 1.238 0.471 0 O-C-N 121.21 -0.931 . . . . 0.0 109.166 -178.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.06 150.54 27.36 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.092 0.957 . . . . 0.0 112.351 174.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -76.77 138.44 39.91 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.275 1.03 . . . . 0.0 109.339 168.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -139.24 144.75 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.332 1.053 . . . . 0.0 109.525 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -80.01 152.62 29.35 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.905 0.882 . . . . 0.0 110.04 171.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.406 HG23 ' HB1' ' A' ' 78' ' ' ALA . 0.6 OUTLIER -163.46 148.05 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.235 1.014 . . . . 0.0 111.028 179.209 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.509 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -90.76 145.37 24.85 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.888 0.475 . . . . 0.0 112.247 177.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -117.51 162.56 17.78 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.767 1.227 . . . . 0.0 111.93 172.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -127.94 136.46 51.36 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.604 0.761 . . . . 0.0 111.531 168.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.7 mmt85 -71.08 152.22 43.72 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.446 1.498 . . . . 0.0 111.624 173.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -54.88 -30.57 58.29 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.788 1.235 . . . . 0.0 112.341 168.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -76.21 -9.95 59.03 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.568 1.547 . . . . 0.0 114.271 175.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.8 10.23 47.16 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.296 1.427 . . . . 0.0 116.313 174.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.3 m -87.61 135.12 33.49 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 119.14 1.47 . . . . 0.0 111.578 176.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 59.3 m -123.24 133.18 54.22 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.467 1.107 . . . . 0.0 112.243 -171.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -150.9 140.47 21.59 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -176.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -102.58 127.46 49.65 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.004 1.722 . . . . 0.0 108.465 168.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 60.9 m -128.45 168.49 15.56 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.435 1.094 . . . . 0.0 110.579 171.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 73.2 mt -79.99 59.85 3.36 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.876 -1.14 . . . . 0.0 110.199 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.3 t -59.06 146.37 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.531 1.532 . . . . 0.0 112.208 -168.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -100.05 69.69 1.53 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 122.56 1.172 . . . . 0.0 112.31 -168.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.9 t -84.67 69.85 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 121.372 -0.83 . . . . 0.0 111.346 -168.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.2 t -111.25 129.2 24.28 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 124.504 1.121 . . . . 0.0 109.464 -178.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -82.96 -168.67 0.61 Allowed 'Trans proline' 0 CA--C 1.553 1.427 0 C-N-CA 123.121 2.548 . . . . 0.0 111.298 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -127.17 128.9 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-O 123.124 1.44 . . . . 0.0 113.945 175.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -111.7 162.2 15.46 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.675 2.39 . . . . 0.0 112.818 -175.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -94.46 -178.95 4.74 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.475 172.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -61.57 -22.18 64.96 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -71.89 -19.98 61.86 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.641 1.177 . . . . 0.0 113.829 170.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.32 -0.03 59.85 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 126.017 1.77 . . . . 0.0 114.372 -176.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.4 140.01 29.94 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.541 1.171 . . . . 0.0 113.146 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.3 p -73.95 98.89 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.668 1.587 . . . . 0.0 109.8 -176.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.96 -30.03 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 118.397 -0.811 . . . . 0.0 111.059 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.7 mmt -135.96 149.91 49.07 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-O 123.455 1.597 . . . . 0.0 110.452 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.2 m-30 -105.61 81.09 1.63 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -175.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.9 mt -99.95 69.99 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 120.206 -1.559 . . . . 0.0 108.295 173.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -73.96 87.64 1.83 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 123.405 1.574 . . . . 0.0 109.398 176.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -59.89 96.54 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 112.845 -1.98 . . . . 0.0 109.862 176.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -83.4 52.76 2.3 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.454 -1.403 . . . . 0.0 111.881 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -79.84 127.08 31.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 122.065 0.936 . . . . 0.0 111.992 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 t -69.36 123.56 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.423 1.089 . . . . 0.0 109.016 172.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 169.25 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo . . . . . 0 CA--C 1.536 0.604 0 CA-C-O 122.3 0.875 . . . . 0.0 112.031 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -63.87 -27.16 68.97 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -168.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -68.45 -50.0 55.72 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.754 0.822 . . . . 0.0 110.371 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 t -75.67 -33.9 60.43 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.835 0.854 . . . . 0.0 112.488 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -59.9 -40.35 88.47 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.454 0.702 . . . . 0.0 110.185 172.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.4 tp -71.6 -45.99 60.55 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-O 118.824 -0.607 . . . . 0.0 112.161 172.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -46.86 -39.75 12.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.587 1.555 . . . . 0.0 113.353 173.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 90.3 m -60.01 -44.77 94.35 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.546 -0.721 . . . . 0.0 112.025 172.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.1 mm -67.3 -35.54 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.881 0.872 . . . . 0.0 110.756 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.4 mm -55.78 -54.95 20.66 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 172.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 -59.96 -28.43 67.65 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.981 0.809 . . . . 0.0 113.038 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.7 tttt -64.27 -41.69 96.79 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 172.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -103.51 1.01 31.76 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 . . . . . 0 N--CA 1.477 0.894 0 C-N-CA 126.872 2.069 . . . . 0.0 114.16 -168.612 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.6 mttp . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -169.72 161.5 9.28 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.392 1.477 . . . . 0.0 113.374 176.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -125.01 167.92 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 126.845 2.058 . . . . 0.0 111.636 170.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.6 mm -125.74 122.43 62.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 125.846 1.658 . . . . 0.0 107.882 173.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.41 152.78 49.43 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 178.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -77.91 106.72 9.95 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 121.561 0.696 . . . . 0.0 111.191 172.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.71 -14.98 61.23 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -94.97 4.14 54.14 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.808 1.243 . . . . 0.0 114.163 -172.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -117.73 140.09 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.482 1.513 . . . . 0.0 110.647 -176.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.34 -26.05 66.28 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -177.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.83 -8.95 59.85 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.223 1.409 . . . . 0.0 114.001 177.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.5 p 35.34 56.12 0.84 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 127.043 2.137 . . . . 0.0 114.214 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.93 153.14 17.92 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -167.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.0 t -79.97 89.97 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 128.64 2.776 . . . . 0.0 108.895 -176.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.5 pt -70.82 -24.64 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.642 1.177 . . . . 0.0 112.2 176.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -154.9 159.77 40.7 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 177.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 25.5 p -142.29 146.8 35.46 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -172.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -92.01 154.1 19.0 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.549 0.69 . . . . 0.0 112.595 167.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -62.9 -33.56 75.57 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.265 0.626 . . . . 0.0 111.14 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.95 -49.95 56.78 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 121.69 -0.631 . . . . 0.0 113.155 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.02 -29.86 67.01 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 119.41 1.605 . . . . 0.0 111.141 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.8 t -59.19 -39.87 83.92 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 120.78 -1.2 . . . . 0.0 110.429 171.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -79.49 -24.79 42.07 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.285 1.034 . . . . 0.0 112.935 173.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.4 tp -59.33 -50.33 74.39 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.438 1.095 . . . . 0.0 110.398 172.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.1 m -86.68 -23.71 25.51 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 175.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.59 31.72 60.37 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 124.481 1.038 . . . . 0.0 114.197 -175.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 17.7 m-30 -95.99 -130.16 0.16 Allowed 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 118.379 1.09 . . . . 0.0 112.146 -175.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.4 t -160.06 149.96 18.19 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 128.026 2.53 . . . . 0.0 108.578 174.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -61.3 -35.35 77.09 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 120.699 -1.251 . . . . 0.0 113.234 -173.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.42 -16.67 48.92 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.436 1.094 . . . . 0.0 113.26 175.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -93.66 -20.86 19.77 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.422 1.889 . . . . 0.0 111.99 178.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 m -95.83 -19.99 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 119.762 1.164 . . . . 0.0 113.296 -174.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 34.3 mmt -50.01 112.97 0.75 Allowed 'General case' 0 C--N 1.342 0.248 0 C-N-CA 124.683 1.193 . . . . 0.0 110.889 -173.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 68.74 21.99 7.56 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.193 1.397 . . . . 0.0 113.549 169.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.3 158.79 86.92 Favored Pre-proline 0 N--CA 1.475 0.785 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.687 167.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.78 140.01 93.23 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.117 1.878 . . . . 0.0 111.481 169.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 3.9 t -69.62 -14.69 62.96 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.043 1.337 . . . . 0.0 112.747 177.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.28 99.8 0.31 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 127.82 2.448 . . . . 0.0 110.544 176.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 30.4 p -55.23 -14.86 1.93 Allowed 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.638 -1.165 . . . . 0.0 113.652 174.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -47.15 -42.82 20.28 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.442 1.497 . . . . 0.0 111.828 167.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -66.81 -12.66 59.77 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 pp -123.05 23.62 9.2 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.282 1.833 . . . . 0.0 113.428 171.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.12 146.85 53.52 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.036 -1.04 . . . . 0.0 112.912 177.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -123.19 -177.43 15.14 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.309 1.433 . . . . 0.0 114.547 -173.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -66.78 -10.15 27.18 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.009 2.473 . . . . 0.0 116.218 -172.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -110.07 -5.34 15.42 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.702 1.201 . . . . 0.0 113.898 170.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.533 HG23 ' H ' ' A' ' 97' ' ' ALA . 3.6 m -71.23 134.1 46.62 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.889 1.222 . . . . 0.0 110.076 177.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -79.88 134.59 36.31 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 122.263 1.03 . . . . 0.0 109.072 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -66.3 -39.71 89.51 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.342 -0.849 . . . . 0.0 110.105 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.8 ptt-85 -55.34 -38.91 69.38 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.559 1.144 . . . . 0.0 113.909 169.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.42 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -63.16 -52.84 60.79 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.987 0.915 . . . . 0.0 110.482 174.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.05 -34.45 78.45 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.181 -178.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.09 -52.81 24.53 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.599 1.16 . . . . 0.0 112.194 176.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -50.18 -40.01 45.59 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.378 0.99 . . . . 0.0 112.921 171.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 46.2 mt -63.62 -49.27 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 121.453 -0.779 . . . . 0.0 111.365 173.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.75 -39.88 59.3 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.777 0.717 . . . . 0.0 111.763 173.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -63.29 -39.76 95.48 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.319 0.648 . . . . 0.0 111.542 175.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.04 -29.7 68.74 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.3 mt -82.79 -34.97 26.87 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.9 pp -70.66 -27.2 63.85 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.976 -0.453 . . . . 0.0 112.056 167.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.93 17.48 9.6 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.315 -0.714 . . . . 0.0 114.2 169.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -51.61 -49.88 61.32 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 118.087 0.944 . . . . 0.0 112.042 173.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -157.01 142.74 17.66 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.52 1.928 . . . . 0.0 110.644 170.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -75.81 118.19 18.35 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.71 -1.244 . . . . 0.0 108.017 169.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -146.23 135.62 22.94 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.851 0.86 . . . . 0.0 112.474 -167.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -86.88 130.0 34.65 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.043 1.337 . . . . 0.0 109.518 168.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.71 144.28 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.21 1.404 . . . . 0.0 109.081 -175.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -79.88 150.62 30.54 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.522 0.729 . . . . 0.0 109.891 171.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.42 HG23 ' HB1' ' A' ' 78' ' ' ALA . 0.7 OUTLIER -160.86 159.98 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.367 1.067 . . . . 0.0 110.32 -177.565 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.533 ' H ' HG23 ' A' ' 74' ' ' THR . . . -102.09 145.31 29.52 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.807 171.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -112.4 152.59 28.47 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.862 1.665 . . . . 0.0 110.645 169.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -127.06 139.56 52.91 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.44 0.638 . . . . 0.0 110.289 167.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -84.9 158.55 20.54 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.786 1.234 . . . . 0.0 112.927 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -54.68 -30.44 55.63 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.574 1.55 . . . . 0.0 112.853 169.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -75.45 -9.94 59.02 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.115 1.366 . . . . 0.0 113.998 175.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.08 3.82 55.6 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.76 1.647 . . . . 0.0 115.763 176.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 54.2 m -84.57 128.24 34.49 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 119.169 1.484 . . . . 0.0 111.347 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 46.9 t -124.43 129.88 51.47 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.065 1.346 . . . . 0.0 112.005 -173.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -150.91 139.96 21.07 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.399 1.079 . . . . 0.0 113.764 -169.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.0 134.87 49.51 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.711 2.404 . . . . 0.0 109.121 172.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 4.5 m -139.04 173.1 11.91 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.66 1.584 . . . . 0.0 110.281 168.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 26.6 tp -76.95 59.84 1.7 Allowed 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.019 -1.051 . . . . 0.0 109.995 173.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.7 t -59.81 146.98 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.955 1.302 . . . . 0.0 110.8 -172.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -100.0 69.72 1.55 Allowed 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 122.802 1.287 . . . . 0.0 112.584 -168.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.1 t -84.19 69.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.343 1.057 . . . . 0.0 110.89 -169.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.2 p -117.88 134.07 23.31 Favored Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 124.038 0.935 . . . . 0.0 111.887 -173.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -86.81 -173.22 1.1 Allowed 'Trans proline' 0 CA--C 1.546 1.089 0 C-N-CA 123.472 2.781 . . . . 0.0 113.445 -172.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.16 127.12 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-O 122.972 1.368 . . . . 0.0 113.483 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -110.62 162.07 15.1 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.634 2.374 . . . . 0.0 112.63 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -92.81 179.97 5.31 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.735 -1.121 . . . . 0.0 112.156 171.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.67 -21.4 65.69 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -70.84 -19.87 62.61 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.481 1.112 . . . . 0.0 113.737 169.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.69 0.09 59.27 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 126.007 1.765 . . . . 0.0 114.406 -176.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.74 139.64 30.36 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.69 1.245 . . . . 0.0 113.292 -178.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.8 p -74.53 100.1 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 125.582 1.553 . . . . 0.0 110.565 -176.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.26 -29.98 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.34 0.656 . . . . 0.0 111.837 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.27 149.99 50.97 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 124.273 1.987 . . . . 0.0 112.732 173.002 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.3 m-30 -104.45 82.05 1.88 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.155 -1.839 . . . . 0.0 107.048 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.3 mt -102.06 69.88 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 171.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.19 86.56 5.59 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.899 0.857 . . . . 0.0 108.858 -178.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -59.94 104.21 0.28 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.544 1.138 . . . . 0.0 110.94 -175.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -83.85 58.13 4.5 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.277 -1.514 . . . . 0.0 111.729 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -79.79 124.95 29.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 122.626 1.203 . . . . 0.0 110.914 176.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 55.9 t -81.99 113.34 21.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 125.048 1.339 . . . . 0.0 108.27 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.474 0.727 0 CA-C-O 120.836 0.351 . . . . 0.0 111.635 -177.964 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 118.757 -0.639 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -66.88 -27.74 43.3 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.129 2.553 . . . . 0.0 115.196 -175.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.1 p -149.54 156.79 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.771 1.628 . . . . 0.0 110.676 -177.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 30.9 ptt-85 -78.16 52.45 1.1 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.902 1.681 . . . . 0.0 114.401 -176.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -122.92 149.95 43.57 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.794 2.037 . . . . 0.0 111.42 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.29 -54.79 3.98 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.982 1.277 . . . . 0.0 113.351 -177.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 44.0 p-80 -88.17 157.5 18.8 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.535 1.134 . . . . 0.0 112.124 170.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.1 t -130.02 136.09 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.99 1.316 . . . . 0.0 109.246 171.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.43 159.96 69.45 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.091 0.956 . . . . 0.0 111.881 173.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -57.64 105.41 0.2 Allowed 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.678 2.252 . . . . 0.0 110.648 170.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -63.96 -26.98 68.83 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -167.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -70.05 -49.98 45.78 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.67 0.668 . . . . 0.0 110.761 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.5 t -78.25 -33.99 49.36 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.547 1.139 . . . . 0.0 112.357 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -59.78 -42.4 93.24 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.306 0.642 . . . . 0.0 109.947 172.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.9 tp -70.12 -45.43 66.89 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-O 118.708 -0.663 . . . . 0.0 111.868 173.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -48.05 -39.87 21.3 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 120.04 1.291 . . . . 0.0 113.207 174.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.6 m -60.07 -44.98 94.35 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.605 -0.684 . . . . 0.0 112.261 172.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.8 mm -66.34 -36.61 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.762 0.825 . . . . 0.0 110.691 175.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.9 mm -55.96 -53.87 33.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.434 0 CA-C-O 118.445 -0.788 . . . . 0.0 109.05 173.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -59.97 -29.0 68.14 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 118.845 0.748 . . . . 0.0 112.54 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 tptt -63.42 -46.2 87.45 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 118.624 -0.703 . . . . 0.0 112.815 172.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -101.41 11.4 39.22 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.05 -29.09 68.3 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.273 1.429 . . . . 0.0 113.698 -167.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.4 15.04 56.44 Favored Glycine 0 CA--C 1.536 1.391 0 N-CA-C 118.02 1.968 . . . . 0.0 118.02 166.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -121.71 -44.08 2.34 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.358 1.463 . . . . 0.0 111.663 -174.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 71.4 m -113.93 -25.24 8.67 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.085 1.754 . . . . 0.0 111.816 168.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.1 mmt-85 -100.06 156.37 17.21 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.265 1.426 . . . . 0.0 112.63 173.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -134.02 145.35 49.37 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.976 1.71 . . . . 0.0 111.953 -168.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -169.9 161.29 8.86 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -171.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -128.03 172.29 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.884 1.274 . . . . 0.0 111.732 174.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.2 mm -130.28 120.07 48.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 125.988 1.715 . . . . 0.0 108.375 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.02 153.78 51.15 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -81.34 108.49 15.0 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.599 0.714 . . . . 0.0 111.469 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.21 -15.82 62.48 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.239 1.015 . . . . 0.0 113.461 177.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -89.96 -2.13 58.1 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.705 1.602 . . . . 0.0 113.906 -172.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.27 140.14 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.105 1.362 . . . . 0.0 110.567 -174.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -59.46 -28.17 66.74 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -177.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -84.16 -3.55 58.21 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.017 1.327 . . . . 0.0 114.469 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.5 p 37.44 51.29 1.17 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 126.899 2.079 . . . . 0.0 114.417 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.77 150.18 24.33 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -167.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.4 t -79.96 89.96 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 127.843 2.457 . . . . 0.0 108.957 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.8 pt -70.0 -24.86 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.08 1.352 . . . . 0.0 112.446 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -154.78 159.71 40.8 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.151 0.98 . . . . 0.0 112.576 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 5.8 p -148.77 145.29 27.52 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.975 -1.078 . . . . 0.0 113.07 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -86.89 156.64 19.76 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 178.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.58 -27.65 67.87 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.621 0.769 . . . . 0.0 111.913 171.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.41 -50.49 52.6 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.331 -0.856 . . . . 0.0 113.03 170.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.57 -38.16 74.36 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 119.652 1.726 . . . . 0.0 110.593 173.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.6 t -60.22 -40.78 91.35 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.821 -0.55 . . . . 0.0 111.098 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -77.62 -26.31 50.48 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.649 0.78 . . . . 0.0 112.969 175.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.0 tp -63.92 -55.81 19.88 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.951 1.3 . . . . 0.0 111.29 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 77.1 m -95.96 -20.05 19.03 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.934 0.894 . . . . 0.0 113.067 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.4 20.21 76.71 Favored Glycine 0 CA--C 1.538 1.491 0 O-C-N 120.988 -1.07 . . . . 0.0 113.847 -174.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -84.87 -129.64 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.97 1.308 . . . . 0.0 110.313 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 41.6 t -159.87 150.12 18.66 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 127.589 2.356 . . . . 0.0 108.288 173.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.1 mtm180 -58.28 -35.28 71.55 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.124 -0.985 . . . . 0.0 112.328 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.42 -21.71 64.35 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -81.85 -20.79 38.23 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.207 1.403 . . . . 0.0 112.511 175.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -105.3 -17.06 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 7.6 mmt -49.89 108.0 0.19 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 125.519 1.528 . . . . 0.0 111.051 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 70.55 18.86 6.39 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.792 1.637 . . . . 0.0 113.793 171.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.12 159.11 76.29 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 123.843 0.857 . . . . 0.0 110.452 167.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -60.34 140.03 89.74 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.532 2.154 . . . . 0.0 111.857 169.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.7 t -67.47 -9.99 47.26 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.844 1.657 . . . . 0.0 113.469 176.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.7 m -62.81 100.17 0.19 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 127.672 2.389 . . . . 0.0 111.507 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 46.4 m -49.93 -23.48 1.99 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.088 1.755 . . . . 0.0 115.299 -176.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -46.99 -41.81 16.94 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.435 1.494 . . . . 0.0 112.863 169.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -63.1 -16.64 60.63 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.28 1.032 . . . . 0.0 113.551 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 pp -123.11 25.25 8.57 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.74 1.616 . . . . 0.0 113.653 173.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -65.01 151.56 45.67 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.109 -0.995 . . . . 0.0 112.181 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -125.6 -177.81 15.05 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.378 1.466 . . . . 0.0 113.694 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -64.65 -10.13 23.45 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.318 2.679 . . . . 0.0 116.293 -171.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -107.6 -7.39 16.49 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.825 1.65 . . . . 0.0 113.341 175.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.526 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 3.8 m -71.71 132.22 44.23 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.074 -1.016 . . . . 0.0 111.335 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -80.01 135.72 36.44 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.081 0.943 . . . . 0.0 110.105 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.3 mmt-85 -66.33 -39.79 89.47 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.737 -0.602 . . . . 0.0 110.658 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 49.5 ptt85 -53.76 -39.07 65.06 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.385 1.074 . . . . 0.0 113.463 171.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.03 -50.21 43.57 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.593 1.157 . . . . 0.0 110.234 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.23 -33.67 76.55 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.137 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.5 -54.98 11.57 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.478 1.111 . . . . 0.0 111.541 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -50.16 -40.14 45.72 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.862 0.865 . . . . 0.0 112.873 172.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.4 mt -65.48 -50.03 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 118.758 0.708 . . . . 0.0 111.018 174.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.09 -39.89 57.13 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.732 -0.651 . . . . 0.0 111.977 174.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -70.03 -37.71 75.69 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.449 0.7 . . . . 0.0 111.669 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.66 -34.02 76.95 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.328 -0.857 . . . . 0.0 111.317 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mt -83.15 -28.88 29.07 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.509 0.724 . . . . 0.0 111.664 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.19 -27.88 69.01 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.819 2.048 . . . . 0.0 111.016 168.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.0 17.36 9.64 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.245 1.402 . . . . 0.0 114.918 170.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.89 -49.93 74.24 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 118.642 1.221 . . . . 0.0 111.231 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -159.9 139.06 10.93 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.886 1.674 . . . . 0.0 111.392 169.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -74.02 101.45 3.87 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 169.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -144.04 140.05 29.32 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.82 1.248 . . . . 0.0 111.828 -168.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -77.49 135.03 38.2 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.506 1.123 . . . . 0.0 111.123 173.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -136.51 153.2 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.038 1.735 . . . . 0.0 108.553 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -79.93 160.07 26.11 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.857 0.863 . . . . 0.0 110.104 169.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.51 HD13 ' CZ ' ' A' ' 98' ' ' PHE . 0.3 OUTLIER -164.35 149.85 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 119.234 0.925 . . . . 0.0 111.448 169.853 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.526 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -88.89 145.33 25.61 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.431 0.692 . . . . 0.0 111.548 172.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.51 ' CZ ' HD13 ' A' ' 96' ' ' ILE . 40.9 m-85 -117.29 160.97 20.25 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.374 1.07 . . . . 0.0 110.999 173.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -125.64 140.04 53.06 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.466 0.65 . . . . 0.0 111.441 169.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -83.99 154.78 23.11 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.418 1.087 . . . . 0.0 112.591 175.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -53.95 -27.85 33.64 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.025 1.73 . . . . 0.0 113.089 171.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -71.42 -9.95 58.99 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.188 1.395 . . . . 0.0 114.181 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.76 18.24 33.06 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.249 1.404 . . . . 0.0 115.831 175.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 71.2 m -107.17 136.86 46.29 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 118.634 1.217 . . . . 0.0 111.717 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 29.5 t -126.21 135.0 51.08 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.858 1.263 . . . . 0.0 112.325 -175.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -149.96 139.98 22.01 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.55 1.14 . . . . 0.0 113.422 -168.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -102.54 125.56 49.3 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.408 1.883 . . . . 0.0 109.139 170.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 61.4 m -129.74 173.16 10.9 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.42 1.488 . . . . 0.0 110.082 173.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 30.4 tp -79.31 59.88 2.96 Favored 'General case' 0 CA--C 1.549 0.911 0 O-C-N 120.592 -1.317 . . . . 0.0 111.644 -176.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 45.7 t -63.41 142.9 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 126.062 1.745 . . . . 0.0 111.623 -173.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -108.81 69.98 0.73 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.203 1.001 . . . . 0.0 112.979 -167.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.8 t -81.25 70.02 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.732 1.213 . . . . 0.0 111.045 -168.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.8 p -121.51 126.53 26.45 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 124.133 0.973 . . . . 0.0 112.247 -175.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -88.93 -176.4 1.39 Allowed 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 123.846 3.031 . . . . 0.0 112.293 -173.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -117.03 133.59 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 123.178 1.465 . . . . 0.0 113.677 -175.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.46 160.78 30.43 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.092 2.157 . . . . 0.0 111.947 -173.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -89.92 -176.27 4.87 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.124 0.97 . . . . 0.0 112.092 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -62.48 -19.98 64.11 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -77.29 -19.97 55.71 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.011 1.324 . . . . 0.0 113.862 170.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.75 -0.13 64.74 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.23 1.395 . . . . 0.0 114.447 -176.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.25 131.38 35.29 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.372 1.086 . . . . 0.0 111.669 174.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.7 p -72.56 98.3 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.73 2.012 . . . . 0.0 111.078 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.7 -29.14 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 123.555 0.742 . . . . 0.0 111.731 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.9 148.6 50.12 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 124.115 1.912 . . . . 0.0 112.834 174.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -102.45 83.93 2.37 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 125.815 1.646 . . . . 0.0 106.766 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.6 mt -99.87 79.29 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 170.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.296 34.5 mt -83.0 86.01 7.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 123.226 1.488 . . . . 0.0 108.946 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -59.93 103.13 0.19 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 113.045 -1.889 . . . . 0.0 109.441 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -85.16 55.63 3.58 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 122.584 1.183 . . . . 0.0 110.885 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -79.83 106.75 12.09 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 123.653 1.692 . . . . 0.0 110.507 -176.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.54 120.32 12.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 125.73 1.612 . . . . 0.0 108.691 170.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.2 146.74 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 O-C-N 123.277 0.36 . . . . 0.0 110.076 175.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 87.9 mtp -142.11 152.36 43.18 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.111 1.364 . . . . 0.0 111.145 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -74.46 153.2 39.27 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.241 1.017 . . . . 0.0 112.646 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 C--O 1.253 1.255 0 C-N-CA 125.363 1.465 . . . . 0.0 112.439 177.799 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.8 ttp . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 118.612 -0.709 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -59.32 151.92 64.38 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.459 2.773 . . . . 0.0 113.901 176.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.0 p -148.95 150.86 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.437 1.495 . . . . 0.0 110.878 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -71.91 134.04 45.79 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.76 0.824 . . . . 0.0 110.644 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -153.21 170.09 21.41 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.981 1.712 . . . . 0.0 112.25 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.32 8.27 58.69 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 125.138 1.352 . . . . 0.0 116.38 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -134.71 141.21 46.46 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.319 1.559 . . . . 0.0 112.746 -175.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.2 t -119.33 140.87 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.292 1.437 . . . . 0.0 109.527 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.58 160.76 9.37 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 123.943 0.897 . . . . 0.0 111.786 171.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -42.15 110.09 0.14 Allowed 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 124.57 3.513 . . . . 0.0 112.329 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -60.02 -28.8 68.03 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -165.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -66.65 -49.85 64.85 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.715 0.806 . . . . 0.0 110.53 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 t -79.2 -34.15 43.21 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.177 0.991 . . . . 0.0 112.428 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -58.41 -39.94 81.11 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.07 0.948 . . . . 0.0 110.458 170.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 44.5 tp -70.07 -45.72 66.44 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 118.813 -0.613 . . . . 0.0 111.999 170.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -46.5 -39.93 11.64 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.975 1.31 . . . . 0.0 112.936 174.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.6 m -58.97 -45.1 91.39 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 121.595 -0.691 . . . . 0.0 111.664 173.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.8 mm -66.1 -36.84 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.89 0.876 . . . . 0.0 110.543 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.2 mm -54.51 -55.79 13.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 CA-C-O 117.777 -1.106 . . . . 0.0 108.545 171.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -59.87 -29.99 68.69 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 120.108 1.322 . . . . 0.0 111.922 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.1 tptt -63.6 -40.64 97.46 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.582 1.153 . . . . 0.0 112.235 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -108.16 -0.14 21.19 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 116.034 1.864 . . . . 0.0 116.034 176.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.17 -29.19 68.51 Favored 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -166.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.66 -1.68 69.11 Favored Glycine 0 CA--C 1.54 1.627 0 N-CA-C 117.75 1.86 . . . . 0.0 117.75 169.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -122.13 -32.17 3.74 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.075 1.75 . . . . 0.0 111.492 169.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.4 m -64.2 -29.98 71.06 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.707 0.803 . . . . 0.0 110.478 167.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -76.35 149.93 36.92 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.395 1.478 . . . . 0.0 112.924 169.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -139.95 153.37 46.89 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 128.872 2.869 . . . . 0.0 108.892 170.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -169.72 160.92 9.03 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -121.25 168.93 13.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 126.892 2.077 . . . . 0.0 111.387 170.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.8 mm -119.1 113.85 42.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 126.105 1.762 . . . . 0.0 106.617 170.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -119.09 148.98 42.44 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.922 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -80.87 113.21 18.92 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.946 0.898 . . . . 0.0 110.068 174.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.03 -12.4 60.32 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -100.01 -7.45 25.04 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.022 1.329 . . . . 0.0 114.041 -169.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 p -105.85 140.07 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.887 1.675 . . . . 0.0 111.285 -177.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.76 -30.73 70.19 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -174.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -77.35 -8.96 58.5 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.272 1.029 . . . . 0.0 113.592 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.8 m 48.63 39.01 12.51 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.746 1.618 . . . . 0.0 113.138 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.21 155.16 27.5 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -166.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.9 t -79.96 93.15 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 129.128 2.971 . . . . 0.0 108.192 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.4 pt -73.51 -23.62 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.174 1.39 . . . . 0.0 112.149 177.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -157.57 159.75 37.43 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.659 1.184 . . . . 0.0 112.014 175.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.3 p -141.68 151.12 42.73 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.821 -1.174 . . . . 0.0 114.125 -175.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -89.77 151.45 21.81 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.674 0.75 . . . . 0.0 111.653 166.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -65.92 -27.04 67.89 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.614 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.36 -50.07 48.72 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 121.156 -0.965 . . . . 0.0 112.778 172.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -29.86 66.96 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 118.845 1.323 . . . . 0.0 111.67 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.6 t -59.31 -39.83 84.29 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.597 -0.689 . . . . 0.0 110.466 170.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -77.75 -30.01 51.35 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 118.905 0.775 . . . . 0.0 112.857 174.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.4 tp -55.92 -52.1 65.3 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.15 1.38 . . . . 0.0 110.911 174.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 57.7 m -90.64 -20.85 22.06 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.16 9.98 84.41 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 126.557 2.027 . . . . 0.0 116.69 174.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -87.57 -120.25 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 119.558 1.679 . . . . 0.0 112.728 -175.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.1 t -159.86 138.63 10.68 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.772 1.629 . . . . 0.0 110.313 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -60.57 -32.64 71.72 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.328 1.051 . . . . 0.0 113.459 -175.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.14 -16.58 33.6 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.505 1.122 . . . . 0.0 113.645 174.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -97.1 -20.78 17.76 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.778 1.631 . . . . 0.0 112.46 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 m -89.92 -17.24 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 120.145 1.339 . . . . 0.0 113.134 -172.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 36.3 mmt -49.85 114.93 1.19 Allowed 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.221 1.009 . . . . 0.0 109.698 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 72.66 21.07 3.61 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.036 1.735 . . . . 0.0 114.355 171.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.05 154.03 88.65 Favored Pre-proline 0 N--CA 1.48 1.031 0 O-C-N 120.762 -1.211 . . . . 0.0 111.074 167.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.18 139.99 57.51 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.62 2.213 . . . . 0.0 111.645 173.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.8 t -69.95 -18.96 63.38 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.179 0.992 . . . . 0.0 112.991 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.0 m -61.39 100.1 0.12 Allowed 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 127.143 2.177 . . . . 0.0 111.614 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 68.3 m -50.44 -19.29 0.82 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 116.43 2.011 . . . . 0.0 116.43 -173.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -56.33 -36.31 68.59 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.036 -1.04 . . . . 0.0 111.635 172.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -57.58 -23.49 51.04 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.373 1.469 . . . . 0.0 113.391 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 pp -119.44 22.87 11.53 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.938 1.695 . . . . 0.0 113.162 176.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -63.25 147.1 51.96 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.379 -0.826 . . . . 0.0 111.993 173.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.72 -173.13 12.89 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 125.189 1.376 . . . . 0.0 113.219 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -62.35 -10.07 17.48 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 123.758 2.972 . . . . 0.0 116.406 -172.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -108.18 -9.34 15.57 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.902 1.681 . . . . 0.0 113.562 176.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.438 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 3.1 m -81.29 141.17 34.33 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.928 0.891 . . . . 0.0 112.153 -174.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -89.08 136.78 32.83 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 122.294 1.045 . . . . 0.0 111.512 171.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.4 mmm-85 -69.98 -39.69 75.78 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.363 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -53.23 -39.29 63.68 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 169.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.9 -52.84 54.31 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 122.221 1.01 . . . . 0.0 110.031 175.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.94 -33.86 77.03 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.882 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.02 -50.92 36.53 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.941 1.696 . . . . 0.0 112.271 176.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -50.2 -41.56 49.88 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.42 1.009 . . . . 0.0 112.306 169.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.7 mt -61.78 -49.9 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 O-C-N 121.653 -0.654 . . . . 0.0 111.001 171.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.07 -39.85 56.97 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.385 -0.817 . . . . 0.0 112.171 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -70.11 -34.88 73.67 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.695 0.798 . . . . 0.0 111.888 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.53 -31.45 69.67 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.656 -0.653 . . . . 0.0 111.744 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 mt -82.78 -32.24 27.84 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.537 0.735 . . . . 0.0 111.604 176.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.07 -33.1 74.72 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.868 2.067 . . . . 0.0 110.833 169.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.78 23.67 6.11 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.551 1.072 . . . . 0.0 115.031 168.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.75 -50.63 62.13 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.168 1.484 . . . . 0.0 110.218 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -151.77 143.41 23.6 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.389 2.276 . . . . 0.0 108.63 172.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -77.71 115.56 17.56 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.703 1.138 . . . . 0.0 108.188 169.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -138.96 137.73 36.67 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.592 1.157 . . . . 0.0 111.646 -168.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -87.03 129.63 34.81 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.177 1.791 . . . . 0.0 109.949 169.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.27 145.97 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.102 1.361 . . . . 0.0 109.355 -175.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -79.97 151.44 30.03 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.457 0.703 . . . . 0.0 109.846 170.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -163.0 147.13 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.06 0.944 . . . . 0.0 110.544 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.438 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -87.58 141.42 28.62 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.206 175.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -106.09 155.19 19.67 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.915 1.286 . . . . 0.0 111.231 169.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -121.83 138.29 54.44 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.796 0.838 . . . . 0.0 109.089 166.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -100.04 152.59 20.04 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.944 1.697 . . . . 0.0 110.504 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.92 -15.59 44.27 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 -171.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -78.28 -11.08 59.91 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.227 1.411 . . . . 0.0 113.72 171.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.86 2.53 56.15 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 126.203 1.859 . . . . 0.0 115.126 -174.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 55.3 m -74.77 128.21 35.01 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.866 1.833 . . . . 0.0 111.328 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 67.1 m -124.47 130.62 52.8 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.696 1.198 . . . . 0.0 111.443 -175.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -150.01 139.93 21.9 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.89 0.876 . . . . 0.0 113.013 -171.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.464 HD13 ' N ' ' A' ' 108' ' ' CYS . 2.2 tm? -110.36 134.79 51.96 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.673 1.989 . . . . 0.0 109.3 172.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.464 ' N ' HD13 ' A' ' 107' ' ' LEU . 2.1 m -138.95 171.64 14.02 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.502 1.521 . . . . 0.0 110.457 169.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 29.5 tp -76.88 59.87 1.68 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.199 0.999 . . . . 0.0 110.088 174.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.0 t -58.29 145.36 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.912 1.285 . . . . 0.0 110.516 -172.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -100.0 69.76 1.55 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.693 1.235 . . . . 0.0 111.277 -168.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.4 t -82.43 69.85 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.268 1.027 . . . . 0.0 110.526 -170.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.3 130.76 24.41 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.004 0.922 . . . . 0.0 110.948 -176.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -85.47 -169.72 0.64 Allowed 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 123.199 2.6 . . . . 0.0 111.888 -174.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.92 130.33 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-O 123.133 1.444 . . . . 0.0 113.947 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.4 mttm -112.82 162.4 15.83 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 127.655 2.382 . . . . 0.0 112.801 -175.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -93.17 -179.98 5.25 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.154 171.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.4 -21.69 65.57 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -70.63 -19.88 62.78 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.532 1.133 . . . . 0.0 113.727 169.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.51 0.32 59.44 Favored Glycine 0 CA--C 1.533 1.156 0 C-N-CA 126.112 1.815 . . . . 0.0 114.423 -176.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.75 139.39 30.61 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.64 1.22 . . . . 0.0 113.274 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.6 p -74.67 98.96 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.484 1.513 . . . . 0.0 109.856 -176.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.37 -30.01 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 118.345 -0.836 . . . . 0.0 110.833 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.9 mmt -136.59 150.04 48.37 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-O 123.85 1.786 . . . . 0.0 110.906 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -104.33 81.11 1.78 Allowed 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 125.564 1.545 . . . . 0.0 107.522 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 36.1 mt -100.44 70.74 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 O-C-N 120.481 -1.387 . . . . 0.0 109.211 172.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 127' ' ' LEU . 1.9 mm? -77.25 85.72 3.69 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 123.44 1.591 . . . . 0.0 109.384 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -60.0 103.05 0.19 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 112.877 -1.965 . . . . 0.0 111.007 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -85.54 62.71 7.65 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.518 -1.364 . . . . 0.0 111.799 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -79.71 131.33 35.92 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.185 -0.947 . . . . 0.0 110.372 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 50.5 t -92.95 114.6 30.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 124.58 1.152 . . . . 0.0 108.118 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.34 136.9 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-O 121.331 0.586 . . . . 0.0 112.094 -175.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 28.1 ptm -127.93 164.78 21.55 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.088 1.755 . . . . 0.0 111.329 173.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.07 153.58 43.51 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 45.0 mttm . . . . . 0 C--O 1.253 1.277 0 C-N-CA 126.019 1.728 . . . . 0.0 112.16 176.566 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.3 mtm . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 119.037 -0.506 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -69.11 156.56 64.66 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.439 2.759 . . . . 0.0 112.514 176.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.2 t -134.53 140.87 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.554 1.542 . . . . 0.0 109.875 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -65.52 145.74 55.73 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.351 1.061 . . . . 0.0 111.938 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.26 145.01 24.76 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.813 1.245 . . . . 0.0 109.981 172.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.76 -147.28 46.42 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 123.226 0.441 . . . . 0.0 112.274 -169.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -73.95 158.99 33.4 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.143 0.977 . . . . 0.0 112.843 175.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.0 t -78.97 121.26 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.702 0.801 . . . . 0.0 109.782 174.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.02 159.93 82.4 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.154 0.982 . . . . 0.0 111.489 173.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.61 103.5 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.68 2.253 . . . . 0.0 111.855 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -65.8 -27.08 68.0 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.989 0.915 . . . . 0.0 113.257 -169.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -70.02 -49.99 45.88 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.023 0.529 . . . . 0.0 110.325 -176.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.5 t -74.13 -35.31 64.09 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.724 0.81 . . . . 0.0 112.509 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -58.24 -41.48 84.27 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.318 0.647 . . . . 0.0 109.909 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.1 tp -75.49 -45.04 40.74 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 118.619 -0.705 . . . . 0.0 112.427 174.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -47.66 -39.81 18.18 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.713 1.605 . . . . 0.0 113.151 175.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.7 m -60.02 -45.16 93.71 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.88 -0.513 . . . . 0.0 111.679 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.5 mm -68.95 -34.77 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.941 0.897 . . . . 0.0 110.931 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.8 mm -54.67 -56.5 10.15 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 171.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -60.8 -27.05 67.73 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 176.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -63.2 -43.1 99.12 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.465 0.706 . . . . 0.0 112.228 172.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -104.66 -0.01 27.98 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -59.74 -29.24 68.01 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.504 1.522 . . . . 0.0 113.751 -167.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.29 -0.02 69.88 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 125.276 1.417 . . . . 0.0 115.731 -176.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -114.61 -47.13 2.92 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.2 1.5 . . . . 0.0 112.969 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.9 m -78.98 3.06 18.26 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 175.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -120.06 151.07 39.56 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.522 1.529 . . . . 0.0 113.303 -173.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -134.46 143.23 47.39 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.349 1.859 . . . . 0.0 111.567 -167.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -169.81 162.36 9.47 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -169.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -122.93 168.96 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 128.039 2.536 . . . . 0.0 111.217 171.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.0 mm -128.24 124.81 63.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 C-N-CA 126.219 1.807 . . . . 0.0 108.378 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.06 154.46 49.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -177.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -77.77 108.27 10.88 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.402 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.01 -19.52 63.32 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -94.84 2.38 55.45 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.701 1.201 . . . . 0.0 113.989 -169.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.49 140.07 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.32 1.448 . . . . 0.0 110.508 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.97 -23.82 65.63 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -86.55 -7.39 58.41 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.344 1.458 . . . . 0.0 114.23 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.0 p 42.92 43.38 3.51 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 126.945 2.098 . . . . 0.0 115.293 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.53 149.9 32.98 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 -167.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.0 t -80.03 89.98 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 128.584 2.753 . . . . 0.0 109.08 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.7 pt -69.96 -24.54 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.993 1.317 . . . . 0.0 112.453 175.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -153.58 159.62 42.22 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.804 0.842 . . . . 0.0 112.86 173.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.0 p -143.21 143.26 31.69 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.289 -0.882 . . . . 0.0 112.687 -177.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -89.67 155.12 19.44 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 173.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -66.93 -19.92 65.81 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.869 -0.519 . . . . 0.0 112.257 174.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.65 -49.91 55.83 Favored Glycine 0 CA--C 1.535 1.283 0 O-C-N 121.33 -0.856 . . . . 0.0 112.212 169.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -56.75 -39.23 73.62 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 119.04 1.42 . . . . 0.0 110.903 172.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.3 t -60.14 -41.3 92.43 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.922 -0.486 . . . . 0.0 111.321 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -77.1 -30.09 55.2 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.679 0.791 . . . . 0.0 112.663 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.18 -53.8 43.59 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.721 1.609 . . . . 0.0 112.174 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 82.7 m -101.12 -19.97 15.53 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.876 1.271 . . . . 0.0 112.787 -173.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.95 11.87 84.75 Favored Glycine 0 CA--C 1.539 1.541 0 CA-C-O 118.715 -1.047 . . . . 0.0 115.502 176.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -90.71 -122.13 0.07 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.956 1.378 . . . . 0.0 111.401 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.4 t -159.89 150.16 18.67 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.929 1.292 . . . . 0.0 111.095 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.0 mtt-85 -50.04 -43.9 51.16 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.576 1.15 . . . . 0.0 111.189 169.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.81 -19.12 64.78 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.378 1.071 . . . . 0.0 113.824 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -86.48 -20.56 27.91 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.473 1.509 . . . . 0.0 112.81 174.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.7 m -102.11 -18.99 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 174.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 5.4 mmt -49.81 107.47 0.15 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.509 1.523 . . . . 0.0 111.46 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 71.47 18.06 5.56 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.818 1.647 . . . . 0.0 113.85 171.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.55 157.12 72.81 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.039 0.936 . . . . 0.0 111.09 167.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.51 140.17 92.43 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.873 3.049 . . . . 0.0 112.879 169.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.3 m -62.95 -13.79 39.19 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 172.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.3 m -65.98 99.92 0.54 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.396 1.478 . . . . 0.0 110.911 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 32.0 p -53.32 -17.56 1.9 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.878 1.671 . . . . 0.0 115.004 -176.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -48.5 -42.88 34.32 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.925 1.29 . . . . 0.0 111.742 168.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -64.42 -16.19 61.93 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 pp -122.99 23.02 9.45 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.32 1.848 . . . . 0.0 113.432 173.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.27 144.57 57.06 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.224 -0.922 . . . . 0.0 112.568 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.54 173.16 22.67 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.067 1.318 . . . . 0.0 113.479 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.14 -9.99 25.6 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.485 2.79 . . . . 0.0 113.825 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.27 -4.69 25.29 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.192 1.797 . . . . 0.0 113.617 174.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.468 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 5.5 m -80.5 143.19 33.51 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 119.329 0.968 . . . . 0.0 111.889 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.2 mm-40 -92.97 145.24 24.52 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 123.453 1.597 . . . . 0.0 114.097 175.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.486 ' H ' ' HD2' ' A' ' 76' ' ' ARG . 1.2 mpt_? -70.11 -42.45 72.67 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 113.463 -1.699 . . . . 0.0 110.874 -175.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -60.05 -38.85 84.0 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.584 1.154 . . . . 0.0 113.5 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.42 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -63.69 -53.01 57.93 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.044 0.938 . . . . 0.0 109.972 174.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.73 -34.6 78.57 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.551 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.96 -53.29 18.45 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.951 1.301 . . . . 0.0 111.94 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -50.13 -41.6 49.08 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.18 0.9 . . . . 0.0 112.13 171.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 47.7 mt -63.8 -49.79 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 O-C-N 121.834 -0.541 . . . . 0.0 111.493 174.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.87 -39.81 54.77 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.167 0.587 . . . . 0.0 111.912 174.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -67.61 -39.56 84.73 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.553 0.615 . . . . 0.0 111.705 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.45 -27.16 65.01 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.833 -0.542 . . . . 0.0 112.162 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 mt -88.57 -31.53 18.59 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.235 0.614 . . . . 0.0 111.388 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.43 -36.11 79.44 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.31 1.844 . . . . 0.0 109.845 168.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 113.71 22.42 5.39 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.828 1.204 . . . . 0.0 114.821 171.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.24 -50.0 74.84 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 118.374 1.087 . . . . 0.0 111.399 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -159.73 148.6 17.7 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.448 1.499 . . . . 0.0 112.243 170.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -70.97 111.24 6.2 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 167.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -148.07 136.64 21.61 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.41 1.084 . . . . 0.0 111.392 -174.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -84.03 133.59 34.66 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.269 1.428 . . . . 0.0 110.606 171.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.61 146.3 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.434 1.494 . . . . 0.0 109.143 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -80.0 153.9 28.55 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.996 0.918 . . . . 0.0 110.598 172.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.42 HG23 ' HB1' ' A' ' 78' ' ' ALA . 0.6 OUTLIER -163.74 149.5 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.114 0.966 . . . . 0.0 111.428 179.177 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.468 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -90.47 145.32 25.0 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.483 174.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -116.64 162.28 17.89 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.632 1.173 . . . . 0.0 111.394 171.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -126.55 137.89 53.41 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.608 0.718 . . . . 0.0 110.59 167.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -92.83 157.59 16.31 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.288 1.835 . . . . 0.0 111.693 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -55.66 -30.55 61.21 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.103 1.761 . . . . 0.0 113.616 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.4 p30 -77.28 -9.89 59.09 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 175.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.51 -1.15 49.56 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 126.247 1.879 . . . . 0.0 115.298 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.4 m -70.1 130.86 43.25 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.35 1.575 . . . . 0.0 111.483 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 80.5 m -119.91 129.48 54.38 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.748 1.219 . . . . 0.0 110.969 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -151.03 140.01 21.01 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -172.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.436 HD13 ' N ' ' A' ' 108' ' ' CYS . 1.6 tm? -110.83 131.77 54.77 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 127.19 2.196 . . . . 0.0 108.144 168.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.436 ' N ' HD13 ' A' ' 107' ' ' LEU . 5.6 m -138.96 179.17 6.65 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.174 1.39 . . . . 0.0 110.93 170.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 76.9 mt -77.61 60.0 2.07 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.153 0.981 . . . . 0.0 110.763 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.6 t -60.57 142.29 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.739 1.215 . . . . 0.0 110.751 -173.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -102.91 69.72 1.06 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 122.076 0.941 . . . . 0.0 110.769 -168.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.5 t -83.56 69.76 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.835 0.826 . . . . 0.0 109.786 -169.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.47 134.31 24.83 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 124.745 1.218 . . . . 0.0 110.054 -174.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -87.55 -164.65 0.2 Allowed 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 123.083 2.522 . . . . 0.0 112.073 -172.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.7 m -124.93 132.94 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 122.922 1.344 . . . . 0.0 112.941 174.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -118.5 160.95 20.83 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.752 2.021 . . . . 0.0 111.794 -171.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -90.03 179.97 5.82 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.095 0.958 . . . . 0.0 111.976 172.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.72 -21.59 64.63 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -71.24 -19.92 62.31 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.615 1.166 . . . . 0.0 113.866 170.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.7 -1.87 60.12 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.791 1.662 . . . . 0.0 114.307 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -85.99 139.45 31.18 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.57 1.185 . . . . 0.0 113.25 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -74.41 100.02 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 125.828 1.651 . . . . 0.0 110.503 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.86 -30.06 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 118.194 -0.907 . . . . 0.0 111.367 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.8 mmt -136.27 148.33 47.95 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 123.517 1.627 . . . . 0.0 111.077 178.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -103.13 86.84 2.77 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.915 1.686 . . . . 0.0 108.088 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.8 mt -106.49 69.9 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 170.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.02 88.95 2.98 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.259 1.028 . . . . 0.0 108.748 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -59.82 107.03 0.55 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.151 1.381 . . . . 0.0 110.203 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -84.67 52.22 2.34 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 120.617 -1.302 . . . . 0.0 112.169 -176.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -79.89 106.9 12.25 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 123.793 1.759 . . . . 0.0 112.678 -176.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 22.3 t -64.17 112.52 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 125.802 1.641 . . . . 0.0 108.296 169.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.45 140.9 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.832 0.348 . . . . 0.0 111.026 177.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 27.9 ptm -136.33 173.4 11.75 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.645 1.578 . . . . 0.0 112.198 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.91 154.95 32.28 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.808 1.243 . . . . 0.0 113.737 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt . . . . . 0 C--O 1.253 1.283 0 C-N-CA 126.02 1.728 . . . . 0.0 112.517 -175.214 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.0 mtt . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 119.224 -0.417 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -69.44 170.6 15.81 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.371 2.714 . . . . 0.0 111.673 169.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.0 t -63.52 130.03 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.567 0.747 . . . . 0.0 110.182 176.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 -93.57 20.04 7.82 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.268 1.427 . . . . 0.0 113.98 -171.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.18 155.6 46.76 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.705 2.002 . . . . 0.0 111.667 -176.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.81 3.16 83.64 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 125.024 1.297 . . . . 0.0 115.567 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -143.79 173.33 11.78 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.832 1.653 . . . . 0.0 112.058 176.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.7 p -129.97 151.43 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.58 1.552 . . . . 0.0 110.982 175.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.66 159.97 57.03 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 123.83 0.852 . . . . 0.0 111.696 171.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -58.57 107.97 0.37 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.103 2.536 . . . . 0.0 111.197 173.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -64.55 -26.59 68.48 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -168.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -69.97 -49.97 46.4 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.49 0.586 . . . . 0.0 110.585 -176.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.1 t -77.3 -33.41 55.68 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.133 0.973 . . . . 0.0 112.304 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -60.04 -41.02 91.35 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.667 -0.646 . . . . 0.0 110.184 172.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.2 tp -71.03 -45.11 64.5 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-O 118.696 -0.669 . . . . 0.0 112.041 172.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -47.68 -39.75 18.17 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.203 1.365 . . . . 0.0 113.279 173.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 90.2 m -60.16 -43.67 95.62 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.521 -0.737 . . . . 0.0 112.326 172.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.4 mm -68.59 -35.28 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.898 0.879 . . . . 0.0 110.938 175.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 26.2 mm -55.49 -54.5 24.83 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.483 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 171.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 55.5 mtm180 -60.32 -27.36 67.27 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.8 0.727 . . . . 0.0 112.959 176.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.3 tptt -65.09 -40.47 94.64 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 118.631 -0.7 . . . . 0.0 112.757 172.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -106.03 2.4 27.26 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -55.64 -29.0 58.5 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.536 1.935 . . . . 0.0 114.266 -167.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.82 -1.63 68.59 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.695 1.617 . . . . 0.0 116.4 169.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -119.84 -13.14 9.1 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.597 1.559 . . . . 0.0 112.106 168.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.9 p -76.12 8.51 3.19 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 128.016 2.526 . . . . 0.0 115.054 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.82 163.86 4.2 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.335 1.454 . . . . 0.0 113.682 178.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.96 146.1 28.02 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.972 2.109 . . . . 0.0 115.173 -167.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -169.79 163.13 9.76 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -121.71 169.77 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.887 169.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.9 mm -123.2 114.65 42.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 126.069 1.747 . . . . 0.0 107.015 173.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.17 153.16 40.43 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.475 175.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -85.21 120.83 27.13 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.37 -9.62 59.34 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 46.0 mmm-85 -100.1 5.68 44.93 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.886 1.674 . . . . 0.0 114.246 -172.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.4 m -119.61 139.9 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 126.117 1.767 . . . . 0.0 111.73 -174.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.12 -24.4 65.01 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.85 0.86 . . . . 0.0 113.142 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.56 -12.3 59.95 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.169 1.388 . . . . 0.0 112.431 173.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.9 m 46.73 37.95 5.28 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.899 1.68 . . . . 0.0 112.782 -175.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.31 149.86 40.46 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -165.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.4 t -80.66 90.0 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 C-N-CA 128.667 2.787 . . . . 0.0 108.631 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.4 pt -69.95 -24.15 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.162 1.385 . . . . 0.0 112.207 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -155.62 159.82 39.93 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.802 1.241 . . . . 0.0 112.93 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.3 p -143.23 139.96 30.48 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.873 -1.142 . . . . 0.0 112.879 -175.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -83.73 157.98 21.94 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -61.26 -28.22 69.02 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.547 0.739 . . . . 0.0 111.429 171.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.58 -49.97 59.06 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.71 -1.05 . . . . 0.0 113.296 170.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.76 -40.6 69.52 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 120.064 1.932 . . . . 0.0 110.662 172.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.4 t -60.24 -40.65 90.98 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.625 0.37 . . . . 0.0 111.074 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -76.23 -29.62 57.61 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.965 0.906 . . . . 0.0 112.579 176.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.7 tp -64.28 -55.78 19.1 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.935 1.294 . . . . 0.0 111.733 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.1 m -99.59 -20.06 16.54 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.72 0.808 . . . . 0.0 112.794 -172.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.94 14.51 82.55 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-O 118.871 -0.96 . . . . 0.0 115.413 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -89.96 -128.79 0.08 Allowed 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 118.845 1.322 . . . . 0.0 111.762 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.9 t -159.95 150.19 18.6 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.635 1.974 . . . . 0.0 109.789 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.5 mtt85 -50.88 -40.37 56.27 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.329 1.052 . . . . 0.0 112.52 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.7 -21.2 62.63 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.351 1.06 . . . . 0.0 113.537 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -85.38 -20.96 29.08 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.638 1.575 . . . . 0.0 112.296 177.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -105.37 -20.03 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 5.8 mmt -49.97 107.76 0.17 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.845 1.658 . . . . 0.0 111.306 -174.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 70.24 18.4 6.89 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.383 1.473 . . . . 0.0 113.558 170.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.75 161.38 61.37 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 123.882 0.873 . . . . 0.0 110.553 167.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -56.19 140.06 86.79 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.992 2.461 . . . . 0.0 113.165 171.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 34.9 t -67.65 -10.05 48.76 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.128 1.371 . . . . 0.0 113.158 170.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -61.29 100.19 0.12 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 128.01 2.524 . . . . 0.0 110.866 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 33.8 m -50.03 -13.11 0.09 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.461 1.904 . . . . 0.0 115.903 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -52.79 -37.02 59.17 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.844 1.258 . . . . 0.0 111.776 167.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -55.83 -21.78 21.48 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.396 1.479 . . . . 0.0 113.343 171.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.13 20.03 14.6 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 127.611 2.364 . . . . 0.0 111.824 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -72.81 142.2 48.03 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.319 -1.488 . . . . 0.0 111.324 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.68 -170.11 11.99 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.665 1.602 . . . . 0.0 113.123 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -64.6 -10.13 23.29 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.29 2.66 . . . . 0.0 116.26 -170.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -110.07 -2.03 17.22 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.852 1.661 . . . . 0.0 114.415 175.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.503 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 6.0 m -78.53 137.83 38.1 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.704 1.138 . . . . 0.0 112.298 -175.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -82.58 132.22 35.2 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 122.636 1.208 . . . . 0.0 110.59 172.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.7 mmt85 -70.0 -39.9 75.61 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.185 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -56.87 -35.68 69.2 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.682 1.193 . . . . 0.0 113.599 169.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.48 -50.24 53.79 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.648 0.779 . . . . 0.0 110.907 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.32 -34.95 78.81 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.34 -53.01 27.03 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.832 1.253 . . . . 0.0 112.012 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -50.16 -40.8 47.69 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.39 0.996 . . . . 0.0 112.731 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 29.7 mt -63.82 -49.75 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 O-C-N 121.708 -0.62 . . . . 0.0 111.08 174.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.81 -39.94 59.6 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.565 0.621 . . . . 0.0 111.958 173.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -63.51 -39.82 95.43 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.243 0.617 . . . . 0.0 111.635 175.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.16 -28.75 66.7 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mt -84.07 -40.09 18.75 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 pp -66.02 -28.72 69.08 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 118.46 0.573 . . . . 0.0 112.212 169.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.75 18.91 8.55 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 119.031 -0.872 . . . . 0.0 113.965 169.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.27 -50.01 65.73 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 118.372 1.086 . . . . 0.0 110.303 169.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -162.69 129.97 3.68 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.924 1.689 . . . . 0.0 111.648 168.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -68.81 116.55 9.43 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.193 1.397 . . . . 0.0 108.633 172.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -151.73 142.93 23.29 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.851 1.26 . . . . 0.0 111.706 -169.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -83.72 130.69 34.96 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.449 1.5 . . . . 0.0 110.554 169.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.6 153.1 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.508 1.523 . . . . 0.0 109.077 -177.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -79.87 158.83 26.62 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.429 0.691 . . . . 0.0 109.477 170.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -166.71 150.16 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.437 1.095 . . . . 0.0 110.08 175.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.503 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -91.4 145.35 24.7 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.276 172.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -114.61 162.3 16.94 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.76 1.224 . . . . 0.0 111.276 172.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -132.13 140.06 48.65 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.831 0.852 . . . . 0.0 111.495 168.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.2 mtp-105 -88.68 166.66 13.94 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 125.296 1.439 . . . . 0.0 113.393 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -57.81 -33.25 68.39 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.04 2.136 . . . . 0.0 112.88 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -76.99 -9.86 58.98 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.814 1.246 . . . . 0.0 114.235 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.6 -1.3 59.99 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.573 1.559 . . . . 0.0 115.842 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.5 m -72.88 139.66 47.03 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.735 1.767 . . . . 0.0 111.139 176.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 29.3 p -136.01 140.05 43.59 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -178.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -150.89 142.02 23.13 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.378 1.071 . . . . 0.0 113.359 -172.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.499 HD13 ' N ' ' A' ' 108' ' ' CYS . 2.2 tm? -102.61 135.21 44.67 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.419 1.888 . . . . 0.0 109.763 169.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.499 ' N ' HD13 ' A' ' 107' ' ' LEU . 1.9 m -139.83 170.27 16.18 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.319 1.448 . . . . 0.0 110.246 167.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 28.7 tp -77.37 59.92 1.93 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.939 0.896 . . . . 0.0 109.603 172.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.1 t -57.1 147.65 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.959 1.303 . . . . 0.0 110.55 -172.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -99.84 69.68 1.58 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 122.951 1.358 . . . . 0.0 111.177 -169.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.3 t -83.3 69.86 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.571 1.149 . . . . 0.0 110.594 -169.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -121.9 129.03 25.32 Favored Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 123.57 0.748 . . . . 0.0 112.915 -174.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -88.15 -179.49 2.44 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.713 2.942 . . . . 0.0 112.669 -175.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.46 138.43 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 122.925 1.345 . . . . 0.0 114.018 -172.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -118.84 163.08 17.43 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 127.041 2.136 . . . . 0.0 112.38 -169.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -94.31 -179.98 5.1 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.204 1.002 . . . . 0.0 111.937 171.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.77 -21.35 64.49 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -71.41 -19.87 62.2 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.604 1.162 . . . . 0.0 113.893 170.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.12 5.61 60.67 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.6 1.571 . . . . 0.0 114.431 -176.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.89 139.58 30.38 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 118.362 1.081 . . . . 0.0 113.025 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.1 p -73.55 100.05 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.921 1.688 . . . . 0.0 110.641 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.12 -30.0 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.255 177.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 10.3 mmt -135.37 147.36 49.03 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 123.567 1.651 . . . . 0.0 111.347 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -103.95 79.97 1.7 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 126.477 1.911 . . . . 0.0 107.24 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.7 mt -99.96 73.14 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 122.398 1.094 . . . . 0.0 108.999 175.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.281 17.5 mt -77.89 86.62 4.11 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 122.752 1.263 . . . . 0.0 108.934 -178.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -59.84 103.18 0.19 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.094 1.757 . . . . 0.0 109.96 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -84.97 61.31 6.78 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 120.916 -1.115 . . . . 0.0 111.197 -177.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -79.75 128.27 33.21 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 121.949 0.881 . . . . 0.0 110.687 175.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.4 t -88.2 114.06 26.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 124.72 1.208 . . . . 0.0 108.128 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.37 135.8 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 121.084 0.468 . . . . 0.0 111.956 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 94.9 mtp -101.74 149.66 23.93 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.774 1.63 . . . . 0.0 110.97 174.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -69.63 152.19 45.02 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.773 1.229 . . . . 0.0 112.554 175.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? . . . . . 0 C--O 1.253 1.274 0 C-N-CA 125.088 1.355 . . . . 0.0 113.69 177.44 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 118.742 -0.647 . . . . 0.0 110.387 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -70.47 153.81 65.37 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.289 2.659 . . . . 0.0 112.584 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 45.4 t -137.46 139.66 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.552 1.541 . . . . 0.0 109.852 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -81.72 74.73 8.7 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.745 1.218 . . . . 0.0 110.766 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -132.32 163.13 29.34 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 127.148 2.179 . . . . 0.0 112.32 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.51 -26.29 3.11 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 125.31 1.433 . . . . 0.0 114.107 -171.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -143.72 151.19 39.72 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.088 2.155 . . . . 0.0 109.691 169.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.1 p -129.99 136.9 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.477 1.111 . . . . 0.0 111.074 175.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.63 160.95 69.95 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.641 0.776 . . . . 0.0 110.988 169.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -51.57 109.96 0.38 Allowed 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.205 2.603 . . . . 0.0 110.905 169.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -64.74 -28.73 69.79 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -166.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -68.1 -49.82 58.77 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.287 0.635 . . . . 0.0 110.361 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 t -75.82 -35.43 60.02 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.932 0.893 . . . . 0.0 112.345 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -58.04 -41.82 84.08 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.509 0.724 . . . . 0.0 110.024 173.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.7 tp -73.12 -44.47 60.22 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 118.959 -0.543 . . . . 0.0 112.27 173.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -48.61 -39.91 25.61 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.798 1.181 . . . . 0.0 112.424 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.0 m -60.12 -42.89 95.73 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 121.52 -0.737 . . . . 0.0 112.434 173.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.7 mm -69.09 -30.59 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.228 1.011 . . . . 0.0 110.334 176.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.3 mm -60.02 -51.62 70.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 172.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.5 mmp_? -59.9 -30.08 68.78 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.728 1.149 . . . . 0.0 111.812 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -64.48 -45.55 86.89 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.789 0.836 . . . . 0.0 112.519 176.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -100.97 3.14 41.36 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 178.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -57.35 -29.09 63.72 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.149 1.38 . . . . 0.0 113.313 -167.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.05 8.86 85.06 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.667 1.127 . . . . 0.0 115.701 171.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -125.31 -58.09 1.46 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.402 1.101 . . . . 0.0 112.029 174.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 62.2 p -70.84 -30.25 66.6 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.712 -0.618 . . . . 0.0 112.25 174.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.8 mmt85 -117.84 149.95 39.97 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 127.176 2.191 . . . . 0.0 109.39 169.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.12 150.18 51.5 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.354 1.462 . . . . 0.0 112.127 -167.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -169.75 163.32 9.87 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 116.76 2.133 . . . . 0.0 116.76 -170.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -126.66 170.15 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 128.231 2.612 . . . . 0.0 110.682 174.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.6 mm -124.18 117.71 51.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 126.033 1.733 . . . . 0.0 107.727 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.81 153.94 40.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.661 1.219 . . . . 0.0 111.931 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -83.74 110.46 18.33 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.77 1.228 . . . . 0.0 110.292 176.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.84 -12.53 60.4 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -100.17 -5.21 28.11 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.81 1.244 . . . . 0.0 113.812 -169.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 p -109.24 140.0 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.715 1.606 . . . . 0.0 111.339 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.99 -23.95 67.69 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -175.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -85.29 -5.92 59.29 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.153 1.381 . . . . 0.0 113.723 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.0 p 44.27 32.86 0.74 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 128.005 2.522 . . . . 0.0 116.123 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.82 156.3 34.59 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 116.767 2.136 . . . . 0.0 116.767 -167.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.9 t -79.94 91.27 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.15 0 C-N-CA 129.354 3.061 . . . . 0.0 109.148 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.5 pt -69.93 -23.74 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 126.096 1.758 . . . . 0.0 112.991 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -155.9 159.94 39.73 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.768 1.227 . . . . 0.0 112.917 177.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.46 ' SG ' HG23 ' A' ' 59' ' ' VAL . 4.0 m -139.84 140.78 36.63 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.813 -1.179 . . . . 0.0 111.32 -169.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -93.31 153.46 18.55 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 169.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -65.18 -23.96 67.24 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 122.031 -0.418 . . . . 0.0 111.583 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.93 -50.0 46.27 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 119.191 -0.783 . . . . 0.0 112.515 169.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -39.55 83.35 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 119.454 1.627 . . . . 0.0 110.897 175.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 16.1 t -60.19 -40.8 91.27 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 121.665 -0.647 . . . . 0.0 110.758 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -78.67 -28.7 45.34 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.066 0.946 . . . . 0.0 112.473 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 52.8 tp -62.13 -55.78 25.44 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.786 1.234 . . . . 0.0 111.412 175.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 77.7 m -97.43 -20.2 17.94 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 -172.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.27 12.9 83.86 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-O 118.692 -1.06 . . . . 0.0 115.459 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -88.92 -124.3 0.05 Allowed 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 119.172 1.486 . . . . 0.0 111.095 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.9 t -159.97 150.16 18.52 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.312 1.845 . . . . 0.0 109.683 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -52.19 -37.52 55.07 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.429 -0.795 . . . . 0.0 112.432 171.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.0 -20.19 63.63 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -86.17 -20.84 28.0 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.599 1.56 . . . . 0.0 112.55 176.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.46 HG23 ' SG ' ' A' ' 44' ' ' CYS . 15.5 m -105.42 -17.37 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 125.229 1.412 . . . . 0.0 114.377 176.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 3.3 mmt -49.87 113.14 0.78 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.809 1.644 . . . . 0.0 111.223 -175.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 67.07 29.76 7.77 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.766 1.627 . . . . 0.0 112.378 169.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -106.74 154.0 40.38 Favored Pre-proline 0 N--CA 1.471 0.593 0 CA-C-O 117.283 -1.342 . . . . 0.0 112.606 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -48.64 135.25 27.5 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.576 2.85 . . . . 0.0 113.934 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 14.3 t -68.17 -9.79 49.43 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.296 1.038 . . . . 0.0 113.236 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.37 87.26 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.573 1.949 . . . . 0.0 110.848 175.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 26.2 p -54.48 -13.04 0.82 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.611 2.365 . . . . 0.0 114.733 -171.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.554 ' HA ' ' CG ' ' A' ' 70' ' ' HIS . 1.6 p30 -51.15 -22.9 2.81 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 167.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -53.49 -23.55 10.61 Favored 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 169.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.287 2.0 pp -123.14 24.0 9.0 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 170.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.554 ' CG ' ' HA ' ' A' ' 67' ' ' ASP . 1.8 m-70 -67.46 146.45 53.98 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.327 -1.483 . . . . 0.0 112.573 169.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.21 -178.95 23.37 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 124.955 1.264 . . . . 0.0 113.844 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.52 -9.99 24.59 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.591 2.861 . . . . 0.0 114.32 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -89.97 -10.15 46.11 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.009 1.324 . . . . 0.0 113.087 174.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.67 HG23 ' H ' ' A' ' 97' ' ' ALA . 3.0 m -84.16 143.63 29.52 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -168.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -84.55 138.36 32.79 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.651 1.215 . . . . 0.0 112.605 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.9 mmt85 -69.99 -39.99 75.58 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.51 -0.743 . . . . 0.0 111.208 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -57.59 -37.42 73.18 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.221 1.408 . . . . 0.0 113.822 170.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.9 -53.31 52.49 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.005 0.907 . . . . 0.0 110.055 173.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.86 -35.1 79.52 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.423 -0.808 . . . . 0.0 113.009 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.14 -54.1 20.42 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.173 1.389 . . . . 0.0 111.623 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -50.22 -40.83 48.65 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.212 0.914 . . . . 0.0 112.777 171.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.3 mt -63.74 -49.22 83.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 O-C-N 121.495 -0.753 . . . . 0.0 111.433 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.74 -39.99 59.43 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.346 0.521 . . . . 0.0 111.677 173.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -63.43 -39.96 95.88 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.347 0.659 . . . . 0.0 111.796 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.51 -30.3 69.08 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 176.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 mt -83.18 -35.52 25.42 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 pp -70.49 -27.87 64.54 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 118.326 0.512 . . . . 0.0 111.914 168.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.94 16.36 10.75 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.095 -0.836 . . . . 0.0 114.244 168.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.89 -49.82 65.12 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 118.265 1.033 . . . . 0.0 111.99 175.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -155.56 141.66 18.33 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.602 1.561 . . . . 0.0 111.649 171.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -79.31 110.15 14.32 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.199 -0.938 . . . . 0.0 109.164 170.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -155.88 145.27 20.87 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.312 1.045 . . . . 0.0 111.203 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -76.77 143.12 40.08 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.143 1.377 . . . . 0.0 111.638 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -136.49 145.32 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.995 0.918 . . . . 0.0 110.105 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -81.15 147.97 29.8 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.113 0.965 . . . . 0.0 109.99 170.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -158.46 156.93 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 110.27 -176.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.67 ' H ' HG23 ' A' ' 74' ' ' THR . . . -110.12 145.34 37.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.107 0.963 . . . . 0.0 112.41 175.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -130.61 156.14 45.37 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.821 1.248 . . . . 0.0 111.472 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -120.43 138.34 53.84 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.703 0.764 . . . . 0.0 111.913 168.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 28.3 mtp-105 -80.51 166.64 20.99 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.394 1.477 . . . . 0.0 112.847 177.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -56.56 -32.38 65.11 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.616 1.967 . . . . 0.0 113.109 175.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -78.25 -9.89 59.42 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 175.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.75 -1.09 58.04 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.693 1.616 . . . . 0.0 115.826 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 73.3 m -70.15 128.56 36.71 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 119.778 1.789 . . . . 0.0 111.036 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 45.5 t -128.65 125.61 38.43 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.717 1.207 . . . . 0.0 112.201 -170.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -150.96 149.68 29.9 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -171.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.01 125.27 46.04 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.596 1.958 . . . . 0.0 107.177 167.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.406 ' SG ' HG13 ' A' ' 131' ' ' VAL . 81.1 m -125.7 168.47 13.71 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.571 1.148 . . . . 0.0 110.31 169.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.25 59.89 2.93 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.652 -1.28 . . . . 0.0 110.244 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.0 t -63.06 147.48 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.811 1.244 . . . . 0.0 111.206 -172.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -103.58 69.74 1.0 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.724 0.774 . . . . 0.0 111.723 -168.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.4 t -83.22 69.75 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 121.339 -0.851 . . . . 0.0 110.965 -168.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.7 m -112.92 136.47 21.68 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 124.728 1.211 . . . . 0.0 110.368 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -86.13 -161.64 0.13 Allowed 'Trans proline' 0 CA--C 1.552 1.421 0 C-N-CA 123.105 2.536 . . . . 0.0 110.08 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.7 m -127.1 131.13 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-O 122.992 1.377 . . . . 0.0 113.062 172.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.1 pmtp? -122.01 160.04 25.75 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.947 2.099 . . . . 0.0 112.253 -176.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -90.07 -179.41 5.67 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.794 0.838 . . . . 0.0 111.499 178.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.88 -21.7 61.36 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -73.64 -19.91 60.72 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.713 1.205 . . . . 0.0 114.134 171.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.89 -4.28 63.07 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.47 1.51 . . . . 0.0 114.142 -176.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -79.84 129.25 34.32 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 118.26 1.03 . . . . 0.0 112.025 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.7 p -67.86 99.74 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 127.008 2.123 . . . . 0.0 110.509 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.97 -29.63 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.795 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.73 149.96 49.37 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 124.002 1.858 . . . . 0.0 111.713 174.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -103.01 80.03 1.82 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.149 -1.387 . . . . 0.0 107.797 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.0 mt -100.0 71.32 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 O-C-N 120.24 -1.537 . . . . 0.0 108.336 171.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.41 HD22 ' N ' ' A' ' 127' ' ' LEU . 1.8 mm? -74.33 86.86 1.99 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 123.362 1.553 . . . . 0.0 109.453 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -59.85 103.08 0.18 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 112.847 -1.979 . . . . 0.0 110.326 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -87.15 53.35 2.79 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 120.543 -1.348 . . . . 0.0 111.937 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -79.86 106.96 12.27 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 123.569 1.652 . . . . 0.0 111.868 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.406 HG13 ' SG ' ' A' ' 108' ' ' CYS . 3.4 t -59.85 118.91 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.435 1.494 . . . . 0.0 108.89 169.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.38 145.99 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 122.463 0.305 . . . . 0.0 110.603 170.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 78.3 mtm -142.74 155.17 44.82 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.675 1.59 . . . . 0.0 111.012 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -73.06 151.81 41.53 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.163 0.985 . . . . 0.0 112.616 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 C--O 1.252 1.213 0 C-N-CA 125.405 1.482 . . . . 0.0 112.102 178.143 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.287 51.8 tpp . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 116.871 -1.537 . . . . 0.0 113.132 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.51 135.6 54.13 Favored 'Trans proline' 0 C--N 1.356 0.948 0 CA-C-N 122.542 1.943 . . . . 0.0 113.45 -175.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.51 149.43 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.143 0.977 . . . . 0.0 112.652 -174.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -75.32 144.53 42.36 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.213 1.005 . . . . 0.0 111.362 176.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.64 148.73 25.83 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.781 1.633 . . . . 0.0 112.081 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.94 -24.17 60.37 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 124.187 0.899 . . . . 0.0 114.569 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -143.85 154.08 43.01 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.069 1.748 . . . . 0.0 110.781 175.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.57 110.02 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 122.051 0.929 . . . . 0.0 112.175 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.7 160.38 80.03 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.438 1.095 . . . . 0.0 110.163 168.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -44.99 110.11 0.21 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 124.161 3.241 . . . . 0.0 111.817 174.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -63.12 -29.05 70.49 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -164.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -70.02 -49.98 46.0 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.096 0.862 . . . . 0.0 110.72 -176.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 t -77.05 -35.51 56.75 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.685 1.194 . . . . 0.0 112.392 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -57.04 -45.68 82.98 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.284 0.634 . . . . 0.0 110.143 170.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.6 tp -69.95 -42.28 73.43 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 118.549 -0.738 . . . . 0.0 111.237 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -50.01 -39.85 42.69 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.125 1.33 . . . . 0.0 113.073 172.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 58.1 m -60.13 -42.24 94.4 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.348 0.659 . . . . 0.0 112.503 171.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.1 mm -68.49 -35.35 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 O-C-N 121.204 -0.935 . . . . 0.0 110.023 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.5 mm -56.5 -51.14 68.71 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 CA-C-O 117.903 -1.046 . . . . 0.0 108.713 170.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -27.71 66.69 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.145 1.339 . . . . 0.0 112.906 175.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -66.78 -43.92 82.73 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.563 1.145 . . . . 0.0 112.449 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -107.91 7.61 28.11 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -55.49 -29.0 58.01 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.39 1.476 . . . . 0.0 114.504 -167.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.52 33.85 41.92 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 115.605 1.002 . . . . 0.0 115.605 169.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -61.66 -17.78 56.85 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 118.897 1.348 . . . . 0.0 113.895 175.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.6 p -89.3 19.81 4.16 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.177 2.191 . . . . 0.0 113.994 173.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 mmt85 -51.98 149.93 4.67 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.053 1.741 . . . . 0.0 114.644 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.1 151.81 45.63 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 128.171 2.588 . . . . 0.0 110.907 173.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -169.76 163.11 9.83 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 -172.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -121.29 170.83 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.277 1.431 . . . . 0.0 111.512 170.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.0 mm -123.48 116.99 49.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 126.154 1.782 . . . . 0.0 107.428 172.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.5 149.97 50.36 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -76.42 106.67 8.19 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.511 0.672 . . . . 0.0 111.445 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.6 -13.17 60.97 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -91.64 0.91 57.46 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.855 1.662 . . . . 0.0 114.117 -173.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.77 140.12 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.438 1.495 . . . . 0.0 110.943 -173.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -59.78 -26.6 65.85 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.95 -8.65 59.69 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.674 1.19 . . . . 0.0 113.937 177.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 27.1 p 36.46 51.34 0.85 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.241 2.217 . . . . 0.0 115.631 175.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.03 160.2 14.5 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -168.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.2 t -79.85 89.97 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 129.028 2.931 . . . . 0.0 109.071 -171.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.4 pt -69.95 -24.27 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.241 1.416 . . . . 0.0 112.201 175.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -155.35 159.71 40.15 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.197 0.999 . . . . 0.0 111.836 172.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.4 p -142.22 149.07 39.17 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -177.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -86.44 149.99 24.6 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.623 0.725 . . . . 0.0 111.559 168.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -67.87 -24.93 65.29 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.597 176.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.39 -50.0 49.18 Favored Glycine 0 CA--C 1.534 1.239 0 O-C-N 120.903 -1.123 . . . . 0.0 112.941 170.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -29.85 66.79 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 118.965 1.383 . . . . 0.0 111.376 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 23.2 t -60.04 -39.78 87.1 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.186 0.994 . . . . 0.0 110.2 172.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -78.21 -29.99 48.64 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.328 -0.857 . . . . 0.0 112.403 174.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.8 tp -56.44 -53.9 51.99 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.371 1.068 . . . . 0.0 110.602 174.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.8 p -80.01 -27.91 39.5 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.2 12.78 75.59 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 125.531 1.539 . . . . 0.0 115.986 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -89.04 -121.47 0.05 Allowed 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 119.552 1.676 . . . . 0.0 112.899 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.4 t -159.9 144.36 14.78 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.346 1.858 . . . . 0.0 109.981 -176.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.2 ptm85 -64.69 -30.02 71.03 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 120.891 -1.131 . . . . 0.0 113.593 -173.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.47 -16.76 39.7 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.211 1.005 . . . . 0.0 113.361 172.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -89.94 -20.57 23.19 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.532 1.933 . . . . 0.0 112.225 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 m -96.23 -19.98 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-N 119.243 0.928 . . . . 0.0 113.331 -173.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 35.3 mmt -50.01 115.71 1.52 Allowed 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.522 1.129 . . . . 0.0 111.014 -170.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 67.66 29.49 6.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.696 1.598 . . . . 0.0 112.862 169.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -100.81 151.63 37.65 Favored Pre-proline 0 N--CA 1.477 0.882 0 CA-C-O 117.756 -1.116 . . . . 0.0 113.716 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -54.54 135.28 65.82 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.262 2.641 . . . . 0.0 113.171 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 49.6 t -68.73 -12.54 61.56 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 126.349 1.86 . . . . 0.0 112.894 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -63.61 100.11 0.26 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 126.708 2.003 . . . . 0.0 111.046 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 30.2 p -49.89 -19.42 0.68 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.397 1.879 . . . . 0.0 115.614 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -48.13 -43.94 31.62 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.755 1.222 . . . . 0.0 111.939 169.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -67.06 -11.48 57.22 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 pp -123.1 20.04 9.9 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.95 1.7 . . . . 0.0 113.523 172.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -60.8 144.38 52.67 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.312 -0.868 . . . . 0.0 113.241 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.97 172.05 19.51 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 125.216 1.389 . . . . 0.0 113.074 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -65.92 -10.17 25.91 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.448 2.099 . . . . 0.0 116.062 -172.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 77.5 mtm-85 -110.1 0.05 18.18 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.765 1.626 . . . . 0.0 114.91 171.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 6.9 m -67.58 136.68 54.85 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.976 1.262 . . . . 0.0 111.305 175.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -82.64 132.81 35.18 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.581 1.181 . . . . 0.0 110.636 175.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -67.65 -39.79 84.59 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.585 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -41.37 63.5 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.432 1.093 . . . . 0.0 113.397 169.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.403 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -67.78 -49.98 59.52 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 124.44 1.096 . . . . 0.0 110.211 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.25 -33.41 75.75 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.301 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.04 -51.14 34.53 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.302 1.441 . . . . 0.0 112.495 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -49.94 -43.42 49.89 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.779 1.232 . . . . 0.0 111.223 170.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.4 mt -64.06 -49.16 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 121.895 -0.503 . . . . 0.0 111.256 174.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.01 -39.87 56.82 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.575 -0.726 . . . . 0.0 112.175 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -69.06 -38.07 78.86 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.582 0.753 . . . . 0.0 111.379 176.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.6 -33.02 74.73 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.446 -0.784 . . . . 0.0 111.496 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mt -82.62 -29.66 29.98 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.417 0.687 . . . . 0.0 111.9 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.26 -28.75 69.56 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.338 2.255 . . . . 0.0 111.001 169.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.98 18.22 8.99 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.043 1.306 . . . . 0.0 114.799 169.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.55 -49.99 74.45 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.63 1.215 . . . . 0.0 111.024 177.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -163.0 144.35 9.82 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.364 1.865 . . . . 0.0 110.98 169.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -72.07 117.59 13.88 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 167.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.5 tpp180 -149.31 137.23 20.49 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.446 1.098 . . . . 0.0 111.161 -176.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -76.79 127.42 32.72 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.216 1.006 . . . . 0.0 109.958 169.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -129.05 154.46 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.423 1.489 . . . . 0.0 108.863 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -79.9 160.12 26.13 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.221 1.008 . . . . 0.0 110.302 169.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.403 HG23 ' HB1' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -166.59 152.85 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.133 0.973 . . . . 0.0 111.115 169.759 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -85.88 145.32 27.23 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.122 174.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -115.39 163.03 16.31 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.345 1.458 . . . . 0.0 111.506 169.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -135.38 140.09 44.72 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.089 0.471 . . . . 0.0 111.799 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 19.4 mmm-85 -74.19 140.12 44.9 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 168.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -13.8 2.82 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -171.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -72.61 -9.99 59.26 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.198 1.399 . . . . 0.0 113.829 170.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.64 4.43 26.55 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 126.332 1.92 . . . . 0.0 115.467 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 52.6 m -86.5 100.23 12.23 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 118.838 1.319 . . . . 0.0 111.631 -173.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 25.2 t -106.33 137.84 43.59 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.107 1.363 . . . . 0.0 113.924 -172.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -150.99 146.05 25.97 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.439 1.496 . . . . 0.0 113.184 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -100.04 125.45 46.1 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.927 1.691 . . . . 0.0 109.233 170.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 78.2 m -129.6 173.6 10.45 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.048 1.339 . . . . 0.0 110.51 171.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 70.9 mt -79.88 59.84 3.29 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.006 -1.059 . . . . 0.0 111.403 -175.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 47.1 t -62.42 141.83 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.584 1.554 . . . . 0.0 111.426 -172.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -105.26 69.95 0.87 Allowed 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 122.486 1.136 . . . . 0.0 112.554 -168.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.8 t -81.18 70.77 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.071 1.348 . . . . 0.0 111.43 -168.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.8 p -120.5 129.28 25.4 Favored Pre-proline 0 N--CA 1.484 1.249 0 CA-C-O 118.408 -0.806 . . . . 0.0 111.945 -176.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -88.18 -166.61 0.27 Allowed 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.972 3.114 . . . . 0.0 112.435 -173.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -126.29 131.37 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 122.991 1.377 . . . . 0.0 113.415 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -119.01 159.95 22.92 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.081 2.153 . . . . 0.0 111.507 -172.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -89.89 -179.96 5.84 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.02 0.928 . . . . 0.0 111.935 174.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.18 -21.72 64.06 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -72.23 -19.89 61.64 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.698 1.199 . . . . 0.0 113.916 170.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.46 0.9 60.84 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.588 1.566 . . . . 0.0 114.238 -176.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -87.93 139.16 30.8 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.538 1.169 . . . . 0.0 112.937 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.7 p -77.99 98.34 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 125.142 1.377 . . . . 0.0 110.872 -174.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.63 -29.97 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.002 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.8 mmt -136.2 148.04 47.92 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 123.502 1.62 . . . . 0.0 111.122 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.7 m-30 -105.15 87.59 2.67 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 125.767 1.627 . . . . 0.0 106.733 -178.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 43.4 mt -103.83 73.76 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 122.574 1.178 . . . . 0.0 108.471 174.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.312 34.9 mt -80.62 84.06 6.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 123.208 1.48 . . . . 0.0 110.064 -176.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -59.87 104.74 0.32 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.018 2.127 . . . . 0.0 110.825 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -87.41 58.17 4.82 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 120.614 -1.304 . . . . 0.0 112.378 -175.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -79.79 106.89 12.14 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 124.772 2.225 . . . . 0.0 112.46 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 42.8 t -65.63 110.75 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 127.344 2.258 . . . . 0.0 109.218 174.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p -140.37 137.89 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 71.0 mtm -142.87 158.12 43.93 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.001 1.72 . . . . 0.0 110.731 169.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -75.19 147.96 39.96 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.923 -0.486 . . . . 0.0 111.705 169.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.109 0 C-N-CA 126.063 1.745 . . . . 0.0 112.778 -175.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 119.2 -0.429 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.86 -13.9 15.76 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.289 2.659 . . . . 0.0 114.325 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.0 m -73.91 20.0 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 125.696 1.598 . . . . 0.0 114.928 -175.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 54.8 ptt85 -93.81 19.76 8.46 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 126.472 1.909 . . . . 0.0 113.822 176.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 42.4 ptt85 -152.83 60.97 0.79 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 127.916 2.486 . . . . 0.0 109.76 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.39 -171.54 43.38 Favored Glycine 0 CA--C 1.538 1.492 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.044 -168.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -71.82 138.53 48.37 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.506 -0.997 . . . . 0.0 111.938 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.4 t -130.1 142.82 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.711 1.604 . . . . 0.0 109.034 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.43 159.89 28.53 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 123.515 0.726 . . . . 0.0 112.097 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.05 106.34 0.65 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.091 2.528 . . . . 0.0 112.169 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -66.22 -26.52 67.41 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -169.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -69.99 -49.92 46.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.359 0.664 . . . . 0.0 110.39 -176.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.2 t -76.21 -34.53 59.27 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.04 0.936 . . . . 0.0 112.399 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -58.86 -41.77 87.81 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.693 -0.629 . . . . 0.0 110.29 172.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.5 tp -70.71 -45.52 64.8 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-O 118.76 -0.638 . . . . 0.0 112.072 173.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -47.47 -39.81 16.75 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.261 1.424 . . . . 0.0 113.213 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 85.5 m -60.09 -44.6 94.67 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.639 -0.663 . . . . 0.0 112.235 172.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.6 mm -67.31 -35.86 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.952 0.901 . . . . 0.0 110.661 175.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.9 mm -55.79 -54.38 26.98 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 CA-C-O 118.356 -0.83 . . . . 0.0 108.845 172.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 55.4 mtm180 -60.01 -28.44 67.73 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.115 0.871 . . . . 0.0 112.979 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.1 tttt -64.23 -41.16 97.13 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 172.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -105.77 2.99 28.35 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -55.25 -29.02 57.25 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.6 1.96 . . . . 0.0 115.239 -167.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.34 55.44 6.17 Favored Glycine 0 CA--C 1.532 1.127 0 O-C-N 121.558 -0.714 . . . . 0.0 112.9 177.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -65.0 -6.31 8.29 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 -171.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 63.3 p -72.61 -19.08 61.53 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.719 1.208 . . . . 0.0 112.989 168.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 -82.79 153.43 25.23 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.144 1.778 . . . . 0.0 111.177 175.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.27 148.67 33.66 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.739 1.616 . . . . 0.0 112.15 -169.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -169.79 161.31 9.08 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -171.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -120.08 172.15 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.548 1.539 . . . . 0.0 111.248 173.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.5 mm -130.01 117.79 42.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 125.621 1.568 . . . . 0.0 107.92 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.12 148.99 52.03 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -81.79 106.61 13.86 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.688 0.756 . . . . 0.0 110.539 174.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.23 -9.31 58.48 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -95.19 -5.79 43.14 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.639 1.176 . . . . 0.0 114.112 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.79 140.21 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.942 1.297 . . . . 0.0 109.952 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -56.1 -31.07 62.93 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -175.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -83.83 -9.1 59.01 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 73.7 m 45.33 51.18 9.59 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.045 1.738 . . . . 0.0 113.112 -177.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.23 153.08 22.27 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -167.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 67.5 t -80.07 90.04 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 127.957 2.503 . . . . 0.0 108.947 -178.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.7 pt -69.94 -24.21 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.648 1.179 . . . . 0.0 112.141 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -155.38 159.71 40.12 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.475 1.11 . . . . 0.0 112.237 175.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.4 p -139.88 150.94 45.23 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.925 -1.109 . . . . 0.0 112.76 175.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -83.66 156.13 22.81 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 175.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -61.15 -27.77 68.64 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.887 -0.508 . . . . 0.0 111.768 172.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.85 -51.62 44.06 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-O 118.99 -0.894 . . . . 0.0 112.727 169.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.42 -40.11 67.97 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.592 1.696 . . . . 0.0 110.404 174.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.1 t -60.27 -40.91 92.06 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.032 0.533 . . . . 0.0 111.725 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -75.7 -28.93 58.81 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.763 0.825 . . . . 0.0 112.453 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 50.7 tp -66.57 -55.71 14.18 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.206 1.402 . . . . 0.0 111.483 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 33.6 m -93.76 -20.9 19.68 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.092 0.957 . . . . 0.0 112.726 -173.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 72.25 11.57 75.63 Favored Glycine 0 CA--C 1.541 1.706 0 N-CA-C 116.027 1.171 . . . . 0.0 116.027 177.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -90.49 -118.15 0.07 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.239 1.519 . . . . 0.0 111.058 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.3 t -159.91 150.13 18.6 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.945 1.698 . . . . 0.0 110.518 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -55.06 -38.67 68.33 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.947 1.299 . . . . 0.0 112.148 178.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.1 -20.08 63.66 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.352 1.061 . . . . 0.0 113.61 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -82.35 -20.74 36.65 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.212 1.405 . . . . 0.0 112.123 175.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -105.36 -18.59 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 32.2 mmt -49.89 111.77 0.56 Allowed 'General case' 0 C--N 1.344 0.34 0 CA-C-N 119.637 1.108 . . . . 0.0 111.083 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 71.03 18.13 5.99 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.108 1.763 . . . . 0.0 113.652 170.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.49 162.07 70.01 Favored Pre-proline 0 N--CA 1.474 0.727 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.668 167.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -57.67 140.01 92.11 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.961 2.441 . . . . 0.0 112.648 170.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 32.4 t -67.56 -14.3 62.81 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.249 1.019 . . . . 0.0 112.617 171.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.0 m -64.65 100.1 0.36 Allowed 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 126.714 2.005 . . . . 0.0 110.585 176.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 29.6 p -51.58 -18.62 1.19 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.894 1.678 . . . . 0.0 115.402 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -48.71 -41.84 33.11 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.114 1.365 . . . . 0.0 111.375 169.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -56.29 -24.71 44.96 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.716 1.606 . . . . 0.0 113.355 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 pp -123.14 19.98 9.88 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.419 1.887 . . . . 0.0 114.084 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.76 150.46 47.84 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.916 -1.115 . . . . 0.0 113.375 -177.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -130.58 -173.07 13.27 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.799 1.19 . . . . 0.0 115.532 -169.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -68.95 -10.17 28.39 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.383 2.722 . . . . 0.0 115.876 -169.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.4 ttm-85 -109.98 -4.7 15.76 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.086 1.354 . . . . 0.0 113.284 171.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.535 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 3.2 m -75.43 136.64 40.71 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.451 1.023 . . . . 0.0 110.489 -177.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -80.39 132.77 35.81 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 122.738 1.256 . . . . 0.0 109.675 171.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -68.24 -39.75 82.19 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.514 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -53.08 -38.95 62.97 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.488 1.115 . . . . 0.0 113.87 169.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.42 -50.28 53.92 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.357 1.063 . . . . 0.0 110.707 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.48 -33.88 76.91 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.03 -51.47 31.95 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.859 1.264 . . . . 0.0 112.435 177.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -50.07 -41.87 48.87 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.659 1.183 . . . . 0.0 111.916 170.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 34.3 mt -63.65 -49.62 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 O-C-N 121.745 -0.597 . . . . 0.0 111.077 173.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.63 -39.8 51.39 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.208 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -69.43 -36.78 76.99 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.601 0.76 . . . . 0.0 111.685 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.35 -31.09 70.24 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.503 -0.748 . . . . 0.0 111.547 177.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mt -82.59 -31.76 28.79 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.437 0.695 . . . . 0.0 111.342 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.44 -29.75 70.99 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.112 2.165 . . . . 0.0 111.311 169.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.95 20.22 7.71 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.907 1.241 . . . . 0.0 114.929 169.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.23 -50.04 74.69 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 118.857 1.328 . . . . 0.0 110.79 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -163.66 144.98 9.14 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.464 2.306 . . . . 0.0 109.34 168.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -84.9 122.26 28.93 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.984 -1.073 . . . . 0.0 108.728 170.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.8 tpp180 -154.64 150.11 27.32 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.019 1.328 . . . . 0.0 110.537 -169.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -76.73 135.29 39.03 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 171.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -129.42 154.2 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.953 1.301 . . . . 0.0 108.66 172.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -79.83 160.12 26.22 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.084 0.953 . . . . 0.0 109.642 169.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -168.46 150.55 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.362 0.983 . . . . 0.0 110.945 169.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.535 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -89.54 145.36 25.33 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.937 173.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -112.29 159.78 18.3 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.459 1.503 . . . . 0.0 111.771 169.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -132.79 140.01 47.8 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.434 0.694 . . . . 0.0 111.102 169.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -82.47 160.24 22.72 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.938 1.295 . . . . 0.0 113.282 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -54.31 -30.74 52.11 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.613 1.965 . . . . 0.0 113.125 170.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -76.81 -9.95 59.03 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.121 1.368 . . . . 0.0 113.985 175.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.31 4.66 56.24 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 125.755 1.645 . . . . 0.0 115.886 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 58.7 m -87.94 132.26 34.29 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.061 1.431 . . . . 0.0 111.642 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 27.0 p -124.28 140.01 53.36 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.654 1.182 . . . . 0.0 113.529 -174.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -151.0 140.06 21.08 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.306 1.442 . . . . 0.0 113.29 -170.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.476 HD13 ' N ' ' A' ' 108' ' ' CYS . 2.0 tm? -110.16 136.12 49.88 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.916 2.086 . . . . 0.0 109.311 171.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.476 ' N ' HD13 ' A' ' 107' ' ' LEU . 1.6 m -142.28 178.69 7.39 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.318 1.447 . . . . 0.0 111.653 170.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -78.15 59.85 2.32 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.48 1.112 . . . . 0.0 110.192 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.4 t -60.45 146.76 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.975 1.71 . . . . 0.0 111.572 -171.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -102.25 69.71 1.15 Allowed 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 122.437 1.113 . . . . 0.0 112.981 -167.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.0 t -83.44 69.93 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.761 0.824 . . . . 0.0 110.052 -169.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 49.1 t -118.7 123.73 28.91 Favored Pre-proline 0 N--CA 1.484 1.26 0 CA-C-O 118.074 -0.965 . . . . 0.0 111.945 -169.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -81.37 179.91 5.47 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.534 2.823 . . . . 0.0 114.577 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.4 133.05 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.191 1.396 . . . . 0.0 112.928 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -118.74 166.65 12.51 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.421 1.888 . . . . 0.0 112.509 -169.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -96.79 -179.99 4.77 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.995 0.918 . . . . 0.0 112.029 170.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.0 -21.42 64.85 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -71.01 -19.87 62.46 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.574 1.15 . . . . 0.0 113.785 170.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.71 4.29 60.56 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.699 1.619 . . . . 0.0 114.432 -176.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -91.13 138.84 31.29 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.443 1.122 . . . . 0.0 113.014 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.06 100.18 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 126.123 1.769 . . . . 0.0 110.784 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.93 -29.51 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 118.805 -0.616 . . . . 0.0 111.915 173.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.63 147.87 51.5 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 124.248 1.975 . . . . 0.0 113.465 173.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -100.09 84.85 2.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 113.204 -1.816 . . . . 0.0 107.344 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 39.4 mt -100.02 69.99 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 169.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.5 mt -80.5 87.18 5.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.352 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -59.78 104.13 0.26 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.711 -178.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -83.91 49.94 1.72 Allowed 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.406 -1.434 . . . . 0.0 111.778 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -82.26 106.89 14.51 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 123.799 1.761 . . . . 0.0 112.846 -177.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 41.3 t -58.28 113.02 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 127.119 2.168 . . . . 0.0 109.286 170.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p -140.47 141.46 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 123.111 0.564 . . . . 0.0 111.359 176.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 20.5 ptp -139.01 155.43 47.99 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.467 1.507 . . . . 0.0 111.382 172.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -74.09 143.93 45.19 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.887 0.875 . . . . 0.0 111.868 173.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt . . . . . 0 C--O 1.254 1.329 0 C-N-CA 126.28 1.832 . . . . 0.0 111.827 -177.618 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 mmt . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -69.27 159.21 54.64 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.531 2.821 . . . . 0.0 112.641 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.9 m -135.22 158.06 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 125.764 1.625 . . . . 0.0 111.661 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -78.05 58.67 2.03 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.205 1.402 . . . . 0.0 113.795 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 61.4 ttt-85 -58.82 133.81 56.32 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.632 1.173 . . . . 0.0 111.404 176.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.75 9.63 86.76 Favored Glycine 0 CA--C 1.54 1.654 0 N-CA-C 115.592 0.997 . . . . 0.0 115.592 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -64.68 145.6 55.96 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.033 1.416 . . . . 0.0 112.349 175.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -82.01 123.43 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.155 0.982 . . . . 0.0 110.839 -175.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.36 159.89 37.05 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 124.612 1.165 . . . . 0.0 112.316 174.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -58.78 106.8 0.3 Allowed 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.141 2.56 . . . . 0.0 111.682 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -65.47 -26.49 67.96 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.774 1.028 . . . . 0.0 113.774 -168.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -69.98 -50.03 45.74 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.508 0.594 . . . . 0.0 110.493 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 t -77.0 -34.58 57.51 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.17 0.988 . . . . 0.0 112.378 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -59.17 -41.65 88.93 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.073 0.549 . . . . 0.0 110.165 172.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.6 tp -70.95 -45.25 64.48 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-O 118.654 -0.689 . . . . 0.0 112.04 173.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -47.83 -39.81 19.46 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 120.154 1.343 . . . . 0.0 113.146 174.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.6 m -60.01 -44.32 94.66 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.64 -0.663 . . . . 0.0 112.282 172.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.2 mm -67.94 -35.38 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.978 0.911 . . . . 0.0 110.837 175.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.2 mm -55.71 -54.53 25.11 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.462 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 172.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 -60.81 -27.51 68.1 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.125 0.875 . . . . 0.0 113.163 176.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -63.81 -42.14 97.75 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.436 0.694 . . . . 0.0 112.386 172.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -106.09 2.33 27.07 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -55.06 -29.17 56.94 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.352 1.861 . . . . 0.0 114.639 -167.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.64 55.43 11.77 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.159 0.885 . . . . 0.0 113.444 172.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -62.02 -4.21 1.54 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.945 2.098 . . . . 0.0 115.116 -169.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 72.6 p -74.87 15.2 0.41 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.125 1.77 . . . . 0.0 113.072 167.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.8 mtt180 -51.91 155.62 1.73 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.143 1.377 . . . . 0.0 113.216 173.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -113.26 138.43 50.02 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.916 1.287 . . . . 0.0 112.383 -166.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -169.79 162.37 9.51 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -173.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -119.98 172.23 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.337 1.455 . . . . 0.0 111.344 173.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.4 mm -127.08 118.44 50.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 125.764 1.626 . . . . 0.0 107.498 172.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.72 145.36 51.92 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -79.37 106.47 11.42 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.524 0.678 . . . . 0.0 110.684 176.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.52 -7.06 51.82 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -176.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -99.97 -4.68 29.59 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.91 1.284 . . . . 0.0 114.272 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.12 140.26 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.234 1.414 . . . . 0.0 110.243 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -55.06 -26.32 36.81 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -174.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -92.98 -10.32 36.75 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.944 1.298 . . . . 0.0 114.286 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 93.7 m 47.03 55.76 7.62 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.166 1.786 . . . . 0.0 113.259 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.97 157.8 16.61 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 -168.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.6 t -79.95 92.69 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 128.696 2.798 . . . . 0.0 108.728 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.0 pt -72.44 -24.76 22.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.21 1.404 . . . . 0.0 112.228 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -156.84 159.81 38.57 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.272 1.029 . . . . 0.0 112.359 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.4 p -139.94 151.94 45.96 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.094 -1.003 . . . . 0.0 113.368 -175.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -89.2 149.93 22.9 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.711 0.767 . . . . 0.0 111.672 167.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -65.09 -31.15 72.22 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.378 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.22 -50.83 38.6 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 119.451 -0.638 . . . . 0.0 112.812 172.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -29.85 66.9 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 119.258 1.529 . . . . 0.0 111.766 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 13.9 t -60.05 -40.03 88.01 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.542 -0.724 . . . . 0.0 110.962 171.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -80.19 -30.1 38.72 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 121.432 -0.793 . . . . 0.0 112.828 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.4 tp -54.93 -54.35 43.87 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.666 1.586 . . . . 0.0 110.111 172.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.3 m -80.0 -31.12 39.71 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 122.542 0.337 . . . . 0.0 111.624 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.93 17.22 63.67 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 125.438 1.494 . . . . 0.0 115.672 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -98.72 -118.88 0.14 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.073 1.349 . . . . 0.0 112.349 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.1 t -159.84 142.65 13.75 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.863 1.265 . . . . 0.0 111.499 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -59.61 -33.35 71.38 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.637 1.175 . . . . 0.0 113.07 -177.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.76 -16.63 42.24 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.628 1.171 . . . . 0.0 113.211 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -96.67 -20.76 18.04 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.505 1.522 . . . . 0.0 112.561 177.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 m -90.75 -20.04 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 CA-C-N 120.315 1.416 . . . . 0.0 113.378 -175.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 36.1 mmt -51.17 114.47 1.21 Allowed 'General case' 0 C--N 1.339 0.135 0 C-N-CA 124.283 1.033 . . . . 0.0 110.218 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 73.72 20.46 2.99 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.453 1.901 . . . . 0.0 114.769 173.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.98 152.95 95.77 Favored Pre-proline 0 N--CA 1.479 0.982 0 O-C-N 120.6 -1.313 . . . . 0.0 111.304 167.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -62.13 140.02 81.55 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.518 2.146 . . . . 0.0 110.714 170.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 18.9 t -65.19 -11.8 44.52 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.59 0.756 . . . . 0.0 112.879 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.06 87.69 0.11 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.91 1.684 . . . . 0.0 110.152 170.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 22.7 p -50.86 -13.08 0.12 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.229 2.212 . . . . 0.0 114.802 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.483 ' HA ' ' CG ' ' A' ' 70' ' ' HIS . 22.8 t70 -46.45 -31.84 2.93 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.088 1.355 . . . . 0.0 112.505 167.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -55.47 -22.15 19.52 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 174.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 pp -122.96 20.82 9.95 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.528 1.931 . . . . 0.0 114.593 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.561 ' CG ' HG21 ' A' ' 74' ' ' THR . 36.9 m170 -69.42 151.57 45.95 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 120.753 -1.217 . . . . 0.0 113.652 174.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -124.34 -173.37 13.81 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.715 1.626 . . . . 0.0 114.461 -172.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.71 -10.04 27.93 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.601 2.867 . . . . 0.0 115.24 -171.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.4 tpt85 -94.72 -10.05 32.85 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.68 1.192 . . . . 0.0 113.21 171.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.561 HG21 ' CG ' ' A' ' 70' ' ' HIS . 2.0 m -83.17 138.41 33.66 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -169.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -93.2 138.04 31.97 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.744 1.259 . . . . 0.0 111.71 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.6 mmm-85 -69.26 -39.79 78.2 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.773 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.3 ptt-85 -52.18 -39.47 60.12 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 169.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.41 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -65.22 -51.4 61.15 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 122.053 0.93 . . . . 0.0 109.971 174.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.84 -35.77 79.23 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.02 -52.09 26.94 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 126.171 1.789 . . . . 0.0 111.345 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -50.07 -40.76 46.39 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.589 1.086 . . . . 0.0 112.906 169.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 40.6 mt -63.46 -50.24 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 119.183 -0.437 . . . . 0.0 111.343 173.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.74 -39.89 59.27 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.713 0.688 . . . . 0.0 111.904 174.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -63.46 -39.06 93.45 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.517 0.727 . . . . 0.0 111.716 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.01 -29.5 68.52 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 174.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mt -82.44 -38.9 23.33 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 pp -68.99 -29.65 67.89 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 169.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.85 18.27 9.02 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.927 -0.929 . . . . 0.0 114.042 169.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.6 -49.88 69.38 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 118.77 1.285 . . . . 0.0 110.664 173.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -158.49 134.18 8.9 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.584 1.954 . . . . 0.0 109.777 167.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -74.54 120.47 20.14 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.143 -0.973 . . . . 0.0 108.454 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -143.3 136.78 28.31 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.397 1.079 . . . . 0.0 111.685 -168.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -81.37 130.19 34.93 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.469 1.108 . . . . 0.0 109.384 169.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -136.58 145.63 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.611 1.165 . . . . 0.0 109.333 -174.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.95 150.75 30.39 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.876 0.871 . . . . 0.0 109.714 169.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.41 HG23 ' HB1' ' A' ' 78' ' ' ALA . 0.6 OUTLIER -162.01 146.56 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.614 1.165 . . . . 0.0 110.083 -179.113 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.471 ' H ' HG23 ' A' ' 74' ' ' THR . . . -91.06 145.46 24.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.051 0.541 . . . . 0.0 112.263 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -122.26 157.75 30.99 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.539 1.136 . . . . 0.0 111.633 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -120.9 140.07 52.33 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.31 0.644 . . . . 0.0 110.415 167.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -95.52 162.28 13.71 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.246 1.418 . . . . 0.0 111.656 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -57.78 -29.09 64.57 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.359 1.864 . . . . 0.0 113.189 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -74.24 -9.95 59.12 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.82 1.248 . . . . 0.0 113.859 175.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.93 6.73 56.92 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.602 1.572 . . . . 0.0 115.561 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 63.4 m -87.51 137.99 31.86 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 118.812 1.306 . . . . 0.0 111.247 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 44.0 t -134.13 128.04 33.3 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.176 0.99 . . . . 0.0 112.598 -177.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -151.05 155.52 39.17 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -174.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.413 HD13 ' N ' ' A' ' 108' ' ' CYS . 1.9 tm? -99.91 131.66 45.74 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.668 1.987 . . . . 0.0 109.736 169.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.413 ' N ' HD13 ' A' ' 107' ' ' LEU . 56.8 m -135.13 168.07 19.82 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.643 1.577 . . . . 0.0 110.256 169.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.07 59.94 3.44 Favored 'General case' 0 CA--C 1.548 0.869 0 O-C-N 121.038 -1.039 . . . . 0.0 111.128 -175.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.8 t -59.85 147.88 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.261 1.424 . . . . 0.0 111.716 -171.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -105.19 69.67 0.86 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 122.475 1.131 . . . . 0.0 111.812 -168.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 19.9 t -82.54 69.96 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.213 1.005 . . . . 0.0 110.695 -169.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.6 p -117.26 130.0 24.94 Favored Pre-proline 0 N--CA 1.485 1.285 0 C-N-CA 124.202 1.001 . . . . 0.0 112.973 -171.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -82.21 -177.57 3.57 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 124.828 3.686 . . . . 0.0 114.488 -173.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.425 HG23 ' HB2' ' A' ' 124' ' ' MET . 15.7 m -123.69 124.72 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-O 123.08 1.419 . . . . 0.0 112.802 171.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -109.73 165.61 11.56 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.33 2.252 . . . . 0.0 112.27 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -95.17 179.91 5.03 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 114.781 -1.1 . . . . 0.0 112.244 170.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.65 -21.4 65.67 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -70.19 -19.93 63.15 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.575 1.15 . . . . 0.0 113.677 169.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.36 2.2 59.03 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 126.048 1.785 . . . . 0.0 114.489 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.03 139.59 30.49 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 118.506 1.153 . . . . 0.0 113.324 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.8 p -71.26 100.14 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 125.395 1.478 . . . . 0.0 110.542 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.54 -29.97 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.091 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.037 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.425 ' HB2' HG23 ' A' ' 115' ' ' VAL . 10.1 mmt -136.46 143.63 43.97 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 123.705 1.717 . . . . 0.0 111.081 177.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -100.15 87.69 3.52 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 125.381 1.472 . . . . 0.0 107.756 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 36.4 mt -102.27 69.92 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 169.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.9 mt -79.94 87.72 5.35 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 122.284 1.04 . . . . 0.0 109.55 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -59.84 109.03 0.84 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.002 1.321 . . . . 0.0 110.643 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -87.43 49.98 1.92 Allowed 'General case' 0 CA--C 1.533 0.315 0 O-C-N 120.571 -1.331 . . . . 0.0 111.75 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -79.85 106.97 12.26 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 123.838 1.78 . . . . 0.0 111.536 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 20.1 t -60.13 119.93 5.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 126.718 2.007 . . . . 0.0 109.179 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.34 145.63 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 120.761 0.315 . . . . 0.0 111.078 175.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 91.8 mtp -129.77 153.72 47.93 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.974 1.71 . . . . 0.0 110.801 173.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.9 154.86 40.39 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.092 0.957 . . . . 0.0 113.066 175.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt . . . . . 0 C--O 1.253 1.27 0 C-N-CA 126.388 1.875 . . . . 0.0 111.787 -177.697 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 119.088 -0.482 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.56 169.22 22.8 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 123.973 3.115 . . . . 0.0 113.157 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . 0.288 33.0 m 50.03 33.61 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 127.291 2.236 . . . . 0.0 115.96 170.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 36.0 mtp-105 -70.49 152.64 43.79 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.639 1.176 . . . . 0.0 112.416 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -73.83 165.51 24.99 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.231 1.412 . . . . 0.0 113.079 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -150.47 167.9 30.31 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.264 1.412 . . . . 0.0 112.996 176.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -143.75 149.49 37.19 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.263 1.425 . . . . 0.0 112.202 -175.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.2 t -130.04 135.81 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.704 1.602 . . . . 0.0 109.243 173.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.63 159.83 57.92 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.554 0.742 . . . . 0.0 112.188 177.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.57 104.5 0.79 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.888 2.392 . . . . 0.0 112.107 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -66.57 -26.61 67.2 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.118 0.967 . . . . 0.0 113.208 -170.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -70.05 -49.86 47.0 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.526 0.73 . . . . 0.0 110.419 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 t -75.83 -33.87 60.08 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.954 0.902 . . . . 0.0 112.385 178.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -59.41 -41.17 88.84 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.743 -0.598 . . . . 0.0 110.438 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.6 tp -70.28 -44.84 67.56 Favored 'General case' 0 C--O 1.22 -0.447 0 CA-C-O 118.927 -0.559 . . . . 0.0 111.907 171.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -48.07 -39.7 20.93 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 120.003 1.274 . . . . 0.0 113.556 174.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.2 m -60.03 -42.58 94.68 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 121.704 -0.622 . . . . 0.0 112.289 172.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.5 mm -69.29 -34.15 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 O-C-N 121.113 -0.992 . . . . 0.0 110.857 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.9 mm -55.7 -54.32 27.42 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 169.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.92 -23.96 63.95 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.629 1.104 . . . . 0.0 113.436 175.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -68.62 -43.84 75.52 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.146 0.885 . . . . 0.0 112.495 171.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -102.75 0.26 32.63 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -56.59 -29.12 61.75 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.044 2.137 . . . . 0.0 114.141 -168.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.37 -1.65 60.06 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 125.869 1.7 . . . . 0.0 116.041 176.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -104.16 -25.43 12.93 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.616 1.566 . . . . 0.0 111.407 169.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.5 p -75.6 26.9 0.11 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 129.708 3.203 . . . . 0.0 114.513 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.39 168.84 3.26 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.618 1.167 . . . . 0.0 112.984 176.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -63.89 133.84 54.05 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.882 1.673 . . . . 0.0 113.902 -167.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -169.77 163.38 9.83 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.499 1.519 . . . . 0.0 113.935 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -120.9 170.48 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.849 1.26 . . . . 0.0 112.129 171.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.0 mm -120.66 114.44 43.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 168.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.07 152.82 43.82 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.653 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -85.86 119.39 26.13 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.8 -11.69 59.91 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.538 0.735 . . . . 0.0 112.891 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -100.05 -1.51 36.74 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.186 1.394 . . . . 0.0 114.185 -171.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.8 m -104.27 140.14 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 127.053 2.141 . . . . 0.0 111.58 -177.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -64.59 -27.86 69.24 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.395 1.078 . . . . 0.0 113.11 -174.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -84.47 -6.89 59.42 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.431 1.092 . . . . 0.0 113.28 173.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 46.7 m 49.47 39.89 17.74 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.781 1.632 . . . . 0.0 112.666 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.41 149.93 43.83 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -166.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.4 t -80.01 90.03 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 129.323 3.049 . . . . 0.0 108.511 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.3 pt -69.98 -21.87 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.949 1.3 . . . . 0.0 112.343 178.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -158.99 159.71 35.13 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.051 1.34 . . . . 0.0 111.711 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.4 p -139.98 148.3 41.7 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 120.77 -1.206 . . . . 0.0 113.876 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -82.56 151.33 26.46 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.489 0.662 . . . . 0.0 110.704 166.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -66.48 -28.67 68.76 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.512 175.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.1 -50.79 54.05 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 121.267 -0.896 . . . . 0.0 112.867 173.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -29.85 66.92 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.202 1.501 . . . . 0.0 110.581 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.6 t -60.04 -39.77 87.09 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.555 0.742 . . . . 0.0 110.266 173.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -78.15 -27.92 48.22 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.016 0.926 . . . . 0.0 112.534 173.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.7 tp -60.65 -49.39 77.7 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.471 1.108 . . . . 0.0 111.462 175.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 26.9 p -79.97 -27.4 39.72 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 169.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.2 24.52 61.2 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 125.168 1.366 . . . . 0.0 114.515 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.3 m-30 -90.21 -129.96 0.09 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.154 1.382 . . . . 0.0 111.887 -177.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.7 t -159.9 150.16 18.65 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.604 2.362 . . . . 0.0 109.013 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 67.6 mtp85 -56.27 -43.05 78.4 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 121.059 -1.026 . . . . 0.0 112.112 -171.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.4 -18.12 63.37 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.741 1.216 . . . . 0.0 113.69 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -86.84 -20.72 27.08 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.116 1.766 . . . . 0.0 112.178 176.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.4 m -103.57 -20.2 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -177.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 33.8 mmt -50.0 113.64 0.9 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 124.084 0.954 . . . . 0.0 110.709 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 71.47 20.47 4.84 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.03 1.732 . . . . 0.0 113.744 169.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.52 160.12 75.68 Favored Pre-proline 0 N--CA 1.475 0.808 0 CA-C-O 118.145 -0.931 . . . . 0.0 111.557 167.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.09 140.05 91.63 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.732 2.288 . . . . 0.0 113.073 173.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 37.8 t -63.95 -17.7 63.52 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.592 1.157 . . . . 0.0 112.384 170.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.7 m -64.83 89.45 0.07 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.471 1.908 . . . . 0.0 110.795 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 26.8 p -52.95 -13.29 0.42 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.655 1.982 . . . . 0.0 115.127 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -46.35 -37.79 7.97 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.456 1.502 . . . . 0.0 111.416 166.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.83 -23.08 63.07 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.25 3.0 pp -123.13 28.15 7.28 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.205 1.802 . . . . 0.0 113.729 174.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.43 148.71 47.8 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.913 -1.117 . . . . 0.0 113.27 172.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.85 173.77 22.87 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.714 1.626 . . . . 0.0 114.603 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.56 -10.11 27.24 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.308 2.672 . . . . 0.0 114.152 -174.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -110.04 0.02 18.25 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.165 1.386 . . . . 0.0 113.879 170.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.525 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 18.6 m -71.42 139.0 49.53 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.726 1.148 . . . . 0.0 111.384 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -79.96 129.94 34.89 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 123.099 1.428 . . . . 0.0 109.59 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -70.16 -39.7 75.16 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.398 -176.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -56.63 -36.75 69.85 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 170.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.419 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -66.55 -51.7 53.6 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 122.029 0.919 . . . . 0.0 110.324 174.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.0 -33.27 75.66 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.449 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.01 -50.16 44.3 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.321 1.449 . . . . 0.0 112.18 177.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -49.99 -41.06 46.19 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.563 1.074 . . . . 0.0 112.09 169.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 20.9 mt -64.07 -49.68 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 118.518 0.599 . . . . 0.0 111.937 172.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.12 -39.83 44.27 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.453 0.57 . . . . 0.0 112.022 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -68.43 -39.35 81.56 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.376 0.67 . . . . 0.0 111.764 176.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.15 -27.75 65.83 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.836 -0.54 . . . . 0.0 112.157 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mt -88.02 -34.77 17.9 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.302 0.641 . . . . 0.0 110.538 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.58 -37.63 73.49 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.275 1.83 . . . . 0.0 110.142 168.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 117.46 22.43 4.07 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.691 1.139 . . . . 0.0 114.962 170.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.08 -50.0 75.03 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 118.644 1.222 . . . . 0.0 111.036 174.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -162.74 143.85 9.97 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.173 1.789 . . . . 0.0 111.145 169.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.45 118.4 13.21 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 168.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.9 tpp180 -151.75 138.35 18.73 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.61 1.164 . . . . 0.0 111.685 -173.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -80.63 128.72 33.94 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.693 1.197 . . . . 0.0 110.091 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.34 148.94 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.319 1.447 . . . . 0.0 108.813 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -79.94 157.13 26.96 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.061 0.944 . . . . 0.0 110.399 171.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.579 HD11 HG21 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -164.11 149.13 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.994 0.918 . . . . 0.0 110.629 171.679 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.525 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -84.36 145.39 28.25 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.726 176.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -117.0 156.2 27.89 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.523 1.129 . . . . 0.0 111.155 175.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -122.75 140.17 53.18 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.173 0.511 . . . . 0.0 110.263 168.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -91.01 146.32 23.95 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.769 1.228 . . . . 0.0 109.687 175.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -49.86 -30.51 10.09 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 126.728 2.011 . . . . 0.0 114.577 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -75.67 -9.82 58.92 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 109.91 28.11 4.32 Favored Glycine 0 CA--C 1.536 1.397 0 N-CA-C 115.905 1.122 . . . . 0.0 115.905 169.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.6 m -119.02 138.54 52.76 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.529 1.132 . . . . 0.0 111.229 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 32.0 p -135.99 140.03 43.61 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -150.93 148.62 28.63 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.837 1.255 . . . . 0.0 113.723 -173.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -99.98 120.94 40.6 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.471 1.509 . . . . 0.0 108.296 167.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 75.3 m -122.74 163.49 20.08 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.465 1.506 . . . . 0.0 109.579 174.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 67.4 mt -79.99 59.85 3.36 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.211 -0.931 . . . . 0.0 111.25 -175.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.555 HG21 HD12 ' A' ' 96' ' ' ILE . 14.5 m -65.2 144.82 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.6 1.96 . . . . 0.0 111.69 -173.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -107.68 69.85 0.76 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 122.42 1.105 . . . . 0.0 112.394 -167.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.579 HG21 HD11 ' A' ' 96' ' ' ILE . 12.8 t -81.37 69.92 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.762 1.225 . . . . 0.0 111.452 -168.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.49 131.99 24.32 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 124.317 1.047 . . . . 0.0 112.364 -175.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -86.18 -170.65 0.71 Allowed 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 123.544 2.83 . . . . 0.0 112.911 -172.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -123.17 129.85 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 122.868 1.318 . . . . 0.0 112.688 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -117.64 159.86 22.23 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.006 2.122 . . . . 0.0 111.277 -174.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -89.88 -179.8 5.81 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.947 0.899 . . . . 0.0 111.923 175.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.17 -21.77 64.09 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -72.45 -19.91 61.49 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.656 1.182 . . . . 0.0 113.884 170.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.54 0.55 60.89 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.622 1.582 . . . . 0.0 114.203 -176.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -87.35 139.39 30.6 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.465 1.132 . . . . 0.0 112.927 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.8 p -77.63 100.0 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 125.449 1.5 . . . . 0.0 111.114 -175.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.25 -30.0 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.71 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.89 150.0 49.19 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 123.997 1.856 . . . . 0.0 113.053 173.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -103.73 84.07 2.22 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 126.166 1.786 . . . . 0.0 107.475 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 44.3 mt -99.97 70.01 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 122.855 1.312 . . . . 0.0 108.697 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.277 22.0 mt -78.74 85.4 4.75 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 122.998 1.38 . . . . 0.0 110.051 -177.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -59.89 105.71 0.42 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.456 1.902 . . . . 0.0 110.143 175.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -86.13 53.97 2.98 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.559 -1.338 . . . . 0.0 110.017 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -79.76 106.66 11.94 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 124.168 1.937 . . . . 0.0 111.241 -168.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.7 t -61.19 112.34 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 113.452 -1.704 . . . . 0.0 108.242 177.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.32 142.05 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 175.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 78.6 mtm -141.35 147.43 38.06 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.01 1.324 . . . . 0.0 111.552 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -70.74 153.55 42.68 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.686 1.194 . . . . 0.0 112.956 176.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 60.9 mttp . . . . . 0 C--O 1.252 1.221 0 C-N-CA 125.939 1.696 . . . . 0.0 112.295 -169.11 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 119.042 -0.504 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -59.81 154.45 49.63 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.634 2.89 . . . . 0.0 113.121 170.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.6 t -72.79 129.37 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.655 0.782 . . . . 0.0 110.622 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 25.1 ptt-85 -135.52 19.9 3.34 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.669 1.588 . . . . 0.0 114.428 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 -49.87 136.75 17.68 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.265 1.826 . . . . 0.0 113.091 -170.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.49 7.85 64.69 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 124.691 1.138 . . . . 0.0 114.403 -170.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -64.93 155.99 32.58 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.115 1.366 . . . . 0.0 112.973 173.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.3 m -79.34 146.81 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.324 1.45 . . . . 0.0 112.638 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.22 159.94 74.1 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 124.065 0.946 . . . . 0.0 111.274 169.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -58.91 108.38 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.283 2.655 . . . . 0.0 111.434 174.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -63.74 -27.5 69.24 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -168.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -70.01 -50.03 45.51 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.614 0.643 . . . . 0.0 110.473 -175.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.4 t -77.27 -34.4 55.72 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.433 1.093 . . . . 0.0 112.373 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -58.82 -41.98 88.11 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.036 0.534 . . . . 0.0 110.161 172.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.45 -44.18 68.32 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 118.82 -0.609 . . . . 0.0 112.07 172.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -48.92 -39.99 28.36 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.865 1.211 . . . . 0.0 112.316 175.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.0 m -60.18 -43.1 96.11 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.399 -0.813 . . . . 0.0 112.718 172.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.8 mm -67.94 -35.76 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 O-C-N 121.306 -0.871 . . . . 0.0 110.389 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.4 mm -55.72 -54.57 24.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 172.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -24.36 64.25 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.568 1.147 . . . . 0.0 113.383 177.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -69.44 -44.65 70.85 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.616 1.166 . . . . 0.0 113.557 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -105.54 4.15 30.12 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -54.37 -29.08 47.23 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.473 1.909 . . . . 0.0 115.169 -167.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.01 -1.62 31.25 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.433 1.492 . . . . 0.0 116.651 170.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -105.66 -5.69 19.82 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.584 1.554 . . . . 0.0 113.181 -174.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 63.6 p -93.73 16.4 14.08 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.01 2.124 . . . . 0.0 113.463 174.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.8 mtt85 -69.19 156.88 37.98 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.074 1.75 . . . . 0.0 114.75 -173.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.1 147.73 40.69 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.308 1.843 . . . . 0.0 113.577 -169.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -169.93 160.18 8.23 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 -172.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 pp -119.92 166.07 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 127.637 2.375 . . . . 0.0 111.052 173.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.8 mm -130.78 118.04 40.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 125.206 1.402 . . . . 0.0 108.206 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.09 156.36 44.66 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -78.88 129.58 34.71 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 169.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.65 -11.87 52.76 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 169.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -94.37 0.4 55.47 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.949 1.7 . . . . 0.0 114.05 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.7 m -109.52 138.89 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 125.692 1.597 . . . . 0.0 111.153 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -63.86 -28.01 69.55 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.822 0.849 . . . . 0.0 112.941 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -81.92 -5.95 58.7 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.49 1.116 . . . . 0.0 113.671 175.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.0 p 45.06 37.41 2.5 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 127.028 2.131 . . . . 0.0 113.709 -175.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.05 150.01 40.86 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -167.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 64.7 t -79.99 90.91 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 129.454 3.102 . . . . 0.0 108.787 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.6 pt -69.99 -23.81 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.116 1.366 . . . . 0.0 112.267 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -156.41 159.72 38.97 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.346 1.058 . . . . 0.0 112.157 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.5 p -143.64 155.79 44.36 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 120.76 -1.212 . . . . 0.0 112.812 172.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -92.29 156.89 16.96 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -58.41 -29.05 65.79 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.708 0.803 . . . . 0.0 111.578 172.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.09 -49.83 41.66 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.416 1.008 . . . . 0.0 113.34 168.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.97 -38.48 76.11 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 119.343 1.572 . . . . 0.0 110.421 174.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.8 t -60.21 -39.86 88.11 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.881 -0.512 . . . . 0.0 111.051 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -74.71 -28.3 60.74 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 121.247 -0.908 . . . . 0.0 112.833 175.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.5 tp -66.85 -55.81 13.15 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.761 1.224 . . . . 0.0 111.594 177.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 64.2 m -98.77 -19.89 17.2 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.526 1.131 . . . . 0.0 113.054 -172.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.78 10.0 83.2 Favored Glycine 0 CA--C 1.541 1.696 0 N-CA-C 116.143 1.217 . . . . 0.0 116.143 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -89.21 -116.86 0.06 Allowed 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 119.072 1.436 . . . . 0.0 111.451 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.7 t -160.02 150.08 18.36 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.229 1.411 . . . . 0.0 110.948 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.9 mtp-105 -55.36 -40.78 71.7 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.402 1.081 . . . . 0.0 111.623 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.52 -19.15 63.33 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.489 1.116 . . . . 0.0 113.766 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -85.67 -20.65 29.1 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.966 1.307 . . . . 0.0 112.712 174.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.7 m -100.97 -20.05 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 174.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 30.2 mmt -49.91 113.24 0.8 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.423 1.089 . . . . 0.0 111.089 -177.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 71.49 15.74 6.08 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.839 1.656 . . . . 0.0 113.977 170.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.83 160.16 74.82 Favored Pre-proline 0 N--CA 1.475 0.803 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.414 167.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.03 140.1 85.92 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.801 2.334 . . . . 0.0 111.834 169.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.4 t -69.39 -12.58 61.77 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.807 0.843 . . . . 0.0 113.091 177.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.7 m -64.76 97.86 0.24 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.373 1.869 . . . . 0.0 110.731 177.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 31.8 p -52.67 -15.05 0.61 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.075 1.75 . . . . 0.0 115.134 -177.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -47.36 -38.98 14.06 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.746 1.219 . . . . 0.0 111.854 168.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.07 -19.76 63.27 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 pp -123.0 24.91 8.78 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.428 1.891 . . . . 0.0 113.045 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.53 145.67 53.69 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.308 -0.87 . . . . 0.0 112.419 174.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -110.8 178.97 19.98 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.532 1.539 . . . . 0.0 113.558 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.05 -10.07 27.73 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.493 2.795 . . . . 0.0 114.208 -177.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.25 -10.09 24.54 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.649 1.579 . . . . 0.0 112.582 172.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 97' ' ' ALA . 2.9 m -80.24 138.37 36.8 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.717 -1.239 . . . . 0.0 111.541 -175.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -87.64 135.26 33.44 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.384 1.088 . . . . 0.0 110.709 174.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.4 mmm-85 -66.26 -39.68 89.62 Favored 'General case' 0 C--O 1.219 -0.536 0 O-C-N 121.43 -0.794 . . . . 0.0 111.074 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -53.68 -38.34 64.1 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 171.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.38 -52.35 47.68 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.942 0.877 . . . . 0.0 110.027 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.55 -33.79 76.73 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.554 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.01 -52.19 26.16 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.859 1.664 . . . . 0.0 112.314 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -50.13 -42.02 49.88 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.455 1.025 . . . . 0.0 112.287 170.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 48.9 mt -62.94 -49.34 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 O-C-N 121.876 -0.515 . . . . 0.0 111.052 173.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.27 -39.93 57.8 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.592 -0.718 . . . . 0.0 112.114 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -68.68 -37.67 79.77 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.636 0.774 . . . . 0.0 111.477 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.37 -33.0 74.73 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.436 -0.79 . . . . 0.0 111.311 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 mt -82.06 -29.83 31.68 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.469 0.707 . . . . 0.0 112.119 177.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.3 -28.75 69.54 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.216 2.206 . . . . 0.0 110.766 168.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.95 17.66 9.44 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.196 1.379 . . . . 0.0 114.905 169.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.4 -50.04 67.01 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.648 1.224 . . . . 0.0 111.182 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -150.59 141.36 22.76 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.658 1.583 . . . . 0.0 111.621 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -79.59 104.02 9.9 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 166.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.7 tpt85 -145.11 136.79 25.43 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.242 1.017 . . . . 0.0 111.433 -171.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -82.02 133.04 35.26 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.572 1.549 . . . . 0.0 109.632 169.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.22 146.42 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.406 1.483 . . . . 0.0 108.9 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.01 153.86 28.57 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.644 0.778 . . . . 0.0 110.404 172.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -161.33 158.57 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.728 1.211 . . . . 0.0 110.537 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.516 ' H ' HG23 ' A' ' 74' ' ' THR . . . -100.09 145.44 27.95 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.671 0.789 . . . . 0.0 112.181 174.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -115.91 158.61 22.75 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.561 1.145 . . . . 0.0 111.041 169.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -127.44 137.46 52.71 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.519 0.728 . . . . 0.0 110.241 168.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -81.26 159.7 24.44 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.191 0.997 . . . . 0.0 112.611 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -55.43 -29.05 57.89 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.786 1.635 . . . . 0.0 112.979 171.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -80.02 -9.9 59.73 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.022 1.329 . . . . 0.0 113.774 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.37 0.69 53.74 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 126.106 1.813 . . . . 0.0 115.822 178.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.0 m -78.23 128.0 33.09 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.108 1.454 . . . . 0.0 111.741 -178.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 61.5 m -115.7 137.93 51.6 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.742 1.217 . . . . 0.0 112.317 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -151.03 139.92 20.92 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.429 ' HB2' ' HB2' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -116.25 121.37 41.83 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 127.091 2.156 . . . . 0.0 108.341 169.123 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 89.0 m -129.37 177.47 7.16 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.429 1.492 . . . . 0.0 110.218 169.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 25.0 tp -78.36 59.92 2.45 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.688 -1.258 . . . . 0.0 110.821 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 49.8 t -55.82 146.06 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.129 1.372 . . . . 0.0 111.194 -172.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -100.03 69.81 1.55 Allowed 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 122.948 1.356 . . . . 0.0 112.047 -167.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.3 t -83.84 69.84 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.37 1.068 . . . . 0.0 110.62 -169.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.77 134.99 23.52 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 124.989 1.316 . . . . 0.0 110.512 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -88.5 -166.41 0.26 Allowed 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 123.517 2.811 . . . . 0.0 113.153 -170.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.65 131.08 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-O 122.927 1.346 . . . . 0.0 113.628 173.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -116.99 160.25 21.23 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.18 2.192 . . . . 0.0 111.744 -173.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -90.02 179.99 5.82 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.065 0.946 . . . . 0.0 112.081 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.99 -21.46 64.87 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -71.2 -19.9 62.34 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.575 1.15 . . . . 0.0 113.819 170.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.08 3.55 60.35 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.599 1.571 . . . . 0.0 114.337 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.06 139.8 30.28 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.585 1.193 . . . . 0.0 113.053 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.2 p -74.34 99.95 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.868 1.667 . . . . 0.0 110.914 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.0 -29.63 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.565 0.746 . . . . 0.0 111.792 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.97 149.14 52.26 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 124.251 1.977 . . . . 0.0 112.626 173.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.2 m-30 -105.01 79.99 1.57 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.27 -1.787 . . . . 0.0 106.886 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 44.3 mt -100.59 70.41 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 169.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.09 89.23 3.6 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.923 0.868 . . . . 0.0 108.822 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -59.86 106.44 0.49 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.663 1.185 . . . . 0.0 110.797 -177.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -84.02 53.21 2.52 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.546 -1.346 . . . . 0.0 112.52 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -79.73 127.2 31.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 122.196 0.998 . . . . 0.0 111.109 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 65.6 t -81.14 117.76 27.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 125.169 1.388 . . . . 0.0 108.327 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.36 140.56 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-O 121.416 0.626 . . . . 0.0 112.642 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 28.5 ptm -133.12 172.48 12.59 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.611 1.964 . . . . 0.0 110.783 174.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.74 135.1 57.48 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.697 0.799 . . . . 0.0 112.043 177.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 86.1 tttt . . . . . 0 C--O 1.253 1.266 0 C-N-CA 125.891 1.676 . . . . 0.0 112.627 -176.456 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -60.05 155.76 43.04 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.735 2.956 . . . . 0.0 114.155 177.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 46.7 t -74.17 136.54 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.277 1.031 . . . . 0.0 110.426 176.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 94.1 mtm-85 -70.63 153.23 43.06 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.484 1.114 . . . . 0.0 112.652 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -137.96 147.96 44.77 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.12 1.768 . . . . 0.0 110.828 173.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.85 9.59 62.96 Favored Glycine 0 CA--C 1.54 1.629 0 C-N-CA 124.499 1.047 . . . . 0.0 115.499 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 -84.18 162.35 20.24 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.258 1.823 . . . . 0.0 113.065 -178.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.4 t -79.46 137.08 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.106 0.962 . . . . 0.0 109.346 172.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.09 159.88 19.15 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.924 0.89 . . . . 0.0 111.997 173.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -52.39 110.01 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.688 2.925 . . . . 0.0 111.858 174.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -65.47 -26.94 68.16 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -167.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -68.76 -49.99 54.15 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.672 0.789 . . . . 0.0 110.299 -178.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 t -74.55 -35.76 63.1 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.716 0.806 . . . . 0.0 112.114 178.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.06 -39.98 83.72 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.498 0.719 . . . . 0.0 110.423 174.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.2 tp -69.99 -45.83 66.46 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.984 0.514 . . . . 0.0 111.869 170.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -47.61 -39.78 17.78 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.974 1.261 . . . . 0.0 113.742 175.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 92.8 m -60.03 -41.69 92.77 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 121.579 -0.701 . . . . 0.0 112.371 172.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.2 mm -68.66 -35.29 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 O-C-N 121.154 -0.966 . . . . 0.0 110.219 174.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.5 mm -56.54 -51.65 62.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 CA-C-O 117.765 -1.112 . . . . 0.0 108.865 170.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -29.02 67.94 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.932 1.242 . . . . 0.0 112.255 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.9 tttp -66.69 -42.79 85.92 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.336 1.054 . . . . 0.0 113.055 174.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -103.65 1.91 32.55 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -56.0 -29.02 59.71 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.183 1.793 . . . . 0.0 114.804 -167.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.42 55.41 3.98 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 121.246 -0.909 . . . . 0.0 111.998 -175.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -71.48 7.07 1.52 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.297 2.239 . . . . 0.0 114.039 -173.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.3 p -73.36 13.85 0.4 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.067 1.747 . . . . 0.0 112.528 167.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -53.27 149.86 6.83 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.789 1.636 . . . . 0.0 112.276 169.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.15 147.68 29.78 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 127.157 2.183 . . . . 0.0 112.241 -172.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -169.79 159.64 8.14 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 -175.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 pp -120.04 172.87 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 126.022 1.729 . . . . 0.0 111.036 174.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.5 mm -131.64 119.72 43.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 125.999 1.72 . . . . 0.0 107.781 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -137.49 152.33 49.41 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -175.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -76.91 107.92 9.58 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.6 174.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.07 -17.42 63.24 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -95.67 2.61 54.14 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.119 1.367 . . . . 0.0 114.034 -169.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.18 140.23 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.797 1.639 . . . . 0.0 110.109 -177.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -57.53 -28.37 63.42 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.18 -14.81 59.31 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.847 1.259 . . . . 0.0 113.982 178.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 82.7 m 43.87 50.67 6.97 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.5 1.52 . . . . 0.0 113.377 -177.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.51 150.02 21.95 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -166.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 98.3 t -79.84 90.0 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 128.011 2.524 . . . . 0.0 109.387 -175.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.5 pt -70.02 -23.75 25.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.837 1.255 . . . . 0.0 112.223 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -155.74 159.83 39.8 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.449 1.099 . . . . 0.0 112.329 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.4 p -140.01 154.69 47.2 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.809 -1.182 . . . . 0.0 113.227 173.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -85.94 153.48 22.16 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 174.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -63.29 -24.1 67.71 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.673 173.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.73 -49.99 45.07 Favored Glycine 0 CA--C 1.532 1.138 0 O-C-N 121.308 -0.87 . . . . 0.0 112.249 168.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -37.25 78.59 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 119.208 1.504 . . . . 0.0 110.852 175.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.2 t -60.09 -39.97 87.97 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.538 -0.726 . . . . 0.0 110.896 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -73.93 -30.04 62.35 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.541 0.736 . . . . 0.0 112.327 175.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.4 tp -64.72 -55.67 18.5 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.274 1.029 . . . . 0.0 112.18 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 78.1 m -97.68 -20.71 17.45 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -172.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.21 15.15 81.3 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-O 118.735 -1.036 . . . . 0.0 115.633 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -88.85 -124.26 0.05 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 119.129 1.465 . . . . 0.0 111.316 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.3 m -159.92 150.09 18.57 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.903 2.081 . . . . 0.0 109.719 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -57.07 -36.19 70.26 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.21 -20.68 59.84 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.886 1.274 . . . . 0.0 113.613 174.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -83.15 -20.89 33.9 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.743 1.617 . . . . 0.0 112.279 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -104.46 -19.29 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 177.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 33.4 mmt -49.99 115.4 1.39 Allowed 'General case' 0 C--N 1.343 0.286 0 CA-C-O 122.172 0.986 . . . . 0.0 110.877 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 72.2 17.67 4.93 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.713 2.005 . . . . 0.0 113.703 169.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.57 154.48 81.38 Favored Pre-proline 0 N--CA 1.473 0.697 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.339 167.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -65.41 140.16 62.42 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.983 3.122 . . . . 0.0 112.043 171.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 96.0 m -62.18 -10.0 9.31 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.4 m -65.24 96.47 0.22 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.198 1.799 . . . . 0.0 110.763 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 61.6 m -50.37 -20.01 0.99 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.629 1.972 . . . . 0.0 115.789 -171.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -46.56 -39.48 11.08 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.059 1.344 . . . . 0.0 112.395 169.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -60.98 -20.17 62.03 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 pp -122.98 23.73 9.21 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.885 1.674 . . . . 0.0 113.229 176.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -64.57 147.18 53.4 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.354 -0.842 . . . . 0.0 112.338 175.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.72 -169.69 11.88 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 125.574 1.559 . . . . 0.0 113.989 -176.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -64.68 -10.13 23.53 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.533 2.822 . . . . 0.0 116.378 -170.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.4 mmm-85 -104.96 -10.1 17.48 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.466 1.506 . . . . 0.0 113.601 174.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.469 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 2.9 m -79.21 133.09 36.69 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.228 0.922 . . . . 0.0 111.608 -169.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -85.2 137.03 33.26 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 122.409 1.1 . . . . 0.0 110.683 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -69.48 -39.69 77.53 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.948 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.9 ptt-85 -53.64 -40.31 65.74 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 169.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.4 -50.66 62.71 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.029 0.931 . . . . 0.0 110.261 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.82 -33.85 76.98 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.457 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.98 -51.89 28.82 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.239 1.416 . . . . 0.0 112.098 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -49.97 -41.91 47.69 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.594 1.158 . . . . 0.0 111.799 170.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.7 mt -64.38 -49.13 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 121.824 -0.547 . . . . 0.0 111.602 173.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.49 -39.94 49.7 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.859 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -70.3 -38.78 75.04 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.758 0.823 . . . . 0.0 111.734 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.42 -32.69 73.74 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.455 -0.778 . . . . 0.0 111.399 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mt -86.94 -27.98 23.01 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.814 0.846 . . . . 0.0 111.521 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.98 -30.19 70.76 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.579 1.952 . . . . 0.0 110.658 168.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.94 22.52 6.56 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.725 1.155 . . . . 0.0 114.319 170.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.33 -49.95 75.36 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.405 1.102 . . . . 0.0 109.81 171.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -166.95 141.36 3.93 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.786 2.435 . . . . 0.0 109.534 167.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -72.67 120.52 18.4 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.897 -1.127 . . . . 0.0 108.485 169.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 26.2 tpp180 -157.56 140.3 14.92 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.542 1.537 . . . . 0.0 110.243 -168.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -81.57 137.36 35.53 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.714 0.806 . . . . 0.0 111.628 175.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.0 t -137.83 150.09 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 126.55 1.94 . . . . 0.0 108.183 177.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -79.97 158.37 26.59 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.073 0.949 . . . . 0.0 110.573 171.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.52 HD11 HG21 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -164.29 152.56 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.526 1.13 . . . . 0.0 110.269 171.637 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.469 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -85.88 145.35 27.21 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.008 176.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.511 ' CE1' HD13 ' A' ' 96' ' ' ILE . 22.2 m-85 -117.31 162.04 18.55 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.822 1.249 . . . . 0.0 111.771 176.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -131.15 140.01 49.88 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.017 0.927 . . . . 0.0 111.5 168.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 24.5 mtp-105 -86.29 166.63 15.5 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.553 1.541 . . . . 0.0 113.088 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -58.15 -30.94 66.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.93 2.092 . . . . 0.0 112.839 174.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -78.06 -9.87 59.35 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.876 1.27 . . . . 0.0 114.047 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.65 -0.8 61.37 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 125.701 1.62 . . . . 0.0 116.003 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.0 t -76.46 140.87 41.43 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.799 1.799 . . . . 0.0 111.39 176.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 23.7 p -137.51 137.25 38.45 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -174.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -151.05 148.4 28.29 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.87 1.268 . . . . 0.0 114.256 -172.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -102.6 125.06 49.2 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.52 1.528 . . . . 0.0 108.337 167.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 67.7 m -128.11 166.27 18.79 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.264 1.426 . . . . 0.0 109.867 172.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 mp -80.05 59.81 3.39 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.071 -1.018 . . . . 0.0 110.238 -176.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.472 HG21 HD12 ' A' ' 96' ' ' ILE . 18.2 m -67.66 148.02 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.294 1.838 . . . . 0.0 111.623 -169.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -109.34 69.72 0.71 Allowed 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 122.545 1.164 . . . . 0.0 113.397 -166.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.52 HG21 HD11 ' A' ' 96' ' ' ILE . 10.8 t -80.62 69.8 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 125.093 1.357 . . . . 0.0 110.003 -171.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.7 p -123.79 130.79 24.31 Favored Pre-proline 0 N--CA 1.484 1.259 0 C-N-CA 124.922 1.289 . . . . 0.0 112.535 -169.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -83.05 179.92 4.85 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.237 1.958 . . . . 0.0 113.34 -174.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -123.18 135.62 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 123.089 1.424 . . . . 0.0 112.334 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.09 165.03 22.03 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.779 2.032 . . . . 0.0 112.152 -169.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -89.99 -177.04 5.09 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.139 1.376 . . . . 0.0 111.958 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.8 -19.96 65.41 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -80.04 -19.85 46.67 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.683 1.193 . . . . 0.0 113.087 170.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.35 8.98 59.52 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.345 1.45 . . . . 0.0 114.147 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -84.59 129.25 34.87 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.347 1.574 . . . . 0.0 110.802 175.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.29 99.99 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 125.82 1.648 . . . . 0.0 110.279 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.8 -29.96 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 118.402 -0.809 . . . . 0.0 111.263 176.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.6 mmt -138.0 148.5 45.22 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 123.835 1.779 . . . . 0.0 111.911 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -101.44 87.07 3.1 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 126.613 1.965 . . . . 0.0 108.307 175.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 40.9 mt -100.72 70.82 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 169.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.3 mt -78.65 84.92 4.72 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.801 0.81 . . . . 0.0 109.672 -174.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -59.9 109.74 1.01 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.072 1.349 . . . . 0.0 110.885 -176.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -85.2 49.86 1.83 Allowed 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.215 -1.553 . . . . 0.0 110.857 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -85.54 106.88 17.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 123.468 1.604 . . . . 0.0 113.412 -168.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.0 t -55.16 114.3 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 113.624 -1.625 . . . . 0.0 109.02 171.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p -140.39 144.58 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 171.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 84.7 mtp -142.79 153.86 43.66 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.602 1.161 . . . . 0.0 111.329 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -73.85 153.43 39.9 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.212 1.005 . . . . 0.0 112.659 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 65.3 pttt . . . . . 0 C--O 1.254 1.299 0 C-N-CA 125.116 1.366 . . . . 0.0 113.732 178.035 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 119.115 -0.469 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.26 168.53 23.91 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.719 2.946 . . . . 0.0 112.812 177.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.3 m -66.63 157.14 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.29 1.036 . . . . 0.0 112.171 172.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -66.69 158.4 30.21 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.738 1.215 . . . . 0.0 113.152 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -123.52 146.48 48.06 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.556 1.942 . . . . 0.0 109.944 169.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.28 24.8 73.59 Favored Glycine 0 CA--C 1.54 1.639 0 C-N-CA 123.411 0.529 . . . . 0.0 113.912 -171.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -117.51 148.2 42.07 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.708 2.003 . . . . 0.0 111.718 -173.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.6 t -126.33 117.77 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.989 1.315 . . . . 0.0 107.624 169.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.06 159.93 52.06 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.401 0.68 . . . . 0.0 111.119 174.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.08 107.5 0.26 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.898 2.398 . . . . 0.0 111.159 174.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -64.36 -26.87 68.66 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -167.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -69.31 -49.86 51.98 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.28 0.632 . . . . 0.0 110.303 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 t -78.69 -32.71 47.16 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.393 1.077 . . . . 0.0 112.883 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -55.26 -44.64 75.77 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.276 1.03 . . . . 0.0 109.594 168.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.7 tp -72.21 -45.22 61.17 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 118.594 -0.717 . . . . 0.0 112.135 175.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -46.73 -39.99 12.62 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.527 1.531 . . . . 0.0 113.349 173.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.4 m -60.0 -45.9 91.22 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.468 173.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.1 mm -68.1 -36.14 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.859 0.864 . . . . 0.0 111.235 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.3 mm -53.28 -57.65 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 172.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -63.43 -24.72 67.96 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.614 0.765 . . . . 0.0 112.946 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.7 tptt -61.63 -45.09 95.56 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 118.347 -0.835 . . . . 0.0 111.974 170.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -103.97 -0.18 29.22 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 116.177 1.918 . . . . 0.0 116.177 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -60.02 -29.12 68.28 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.318 1.847 . . . . 0.0 115.736 -168.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.25 55.46 0.91 Allowed Glycine 0 CA--C 1.539 1.555 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -164.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -84.15 4.48 30.29 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 128.284 2.633 . . . . 0.0 114.615 -168.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.6 m -57.65 -4.1 0.24 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.833 2.053 . . . . 0.0 114.204 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.7 174.36 6.05 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.412 0.685 . . . . 0.0 112.609 168.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 ptpp? -59.35 137.81 57.86 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.71 1.604 . . . . 0.0 114.814 -173.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -169.79 167.22 9.42 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.686 1.594 . . . . 0.0 114.212 -177.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 pp -120.04 169.41 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.722 1.209 . . . . 0.0 111.12 167.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.6 mm -125.54 117.94 50.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 126.058 1.743 . . . . 0.0 107.11 171.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.36 147.66 50.64 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -81.01 106.55 13.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.648 0.737 . . . . 0.0 110.644 175.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.88 -6.48 51.01 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 53.1 mmm-85 -100.05 1.85 42.75 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.798 1.639 . . . . 0.0 114.133 -177.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -108.96 140.22 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.381 1.473 . . . . 0.0 109.974 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -55.7 -29.92 60.22 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -175.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -83.89 -12.67 55.15 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 95.9 m 42.99 58.8 3.13 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.497 1.919 . . . . 0.0 113.518 -177.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.0 156.97 16.12 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -168.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.3 t -79.9 89.94 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 128.272 2.629 . . . . 0.0 108.858 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.7 pt -70.48 -25.39 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.857 1.263 . . . . 0.0 112.185 176.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -156.76 159.79 38.64 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.916 0.886 . . . . 0.0 112.701 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 7.9 p -145.34 147.58 32.46 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.209 -0.932 . . . . 0.0 113.289 -169.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -86.26 152.4 22.81 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.503 0.668 . . . . 0.0 112.537 169.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -61.98 -36.06 80.33 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.215 0.606 . . . . 0.0 111.252 171.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.0 -49.94 53.31 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 121.292 -0.88 . . . . 0.0 112.911 175.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -29.94 66.93 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 118.939 1.37 . . . . 0.0 110.823 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.9 t -60.18 -40.03 88.59 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.007 -1.058 . . . . 0.0 111.181 172.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -78.74 -30.02 45.55 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.977 0.911 . . . . 0.0 112.385 175.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.3 tp -55.17 -52.72 62.4 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.886 1.274 . . . . 0.0 110.244 171.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 57.5 m -80.03 -29.17 39.27 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.15 0.5 . . . . 0.0 112.316 176.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.29 26.07 58.13 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 125.376 1.465 . . . . 0.0 114.143 -173.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 16.1 m-30 -94.7 -130.11 0.14 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.881 1.272 . . . . 0.0 111.865 -173.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.0 t -159.88 140.38 11.98 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 127.117 2.167 . . . . 0.0 108.741 175.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.8 mtm105 -64.75 -31.33 72.51 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 120.92 -1.113 . . . . 0.0 113.246 -171.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.81 -16.66 29.98 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.023 0.929 . . . . 0.0 113.403 172.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -95.6 -20.82 18.67 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.476 1.91 . . . . 0.0 112.14 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.1 m -89.89 -18.12 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-N 119.489 1.04 . . . . 0.0 112.694 -174.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 33.6 mmt -49.73 115.42 1.36 Allowed 'General case' 0 C--N 1.341 0.204 0 C-N-CA 125.041 1.336 . . . . 0.0 110.486 -172.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 69.0 21.03 7.58 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.283 1.433 . . . . 0.0 113.62 169.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.72 155.1 93.87 Favored Pre-proline 0 N--CA 1.475 0.794 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.528 167.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.12 140.04 93.23 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.47 2.113 . . . . 0.0 111.649 169.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 37.4 t -64.36 -17.66 63.93 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.62 1.168 . . . . 0.0 112.914 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.6 m -62.61 99.98 0.17 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 127.09 2.156 . . . . 0.0 111.232 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 28.0 p -55.14 -14.17 1.54 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.446 1.498 . . . . 0.0 114.918 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -49.33 -40.06 33.82 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.778 1.231 . . . . 0.0 111.587 168.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -66.73 -11.0 52.77 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 pp -123.04 20.52 9.92 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.14 1.776 . . . . 0.0 113.744 170.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -63.74 144.38 57.08 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.136 -0.978 . . . . 0.0 113.084 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -109.15 175.87 19.36 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.691 1.615 . . . . 0.0 113.754 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.56 -10.05 27.89 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.445 2.763 . . . . 0.0 114.629 -175.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -103.14 -7.63 21.12 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.206 1.402 . . . . 0.0 113.696 170.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.472 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 5.0 m -70.85 134.58 47.44 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.536 1.062 . . . . 0.0 110.355 178.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -81.97 137.39 35.14 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.643 0.735 . . . . 0.0 110.2 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -66.35 -39.85 89.43 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.697 -0.627 . . . . 0.0 110.855 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.5 ptt-85 -55.59 -41.18 73.04 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.802 0.841 . . . . 0.0 113.008 171.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.429 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -64.56 -51.35 63.23 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.766 0.826 . . . . 0.0 110.364 177.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.44 -33.65 76.19 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.247 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.06 -52.77 21.25 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.762 1.225 . . . . 0.0 111.983 177.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -50.0 -42.18 48.64 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.719 1.208 . . . . 0.0 111.859 171.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 54.3 mt -63.8 -51.04 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 121.878 -0.514 . . . . 0.0 110.897 174.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.37 -39.9 58.1 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 118.604 -0.713 . . . . 0.0 112.116 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -69.09 -36.58 77.73 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.64 0.776 . . . . 0.0 111.601 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.49 -30.11 68.87 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.684 -0.635 . . . . 0.0 111.673 177.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mt -83.59 -31.33 26.36 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.565 0.746 . . . . 0.0 111.445 176.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.77 -30.08 71.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.249 2.22 . . . . 0.0 111.484 169.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.05 19.92 7.83 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.797 1.189 . . . . 0.0 114.953 169.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.89 -50.01 73.93 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 118.868 1.334 . . . . 0.0 110.5 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -162.8 141.47 8.63 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.608 2.363 . . . . 0.0 108.934 168.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -78.73 120.47 23.42 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.987 -1.071 . . . . 0.0 108.654 170.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.9 tpp180 -152.19 136.62 16.79 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.311 1.444 . . . . 0.0 109.857 -169.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -79.61 134.44 36.45 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.302 0.641 . . . . 0.0 110.578 173.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.29 148.2 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.645 1.578 . . . . 0.0 109.126 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -79.87 155.73 27.67 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.108 0.963 . . . . 0.0 110.381 172.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.429 HG23 ' HB1' ' A' ' 78' ' ' ALA . 0.7 OUTLIER -163.39 149.75 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.357 1.063 . . . . 0.0 110.858 179.749 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -87.14 145.37 26.46 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.844 176.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -112.3 145.69 39.55 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.032 1.333 . . . . 0.0 111.675 169.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.66 132.27 53.81 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.535 0.734 . . . . 0.0 109.394 167.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 28.7 mtp-105 -100.04 153.35 19.28 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.738 1.615 . . . . 0.0 112.881 -168.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -58.9 -29.44 67.05 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.688 1.195 . . . . 0.0 112.287 171.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -72.27 -10.03 59.25 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.471 1.508 . . . . 0.0 113.878 175.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.49 0.87 55.53 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.49 1.519 . . . . 0.0 115.397 177.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.51 148.72 47.92 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.85 1.325 . . . . 0.0 111.273 174.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 34.3 t -152.0 110.62 3.79 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.245 0.93 . . . . 0.0 111.421 175.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -151.0 151.75 32.52 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -173.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -102.2 126.43 49.17 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.421 1.889 . . . . 0.0 108.989 168.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 73.5 m -130.29 171.47 12.88 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.94 1.296 . . . . 0.0 110.618 170.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 mp -79.96 59.85 3.34 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 120.947 -1.095 . . . . 0.0 110.921 -175.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.0 t -61.28 140.68 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.179 1.391 . . . . 0.0 111.932 -170.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -101.59 69.78 1.24 Allowed 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 123.109 1.433 . . . . 0.0 112.447 -169.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.8 t -78.18 69.97 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.271 1.828 . . . . 0.0 111.481 -173.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.4 p -120.86 131.19 24.54 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.085 -1.009 . . . . 0.0 113.56 -171.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -85.58 -178.9 3.18 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 125.028 3.819 . . . . 0.0 115.578 -169.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.9 m -123.69 131.36 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-O 122.844 1.307 . . . . 0.0 113.048 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -115.4 163.05 16.29 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.876 2.07 . . . . 0.0 111.82 -171.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -95.64 -179.96 4.92 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.269 1.028 . . . . 0.0 112.009 172.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -61.82 -19.99 63.15 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -177.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -71.37 -21.59 62.0 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.529 1.132 . . . . 0.0 113.57 170.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.75 5.25 57.7 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 125.581 1.562 . . . . 0.0 114.695 -174.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -97.51 142.24 29.59 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.852 1.326 . . . . 0.0 113.581 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.7 p -71.12 100.16 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.955 1.702 . . . . 0.0 111.089 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.45 -29.25 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 118.631 -0.7 . . . . 0.0 111.68 174.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.35 147.59 51.83 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 124.277 1.989 . . . . 0.0 113.236 172.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -99.2 86.03 3.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 112.994 -1.912 . . . . 0.0 107.284 173.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 36.3 mt -101.43 70.0 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 122.834 1.302 . . . . 0.0 108.631 170.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.253 17.7 mt -80.27 83.57 6.09 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.118 -177.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -59.8 103.09 0.18 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.429 1.892 . . . . 0.0 110.443 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -83.32 57.41 3.98 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.679 -1.263 . . . . 0.0 112.593 -174.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -79.74 106.93 12.13 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 124.576 2.132 . . . . 0.0 112.265 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.1 t -61.19 110.39 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 C-N-CA 127.24 2.216 . . . . 0.0 109.051 170.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p -140.43 140.39 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 120.805 0.336 . . . . 0.0 111.699 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 85.2 mtp -139.3 151.67 46.61 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.336 1.454 . . . . 0.0 110.897 169.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -72.53 150.19 43.41 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.037 0.935 . . . . 0.0 112.499 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 C--O 1.252 1.197 0 C-N-CA 126.537 1.935 . . . . 0.0 111.895 -177.531 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 ttp . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 118.433 -0.794 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -63.31 -29.57 72.82 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.127 2.551 . . . . 0.0 115.073 -177.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . 0.322 6.6 p 45.75 40.36 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 127.089 2.156 . . . . 0.0 114.472 172.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 56.68 25.21 9.82 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 127.003 2.121 . . . . 0.0 115.271 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -72.67 155.79 39.63 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.953 1.301 . . . . 0.0 112.082 174.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.17 -164.25 52.18 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.416 1.008 . . . . 0.0 114.178 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -143.84 148.32 35.34 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.267 1.427 . . . . 0.0 111.704 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.6 t -130.1 135.39 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.505 1.522 . . . . 0.0 109.437 174.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.99 159.9 60.54 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 123.677 0.791 . . . . 0.0 112.102 176.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.37 105.15 0.57 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.904 2.403 . . . . 0.0 111.947 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -66.13 -26.65 67.54 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.106 0.962 . . . . 0.0 113.332 -169.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -70.06 -49.9 46.44 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.339 0.656 . . . . 0.0 110.399 -176.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 t -76.13 -33.92 59.42 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.992 0.917 . . . . 0.0 112.32 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -59.96 -40.79 90.23 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.196 0.599 . . . . 0.0 110.328 173.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.3 tp -70.64 -45.68 64.71 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 118.781 -0.628 . . . . 0.0 111.759 171.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.9 -39.78 19.95 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.04 1.291 . . . . 0.0 113.475 175.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 86.6 m -60.12 -42.09 94.04 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.701 -0.624 . . . . 0.0 112.434 172.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.1 mm -68.79 -35.18 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 121.112 -0.993 . . . . 0.0 110.454 174.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.9 mm -56.83 -50.89 73.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 CA-C-O 117.673 -1.156 . . . . 0.0 108.668 170.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.79 -27.76 66.85 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.527 1.512 . . . . 0.0 113.15 174.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -65.82 -42.03 91.11 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.832 0.853 . . . . 0.0 112.361 173.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -107.11 2.43 24.9 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -57.27 -29.16 63.62 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.378 1.871 . . . . 0.0 114.311 -168.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.67 -1.7 5.35 Favored Glycine 0 CA--C 1.544 1.858 0 C-N-CA 125.711 1.624 . . . . 0.0 116.257 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -100.79 0.2 38.32 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.978 1.711 . . . . 0.0 112.738 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.5 m -75.1 -10.59 59.62 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.531 1.532 . . . . 0.0 113.094 173.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -63.21 157.75 21.78 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.339 1.456 . . . . 0.0 111.736 170.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.06 132.65 35.89 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.129 0.971 . . . . 0.0 110.515 -174.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -169.84 159.1 7.73 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 122.498 1.142 . . . . 0.0 112.899 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -123.91 171.56 12.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.755 173.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.4 mm -127.06 117.25 47.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 125.99 1.716 . . . . 0.0 106.772 174.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.12 148.83 50.6 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -80.74 106.45 12.76 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.388 0.614 . . . . 0.0 110.829 175.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.26 -6.48 53.27 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -96.1 -1.43 48.63 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.579 1.551 . . . . 0.0 113.797 -178.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -110.42 140.18 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.32 1.448 . . . . 0.0 109.951 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -57.4 -23.45 49.38 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -174.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -90.41 -10.53 43.5 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.381 1.472 . . . . 0.0 114.447 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 80.9 m 44.32 54.0 6.45 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.326 1.85 . . . . 0.0 114.663 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.03 158.52 15.77 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -168.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.8 t -79.93 89.97 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 128.624 2.769 . . . . 0.0 109.592 -172.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.4 pt -70.0 -24.46 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.256 1.422 . . . . 0.0 112.393 176.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -153.6 159.6 42.19 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.046 0.938 . . . . 0.0 112.276 174.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 10.0 p -147.27 142.54 27.3 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.038 -1.039 . . . . 0.0 113.268 -173.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -84.78 153.61 22.89 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -61.86 -29.82 70.44 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.757 0.423 . . . . 0.0 111.399 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.36 -49.92 43.01 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 123.945 0.783 . . . . 0.0 112.747 169.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -38.39 81.43 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 119.52 1.66 . . . . 0.0 110.644 175.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.6 t -60.18 -39.9 88.1 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.594 -0.691 . . . . 0.0 110.566 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -74.81 -30.02 61.28 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.339 0.655 . . . . 0.0 112.238 175.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 66.3 tp -63.83 -55.74 20.69 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.245 1.018 . . . . 0.0 111.83 177.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 59.9 m -95.68 -20.01 19.25 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.291 0.636 . . . . 0.0 112.661 -174.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.53 10.05 86.48 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-O 118.339 -1.256 . . . . 0.0 115.549 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -87.97 -121.73 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 119.46 1.63 . . . . 0.0 111.217 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.1 t -159.98 150.22 18.56 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.535 1.934 . . . . 0.0 109.96 -176.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -50.0 -41.13 46.41 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.259 1.024 . . . . 0.0 112.099 172.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.07 -19.94 63.47 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.321 1.048 . . . . 0.0 113.532 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -84.72 -20.71 30.73 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.635 1.574 . . . . 0.0 112.311 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -105.4 -18.84 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 125.66 1.584 . . . . 0.0 115.127 175.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 7.0 mmt -49.81 112.08 0.6 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.402 1.481 . . . . 0.0 111.647 -174.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 67.3 30.82 6.87 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.358 1.863 . . . . 0.0 112.745 171.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -106.75 154.85 39.87 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-O 117.599 -1.191 . . . . 0.0 112.984 177.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.86 137.59 60.75 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.282 2.654 . . . . 0.0 114.124 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 49.4 t -70.11 -9.94 57.14 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 125.427 1.491 . . . . 0.0 113.616 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.0 m -66.33 100.01 0.6 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 127.044 2.138 . . . . 0.0 111.671 -176.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 32.5 m -50.05 -13.2 0.1 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 127.031 2.132 . . . . 0.0 116.478 -176.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -53.7 -35.18 60.85 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.071 0.948 . . . . 0.0 111.607 168.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.9 -10.39 20.61 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 174.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.02 19.95 10.78 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.936 2.494 . . . . 0.0 111.08 178.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.52 138.43 45.03 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.589 -1.32 . . . . 0.0 111.905 177.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.72 -169.31 11.78 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.518 1.532 . . . . 0.0 113.57 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -61.23 -10.01 14.31 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 124.253 3.302 . . . . 0.0 117.049 -174.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -107.75 -10.01 15.68 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.943 1.297 . . . . 0.0 113.522 174.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.511 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 3.2 m -82.12 138.35 34.78 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.098 0.863 . . . . 0.0 112.109 -170.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -91.47 134.06 34.96 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 122.32 1.057 . . . . 0.0 110.75 176.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.5 mmm-85 -66.9 -39.71 87.51 Favored 'General case' 0 C--O 1.222 -0.394 0 O-C-N 121.65 -0.657 . . . . 0.0 110.593 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 46.7 ptt85 -51.39 -38.62 54.33 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 170.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.07 -50.71 38.32 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.523 1.129 . . . . 0.0 110.294 177.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.37 -33.85 76.43 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.465 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.06 -53.14 18.81 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.663 1.585 . . . . 0.0 112.22 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -50.14 -41.04 48.13 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.323 0.965 . . . . 0.0 112.514 170.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.8 mt -63.0 -49.69 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 121.684 -0.635 . . . . 0.0 111.368 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.3 -39.95 57.95 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.47 0.577 . . . . 0.0 111.944 174.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -62.97 -40.55 98.05 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.423 0.689 . . . . 0.0 111.723 175.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.49 -31.94 72.43 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 176.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 mt -84.16 -35.9 23.25 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -175.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 pp -69.63 -28.19 65.71 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.455 0.57 . . . . 0.0 111.693 168.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.88 14.77 13.02 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 119.078 -0.846 . . . . 0.0 113.986 168.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.69 -49.88 75.05 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 118.333 1.066 . . . . 0.0 111.216 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -160.3 129.99 5.18 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.859 1.264 . . . . 0.0 112.797 169.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -79.77 124.81 28.94 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.233 1.813 . . . . 0.0 109.084 173.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.1 ttp-105 -159.88 165.08 32.93 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.465 1.506 . . . . 0.0 110.999 171.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -76.73 137.07 39.11 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.7 0.8 . . . . 0.0 110.173 170.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.62 152.36 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.958 1.303 . . . . 0.0 108.917 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -79.89 160.04 26.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.325 0.65 . . . . 0.0 109.609 169.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.511 HD13 ' CZ ' ' A' ' 98' ' ' PHE . 0.2 OUTLIER -165.85 147.65 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.156 0.889 . . . . 0.0 110.64 168.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.511 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -90.39 145.43 24.95 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.009 173.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.511 ' CZ ' HD13 ' A' ' 96' ' ' ILE . 54.9 m-85 -118.17 157.2 27.39 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.0 0.92 . . . . 0.0 111.505 173.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -121.14 140.07 52.49 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.467 1.107 . . . . 0.0 110.443 169.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 24.7 mtp-105 -89.81 160.18 16.64 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.573 1.149 . . . . 0.0 111.379 175.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -21.23 65.01 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 172.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -75.24 -10.02 59.08 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.642 1.577 . . . . 0.0 113.61 172.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.81 6.75 67.1 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.384 1.468 . . . . 0.0 115.223 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.8 t -78.94 134.18 36.87 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 118.813 1.306 . . . . 0.0 110.817 175.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 60.8 m -131.61 128.95 40.23 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.635 1.174 . . . . 0.0 111.707 -172.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -151.04 142.72 23.68 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -174.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.429 HD13 ' N ' ' A' ' 108' ' ' CYS . 1.6 tm? -109.57 129.94 55.54 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.06 2.144 . . . . 0.0 108.504 168.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.429 ' N ' HD13 ' A' ' 107' ' ' LEU . 2.2 m -135.84 178.81 6.76 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.368 1.467 . . . . 0.0 111.605 172.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.5 mt -76.69 59.94 1.62 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.416 1.086 . . . . 0.0 111.129 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 36.4 t -61.28 145.16 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.936 1.295 . . . . 0.0 111.406 -173.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -104.16 69.68 0.94 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 122.274 1.035 . . . . 0.0 112.11 -168.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.0 t -83.5 69.91 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.744 0.817 . . . . 0.0 110.476 -169.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 44.8 t -117.12 123.33 30.2 Favored Pre-proline 0 N--CA 1.483 1.213 0 CA-C-O 117.723 -1.132 . . . . 0.0 110.603 -174.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -87.26 -170.36 0.59 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.479 2.786 . . . . 0.0 113.084 -175.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -123.53 126.78 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 123.018 1.39 . . . . 0.0 113.213 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.6 mtmt -112.26 161.12 16.95 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.588 2.355 . . . . 0.0 112.415 -176.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -92.23 179.98 5.41 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.663 -1.153 . . . . 0.0 112.19 172.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.41 -21.69 65.58 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -71.23 -19.89 62.32 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.558 1.143 . . . . 0.0 113.753 170.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.96 4.25 60.23 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.641 1.591 . . . . 0.0 114.322 -176.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -93.19 140.75 29.18 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.462 1.131 . . . . 0.0 113.132 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.14 100.01 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.486 1.514 . . . . 0.0 110.696 -174.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.56 -29.08 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 123.768 0.827 . . . . 0.0 111.795 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.88 148.45 52.29 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 124.111 1.91 . . . . 0.0 112.555 169.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -100.81 85.13 2.83 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.258 -1.792 . . . . 0.0 107.045 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 40.2 mt -99.98 70.04 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 122.86 1.314 . . . . 0.0 108.678 170.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.317 34.7 mt -78.59 88.55 4.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 123.356 1.55 . . . . 0.0 109.843 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -59.88 103.13 0.19 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.501 1.921 . . . . 0.0 110.139 173.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -87.19 50.99 2.12 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 120.683 -1.261 . . . . 0.0 111.85 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -79.97 106.86 12.3 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 124.182 1.944 . . . . 0.0 112.066 -176.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 32.6 t -64.43 114.3 2.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 126.813 2.045 . . . . 0.0 108.694 171.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p -140.39 136.23 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 122.633 0.373 . . . . 0.0 110.637 176.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 97.1 mtp -80.06 165.12 22.84 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 122.725 1.25 . . . . 0.0 112.444 -173.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.79 149.21 50.53 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.459 1.504 . . . . 0.0 112.625 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.7 tptt . . . . . 0 C--O 1.251 1.179 0 C-N-CA 125.886 1.674 . . . . 0.0 111.487 179.872 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 118.91 -0.567 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -70.43 162.23 43.15 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.445 2.763 . . . . 0.0 112.76 176.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.64 155.98 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.328 1.051 . . . . 0.0 112.317 174.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 81.4 mtt85 -129.69 153.94 47.65 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.626 1.571 . . . . 0.0 111.782 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -147.85 163.37 36.96 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.063 1.745 . . . . 0.0 112.537 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.28 -173.37 52.98 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.529 1.061 . . . . 0.0 114.559 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -76.96 159.59 29.83 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.327 1.451 . . . . 0.0 113.271 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.3 p -82.3 146.88 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.494 1.118 . . . . 0.0 111.047 171.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.9 159.96 17.7 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 124.168 0.987 . . . . 0.0 111.403 169.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -43.9 110.05 0.18 Allowed 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 124.503 3.468 . . . . 0.0 112.449 175.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -59.97 -27.25 66.68 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 115.103 1.519 . . . . 0.0 115.103 -165.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -69.99 -49.86 47.34 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.851 0.751 . . . . 0.0 110.407 -176.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 t -76.71 -36.2 57.35 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.1 0.96 . . . . 0.0 112.225 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -57.93 -39.99 79.38 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.951 0.9 . . . . 0.0 110.506 172.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.1 tp -71.49 -44.78 64.09 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.047 0.539 . . . . 0.0 112.266 170.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -47.87 -39.93 20.14 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 120.004 1.275 . . . . 0.0 113.583 176.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.1 m -60.08 -42.6 94.93 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 172.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.1 mm -69.0 -33.96 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.077 0.951 . . . . 0.0 110.436 176.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.5 mm -56.97 -53.7 39.56 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-O 118.202 -0.904 . . . . 0.0 108.714 169.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -25.15 64.9 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.551 1.069 . . . . 0.0 112.924 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.4 tttt -68.8 -45.09 72.17 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.303 1.041 . . . . 0.0 113.443 171.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -100.07 0.28 40.5 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -53.67 -29.02 36.72 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.3 2.24 . . . . 0.0 113.53 -169.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.21 55.52 0.91 Allowed Glycine 0 CA--C 1.531 1.032 0 C-N-CA 125.381 1.467 . . . . 0.0 112.48 -169.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -59.73 -17.17 32.71 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 120.884 -1.363 . . . . 0.0 112.719 174.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.8 p -78.05 -11.31 59.9 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.892 2.077 . . . . 0.0 115.195 178.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . 0.343 0.0 OUTLIER -72.89 167.68 20.49 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 120.753 1.615 . . . . 0.0 112.143 174.132 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.51 144.78 54.49 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.615 1.566 . . . . 0.0 114.868 -167.043 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -169.72 162.49 9.69 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 123.339 1.542 . . . . 0.0 114.455 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 pp -128.35 170.25 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 127.238 2.215 . . . . 0.0 111.15 172.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.5 mm -127.23 120.05 54.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 126.389 1.876 . . . . 0.0 107.293 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.423 ' HB3' ' HB3' ' A' ' 125' ' ' PHE . . . -125.38 149.16 48.4 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 123.829 0.852 . . . . 0.0 112.553 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -81.14 108.82 15.12 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.519 0.676 . . . . 0.0 110.746 172.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.92 -15.73 63.11 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -100.07 3.02 43.79 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.947 1.299 . . . . 0.0 114.116 -169.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.71 140.13 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.36 1.464 . . . . 0.0 110.726 -176.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -60.09 -27.04 66.67 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -176.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -83.46 -10.22 58.51 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.771 1.229 . . . . 0.0 114.204 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 24.9 m 45.56 47.82 11.18 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.28 1.832 . . . . 0.0 113.449 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.97 152.25 26.81 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -167.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.7 t -79.98 90.0 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 127.914 2.486 . . . . 0.0 108.758 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.8 pt -70.03 -24.78 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.731 1.212 . . . . 0.0 112.462 178.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -153.7 159.62 42.07 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.015 0.926 . . . . 0.0 112.484 174.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.2 p -147.85 145.73 28.82 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.111 -0.993 . . . . 0.0 113.077 -175.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -93.03 159.46 15.3 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -64.01 -23.62 67.4 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.531 -0.731 . . . . 0.0 112.384 175.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.74 -50.03 62.91 Favored Glycine 0 CA--C 1.537 1.413 0 CA-C-O 119.015 -0.881 . . . . 0.0 112.669 169.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -38.33 68.74 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.529 1.665 . . . . 0.0 109.787 172.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.7 t -60.25 -39.98 88.65 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.808 -0.558 . . . . 0.0 111.128 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -74.99 -30.03 61.05 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 175.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.8 tp -64.85 -54.57 28.93 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.683 1.593 . . . . 0.0 112.193 178.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 84.0 m -92.8 -22.58 19.24 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.126 0.971 . . . . 0.0 112.431 -178.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.5 10.04 85.84 Favored Glycine 0 CA--C 1.539 1.573 0 N-CA-C 115.758 1.063 . . . . 0.0 115.758 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -93.94 -116.71 0.1 Allowed 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 118.735 1.267 . . . . 0.0 111.68 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.3 t -159.9 150.12 18.62 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.532 1.533 . . . . 0.0 110.719 -177.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.7 mtm180 -57.63 -36.36 71.72 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.662 1.185 . . . . 0.0 112.426 177.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.32 -20.77 63.32 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.182 0.993 . . . . 0.0 113.503 174.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -84.4 -20.77 31.33 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.118 1.367 . . . . 0.0 112.268 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.5 m -105.39 -11.83 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 10.4 mmt -49.86 107.37 0.15 Allowed 'General case' 0 C--N 1.34 0.191 0 C-N-CA 125.078 1.351 . . . . 0.0 110.427 176.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 68.13 22.43 8.31 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.729 1.612 . . . . 0.0 113.224 172.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.58 161.75 57.98 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 124.887 1.275 . . . . 0.0 110.682 168.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -60.45 137.42 74.04 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.7 2.267 . . . . 0.0 113.032 175.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 23.5 t -70.04 -19.83 63.28 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.509 1.124 . . . . 0.0 112.756 170.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -60.36 100.13 0.09 Allowed 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 127.927 2.491 . . . . 0.0 111.222 178.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 54.7 m -49.98 -13.25 0.1 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.829 2.052 . . . . 0.0 116.35 -176.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -55.11 -39.45 69.39 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.979 1.311 . . . . 0.0 111.26 167.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -58.38 -20.12 41.38 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.57 1.548 . . . . 0.0 113.094 172.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.14 20.0 18.85 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 127.498 2.319 . . . . 0.0 112.169 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -56.37 136.98 53.42 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.657 -1.277 . . . . 0.0 113.482 174.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -130.58 177.2 18.49 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 126.343 1.925 . . . . 0.0 111.687 168.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -64.21 -10.13 22.36 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.524 2.816 . . . . 0.0 115.603 -176.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -104.11 -9.95 18.35 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.739 1.615 . . . . 0.0 113.369 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.571 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 3.4 m -76.63 139.42 40.59 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.297 0.953 . . . . 0.0 111.996 -173.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -84.23 129.91 34.86 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 123.126 1.441 . . . . 0.0 109.847 175.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -70.19 -39.91 74.94 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.14 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -59.53 -35.69 74.68 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.27 1.428 . . . . 0.0 113.919 170.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.27 -50.78 64.45 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.427 0.691 . . . . 0.0 110.604 173.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.03 -33.37 75.89 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.22 -52.3 42.74 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.513 1.125 . . . . 0.0 112.192 176.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -50.16 -42.12 50.38 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.053 0.941 . . . . 0.0 112.66 170.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 35.8 mt -63.61 -48.69 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 O-C-N 121.588 -0.695 . . . . 0.0 111.021 174.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.03 -39.82 56.77 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.526 0.603 . . . . 0.0 111.831 173.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -67.84 -38.24 82.92 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.586 0.63 . . . . 0.0 111.952 175.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.99 -26.85 64.28 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.267 0.627 . . . . 0.0 112.565 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 mt -87.74 -33.63 18.63 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.304 0.642 . . . . 0.0 110.95 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -37.68 81.38 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.197 1.799 . . . . 0.0 110.009 169.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.02 26.37 4.98 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.796 1.189 . . . . 0.0 114.724 171.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.73 -49.93 74.45 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 118.685 1.242 . . . . 0.0 111.204 173.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -159.0 148.85 19.12 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.066 2.146 . . . . 0.0 109.52 169.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -81.31 117.79 22.09 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.998 -1.063 . . . . 0.0 108.567 172.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 -144.85 136.67 25.69 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.355 1.062 . . . . 0.0 111.623 -169.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -83.22 132.06 35.07 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.429 1.492 . . . . 0.0 110.053 171.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -136.41 151.11 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.444 1.498 . . . . 0.0 109.043 -177.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.73 157.09 27.23 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.275 0.63 . . . . 0.0 109.652 170.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -165.71 148.47 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.073 0.949 . . . . 0.0 110.675 176.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.571 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -87.11 145.32 26.49 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.585 175.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -112.65 160.45 17.88 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.213 1.405 . . . . 0.0 110.634 169.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -125.3 140.1 53.12 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.781 0.8 . . . . 0.0 111.079 169.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 17.6 tpp85 -84.39 150.38 25.38 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.147 1.779 . . . . 0.0 109.921 176.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -55.02 -28.98 56.32 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.992 1.717 . . . . 0.0 113.578 175.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -75.71 -9.95 59.02 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.025 1.33 . . . . 0.0 114.1 175.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.81 -0.04 39.21 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 126.205 1.86 . . . . 0.0 115.576 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 45.2 m -78.8 126.44 30.72 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 119.068 1.434 . . . . 0.0 111.566 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 67.4 m -114.83 134.52 55.06 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.244 1.017 . . . . 0.0 111.667 -176.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -149.97 139.95 21.96 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.979 0.912 . . . . 0.0 112.978 -170.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.477 HD13 ' N ' ' A' ' 108' ' ' CYS . 2.2 tm? -115.76 136.23 53.26 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.493 1.917 . . . . 0.0 110.104 176.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.477 ' N ' HD13 ' A' ' 107' ' ' LEU . 1.7 m -139.34 169.54 17.57 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.757 1.623 . . . . 0.0 109.931 168.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.4 tt -78.54 60.01 2.57 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 121.849 0.833 . . . . 0.0 109.31 172.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.1 t -52.99 149.2 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.962 1.705 . . . . 0.0 110.645 -174.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -99.79 69.74 1.6 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 123.172 1.463 . . . . 0.0 110.811 -168.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.8 t -83.2 69.95 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.677 1.191 . . . . 0.0 110.255 -170.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.85 131.24 24.23 Favored Pre-proline 0 N--CA 1.478 0.932 0 C-N-CA 124.05 0.94 . . . . 0.0 110.712 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -85.1 -168.67 0.53 Allowed 'Trans proline' 0 CA--C 1.551 1.348 0 C-N-CA 123.109 2.539 . . . . 0.0 111.481 -174.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.52 129.52 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-O 123.026 1.394 . . . . 0.0 113.656 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -112.1 162.16 15.73 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.666 2.386 . . . . 0.0 112.838 -176.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -92.85 179.96 5.31 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.499 1.12 . . . . 0.0 112.207 171.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.42 -21.69 65.6 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -70.85 -19.92 62.59 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.563 1.145 . . . . 0.0 113.738 169.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.6 -0.02 59.44 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.007 1.765 . . . . 0.0 114.358 -176.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.6 139.98 30.0 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.609 1.204 . . . . 0.0 113.246 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.7 p -75.97 99.96 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 125.515 1.526 . . . . 0.0 110.216 -175.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.04 -28.9 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.641 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.71 149.99 50.55 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 124.012 1.863 . . . . 0.0 111.922 173.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.423 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 2.3 m-30 -104.02 80.22 1.71 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.857 -1.52 . . . . 0.0 107.843 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.6 mt -99.98 71.15 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 120.611 -1.305 . . . . 0.0 108.789 171.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.419 HD22 ' N ' ' A' ' 127' ' ' LEU . 2.0 mm? -76.91 85.19 3.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 123.41 1.576 . . . . 0.0 108.878 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -59.91 103.8 0.24 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 112.958 -1.928 . . . . 0.0 109.931 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -85.81 59.12 5.44 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 120.69 -1.256 . . . . 0.0 111.784 -177.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -79.77 126.58 31.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 122.163 0.983 . . . . 0.0 110.908 175.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.5 t -81.99 113.2 20.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 125.225 1.41 . . . . 0.0 108.403 -178.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p -140.35 137.4 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.092 0.473 . . . . 0.0 112.077 -176.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 21.2 ptp -137.4 158.66 43.92 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.653 1.581 . . . . 0.0 111.306 171.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -72.23 151.74 42.67 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.178 0.991 . . . . 0.0 112.656 177.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 65.4 pttt . . . . . 0 C--O 1.253 1.258 0 C-N-CA 125.183 1.393 . . . . 0.0 113.802 177.91 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 118.771 -0.633 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.98 158.29 55.76 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.219 2.613 . . . . 0.0 112.61 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.8 m -96.08 19.97 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 125.204 1.402 . . . . 0.0 113.653 -178.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -71.97 144.63 48.81 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.14 1.376 . . . . 0.0 111.922 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -150.48 160.11 44.01 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.954 1.702 . . . . 0.0 112.465 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.59 177.91 39.2 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.726 1.155 . . . . 0.0 114.757 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -87.08 161.44 18.13 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.565 1.546 . . . . 0.0 113.0 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.3 t -82.03 138.17 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.268 1.027 . . . . 0.0 109.409 172.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.62 159.93 22.06 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.753 0.821 . . . . 0.0 112.075 173.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -52.97 110.05 0.43 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.629 2.886 . . . . 0.0 111.703 174.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -65.62 -27.13 68.18 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -167.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -69.17 -49.86 52.94 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.519 0.727 . . . . 0.0 110.385 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 t -75.52 -34.02 60.76 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.835 0.854 . . . . 0.0 112.405 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -59.92 -41.07 90.94 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.577 -0.702 . . . . 0.0 110.157 172.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.2 tp -70.85 -45.58 64.22 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.076 172.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -47.43 -39.83 16.55 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.238 1.415 . . . . 0.0 113.217 173.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 90.7 m -60.11 -44.02 95.15 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.615 -0.678 . . . . 0.0 112.205 172.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.5 mm -67.81 -35.7 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.834 0.854 . . . . 0.0 110.868 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.4 mm -55.62 -54.44 25.79 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 52.7 mtm180 -60.16 -29.38 68.63 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 118.981 0.809 . . . . 0.0 112.809 176.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.4 tptt -62.82 -42.42 99.72 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 118.676 -0.678 . . . . 0.0 112.265 173.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -104.51 1.64 30.06 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 178.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -57.77 -29.04 64.51 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.834 1.654 . . . . 0.0 113.894 -167.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.85 55.42 4.49 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -168.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -55.67 -26.88 47.02 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.836 1.654 . . . . 0.0 114.953 -168.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.7 m -67.53 -19.78 65.34 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.2 1.0 . . . . 0.0 113.415 175.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.8 mmt85 -92.55 150.0 21.01 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.368 1.867 . . . . 0.0 110.902 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.19 146.9 38.49 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.845 1.658 . . . . 0.0 111.82 -171.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -169.77 155.4 5.83 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 123.975 1.845 . . . . 0.0 115.074 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -119.9 165.45 15.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 128.025 2.53 . . . . 0.0 110.167 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.8 mm -127.58 113.71 32.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.52 155.91 39.86 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.884 0.85 . . . . 0.0 112.142 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.9 t-20 -85.72 122.3 29.62 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 176.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.46 -9.18 59.77 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -100.03 6.09 45.06 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.974 1.31 . . . . 0.0 113.477 -173.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.8 m -114.08 139.16 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 126.728 2.011 . . . . 0.0 111.378 -177.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.52 -23.26 65.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.133 0.973 . . . . 0.0 113.456 -175.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -90.8 0.56 57.42 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.538 1.535 . . . . 0.0 113.399 174.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 27.8 p 42.08 46.92 3.8 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.969 1.707 . . . . 0.0 113.098 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.1 149.8 31.97 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -167.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.2 t -81.71 92.37 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 128.762 2.825 . . . . 0.0 109.009 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.6 pt -70.43 -23.14 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 126.195 1.798 . . . . 0.0 112.692 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -158.19 159.73 36.42 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.448 1.499 . . . . 0.0 112.592 174.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.5 p -147.08 154.4 41.12 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.406 -1.434 . . . . 0.0 113.322 173.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -96.23 157.46 15.89 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -59.36 -28.97 67.34 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.186 0.994 . . . . 0.0 112.006 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.86 -50.04 39.42 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.04 0.828 . . . . 0.0 112.918 169.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.92 -35.54 78.71 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 119.321 1.561 . . . . 0.0 110.706 176.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.0 t -60.04 -39.87 87.43 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.171 -0.956 . . . . 0.0 110.548 176.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -75.85 -25.69 56.46 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 174.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 53.4 tp -64.86 -55.74 17.64 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.089 0.956 . . . . 0.0 111.806 175.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.5 m -94.82 -21.15 18.88 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -174.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.73 22.6 78.14 Favored Glycine 0 CA--C 1.539 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 113.564 -169.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.6 m-30 -91.49 -130.1 0.1 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.288 1.435 . . . . 0.0 110.979 -176.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.5 t -162.11 150.17 14.67 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.794 2.438 . . . . 0.0 109.045 177.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.7 ttp180 -50.14 -40.88 47.69 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.751 0.82 . . . . 0.0 111.907 170.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.77 -20.81 63.98 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -87.41 -20.69 26.3 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.335 1.454 . . . . 0.0 113.069 175.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -104.73 -16.33 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 176.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.4 mmt -49.92 110.34 0.38 Allowed 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.424 1.489 . . . . 0.0 111.388 -177.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 71.13 17.05 6.18 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.472 1.509 . . . . 0.0 113.764 171.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.43 160.81 63.99 Favored Pre-proline 0 N--CA 1.475 0.812 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.397 166.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -58.48 140.08 93.2 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.539 2.159 . . . . 0.0 111.639 169.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.504 ' SG ' HD13 ' A' ' 86' ' ' LEU . 1.4 p -64.69 -10.0 23.92 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 169.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.0 m -64.49 93.42 0.1 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.218 1.807 . . . . 0.0 111.683 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 28.4 p -53.13 -14.27 0.62 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.337 1.855 . . . . 0.0 115.34 -176.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -48.13 -40.04 22.43 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.098 0.959 . . . . 0.0 111.565 167.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.85 -19.96 63.17 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 pp -123.1 23.8 9.1 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.476 1.91 . . . . 0.0 113.052 176.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -60.87 140.01 57.81 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.086 -1.009 . . . . 0.0 112.826 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -95.18 171.45 29.71 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.828 1.204 . . . . 0.0 113.325 175.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.0 -10.05 27.19 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.495 2.797 . . . . 0.0 114.446 -177.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -91.55 -9.27 44.9 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.492 1.917 . . . . 0.0 113.442 174.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.6 m -78.02 139.86 39.13 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.984 0.914 . . . . 0.0 112.428 -173.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -85.34 131.68 34.37 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.743 1.259 . . . . 0.0 109.946 168.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.6 mmm-85 -65.79 -39.66 91.18 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.866 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.22 -41.83 50.52 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 169.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.66 -51.23 61.15 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.311 1.044 . . . . 0.0 110.122 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.26 -33.81 76.66 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.729 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.04 -51.39 32.5 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.022 1.729 . . . . 0.0 112.662 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -50.01 -43.89 50.86 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.686 1.194 . . . . 0.0 111.062 170.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 51.2 mt -62.91 -49.52 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.118 174.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.08 -39.86 57.04 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-O 118.248 -0.882 . . . . 0.0 112.179 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -69.0 -38.51 79.3 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.895 0.77 . . . . 0.0 111.466 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.18 -34.85 78.97 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.557 -0.714 . . . . 0.0 111.949 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.504 HD13 ' SG ' ' A' ' 64' ' ' CYS . 3.0 mt -84.87 -24.66 28.43 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.393 0.677 . . . . 0.0 111.674 177.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.78 -30.04 70.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.788 2.035 . . . . 0.0 110.062 168.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.07 17.93 9.16 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.063 1.316 . . . . 0.0 114.84 169.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.94 -50.13 65.48 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.845 1.323 . . . . 0.0 111.126 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -151.94 141.54 21.75 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.843 1.657 . . . . 0.0 111.312 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -74.61 114.52 13.11 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 166.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -149.28 137.26 20.55 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.951 0.9 . . . . 0.0 111.557 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -84.84 130.44 34.66 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.585 1.554 . . . . 0.0 110.196 169.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.6 153.64 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.525 1.53 . . . . 0.0 108.896 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -79.88 160.04 26.19 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.278 1.031 . . . . 0.0 109.812 169.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -169.75 151.92 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.584 1.154 . . . . 0.0 111.129 173.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.48 145.42 25.31 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 174.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -115.15 162.07 17.54 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.968 1.707 . . . . 0.0 111.722 168.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -136.51 140.18 42.82 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.232 0.613 . . . . 0.0 110.792 168.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -84.69 152.43 23.76 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.332 1.053 . . . . 0.0 112.658 177.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -55.1 -25.14 29.51 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.968 1.707 . . . . 0.0 112.974 169.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.54 -11.12 60.72 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.395 1.478 . . . . 0.0 113.949 174.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.61 41.33 5.11 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.843 1.211 . . . . 0.0 114.833 175.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.0 t -136.71 141.71 43.07 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.499 1.12 . . . . 0.0 111.629 176.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 23.9 p -129.82 139.62 51.19 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.423 1.489 . . . . 0.0 113.508 -171.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -150.23 139.94 21.71 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.899 1.279 . . . . 0.0 113.457 -168.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.462 HD13 ' N ' ' A' ' 108' ' ' CYS . 1.6 tm? -108.44 134.34 51.36 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.918 2.087 . . . . 0.0 108.667 169.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.462 ' N ' HD13 ' A' ' 107' ' ' LEU . 1.9 m -140.0 179.11 6.8 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.292 1.437 . . . . 0.0 111.559 171.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.2 mp -78.23 60.0 2.4 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.652 1.181 . . . . 0.0 109.904 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 16.6 t -63.2 145.58 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.587 1.155 . . . . 0.0 111.261 -171.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -107.63 69.74 0.75 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.615 1.198 . . . . 0.0 112.055 -168.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.6 t -84.05 69.86 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.016 0.927 . . . . 0.0 110.886 -169.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.17 136.12 26.07 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 124.611 1.164 . . . . 0.0 111.253 -174.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -86.88 -169.17 0.48 Allowed 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 123.603 2.869 . . . . 0.0 113.361 -172.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -126.47 132.33 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-O 122.835 1.302 . . . . 0.0 113.689 175.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -111.87 166.62 11.05 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 127.042 2.137 . . . . 0.0 112.389 -174.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -97.23 179.95 4.72 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.272 169.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.78 -21.21 65.7 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -70.11 -19.85 63.21 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.583 1.153 . . . . 0.0 113.68 169.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.6 6.5 59.58 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.811 1.672 . . . . 0.0 114.458 -176.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -97.13 141.76 29.87 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.54 1.17 . . . . 0.0 113.594 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.8 100.01 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 126.0 1.72 . . . . 0.0 110.615 -176.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.02 -29.6 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.113 177.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.53 149.98 51.68 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 124.288 1.994 . . . . 0.0 112.646 173.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -104.52 79.89 1.62 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 113.222 -1.808 . . . . 0.0 107.41 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.1 mt -99.91 69.95 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 170.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.66 88.25 4.57 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.985 0.898 . . . . 0.0 108.828 -178.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -59.85 104.22 0.27 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.767 1.227 . . . . 0.0 111.419 -174.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -82.81 53.61 2.45 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.18 -1.575 . . . . 0.0 112.163 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -79.94 106.84 12.26 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 124.076 1.893 . . . . 0.0 112.782 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.1 t -64.77 111.81 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 127.002 2.121 . . . . 0.0 108.738 170.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p -140.42 137.6 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 122.758 0.423 . . . . 0.0 110.551 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 77.4 mtm -85.6 159.07 19.95 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.83 1.252 . . . . 0.0 111.761 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -70.8 156.77 39.13 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.885 1.274 . . . . 0.0 113.197 175.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 62.0 tttp . . . . . 0 C--O 1.252 1.232 0 C-N-CA 125.95 1.7 . . . . 0.0 111.461 179.838 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.2 mtm . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 119.062 -0.494 . . . . 0.0 110.529 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.06 154.82 71.67 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.369 2.712 . . . . 0.0 112.76 177.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.8 m -74.31 156.15 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.466 1.107 . . . . 0.0 112.619 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -130.68 147.73 52.38 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.499 1.52 . . . . 0.0 110.755 172.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.38 140.64 22.24 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.346 1.459 . . . . 0.0 112.683 177.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.94 -17.95 55.22 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 124.853 1.216 . . . . 0.0 113.754 169.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -71.9 149.75 44.84 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.826 1.25 . . . . 0.0 112.006 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.3 t -79.93 109.86 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.927 0.891 . . . . 0.0 110.947 -176.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.96 170.0 11.32 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 125.444 1.498 . . . . 0.0 109.497 167.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -32.93 110.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 124.851 3.701 . . . . 0.0 112.737 171.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -59.91 -27.41 66.72 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -163.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -67.84 -49.95 59.35 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.731 0.696 . . . . 0.0 110.143 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.6 t -79.77 -35.19 39.02 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.59 1.156 . . . . 0.0 112.679 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -57.97 -39.88 79.25 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.567 1.147 . . . . 0.0 110.243 171.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.8 tp -74.84 -45.49 42.87 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 118.885 -0.579 . . . . 0.0 112.468 170.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -47.8 -39.82 19.31 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.845 1.258 . . . . 0.0 112.628 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 91.3 m -60.07 -42.58 94.84 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.538 -0.726 . . . . 0.0 111.875 175.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.4 mm -68.5 -33.66 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 123.839 0.856 . . . . 0.0 110.194 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.3 mm -59.33 -52.99 54.32 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.517 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 173.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -59.88 -29.21 68.16 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.477 1.111 . . . . 0.0 111.673 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -67.21 -42.11 84.63 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.813 1.245 . . . . 0.0 113.167 175.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -102.84 -0.01 31.96 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -59.88 -29.34 68.26 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.711 1.204 . . . . 0.0 113.391 -166.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.6 -1.72 2.18 Favored Glycine 0 CA--C 1.544 1.849 0 C-N-CA 126.438 1.971 . . . . 0.0 116.794 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -133.61 -10.63 2.77 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.247 1.419 . . . . 0.0 114.451 -172.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.9 p -78.83 -15.8 57.92 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.1 mmt85 -78.8 160.42 27.39 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.71 1.604 . . . . 0.0 113.841 -168.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.15 150.25 44.0 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.494 1.918 . . . . 0.0 112.878 -175.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -169.81 162.99 9.7 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 123.312 1.529 . . . . 0.0 115.094 -171.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -126.57 168.93 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 127.951 2.501 . . . . 0.0 111.203 173.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.5 mm -129.99 120.08 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 126.224 1.81 . . . . 0.0 108.165 178.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.5 155.23 48.96 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -78.58 114.68 17.71 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.977 169.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.03 -17.47 58.78 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -178.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 -96.14 5.93 49.96 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.794 1.238 . . . . 0.0 113.831 -170.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.98 140.16 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.744 1.618 . . . . 0.0 110.694 -175.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -58.19 -29.46 65.67 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.054 0.942 . . . . 0.0 113.187 -176.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -82.73 -5.81 59.08 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.5 p 39.08 45.76 1.08 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.678 1.991 . . . . 0.0 114.646 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.02 149.96 26.63 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 -166.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.1 t -79.94 97.22 2.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 128.907 2.883 . . . . 0.0 108.221 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.6 pt -76.67 -24.02 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.556 1.542 . . . . 0.0 111.735 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -153.6 159.44 42.14 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.963 0.905 . . . . 0.0 112.398 171.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 9.1 p -149.29 143.58 25.93 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.971 -1.08 . . . . 0.0 112.901 -174.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -88.79 157.7 18.4 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 -178.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.48 -31.18 67.6 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.533 -0.729 . . . . 0.0 111.706 169.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.91 -49.81 57.21 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.052 0.834 . . . . 0.0 113.249 169.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -58.32 -37.67 75.58 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 119.05 1.425 . . . . 0.0 109.337 176.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.1 t -60.01 -40.28 88.74 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.108 0.563 . . . . 0.0 111.549 177.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -71.06 -30.29 66.4 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.323 -0.86 . . . . 0.0 112.524 173.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.4 tp -70.12 -44.95 67.91 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.103 1.361 . . . . 0.0 114.196 -177.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 2.2 t -99.57 -24.08 14.86 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.634 0.773 . . . . 0.0 111.869 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.11 10.73 86.0 Favored Glycine 0 CA--C 1.541 1.672 0 O-C-N 120.928 -1.107 . . . . 0.0 115.825 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -94.24 -114.71 0.11 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 118.975 1.387 . . . . 0.0 111.911 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.9 t -159.99 148.97 17.49 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.946 1.299 . . . . 0.0 111.818 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 86.7 mtm-85 -53.74 -41.44 67.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.819 1.248 . . . . 0.0 111.811 171.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.79 -19.52 62.6 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.613 1.165 . . . . 0.0 113.355 177.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -88.37 -20.67 25.01 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.037 1.335 . . . . 0.0 112.911 175.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.7 m -103.67 -3.55 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 35.6 mmt -49.93 114.48 1.09 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.136 0.88 . . . . 0.0 109.804 172.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 70.57 23.93 4.61 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.856 1.662 . . . . 0.0 112.885 172.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -101.32 152.06 37.88 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 124.523 1.129 . . . . 0.0 112.342 -176.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.26 140.07 57.4 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.168 2.579 . . . . 0.0 113.227 -174.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.4 m -67.31 -13.25 61.82 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 173.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.7 m -68.17 100.04 0.97 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.416 1.086 . . . . 0.0 110.853 -176.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 30.4 p -54.56 -13.35 0.94 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.607 1.963 . . . . 0.0 116.123 -173.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -55.85 -36.59 67.7 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.877 -1.14 . . . . 0.0 111.267 169.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -54.7 -24.86 23.91 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.272 1.429 . . . . 0.0 113.509 173.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 pp -123.1 27.71 7.49 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.985 1.714 . . . . 0.0 113.029 177.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -62.63 145.79 53.67 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.231 -0.918 . . . . 0.0 111.984 172.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -127.43 -176.72 14.57 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 125.3 1.429 . . . . 0.0 113.157 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -66.51 -10.14 26.71 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.726 2.284 . . . . 0.0 116.512 -169.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.5 ttm105 -110.08 -2.75 16.81 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.768 1.627 . . . . 0.0 113.865 173.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.486 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 3.7 m -78.52 140.35 38.56 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.053 -1.029 . . . . 0.0 112.047 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -90.22 133.05 35.16 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 123.221 1.486 . . . . 0.0 111.65 172.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.7 mmm-85 -69.19 -39.79 78.45 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.302 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -55.57 -38.5 69.44 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.875 0.761 . . . . 0.0 112.956 171.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.412 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -65.8 -51.21 60.91 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 122.119 0.961 . . . . 0.0 109.88 177.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.44 -33.52 76.07 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.837 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.01 -50.01 45.78 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.01 1.724 . . . . 0.0 112.798 177.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -50.17 -42.93 51.99 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.251 1.021 . . . . 0.0 111.372 169.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.4 mt -62.62 -47.71 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 121.798 -0.564 . . . . 0.0 111.605 172.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.28 -39.96 46.9 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.661 -0.685 . . . . 0.0 112.193 174.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -69.01 -38.27 79.14 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.652 0.781 . . . . 0.0 111.551 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.1 -33.17 75.18 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.374 -0.828 . . . . 0.0 111.571 177.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mt -81.59 -29.99 33.15 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.668 0.787 . . . . 0.0 111.987 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.83 -28.72 69.19 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.393 2.277 . . . . 0.0 111.125 169.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.98 17.94 9.21 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.972 1.272 . . . . 0.0 114.873 169.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.36 -49.99 75.39 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.554 1.177 . . . . 0.0 111.495 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -161.39 152.63 18.64 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.517 1.527 . . . . 0.0 112.246 171.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -77.65 110.68 12.69 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 168.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.5 tpp180 -151.0 139.03 20.03 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.461 1.104 . . . . 0.0 110.949 -174.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -76.76 137.19 39.15 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.724 0.81 . . . . 0.0 110.342 170.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.11 148.75 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.772 1.229 . . . . 0.0 109.072 173.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.93 155.48 27.7 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.824 0.85 . . . . 0.0 110.294 171.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.412 HG23 ' HB1' ' A' ' 78' ' ' ALA . 0.3 OUTLIER -164.29 151.21 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 119.228 0.922 . . . . 0.0 111.146 173.169 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.486 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -88.22 145.36 25.92 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.092 176.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -118.04 143.71 46.19 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.504 1.121 . . . . 0.0 112.161 172.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -109.99 140.15 44.32 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.422 0.689 . . . . 0.0 111.336 173.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.6 mmt-85 -81.8 141.16 33.73 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 168.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -49.97 -26.95 4.71 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.994 2.117 . . . . 0.0 113.607 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -64.35 -17.39 63.66 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.316 1.446 . . . . 0.0 114.086 174.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.41 41.26 1.65 Allowed Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.463 1.506 . . . . 0.0 115.453 172.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.3 t -141.97 138.49 31.95 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 118.756 1.278 . . . . 0.0 112.217 175.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 28.9 t -128.9 138.8 52.22 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.483 1.513 . . . . 0.0 113.277 -172.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -150.95 151.33 31.97 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -100.9 127.99 47.13 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 127.917 2.487 . . . . 0.0 109.956 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 41.6 m -132.76 177.92 7.26 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.567 1.547 . . . . 0.0 111.134 171.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -80.05 59.92 3.42 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.415 1.086 . . . . 0.0 110.846 -177.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.5 t -62.16 141.69 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.716 1.606 . . . . 0.0 111.658 -172.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -102.61 69.83 1.11 Allowed 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 122.231 1.015 . . . . 0.0 112.175 -168.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.7 t -83.25 69.84 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 121.391 -0.818 . . . . 0.0 110.726 -168.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.5 t -117.92 127.26 26.74 Favored Pre-proline 0 N--CA 1.473 0.718 0 CA-C-O 117.801 -1.095 . . . . 0.0 109.363 -176.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.488 ' HB3' HD11 ' A' ' 127' ' ' LEU . 60.2 Cg_endo -82.32 -170.09 0.88 Allowed 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.212 2.608 . . . . 0.0 112.434 -177.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -119.89 127.24 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-O 122.865 1.317 . . . . 0.0 112.548 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -121.06 160.02 24.49 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 127.012 2.125 . . . . 0.0 111.909 -176.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -89.87 -179.53 5.75 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.807 0.843 . . . . 0.0 111.556 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -60.02 -21.61 61.55 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -73.68 -19.94 60.69 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.803 1.241 . . . . 0.0 114.156 171.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.92 -4.27 63.0 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.529 1.538 . . . . 0.0 114.073 -176.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -79.77 129.38 34.43 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.308 1.054 . . . . 0.0 111.973 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.67 99.99 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 127.215 2.206 . . . . 0.0 110.536 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.54 -30.04 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 123.397 0.679 . . . . 0.0 111.983 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.52 149.99 50.73 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 124.215 1.96 . . . . 0.0 112.642 174.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.8 m-30 -103.84 80.76 1.8 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.408 -1.724 . . . . 0.0 107.662 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.4 mt -101.18 71.32 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 169.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.488 HD11 ' HB3' ' A' ' 114' ' ' PRO . 0.6 OUTLIER -76.02 90.39 3.03 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 122.32 1.057 . . . . 0.0 108.803 175.519 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -59.97 95.16 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.112 1.365 . . . . 0.0 110.553 176.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -80.99 51.85 1.65 Allowed 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.544 -1.348 . . . . 0.0 112.636 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -79.86 106.81 12.16 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 124.296 1.998 . . . . 0.0 112.681 -176.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 41.2 t -62.49 113.75 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 127.377 2.271 . . . . 0.0 108.917 170.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.35 138.48 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 120.957 0.408 . . . . 0.0 111.316 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 28.6 ptm -92.69 178.55 5.76 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.021 1.728 . . . . 0.0 112.777 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -121.11 152.09 39.11 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.133 1.773 . . . . 0.0 112.44 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 22.5 pttp . . . . . 0 C--O 1.25 1.083 0 C-N-CA 125.252 1.421 . . . . 0.0 113.568 -174.416 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 119.098 -0.477 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -69.1 157.66 60.82 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.479 2.786 . . . . 0.0 112.607 177.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.9 m -135.14 156.78 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.837 1.655 . . . . 0.0 111.899 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -145.35 164.31 31.85 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.628 1.571 . . . . 0.0 113.033 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 21.1 ttp180 -71.73 146.4 48.17 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.147 1.379 . . . . 0.0 111.132 171.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.1 -174.0 26.34 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.368 0.985 . . . . 0.0 114.376 174.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -74.12 142.26 45.56 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.75 -0.853 . . . . 0.0 112.177 175.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.5 t -130.04 135.83 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.643 1.577 . . . . 0.0 109.014 173.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.37 159.86 63.32 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 123.696 0.798 . . . . 0.0 112.139 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.13 103.58 0.77 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.818 2.346 . . . . 0.0 112.233 -178.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -66.34 -27.17 67.68 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.184 0.993 . . . . 0.0 113.095 -171.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -70.09 -49.85 46.79 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.273 0.629 . . . . 0.0 110.415 -177.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 t -75.61 -34.7 60.61 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.028 0.931 . . . . 0.0 112.377 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -57.93 -42.72 85.45 Favored 'General case' 0 C--N 1.341 0.238 0 O-C-N 121.859 -0.526 . . . . 0.0 110.296 171.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.3 tp -70.02 -44.65 68.85 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 118.869 -0.586 . . . . 0.0 112.062 173.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -48.45 -40.01 24.79 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.882 1.219 . . . . 0.0 112.389 175.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.1 m -60.19 -43.09 96.2 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 121.486 -0.759 . . . . 0.0 112.502 172.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.2 mm -67.7 -35.67 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 123.962 0.905 . . . . 0.0 110.783 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.5 mm -56.21 -54.97 21.42 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 172.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -26.75 66.22 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.469 1.108 . . . . 0.0 112.978 176.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -65.31 -46.56 79.88 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 118.155 -0.926 . . . . 0.0 112.193 172.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -104.04 0.0 29.3 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -53.72 -29.16 38.04 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 116.72 2.119 . . . . 0.0 116.72 -165.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.58 -1.8 1.01 Allowed Glycine 0 CA--C 1.544 1.845 0 C-N-CA 126.098 1.809 . . . . 0.0 117.579 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -112.19 -26.01 9.02 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.303 1.551 . . . . 0.0 113.555 -170.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 65.3 m -89.28 16.3 7.62 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.821 1.248 . . . . 0.0 112.651 169.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.7 mmt-85 -89.67 163.58 15.07 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.226 1.81 . . . . 0.0 112.767 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -122.0 145.26 48.3 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.594 1.957 . . . . 0.0 111.419 -169.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -169.69 162.1 9.59 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -171.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.6 pp -123.3 169.13 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 127.754 2.422 . . . . 0.0 111.864 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.7 mm -127.74 119.07 50.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 126.365 1.866 . . . . 0.0 108.06 174.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.32 154.6 46.71 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 -177.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -77.38 106.69 9.3 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.287 172.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.81 -15.87 61.17 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -96.09 5.94 49.97 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.918 1.287 . . . . 0.0 114.057 -171.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.99 140.19 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.087 1.755 . . . . 0.0 110.912 -173.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -59.92 -23.56 63.61 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -176.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -76.03 -20.78 57.5 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.238 1.015 . . . . 0.0 113.578 174.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 15.6 m 45.1 42.85 7.04 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.017 1.727 . . . . 0.0 113.991 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.05 164.12 12.13 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 117.282 2.327 . . . . 0.0 117.282 -166.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 67.6 t -79.78 96.97 2.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 128.633 2.773 . . . . 0.0 108.419 -170.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.7 pt -78.76 -24.44 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.637 1.575 . . . . 0.0 111.47 173.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -153.79 159.68 41.98 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.952 0.901 . . . . 0.0 111.424 171.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 25.0 p -144.21 151.39 39.41 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.167 -0.958 . . . . 0.0 112.84 -173.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -87.8 153.27 21.47 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.721 0.772 . . . . 0.0 112.381 168.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -62.81 -32.87 74.14 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.305 0.642 . . . . 0.0 111.254 173.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.94 -50.04 56.41 Favored Glycine 0 CA--C 1.532 1.113 0 O-C-N 121.346 -0.846 . . . . 0.0 112.794 175.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -29.87 66.97 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 118.857 1.328 . . . . 0.0 111.56 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.7 t -59.97 -39.94 87.36 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.344 -0.848 . . . . 0.0 110.877 171.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -77.05 -30.13 55.46 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.435 -0.791 . . . . 0.0 112.387 174.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.6 tp -57.36 -55.72 31.1 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.277 1.431 . . . . 0.0 110.838 175.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.9 p -79.98 -28.08 39.57 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 175.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.53 9.96 74.42 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.913 1.72 . . . . 0.0 115.919 178.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -86.04 -121.83 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 119.547 1.674 . . . . 0.0 112.603 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.3 t -159.88 142.88 13.87 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.12 1.768 . . . . 0.0 110.036 -176.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -63.7 -33.97 76.82 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 121.168 -0.957 . . . . 0.0 112.178 -173.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.87 -16.65 43.99 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.578 1.151 . . . . 0.0 113.778 173.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -94.04 -20.56 19.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.211 2.204 . . . . 0.0 112.602 177.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 m -89.9 -20.05 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-N 120.254 1.388 . . . . 0.0 112.823 -173.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 35.1 mmt -49.98 118.57 2.98 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.587 1.155 . . . . 0.0 110.263 -174.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 72.56 20.33 3.9 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.825 1.65 . . . . 0.0 114.098 170.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -89.92 150.93 44.64 Favored Pre-proline 0 N--CA 1.484 1.231 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 169.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -64.24 140.02 68.91 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 124.062 3.174 . . . . 0.0 113.165 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 76.9 m -70.08 -12.36 61.55 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 169.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.1 m -59.08 100.09 0.06 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 126.888 2.075 . . . . 0.0 110.304 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 54.4 m -53.64 -13.21 0.61 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 -170.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -54.25 -38.31 65.63 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.399 1.08 . . . . 0.0 111.359 167.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -59.89 -20.36 56.82 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.457 1.503 . . . . 0.0 112.918 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.55 20.03 14.98 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 127.377 2.271 . . . . 0.0 111.52 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.05 149.2 45.09 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.629 -1.294 . . . . 0.0 112.826 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.7 -172.41 12.66 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.573 1.559 . . . . 0.0 112.45 172.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.35 -9.99 24.28 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.412 2.741 . . . . 0.0 114.781 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -96.46 -10.1 28.23 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.14 1.376 . . . . 0.0 113.555 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.3 m -82.83 139.72 33.33 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 119.237 0.926 . . . . 0.0 112.181 -170.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -95.74 143.65 26.81 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 122.684 1.23 . . . . 0.0 112.139 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.4 ' HD2' ' H ' ' A' ' 76' ' ' ARG . 0.4 OUTLIER -68.79 -39.88 79.92 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.93 -176.834 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -57.94 -40.71 81.16 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.259 1.024 . . . . 0.0 112.912 174.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.424 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -64.73 -52.19 58.38 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.368 1.067 . . . . 0.0 110.039 176.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.88 -34.79 79.23 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.07 -54.82 11.42 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.69 1.196 . . . . 0.0 111.563 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -50.15 -40.06 45.29 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.243 1.017 . . . . 0.0 112.405 172.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 49.6 mt -64.42 -50.61 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 O-C-N 121.704 -0.623 . . . . 0.0 111.442 173.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.1 -39.93 57.26 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 118.481 -0.771 . . . . 0.0 111.806 175.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -70.63 -37.16 73.76 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.617 0.767 . . . . 0.0 111.852 176.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.34 -33.41 74.25 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.484 -0.76 . . . . 0.0 111.243 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 mt -81.67 -31.96 32.01 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.287 0.635 . . . . 0.0 111.571 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.94 -29.25 70.65 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.494 1.918 . . . . 0.0 111.518 169.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.99 18.44 8.81 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.912 1.244 . . . . 0.0 114.929 169.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.95 -49.9 75.57 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 118.623 1.211 . . . . 0.0 111.424 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -156.75 146.2 20.56 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.535 1.934 . . . . 0.0 110.232 171.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -74.83 113.63 12.33 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 169.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -143.31 136.28 27.79 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.331 -167.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -87.72 129.86 35.01 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.424 1.49 . . . . 0.0 109.535 169.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.1 t -136.09 142.88 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.348 1.459 . . . . 0.0 108.705 -175.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -80.03 150.43 30.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.635 0.774 . . . . 0.0 110.093 172.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.424 HG23 ' HB1' ' A' ' 78' ' ' ALA . 0.6 OUTLIER -161.57 148.88 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.255 1.022 . . . . 0.0 110.843 -179.031 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.04 145.36 25.53 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.3 173.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -119.48 157.55 28.06 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.373 1.069 . . . . 0.0 111.165 175.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -113.93 140.06 48.7 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.834 0.854 . . . . 0.0 109.836 167.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -93.94 150.33 20.46 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.154 1.381 . . . . 0.0 109.585 170.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -17.64 60.73 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -171.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -73.1 -10.03 59.36 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.036 1.334 . . . . 0.0 113.659 172.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.0 9.31 37.34 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.693 1.616 . . . . 0.0 115.442 176.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 63.8 m -91.44 133.16 35.72 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.851 1.326 . . . . 0.0 111.198 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 49.6 t -134.44 129.37 35.17 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.827 0.851 . . . . 0.0 112.86 -176.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -151.01 153.35 34.98 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -173.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.443 HD13 ' N ' ' A' ' 108' ' ' CYS . 2.5 tm? -100.04 135.35 41.61 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.772 2.029 . . . . 0.0 110.435 173.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.443 ' N ' HD13 ' A' ' 107' ' ' LEU . 2.1 m -139.24 170.0 16.75 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.524 1.529 . . . . 0.0 110.706 168.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 31.1 tp -78.33 60.79 2.63 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.796 1.238 . . . . 0.0 110.69 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.7 t -60.79 145.23 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.691 1.196 . . . . 0.0 111.206 -174.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -104.1 69.69 0.95 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 122.493 1.139 . . . . 0.0 111.195 -169.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.1 t -82.76 69.81 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.022 0.929 . . . . 0.0 110.228 -169.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.89 132.46 23.91 Favored Pre-proline 0 N--CA 1.483 1.183 0 C-N-CA 124.26 1.024 . . . . 0.0 111.88 -171.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -88.54 -174.28 1.04 Allowed 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 123.595 2.863 . . . . 0.0 113.797 -171.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.85 129.26 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-O 122.854 1.311 . . . . 0.0 113.658 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -107.72 170.56 7.91 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 127.001 2.12 . . . . 0.0 112.31 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -104.13 179.91 4.14 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 113.666 -1.606 . . . . 0.0 112.346 169.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.25 -19.95 65.01 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -69.34 -19.96 63.86 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.458 1.103 . . . . 0.0 113.681 170.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.95 18.69 49.94 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.468 1.032 . . . . 0.0 113.842 -173.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -110.86 142.4 42.95 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.317 1.047 . . . . 0.0 113.448 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.6 p -74.99 100.06 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.946 1.698 . . . . 0.0 110.814 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.13 -28.94 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 123.303 0.641 . . . . 0.0 111.993 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.33 149.88 50.9 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-O 124.24 1.971 . . . . 0.0 112.654 174.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.8 m-30 -104.87 82.62 1.9 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.222 -1.808 . . . . 0.0 107.337 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.8 mt -100.83 69.88 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 170.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.49 88.93 5.61 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.99 0.9 . . . . 0.0 108.696 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -59.89 108.86 0.82 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.637 1.175 . . . . 0.0 110.712 -176.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -84.17 52.53 2.35 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 120.407 -1.433 . . . . 0.0 112.196 -176.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -79.93 106.89 12.29 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 123.998 1.856 . . . . 0.0 112.294 -178.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 37.0 t -64.74 112.42 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 C-N-CA 126.308 1.843 . . . . 0.0 108.633 171.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p -140.36 138.79 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 122.842 0.457 . . . . 0.0 110.041 175.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.2 ptp -83.99 178.77 7.73 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.73 1.212 . . . . 0.0 112.47 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -59.67 157.7 11.41 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.893 1.277 . . . . 0.0 112.498 175.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 86.3 tttt . . . . . 0 C--O 1.254 1.307 0 C-N-CA 125.626 1.57 . . . . 0.0 113.731 -172.127 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.955 -0.545 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.64 -17.81 7.1 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 123.341 2.694 . . . . 0.0 115.199 -174.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.8 t -130.48 152.92 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 125.663 1.585 . . . . 0.0 111.086 -169.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 57.45 43.46 22.97 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.576 1.95 . . . . 0.0 114.007 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.8 ppt_? -139.94 154.13 47.12 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.033 1.733 . . . . 0.0 111.969 169.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.21 5.72 59.58 Favored Glycine 0 CA--C 1.541 1.71 0 C-N-CA 124.514 1.055 . . . . 0.0 115.419 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 55.1 p-80 -84.91 162.47 19.44 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.282 1.833 . . . . 0.0 112.79 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.2 t -75.1 130.89 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.707 0.803 . . . . 0.0 109.335 172.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.03 159.92 24.64 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 123.62 0.768 . . . . 0.0 111.942 174.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -52.97 110.0 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.525 2.816 . . . . 0.0 111.774 174.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -66.38 -26.79 67.43 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -168.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -68.32 -49.92 57.04 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.719 0.808 . . . . 0.0 110.272 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 t -74.35 -36.43 63.61 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.751 0.821 . . . . 0.0 112.307 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -57.9 -40.02 79.31 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.27 0.628 . . . . 0.0 110.541 173.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.5 tp -71.19 -44.28 65.77 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 118.957 -0.544 . . . . 0.0 112.4 171.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -47.51 -39.9 17.33 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.951 1.3 . . . . 0.0 112.743 175.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 57.0 m -60.14 -42.27 94.47 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 121.193 -0.942 . . . . 0.0 112.549 172.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.8 mm -70.09 -33.31 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.311 1.045 . . . . 0.0 110.785 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.9 mm -56.43 -55.62 18.14 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.426 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 169.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -23.74 63.71 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.303 1.041 . . . . 0.0 113.354 177.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.2 tptp -68.96 -45.49 70.58 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.166 0.986 . . . . 0.0 112.989 171.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -102.45 -0.08 32.98 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -51.57 -28.97 15.51 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 127.256 2.222 . . . . 0.0 116.544 -167.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.5 55.53 6.7 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 118.951 0.796 . . . . 0.0 112.449 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -63.6 9.34 0.06 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.606 2.362 . . . . 0.0 116.521 -169.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.2 p -75.56 5.87 5.45 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.241 1.416 . . . . 0.0 111.695 165.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.8 mtt180 -53.62 158.47 1.85 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.154 1.782 . . . . 0.0 112.518 170.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -114.38 145.14 42.19 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.515 1.126 . . . . 0.0 112.601 -168.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -169.78 159.25 7.92 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 123.189 1.471 . . . . 0.0 114.916 -175.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -120.03 169.01 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 127.574 2.35 . . . . 0.0 111.208 172.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.0 mm -125.25 120.07 57.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 125.957 1.703 . . . . 0.0 107.365 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.0 152.56 48.48 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 178.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -77.31 110.72 12.27 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.301 0.572 . . . . 0.0 111.53 173.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.21 -15.51 61.94 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -99.92 4.63 45.1 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.536 1.309 . . . . 0.0 114.536 -169.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -119.73 140.05 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.422 1.489 . . . . 0.0 110.882 -175.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.4 -23.17 65.62 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -175.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -83.37 -14.52 52.63 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.899 1.28 . . . . 0.0 113.725 175.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.1 m 43.3 54.4 5.14 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.52 1.928 . . . . 0.0 113.528 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.84 154.71 17.59 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -168.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 80.8 t -79.95 90.01 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 128.111 2.565 . . . . 0.0 108.799 -176.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.7 pt -70.11 -23.79 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.698 1.199 . . . . 0.0 112.376 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -155.55 159.66 39.88 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.858 0.863 . . . . 0.0 112.258 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 18.5 p -142.96 139.96 30.89 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 121.342 -0.848 . . . . 0.0 113.069 -173.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -81.82 152.41 26.93 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.724 0.773 . . . . 0.0 112.748 170.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -61.97 -32.26 72.69 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.509 0.724 . . . . 0.0 111.252 175.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.45 -52.55 32.39 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 121.46 -0.775 . . . . 0.0 112.975 172.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.13 -29.73 66.73 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 119.21 1.505 . . . . 0.0 111.136 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.7 t -58.79 -39.82 82.22 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.528 -0.732 . . . . 0.0 110.619 171.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -79.23 -28.31 42.47 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.688 0.795 . . . . 0.0 113.056 174.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.2 tp -57.87 -53.09 62.15 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.051 1.341 . . . . 0.0 110.85 174.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 79.8 m -90.04 -20.01 23.73 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 177.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.71 34.01 40.55 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 124.312 0.958 . . . . 0.0 114.737 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -99.01 -130.18 0.21 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.564 1.146 . . . . 0.0 112.357 -176.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.7 m -159.84 142.88 13.92 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 128.669 2.787 . . . . 0.0 108.143 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -63.98 -40.11 95.65 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 120.922 -1.111 . . . . 0.0 112.934 -169.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.38 -18.04 56.88 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.522 1.129 . . . . 0.0 113.528 174.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -90.21 -20.72 22.7 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.183 1.393 . . . . 0.0 112.179 178.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.7 m -92.7 -14.49 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 CA-C-N 119.31 0.959 . . . . 0.0 113.546 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 35.5 mmt -49.87 114.01 0.98 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.915 1.286 . . . . 0.0 110.467 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 70.15 21.77 5.85 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.88 1.672 . . . . 0.0 113.74 169.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.34 158.84 86.14 Favored Pre-proline 0 N--CA 1.474 0.768 0 O-C-N 121.345 -0.847 . . . . 0.0 111.138 167.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.51 132.99 49.08 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.593 2.196 . . . . 0.0 112.209 171.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 4.6 t -69.99 -23.68 63.19 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.76 1.224 . . . . 0.0 112.548 174.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.0 m -57.04 100.14 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 128.092 2.557 . . . . 0.0 111.792 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 57.7 m -50.04 -21.74 1.35 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -174.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -52.67 -39.19 61.65 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.242 1.017 . . . . 0.0 112.014 171.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -56.14 -24.41 40.85 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.785 1.634 . . . . 0.0 113.4 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 pp -123.08 25.0 8.7 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.048 1.739 . . . . 0.0 113.284 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -63.5 147.26 51.85 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.37 -0.831 . . . . 0.0 112.613 176.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.5 -174.6 13.7 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 125.69 1.615 . . . . 0.0 113.709 -176.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -67.91 -4.38 12.28 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.995 3.13 . . . . 0.0 116.098 -170.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 78.9 mmt-85 -110.26 -10.05 14.64 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 119.609 1.095 . . . . 0.0 113.519 169.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.8 m -73.94 134.98 43.22 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.23 0.923 . . . . 0.0 110.812 -173.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -85.38 137.46 32.92 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.84 0.829 . . . . 0.0 110.029 173.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.0 mmm-85 -67.36 -39.67 85.73 Favored 'General case' 0 C--O 1.219 -0.517 0 O-C-N 121.402 -0.811 . . . . 0.0 111.084 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.1 ptt-85 -53.6 -38.63 64.15 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 169.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.85 -52.15 52.84 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 122.04 0.924 . . . . 0.0 110.079 175.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.42 -33.8 76.8 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.618 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.12 -51.85 28.33 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.783 1.633 . . . . 0.0 112.057 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -50.17 -41.62 49.53 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.456 1.025 . . . . 0.0 112.341 169.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 46.2 mt -62.94 -50.03 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 O-C-N 121.769 -0.582 . . . . 0.0 111.047 172.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.08 -39.79 56.89 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.374 -0.822 . . . . 0.0 112.173 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -69.84 -37.95 76.35 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.589 0.755 . . . . 0.0 111.473 176.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.23 -32.88 74.22 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.536 -0.727 . . . . 0.0 111.075 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mt -81.35 -33.47 32.39 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.452 0.701 . . . . 0.0 111.693 176.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.05 -28.47 69.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.791 2.036 . . . . 0.0 111.28 169.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.09 17.6 9.41 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.007 1.289 . . . . 0.0 114.84 169.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.85 -49.91 75.55 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 118.526 1.163 . . . . 0.0 111.439 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -161.56 151.65 17.14 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.695 1.598 . . . . 0.0 111.926 171.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -72.18 112.98 8.73 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 167.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.5 tpp180 -148.26 135.97 20.78 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.268 1.027 . . . . 0.0 111.431 -176.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -83.87 131.95 34.83 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.403 1.481 . . . . 0.0 110.204 169.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.7 t -134.93 146.12 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.353 1.461 . . . . 0.0 109.074 -176.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -80.05 152.5 29.36 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.773 0.829 . . . . 0.0 110.011 171.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -163.25 148.71 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.42 1.088 . . . . 0.0 110.813 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.8 145.38 25.22 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.665 174.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -117.18 154.14 31.61 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.677 1.191 . . . . 0.0 111.088 172.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -123.9 140.05 53.36 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.535 0.734 . . . . 0.0 110.811 169.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -83.11 162.12 21.42 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.953 1.301 . . . . 0.0 113.28 177.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -50.05 -35.28 24.42 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.469 1.908 . . . . 0.0 113.417 171.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -81.75 -9.91 59.51 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.56 1.144 . . . . 0.0 113.946 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.96 2.07 48.86 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.789 1.661 . . . . 0.0 115.382 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.5 m -74.66 125.11 27.99 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.936 1.368 . . . . 0.0 110.717 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 19.1 t -127.9 132.75 49.28 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.208 1.003 . . . . 0.0 112.589 -170.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -151.06 139.98 20.95 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.57 1.148 . . . . 0.0 113.825 -169.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.419 HD13 ' N ' ' A' ' 108' ' ' CYS . 1.9 tm? -104.81 128.75 53.08 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.405 1.882 . . . . 0.0 109.033 168.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.419 ' N ' HD13 ' A' ' 107' ' ' LEU . 62.3 m -134.99 172.66 12.69 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.422 1.489 . . . . 0.0 110.018 169.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 28.6 tp -79.98 59.88 3.37 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.983 -1.073 . . . . 0.0 110.81 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.7 t -58.42 146.28 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.253 1.421 . . . . 0.0 111.662 -171.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -100.87 69.72 1.35 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 122.608 1.194 . . . . 0.0 111.622 -168.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.7 t -83.32 69.86 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.229 1.011 . . . . 0.0 110.389 -169.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.0 p -119.51 133.47 23.8 Favored Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 124.689 1.195 . . . . 0.0 111.441 -173.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -88.79 -171.34 0.57 Allowed 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 123.761 2.974 . . . . 0.0 113.55 -171.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.7 m -127.81 127.19 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-O 122.811 1.291 . . . . 0.0 113.573 174.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -114.12 165.07 13.02 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 127.273 2.229 . . . . 0.0 112.202 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -94.22 179.99 5.12 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.654 174.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.65 -20.62 63.61 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -71.39 -19.87 62.21 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.546 1.139 . . . . 0.0 114.025 171.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.95 0.96 58.6 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 124.815 1.197 . . . . 0.0 114.127 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.21 126.25 37.21 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.485 1.114 . . . . 0.0 112.025 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.7 p -59.95 99.8 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 128.214 2.605 . . . . 0.0 109.796 171.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.22 -30.06 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.975 177.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.9 mmt -135.46 148.37 49.23 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 124.167 1.937 . . . . 0.0 111.128 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.8 m-30 -104.85 80.39 1.63 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.934 1.694 . . . . 0.0 106.749 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.0 mt -100.05 69.85 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 171.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.87 90.14 4.7 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -59.81 109.05 0.84 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.515 1.126 . . . . 0.0 110.857 -176.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -84.46 49.98 1.79 Allowed 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.233 -1.542 . . . . 0.0 112.515 -177.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -79.84 107.05 12.32 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 123.685 1.707 . . . . 0.0 111.98 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.3 t -57.94 115.82 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 127.166 2.186 . . . . 0.0 109.44 170.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.47 144.12 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 176.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 78.5 mtm -137.0 154.87 50.3 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.062 1.745 . . . . 0.0 110.834 169.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -73.77 157.06 37.13 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.133 0.973 . . . . 0.0 113.28 176.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.8 tptt . . . . . 0 C--O 1.252 1.211 0 C-N-CA 125.912 1.685 . . . . 0.0 111.381 179.773 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.3 mtm . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -69.14 157.67 60.7 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.435 2.757 . . . . 0.0 112.634 177.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.8 t -133.06 137.96 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.609 1.563 . . . . 0.0 109.847 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -88.82 19.93 3.8 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -173.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.8 161.65 42.24 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 127.098 2.159 . . . . 0.0 112.385 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.74 143.32 9.0 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.35 1.452 . . . . 0.0 111.986 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -143.9 162.65 35.58 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.505 1.522 . . . . 0.0 112.705 -170.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.75 142.47 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.649 1.18 . . . . 0.0 109.476 171.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.19 159.87 13.77 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 123.813 0.845 . . . . 0.0 112.193 174.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -54.46 110.1 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.671 2.914 . . . . 0.0 113.149 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -68.48 -25.22 64.86 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.485 -0.76 . . . . 0.0 112.855 -169.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -66.7 -49.85 64.74 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.07 0.948 . . . . 0.0 110.384 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 t -75.71 -35.8 60.17 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.829 0.852 . . . . 0.0 112.347 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -57.8 -40.69 80.5 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.138 0.575 . . . . 0.0 110.388 172.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.1 tp -72.54 -43.63 63.25 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 118.607 -0.711 . . . . 0.0 112.289 172.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -48.58 -39.97 25.66 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 120.077 1.308 . . . . 0.0 112.164 175.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 78.9 m -60.12 -42.64 95.21 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 121.607 -0.683 . . . . 0.0 112.732 173.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.1 mm -69.95 -32.74 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.219 1.008 . . . . 0.0 111.011 176.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.7 mm -57.08 -55.8 18.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 170.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -25.33 64.98 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 176.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.1 tptt -68.58 -42.19 78.61 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.087 0.955 . . . . 0.0 112.271 172.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -114.99 16.39 17.14 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 -175.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -60.08 -29.05 68.31 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 -166.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.54 55.47 28.68 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 119.019 0.827 . . . . 0.0 113.188 172.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -58.07 -6.71 0.64 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 116.858 2.17 . . . . 0.0 116.858 -168.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.8 m -69.88 -18.76 63.43 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 120.927 -1.108 . . . . 0.0 112.323 167.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -78.1 154.58 31.18 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.787 2.035 . . . . 0.0 110.904 172.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -111.82 149.08 32.27 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.482 1.513 . . . . 0.0 113.496 -168.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -169.78 162.45 9.55 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -172.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 pp -129.25 170.66 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 127.323 2.249 . . . . 0.0 111.347 175.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.1 mm -126.21 114.45 38.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 126.368 1.867 . . . . 0.0 107.388 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.5 150.26 41.85 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 124.325 1.05 . . . . 0.0 111.614 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -81.72 114.03 20.11 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.391 1.076 . . . . 0.0 110.37 176.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.82 4.16 45.55 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 175.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -100.19 -3.38 31.74 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.397 1.479 . . . . 0.0 113.936 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 p -118.15 139.29 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.83 1.652 . . . . 0.0 111.501 -176.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -62.15 -26.39 68.3 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.926 0.89 . . . . 0.0 112.937 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -77.53 -8.88 58.48 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.824 1.25 . . . . 0.0 113.93 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.0 p 43.62 35.4 0.99 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 126.991 2.116 . . . . 0.0 114.877 -176.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.71 154.87 29.73 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -167.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 98.9 t -79.99 89.99 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 129.143 2.977 . . . . 0.0 109.02 -175.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.0 pt -69.94 -24.25 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.462 1.505 . . . . 0.0 112.392 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -153.92 159.66 41.82 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.281 1.033 . . . . 0.0 112.224 171.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 18.6 p -143.77 147.35 34.05 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.817 -1.177 . . . . 0.0 112.798 -177.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -89.74 156.86 18.24 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 176.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -58.81 -27.4 65.04 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.277 0.631 . . . . 0.0 111.626 169.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.7 -56.64 12.84 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 119.218 -0.768 . . . . 0.0 112.465 169.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -53.19 -39.49 63.69 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.4 1.6 . . . . 0.0 111.371 174.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.3 t -60.14 -40.06 88.47 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.901 -0.5 . . . . 0.0 111.308 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -78.56 -25.86 45.49 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.978 0.911 . . . . 0.0 112.979 176.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 36.2 tp -66.26 -55.74 14.66 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.877 1.271 . . . . 0.0 111.213 176.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 78.4 m -93.35 -22.06 19.18 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.638 0.775 . . . . 0.0 113.084 -176.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.22 20.07 79.82 Favored Glycine 0 CA--C 1.539 1.586 0 O-C-N 121.034 -1.041 . . . . 0.0 113.855 -171.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -87.47 -130.02 0.06 Allowed 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 118.493 1.147 . . . . 0.0 110.839 -176.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.0 t -160.66 150.16 17.31 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 127.862 2.465 . . . . 0.0 108.846 176.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.08 -38.87 54.29 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 121.466 -0.771 . . . . 0.0 112.624 172.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.51 -19.99 64.16 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.56 1.144 . . . . 0.0 113.737 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -86.76 -20.73 27.19 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.267 1.427 . . . . 0.0 113.189 174.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -105.41 -18.49 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 176.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.5 mmt -49.84 111.41 0.51 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.491 1.517 . . . . 0.0 111.248 -172.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 66.83 30.67 7.76 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.823 1.649 . . . . 0.0 112.544 170.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -107.21 154.4 40.52 Favored Pre-proline 0 N--CA 1.471 0.61 0 CA-C-O 117.321 -1.323 . . . . 0.0 112.594 176.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -50.59 134.82 40.56 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.267 2.645 . . . . 0.0 113.95 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 52.7 t -66.68 -17.86 65.07 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.727 1.211 . . . . 0.0 112.981 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.2 m -61.88 99.99 0.14 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.211 1.804 . . . . 0.0 111.859 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 27.8 p -54.08 -15.69 1.59 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -175.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -52.85 -38.74 61.85 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.991 0.917 . . . . 0.0 111.523 170.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -64.78 -15.19 61.32 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 pp -123.06 25.38 8.54 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.118 1.767 . . . . 0.0 113.358 172.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -62.34 148.33 45.52 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.197 -0.94 . . . . 0.0 112.62 176.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.96 -179.75 16.04 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 125.126 1.346 . . . . 0.0 114.09 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -63.5 -10.01 20.17 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.572 2.848 . . . . 0.0 116.629 -174.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -110.03 -2.27 17.13 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.412 1.485 . . . . 0.0 114.15 173.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.509 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 3.2 m -80.8 139.99 35.72 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.348 0.976 . . . . 0.0 111.944 -177.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -87.27 135.61 33.25 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 122.493 1.139 . . . . 0.0 111.407 171.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.8 mmm-85 -69.79 -39.74 76.43 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 118.573 -0.727 . . . . 0.0 110.965 176.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.2 ptp85 -54.13 -38.37 65.37 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 169.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.406 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -65.23 -52.81 52.21 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 122.111 0.958 . . . . 0.0 110.05 174.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.24 -32.71 74.52 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.695 -178.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.1 -50.22 43.03 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.17 1.788 . . . . 0.0 112.559 176.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -50.11 -42.61 50.7 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.659 1.118 . . . . 0.0 111.975 169.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 43.0 mt -61.31 -48.83 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.857 -0.527 . . . . 0.0 111.271 173.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.56 -39.88 58.69 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.131 0.572 . . . . 0.0 111.957 174.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -62.63 -40.81 98.18 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.556 0.742 . . . . 0.0 111.284 175.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.01 -29.13 68.05 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 175.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mt -86.55 -32.48 20.67 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.1 pp -71.48 -30.3 65.83 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.618 -0.676 . . . . 0.0 111.227 167.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.83 20.06 7.85 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 118.988 -0.896 . . . . 0.0 113.823 168.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.27 -50.0 68.28 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 118.486 1.143 . . . . 0.0 111.179 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -167.27 150.21 6.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.938 2.095 . . . . 0.0 110.566 169.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -86.84 130.15 34.59 Favored 'General case' 0 C--O 1.238 0.471 0 O-C-N 121.21 -0.931 . . . . 0.0 109.166 -178.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.06 150.54 27.36 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.092 0.957 . . . . 0.0 112.351 174.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -76.77 138.44 39.91 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.275 1.03 . . . . 0.0 109.339 168.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -139.24 144.75 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.332 1.053 . . . . 0.0 109.525 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -80.01 152.62 29.35 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.905 0.882 . . . . 0.0 110.04 171.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.406 HG23 ' HB1' ' A' ' 78' ' ' ALA . 0.6 OUTLIER -163.46 148.05 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.235 1.014 . . . . 0.0 111.028 179.209 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.509 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -90.76 145.37 24.85 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.888 0.475 . . . . 0.0 112.247 177.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -117.51 162.56 17.78 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.767 1.227 . . . . 0.0 111.93 172.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -127.94 136.46 51.36 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.604 0.761 . . . . 0.0 111.531 168.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.7 mmt85 -71.08 152.22 43.72 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.446 1.498 . . . . 0.0 111.624 173.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -54.88 -30.57 58.29 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.788 1.235 . . . . 0.0 112.341 168.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -76.21 -9.95 59.03 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.568 1.547 . . . . 0.0 114.271 175.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.8 10.23 47.16 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.296 1.427 . . . . 0.0 116.313 174.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.3 m -87.61 135.12 33.49 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 119.14 1.47 . . . . 0.0 111.578 176.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 59.3 m -123.24 133.18 54.22 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.467 1.107 . . . . 0.0 112.243 -171.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -150.9 140.47 21.59 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -176.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -102.58 127.46 49.65 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.004 1.722 . . . . 0.0 108.465 168.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 60.9 m -128.45 168.49 15.56 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.435 1.094 . . . . 0.0 110.579 171.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 73.2 mt -79.99 59.85 3.36 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.876 -1.14 . . . . 0.0 110.199 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.3 t -59.06 146.37 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.531 1.532 . . . . 0.0 112.208 -168.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -100.05 69.69 1.53 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 122.56 1.172 . . . . 0.0 112.31 -168.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.9 t -84.67 69.85 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 121.372 -0.83 . . . . 0.0 111.346 -168.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.2 t -111.25 129.2 24.28 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 124.504 1.121 . . . . 0.0 109.464 -178.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -82.96 -168.67 0.61 Allowed 'Trans proline' 0 CA--C 1.553 1.427 0 C-N-CA 123.121 2.548 . . . . 0.0 111.298 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -127.17 128.9 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-O 123.124 1.44 . . . . 0.0 113.945 175.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -111.7 162.2 15.46 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.675 2.39 . . . . 0.0 112.818 -175.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -94.46 -178.95 4.74 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.475 172.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -61.57 -22.18 64.96 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -71.89 -19.98 61.86 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.641 1.177 . . . . 0.0 113.829 170.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.32 -0.03 59.85 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 126.017 1.77 . . . . 0.0 114.372 -176.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.4 140.01 29.94 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.541 1.171 . . . . 0.0 113.146 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.3 p -73.95 98.89 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.668 1.587 . . . . 0.0 109.8 -176.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.96 -30.03 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 118.397 -0.811 . . . . 0.0 111.059 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.7 mmt -135.96 149.91 49.07 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-O 123.455 1.597 . . . . 0.0 110.452 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.2 m-30 -105.61 81.09 1.63 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -175.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.9 mt -99.95 69.99 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 120.206 -1.559 . . . . 0.0 108.295 173.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -73.96 87.64 1.83 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 123.405 1.574 . . . . 0.0 109.398 176.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -59.89 96.54 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 112.845 -1.98 . . . . 0.0 109.862 176.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -83.4 52.76 2.3 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.454 -1.403 . . . . 0.0 111.881 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -79.84 127.08 31.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 122.065 0.936 . . . . 0.0 111.992 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 t -69.36 123.56 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.423 1.089 . . . . 0.0 109.016 172.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.46 145.24 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 169.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.2 ptp -142.87 157.66 44.38 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.858 1.263 . . . . 0.0 111.865 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -76.18 145.93 39.5 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.374 0.67 . . . . 0.0 111.68 169.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt . . . . . 0 C--O 1.253 1.278 0 C-N-CA 125.973 1.709 . . . . 0.0 111.784 -174.494 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.4 ttm . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 118.775 -0.631 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -71.07 -22.92 25.54 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.27 2.647 . . . . 0.0 114.098 -175.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.0 m -119.56 154.4 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 126.321 1.848 . . . . 0.0 111.308 173.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.9 ptp85 -157.13 162.95 39.39 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.327 1.451 . . . . 0.0 112.776 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -81.59 146.92 29.86 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.335 1.054 . . . . 0.0 110.941 168.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.97 -155.97 48.02 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 123.612 0.625 . . . . 0.0 113.725 -175.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -77.85 162.43 26.87 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.13 1.372 . . . . 0.0 113.462 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.9 p -90.15 148.69 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.874 1.269 . . . . 0.0 110.956 170.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.36 159.93 27.55 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 123.531 0.732 . . . . 0.0 111.561 169.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -51.6 110.16 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.803 3.002 . . . . 0.0 112.031 174.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -63.87 -27.16 68.97 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -168.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -68.45 -50.0 55.72 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.754 0.822 . . . . 0.0 110.371 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 t -75.67 -33.9 60.43 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.835 0.854 . . . . 0.0 112.488 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -59.9 -40.35 88.47 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.454 0.702 . . . . 0.0 110.185 172.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.4 tp -71.6 -45.99 60.55 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-O 118.824 -0.607 . . . . 0.0 112.161 172.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -46.86 -39.75 12.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.587 1.555 . . . . 0.0 113.353 173.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 90.3 m -60.01 -44.77 94.35 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.546 -0.721 . . . . 0.0 112.025 172.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.1 mm -67.3 -35.54 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.881 0.872 . . . . 0.0 110.756 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.4 mm -55.78 -54.95 20.66 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 172.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 -59.96 -28.43 67.65 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.981 0.809 . . . . 0.0 113.038 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.7 tttt -64.27 -41.69 96.79 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 172.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -103.51 1.01 31.76 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -57.43 -26.96 61.96 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.872 2.069 . . . . 0.0 114.16 -168.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.71 42.9 30.49 Favored Glycine 0 CA--C 1.532 1.147 0 O-C-N 121.284 -0.885 . . . . 0.0 113.066 -178.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -63.39 -10.18 15.69 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.875 1.67 . . . . 0.0 113.421 -173.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 51.1 p -61.66 -8.56 4.69 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.938 1.695 . . . . 0.0 114.774 171.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . 0.369 0.0 OUTLIER -69.21 -175.24 0.74 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 119.777 1.171 . . . . 0.0 113.591 169.287 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -62.1 130.5 45.76 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.764 1.626 . . . . 0.0 113.181 -167.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -169.72 161.5 9.28 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.392 1.477 . . . . 0.0 113.374 176.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -125.01 167.92 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 126.845 2.058 . . . . 0.0 111.636 170.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.6 mm -125.74 122.43 62.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 125.846 1.658 . . . . 0.0 107.882 173.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.41 152.78 49.43 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 178.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -77.91 106.72 9.95 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 121.561 0.696 . . . . 0.0 111.191 172.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.71 -14.98 61.23 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -94.97 4.14 54.14 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.808 1.243 . . . . 0.0 114.163 -172.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -117.73 140.09 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.482 1.513 . . . . 0.0 110.647 -176.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.34 -26.05 66.28 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -177.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.83 -8.95 59.85 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.223 1.409 . . . . 0.0 114.001 177.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.5 p 35.34 56.12 0.84 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 127.043 2.137 . . . . 0.0 114.214 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.93 153.14 17.92 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -167.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.0 t -79.97 89.97 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 128.64 2.776 . . . . 0.0 108.895 -176.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.5 pt -70.82 -24.64 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.642 1.177 . . . . 0.0 112.2 176.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -154.9 159.77 40.7 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 177.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 25.5 p -142.29 146.8 35.46 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -172.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -92.01 154.1 19.0 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.549 0.69 . . . . 0.0 112.595 167.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -62.9 -33.56 75.57 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.265 0.626 . . . . 0.0 111.14 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.95 -49.95 56.78 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 121.69 -0.631 . . . . 0.0 113.155 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.02 -29.86 67.01 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 119.41 1.605 . . . . 0.0 111.141 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.8 t -59.19 -39.87 83.92 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 120.78 -1.2 . . . . 0.0 110.429 171.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -79.49 -24.79 42.07 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.285 1.034 . . . . 0.0 112.935 173.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.4 tp -59.33 -50.33 74.39 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.438 1.095 . . . . 0.0 110.398 172.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.1 m -86.68 -23.71 25.51 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 175.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.59 31.72 60.37 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 124.481 1.038 . . . . 0.0 114.197 -175.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 17.7 m-30 -95.99 -130.16 0.16 Allowed 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 118.379 1.09 . . . . 0.0 112.146 -175.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.4 t -160.06 149.96 18.19 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 128.026 2.53 . . . . 0.0 108.578 174.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -61.3 -35.35 77.09 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 120.699 -1.251 . . . . 0.0 113.234 -173.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.42 -16.67 48.92 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.436 1.094 . . . . 0.0 113.26 175.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -93.66 -20.86 19.77 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.422 1.889 . . . . 0.0 111.99 178.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 m -95.83 -19.99 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 119.762 1.164 . . . . 0.0 113.296 -174.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 34.3 mmt -50.01 112.97 0.75 Allowed 'General case' 0 C--N 1.342 0.248 0 C-N-CA 124.683 1.193 . . . . 0.0 110.889 -173.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 68.74 21.99 7.56 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.193 1.397 . . . . 0.0 113.549 169.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.3 158.79 86.92 Favored Pre-proline 0 N--CA 1.475 0.785 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.687 167.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.78 140.01 93.23 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.117 1.878 . . . . 0.0 111.481 169.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 3.9 t -69.62 -14.69 62.96 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.043 1.337 . . . . 0.0 112.747 177.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.28 99.8 0.31 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 127.82 2.448 . . . . 0.0 110.544 176.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 30.4 p -55.23 -14.86 1.93 Allowed 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.638 -1.165 . . . . 0.0 113.652 174.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -47.15 -42.82 20.28 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.442 1.497 . . . . 0.0 111.828 167.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -66.81 -12.66 59.77 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 pp -123.05 23.62 9.2 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.282 1.833 . . . . 0.0 113.428 171.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.12 146.85 53.52 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.036 -1.04 . . . . 0.0 112.912 177.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -123.19 -177.43 15.14 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.309 1.433 . . . . 0.0 114.547 -173.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -66.78 -10.15 27.18 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.009 2.473 . . . . 0.0 116.218 -172.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -110.07 -5.34 15.42 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.702 1.201 . . . . 0.0 113.898 170.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.533 HG23 ' H ' ' A' ' 97' ' ' ALA . 3.6 m -71.23 134.1 46.62 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.889 1.222 . . . . 0.0 110.076 177.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -79.88 134.59 36.31 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 122.263 1.03 . . . . 0.0 109.072 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -66.3 -39.71 89.51 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.342 -0.849 . . . . 0.0 110.105 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.8 ptt-85 -55.34 -38.91 69.38 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.559 1.144 . . . . 0.0 113.909 169.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.42 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -63.16 -52.84 60.79 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.987 0.915 . . . . 0.0 110.482 174.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.05 -34.45 78.45 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.181 -178.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.09 -52.81 24.53 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.599 1.16 . . . . 0.0 112.194 176.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -50.18 -40.01 45.59 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.378 0.99 . . . . 0.0 112.921 171.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 46.2 mt -63.62 -49.27 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 121.453 -0.779 . . . . 0.0 111.365 173.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.75 -39.88 59.3 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.777 0.717 . . . . 0.0 111.763 173.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -63.29 -39.76 95.48 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.319 0.648 . . . . 0.0 111.542 175.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.04 -29.7 68.74 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.3 mt -82.79 -34.97 26.87 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.9 pp -70.66 -27.2 63.85 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.976 -0.453 . . . . 0.0 112.056 167.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.93 17.48 9.6 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.315 -0.714 . . . . 0.0 114.2 169.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -51.61 -49.88 61.32 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 118.087 0.944 . . . . 0.0 112.042 173.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -157.01 142.74 17.66 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.52 1.928 . . . . 0.0 110.644 170.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -75.81 118.19 18.35 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.71 -1.244 . . . . 0.0 108.017 169.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -146.23 135.62 22.94 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.851 0.86 . . . . 0.0 112.474 -167.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -86.88 130.0 34.65 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.043 1.337 . . . . 0.0 109.518 168.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.71 144.28 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.21 1.404 . . . . 0.0 109.081 -175.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -79.88 150.62 30.54 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.522 0.729 . . . . 0.0 109.891 171.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.42 HG23 ' HB1' ' A' ' 78' ' ' ALA . 0.7 OUTLIER -160.86 159.98 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.367 1.067 . . . . 0.0 110.32 -177.565 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.533 ' H ' HG23 ' A' ' 74' ' ' THR . . . -102.09 145.31 29.52 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.807 171.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -112.4 152.59 28.47 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.862 1.665 . . . . 0.0 110.645 169.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -127.06 139.56 52.91 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.44 0.638 . . . . 0.0 110.289 167.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -84.9 158.55 20.54 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.786 1.234 . . . . 0.0 112.927 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -54.68 -30.44 55.63 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.574 1.55 . . . . 0.0 112.853 169.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -75.45 -9.94 59.02 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.115 1.366 . . . . 0.0 113.998 175.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.08 3.82 55.6 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.76 1.647 . . . . 0.0 115.763 176.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 54.2 m -84.57 128.24 34.49 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 119.169 1.484 . . . . 0.0 111.347 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 46.9 t -124.43 129.88 51.47 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.065 1.346 . . . . 0.0 112.005 -173.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -150.91 139.96 21.07 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.399 1.079 . . . . 0.0 113.764 -169.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.0 134.87 49.51 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.711 2.404 . . . . 0.0 109.121 172.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 4.5 m -139.04 173.1 11.91 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.66 1.584 . . . . 0.0 110.281 168.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 26.6 tp -76.95 59.84 1.7 Allowed 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.019 -1.051 . . . . 0.0 109.995 173.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.7 t -59.81 146.98 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.955 1.302 . . . . 0.0 110.8 -172.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -100.0 69.72 1.55 Allowed 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 122.802 1.287 . . . . 0.0 112.584 -168.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.1 t -84.19 69.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.343 1.057 . . . . 0.0 110.89 -169.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.2 p -117.88 134.07 23.31 Favored Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 124.038 0.935 . . . . 0.0 111.887 -173.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -86.81 -173.22 1.1 Allowed 'Trans proline' 0 CA--C 1.546 1.089 0 C-N-CA 123.472 2.781 . . . . 0.0 113.445 -172.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.16 127.12 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-O 122.972 1.368 . . . . 0.0 113.483 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -110.62 162.07 15.1 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.634 2.374 . . . . 0.0 112.63 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -92.81 179.97 5.31 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.735 -1.121 . . . . 0.0 112.156 171.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.67 -21.4 65.69 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -70.84 -19.87 62.61 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.481 1.112 . . . . 0.0 113.737 169.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.69 0.09 59.27 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 126.007 1.765 . . . . 0.0 114.406 -176.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.74 139.64 30.36 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.69 1.245 . . . . 0.0 113.292 -178.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.8 p -74.53 100.1 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 125.582 1.553 . . . . 0.0 110.565 -176.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.26 -29.98 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.34 0.656 . . . . 0.0 111.837 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.27 149.99 50.97 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 124.273 1.987 . . . . 0.0 112.732 173.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.3 m-30 -104.45 82.05 1.88 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.155 -1.839 . . . . 0.0 107.048 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.3 mt -102.06 69.88 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 171.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.19 86.56 5.59 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.899 0.857 . . . . 0.0 108.858 -178.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -59.94 104.21 0.28 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.544 1.138 . . . . 0.0 110.94 -175.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -83.85 58.13 4.5 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.277 -1.514 . . . . 0.0 111.729 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -79.79 124.95 29.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 122.626 1.203 . . . . 0.0 110.914 176.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 55.9 t -81.99 113.34 21.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 125.048 1.339 . . . . 0.0 108.27 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.6 p -140.38 135.99 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 120.836 0.351 . . . . 0.0 111.635 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 27.8 ptm -142.82 158.74 43.33 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.34 1.456 . . . . 0.0 111.722 173.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -72.54 149.63 43.89 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.951 0.9 . . . . 0.0 112.202 173.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 87.1 tttt . . . . . 0 C--O 1.252 1.204 0 C-N-CA 125.792 1.637 . . . . 0.0 111.505 179.86 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo . . . . . 0 CA--C 1.532 0.406 0 CA-C-O 122.173 0.822 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -63.96 -26.98 68.83 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -167.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -70.05 -49.98 45.78 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.67 0.668 . . . . 0.0 110.761 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.5 t -78.25 -33.99 49.36 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.547 1.139 . . . . 0.0 112.357 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -59.78 -42.4 93.24 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.306 0.642 . . . . 0.0 109.947 172.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.9 tp -70.12 -45.43 66.89 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-O 118.708 -0.663 . . . . 0.0 111.868 173.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -48.05 -39.87 21.3 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 120.04 1.291 . . . . 0.0 113.207 174.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.6 m -60.07 -44.98 94.35 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.605 -0.684 . . . . 0.0 112.261 172.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.8 mm -66.34 -36.61 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.762 0.825 . . . . 0.0 110.691 175.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.9 mm -55.96 -53.87 33.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.434 0 CA-C-O 118.445 -0.788 . . . . 0.0 109.05 173.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -59.97 -29.0 68.14 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 118.845 0.748 . . . . 0.0 112.54 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 tptt -63.42 -46.2 87.45 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 118.624 -0.703 . . . . 0.0 112.815 172.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -101.41 11.4 39.22 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.549 0.924 0 C-N-CA 125.273 1.429 . . . . 0.0 113.698 -167.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 mptt . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 118.863 -0.589 . . . . 0.0 111.953 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -169.9 161.29 8.86 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -171.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -128.03 172.29 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.884 1.274 . . . . 0.0 111.732 174.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.2 mm -130.28 120.07 48.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 125.988 1.715 . . . . 0.0 108.375 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.02 153.78 51.15 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -81.34 108.49 15.0 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.599 0.714 . . . . 0.0 111.469 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.21 -15.82 62.48 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.239 1.015 . . . . 0.0 113.461 177.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -89.96 -2.13 58.1 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.705 1.602 . . . . 0.0 113.906 -172.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.27 140.14 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.105 1.362 . . . . 0.0 110.567 -174.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -59.46 -28.17 66.74 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -177.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -84.16 -3.55 58.21 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.017 1.327 . . . . 0.0 114.469 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.5 p 37.44 51.29 1.17 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 126.899 2.079 . . . . 0.0 114.417 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.77 150.18 24.33 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -167.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.4 t -79.96 89.96 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 127.843 2.457 . . . . 0.0 108.957 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.8 pt -70.0 -24.86 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.08 1.352 . . . . 0.0 112.446 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -154.78 159.71 40.8 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.151 0.98 . . . . 0.0 112.576 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 5.8 p -148.77 145.29 27.52 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.975 -1.078 . . . . 0.0 113.07 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -86.89 156.64 19.76 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 178.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.58 -27.65 67.87 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.621 0.769 . . . . 0.0 111.913 171.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.41 -50.49 52.6 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.331 -0.856 . . . . 0.0 113.03 170.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.57 -38.16 74.36 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 119.652 1.726 . . . . 0.0 110.593 173.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.6 t -60.22 -40.78 91.35 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.821 -0.55 . . . . 0.0 111.098 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -77.62 -26.31 50.48 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.649 0.78 . . . . 0.0 112.969 175.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.0 tp -63.92 -55.81 19.88 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.951 1.3 . . . . 0.0 111.29 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 77.1 m -95.96 -20.05 19.03 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.934 0.894 . . . . 0.0 113.067 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.4 20.21 76.71 Favored Glycine 0 CA--C 1.538 1.491 0 O-C-N 120.988 -1.07 . . . . 0.0 113.847 -174.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -84.87 -129.64 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.97 1.308 . . . . 0.0 110.313 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 41.6 t -159.87 150.12 18.66 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 127.589 2.356 . . . . 0.0 108.288 173.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.1 mtm180 -58.28 -35.28 71.55 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.124 -0.985 . . . . 0.0 112.328 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.42 -21.71 64.35 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -81.85 -20.79 38.23 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.207 1.403 . . . . 0.0 112.511 175.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -105.3 -17.06 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 7.6 mmt -49.89 108.0 0.19 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 125.519 1.528 . . . . 0.0 111.051 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 70.55 18.86 6.39 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.792 1.637 . . . . 0.0 113.793 171.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.12 159.11 76.29 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 123.843 0.857 . . . . 0.0 110.452 167.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -60.34 140.03 89.74 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.532 2.154 . . . . 0.0 111.857 169.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.7 t -67.47 -9.99 47.26 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.844 1.657 . . . . 0.0 113.469 176.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.7 m -62.81 100.17 0.19 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 127.672 2.389 . . . . 0.0 111.507 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 46.4 m -49.93 -23.48 1.99 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.088 1.755 . . . . 0.0 115.299 -176.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -46.99 -41.81 16.94 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.435 1.494 . . . . 0.0 112.863 169.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -63.1 -16.64 60.63 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.28 1.032 . . . . 0.0 113.551 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 pp -123.11 25.25 8.57 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.74 1.616 . . . . 0.0 113.653 173.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -65.01 151.56 45.67 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.109 -0.995 . . . . 0.0 112.181 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -125.6 -177.81 15.05 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.378 1.466 . . . . 0.0 113.694 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -64.65 -10.13 23.45 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.318 2.679 . . . . 0.0 116.293 -171.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -107.6 -7.39 16.49 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.825 1.65 . . . . 0.0 113.341 175.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.526 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 3.8 m -71.71 132.22 44.23 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.074 -1.016 . . . . 0.0 111.335 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -80.01 135.72 36.44 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.081 0.943 . . . . 0.0 110.105 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.3 mmt-85 -66.33 -39.79 89.47 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.737 -0.602 . . . . 0.0 110.658 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 49.5 ptt85 -53.76 -39.07 65.06 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.385 1.074 . . . . 0.0 113.463 171.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.03 -50.21 43.57 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.593 1.157 . . . . 0.0 110.234 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.23 -33.67 76.55 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.137 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.5 -54.98 11.57 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.478 1.111 . . . . 0.0 111.541 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -50.16 -40.14 45.72 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.862 0.865 . . . . 0.0 112.873 172.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.4 mt -65.48 -50.03 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 118.758 0.708 . . . . 0.0 111.018 174.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.09 -39.89 57.13 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.732 -0.651 . . . . 0.0 111.977 174.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -70.03 -37.71 75.69 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.449 0.7 . . . . 0.0 111.669 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.66 -34.02 76.95 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.328 -0.857 . . . . 0.0 111.317 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mt -83.15 -28.88 29.07 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.509 0.724 . . . . 0.0 111.664 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.19 -27.88 69.01 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.819 2.048 . . . . 0.0 111.016 168.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.0 17.36 9.64 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.245 1.402 . . . . 0.0 114.918 170.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.89 -49.93 74.24 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 118.642 1.221 . . . . 0.0 111.231 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -159.9 139.06 10.93 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.886 1.674 . . . . 0.0 111.392 169.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -74.02 101.45 3.87 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 169.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -144.04 140.05 29.32 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.82 1.248 . . . . 0.0 111.828 -168.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -77.49 135.03 38.2 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.506 1.123 . . . . 0.0 111.123 173.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -136.51 153.2 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.038 1.735 . . . . 0.0 108.553 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -79.93 160.07 26.11 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.857 0.863 . . . . 0.0 110.104 169.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.51 HD13 ' CZ ' ' A' ' 98' ' ' PHE . 0.3 OUTLIER -164.35 149.85 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 119.234 0.925 . . . . 0.0 111.448 169.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.526 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -88.89 145.33 25.61 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.431 0.692 . . . . 0.0 111.548 172.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.51 ' CZ ' HD13 ' A' ' 96' ' ' ILE . 40.9 m-85 -117.29 160.97 20.25 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.374 1.07 . . . . 0.0 110.999 173.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -125.64 140.04 53.06 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.466 0.65 . . . . 0.0 111.441 169.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -83.99 154.78 23.11 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.418 1.087 . . . . 0.0 112.591 175.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -53.95 -27.85 33.64 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.025 1.73 . . . . 0.0 113.089 171.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -71.42 -9.95 58.99 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.188 1.395 . . . . 0.0 114.181 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.76 18.24 33.06 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.249 1.404 . . . . 0.0 115.831 175.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 71.2 m -107.17 136.86 46.29 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 118.634 1.217 . . . . 0.0 111.717 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 29.5 t -126.21 135.0 51.08 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.858 1.263 . . . . 0.0 112.325 -175.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -149.96 139.98 22.01 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.55 1.14 . . . . 0.0 113.422 -168.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -102.54 125.56 49.3 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.408 1.883 . . . . 0.0 109.139 170.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 61.4 m -129.74 173.16 10.9 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.42 1.488 . . . . 0.0 110.082 173.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 30.4 tp -79.31 59.88 2.96 Favored 'General case' 0 CA--C 1.549 0.911 0 O-C-N 120.592 -1.317 . . . . 0.0 111.644 -176.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 45.7 t -63.41 142.9 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 126.062 1.745 . . . . 0.0 111.623 -173.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -108.81 69.98 0.73 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.203 1.001 . . . . 0.0 112.979 -167.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.8 t -81.25 70.02 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.732 1.213 . . . . 0.0 111.045 -168.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.8 p -121.51 126.53 26.45 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 124.133 0.973 . . . . 0.0 112.247 -175.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -88.93 -176.4 1.39 Allowed 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 123.846 3.031 . . . . 0.0 112.293 -173.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -117.03 133.59 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 123.178 1.465 . . . . 0.0 113.677 -175.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.46 160.78 30.43 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.092 2.157 . . . . 0.0 111.947 -173.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -89.92 -176.27 4.87 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.124 0.97 . . . . 0.0 112.092 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -62.48 -19.98 64.11 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -77.29 -19.97 55.71 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.011 1.324 . . . . 0.0 113.862 170.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.75 -0.13 64.74 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.23 1.395 . . . . 0.0 114.447 -176.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.25 131.38 35.29 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.372 1.086 . . . . 0.0 111.669 174.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.7 p -72.56 98.3 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.73 2.012 . . . . 0.0 111.078 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.7 -29.14 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 123.555 0.742 . . . . 0.0 111.731 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.9 148.6 50.12 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 124.115 1.912 . . . . 0.0 112.834 174.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -102.45 83.93 2.37 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 125.815 1.646 . . . . 0.0 106.766 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.6 mt -99.87 79.29 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 170.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.296 34.5 mt -83.0 86.01 7.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 123.226 1.488 . . . . 0.0 108.946 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -59.93 103.13 0.19 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 113.045 -1.889 . . . . 0.0 109.441 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -85.16 55.63 3.58 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 122.584 1.183 . . . . 0.0 110.885 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -79.83 106.75 12.09 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 123.653 1.692 . . . . 0.0 110.507 -176.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.54 120.32 12.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 125.73 1.612 . . . . 0.0 108.691 170.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.472 0.667 0 O-C-N 123.277 0.36 . . . . 0.0 110.076 175.113 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo . . . . . 0 CA--C 1.535 0.551 0 CA-C-O 122.282 0.868 . . . . 0.0 112.329 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -60.02 -28.8 68.03 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -165.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -66.65 -49.85 64.85 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.715 0.806 . . . . 0.0 110.53 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 t -79.2 -34.15 43.21 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.177 0.991 . . . . 0.0 112.428 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -58.41 -39.94 81.11 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.07 0.948 . . . . 0.0 110.458 170.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 44.5 tp -70.07 -45.72 66.44 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 118.813 -0.613 . . . . 0.0 111.999 170.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -46.5 -39.93 11.64 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.975 1.31 . . . . 0.0 112.936 174.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.6 m -58.97 -45.1 91.39 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 121.595 -0.691 . . . . 0.0 111.664 173.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.8 mm -66.1 -36.84 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.89 0.876 . . . . 0.0 110.543 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.2 mm -54.51 -55.79 13.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 CA-C-O 117.777 -1.106 . . . . 0.0 108.545 171.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -59.87 -29.99 68.69 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 120.108 1.322 . . . . 0.0 111.922 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.1 tptt -63.6 -40.64 97.46 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.582 1.153 . . . . 0.0 112.235 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -108.16 -0.14 21.19 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 116.034 1.864 . . . . 0.0 116.034 176.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.554 1.101 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -166.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -169.72 160.92 9.03 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -121.25 168.93 13.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 126.892 2.077 . . . . 0.0 111.387 170.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.8 mm -119.1 113.85 42.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 126.105 1.762 . . . . 0.0 106.617 170.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -119.09 148.98 42.44 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.922 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -80.87 113.21 18.92 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.946 0.898 . . . . 0.0 110.068 174.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.03 -12.4 60.32 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -100.01 -7.45 25.04 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.022 1.329 . . . . 0.0 114.041 -169.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 p -105.85 140.07 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.887 1.675 . . . . 0.0 111.285 -177.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.76 -30.73 70.19 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -174.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -77.35 -8.96 58.5 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.272 1.029 . . . . 0.0 113.592 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.8 m 48.63 39.01 12.51 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.746 1.618 . . . . 0.0 113.138 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.21 155.16 27.5 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -166.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.9 t -79.96 93.15 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 129.128 2.971 . . . . 0.0 108.192 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.4 pt -73.51 -23.62 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.174 1.39 . . . . 0.0 112.149 177.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -157.57 159.75 37.43 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.659 1.184 . . . . 0.0 112.014 175.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.3 p -141.68 151.12 42.73 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.821 -1.174 . . . . 0.0 114.125 -175.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -89.77 151.45 21.81 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.674 0.75 . . . . 0.0 111.653 166.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -65.92 -27.04 67.89 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.614 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.36 -50.07 48.72 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 121.156 -0.965 . . . . 0.0 112.778 172.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -29.86 66.96 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 118.845 1.323 . . . . 0.0 111.67 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.6 t -59.31 -39.83 84.29 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.597 -0.689 . . . . 0.0 110.466 170.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -77.75 -30.01 51.35 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 118.905 0.775 . . . . 0.0 112.857 174.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.4 tp -55.92 -52.1 65.3 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.15 1.38 . . . . 0.0 110.911 174.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 57.7 m -90.64 -20.85 22.06 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.16 9.98 84.41 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 126.557 2.027 . . . . 0.0 116.69 174.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -87.57 -120.25 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 119.558 1.679 . . . . 0.0 112.728 -175.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.1 t -159.86 138.63 10.68 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.772 1.629 . . . . 0.0 110.313 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -60.57 -32.64 71.72 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.328 1.051 . . . . 0.0 113.459 -175.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.14 -16.58 33.6 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.505 1.122 . . . . 0.0 113.645 174.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -97.1 -20.78 17.76 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.778 1.631 . . . . 0.0 112.46 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 m -89.92 -17.24 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 120.145 1.339 . . . . 0.0 113.134 -172.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 36.3 mmt -49.85 114.93 1.19 Allowed 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.221 1.009 . . . . 0.0 109.698 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 72.66 21.07 3.61 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.036 1.735 . . . . 0.0 114.355 171.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.05 154.03 88.65 Favored Pre-proline 0 N--CA 1.48 1.031 0 O-C-N 120.762 -1.211 . . . . 0.0 111.074 167.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.18 139.99 57.51 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.62 2.213 . . . . 0.0 111.645 173.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.8 t -69.95 -18.96 63.38 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.179 0.992 . . . . 0.0 112.991 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.0 m -61.39 100.1 0.12 Allowed 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 127.143 2.177 . . . . 0.0 111.614 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 68.3 m -50.44 -19.29 0.82 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 116.43 2.011 . . . . 0.0 116.43 -173.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -56.33 -36.31 68.59 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.036 -1.04 . . . . 0.0 111.635 172.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -57.58 -23.49 51.04 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.373 1.469 . . . . 0.0 113.391 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 pp -119.44 22.87 11.53 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.938 1.695 . . . . 0.0 113.162 176.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -63.25 147.1 51.96 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.379 -0.826 . . . . 0.0 111.993 173.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.72 -173.13 12.89 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 125.189 1.376 . . . . 0.0 113.219 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -62.35 -10.07 17.48 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 123.758 2.972 . . . . 0.0 116.406 -172.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -108.18 -9.34 15.57 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.902 1.681 . . . . 0.0 113.562 176.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.438 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 3.1 m -81.29 141.17 34.33 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.928 0.891 . . . . 0.0 112.153 -174.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -89.08 136.78 32.83 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 122.294 1.045 . . . . 0.0 111.512 171.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.4 mmm-85 -69.98 -39.69 75.78 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.363 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -53.23 -39.29 63.68 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 169.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.9 -52.84 54.31 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 122.221 1.01 . . . . 0.0 110.031 175.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.94 -33.86 77.03 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.882 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.02 -50.92 36.53 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.941 1.696 . . . . 0.0 112.271 176.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -50.2 -41.56 49.88 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.42 1.009 . . . . 0.0 112.306 169.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.7 mt -61.78 -49.9 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 O-C-N 121.653 -0.654 . . . . 0.0 111.001 171.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.07 -39.85 56.97 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.385 -0.817 . . . . 0.0 112.171 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -70.11 -34.88 73.67 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.695 0.798 . . . . 0.0 111.888 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.53 -31.45 69.67 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.656 -0.653 . . . . 0.0 111.744 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 mt -82.78 -32.24 27.84 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.537 0.735 . . . . 0.0 111.604 176.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.07 -33.1 74.72 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.868 2.067 . . . . 0.0 110.833 169.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.78 23.67 6.11 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.551 1.072 . . . . 0.0 115.031 168.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.75 -50.63 62.13 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.168 1.484 . . . . 0.0 110.218 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -151.77 143.41 23.6 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.389 2.276 . . . . 0.0 108.63 172.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -77.71 115.56 17.56 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.703 1.138 . . . . 0.0 108.188 169.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -138.96 137.73 36.67 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.592 1.157 . . . . 0.0 111.646 -168.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -87.03 129.63 34.81 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.177 1.791 . . . . 0.0 109.949 169.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.27 145.97 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.102 1.361 . . . . 0.0 109.355 -175.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -79.97 151.44 30.03 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.457 0.703 . . . . 0.0 109.846 170.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -163.0 147.13 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.06 0.944 . . . . 0.0 110.544 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.438 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -87.58 141.42 28.62 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.206 175.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -106.09 155.19 19.67 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.915 1.286 . . . . 0.0 111.231 169.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -121.83 138.29 54.44 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.796 0.838 . . . . 0.0 109.089 166.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -100.04 152.59 20.04 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.944 1.697 . . . . 0.0 110.504 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.92 -15.59 44.27 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 -171.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -78.28 -11.08 59.91 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.227 1.411 . . . . 0.0 113.72 171.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.86 2.53 56.15 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 126.203 1.859 . . . . 0.0 115.126 -174.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 55.3 m -74.77 128.21 35.01 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.866 1.833 . . . . 0.0 111.328 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 67.1 m -124.47 130.62 52.8 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.696 1.198 . . . . 0.0 111.443 -175.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -150.01 139.93 21.9 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.89 0.876 . . . . 0.0 113.013 -171.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.464 HD13 ' N ' ' A' ' 108' ' ' CYS . 2.2 tm? -110.36 134.79 51.96 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.673 1.989 . . . . 0.0 109.3 172.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.464 ' N ' HD13 ' A' ' 107' ' ' LEU . 2.1 m -138.95 171.64 14.02 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.502 1.521 . . . . 0.0 110.457 169.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 29.5 tp -76.88 59.87 1.68 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.199 0.999 . . . . 0.0 110.088 174.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.0 t -58.29 145.36 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.912 1.285 . . . . 0.0 110.516 -172.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -100.0 69.76 1.55 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.693 1.235 . . . . 0.0 111.277 -168.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.4 t -82.43 69.85 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.268 1.027 . . . . 0.0 110.526 -170.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.3 130.76 24.41 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.004 0.922 . . . . 0.0 110.948 -176.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -85.47 -169.72 0.64 Allowed 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 123.199 2.6 . . . . 0.0 111.888 -174.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.92 130.33 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-O 123.133 1.444 . . . . 0.0 113.947 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.4 mttm -112.82 162.4 15.83 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 127.655 2.382 . . . . 0.0 112.801 -175.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -93.17 -179.98 5.25 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.154 171.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.4 -21.69 65.57 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -70.63 -19.88 62.78 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.532 1.133 . . . . 0.0 113.727 169.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.51 0.32 59.44 Favored Glycine 0 CA--C 1.533 1.156 0 C-N-CA 126.112 1.815 . . . . 0.0 114.423 -176.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.75 139.39 30.61 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.64 1.22 . . . . 0.0 113.274 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.6 p -74.67 98.96 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.484 1.513 . . . . 0.0 109.856 -176.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.37 -30.01 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 118.345 -0.836 . . . . 0.0 110.833 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.9 mmt -136.59 150.04 48.37 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-O 123.85 1.786 . . . . 0.0 110.906 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -104.33 81.11 1.78 Allowed 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 125.564 1.545 . . . . 0.0 107.522 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 36.1 mt -100.44 70.74 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 O-C-N 120.481 -1.387 . . . . 0.0 109.211 172.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 127' ' ' LEU . 1.9 mm? -77.25 85.72 3.69 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 123.44 1.591 . . . . 0.0 109.384 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -60.0 103.05 0.19 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 112.877 -1.965 . . . . 0.0 111.007 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -85.54 62.71 7.65 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.518 -1.364 . . . . 0.0 111.799 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -79.71 131.33 35.92 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.185 -0.947 . . . . 0.0 110.372 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 50.5 t -92.95 114.6 30.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 124.58 1.152 . . . . 0.0 108.118 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.472 0.675 0 CA-C-O 121.331 0.586 . . . . 0.0 112.094 -175.565 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo . . . . . 0 CA--C 1.533 0.436 0 CA-C-O 122.729 1.054 . . . . 0.0 111.855 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -65.8 -27.08 68.0 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.989 0.915 . . . . 0.0 113.257 -169.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -70.02 -49.99 45.88 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.023 0.529 . . . . 0.0 110.325 -176.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.5 t -74.13 -35.31 64.09 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.724 0.81 . . . . 0.0 112.509 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -58.24 -41.48 84.27 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.318 0.647 . . . . 0.0 109.909 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.1 tp -75.49 -45.04 40.74 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 118.619 -0.705 . . . . 0.0 112.427 174.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -47.66 -39.81 18.18 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.713 1.605 . . . . 0.0 113.151 175.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.7 m -60.02 -45.16 93.71 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.88 -0.513 . . . . 0.0 111.679 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.5 mm -68.95 -34.77 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.941 0.897 . . . . 0.0 110.931 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.8 mm -54.67 -56.5 10.15 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 171.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -60.8 -27.05 67.73 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 176.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -63.2 -43.1 99.12 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.465 0.706 . . . . 0.0 112.228 172.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -104.66 -0.01 27.98 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 . . . . . 0 N--CA 1.477 0.887 0 C-N-CA 125.504 1.522 . . . . 0.0 113.751 -167.499 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.2 mptt . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 118.95 -0.548 . . . . 0.0 111.567 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -169.81 162.36 9.47 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -169.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -122.93 168.96 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 128.039 2.536 . . . . 0.0 111.217 171.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.0 mm -128.24 124.81 63.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 C-N-CA 126.219 1.807 . . . . 0.0 108.378 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.06 154.46 49.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -177.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -77.77 108.27 10.88 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.402 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.01 -19.52 63.32 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -94.84 2.38 55.45 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.701 1.201 . . . . 0.0 113.989 -169.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.49 140.07 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.32 1.448 . . . . 0.0 110.508 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.97 -23.82 65.63 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -86.55 -7.39 58.41 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.344 1.458 . . . . 0.0 114.23 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.0 p 42.92 43.38 3.51 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 126.945 2.098 . . . . 0.0 115.293 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.53 149.9 32.98 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 -167.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.0 t -80.03 89.98 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 128.584 2.753 . . . . 0.0 109.08 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.7 pt -69.96 -24.54 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.993 1.317 . . . . 0.0 112.453 175.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -153.58 159.62 42.22 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.804 0.842 . . . . 0.0 112.86 173.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.0 p -143.21 143.26 31.69 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.289 -0.882 . . . . 0.0 112.687 -177.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -89.67 155.12 19.44 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 173.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -66.93 -19.92 65.81 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.869 -0.519 . . . . 0.0 112.257 174.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.65 -49.91 55.83 Favored Glycine 0 CA--C 1.535 1.283 0 O-C-N 121.33 -0.856 . . . . 0.0 112.212 169.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -56.75 -39.23 73.62 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 119.04 1.42 . . . . 0.0 110.903 172.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.3 t -60.14 -41.3 92.43 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.922 -0.486 . . . . 0.0 111.321 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -77.1 -30.09 55.2 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.679 0.791 . . . . 0.0 112.663 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.18 -53.8 43.59 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.721 1.609 . . . . 0.0 112.174 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 82.7 m -101.12 -19.97 15.53 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.876 1.271 . . . . 0.0 112.787 -173.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.95 11.87 84.75 Favored Glycine 0 CA--C 1.539 1.541 0 CA-C-O 118.715 -1.047 . . . . 0.0 115.502 176.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -90.71 -122.13 0.07 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.956 1.378 . . . . 0.0 111.401 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.4 t -159.89 150.16 18.67 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.929 1.292 . . . . 0.0 111.095 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.0 mtt-85 -50.04 -43.9 51.16 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.576 1.15 . . . . 0.0 111.189 169.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.81 -19.12 64.78 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.378 1.071 . . . . 0.0 113.824 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -86.48 -20.56 27.91 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.473 1.509 . . . . 0.0 112.81 174.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.7 m -102.11 -18.99 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 174.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 5.4 mmt -49.81 107.47 0.15 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.509 1.523 . . . . 0.0 111.46 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 71.47 18.06 5.56 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.818 1.647 . . . . 0.0 113.85 171.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.55 157.12 72.81 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.039 0.936 . . . . 0.0 111.09 167.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.51 140.17 92.43 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.873 3.049 . . . . 0.0 112.879 169.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.3 m -62.95 -13.79 39.19 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 172.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.3 m -65.98 99.92 0.54 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.396 1.478 . . . . 0.0 110.911 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 32.0 p -53.32 -17.56 1.9 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.878 1.671 . . . . 0.0 115.004 -176.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -48.5 -42.88 34.32 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.925 1.29 . . . . 0.0 111.742 168.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -64.42 -16.19 61.93 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 pp -122.99 23.02 9.45 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.32 1.848 . . . . 0.0 113.432 173.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.27 144.57 57.06 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.224 -0.922 . . . . 0.0 112.568 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.54 173.16 22.67 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.067 1.318 . . . . 0.0 113.479 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.14 -9.99 25.6 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.485 2.79 . . . . 0.0 113.825 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.27 -4.69 25.29 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.192 1.797 . . . . 0.0 113.617 174.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.468 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 5.5 m -80.5 143.19 33.51 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 119.329 0.968 . . . . 0.0 111.889 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.2 mm-40 -92.97 145.24 24.52 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 123.453 1.597 . . . . 0.0 114.097 175.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.486 ' H ' ' HD2' ' A' ' 76' ' ' ARG . 1.2 mpt_? -70.11 -42.45 72.67 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 113.463 -1.699 . . . . 0.0 110.874 -175.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -60.05 -38.85 84.0 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.584 1.154 . . . . 0.0 113.5 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.42 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -63.69 -53.01 57.93 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.044 0.938 . . . . 0.0 109.972 174.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.73 -34.6 78.57 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.551 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.96 -53.29 18.45 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.951 1.301 . . . . 0.0 111.94 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -50.13 -41.6 49.08 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.18 0.9 . . . . 0.0 112.13 171.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 47.7 mt -63.8 -49.79 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 O-C-N 121.834 -0.541 . . . . 0.0 111.493 174.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.87 -39.81 54.77 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.167 0.587 . . . . 0.0 111.912 174.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -67.61 -39.56 84.73 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.553 0.615 . . . . 0.0 111.705 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.45 -27.16 65.01 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.833 -0.542 . . . . 0.0 112.162 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 mt -88.57 -31.53 18.59 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.235 0.614 . . . . 0.0 111.388 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.43 -36.11 79.44 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.31 1.844 . . . . 0.0 109.845 168.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 113.71 22.42 5.39 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.828 1.204 . . . . 0.0 114.821 171.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.24 -50.0 74.84 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 118.374 1.087 . . . . 0.0 111.399 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -159.73 148.6 17.7 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.448 1.499 . . . . 0.0 112.243 170.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -70.97 111.24 6.2 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 167.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -148.07 136.64 21.61 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.41 1.084 . . . . 0.0 111.392 -174.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -84.03 133.59 34.66 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.269 1.428 . . . . 0.0 110.606 171.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.61 146.3 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.434 1.494 . . . . 0.0 109.143 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -80.0 153.9 28.55 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.996 0.918 . . . . 0.0 110.598 172.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.42 HG23 ' HB1' ' A' ' 78' ' ' ALA . 0.6 OUTLIER -163.74 149.5 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.114 0.966 . . . . 0.0 111.428 179.177 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.468 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -90.47 145.32 25.0 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.483 174.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -116.64 162.28 17.89 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.632 1.173 . . . . 0.0 111.394 171.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -126.55 137.89 53.41 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.608 0.718 . . . . 0.0 110.59 167.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -92.83 157.59 16.31 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.288 1.835 . . . . 0.0 111.693 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -55.66 -30.55 61.21 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.103 1.761 . . . . 0.0 113.616 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.4 p30 -77.28 -9.89 59.09 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 175.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.51 -1.15 49.56 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 126.247 1.879 . . . . 0.0 115.298 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.4 m -70.1 130.86 43.25 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.35 1.575 . . . . 0.0 111.483 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 80.5 m -119.91 129.48 54.38 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.748 1.219 . . . . 0.0 110.969 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -151.03 140.01 21.01 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -172.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.436 HD13 ' N ' ' A' ' 108' ' ' CYS . 1.6 tm? -110.83 131.77 54.77 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 127.19 2.196 . . . . 0.0 108.144 168.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.436 ' N ' HD13 ' A' ' 107' ' ' LEU . 5.6 m -138.96 179.17 6.65 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.174 1.39 . . . . 0.0 110.93 170.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 76.9 mt -77.61 60.0 2.07 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.153 0.981 . . . . 0.0 110.763 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.6 t -60.57 142.29 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.739 1.215 . . . . 0.0 110.751 -173.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -102.91 69.72 1.06 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 122.076 0.941 . . . . 0.0 110.769 -168.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.5 t -83.56 69.76 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.835 0.826 . . . . 0.0 109.786 -169.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.47 134.31 24.83 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 124.745 1.218 . . . . 0.0 110.054 -174.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -87.55 -164.65 0.2 Allowed 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 123.083 2.522 . . . . 0.0 112.073 -172.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.7 m -124.93 132.94 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 122.922 1.344 . . . . 0.0 112.941 174.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -118.5 160.95 20.83 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.752 2.021 . . . . 0.0 111.794 -171.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -90.03 179.97 5.82 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.095 0.958 . . . . 0.0 111.976 172.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.72 -21.59 64.63 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -71.24 -19.92 62.31 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.615 1.166 . . . . 0.0 113.866 170.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.7 -1.87 60.12 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.791 1.662 . . . . 0.0 114.307 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -85.99 139.45 31.18 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.57 1.185 . . . . 0.0 113.25 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -74.41 100.02 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 125.828 1.651 . . . . 0.0 110.503 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.86 -30.06 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 118.194 -0.907 . . . . 0.0 111.367 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.8 mmt -136.27 148.33 47.95 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 123.517 1.627 . . . . 0.0 111.077 178.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -103.13 86.84 2.77 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.915 1.686 . . . . 0.0 108.088 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.8 mt -106.49 69.9 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 170.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.02 88.95 2.98 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.259 1.028 . . . . 0.0 108.748 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -59.82 107.03 0.55 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.151 1.381 . . . . 0.0 110.203 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -84.67 52.22 2.34 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 120.617 -1.302 . . . . 0.0 112.169 -176.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -79.89 106.9 12.25 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 123.793 1.759 . . . . 0.0 112.678 -176.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 22.3 t -64.17 112.52 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 125.802 1.641 . . . . 0.0 108.296 169.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.47 0.556 0 CA-C-O 120.832 0.348 . . . . 0.0 111.026 177.237 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo . . . . . 0 CA--C 1.535 0.558 0 CA-C-O 122.115 0.798 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -64.55 -26.59 68.48 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -168.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -69.97 -49.97 46.4 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.49 0.586 . . . . 0.0 110.585 -176.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.1 t -77.3 -33.41 55.68 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.133 0.973 . . . . 0.0 112.304 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -60.04 -41.02 91.35 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.667 -0.646 . . . . 0.0 110.184 172.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.2 tp -71.03 -45.11 64.5 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-O 118.696 -0.669 . . . . 0.0 112.041 172.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -47.68 -39.75 18.17 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.203 1.365 . . . . 0.0 113.279 173.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 90.2 m -60.16 -43.67 95.62 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.521 -0.737 . . . . 0.0 112.326 172.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.4 mm -68.59 -35.28 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.898 0.879 . . . . 0.0 110.938 175.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 26.2 mm -55.49 -54.5 24.83 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.483 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 171.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 55.5 mtm180 -60.32 -27.36 67.27 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.8 0.727 . . . . 0.0 112.959 176.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.3 tptt -65.09 -40.47 94.64 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 118.631 -0.7 . . . . 0.0 112.757 172.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -106.03 2.4 27.26 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 CA--C 1.551 1.001 0 C-N-CA 126.536 1.935 . . . . 0.0 114.266 -167.793 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.477 0.917 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -169.79 163.13 9.76 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -121.71 169.77 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.887 169.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.9 mm -123.2 114.65 42.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 126.069 1.747 . . . . 0.0 107.015 173.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.17 153.16 40.43 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.475 175.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -85.21 120.83 27.13 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.37 -9.62 59.34 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 46.0 mmm-85 -100.1 5.68 44.93 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.886 1.674 . . . . 0.0 114.246 -172.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.4 m -119.61 139.9 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 126.117 1.767 . . . . 0.0 111.73 -174.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.12 -24.4 65.01 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.85 0.86 . . . . 0.0 113.142 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.56 -12.3 59.95 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.169 1.388 . . . . 0.0 112.431 173.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.9 m 46.73 37.95 5.28 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.899 1.68 . . . . 0.0 112.782 -175.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.31 149.86 40.46 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -165.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.4 t -80.66 90.0 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 C-N-CA 128.667 2.787 . . . . 0.0 108.631 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.4 pt -69.95 -24.15 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.162 1.385 . . . . 0.0 112.207 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -155.62 159.82 39.93 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.802 1.241 . . . . 0.0 112.93 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.3 p -143.23 139.96 30.48 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.873 -1.142 . . . . 0.0 112.879 -175.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -83.73 157.98 21.94 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -61.26 -28.22 69.02 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.547 0.739 . . . . 0.0 111.429 171.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.58 -49.97 59.06 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.71 -1.05 . . . . 0.0 113.296 170.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.76 -40.6 69.52 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 120.064 1.932 . . . . 0.0 110.662 172.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.4 t -60.24 -40.65 90.98 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.625 0.37 . . . . 0.0 111.074 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -76.23 -29.62 57.61 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.965 0.906 . . . . 0.0 112.579 176.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.7 tp -64.28 -55.78 19.1 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.935 1.294 . . . . 0.0 111.733 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.1 m -99.59 -20.06 16.54 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.72 0.808 . . . . 0.0 112.794 -172.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.94 14.51 82.55 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-O 118.871 -0.96 . . . . 0.0 115.413 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -89.96 -128.79 0.08 Allowed 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 118.845 1.322 . . . . 0.0 111.762 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.9 t -159.95 150.19 18.6 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.635 1.974 . . . . 0.0 109.789 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.5 mtt85 -50.88 -40.37 56.27 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.329 1.052 . . . . 0.0 112.52 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.7 -21.2 62.63 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.351 1.06 . . . . 0.0 113.537 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -85.38 -20.96 29.08 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.638 1.575 . . . . 0.0 112.296 177.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -105.37 -20.03 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 5.8 mmt -49.97 107.76 0.17 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.845 1.658 . . . . 0.0 111.306 -174.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 70.24 18.4 6.89 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.383 1.473 . . . . 0.0 113.558 170.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.75 161.38 61.37 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 123.882 0.873 . . . . 0.0 110.553 167.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -56.19 140.06 86.79 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.992 2.461 . . . . 0.0 113.165 171.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 34.9 t -67.65 -10.05 48.76 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.128 1.371 . . . . 0.0 113.158 170.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -61.29 100.19 0.12 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 128.01 2.524 . . . . 0.0 110.866 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 33.8 m -50.03 -13.11 0.09 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.461 1.904 . . . . 0.0 115.903 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -52.79 -37.02 59.17 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.844 1.258 . . . . 0.0 111.776 167.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -55.83 -21.78 21.48 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.396 1.479 . . . . 0.0 113.343 171.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.13 20.03 14.6 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 127.611 2.364 . . . . 0.0 111.824 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -72.81 142.2 48.03 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.319 -1.488 . . . . 0.0 111.324 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.68 -170.11 11.99 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.665 1.602 . . . . 0.0 113.123 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -64.6 -10.13 23.29 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.29 2.66 . . . . 0.0 116.26 -170.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -110.07 -2.03 17.22 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.852 1.661 . . . . 0.0 114.415 175.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.503 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 6.0 m -78.53 137.83 38.1 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.704 1.138 . . . . 0.0 112.298 -175.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -82.58 132.22 35.2 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 122.636 1.208 . . . . 0.0 110.59 172.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.7 mmt85 -70.0 -39.9 75.61 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.185 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -56.87 -35.68 69.2 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.682 1.193 . . . . 0.0 113.599 169.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.48 -50.24 53.79 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.648 0.779 . . . . 0.0 110.907 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.32 -34.95 78.81 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.34 -53.01 27.03 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.832 1.253 . . . . 0.0 112.012 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -50.16 -40.8 47.69 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.39 0.996 . . . . 0.0 112.731 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 29.7 mt -63.82 -49.75 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 O-C-N 121.708 -0.62 . . . . 0.0 111.08 174.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.81 -39.94 59.6 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.565 0.621 . . . . 0.0 111.958 173.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -63.51 -39.82 95.43 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.243 0.617 . . . . 0.0 111.635 175.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.16 -28.75 66.7 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mt -84.07 -40.09 18.75 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 pp -66.02 -28.72 69.08 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 118.46 0.573 . . . . 0.0 112.212 169.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.75 18.91 8.55 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 119.031 -0.872 . . . . 0.0 113.965 169.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.27 -50.01 65.73 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 118.372 1.086 . . . . 0.0 110.303 169.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -162.69 129.97 3.68 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.924 1.689 . . . . 0.0 111.648 168.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -68.81 116.55 9.43 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.193 1.397 . . . . 0.0 108.633 172.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -151.73 142.93 23.29 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.851 1.26 . . . . 0.0 111.706 -169.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -83.72 130.69 34.96 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.449 1.5 . . . . 0.0 110.554 169.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.6 153.1 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.508 1.523 . . . . 0.0 109.077 -177.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -79.87 158.83 26.62 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.429 0.691 . . . . 0.0 109.477 170.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -166.71 150.16 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.437 1.095 . . . . 0.0 110.08 175.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.503 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -91.4 145.35 24.7 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.276 172.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -114.61 162.3 16.94 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.76 1.224 . . . . 0.0 111.276 172.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -132.13 140.06 48.65 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.831 0.852 . . . . 0.0 111.495 168.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.2 mtp-105 -88.68 166.66 13.94 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 125.296 1.439 . . . . 0.0 113.393 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -57.81 -33.25 68.39 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.04 2.136 . . . . 0.0 112.88 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -76.99 -9.86 58.98 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.814 1.246 . . . . 0.0 114.235 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.6 -1.3 59.99 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.573 1.559 . . . . 0.0 115.842 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.5 m -72.88 139.66 47.03 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.735 1.767 . . . . 0.0 111.139 176.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 29.3 p -136.01 140.05 43.59 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -178.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -150.89 142.02 23.13 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.378 1.071 . . . . 0.0 113.359 -172.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.499 HD13 ' N ' ' A' ' 108' ' ' CYS . 2.2 tm? -102.61 135.21 44.67 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.419 1.888 . . . . 0.0 109.763 169.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.499 ' N ' HD13 ' A' ' 107' ' ' LEU . 1.9 m -139.83 170.27 16.18 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.319 1.448 . . . . 0.0 110.246 167.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 28.7 tp -77.37 59.92 1.93 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.939 0.896 . . . . 0.0 109.603 172.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.1 t -57.1 147.65 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.959 1.303 . . . . 0.0 110.55 -172.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -99.84 69.68 1.58 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 122.951 1.358 . . . . 0.0 111.177 -169.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.3 t -83.3 69.86 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.571 1.149 . . . . 0.0 110.594 -169.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -121.9 129.03 25.32 Favored Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 123.57 0.748 . . . . 0.0 112.915 -174.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -88.15 -179.49 2.44 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.713 2.942 . . . . 0.0 112.669 -175.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.46 138.43 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 122.925 1.345 . . . . 0.0 114.018 -172.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -118.84 163.08 17.43 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 127.041 2.136 . . . . 0.0 112.38 -169.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -94.31 -179.98 5.1 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.204 1.002 . . . . 0.0 111.937 171.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.77 -21.35 64.49 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -71.41 -19.87 62.2 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.604 1.162 . . . . 0.0 113.893 170.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.12 5.61 60.67 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.6 1.571 . . . . 0.0 114.431 -176.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.89 139.58 30.38 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 118.362 1.081 . . . . 0.0 113.025 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.1 p -73.55 100.05 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.921 1.688 . . . . 0.0 110.641 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.12 -30.0 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.255 177.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 10.3 mmt -135.37 147.36 49.03 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 123.567 1.651 . . . . 0.0 111.347 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -103.95 79.97 1.7 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 126.477 1.911 . . . . 0.0 107.24 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.7 mt -99.96 73.14 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 122.398 1.094 . . . . 0.0 108.999 175.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.281 17.5 mt -77.89 86.62 4.11 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 122.752 1.263 . . . . 0.0 108.934 -178.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -59.84 103.18 0.19 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.094 1.757 . . . . 0.0 109.96 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -84.97 61.31 6.78 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 120.916 -1.115 . . . . 0.0 111.197 -177.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -79.75 128.27 33.21 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 121.949 0.881 . . . . 0.0 110.687 175.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.4 t -88.2 114.06 26.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 124.72 1.208 . . . . 0.0 108.128 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 121.084 0.468 . . . . 0.0 111.956 -175.723 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo . . . . . 0 CA--C 1.538 0.687 0 CA-C-O 122.278 0.866 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -64.74 -28.73 69.79 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -166.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -68.1 -49.82 58.77 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.287 0.635 . . . . 0.0 110.361 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 t -75.82 -35.43 60.02 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.932 0.893 . . . . 0.0 112.345 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -58.04 -41.82 84.08 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.509 0.724 . . . . 0.0 110.024 173.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.7 tp -73.12 -44.47 60.22 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 118.959 -0.543 . . . . 0.0 112.27 173.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -48.61 -39.91 25.61 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.798 1.181 . . . . 0.0 112.424 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.0 m -60.12 -42.89 95.73 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 121.52 -0.737 . . . . 0.0 112.434 173.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.7 mm -69.09 -30.59 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.228 1.011 . . . . 0.0 110.334 176.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.3 mm -60.02 -51.62 70.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 172.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.5 mmp_? -59.9 -30.08 68.78 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.728 1.149 . . . . 0.0 111.812 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -64.48 -45.55 86.89 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.789 0.836 . . . . 0.0 112.519 176.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -100.97 3.14 41.36 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 178.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 . . . . . 0 N--CA 1.476 0.856 0 C-N-CA 125.149 1.38 . . . . 0.0 113.313 -167.812 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 118.822 -0.608 . . . . 0.0 112.127 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -169.75 163.32 9.87 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 116.76 2.133 . . . . 0.0 116.76 -170.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -126.66 170.15 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 128.231 2.612 . . . . 0.0 110.682 174.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.6 mm -124.18 117.71 51.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 126.033 1.733 . . . . 0.0 107.727 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.81 153.94 40.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.661 1.219 . . . . 0.0 111.931 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -83.74 110.46 18.33 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.77 1.228 . . . . 0.0 110.292 176.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.84 -12.53 60.4 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -100.17 -5.21 28.11 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.81 1.244 . . . . 0.0 113.812 -169.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 p -109.24 140.0 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.715 1.606 . . . . 0.0 111.339 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.99 -23.95 67.69 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -175.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -85.29 -5.92 59.29 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.153 1.381 . . . . 0.0 113.723 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.0 p 44.27 32.86 0.74 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 128.005 2.522 . . . . 0.0 116.123 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.82 156.3 34.59 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 116.767 2.136 . . . . 0.0 116.767 -167.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.9 t -79.94 91.27 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.15 0 C-N-CA 129.354 3.061 . . . . 0.0 109.148 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.5 pt -69.93 -23.74 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 126.096 1.758 . . . . 0.0 112.991 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -155.9 159.94 39.73 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.768 1.227 . . . . 0.0 112.917 177.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.46 ' SG ' HG23 ' A' ' 59' ' ' VAL . 4.0 m -139.84 140.78 36.63 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.813 -1.179 . . . . 0.0 111.32 -169.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -93.31 153.46 18.55 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 169.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -65.18 -23.96 67.24 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 122.031 -0.418 . . . . 0.0 111.583 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.93 -50.0 46.27 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 119.191 -0.783 . . . . 0.0 112.515 169.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -39.55 83.35 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 119.454 1.627 . . . . 0.0 110.897 175.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 16.1 t -60.19 -40.8 91.27 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 121.665 -0.647 . . . . 0.0 110.758 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -78.67 -28.7 45.34 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.066 0.946 . . . . 0.0 112.473 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 52.8 tp -62.13 -55.78 25.44 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.786 1.234 . . . . 0.0 111.412 175.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 77.7 m -97.43 -20.2 17.94 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 -172.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.27 12.9 83.86 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-O 118.692 -1.06 . . . . 0.0 115.459 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -88.92 -124.3 0.05 Allowed 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 119.172 1.486 . . . . 0.0 111.095 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.9 t -159.97 150.16 18.52 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.312 1.845 . . . . 0.0 109.683 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -52.19 -37.52 55.07 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.429 -0.795 . . . . 0.0 112.432 171.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.0 -20.19 63.63 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -86.17 -20.84 28.0 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.599 1.56 . . . . 0.0 112.55 176.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.46 HG23 ' SG ' ' A' ' 44' ' ' CYS . 15.5 m -105.42 -17.37 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 125.229 1.412 . . . . 0.0 114.377 176.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 3.3 mmt -49.87 113.14 0.78 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.809 1.644 . . . . 0.0 111.223 -175.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 67.07 29.76 7.77 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.766 1.627 . . . . 0.0 112.378 169.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -106.74 154.0 40.38 Favored Pre-proline 0 N--CA 1.471 0.593 0 CA-C-O 117.283 -1.342 . . . . 0.0 112.606 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -48.64 135.25 27.5 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.576 2.85 . . . . 0.0 113.934 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 14.3 t -68.17 -9.79 49.43 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.296 1.038 . . . . 0.0 113.236 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.37 87.26 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.573 1.949 . . . . 0.0 110.848 175.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 26.2 p -54.48 -13.04 0.82 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.611 2.365 . . . . 0.0 114.733 -171.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.554 ' HA ' ' CG ' ' A' ' 70' ' ' HIS . 1.6 p30 -51.15 -22.9 2.81 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 167.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -53.49 -23.55 10.61 Favored 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 169.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.287 2.0 pp -123.14 24.0 9.0 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 170.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.554 ' CG ' ' HA ' ' A' ' 67' ' ' ASP . 1.8 m-70 -67.46 146.45 53.98 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.327 -1.483 . . . . 0.0 112.573 169.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.21 -178.95 23.37 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 124.955 1.264 . . . . 0.0 113.844 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.52 -9.99 24.59 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.591 2.861 . . . . 0.0 114.32 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -89.97 -10.15 46.11 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.009 1.324 . . . . 0.0 113.087 174.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.67 HG23 ' H ' ' A' ' 97' ' ' ALA . 3.0 m -84.16 143.63 29.52 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -168.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -84.55 138.36 32.79 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.651 1.215 . . . . 0.0 112.605 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.9 mmt85 -69.99 -39.99 75.58 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.51 -0.743 . . . . 0.0 111.208 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -57.59 -37.42 73.18 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.221 1.408 . . . . 0.0 113.822 170.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.9 -53.31 52.49 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.005 0.907 . . . . 0.0 110.055 173.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.86 -35.1 79.52 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.423 -0.808 . . . . 0.0 113.009 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.14 -54.1 20.42 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.173 1.389 . . . . 0.0 111.623 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -50.22 -40.83 48.65 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.212 0.914 . . . . 0.0 112.777 171.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.3 mt -63.74 -49.22 83.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 O-C-N 121.495 -0.753 . . . . 0.0 111.433 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.74 -39.99 59.43 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.346 0.521 . . . . 0.0 111.677 173.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -63.43 -39.96 95.88 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.347 0.659 . . . . 0.0 111.796 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.51 -30.3 69.08 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 176.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 mt -83.18 -35.52 25.42 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 pp -70.49 -27.87 64.54 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 118.326 0.512 . . . . 0.0 111.914 168.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.94 16.36 10.75 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.095 -0.836 . . . . 0.0 114.244 168.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.89 -49.82 65.12 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 118.265 1.033 . . . . 0.0 111.99 175.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -155.56 141.66 18.33 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.602 1.561 . . . . 0.0 111.649 171.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -79.31 110.15 14.32 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.199 -0.938 . . . . 0.0 109.164 170.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -155.88 145.27 20.87 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.312 1.045 . . . . 0.0 111.203 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -76.77 143.12 40.08 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.143 1.377 . . . . 0.0 111.638 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -136.49 145.32 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.995 0.918 . . . . 0.0 110.105 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -81.15 147.97 29.8 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.113 0.965 . . . . 0.0 109.99 170.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -158.46 156.93 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 110.27 -176.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.67 ' H ' HG23 ' A' ' 74' ' ' THR . . . -110.12 145.34 37.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.107 0.963 . . . . 0.0 112.41 175.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -130.61 156.14 45.37 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.821 1.248 . . . . 0.0 111.472 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -120.43 138.34 53.84 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.703 0.764 . . . . 0.0 111.913 168.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 28.3 mtp-105 -80.51 166.64 20.99 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.394 1.477 . . . . 0.0 112.847 177.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -56.56 -32.38 65.11 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.616 1.967 . . . . 0.0 113.109 175.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -78.25 -9.89 59.42 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 175.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.75 -1.09 58.04 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.693 1.616 . . . . 0.0 115.826 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 73.3 m -70.15 128.56 36.71 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 119.778 1.789 . . . . 0.0 111.036 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 45.5 t -128.65 125.61 38.43 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.717 1.207 . . . . 0.0 112.201 -170.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -150.96 149.68 29.9 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -171.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.01 125.27 46.04 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.596 1.958 . . . . 0.0 107.177 167.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.406 ' SG ' HG13 ' A' ' 131' ' ' VAL . 81.1 m -125.7 168.47 13.71 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.571 1.148 . . . . 0.0 110.31 169.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.25 59.89 2.93 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.652 -1.28 . . . . 0.0 110.244 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.0 t -63.06 147.48 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.811 1.244 . . . . 0.0 111.206 -172.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -103.58 69.74 1.0 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.724 0.774 . . . . 0.0 111.723 -168.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.4 t -83.22 69.75 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 121.339 -0.851 . . . . 0.0 110.965 -168.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.7 m -112.92 136.47 21.68 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 124.728 1.211 . . . . 0.0 110.368 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -86.13 -161.64 0.13 Allowed 'Trans proline' 0 CA--C 1.552 1.421 0 C-N-CA 123.105 2.536 . . . . 0.0 110.08 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.7 m -127.1 131.13 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-O 122.992 1.377 . . . . 0.0 113.062 172.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.1 pmtp? -122.01 160.04 25.75 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.947 2.099 . . . . 0.0 112.253 -176.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -90.07 -179.41 5.67 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.794 0.838 . . . . 0.0 111.499 178.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.88 -21.7 61.36 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -73.64 -19.91 60.72 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.713 1.205 . . . . 0.0 114.134 171.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.89 -4.28 63.07 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.47 1.51 . . . . 0.0 114.142 -176.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -79.84 129.25 34.32 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 118.26 1.03 . . . . 0.0 112.025 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.7 p -67.86 99.74 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 127.008 2.123 . . . . 0.0 110.509 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.97 -29.63 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.795 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.73 149.96 49.37 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 124.002 1.858 . . . . 0.0 111.713 174.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -103.01 80.03 1.82 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.149 -1.387 . . . . 0.0 107.797 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.0 mt -100.0 71.32 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 O-C-N 120.24 -1.537 . . . . 0.0 108.336 171.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.41 HD22 ' N ' ' A' ' 127' ' ' LEU . 1.8 mm? -74.33 86.86 1.99 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 123.362 1.553 . . . . 0.0 109.453 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -59.85 103.08 0.18 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 112.847 -1.979 . . . . 0.0 110.326 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -87.15 53.35 2.79 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 120.543 -1.348 . . . . 0.0 111.937 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -79.86 106.96 12.27 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 123.569 1.652 . . . . 0.0 111.868 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.406 HG13 ' SG ' ' A' ' 108' ' ' CYS . 3.4 t -59.85 118.91 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.435 1.494 . . . . 0.0 108.89 169.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.471 0.611 0 C-N-CA 122.463 0.305 . . . . 0.0 110.603 170.569 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo . . . . . 0 CA--C 1.536 0.617 0 CA-C-O 122.381 0.909 . . . . 0.0 111.817 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -63.12 -29.05 70.49 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -164.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -70.02 -49.98 46.0 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.096 0.862 . . . . 0.0 110.72 -176.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 t -77.05 -35.51 56.75 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.685 1.194 . . . . 0.0 112.392 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -57.04 -45.68 82.98 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.284 0.634 . . . . 0.0 110.143 170.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.6 tp -69.95 -42.28 73.43 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 118.549 -0.738 . . . . 0.0 111.237 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -50.01 -39.85 42.69 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.125 1.33 . . . . 0.0 113.073 172.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 58.1 m -60.13 -42.24 94.4 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.348 0.659 . . . . 0.0 112.503 171.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.1 mm -68.49 -35.35 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 O-C-N 121.204 -0.935 . . . . 0.0 110.023 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.5 mm -56.5 -51.14 68.71 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 CA-C-O 117.903 -1.046 . . . . 0.0 108.713 170.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -27.71 66.69 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.145 1.339 . . . . 0.0 112.906 175.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -66.78 -43.92 82.73 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.563 1.145 . . . . 0.0 112.449 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -107.91 7.61 28.11 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 . . . . . 0 N--CA 1.48 1.035 0 C-N-CA 125.39 1.476 . . . . 0.0 114.504 -167.526 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 119.199 -0.429 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -169.76 163.11 9.83 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 -172.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -121.29 170.83 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.277 1.431 . . . . 0.0 111.512 170.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.0 mm -123.48 116.99 49.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 126.154 1.782 . . . . 0.0 107.428 172.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.5 149.97 50.36 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -76.42 106.67 8.19 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.511 0.672 . . . . 0.0 111.445 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.6 -13.17 60.97 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -91.64 0.91 57.46 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.855 1.662 . . . . 0.0 114.117 -173.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.77 140.12 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.438 1.495 . . . . 0.0 110.943 -173.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -59.78 -26.6 65.85 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.95 -8.65 59.69 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.674 1.19 . . . . 0.0 113.937 177.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 27.1 p 36.46 51.34 0.85 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.241 2.217 . . . . 0.0 115.631 175.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.03 160.2 14.5 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -168.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.2 t -79.85 89.97 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 129.028 2.931 . . . . 0.0 109.071 -171.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.4 pt -69.95 -24.27 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.241 1.416 . . . . 0.0 112.201 175.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -155.35 159.71 40.15 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.197 0.999 . . . . 0.0 111.836 172.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.4 p -142.22 149.07 39.17 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -177.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -86.44 149.99 24.6 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.623 0.725 . . . . 0.0 111.559 168.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -67.87 -24.93 65.29 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.597 176.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.39 -50.0 49.18 Favored Glycine 0 CA--C 1.534 1.239 0 O-C-N 120.903 -1.123 . . . . 0.0 112.941 170.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -29.85 66.79 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 118.965 1.383 . . . . 0.0 111.376 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 23.2 t -60.04 -39.78 87.1 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.186 0.994 . . . . 0.0 110.2 172.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -78.21 -29.99 48.64 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.328 -0.857 . . . . 0.0 112.403 174.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.8 tp -56.44 -53.9 51.99 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.371 1.068 . . . . 0.0 110.602 174.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.8 p -80.01 -27.91 39.5 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.2 12.78 75.59 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 125.531 1.539 . . . . 0.0 115.986 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -89.04 -121.47 0.05 Allowed 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 119.552 1.676 . . . . 0.0 112.899 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.4 t -159.9 144.36 14.78 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.346 1.858 . . . . 0.0 109.981 -176.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.2 ptm85 -64.69 -30.02 71.03 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 120.891 -1.131 . . . . 0.0 113.593 -173.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.47 -16.76 39.7 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.211 1.005 . . . . 0.0 113.361 172.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -89.94 -20.57 23.19 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.532 1.933 . . . . 0.0 112.225 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 m -96.23 -19.98 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-N 119.243 0.928 . . . . 0.0 113.331 -173.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 35.3 mmt -50.01 115.71 1.52 Allowed 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.522 1.129 . . . . 0.0 111.014 -170.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 67.66 29.49 6.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.696 1.598 . . . . 0.0 112.862 169.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -100.81 151.63 37.65 Favored Pre-proline 0 N--CA 1.477 0.882 0 CA-C-O 117.756 -1.116 . . . . 0.0 113.716 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -54.54 135.28 65.82 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.262 2.641 . . . . 0.0 113.171 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 49.6 t -68.73 -12.54 61.56 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 126.349 1.86 . . . . 0.0 112.894 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -63.61 100.11 0.26 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 126.708 2.003 . . . . 0.0 111.046 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 30.2 p -49.89 -19.42 0.68 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.397 1.879 . . . . 0.0 115.614 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -48.13 -43.94 31.62 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.755 1.222 . . . . 0.0 111.939 169.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -67.06 -11.48 57.22 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 pp -123.1 20.04 9.9 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.95 1.7 . . . . 0.0 113.523 172.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -60.8 144.38 52.67 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.312 -0.868 . . . . 0.0 113.241 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.97 172.05 19.51 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 125.216 1.389 . . . . 0.0 113.074 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -65.92 -10.17 25.91 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.448 2.099 . . . . 0.0 116.062 -172.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 77.5 mtm-85 -110.1 0.05 18.18 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.765 1.626 . . . . 0.0 114.91 171.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 6.9 m -67.58 136.68 54.85 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.976 1.262 . . . . 0.0 111.305 175.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -82.64 132.81 35.18 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.581 1.181 . . . . 0.0 110.636 175.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -67.65 -39.79 84.59 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.585 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -41.37 63.5 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.432 1.093 . . . . 0.0 113.397 169.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.403 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -67.78 -49.98 59.52 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 124.44 1.096 . . . . 0.0 110.211 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.25 -33.41 75.75 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.301 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.04 -51.14 34.53 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.302 1.441 . . . . 0.0 112.495 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -49.94 -43.42 49.89 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.779 1.232 . . . . 0.0 111.223 170.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.4 mt -64.06 -49.16 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 121.895 -0.503 . . . . 0.0 111.256 174.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.01 -39.87 56.82 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.575 -0.726 . . . . 0.0 112.175 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -69.06 -38.07 78.86 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.582 0.753 . . . . 0.0 111.379 176.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.6 -33.02 74.73 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.446 -0.784 . . . . 0.0 111.496 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mt -82.62 -29.66 29.98 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.417 0.687 . . . . 0.0 111.9 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.26 -28.75 69.56 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.338 2.255 . . . . 0.0 111.001 169.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.98 18.22 8.99 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.043 1.306 . . . . 0.0 114.799 169.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.55 -49.99 74.45 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.63 1.215 . . . . 0.0 111.024 177.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -163.0 144.35 9.82 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.364 1.865 . . . . 0.0 110.98 169.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -72.07 117.59 13.88 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 167.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.5 tpp180 -149.31 137.23 20.49 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.446 1.098 . . . . 0.0 111.161 -176.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -76.79 127.42 32.72 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.216 1.006 . . . . 0.0 109.958 169.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -129.05 154.46 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.423 1.489 . . . . 0.0 108.863 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -79.9 160.12 26.13 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.221 1.008 . . . . 0.0 110.302 169.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.403 HG23 ' HB1' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -166.59 152.85 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.133 0.973 . . . . 0.0 111.115 169.759 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -85.88 145.32 27.23 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.122 174.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -115.39 163.03 16.31 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.345 1.458 . . . . 0.0 111.506 169.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -135.38 140.09 44.72 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.089 0.471 . . . . 0.0 111.799 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 19.4 mmm-85 -74.19 140.12 44.9 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 168.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -13.8 2.82 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -171.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -72.61 -9.99 59.26 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.198 1.399 . . . . 0.0 113.829 170.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.64 4.43 26.55 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 126.332 1.92 . . . . 0.0 115.467 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 52.6 m -86.5 100.23 12.23 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 118.838 1.319 . . . . 0.0 111.631 -173.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 25.2 t -106.33 137.84 43.59 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.107 1.363 . . . . 0.0 113.924 -172.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -150.99 146.05 25.97 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.439 1.496 . . . . 0.0 113.184 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -100.04 125.45 46.1 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.927 1.691 . . . . 0.0 109.233 170.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 78.2 m -129.6 173.6 10.45 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.048 1.339 . . . . 0.0 110.51 171.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 70.9 mt -79.88 59.84 3.29 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.006 -1.059 . . . . 0.0 111.403 -175.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 47.1 t -62.42 141.83 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.584 1.554 . . . . 0.0 111.426 -172.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -105.26 69.95 0.87 Allowed 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 122.486 1.136 . . . . 0.0 112.554 -168.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.8 t -81.18 70.77 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.071 1.348 . . . . 0.0 111.43 -168.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.8 p -120.5 129.28 25.4 Favored Pre-proline 0 N--CA 1.484 1.249 0 CA-C-O 118.408 -0.806 . . . . 0.0 111.945 -176.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -88.18 -166.61 0.27 Allowed 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.972 3.114 . . . . 0.0 112.435 -173.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -126.29 131.37 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 122.991 1.377 . . . . 0.0 113.415 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -119.01 159.95 22.92 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.081 2.153 . . . . 0.0 111.507 -172.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -89.89 -179.96 5.84 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.02 0.928 . . . . 0.0 111.935 174.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.18 -21.72 64.06 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -72.23 -19.89 61.64 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.698 1.199 . . . . 0.0 113.916 170.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.46 0.9 60.84 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.588 1.566 . . . . 0.0 114.238 -176.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -87.93 139.16 30.8 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.538 1.169 . . . . 0.0 112.937 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.7 p -77.99 98.34 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 125.142 1.377 . . . . 0.0 110.872 -174.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.63 -29.97 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.002 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.8 mmt -136.2 148.04 47.92 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 123.502 1.62 . . . . 0.0 111.122 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.7 m-30 -105.15 87.59 2.67 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 125.767 1.627 . . . . 0.0 106.733 -178.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 43.4 mt -103.83 73.76 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 122.574 1.178 . . . . 0.0 108.471 174.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.312 34.9 mt -80.62 84.06 6.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 123.208 1.48 . . . . 0.0 110.064 -176.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -59.87 104.74 0.32 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.018 2.127 . . . . 0.0 110.825 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -87.41 58.17 4.82 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 120.614 -1.304 . . . . 0.0 112.378 -175.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -79.79 106.89 12.14 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 124.772 2.225 . . . . 0.0 112.46 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 42.8 t -65.63 110.75 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 127.344 2.258 . . . . 0.0 109.218 174.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 179.477 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo . . . . . 0 CA--C 1.535 0.564 0 CA-C-O 122.446 0.936 . . . . 0.0 112.169 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -66.22 -26.52 67.41 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -169.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -69.99 -49.92 46.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.359 0.664 . . . . 0.0 110.39 -176.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.2 t -76.21 -34.53 59.27 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.04 0.936 . . . . 0.0 112.399 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -58.86 -41.77 87.81 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.693 -0.629 . . . . 0.0 110.29 172.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.5 tp -70.71 -45.52 64.8 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-O 118.76 -0.638 . . . . 0.0 112.072 173.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -47.47 -39.81 16.75 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.261 1.424 . . . . 0.0 113.213 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 85.5 m -60.09 -44.6 94.67 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.639 -0.663 . . . . 0.0 112.235 172.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.6 mm -67.31 -35.86 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.952 0.901 . . . . 0.0 110.661 175.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.9 mm -55.79 -54.38 26.98 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 CA-C-O 118.356 -0.83 . . . . 0.0 108.845 172.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 55.4 mtm180 -60.01 -28.44 67.73 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.115 0.871 . . . . 0.0 112.979 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.1 tttt -64.23 -41.16 97.13 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 172.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -105.77 2.99 28.35 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 N--CA 1.478 0.931 0 C-N-CA 126.6 1.96 . . . . 0.0 115.239 -167.14 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 118.988 -0.529 . . . . 0.0 112.15 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -169.79 161.31 9.08 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -171.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -120.08 172.15 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.548 1.539 . . . . 0.0 111.248 173.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.5 mm -130.01 117.79 42.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 125.621 1.568 . . . . 0.0 107.92 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.12 148.99 52.03 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -81.79 106.61 13.86 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.688 0.756 . . . . 0.0 110.539 174.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.23 -9.31 58.48 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -95.19 -5.79 43.14 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.639 1.176 . . . . 0.0 114.112 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.79 140.21 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.942 1.297 . . . . 0.0 109.952 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -56.1 -31.07 62.93 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -175.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -83.83 -9.1 59.01 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 73.7 m 45.33 51.18 9.59 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.045 1.738 . . . . 0.0 113.112 -177.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.23 153.08 22.27 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -167.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 67.5 t -80.07 90.04 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 127.957 2.503 . . . . 0.0 108.947 -178.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.7 pt -69.94 -24.21 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.648 1.179 . . . . 0.0 112.141 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -155.38 159.71 40.12 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.475 1.11 . . . . 0.0 112.237 175.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.4 p -139.88 150.94 45.23 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.925 -1.109 . . . . 0.0 112.76 175.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -83.66 156.13 22.81 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 175.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -61.15 -27.77 68.64 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.887 -0.508 . . . . 0.0 111.768 172.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.85 -51.62 44.06 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-O 118.99 -0.894 . . . . 0.0 112.727 169.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.42 -40.11 67.97 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.592 1.696 . . . . 0.0 110.404 174.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.1 t -60.27 -40.91 92.06 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.032 0.533 . . . . 0.0 111.725 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -75.7 -28.93 58.81 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.763 0.825 . . . . 0.0 112.453 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 50.7 tp -66.57 -55.71 14.18 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.206 1.402 . . . . 0.0 111.483 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 33.6 m -93.76 -20.9 19.68 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.092 0.957 . . . . 0.0 112.726 -173.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 72.25 11.57 75.63 Favored Glycine 0 CA--C 1.541 1.706 0 N-CA-C 116.027 1.171 . . . . 0.0 116.027 177.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -90.49 -118.15 0.07 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.239 1.519 . . . . 0.0 111.058 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.3 t -159.91 150.13 18.6 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.945 1.698 . . . . 0.0 110.518 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -55.06 -38.67 68.33 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.947 1.299 . . . . 0.0 112.148 178.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.1 -20.08 63.66 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.352 1.061 . . . . 0.0 113.61 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -82.35 -20.74 36.65 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.212 1.405 . . . . 0.0 112.123 175.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -105.36 -18.59 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 32.2 mmt -49.89 111.77 0.56 Allowed 'General case' 0 C--N 1.344 0.34 0 CA-C-N 119.637 1.108 . . . . 0.0 111.083 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 71.03 18.13 5.99 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.108 1.763 . . . . 0.0 113.652 170.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.49 162.07 70.01 Favored Pre-proline 0 N--CA 1.474 0.727 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.668 167.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -57.67 140.01 92.11 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.961 2.441 . . . . 0.0 112.648 170.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 32.4 t -67.56 -14.3 62.81 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.249 1.019 . . . . 0.0 112.617 171.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.0 m -64.65 100.1 0.36 Allowed 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 126.714 2.005 . . . . 0.0 110.585 176.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 29.6 p -51.58 -18.62 1.19 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.894 1.678 . . . . 0.0 115.402 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -48.71 -41.84 33.11 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.114 1.365 . . . . 0.0 111.375 169.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -56.29 -24.71 44.96 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.716 1.606 . . . . 0.0 113.355 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 pp -123.14 19.98 9.88 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.419 1.887 . . . . 0.0 114.084 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.76 150.46 47.84 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.916 -1.115 . . . . 0.0 113.375 -177.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -130.58 -173.07 13.27 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.799 1.19 . . . . 0.0 115.532 -169.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -68.95 -10.17 28.39 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.383 2.722 . . . . 0.0 115.876 -169.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.4 ttm-85 -109.98 -4.7 15.76 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.086 1.354 . . . . 0.0 113.284 171.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.535 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 3.2 m -75.43 136.64 40.71 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.451 1.023 . . . . 0.0 110.489 -177.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -80.39 132.77 35.81 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 122.738 1.256 . . . . 0.0 109.675 171.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -68.24 -39.75 82.19 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.514 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -53.08 -38.95 62.97 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.488 1.115 . . . . 0.0 113.87 169.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.42 -50.28 53.92 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.357 1.063 . . . . 0.0 110.707 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.48 -33.88 76.91 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.03 -51.47 31.95 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.859 1.264 . . . . 0.0 112.435 177.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -50.07 -41.87 48.87 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.659 1.183 . . . . 0.0 111.916 170.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 34.3 mt -63.65 -49.62 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 O-C-N 121.745 -0.597 . . . . 0.0 111.077 173.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.63 -39.8 51.39 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.208 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -69.43 -36.78 76.99 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.601 0.76 . . . . 0.0 111.685 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.35 -31.09 70.24 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.503 -0.748 . . . . 0.0 111.547 177.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mt -82.59 -31.76 28.79 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.437 0.695 . . . . 0.0 111.342 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.44 -29.75 70.99 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.112 2.165 . . . . 0.0 111.311 169.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.95 20.22 7.71 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.907 1.241 . . . . 0.0 114.929 169.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.23 -50.04 74.69 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 118.857 1.328 . . . . 0.0 110.79 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -163.66 144.98 9.14 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.464 2.306 . . . . 0.0 109.34 168.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -84.9 122.26 28.93 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.984 -1.073 . . . . 0.0 108.728 170.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.8 tpp180 -154.64 150.11 27.32 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.019 1.328 . . . . 0.0 110.537 -169.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -76.73 135.29 39.03 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 171.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -129.42 154.2 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.953 1.301 . . . . 0.0 108.66 172.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -79.83 160.12 26.22 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.084 0.953 . . . . 0.0 109.642 169.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -168.46 150.55 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.362 0.983 . . . . 0.0 110.945 169.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.535 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -89.54 145.36 25.33 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.937 173.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -112.29 159.78 18.3 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.459 1.503 . . . . 0.0 111.771 169.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -132.79 140.01 47.8 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.434 0.694 . . . . 0.0 111.102 169.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -82.47 160.24 22.72 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.938 1.295 . . . . 0.0 113.282 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -54.31 -30.74 52.11 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.613 1.965 . . . . 0.0 113.125 170.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -76.81 -9.95 59.03 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.121 1.368 . . . . 0.0 113.985 175.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.31 4.66 56.24 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 125.755 1.645 . . . . 0.0 115.886 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 58.7 m -87.94 132.26 34.29 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.061 1.431 . . . . 0.0 111.642 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 27.0 p -124.28 140.01 53.36 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.654 1.182 . . . . 0.0 113.529 -174.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -151.0 140.06 21.08 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.306 1.442 . . . . 0.0 113.29 -170.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.476 HD13 ' N ' ' A' ' 108' ' ' CYS . 2.0 tm? -110.16 136.12 49.88 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.916 2.086 . . . . 0.0 109.311 171.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.476 ' N ' HD13 ' A' ' 107' ' ' LEU . 1.6 m -142.28 178.69 7.39 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.318 1.447 . . . . 0.0 111.653 170.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -78.15 59.85 2.32 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.48 1.112 . . . . 0.0 110.192 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.4 t -60.45 146.76 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.975 1.71 . . . . 0.0 111.572 -171.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -102.25 69.71 1.15 Allowed 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 122.437 1.113 . . . . 0.0 112.981 -167.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.0 t -83.44 69.93 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.761 0.824 . . . . 0.0 110.052 -169.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 49.1 t -118.7 123.73 28.91 Favored Pre-proline 0 N--CA 1.484 1.26 0 CA-C-O 118.074 -0.965 . . . . 0.0 111.945 -169.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -81.37 179.91 5.47 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.534 2.823 . . . . 0.0 114.577 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.4 133.05 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.191 1.396 . . . . 0.0 112.928 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -118.74 166.65 12.51 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.421 1.888 . . . . 0.0 112.509 -169.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -96.79 -179.99 4.77 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.995 0.918 . . . . 0.0 112.029 170.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.0 -21.42 64.85 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -71.01 -19.87 62.46 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.574 1.15 . . . . 0.0 113.785 170.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.71 4.29 60.56 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.699 1.619 . . . . 0.0 114.432 -176.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -91.13 138.84 31.29 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.443 1.122 . . . . 0.0 113.014 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.06 100.18 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 126.123 1.769 . . . . 0.0 110.784 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.93 -29.51 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 118.805 -0.616 . . . . 0.0 111.915 173.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.63 147.87 51.5 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 124.248 1.975 . . . . 0.0 113.465 173.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -100.09 84.85 2.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 113.204 -1.816 . . . . 0.0 107.344 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 39.4 mt -100.02 69.99 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 169.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.5 mt -80.5 87.18 5.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.352 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -59.78 104.13 0.26 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.711 -178.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -83.91 49.94 1.72 Allowed 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.406 -1.434 . . . . 0.0 111.778 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -82.26 106.89 14.51 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 123.799 1.761 . . . . 0.0 112.846 -177.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 41.3 t -58.28 113.02 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 127.119 2.168 . . . . 0.0 109.286 170.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.472 0.647 0 C-N-CA 123.111 0.564 . . . . 0.0 111.359 176.083 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo . . . . . 0 CA--C 1.535 0.537 0 CA-C-O 122.362 0.901 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -65.47 -26.49 67.96 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.774 1.028 . . . . 0.0 113.774 -168.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -69.98 -50.03 45.74 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.508 0.594 . . . . 0.0 110.493 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 t -77.0 -34.58 57.51 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.17 0.988 . . . . 0.0 112.378 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -59.17 -41.65 88.93 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.073 0.549 . . . . 0.0 110.165 172.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.6 tp -70.95 -45.25 64.48 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-O 118.654 -0.689 . . . . 0.0 112.04 173.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -47.83 -39.81 19.46 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 120.154 1.343 . . . . 0.0 113.146 174.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.6 m -60.01 -44.32 94.66 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.64 -0.663 . . . . 0.0 112.282 172.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.2 mm -67.94 -35.38 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.978 0.911 . . . . 0.0 110.837 175.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.2 mm -55.71 -54.53 25.11 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.462 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 172.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 -60.81 -27.51 68.1 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.125 0.875 . . . . 0.0 113.163 176.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -63.81 -42.14 97.75 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.436 0.694 . . . . 0.0 112.386 172.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -106.09 2.33 27.07 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 . . . . . 0 N--CA 1.479 0.976 0 C-N-CA 126.352 1.861 . . . . 0.0 114.639 -167.389 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? . . . . . 0 N--CA 1.476 0.86 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -169.79 162.37 9.51 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -173.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -119.98 172.23 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.337 1.455 . . . . 0.0 111.344 173.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.4 mm -127.08 118.44 50.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 125.764 1.626 . . . . 0.0 107.498 172.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.72 145.36 51.92 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -79.37 106.47 11.42 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.524 0.678 . . . . 0.0 110.684 176.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.52 -7.06 51.82 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -176.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -99.97 -4.68 29.59 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.91 1.284 . . . . 0.0 114.272 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.12 140.26 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.234 1.414 . . . . 0.0 110.243 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -55.06 -26.32 36.81 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -174.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -92.98 -10.32 36.75 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.944 1.298 . . . . 0.0 114.286 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 93.7 m 47.03 55.76 7.62 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.166 1.786 . . . . 0.0 113.259 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.97 157.8 16.61 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 -168.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.6 t -79.95 92.69 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 128.696 2.798 . . . . 0.0 108.728 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.0 pt -72.44 -24.76 22.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.21 1.404 . . . . 0.0 112.228 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -156.84 159.81 38.57 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.272 1.029 . . . . 0.0 112.359 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.4 p -139.94 151.94 45.96 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.094 -1.003 . . . . 0.0 113.368 -175.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -89.2 149.93 22.9 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.711 0.767 . . . . 0.0 111.672 167.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -65.09 -31.15 72.22 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.378 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.22 -50.83 38.6 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 119.451 -0.638 . . . . 0.0 112.812 172.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -29.85 66.9 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 119.258 1.529 . . . . 0.0 111.766 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 13.9 t -60.05 -40.03 88.01 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.542 -0.724 . . . . 0.0 110.962 171.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -80.19 -30.1 38.72 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 121.432 -0.793 . . . . 0.0 112.828 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.4 tp -54.93 -54.35 43.87 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.666 1.586 . . . . 0.0 110.111 172.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.3 m -80.0 -31.12 39.71 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 122.542 0.337 . . . . 0.0 111.624 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.93 17.22 63.67 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 125.438 1.494 . . . . 0.0 115.672 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -98.72 -118.88 0.14 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.073 1.349 . . . . 0.0 112.349 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.1 t -159.84 142.65 13.75 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.863 1.265 . . . . 0.0 111.499 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -59.61 -33.35 71.38 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.637 1.175 . . . . 0.0 113.07 -177.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.76 -16.63 42.24 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.628 1.171 . . . . 0.0 113.211 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -96.67 -20.76 18.04 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.505 1.522 . . . . 0.0 112.561 177.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 m -90.75 -20.04 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 CA-C-N 120.315 1.416 . . . . 0.0 113.378 -175.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 36.1 mmt -51.17 114.47 1.21 Allowed 'General case' 0 C--N 1.339 0.135 0 C-N-CA 124.283 1.033 . . . . 0.0 110.218 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 73.72 20.46 2.99 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.453 1.901 . . . . 0.0 114.769 173.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.98 152.95 95.77 Favored Pre-proline 0 N--CA 1.479 0.982 0 O-C-N 120.6 -1.313 . . . . 0.0 111.304 167.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -62.13 140.02 81.55 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.518 2.146 . . . . 0.0 110.714 170.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 18.9 t -65.19 -11.8 44.52 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.59 0.756 . . . . 0.0 112.879 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.06 87.69 0.11 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.91 1.684 . . . . 0.0 110.152 170.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 22.7 p -50.86 -13.08 0.12 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.229 2.212 . . . . 0.0 114.802 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.483 ' HA ' ' CG ' ' A' ' 70' ' ' HIS . 22.8 t70 -46.45 -31.84 2.93 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.088 1.355 . . . . 0.0 112.505 167.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -55.47 -22.15 19.52 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 174.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 pp -122.96 20.82 9.95 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.528 1.931 . . . . 0.0 114.593 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.561 ' CG ' HG21 ' A' ' 74' ' ' THR . 2.1 m-70 -69.42 151.57 45.95 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 120.753 -1.217 . . . . 0.0 113.652 174.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -124.34 -173.37 13.81 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.715 1.626 . . . . 0.0 114.461 -172.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.71 -10.04 27.93 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.601 2.867 . . . . 0.0 115.24 -171.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.4 tpt85 -94.72 -10.05 32.85 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.68 1.192 . . . . 0.0 113.21 171.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.561 HG21 ' CG ' ' A' ' 70' ' ' HIS . 2.0 m -83.17 138.41 33.66 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -169.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -93.2 138.04 31.97 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.744 1.259 . . . . 0.0 111.71 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.6 mmm-85 -69.26 -39.79 78.2 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.773 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.3 ptt-85 -52.18 -39.47 60.12 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 169.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.41 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -65.22 -51.4 61.15 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 122.053 0.93 . . . . 0.0 109.971 174.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.84 -35.77 79.23 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.02 -52.09 26.94 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 126.171 1.789 . . . . 0.0 111.345 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -50.07 -40.76 46.39 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.589 1.086 . . . . 0.0 112.906 169.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 40.6 mt -63.46 -50.24 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 119.183 -0.437 . . . . 0.0 111.343 173.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.74 -39.89 59.27 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.713 0.688 . . . . 0.0 111.904 174.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -63.46 -39.06 93.45 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.517 0.727 . . . . 0.0 111.716 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.01 -29.5 68.52 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 174.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mt -82.44 -38.9 23.33 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 pp -68.99 -29.65 67.89 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 169.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.85 18.27 9.02 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.927 -0.929 . . . . 0.0 114.042 169.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.6 -49.88 69.38 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 118.77 1.285 . . . . 0.0 110.664 173.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -158.49 134.18 8.9 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.584 1.954 . . . . 0.0 109.777 167.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -74.54 120.47 20.14 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.143 -0.973 . . . . 0.0 108.454 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -143.3 136.78 28.31 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.397 1.079 . . . . 0.0 111.685 -168.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -81.37 130.19 34.93 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.469 1.108 . . . . 0.0 109.384 169.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -136.58 145.63 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.611 1.165 . . . . 0.0 109.333 -174.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.95 150.75 30.39 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.876 0.871 . . . . 0.0 109.714 169.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.41 HG23 ' HB1' ' A' ' 78' ' ' ALA . 0.6 OUTLIER -162.01 146.56 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.614 1.165 . . . . 0.0 110.083 -179.113 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.471 ' H ' HG23 ' A' ' 74' ' ' THR . . . -91.06 145.46 24.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.051 0.541 . . . . 0.0 112.263 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -122.26 157.75 30.99 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.539 1.136 . . . . 0.0 111.633 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -120.9 140.07 52.33 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.31 0.644 . . . . 0.0 110.415 167.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -95.52 162.28 13.71 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.246 1.418 . . . . 0.0 111.656 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -57.78 -29.09 64.57 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.359 1.864 . . . . 0.0 113.189 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -74.24 -9.95 59.12 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.82 1.248 . . . . 0.0 113.859 175.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.93 6.73 56.92 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.602 1.572 . . . . 0.0 115.561 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 63.4 m -87.51 137.99 31.86 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 118.812 1.306 . . . . 0.0 111.247 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 44.0 t -134.13 128.04 33.3 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.176 0.99 . . . . 0.0 112.598 -177.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -151.05 155.52 39.17 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -174.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.413 HD13 ' N ' ' A' ' 108' ' ' CYS . 1.9 tm? -99.91 131.66 45.74 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.668 1.987 . . . . 0.0 109.736 169.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.413 ' N ' HD13 ' A' ' 107' ' ' LEU . 56.8 m -135.13 168.07 19.82 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.643 1.577 . . . . 0.0 110.256 169.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.07 59.94 3.44 Favored 'General case' 0 CA--C 1.548 0.869 0 O-C-N 121.038 -1.039 . . . . 0.0 111.128 -175.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.8 t -59.85 147.88 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.261 1.424 . . . . 0.0 111.716 -171.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -105.19 69.67 0.86 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 122.475 1.131 . . . . 0.0 111.812 -168.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 19.9 t -82.54 69.96 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.213 1.005 . . . . 0.0 110.695 -169.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.6 p -117.26 130.0 24.94 Favored Pre-proline 0 N--CA 1.485 1.285 0 C-N-CA 124.202 1.001 . . . . 0.0 112.973 -171.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -82.21 -177.57 3.57 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 124.828 3.686 . . . . 0.0 114.488 -173.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.425 HG23 ' HB2' ' A' ' 124' ' ' MET . 15.7 m -123.69 124.72 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-O 123.08 1.419 . . . . 0.0 112.802 171.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -109.73 165.61 11.56 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.33 2.252 . . . . 0.0 112.27 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -95.17 179.91 5.03 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 114.781 -1.1 . . . . 0.0 112.244 170.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.65 -21.4 65.67 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -70.19 -19.93 63.15 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.575 1.15 . . . . 0.0 113.677 169.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.36 2.2 59.03 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 126.048 1.785 . . . . 0.0 114.489 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.03 139.59 30.49 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 118.506 1.153 . . . . 0.0 113.324 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.8 p -71.26 100.14 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 125.395 1.478 . . . . 0.0 110.542 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.54 -29.97 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.091 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.037 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.425 ' HB2' HG23 ' A' ' 115' ' ' VAL . 10.1 mmt -136.46 143.63 43.97 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 123.705 1.717 . . . . 0.0 111.081 177.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -100.15 87.69 3.52 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 125.381 1.472 . . . . 0.0 107.756 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 36.4 mt -102.27 69.92 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 169.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.9 mt -79.94 87.72 5.35 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 122.284 1.04 . . . . 0.0 109.55 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -59.84 109.03 0.84 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.002 1.321 . . . . 0.0 110.643 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -87.43 49.98 1.92 Allowed 'General case' 0 CA--C 1.533 0.315 0 O-C-N 120.571 -1.331 . . . . 0.0 111.75 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -79.85 106.97 12.26 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 123.838 1.78 . . . . 0.0 111.536 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 20.1 t -60.13 119.93 5.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 126.718 2.007 . . . . 0.0 109.179 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 120.761 0.315 . . . . 0.0 111.078 175.054 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 CA--C 1.534 0.513 0 CA-C-O 122.594 0.998 . . . . 0.0 112.107 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -66.57 -26.61 67.2 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.118 0.967 . . . . 0.0 113.208 -170.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -70.05 -49.86 47.0 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.526 0.73 . . . . 0.0 110.419 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 t -75.83 -33.87 60.08 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.954 0.902 . . . . 0.0 112.385 178.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -59.41 -41.17 88.84 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.743 -0.598 . . . . 0.0 110.438 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.6 tp -70.28 -44.84 67.56 Favored 'General case' 0 C--O 1.22 -0.447 0 CA-C-O 118.927 -0.559 . . . . 0.0 111.907 171.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -48.07 -39.7 20.93 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 120.003 1.274 . . . . 0.0 113.556 174.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.2 m -60.03 -42.58 94.68 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 121.704 -0.622 . . . . 0.0 112.289 172.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.5 mm -69.29 -34.15 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 O-C-N 121.113 -0.992 . . . . 0.0 110.857 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.9 mm -55.7 -54.32 27.42 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 169.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.92 -23.96 63.95 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.629 1.104 . . . . 0.0 113.436 175.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -68.62 -43.84 75.52 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.146 0.885 . . . . 0.0 112.495 171.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -102.75 0.26 32.63 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 . . . . . 0 CA--C 1.548 0.897 0 C-N-CA 127.044 2.137 . . . . 0.0 114.141 -168.684 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -169.77 163.38 9.83 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.499 1.519 . . . . 0.0 113.935 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -120.9 170.48 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.849 1.26 . . . . 0.0 112.129 171.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.0 mm -120.66 114.44 43.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 168.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.07 152.82 43.82 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.653 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -85.86 119.39 26.13 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.8 -11.69 59.91 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.538 0.735 . . . . 0.0 112.891 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -100.05 -1.51 36.74 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.186 1.394 . . . . 0.0 114.185 -171.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.8 m -104.27 140.14 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 127.053 2.141 . . . . 0.0 111.58 -177.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -64.59 -27.86 69.24 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.395 1.078 . . . . 0.0 113.11 -174.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -84.47 -6.89 59.42 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.431 1.092 . . . . 0.0 113.28 173.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 46.7 m 49.47 39.89 17.74 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.781 1.632 . . . . 0.0 112.666 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.41 149.93 43.83 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -166.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.4 t -80.01 90.03 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 129.323 3.049 . . . . 0.0 108.511 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.3 pt -69.98 -21.87 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.949 1.3 . . . . 0.0 112.343 178.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -158.99 159.71 35.13 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.051 1.34 . . . . 0.0 111.711 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.4 p -139.98 148.3 41.7 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 120.77 -1.206 . . . . 0.0 113.876 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -82.56 151.33 26.46 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.489 0.662 . . . . 0.0 110.704 166.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -66.48 -28.67 68.76 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.512 175.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.1 -50.79 54.05 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 121.267 -0.896 . . . . 0.0 112.867 173.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -29.85 66.92 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.202 1.501 . . . . 0.0 110.581 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.6 t -60.04 -39.77 87.09 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.555 0.742 . . . . 0.0 110.266 173.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -78.15 -27.92 48.22 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.016 0.926 . . . . 0.0 112.534 173.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.7 tp -60.65 -49.39 77.7 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.471 1.108 . . . . 0.0 111.462 175.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 26.9 p -79.97 -27.4 39.72 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 169.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.2 24.52 61.2 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 125.168 1.366 . . . . 0.0 114.515 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.3 m-30 -90.21 -129.96 0.09 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.154 1.382 . . . . 0.0 111.887 -177.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.7 t -159.9 150.16 18.65 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.604 2.362 . . . . 0.0 109.013 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 67.6 mtp85 -56.27 -43.05 78.4 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 121.059 -1.026 . . . . 0.0 112.112 -171.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.4 -18.12 63.37 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.741 1.216 . . . . 0.0 113.69 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -86.84 -20.72 27.08 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.116 1.766 . . . . 0.0 112.178 176.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.4 m -103.57 -20.2 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -177.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 33.8 mmt -50.0 113.64 0.9 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 124.084 0.954 . . . . 0.0 110.709 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 71.47 20.47 4.84 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.03 1.732 . . . . 0.0 113.744 169.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.52 160.12 75.68 Favored Pre-proline 0 N--CA 1.475 0.808 0 CA-C-O 118.145 -0.931 . . . . 0.0 111.557 167.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.09 140.05 91.63 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.732 2.288 . . . . 0.0 113.073 173.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 37.8 t -63.95 -17.7 63.52 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.592 1.157 . . . . 0.0 112.384 170.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.7 m -64.83 89.45 0.07 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.471 1.908 . . . . 0.0 110.795 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 26.8 p -52.95 -13.29 0.42 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.655 1.982 . . . . 0.0 115.127 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -46.35 -37.79 7.97 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.456 1.502 . . . . 0.0 111.416 166.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.83 -23.08 63.07 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.25 3.0 pp -123.13 28.15 7.28 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.205 1.802 . . . . 0.0 113.729 174.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.43 148.71 47.8 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.913 -1.117 . . . . 0.0 113.27 172.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.85 173.77 22.87 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.714 1.626 . . . . 0.0 114.603 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.56 -10.11 27.24 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.308 2.672 . . . . 0.0 114.152 -174.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -110.04 0.02 18.25 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.165 1.386 . . . . 0.0 113.879 170.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.525 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 18.6 m -71.42 139.0 49.53 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.726 1.148 . . . . 0.0 111.384 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -79.96 129.94 34.89 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 123.099 1.428 . . . . 0.0 109.59 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -70.16 -39.7 75.16 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.398 -176.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -56.63 -36.75 69.85 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 170.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.419 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -66.55 -51.7 53.6 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 122.029 0.919 . . . . 0.0 110.324 174.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.0 -33.27 75.66 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.449 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.01 -50.16 44.3 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.321 1.449 . . . . 0.0 112.18 177.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -49.99 -41.06 46.19 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.563 1.074 . . . . 0.0 112.09 169.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 20.9 mt -64.07 -49.68 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 118.518 0.599 . . . . 0.0 111.937 172.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.12 -39.83 44.27 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.453 0.57 . . . . 0.0 112.022 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -68.43 -39.35 81.56 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.376 0.67 . . . . 0.0 111.764 176.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.15 -27.75 65.83 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.836 -0.54 . . . . 0.0 112.157 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mt -88.02 -34.77 17.9 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.302 0.641 . . . . 0.0 110.538 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.58 -37.63 73.49 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.275 1.83 . . . . 0.0 110.142 168.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 117.46 22.43 4.07 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.691 1.139 . . . . 0.0 114.962 170.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.08 -50.0 75.03 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 118.644 1.222 . . . . 0.0 111.036 174.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -162.74 143.85 9.97 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.173 1.789 . . . . 0.0 111.145 169.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.45 118.4 13.21 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 168.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.9 tpp180 -151.75 138.35 18.73 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.61 1.164 . . . . 0.0 111.685 -173.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -80.63 128.72 33.94 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.693 1.197 . . . . 0.0 110.091 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.34 148.94 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.319 1.447 . . . . 0.0 108.813 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -79.94 157.13 26.96 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.061 0.944 . . . . 0.0 110.399 171.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.579 HD11 HG21 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -164.11 149.13 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.994 0.918 . . . . 0.0 110.629 171.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.525 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -84.36 145.39 28.25 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.726 176.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -117.0 156.2 27.89 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.523 1.129 . . . . 0.0 111.155 175.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -122.75 140.17 53.18 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.173 0.511 . . . . 0.0 110.263 168.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -91.01 146.32 23.95 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.769 1.228 . . . . 0.0 109.687 175.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -49.86 -30.51 10.09 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 126.728 2.011 . . . . 0.0 114.577 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -75.67 -9.82 58.92 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 109.91 28.11 4.32 Favored Glycine 0 CA--C 1.536 1.397 0 N-CA-C 115.905 1.122 . . . . 0.0 115.905 169.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.6 m -119.02 138.54 52.76 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.529 1.132 . . . . 0.0 111.229 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 32.0 p -135.99 140.03 43.61 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -150.93 148.62 28.63 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.837 1.255 . . . . 0.0 113.723 -173.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -99.98 120.94 40.6 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.471 1.509 . . . . 0.0 108.296 167.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 75.3 m -122.74 163.49 20.08 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.465 1.506 . . . . 0.0 109.579 174.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 67.4 mt -79.99 59.85 3.36 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.211 -0.931 . . . . 0.0 111.25 -175.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.555 HG21 HD12 ' A' ' 96' ' ' ILE . 14.5 m -65.2 144.82 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.6 1.96 . . . . 0.0 111.69 -173.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -107.68 69.85 0.76 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 122.42 1.105 . . . . 0.0 112.394 -167.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.579 HG21 HD11 ' A' ' 96' ' ' ILE . 12.8 t -81.37 69.92 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.762 1.225 . . . . 0.0 111.452 -168.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.49 131.99 24.32 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 124.317 1.047 . . . . 0.0 112.364 -175.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -86.18 -170.65 0.71 Allowed 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 123.544 2.83 . . . . 0.0 112.911 -172.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -123.17 129.85 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 122.868 1.318 . . . . 0.0 112.688 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -117.64 159.86 22.23 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.006 2.122 . . . . 0.0 111.277 -174.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -89.88 -179.8 5.81 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.947 0.899 . . . . 0.0 111.923 175.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.17 -21.77 64.09 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -72.45 -19.91 61.49 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.656 1.182 . . . . 0.0 113.884 170.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.54 0.55 60.89 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.622 1.582 . . . . 0.0 114.203 -176.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -87.35 139.39 30.6 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.465 1.132 . . . . 0.0 112.927 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.8 p -77.63 100.0 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 125.449 1.5 . . . . 0.0 111.114 -175.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.25 -30.0 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.71 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.89 150.0 49.19 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 123.997 1.856 . . . . 0.0 113.053 173.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -103.73 84.07 2.22 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 126.166 1.786 . . . . 0.0 107.475 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 44.3 mt -99.97 70.01 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 122.855 1.312 . . . . 0.0 108.697 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.277 22.0 mt -78.74 85.4 4.75 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 122.998 1.38 . . . . 0.0 110.051 -177.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -59.89 105.71 0.42 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.456 1.902 . . . . 0.0 110.143 175.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -86.13 53.97 2.98 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.559 -1.338 . . . . 0.0 110.017 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -79.76 106.66 11.94 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 124.168 1.937 . . . . 0.0 111.241 -168.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.7 t -61.19 112.34 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 113.452 -1.704 . . . . 0.0 108.242 177.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.467 0.381 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 175.789 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo . . . . . 0 CA--C 1.535 0.554 0 CA-C-O 122.164 0.818 . . . . 0.0 111.434 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -63.74 -27.5 69.24 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -168.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -70.01 -50.03 45.51 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.614 0.643 . . . . 0.0 110.473 -175.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.4 t -77.27 -34.4 55.72 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.433 1.093 . . . . 0.0 112.373 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -58.82 -41.98 88.11 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.036 0.534 . . . . 0.0 110.161 172.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.45 -44.18 68.32 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 118.82 -0.609 . . . . 0.0 112.07 172.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -48.92 -39.99 28.36 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.865 1.211 . . . . 0.0 112.316 175.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.0 m -60.18 -43.1 96.11 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.399 -0.813 . . . . 0.0 112.718 172.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.8 mm -67.94 -35.76 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 O-C-N 121.306 -0.871 . . . . 0.0 110.389 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.4 mm -55.72 -54.57 24.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 172.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -24.36 64.25 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.568 1.147 . . . . 0.0 113.383 177.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -69.44 -44.65 70.85 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.616 1.166 . . . . 0.0 113.557 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -105.54 4.15 30.12 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 . . . . . 0 N--CA 1.477 0.893 0 C-N-CA 126.473 1.909 . . . . 0.0 115.169 -167.69 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -169.93 160.18 8.23 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 -172.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 pp -119.92 166.07 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 127.637 2.375 . . . . 0.0 111.052 173.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.8 mm -130.78 118.04 40.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 125.206 1.402 . . . . 0.0 108.206 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.09 156.36 44.66 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -78.88 129.58 34.71 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 169.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.65 -11.87 52.76 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 169.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -94.37 0.4 55.47 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.949 1.7 . . . . 0.0 114.05 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.7 m -109.52 138.89 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 125.692 1.597 . . . . 0.0 111.153 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -63.86 -28.01 69.55 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.822 0.849 . . . . 0.0 112.941 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -81.92 -5.95 58.7 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.49 1.116 . . . . 0.0 113.671 175.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.0 p 45.06 37.41 2.5 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 127.028 2.131 . . . . 0.0 113.709 -175.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.05 150.01 40.86 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -167.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 64.7 t -79.99 90.91 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 129.454 3.102 . . . . 0.0 108.787 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.6 pt -69.99 -23.81 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.116 1.366 . . . . 0.0 112.267 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -156.41 159.72 38.97 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.346 1.058 . . . . 0.0 112.157 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.5 p -143.64 155.79 44.36 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 120.76 -1.212 . . . . 0.0 112.812 172.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -92.29 156.89 16.96 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -58.41 -29.05 65.79 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.708 0.803 . . . . 0.0 111.578 172.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.09 -49.83 41.66 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.416 1.008 . . . . 0.0 113.34 168.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.97 -38.48 76.11 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 119.343 1.572 . . . . 0.0 110.421 174.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.8 t -60.21 -39.86 88.11 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.881 -0.512 . . . . 0.0 111.051 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -74.71 -28.3 60.74 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 121.247 -0.908 . . . . 0.0 112.833 175.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.5 tp -66.85 -55.81 13.15 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.761 1.224 . . . . 0.0 111.594 177.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 64.2 m -98.77 -19.89 17.2 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.526 1.131 . . . . 0.0 113.054 -172.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.78 10.0 83.2 Favored Glycine 0 CA--C 1.541 1.696 0 N-CA-C 116.143 1.217 . . . . 0.0 116.143 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -89.21 -116.86 0.06 Allowed 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 119.072 1.436 . . . . 0.0 111.451 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.7 t -160.02 150.08 18.36 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.229 1.411 . . . . 0.0 110.948 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.9 mtp-105 -55.36 -40.78 71.7 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.402 1.081 . . . . 0.0 111.623 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.52 -19.15 63.33 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.489 1.116 . . . . 0.0 113.766 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -85.67 -20.65 29.1 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.966 1.307 . . . . 0.0 112.712 174.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.7 m -100.97 -20.05 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 174.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 30.2 mmt -49.91 113.24 0.8 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.423 1.089 . . . . 0.0 111.089 -177.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 71.49 15.74 6.08 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.839 1.656 . . . . 0.0 113.977 170.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.83 160.16 74.82 Favored Pre-proline 0 N--CA 1.475 0.803 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.414 167.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.03 140.1 85.92 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.801 2.334 . . . . 0.0 111.834 169.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.4 t -69.39 -12.58 61.77 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.807 0.843 . . . . 0.0 113.091 177.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.7 m -64.76 97.86 0.24 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.373 1.869 . . . . 0.0 110.731 177.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 31.8 p -52.67 -15.05 0.61 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.075 1.75 . . . . 0.0 115.134 -177.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -47.36 -38.98 14.06 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.746 1.219 . . . . 0.0 111.854 168.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.07 -19.76 63.27 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 pp -123.0 24.91 8.78 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.428 1.891 . . . . 0.0 113.045 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.53 145.67 53.69 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.308 -0.87 . . . . 0.0 112.419 174.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -110.8 178.97 19.98 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.532 1.539 . . . . 0.0 113.558 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.05 -10.07 27.73 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.493 2.795 . . . . 0.0 114.208 -177.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.25 -10.09 24.54 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.649 1.579 . . . . 0.0 112.582 172.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 97' ' ' ALA . 2.9 m -80.24 138.37 36.8 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.717 -1.239 . . . . 0.0 111.541 -175.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -87.64 135.26 33.44 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.384 1.088 . . . . 0.0 110.709 174.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.4 mmm-85 -66.26 -39.68 89.62 Favored 'General case' 0 C--O 1.219 -0.536 0 O-C-N 121.43 -0.794 . . . . 0.0 111.074 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -53.68 -38.34 64.1 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 171.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.38 -52.35 47.68 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.942 0.877 . . . . 0.0 110.027 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.55 -33.79 76.73 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.554 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.01 -52.19 26.16 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.859 1.664 . . . . 0.0 112.314 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -50.13 -42.02 49.88 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.455 1.025 . . . . 0.0 112.287 170.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 48.9 mt -62.94 -49.34 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 O-C-N 121.876 -0.515 . . . . 0.0 111.052 173.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.27 -39.93 57.8 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.592 -0.718 . . . . 0.0 112.114 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -68.68 -37.67 79.77 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.636 0.774 . . . . 0.0 111.477 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.37 -33.0 74.73 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.436 -0.79 . . . . 0.0 111.311 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 mt -82.06 -29.83 31.68 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.469 0.707 . . . . 0.0 112.119 177.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.3 -28.75 69.54 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.216 2.206 . . . . 0.0 110.766 168.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.95 17.66 9.44 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.196 1.379 . . . . 0.0 114.905 169.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.4 -50.04 67.01 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.648 1.224 . . . . 0.0 111.182 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -150.59 141.36 22.76 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.658 1.583 . . . . 0.0 111.621 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -79.59 104.02 9.9 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 166.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.7 tpt85 -145.11 136.79 25.43 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.242 1.017 . . . . 0.0 111.433 -171.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -82.02 133.04 35.26 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.572 1.549 . . . . 0.0 109.632 169.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.22 146.42 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.406 1.483 . . . . 0.0 108.9 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.01 153.86 28.57 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.644 0.778 . . . . 0.0 110.404 172.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -161.33 158.57 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.728 1.211 . . . . 0.0 110.537 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.516 ' H ' HG23 ' A' ' 74' ' ' THR . . . -100.09 145.44 27.95 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.671 0.789 . . . . 0.0 112.181 174.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -115.91 158.61 22.75 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.561 1.145 . . . . 0.0 111.041 169.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -127.44 137.46 52.71 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.519 0.728 . . . . 0.0 110.241 168.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -81.26 159.7 24.44 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.191 0.997 . . . . 0.0 112.611 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -55.43 -29.05 57.89 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.786 1.635 . . . . 0.0 112.979 171.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -80.02 -9.9 59.73 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.022 1.329 . . . . 0.0 113.774 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.37 0.69 53.74 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 126.106 1.813 . . . . 0.0 115.822 178.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.0 m -78.23 128.0 33.09 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.108 1.454 . . . . 0.0 111.741 -178.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 61.5 m -115.7 137.93 51.6 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.742 1.217 . . . . 0.0 112.317 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -151.03 139.92 20.92 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.429 ' HB2' ' HB2' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -116.25 121.37 41.83 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 127.091 2.156 . . . . 0.0 108.341 169.123 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 89.0 m -129.37 177.47 7.16 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.429 1.492 . . . . 0.0 110.218 169.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 25.0 tp -78.36 59.92 2.45 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.688 -1.258 . . . . 0.0 110.821 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 49.8 t -55.82 146.06 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.129 1.372 . . . . 0.0 111.194 -172.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -100.03 69.81 1.55 Allowed 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 122.948 1.356 . . . . 0.0 112.047 -167.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.3 t -83.84 69.84 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.37 1.068 . . . . 0.0 110.62 -169.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.77 134.99 23.52 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 124.989 1.316 . . . . 0.0 110.512 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -88.5 -166.41 0.26 Allowed 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 123.517 2.811 . . . . 0.0 113.153 -170.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.65 131.08 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-O 122.927 1.346 . . . . 0.0 113.628 173.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -116.99 160.25 21.23 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.18 2.192 . . . . 0.0 111.744 -173.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -90.02 179.99 5.82 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.065 0.946 . . . . 0.0 112.081 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.99 -21.46 64.87 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -71.2 -19.9 62.34 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.575 1.15 . . . . 0.0 113.819 170.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.08 3.55 60.35 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.599 1.571 . . . . 0.0 114.337 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.06 139.8 30.28 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.585 1.193 . . . . 0.0 113.053 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.2 p -74.34 99.95 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.868 1.667 . . . . 0.0 110.914 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.0 -29.63 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.565 0.746 . . . . 0.0 111.792 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.97 149.14 52.26 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 124.251 1.977 . . . . 0.0 112.626 173.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.2 m-30 -105.01 79.99 1.57 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.27 -1.787 . . . . 0.0 106.886 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 44.3 mt -100.59 70.41 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 169.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.09 89.23 3.6 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.923 0.868 . . . . 0.0 108.822 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -59.86 106.44 0.49 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.663 1.185 . . . . 0.0 110.797 -177.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -84.02 53.21 2.52 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.546 -1.346 . . . . 0.0 112.52 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -79.73 127.2 31.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 122.196 0.998 . . . . 0.0 111.109 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 65.6 t -81.14 117.76 27.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 125.169 1.388 . . . . 0.0 108.327 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.477 0.903 0 CA-C-O 121.416 0.626 . . . . 0.0 112.642 -178.691 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo . . . . . 0 CA--C 1.536 0.612 0 CA-C-O 122.388 0.912 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -65.47 -26.94 68.16 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -167.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -68.76 -49.99 54.15 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.672 0.789 . . . . 0.0 110.299 -178.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 t -74.55 -35.76 63.1 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.716 0.806 . . . . 0.0 112.114 178.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.06 -39.98 83.72 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.498 0.719 . . . . 0.0 110.423 174.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.2 tp -69.99 -45.83 66.46 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.984 0.514 . . . . 0.0 111.869 170.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -47.61 -39.78 17.78 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.974 1.261 . . . . 0.0 113.742 175.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 92.8 m -60.03 -41.69 92.77 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 121.579 -0.701 . . . . 0.0 112.371 172.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.2 mm -68.66 -35.29 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 O-C-N 121.154 -0.966 . . . . 0.0 110.219 174.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.5 mm -56.54 -51.65 62.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 CA-C-O 117.765 -1.112 . . . . 0.0 108.865 170.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -29.02 67.94 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.932 1.242 . . . . 0.0 112.255 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.9 tttp -66.69 -42.79 85.92 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.336 1.054 . . . . 0.0 113.055 174.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -103.65 1.91 32.55 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 . . . . . 0 N--CA 1.476 0.874 0 C-N-CA 126.183 1.793 . . . . 0.0 114.804 -167.875 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.483 1.207 0 CA-C-O 118.794 -0.622 . . . . 0.0 112.241 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -169.79 159.64 8.14 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 -175.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 pp -120.04 172.87 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 126.022 1.729 . . . . 0.0 111.036 174.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.5 mm -131.64 119.72 43.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 125.999 1.72 . . . . 0.0 107.781 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -137.49 152.33 49.41 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -175.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -76.91 107.92 9.58 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.6 174.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.07 -17.42 63.24 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -95.67 2.61 54.14 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.119 1.367 . . . . 0.0 114.034 -169.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.18 140.23 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.797 1.639 . . . . 0.0 110.109 -177.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -57.53 -28.37 63.42 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.18 -14.81 59.31 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.847 1.259 . . . . 0.0 113.982 178.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 82.7 m 43.87 50.67 6.97 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.5 1.52 . . . . 0.0 113.377 -177.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.51 150.02 21.95 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -166.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 98.3 t -79.84 90.0 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 128.011 2.524 . . . . 0.0 109.387 -175.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.5 pt -70.02 -23.75 25.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.837 1.255 . . . . 0.0 112.223 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -155.74 159.83 39.8 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.449 1.099 . . . . 0.0 112.329 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.4 p -140.01 154.69 47.2 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.809 -1.182 . . . . 0.0 113.227 173.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -85.94 153.48 22.16 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 174.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -63.29 -24.1 67.71 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.673 173.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.73 -49.99 45.07 Favored Glycine 0 CA--C 1.532 1.138 0 O-C-N 121.308 -0.87 . . . . 0.0 112.249 168.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -37.25 78.59 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 119.208 1.504 . . . . 0.0 110.852 175.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.2 t -60.09 -39.97 87.97 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.538 -0.726 . . . . 0.0 110.896 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -73.93 -30.04 62.35 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.541 0.736 . . . . 0.0 112.327 175.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.4 tp -64.72 -55.67 18.5 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.274 1.029 . . . . 0.0 112.18 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 78.1 m -97.68 -20.71 17.45 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -172.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.21 15.15 81.3 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-O 118.735 -1.036 . . . . 0.0 115.633 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -88.85 -124.26 0.05 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 119.129 1.465 . . . . 0.0 111.316 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.3 m -159.92 150.09 18.57 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.903 2.081 . . . . 0.0 109.719 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -57.07 -36.19 70.26 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.21 -20.68 59.84 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.886 1.274 . . . . 0.0 113.613 174.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -83.15 -20.89 33.9 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.743 1.617 . . . . 0.0 112.279 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -104.46 -19.29 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 177.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 33.4 mmt -49.99 115.4 1.39 Allowed 'General case' 0 C--N 1.343 0.286 0 CA-C-O 122.172 0.986 . . . . 0.0 110.877 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 72.2 17.67 4.93 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.713 2.005 . . . . 0.0 113.703 169.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.57 154.48 81.38 Favored Pre-proline 0 N--CA 1.473 0.697 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.339 167.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -65.41 140.16 62.42 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.983 3.122 . . . . 0.0 112.043 171.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 96.0 m -62.18 -10.0 9.31 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.4 m -65.24 96.47 0.22 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.198 1.799 . . . . 0.0 110.763 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 61.6 m -50.37 -20.01 0.99 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.629 1.972 . . . . 0.0 115.789 -171.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -46.56 -39.48 11.08 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.059 1.344 . . . . 0.0 112.395 169.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -60.98 -20.17 62.03 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 pp -122.98 23.73 9.21 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.885 1.674 . . . . 0.0 113.229 176.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -64.57 147.18 53.4 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.354 -0.842 . . . . 0.0 112.338 175.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.72 -169.69 11.88 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 125.574 1.559 . . . . 0.0 113.989 -176.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -64.68 -10.13 23.53 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.533 2.822 . . . . 0.0 116.378 -170.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.4 mmm-85 -104.96 -10.1 17.48 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.466 1.506 . . . . 0.0 113.601 174.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.469 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 2.9 m -79.21 133.09 36.69 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.228 0.922 . . . . 0.0 111.608 -169.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -85.2 137.03 33.26 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 122.409 1.1 . . . . 0.0 110.683 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -69.48 -39.69 77.53 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.948 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.9 ptt-85 -53.64 -40.31 65.74 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 169.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.4 -50.66 62.71 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.029 0.931 . . . . 0.0 110.261 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.82 -33.85 76.98 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.457 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.98 -51.89 28.82 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.239 1.416 . . . . 0.0 112.098 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -49.97 -41.91 47.69 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.594 1.158 . . . . 0.0 111.799 170.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.7 mt -64.38 -49.13 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 121.824 -0.547 . . . . 0.0 111.602 173.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.49 -39.94 49.7 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.859 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -70.3 -38.78 75.04 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.758 0.823 . . . . 0.0 111.734 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.42 -32.69 73.74 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.455 -0.778 . . . . 0.0 111.399 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mt -86.94 -27.98 23.01 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.814 0.846 . . . . 0.0 111.521 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.98 -30.19 70.76 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.579 1.952 . . . . 0.0 110.658 168.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.94 22.52 6.56 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.725 1.155 . . . . 0.0 114.319 170.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.33 -49.95 75.36 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.405 1.102 . . . . 0.0 109.81 171.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -166.95 141.36 3.93 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.786 2.435 . . . . 0.0 109.534 167.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -72.67 120.52 18.4 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.897 -1.127 . . . . 0.0 108.485 169.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 26.2 tpp180 -157.56 140.3 14.92 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.542 1.537 . . . . 0.0 110.243 -168.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -81.57 137.36 35.53 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.714 0.806 . . . . 0.0 111.628 175.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.0 t -137.83 150.09 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 126.55 1.94 . . . . 0.0 108.183 177.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -79.97 158.37 26.59 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.073 0.949 . . . . 0.0 110.573 171.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.52 HD11 HG21 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -164.29 152.56 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.526 1.13 . . . . 0.0 110.269 171.637 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.469 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -85.88 145.35 27.21 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.008 176.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.511 ' CE1' HD13 ' A' ' 96' ' ' ILE . 22.2 m-85 -117.31 162.04 18.55 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.822 1.249 . . . . 0.0 111.771 176.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -131.15 140.01 49.88 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.017 0.927 . . . . 0.0 111.5 168.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 24.5 mtp-105 -86.29 166.63 15.5 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.553 1.541 . . . . 0.0 113.088 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -58.15 -30.94 66.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.93 2.092 . . . . 0.0 112.839 174.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -78.06 -9.87 59.35 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.876 1.27 . . . . 0.0 114.047 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.65 -0.8 61.37 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 125.701 1.62 . . . . 0.0 116.003 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.0 t -76.46 140.87 41.43 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.799 1.799 . . . . 0.0 111.39 176.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 23.7 p -137.51 137.25 38.45 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -174.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -151.05 148.4 28.29 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.87 1.268 . . . . 0.0 114.256 -172.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -102.6 125.06 49.2 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.52 1.528 . . . . 0.0 108.337 167.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 67.7 m -128.11 166.27 18.79 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.264 1.426 . . . . 0.0 109.867 172.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 mp -80.05 59.81 3.39 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.071 -1.018 . . . . 0.0 110.238 -176.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.472 HG21 HD12 ' A' ' 96' ' ' ILE . 18.2 m -67.66 148.02 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.294 1.838 . . . . 0.0 111.623 -169.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -109.34 69.72 0.71 Allowed 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 122.545 1.164 . . . . 0.0 113.397 -166.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.52 HG21 HD11 ' A' ' 96' ' ' ILE . 10.8 t -80.62 69.8 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 125.093 1.357 . . . . 0.0 110.003 -171.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.7 p -123.79 130.79 24.31 Favored Pre-proline 0 N--CA 1.484 1.259 0 C-N-CA 124.922 1.289 . . . . 0.0 112.535 -169.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -83.05 179.92 4.85 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.237 1.958 . . . . 0.0 113.34 -174.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -123.18 135.62 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 123.089 1.424 . . . . 0.0 112.334 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.09 165.03 22.03 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.779 2.032 . . . . 0.0 112.152 -169.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -89.99 -177.04 5.09 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.139 1.376 . . . . 0.0 111.958 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.8 -19.96 65.41 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -80.04 -19.85 46.67 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.683 1.193 . . . . 0.0 113.087 170.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.35 8.98 59.52 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.345 1.45 . . . . 0.0 114.147 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -84.59 129.25 34.87 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.347 1.574 . . . . 0.0 110.802 175.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.29 99.99 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 125.82 1.648 . . . . 0.0 110.279 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.8 -29.96 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 118.402 -0.809 . . . . 0.0 111.263 176.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.6 mmt -138.0 148.5 45.22 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 123.835 1.779 . . . . 0.0 111.911 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -101.44 87.07 3.1 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 126.613 1.965 . . . . 0.0 108.307 175.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 40.9 mt -100.72 70.82 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 169.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.3 mt -78.65 84.92 4.72 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.801 0.81 . . . . 0.0 109.672 -174.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -59.9 109.74 1.01 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.072 1.349 . . . . 0.0 110.885 -176.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -85.2 49.86 1.83 Allowed 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.215 -1.553 . . . . 0.0 110.857 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -85.54 106.88 17.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 123.468 1.604 . . . . 0.0 113.412 -168.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.0 t -55.16 114.3 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 113.624 -1.625 . . . . 0.0 109.02 171.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.465 0.315 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 171.178 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo . . . . . 0 CA--C 1.536 0.577 0 CA-C-O 121.963 0.735 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -64.36 -26.87 68.66 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -167.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -69.31 -49.86 51.98 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.28 0.632 . . . . 0.0 110.303 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 t -78.69 -32.71 47.16 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.393 1.077 . . . . 0.0 112.883 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -55.26 -44.64 75.77 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.276 1.03 . . . . 0.0 109.594 168.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.7 tp -72.21 -45.22 61.17 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 118.594 -0.717 . . . . 0.0 112.135 175.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -46.73 -39.99 12.62 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.527 1.531 . . . . 0.0 113.349 173.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.4 m -60.0 -45.9 91.22 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.468 173.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.1 mm -68.1 -36.14 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.859 0.864 . . . . 0.0 111.235 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.3 mm -53.28 -57.65 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 172.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -63.43 -24.72 67.96 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.614 0.765 . . . . 0.0 112.946 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.7 tptt -61.63 -45.09 95.56 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 118.347 -0.835 . . . . 0.0 111.974 170.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -103.97 -0.18 29.22 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 116.177 1.918 . . . . 0.0 116.177 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 . . . . . 0 N--CA 1.477 0.895 0 C-N-CA 126.318 1.847 . . . . 0.0 115.736 -168.48 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 ptpp? . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -169.79 167.22 9.42 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.686 1.594 . . . . 0.0 114.212 -177.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 pp -120.04 169.41 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.722 1.209 . . . . 0.0 111.12 167.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.6 mm -125.54 117.94 50.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 126.058 1.743 . . . . 0.0 107.11 171.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.36 147.66 50.64 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -81.01 106.55 13.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.648 0.737 . . . . 0.0 110.644 175.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.88 -6.48 51.01 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 53.1 mmm-85 -100.05 1.85 42.75 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.798 1.639 . . . . 0.0 114.133 -177.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -108.96 140.22 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.381 1.473 . . . . 0.0 109.974 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -55.7 -29.92 60.22 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -175.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -83.89 -12.67 55.15 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 95.9 m 42.99 58.8 3.13 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.497 1.919 . . . . 0.0 113.518 -177.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.0 156.97 16.12 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -168.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.3 t -79.9 89.94 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 128.272 2.629 . . . . 0.0 108.858 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.7 pt -70.48 -25.39 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.857 1.263 . . . . 0.0 112.185 176.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -156.76 159.79 38.64 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.916 0.886 . . . . 0.0 112.701 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 7.9 p -145.34 147.58 32.46 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.209 -0.932 . . . . 0.0 113.289 -169.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -86.26 152.4 22.81 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.503 0.668 . . . . 0.0 112.537 169.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -61.98 -36.06 80.33 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.215 0.606 . . . . 0.0 111.252 171.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.0 -49.94 53.31 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 121.292 -0.88 . . . . 0.0 112.911 175.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -29.94 66.93 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 118.939 1.37 . . . . 0.0 110.823 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.9 t -60.18 -40.03 88.59 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.007 -1.058 . . . . 0.0 111.181 172.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -78.74 -30.02 45.55 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.977 0.911 . . . . 0.0 112.385 175.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.3 tp -55.17 -52.72 62.4 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.886 1.274 . . . . 0.0 110.244 171.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 57.5 m -80.03 -29.17 39.27 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.15 0.5 . . . . 0.0 112.316 176.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.29 26.07 58.13 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 125.376 1.465 . . . . 0.0 114.143 -173.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 16.1 m-30 -94.7 -130.11 0.14 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.881 1.272 . . . . 0.0 111.865 -173.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.0 t -159.88 140.38 11.98 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 127.117 2.167 . . . . 0.0 108.741 175.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.8 mtm105 -64.75 -31.33 72.51 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 120.92 -1.113 . . . . 0.0 113.246 -171.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.81 -16.66 29.98 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.023 0.929 . . . . 0.0 113.403 172.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -95.6 -20.82 18.67 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.476 1.91 . . . . 0.0 112.14 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.1 m -89.89 -18.12 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-N 119.489 1.04 . . . . 0.0 112.694 -174.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 33.6 mmt -49.73 115.42 1.36 Allowed 'General case' 0 C--N 1.341 0.204 0 C-N-CA 125.041 1.336 . . . . 0.0 110.486 -172.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 69.0 21.03 7.58 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.283 1.433 . . . . 0.0 113.62 169.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.72 155.1 93.87 Favored Pre-proline 0 N--CA 1.475 0.794 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.528 167.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.12 140.04 93.23 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.47 2.113 . . . . 0.0 111.649 169.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 37.4 t -64.36 -17.66 63.93 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.62 1.168 . . . . 0.0 112.914 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.6 m -62.61 99.98 0.17 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 127.09 2.156 . . . . 0.0 111.232 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 28.0 p -55.14 -14.17 1.54 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.446 1.498 . . . . 0.0 114.918 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -49.33 -40.06 33.82 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.778 1.231 . . . . 0.0 111.587 168.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -66.73 -11.0 52.77 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 pp -123.04 20.52 9.92 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.14 1.776 . . . . 0.0 113.744 170.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -63.74 144.38 57.08 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.136 -0.978 . . . . 0.0 113.084 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -109.15 175.87 19.36 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.691 1.615 . . . . 0.0 113.754 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.56 -10.05 27.89 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.445 2.763 . . . . 0.0 114.629 -175.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -103.14 -7.63 21.12 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.206 1.402 . . . . 0.0 113.696 170.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.472 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 5.0 m -70.85 134.58 47.44 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.536 1.062 . . . . 0.0 110.355 178.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -81.97 137.39 35.14 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.643 0.735 . . . . 0.0 110.2 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -66.35 -39.85 89.43 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.697 -0.627 . . . . 0.0 110.855 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.5 ptt-85 -55.59 -41.18 73.04 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.802 0.841 . . . . 0.0 113.008 171.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.429 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -64.56 -51.35 63.23 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.766 0.826 . . . . 0.0 110.364 177.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.44 -33.65 76.19 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.247 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.06 -52.77 21.25 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.762 1.225 . . . . 0.0 111.983 177.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -50.0 -42.18 48.64 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.719 1.208 . . . . 0.0 111.859 171.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 54.3 mt -63.8 -51.04 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 121.878 -0.514 . . . . 0.0 110.897 174.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.37 -39.9 58.1 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 118.604 -0.713 . . . . 0.0 112.116 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -69.09 -36.58 77.73 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.64 0.776 . . . . 0.0 111.601 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.49 -30.11 68.87 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.684 -0.635 . . . . 0.0 111.673 177.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mt -83.59 -31.33 26.36 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.565 0.746 . . . . 0.0 111.445 176.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.77 -30.08 71.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.249 2.22 . . . . 0.0 111.484 169.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.05 19.92 7.83 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.797 1.189 . . . . 0.0 114.953 169.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.89 -50.01 73.93 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 118.868 1.334 . . . . 0.0 110.5 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -162.8 141.47 8.63 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.608 2.363 . . . . 0.0 108.934 168.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -78.73 120.47 23.42 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.987 -1.071 . . . . 0.0 108.654 170.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.9 tpp180 -152.19 136.62 16.79 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.311 1.444 . . . . 0.0 109.857 -169.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -79.61 134.44 36.45 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.302 0.641 . . . . 0.0 110.578 173.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.29 148.2 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.645 1.578 . . . . 0.0 109.126 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -79.87 155.73 27.67 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.108 0.963 . . . . 0.0 110.381 172.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.429 HG23 ' HB1' ' A' ' 78' ' ' ALA . 0.7 OUTLIER -163.39 149.75 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.357 1.063 . . . . 0.0 110.858 179.749 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -87.14 145.37 26.46 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.844 176.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -112.3 145.69 39.55 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.032 1.333 . . . . 0.0 111.675 169.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.66 132.27 53.81 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.535 0.734 . . . . 0.0 109.394 167.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 28.7 mtp-105 -100.04 153.35 19.28 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.738 1.615 . . . . 0.0 112.881 -168.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -58.9 -29.44 67.05 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.688 1.195 . . . . 0.0 112.287 171.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -72.27 -10.03 59.25 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.471 1.508 . . . . 0.0 113.878 175.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.49 0.87 55.53 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.49 1.519 . . . . 0.0 115.397 177.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.51 148.72 47.92 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.85 1.325 . . . . 0.0 111.273 174.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 34.3 t -152.0 110.62 3.79 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.245 0.93 . . . . 0.0 111.421 175.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -151.0 151.75 32.52 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -173.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -102.2 126.43 49.17 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.421 1.889 . . . . 0.0 108.989 168.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 73.5 m -130.29 171.47 12.88 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.94 1.296 . . . . 0.0 110.618 170.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 mp -79.96 59.85 3.34 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 120.947 -1.095 . . . . 0.0 110.921 -175.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.0 t -61.28 140.68 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.179 1.391 . . . . 0.0 111.932 -170.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -101.59 69.78 1.24 Allowed 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 123.109 1.433 . . . . 0.0 112.447 -169.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.8 t -78.18 69.97 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.271 1.828 . . . . 0.0 111.481 -173.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.4 p -120.86 131.19 24.54 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.085 -1.009 . . . . 0.0 113.56 -171.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -85.58 -178.9 3.18 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 125.028 3.819 . . . . 0.0 115.578 -169.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.9 m -123.69 131.36 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-O 122.844 1.307 . . . . 0.0 113.048 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -115.4 163.05 16.29 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.876 2.07 . . . . 0.0 111.82 -171.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -95.64 -179.96 4.92 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.269 1.028 . . . . 0.0 112.009 172.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -61.82 -19.99 63.15 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -177.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -71.37 -21.59 62.0 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.529 1.132 . . . . 0.0 113.57 170.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.75 5.25 57.7 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 125.581 1.562 . . . . 0.0 114.695 -174.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -97.51 142.24 29.59 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.852 1.326 . . . . 0.0 113.581 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.7 p -71.12 100.16 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.955 1.702 . . . . 0.0 111.089 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.45 -29.25 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 118.631 -0.7 . . . . 0.0 111.68 174.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.35 147.59 51.83 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 124.277 1.989 . . . . 0.0 113.236 172.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -99.2 86.03 3.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 112.994 -1.912 . . . . 0.0 107.284 173.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 36.3 mt -101.43 70.0 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 122.834 1.302 . . . . 0.0 108.631 170.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.253 17.7 mt -80.27 83.57 6.09 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.118 -177.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -59.8 103.09 0.18 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.429 1.892 . . . . 0.0 110.443 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -83.32 57.41 3.98 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.679 -1.263 . . . . 0.0 112.593 -174.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -79.74 106.93 12.13 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 124.576 2.132 . . . . 0.0 112.265 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.1 t -61.19 110.39 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 C-N-CA 127.24 2.216 . . . . 0.0 109.051 170.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 120.805 0.336 . . . . 0.0 111.699 -179.753 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo . . . . . 0 CA--C 1.534 0.477 0 CA-C-O 122.614 1.006 . . . . 0.0 111.947 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -66.13 -26.65 67.54 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.106 0.962 . . . . 0.0 113.332 -169.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -70.06 -49.9 46.44 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.339 0.656 . . . . 0.0 110.399 -176.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 t -76.13 -33.92 59.42 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.992 0.917 . . . . 0.0 112.32 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -59.96 -40.79 90.23 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.196 0.599 . . . . 0.0 110.328 173.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.3 tp -70.64 -45.68 64.71 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 118.781 -0.628 . . . . 0.0 111.759 171.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.9 -39.78 19.95 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.04 1.291 . . . . 0.0 113.475 175.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 86.6 m -60.12 -42.09 94.04 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.701 -0.624 . . . . 0.0 112.434 172.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.1 mm -68.79 -35.18 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 121.112 -0.993 . . . . 0.0 110.454 174.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.9 mm -56.83 -50.89 73.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 CA-C-O 117.673 -1.156 . . . . 0.0 108.668 170.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.79 -27.76 66.85 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.527 1.512 . . . . 0.0 113.15 174.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -65.82 -42.03 91.11 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.832 0.853 . . . . 0.0 112.361 173.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -107.11 2.43 24.9 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 . . . . . 0 N--CA 1.478 0.948 0 C-N-CA 126.378 1.871 . . . . 0.0 114.311 -168.098 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 110.515 -0.18 . . . . 0.0 110.515 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -169.84 159.1 7.73 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 122.498 1.142 . . . . 0.0 112.899 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -123.91 171.56 12.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.755 173.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.4 mm -127.06 117.25 47.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 125.99 1.716 . . . . 0.0 106.772 174.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.12 148.83 50.6 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -80.74 106.45 12.76 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.388 0.614 . . . . 0.0 110.829 175.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.26 -6.48 53.27 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -96.1 -1.43 48.63 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.579 1.551 . . . . 0.0 113.797 -178.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -110.42 140.18 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.32 1.448 . . . . 0.0 109.951 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -57.4 -23.45 49.38 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -174.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -90.41 -10.53 43.5 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.381 1.472 . . . . 0.0 114.447 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 80.9 m 44.32 54.0 6.45 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.326 1.85 . . . . 0.0 114.663 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.03 158.52 15.77 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -168.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.8 t -79.93 89.97 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 128.624 2.769 . . . . 0.0 109.592 -172.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.4 pt -70.0 -24.46 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.256 1.422 . . . . 0.0 112.393 176.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -153.6 159.6 42.19 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.046 0.938 . . . . 0.0 112.276 174.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 10.0 p -147.27 142.54 27.3 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.038 -1.039 . . . . 0.0 113.268 -173.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -84.78 153.61 22.89 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -61.86 -29.82 70.44 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.757 0.423 . . . . 0.0 111.399 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.36 -49.92 43.01 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 123.945 0.783 . . . . 0.0 112.747 169.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -38.39 81.43 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 119.52 1.66 . . . . 0.0 110.644 175.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.6 t -60.18 -39.9 88.1 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.594 -0.691 . . . . 0.0 110.566 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -74.81 -30.02 61.28 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.339 0.655 . . . . 0.0 112.238 175.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 66.3 tp -63.83 -55.74 20.69 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.245 1.018 . . . . 0.0 111.83 177.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 59.9 m -95.68 -20.01 19.25 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.291 0.636 . . . . 0.0 112.661 -174.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.53 10.05 86.48 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-O 118.339 -1.256 . . . . 0.0 115.549 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -87.97 -121.73 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 119.46 1.63 . . . . 0.0 111.217 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.1 t -159.98 150.22 18.56 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.535 1.934 . . . . 0.0 109.96 -176.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -50.0 -41.13 46.41 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.259 1.024 . . . . 0.0 112.099 172.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.07 -19.94 63.47 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.321 1.048 . . . . 0.0 113.532 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -84.72 -20.71 30.73 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.635 1.574 . . . . 0.0 112.311 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -105.4 -18.84 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 125.66 1.584 . . . . 0.0 115.127 175.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 7.0 mmt -49.81 112.08 0.6 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.402 1.481 . . . . 0.0 111.647 -174.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 67.3 30.82 6.87 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.358 1.863 . . . . 0.0 112.745 171.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -106.75 154.85 39.87 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-O 117.599 -1.191 . . . . 0.0 112.984 177.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.86 137.59 60.75 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.282 2.654 . . . . 0.0 114.124 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 49.4 t -70.11 -9.94 57.14 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 125.427 1.491 . . . . 0.0 113.616 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.0 m -66.33 100.01 0.6 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 127.044 2.138 . . . . 0.0 111.671 -176.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 32.5 m -50.05 -13.2 0.1 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 127.031 2.132 . . . . 0.0 116.478 -176.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -53.7 -35.18 60.85 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.071 0.948 . . . . 0.0 111.607 168.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.9 -10.39 20.61 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 174.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.02 19.95 10.78 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.936 2.494 . . . . 0.0 111.08 178.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.52 138.43 45.03 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.589 -1.32 . . . . 0.0 111.905 177.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.72 -169.31 11.78 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.518 1.532 . . . . 0.0 113.57 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -61.23 -10.01 14.31 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 124.253 3.302 . . . . 0.0 117.049 -174.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -107.75 -10.01 15.68 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.943 1.297 . . . . 0.0 113.522 174.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.511 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 3.2 m -82.12 138.35 34.78 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.098 0.863 . . . . 0.0 112.109 -170.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -91.47 134.06 34.96 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 122.32 1.057 . . . . 0.0 110.75 176.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.5 mmm-85 -66.9 -39.71 87.51 Favored 'General case' 0 C--O 1.222 -0.394 0 O-C-N 121.65 -0.657 . . . . 0.0 110.593 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 46.7 ptt85 -51.39 -38.62 54.33 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 170.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.07 -50.71 38.32 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.523 1.129 . . . . 0.0 110.294 177.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.37 -33.85 76.43 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.465 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.06 -53.14 18.81 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.663 1.585 . . . . 0.0 112.22 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -50.14 -41.04 48.13 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.323 0.965 . . . . 0.0 112.514 170.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.8 mt -63.0 -49.69 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 121.684 -0.635 . . . . 0.0 111.368 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.3 -39.95 57.95 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.47 0.577 . . . . 0.0 111.944 174.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -62.97 -40.55 98.05 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.423 0.689 . . . . 0.0 111.723 175.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.49 -31.94 72.43 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 176.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 mt -84.16 -35.9 23.25 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -175.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 pp -69.63 -28.19 65.71 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.455 0.57 . . . . 0.0 111.693 168.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.88 14.77 13.02 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 119.078 -0.846 . . . . 0.0 113.986 168.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.69 -49.88 75.05 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 118.333 1.066 . . . . 0.0 111.216 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -160.3 129.99 5.18 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.859 1.264 . . . . 0.0 112.797 169.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -79.77 124.81 28.94 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.233 1.813 . . . . 0.0 109.084 173.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.1 ttp-105 -159.88 165.08 32.93 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.465 1.506 . . . . 0.0 110.999 171.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -76.73 137.07 39.11 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.7 0.8 . . . . 0.0 110.173 170.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.62 152.36 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.958 1.303 . . . . 0.0 108.917 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -79.89 160.04 26.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.325 0.65 . . . . 0.0 109.609 169.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.511 HD13 ' CZ ' ' A' ' 98' ' ' PHE . 0.2 OUTLIER -165.85 147.65 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.156 0.889 . . . . 0.0 110.64 168.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.511 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -90.39 145.43 24.95 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.009 173.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.511 ' CZ ' HD13 ' A' ' 96' ' ' ILE . 54.9 m-85 -118.17 157.2 27.39 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.0 0.92 . . . . 0.0 111.505 173.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -121.14 140.07 52.49 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.467 1.107 . . . . 0.0 110.443 169.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 24.7 mtp-105 -89.81 160.18 16.64 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.573 1.149 . . . . 0.0 111.379 175.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -21.23 65.01 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 172.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -75.24 -10.02 59.08 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.642 1.577 . . . . 0.0 113.61 172.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.81 6.75 67.1 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.384 1.468 . . . . 0.0 115.223 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.8 t -78.94 134.18 36.87 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 118.813 1.306 . . . . 0.0 110.817 175.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 60.8 m -131.61 128.95 40.23 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.635 1.174 . . . . 0.0 111.707 -172.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -151.04 142.72 23.68 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -174.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.429 HD13 ' N ' ' A' ' 108' ' ' CYS . 1.6 tm? -109.57 129.94 55.54 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.06 2.144 . . . . 0.0 108.504 168.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.429 ' N ' HD13 ' A' ' 107' ' ' LEU . 2.2 m -135.84 178.81 6.76 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.368 1.467 . . . . 0.0 111.605 172.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.5 mt -76.69 59.94 1.62 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.416 1.086 . . . . 0.0 111.129 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 36.4 t -61.28 145.16 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.936 1.295 . . . . 0.0 111.406 -173.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -104.16 69.68 0.94 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 122.274 1.035 . . . . 0.0 112.11 -168.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.0 t -83.5 69.91 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.744 0.817 . . . . 0.0 110.476 -169.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 44.8 t -117.12 123.33 30.2 Favored Pre-proline 0 N--CA 1.483 1.213 0 CA-C-O 117.723 -1.132 . . . . 0.0 110.603 -174.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -87.26 -170.36 0.59 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.479 2.786 . . . . 0.0 113.084 -175.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -123.53 126.78 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 123.018 1.39 . . . . 0.0 113.213 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.6 mtmt -112.26 161.12 16.95 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.588 2.355 . . . . 0.0 112.415 -176.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -92.23 179.98 5.41 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.663 -1.153 . . . . 0.0 112.19 172.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.41 -21.69 65.58 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -71.23 -19.89 62.32 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.558 1.143 . . . . 0.0 113.753 170.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.96 4.25 60.23 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.641 1.591 . . . . 0.0 114.322 -176.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -93.19 140.75 29.18 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.462 1.131 . . . . 0.0 113.132 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.14 100.01 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.486 1.514 . . . . 0.0 110.696 -174.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.56 -29.08 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 123.768 0.827 . . . . 0.0 111.795 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.88 148.45 52.29 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 124.111 1.91 . . . . 0.0 112.555 169.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -100.81 85.13 2.83 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.258 -1.792 . . . . 0.0 107.045 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 40.2 mt -99.98 70.04 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 122.86 1.314 . . . . 0.0 108.678 170.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.317 34.7 mt -78.59 88.55 4.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 123.356 1.55 . . . . 0.0 109.843 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -59.88 103.13 0.19 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.501 1.921 . . . . 0.0 110.139 173.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -87.19 50.99 2.12 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 120.683 -1.261 . . . . 0.0 111.85 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -79.97 106.86 12.3 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 124.182 1.944 . . . . 0.0 112.066 -176.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 32.6 t -64.43 114.3 2.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 126.813 2.045 . . . . 0.0 108.694 171.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.475 0.777 0 C-N-CA 122.633 0.373 . . . . 0.0 110.637 176.282 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo . . . . . 0 CA--C 1.536 0.578 0 CA-C-O 122.226 0.844 . . . . 0.0 112.449 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -59.97 -27.25 66.68 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 115.103 1.519 . . . . 0.0 115.103 -165.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -69.99 -49.86 47.34 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.851 0.751 . . . . 0.0 110.407 -176.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 t -76.71 -36.2 57.35 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.1 0.96 . . . . 0.0 112.225 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -57.93 -39.99 79.38 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.951 0.9 . . . . 0.0 110.506 172.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.1 tp -71.49 -44.78 64.09 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.047 0.539 . . . . 0.0 112.266 170.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -47.87 -39.93 20.14 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 120.004 1.275 . . . . 0.0 113.583 176.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.1 m -60.08 -42.6 94.93 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 172.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.1 mm -69.0 -33.96 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.077 0.951 . . . . 0.0 110.436 176.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.5 mm -56.97 -53.7 39.56 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-O 118.202 -0.904 . . . . 0.0 108.714 169.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -25.15 64.9 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.551 1.069 . . . . 0.0 112.924 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.4 tttt -68.8 -45.09 72.17 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.303 1.041 . . . . 0.0 113.443 171.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -100.07 0.28 40.5 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 . . . . . 0 CA--C 1.549 0.94 0 C-N-CA 127.3 2.24 . . . . 0.0 113.53 -169.455 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -169.72 162.49 9.69 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 123.339 1.542 . . . . 0.0 114.455 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 pp -128.35 170.25 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 127.238 2.215 . . . . 0.0 111.15 172.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.5 mm -127.23 120.05 54.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 126.389 1.876 . . . . 0.0 107.293 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.423 ' HB3' ' HB3' ' A' ' 125' ' ' PHE . . . -125.38 149.16 48.4 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 123.829 0.852 . . . . 0.0 112.553 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -81.14 108.82 15.12 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.519 0.676 . . . . 0.0 110.746 172.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.92 -15.73 63.11 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -100.07 3.02 43.79 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.947 1.299 . . . . 0.0 114.116 -169.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.71 140.13 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.36 1.464 . . . . 0.0 110.726 -176.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -60.09 -27.04 66.67 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -176.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -83.46 -10.22 58.51 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.771 1.229 . . . . 0.0 114.204 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 24.9 m 45.56 47.82 11.18 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.28 1.832 . . . . 0.0 113.449 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.97 152.25 26.81 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -167.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.7 t -79.98 90.0 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 127.914 2.486 . . . . 0.0 108.758 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.8 pt -70.03 -24.78 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.731 1.212 . . . . 0.0 112.462 178.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -153.7 159.62 42.07 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.015 0.926 . . . . 0.0 112.484 174.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.2 p -147.85 145.73 28.82 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.111 -0.993 . . . . 0.0 113.077 -175.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -93.03 159.46 15.3 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -64.01 -23.62 67.4 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.531 -0.731 . . . . 0.0 112.384 175.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.74 -50.03 62.91 Favored Glycine 0 CA--C 1.537 1.413 0 CA-C-O 119.015 -0.881 . . . . 0.0 112.669 169.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -38.33 68.74 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.529 1.665 . . . . 0.0 109.787 172.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.7 t -60.25 -39.98 88.65 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.808 -0.558 . . . . 0.0 111.128 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -74.99 -30.03 61.05 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 175.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.8 tp -64.85 -54.57 28.93 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.683 1.593 . . . . 0.0 112.193 178.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 84.0 m -92.8 -22.58 19.24 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.126 0.971 . . . . 0.0 112.431 -178.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.5 10.04 85.84 Favored Glycine 0 CA--C 1.539 1.573 0 N-CA-C 115.758 1.063 . . . . 0.0 115.758 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -93.94 -116.71 0.1 Allowed 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 118.735 1.267 . . . . 0.0 111.68 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.3 t -159.9 150.12 18.62 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.532 1.533 . . . . 0.0 110.719 -177.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.7 mtm180 -57.63 -36.36 71.72 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.662 1.185 . . . . 0.0 112.426 177.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.32 -20.77 63.32 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.182 0.993 . . . . 0.0 113.503 174.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -84.4 -20.77 31.33 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.118 1.367 . . . . 0.0 112.268 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.5 m -105.39 -11.83 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 10.4 mmt -49.86 107.37 0.15 Allowed 'General case' 0 C--N 1.34 0.191 0 C-N-CA 125.078 1.351 . . . . 0.0 110.427 176.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 68.13 22.43 8.31 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.729 1.612 . . . . 0.0 113.224 172.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.58 161.75 57.98 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 124.887 1.275 . . . . 0.0 110.682 168.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -60.45 137.42 74.04 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.7 2.267 . . . . 0.0 113.032 175.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 23.5 t -70.04 -19.83 63.28 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.509 1.124 . . . . 0.0 112.756 170.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -60.36 100.13 0.09 Allowed 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 127.927 2.491 . . . . 0.0 111.222 178.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 54.7 m -49.98 -13.25 0.1 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.829 2.052 . . . . 0.0 116.35 -176.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -55.11 -39.45 69.39 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.979 1.311 . . . . 0.0 111.26 167.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -58.38 -20.12 41.38 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.57 1.548 . . . . 0.0 113.094 172.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.14 20.0 18.85 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 127.498 2.319 . . . . 0.0 112.169 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -56.37 136.98 53.42 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.657 -1.277 . . . . 0.0 113.482 174.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -130.58 177.2 18.49 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 126.343 1.925 . . . . 0.0 111.687 168.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -64.21 -10.13 22.36 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.524 2.816 . . . . 0.0 115.603 -176.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -104.11 -9.95 18.35 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.739 1.615 . . . . 0.0 113.369 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.571 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 3.4 m -76.63 139.42 40.59 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.297 0.953 . . . . 0.0 111.996 -173.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -84.23 129.91 34.86 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 123.126 1.441 . . . . 0.0 109.847 175.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -70.19 -39.91 74.94 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.14 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -59.53 -35.69 74.68 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.27 1.428 . . . . 0.0 113.919 170.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.27 -50.78 64.45 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.427 0.691 . . . . 0.0 110.604 173.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.03 -33.37 75.89 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.22 -52.3 42.74 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.513 1.125 . . . . 0.0 112.192 176.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -50.16 -42.12 50.38 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.053 0.941 . . . . 0.0 112.66 170.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 35.8 mt -63.61 -48.69 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 O-C-N 121.588 -0.695 . . . . 0.0 111.021 174.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.03 -39.82 56.77 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.526 0.603 . . . . 0.0 111.831 173.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -67.84 -38.24 82.92 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.586 0.63 . . . . 0.0 111.952 175.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.99 -26.85 64.28 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.267 0.627 . . . . 0.0 112.565 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 mt -87.74 -33.63 18.63 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.304 0.642 . . . . 0.0 110.95 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -37.68 81.38 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.197 1.799 . . . . 0.0 110.009 169.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.02 26.37 4.98 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.796 1.189 . . . . 0.0 114.724 171.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.73 -49.93 74.45 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 118.685 1.242 . . . . 0.0 111.204 173.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -159.0 148.85 19.12 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.066 2.146 . . . . 0.0 109.52 169.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -81.31 117.79 22.09 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.998 -1.063 . . . . 0.0 108.567 172.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 -144.85 136.67 25.69 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.355 1.062 . . . . 0.0 111.623 -169.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -83.22 132.06 35.07 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.429 1.492 . . . . 0.0 110.053 171.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -136.41 151.11 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.444 1.498 . . . . 0.0 109.043 -177.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.73 157.09 27.23 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.275 0.63 . . . . 0.0 109.652 170.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -165.71 148.47 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.073 0.949 . . . . 0.0 110.675 176.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.571 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -87.11 145.32 26.49 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.585 175.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -112.65 160.45 17.88 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.213 1.405 . . . . 0.0 110.634 169.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -125.3 140.1 53.12 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.781 0.8 . . . . 0.0 111.079 169.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 17.6 tpp85 -84.39 150.38 25.38 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.147 1.779 . . . . 0.0 109.921 176.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -55.02 -28.98 56.32 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.992 1.717 . . . . 0.0 113.578 175.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -75.71 -9.95 59.02 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.025 1.33 . . . . 0.0 114.1 175.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.81 -0.04 39.21 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 126.205 1.86 . . . . 0.0 115.576 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 45.2 m -78.8 126.44 30.72 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 119.068 1.434 . . . . 0.0 111.566 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 67.4 m -114.83 134.52 55.06 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.244 1.017 . . . . 0.0 111.667 -176.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -149.97 139.95 21.96 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.979 0.912 . . . . 0.0 112.978 -170.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.477 HD13 ' N ' ' A' ' 108' ' ' CYS . 2.2 tm? -115.76 136.23 53.26 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.493 1.917 . . . . 0.0 110.104 176.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.477 ' N ' HD13 ' A' ' 107' ' ' LEU . 1.7 m -139.34 169.54 17.57 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.757 1.623 . . . . 0.0 109.931 168.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.4 tt -78.54 60.01 2.57 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 121.849 0.833 . . . . 0.0 109.31 172.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.1 t -52.99 149.2 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.962 1.705 . . . . 0.0 110.645 -174.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -99.79 69.74 1.6 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 123.172 1.463 . . . . 0.0 110.811 -168.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.8 t -83.2 69.95 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.677 1.191 . . . . 0.0 110.255 -170.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.85 131.24 24.23 Favored Pre-proline 0 N--CA 1.478 0.932 0 C-N-CA 124.05 0.94 . . . . 0.0 110.712 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -85.1 -168.67 0.53 Allowed 'Trans proline' 0 CA--C 1.551 1.348 0 C-N-CA 123.109 2.539 . . . . 0.0 111.481 -174.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.52 129.52 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-O 123.026 1.394 . . . . 0.0 113.656 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -112.1 162.16 15.73 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.666 2.386 . . . . 0.0 112.838 -176.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -92.85 179.96 5.31 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.499 1.12 . . . . 0.0 112.207 171.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.42 -21.69 65.6 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -70.85 -19.92 62.59 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.563 1.145 . . . . 0.0 113.738 169.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.6 -0.02 59.44 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.007 1.765 . . . . 0.0 114.358 -176.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.6 139.98 30.0 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.609 1.204 . . . . 0.0 113.246 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.7 p -75.97 99.96 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 125.515 1.526 . . . . 0.0 110.216 -175.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.04 -28.9 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.641 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.71 149.99 50.55 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 124.012 1.863 . . . . 0.0 111.922 173.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.423 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 2.3 m-30 -104.02 80.22 1.71 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.857 -1.52 . . . . 0.0 107.843 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.6 mt -99.98 71.15 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 120.611 -1.305 . . . . 0.0 108.789 171.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.419 HD22 ' N ' ' A' ' 127' ' ' LEU . 2.0 mm? -76.91 85.19 3.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 123.41 1.576 . . . . 0.0 108.878 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -59.91 103.8 0.24 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 112.958 -1.928 . . . . 0.0 109.931 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -85.81 59.12 5.44 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 120.69 -1.256 . . . . 0.0 111.784 -177.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -79.77 126.58 31.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 122.163 0.983 . . . . 0.0 110.908 175.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.5 t -81.99 113.2 20.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 125.225 1.41 . . . . 0.0 108.403 -178.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.474 0.749 0 CA-C-O 121.092 0.473 . . . . 0.0 112.077 -176.76 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo . . . . . 0 CA--C 1.537 0.628 0 CA-C-O 122.403 0.918 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -65.62 -27.13 68.18 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -167.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -69.17 -49.86 52.94 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.519 0.727 . . . . 0.0 110.385 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 t -75.52 -34.02 60.76 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.835 0.854 . . . . 0.0 112.405 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -59.92 -41.07 90.94 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.577 -0.702 . . . . 0.0 110.157 172.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.2 tp -70.85 -45.58 64.22 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.076 172.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -47.43 -39.83 16.55 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.238 1.415 . . . . 0.0 113.217 173.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 90.7 m -60.11 -44.02 95.15 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.615 -0.678 . . . . 0.0 112.205 172.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.5 mm -67.81 -35.7 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.834 0.854 . . . . 0.0 110.868 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.4 mm -55.62 -54.44 25.79 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 52.7 mtm180 -60.16 -29.38 68.63 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 118.981 0.809 . . . . 0.0 112.809 176.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.4 tptt -62.82 -42.42 99.72 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 118.676 -0.678 . . . . 0.0 112.265 173.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -104.51 1.64 30.06 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 178.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 . . . . . 0 N--CA 1.478 0.931 0 C-N-CA 125.834 1.654 . . . . 0.0 113.894 -167.717 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 119.342 -0.361 . . . . 0.0 111.82 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -169.77 155.4 5.83 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 123.975 1.845 . . . . 0.0 115.074 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -119.9 165.45 15.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 128.025 2.53 . . . . 0.0 110.167 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.8 mm -127.58 113.71 32.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.52 155.91 39.86 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.884 0.85 . . . . 0.0 112.142 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.9 t-20 -85.72 122.3 29.62 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 176.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.46 -9.18 59.77 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -100.03 6.09 45.06 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.974 1.31 . . . . 0.0 113.477 -173.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.8 m -114.08 139.16 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 126.728 2.011 . . . . 0.0 111.378 -177.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.52 -23.26 65.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.133 0.973 . . . . 0.0 113.456 -175.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -90.8 0.56 57.42 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.538 1.535 . . . . 0.0 113.399 174.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 27.8 p 42.08 46.92 3.8 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.969 1.707 . . . . 0.0 113.098 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.1 149.8 31.97 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -167.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.2 t -81.71 92.37 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 128.762 2.825 . . . . 0.0 109.009 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.6 pt -70.43 -23.14 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 126.195 1.798 . . . . 0.0 112.692 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -158.19 159.73 36.42 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.448 1.499 . . . . 0.0 112.592 174.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.5 p -147.08 154.4 41.12 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.406 -1.434 . . . . 0.0 113.322 173.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -96.23 157.46 15.89 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -59.36 -28.97 67.34 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.186 0.994 . . . . 0.0 112.006 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.86 -50.04 39.42 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.04 0.828 . . . . 0.0 112.918 169.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.92 -35.54 78.71 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 119.321 1.561 . . . . 0.0 110.706 176.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.0 t -60.04 -39.87 87.43 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.171 -0.956 . . . . 0.0 110.548 176.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -75.85 -25.69 56.46 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 174.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 53.4 tp -64.86 -55.74 17.64 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.089 0.956 . . . . 0.0 111.806 175.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.5 m -94.82 -21.15 18.88 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -174.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.73 22.6 78.14 Favored Glycine 0 CA--C 1.539 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 113.564 -169.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.6 m-30 -91.49 -130.1 0.1 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.288 1.435 . . . . 0.0 110.979 -176.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.5 t -162.11 150.17 14.67 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.794 2.438 . . . . 0.0 109.045 177.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.7 ttp180 -50.14 -40.88 47.69 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.751 0.82 . . . . 0.0 111.907 170.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.77 -20.81 63.98 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -87.41 -20.69 26.3 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.335 1.454 . . . . 0.0 113.069 175.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -104.73 -16.33 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 176.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.4 mmt -49.92 110.34 0.38 Allowed 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.424 1.489 . . . . 0.0 111.388 -177.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 71.13 17.05 6.18 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.472 1.509 . . . . 0.0 113.764 171.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.43 160.81 63.99 Favored Pre-proline 0 N--CA 1.475 0.812 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.397 166.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -58.48 140.08 93.2 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.539 2.159 . . . . 0.0 111.639 169.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.504 ' SG ' HD13 ' A' ' 86' ' ' LEU . 1.4 p -64.69 -10.0 23.92 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 169.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.0 m -64.49 93.42 0.1 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.218 1.807 . . . . 0.0 111.683 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 28.4 p -53.13 -14.27 0.62 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.337 1.855 . . . . 0.0 115.34 -176.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -48.13 -40.04 22.43 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.098 0.959 . . . . 0.0 111.565 167.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.85 -19.96 63.17 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 pp -123.1 23.8 9.1 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.476 1.91 . . . . 0.0 113.052 176.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -60.87 140.01 57.81 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.086 -1.009 . . . . 0.0 112.826 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -95.18 171.45 29.71 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.828 1.204 . . . . 0.0 113.325 175.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.0 -10.05 27.19 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.495 2.797 . . . . 0.0 114.446 -177.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -91.55 -9.27 44.9 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.492 1.917 . . . . 0.0 113.442 174.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.6 m -78.02 139.86 39.13 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.984 0.914 . . . . 0.0 112.428 -173.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -85.34 131.68 34.37 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.743 1.259 . . . . 0.0 109.946 168.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.6 mmm-85 -65.79 -39.66 91.18 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.866 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.22 -41.83 50.52 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 169.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.66 -51.23 61.15 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.311 1.044 . . . . 0.0 110.122 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.26 -33.81 76.66 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.729 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.04 -51.39 32.5 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.022 1.729 . . . . 0.0 112.662 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -50.01 -43.89 50.86 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.686 1.194 . . . . 0.0 111.062 170.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 51.2 mt -62.91 -49.52 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.118 174.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.08 -39.86 57.04 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-O 118.248 -0.882 . . . . 0.0 112.179 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -69.0 -38.51 79.3 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.895 0.77 . . . . 0.0 111.466 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.18 -34.85 78.97 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.557 -0.714 . . . . 0.0 111.949 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.504 HD13 ' SG ' ' A' ' 64' ' ' CYS . 3.0 mt -84.87 -24.66 28.43 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.393 0.677 . . . . 0.0 111.674 177.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.78 -30.04 70.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.788 2.035 . . . . 0.0 110.062 168.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.07 17.93 9.16 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.063 1.316 . . . . 0.0 114.84 169.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.94 -50.13 65.48 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.845 1.323 . . . . 0.0 111.126 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -151.94 141.54 21.75 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.843 1.657 . . . . 0.0 111.312 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -74.61 114.52 13.11 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 166.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -149.28 137.26 20.55 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.951 0.9 . . . . 0.0 111.557 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -84.84 130.44 34.66 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.585 1.554 . . . . 0.0 110.196 169.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.6 153.64 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.525 1.53 . . . . 0.0 108.896 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -79.88 160.04 26.19 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.278 1.031 . . . . 0.0 109.812 169.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -169.75 151.92 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.584 1.154 . . . . 0.0 111.129 173.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.48 145.42 25.31 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 174.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -115.15 162.07 17.54 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.968 1.707 . . . . 0.0 111.722 168.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -136.51 140.18 42.82 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.232 0.613 . . . . 0.0 110.792 168.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -84.69 152.43 23.76 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.332 1.053 . . . . 0.0 112.658 177.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -55.1 -25.14 29.51 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.968 1.707 . . . . 0.0 112.974 169.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.54 -11.12 60.72 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.395 1.478 . . . . 0.0 113.949 174.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.61 41.33 5.11 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.843 1.211 . . . . 0.0 114.833 175.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.0 t -136.71 141.71 43.07 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.499 1.12 . . . . 0.0 111.629 176.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 23.9 p -129.82 139.62 51.19 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.423 1.489 . . . . 0.0 113.508 -171.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -150.23 139.94 21.71 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.899 1.279 . . . . 0.0 113.457 -168.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.462 HD13 ' N ' ' A' ' 108' ' ' CYS . 1.6 tm? -108.44 134.34 51.36 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.918 2.087 . . . . 0.0 108.667 169.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.462 ' N ' HD13 ' A' ' 107' ' ' LEU . 1.9 m -140.0 179.11 6.8 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.292 1.437 . . . . 0.0 111.559 171.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.2 mp -78.23 60.0 2.4 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.652 1.181 . . . . 0.0 109.904 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 16.6 t -63.2 145.58 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.587 1.155 . . . . 0.0 111.261 -171.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -107.63 69.74 0.75 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.615 1.198 . . . . 0.0 112.055 -168.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.6 t -84.05 69.86 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.016 0.927 . . . . 0.0 110.886 -169.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.17 136.12 26.07 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 124.611 1.164 . . . . 0.0 111.253 -174.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -86.88 -169.17 0.48 Allowed 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 123.603 2.869 . . . . 0.0 113.361 -172.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -126.47 132.33 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-O 122.835 1.302 . . . . 0.0 113.689 175.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -111.87 166.62 11.05 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 127.042 2.137 . . . . 0.0 112.389 -174.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -97.23 179.95 4.72 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.272 169.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.78 -21.21 65.7 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -70.11 -19.85 63.21 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.583 1.153 . . . . 0.0 113.68 169.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.6 6.5 59.58 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.811 1.672 . . . . 0.0 114.458 -176.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -97.13 141.76 29.87 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.54 1.17 . . . . 0.0 113.594 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.8 100.01 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 126.0 1.72 . . . . 0.0 110.615 -176.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.02 -29.6 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.113 177.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.53 149.98 51.68 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 124.288 1.994 . . . . 0.0 112.646 173.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -104.52 79.89 1.62 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 113.222 -1.808 . . . . 0.0 107.41 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.1 mt -99.91 69.95 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 170.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.66 88.25 4.57 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.985 0.898 . . . . 0.0 108.828 -178.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -59.85 104.22 0.27 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.767 1.227 . . . . 0.0 111.419 -174.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -82.81 53.61 2.45 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.18 -1.575 . . . . 0.0 112.163 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -79.94 106.84 12.26 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 124.076 1.893 . . . . 0.0 112.782 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.1 t -64.77 111.81 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 127.002 2.121 . . . . 0.0 108.738 170.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.472 0.649 0 C-N-CA 122.758 0.423 . . . . 0.0 110.551 176.99 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo . . . . . 0 CA--C 1.536 0.592 0 CA-C-O 122.785 1.077 . . . . 0.0 112.737 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -59.91 -27.41 66.72 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -163.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -67.84 -49.95 59.35 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.731 0.696 . . . . 0.0 110.143 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.6 t -79.77 -35.19 39.02 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.59 1.156 . . . . 0.0 112.679 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -57.97 -39.88 79.25 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.567 1.147 . . . . 0.0 110.243 171.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.8 tp -74.84 -45.49 42.87 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 118.885 -0.579 . . . . 0.0 112.468 170.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -47.8 -39.82 19.31 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.845 1.258 . . . . 0.0 112.628 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 91.3 m -60.07 -42.58 94.84 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.538 -0.726 . . . . 0.0 111.875 175.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.4 mm -68.5 -33.66 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 123.839 0.856 . . . . 0.0 110.194 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.3 mm -59.33 -52.99 54.32 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.517 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 173.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -59.88 -29.21 68.16 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.477 1.111 . . . . 0.0 111.673 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -67.21 -42.11 84.63 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.813 1.245 . . . . 0.0 113.167 175.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -102.84 -0.01 31.96 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 CA--C 1.549 0.915 0 C-N-CA 124.711 1.204 . . . . 0.0 113.391 -166.311 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -169.81 162.99 9.7 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 123.312 1.529 . . . . 0.0 115.094 -171.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -126.57 168.93 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 127.951 2.501 . . . . 0.0 111.203 173.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.5 mm -129.99 120.08 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 126.224 1.81 . . . . 0.0 108.165 178.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.5 155.23 48.96 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -78.58 114.68 17.71 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.977 169.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.03 -17.47 58.78 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -178.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 -96.14 5.93 49.96 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.794 1.238 . . . . 0.0 113.831 -170.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.98 140.16 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.744 1.618 . . . . 0.0 110.694 -175.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -58.19 -29.46 65.67 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.054 0.942 . . . . 0.0 113.187 -176.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -82.73 -5.81 59.08 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.5 p 39.08 45.76 1.08 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.678 1.991 . . . . 0.0 114.646 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.02 149.96 26.63 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 -166.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.1 t -79.94 97.22 2.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 128.907 2.883 . . . . 0.0 108.221 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.6 pt -76.67 -24.02 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.556 1.542 . . . . 0.0 111.735 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -153.6 159.44 42.14 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.963 0.905 . . . . 0.0 112.398 171.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 9.1 p -149.29 143.58 25.93 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.971 -1.08 . . . . 0.0 112.901 -174.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -88.79 157.7 18.4 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 -178.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.48 -31.18 67.6 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.533 -0.729 . . . . 0.0 111.706 169.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.91 -49.81 57.21 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.052 0.834 . . . . 0.0 113.249 169.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -58.32 -37.67 75.58 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 119.05 1.425 . . . . 0.0 109.337 176.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.1 t -60.01 -40.28 88.74 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.108 0.563 . . . . 0.0 111.549 177.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -71.06 -30.29 66.4 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.323 -0.86 . . . . 0.0 112.524 173.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.4 tp -70.12 -44.95 67.91 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.103 1.361 . . . . 0.0 114.196 -177.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 2.2 t -99.57 -24.08 14.86 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.634 0.773 . . . . 0.0 111.869 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.11 10.73 86.0 Favored Glycine 0 CA--C 1.541 1.672 0 O-C-N 120.928 -1.107 . . . . 0.0 115.825 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -94.24 -114.71 0.11 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 118.975 1.387 . . . . 0.0 111.911 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.9 t -159.99 148.97 17.49 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.946 1.299 . . . . 0.0 111.818 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 86.7 mtm-85 -53.74 -41.44 67.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.819 1.248 . . . . 0.0 111.811 171.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.79 -19.52 62.6 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.613 1.165 . . . . 0.0 113.355 177.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -88.37 -20.67 25.01 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.037 1.335 . . . . 0.0 112.911 175.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.7 m -103.67 -3.55 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 35.6 mmt -49.93 114.48 1.09 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.136 0.88 . . . . 0.0 109.804 172.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 70.57 23.93 4.61 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.856 1.662 . . . . 0.0 112.885 172.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -101.32 152.06 37.88 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 124.523 1.129 . . . . 0.0 112.342 -176.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.26 140.07 57.4 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.168 2.579 . . . . 0.0 113.227 -174.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.4 m -67.31 -13.25 61.82 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 173.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.7 m -68.17 100.04 0.97 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.416 1.086 . . . . 0.0 110.853 -176.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 30.4 p -54.56 -13.35 0.94 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.607 1.963 . . . . 0.0 116.123 -173.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -55.85 -36.59 67.7 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.877 -1.14 . . . . 0.0 111.267 169.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -54.7 -24.86 23.91 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.272 1.429 . . . . 0.0 113.509 173.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 pp -123.1 27.71 7.49 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.985 1.714 . . . . 0.0 113.029 177.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -62.63 145.79 53.67 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.231 -0.918 . . . . 0.0 111.984 172.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -127.43 -176.72 14.57 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 125.3 1.429 . . . . 0.0 113.157 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -66.51 -10.14 26.71 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.726 2.284 . . . . 0.0 116.512 -169.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.5 ttm105 -110.08 -2.75 16.81 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.768 1.627 . . . . 0.0 113.865 173.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.486 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 3.7 m -78.52 140.35 38.56 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.053 -1.029 . . . . 0.0 112.047 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -90.22 133.05 35.16 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 123.221 1.486 . . . . 0.0 111.65 172.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.7 mmm-85 -69.19 -39.79 78.45 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.302 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -55.57 -38.5 69.44 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.875 0.761 . . . . 0.0 112.956 171.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.412 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -65.8 -51.21 60.91 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 122.119 0.961 . . . . 0.0 109.88 177.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.44 -33.52 76.07 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.837 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.01 -50.01 45.78 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.01 1.724 . . . . 0.0 112.798 177.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -50.17 -42.93 51.99 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.251 1.021 . . . . 0.0 111.372 169.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.4 mt -62.62 -47.71 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 121.798 -0.564 . . . . 0.0 111.605 172.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.28 -39.96 46.9 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.661 -0.685 . . . . 0.0 112.193 174.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -69.01 -38.27 79.14 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.652 0.781 . . . . 0.0 111.551 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.1 -33.17 75.18 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.374 -0.828 . . . . 0.0 111.571 177.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mt -81.59 -29.99 33.15 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.668 0.787 . . . . 0.0 111.987 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.83 -28.72 69.19 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.393 2.277 . . . . 0.0 111.125 169.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.98 17.94 9.21 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.972 1.272 . . . . 0.0 114.873 169.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.36 -49.99 75.39 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.554 1.177 . . . . 0.0 111.495 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -161.39 152.63 18.64 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.517 1.527 . . . . 0.0 112.246 171.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -77.65 110.68 12.69 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 168.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.5 tpp180 -151.0 139.03 20.03 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.461 1.104 . . . . 0.0 110.949 -174.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -76.76 137.19 39.15 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.724 0.81 . . . . 0.0 110.342 170.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.11 148.75 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.772 1.229 . . . . 0.0 109.072 173.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.93 155.48 27.7 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.824 0.85 . . . . 0.0 110.294 171.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.412 HG23 ' HB1' ' A' ' 78' ' ' ALA . 0.3 OUTLIER -164.29 151.21 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 119.228 0.922 . . . . 0.0 111.146 173.169 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.486 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -88.22 145.36 25.92 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.092 176.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -118.04 143.71 46.19 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.504 1.121 . . . . 0.0 112.161 172.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -109.99 140.15 44.32 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.422 0.689 . . . . 0.0 111.336 173.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.6 mmt-85 -81.8 141.16 33.73 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 168.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -49.97 -26.95 4.71 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.994 2.117 . . . . 0.0 113.607 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -64.35 -17.39 63.66 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.316 1.446 . . . . 0.0 114.086 174.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.41 41.26 1.65 Allowed Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.463 1.506 . . . . 0.0 115.453 172.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.3 t -141.97 138.49 31.95 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 118.756 1.278 . . . . 0.0 112.217 175.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 28.9 t -128.9 138.8 52.22 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.483 1.513 . . . . 0.0 113.277 -172.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -150.95 151.33 31.97 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -100.9 127.99 47.13 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 127.917 2.487 . . . . 0.0 109.956 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 41.6 m -132.76 177.92 7.26 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.567 1.547 . . . . 0.0 111.134 171.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -80.05 59.92 3.42 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.415 1.086 . . . . 0.0 110.846 -177.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.5 t -62.16 141.69 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.716 1.606 . . . . 0.0 111.658 -172.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -102.61 69.83 1.11 Allowed 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 122.231 1.015 . . . . 0.0 112.175 -168.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.7 t -83.25 69.84 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 121.391 -0.818 . . . . 0.0 110.726 -168.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.5 t -117.92 127.26 26.74 Favored Pre-proline 0 N--CA 1.473 0.718 0 CA-C-O 117.801 -1.095 . . . . 0.0 109.363 -176.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.488 ' HB3' HD11 ' A' ' 127' ' ' LEU . 60.2 Cg_endo -82.32 -170.09 0.88 Allowed 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.212 2.608 . . . . 0.0 112.434 -177.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -119.89 127.24 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-O 122.865 1.317 . . . . 0.0 112.548 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -121.06 160.02 24.49 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 127.012 2.125 . . . . 0.0 111.909 -176.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -89.87 -179.53 5.75 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.807 0.843 . . . . 0.0 111.556 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -60.02 -21.61 61.55 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -73.68 -19.94 60.69 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.803 1.241 . . . . 0.0 114.156 171.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.92 -4.27 63.0 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.529 1.538 . . . . 0.0 114.073 -176.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -79.77 129.38 34.43 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.308 1.054 . . . . 0.0 111.973 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.67 99.99 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 127.215 2.206 . . . . 0.0 110.536 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.54 -30.04 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 123.397 0.679 . . . . 0.0 111.983 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.52 149.99 50.73 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 124.215 1.96 . . . . 0.0 112.642 174.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.8 m-30 -103.84 80.76 1.8 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.408 -1.724 . . . . 0.0 107.662 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.4 mt -101.18 71.32 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 169.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.488 HD11 ' HB3' ' A' ' 114' ' ' PRO . 0.6 OUTLIER -76.02 90.39 3.03 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 122.32 1.057 . . . . 0.0 108.803 175.519 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -59.97 95.16 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.112 1.365 . . . . 0.0 110.553 176.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -80.99 51.85 1.65 Allowed 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.544 -1.348 . . . . 0.0 112.636 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -79.86 106.81 12.16 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 124.296 1.998 . . . . 0.0 112.681 -176.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 41.2 t -62.49 113.75 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 127.377 2.271 . . . . 0.0 108.917 170.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 120.957 0.408 . . . . 0.0 111.316 177.511 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo . . . . . 0 CA--C 1.534 0.502 0 CA-C-O 122.737 1.057 . . . . 0.0 112.233 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -66.34 -27.17 67.68 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.184 0.993 . . . . 0.0 113.095 -171.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -70.09 -49.85 46.79 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.273 0.629 . . . . 0.0 110.415 -177.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 t -75.61 -34.7 60.61 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.028 0.931 . . . . 0.0 112.377 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -57.93 -42.72 85.45 Favored 'General case' 0 C--N 1.341 0.238 0 O-C-N 121.859 -0.526 . . . . 0.0 110.296 171.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.3 tp -70.02 -44.65 68.85 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 118.869 -0.586 . . . . 0.0 112.062 173.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -48.45 -40.01 24.79 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.882 1.219 . . . . 0.0 112.389 175.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.1 m -60.19 -43.09 96.2 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 121.486 -0.759 . . . . 0.0 112.502 172.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.2 mm -67.7 -35.67 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 123.962 0.905 . . . . 0.0 110.783 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.5 mm -56.21 -54.97 21.42 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 172.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -26.75 66.22 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.469 1.108 . . . . 0.0 112.978 176.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -65.31 -46.56 79.88 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 118.155 -0.926 . . . . 0.0 112.193 172.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -104.04 0.0 29.3 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 . . . . . 0 N--CA 1.477 0.893 0 N-CA-C 116.72 2.119 . . . . 0.0 116.72 -165.593 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.7 mptt . . . . . 0 N--CA 1.478 0.973 0 CA-C-O 119.101 -0.476 . . . . 0.0 111.419 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -169.69 162.1 9.59 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -171.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.6 pp -123.3 169.13 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 127.754 2.422 . . . . 0.0 111.864 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.7 mm -127.74 119.07 50.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 126.365 1.866 . . . . 0.0 108.06 174.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.32 154.6 46.71 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 -177.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -77.38 106.69 9.3 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.287 172.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.81 -15.87 61.17 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -96.09 5.94 49.97 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.918 1.287 . . . . 0.0 114.057 -171.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.99 140.19 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.087 1.755 . . . . 0.0 110.912 -173.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -59.92 -23.56 63.61 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -176.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -76.03 -20.78 57.5 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.238 1.015 . . . . 0.0 113.578 174.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 15.6 m 45.1 42.85 7.04 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.017 1.727 . . . . 0.0 113.991 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.05 164.12 12.13 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 117.282 2.327 . . . . 0.0 117.282 -166.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 67.6 t -79.78 96.97 2.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 128.633 2.773 . . . . 0.0 108.419 -170.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.7 pt -78.76 -24.44 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.637 1.575 . . . . 0.0 111.47 173.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -153.79 159.68 41.98 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.952 0.901 . . . . 0.0 111.424 171.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 25.0 p -144.21 151.39 39.41 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.167 -0.958 . . . . 0.0 112.84 -173.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -87.8 153.27 21.47 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.721 0.772 . . . . 0.0 112.381 168.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -62.81 -32.87 74.14 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.305 0.642 . . . . 0.0 111.254 173.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.94 -50.04 56.41 Favored Glycine 0 CA--C 1.532 1.113 0 O-C-N 121.346 -0.846 . . . . 0.0 112.794 175.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -29.87 66.97 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 118.857 1.328 . . . . 0.0 111.56 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.7 t -59.97 -39.94 87.36 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.344 -0.848 . . . . 0.0 110.877 171.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -77.05 -30.13 55.46 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.435 -0.791 . . . . 0.0 112.387 174.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.6 tp -57.36 -55.72 31.1 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.277 1.431 . . . . 0.0 110.838 175.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.9 p -79.98 -28.08 39.57 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 175.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.53 9.96 74.42 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.913 1.72 . . . . 0.0 115.919 178.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -86.04 -121.83 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 119.547 1.674 . . . . 0.0 112.603 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.3 t -159.88 142.88 13.87 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.12 1.768 . . . . 0.0 110.036 -176.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -63.7 -33.97 76.82 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 121.168 -0.957 . . . . 0.0 112.178 -173.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.87 -16.65 43.99 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.578 1.151 . . . . 0.0 113.778 173.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -94.04 -20.56 19.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.211 2.204 . . . . 0.0 112.602 177.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 m -89.9 -20.05 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-N 120.254 1.388 . . . . 0.0 112.823 -173.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 35.1 mmt -49.98 118.57 2.98 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.587 1.155 . . . . 0.0 110.263 -174.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 72.56 20.33 3.9 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.825 1.65 . . . . 0.0 114.098 170.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -89.92 150.93 44.64 Favored Pre-proline 0 N--CA 1.484 1.231 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 169.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -64.24 140.02 68.91 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 124.062 3.174 . . . . 0.0 113.165 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 76.9 m -70.08 -12.36 61.55 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 169.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.1 m -59.08 100.09 0.06 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 126.888 2.075 . . . . 0.0 110.304 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 54.4 m -53.64 -13.21 0.61 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 -170.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -54.25 -38.31 65.63 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.399 1.08 . . . . 0.0 111.359 167.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -59.89 -20.36 56.82 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.457 1.503 . . . . 0.0 112.918 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.55 20.03 14.98 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 127.377 2.271 . . . . 0.0 111.52 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.05 149.2 45.09 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.629 -1.294 . . . . 0.0 112.826 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.7 -172.41 12.66 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.573 1.559 . . . . 0.0 112.45 172.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.35 -9.99 24.28 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.412 2.741 . . . . 0.0 114.781 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -96.46 -10.1 28.23 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.14 1.376 . . . . 0.0 113.555 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.3 m -82.83 139.72 33.33 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 119.237 0.926 . . . . 0.0 112.181 -170.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -95.74 143.65 26.81 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 122.684 1.23 . . . . 0.0 112.139 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.4 ' HD2' ' H ' ' A' ' 76' ' ' ARG . 0.4 OUTLIER -68.79 -39.88 79.92 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.93 -176.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -57.94 -40.71 81.16 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.259 1.024 . . . . 0.0 112.912 174.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.424 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -64.73 -52.19 58.38 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.368 1.067 . . . . 0.0 110.039 176.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.88 -34.79 79.23 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.07 -54.82 11.42 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.69 1.196 . . . . 0.0 111.563 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -50.15 -40.06 45.29 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.243 1.017 . . . . 0.0 112.405 172.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 49.6 mt -64.42 -50.61 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 O-C-N 121.704 -0.623 . . . . 0.0 111.442 173.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.1 -39.93 57.26 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 118.481 -0.771 . . . . 0.0 111.806 175.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -70.63 -37.16 73.76 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.617 0.767 . . . . 0.0 111.852 176.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.34 -33.41 74.25 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.484 -0.76 . . . . 0.0 111.243 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 mt -81.67 -31.96 32.01 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.287 0.635 . . . . 0.0 111.571 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.94 -29.25 70.65 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.494 1.918 . . . . 0.0 111.518 169.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.99 18.44 8.81 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.912 1.244 . . . . 0.0 114.929 169.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.95 -49.9 75.57 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 118.623 1.211 . . . . 0.0 111.424 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -156.75 146.2 20.56 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.535 1.934 . . . . 0.0 110.232 171.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -74.83 113.63 12.33 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 169.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -143.31 136.28 27.79 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.331 -167.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -87.72 129.86 35.01 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.424 1.49 . . . . 0.0 109.535 169.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.1 t -136.09 142.88 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.348 1.459 . . . . 0.0 108.705 -175.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -80.03 150.43 30.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.635 0.774 . . . . 0.0 110.093 172.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.424 HG23 ' HB1' ' A' ' 78' ' ' ALA . 0.6 OUTLIER -161.57 148.88 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.255 1.022 . . . . 0.0 110.843 -179.031 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.04 145.36 25.53 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.3 173.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -119.48 157.55 28.06 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.373 1.069 . . . . 0.0 111.165 175.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -113.93 140.06 48.7 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.834 0.854 . . . . 0.0 109.836 167.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -93.94 150.33 20.46 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.154 1.381 . . . . 0.0 109.585 170.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -17.64 60.73 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -171.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -73.1 -10.03 59.36 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.036 1.334 . . . . 0.0 113.659 172.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.0 9.31 37.34 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.693 1.616 . . . . 0.0 115.442 176.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 63.8 m -91.44 133.16 35.72 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.851 1.326 . . . . 0.0 111.198 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 49.6 t -134.44 129.37 35.17 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.827 0.851 . . . . 0.0 112.86 -176.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -151.01 153.35 34.98 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -173.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.443 HD13 ' N ' ' A' ' 108' ' ' CYS . 2.5 tm? -100.04 135.35 41.61 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.772 2.029 . . . . 0.0 110.435 173.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.443 ' N ' HD13 ' A' ' 107' ' ' LEU . 2.1 m -139.24 170.0 16.75 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.524 1.529 . . . . 0.0 110.706 168.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 31.1 tp -78.33 60.79 2.63 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.796 1.238 . . . . 0.0 110.69 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.7 t -60.79 145.23 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.691 1.196 . . . . 0.0 111.206 -174.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -104.1 69.69 0.95 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 122.493 1.139 . . . . 0.0 111.195 -169.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.1 t -82.76 69.81 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.022 0.929 . . . . 0.0 110.228 -169.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.89 132.46 23.91 Favored Pre-proline 0 N--CA 1.483 1.183 0 C-N-CA 124.26 1.024 . . . . 0.0 111.88 -171.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -88.54 -174.28 1.04 Allowed 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 123.595 2.863 . . . . 0.0 113.797 -171.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.85 129.26 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-O 122.854 1.311 . . . . 0.0 113.658 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -107.72 170.56 7.91 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 127.001 2.12 . . . . 0.0 112.31 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -104.13 179.91 4.14 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 113.666 -1.606 . . . . 0.0 112.346 169.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.25 -19.95 65.01 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -69.34 -19.96 63.86 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.458 1.103 . . . . 0.0 113.681 170.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.95 18.69 49.94 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.468 1.032 . . . . 0.0 113.842 -173.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -110.86 142.4 42.95 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.317 1.047 . . . . 0.0 113.448 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.6 p -74.99 100.06 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.946 1.698 . . . . 0.0 110.814 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.13 -28.94 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 123.303 0.641 . . . . 0.0 111.993 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.33 149.88 50.9 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-O 124.24 1.971 . . . . 0.0 112.654 174.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.8 m-30 -104.87 82.62 1.9 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.222 -1.808 . . . . 0.0 107.337 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.8 mt -100.83 69.88 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 170.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.49 88.93 5.61 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.99 0.9 . . . . 0.0 108.696 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -59.89 108.86 0.82 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.637 1.175 . . . . 0.0 110.712 -176.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -84.17 52.53 2.35 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 120.407 -1.433 . . . . 0.0 112.196 -176.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -79.93 106.89 12.29 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 123.998 1.856 . . . . 0.0 112.294 -178.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 37.0 t -64.74 112.42 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 C-N-CA 126.308 1.843 . . . . 0.0 108.633 171.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.471 0.599 0 C-N-CA 122.842 0.457 . . . . 0.0 110.041 175.198 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo . . . . . 0 CA--C 1.535 0.54 0 CA-C-O 122.459 0.941 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -66.38 -26.79 67.43 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -168.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -68.32 -49.92 57.04 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.719 0.808 . . . . 0.0 110.272 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 t -74.35 -36.43 63.61 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.751 0.821 . . . . 0.0 112.307 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -57.9 -40.02 79.31 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.27 0.628 . . . . 0.0 110.541 173.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.5 tp -71.19 -44.28 65.77 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 118.957 -0.544 . . . . 0.0 112.4 171.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -47.51 -39.9 17.33 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.951 1.3 . . . . 0.0 112.743 175.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 57.0 m -60.14 -42.27 94.47 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 121.193 -0.942 . . . . 0.0 112.549 172.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.8 mm -70.09 -33.31 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.311 1.045 . . . . 0.0 110.785 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.9 mm -56.43 -55.62 18.14 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.426 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 169.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -23.74 63.71 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.303 1.041 . . . . 0.0 113.354 177.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.2 tptp -68.96 -45.49 70.58 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.166 0.986 . . . . 0.0 112.989 171.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -102.45 -0.08 32.98 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 . . . . . 0 N--CA 1.475 0.803 0 C-N-CA 127.256 2.222 . . . . 0.0 116.544 -167.128 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -169.78 159.25 7.92 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 123.189 1.471 . . . . 0.0 114.916 -175.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -120.03 169.01 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 127.574 2.35 . . . . 0.0 111.208 172.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.0 mm -125.25 120.07 57.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 125.957 1.703 . . . . 0.0 107.365 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.0 152.56 48.48 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 178.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -77.31 110.72 12.27 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.301 0.572 . . . . 0.0 111.53 173.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.21 -15.51 61.94 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -99.92 4.63 45.1 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.536 1.309 . . . . 0.0 114.536 -169.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -119.73 140.05 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.422 1.489 . . . . 0.0 110.882 -175.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.4 -23.17 65.62 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -175.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -83.37 -14.52 52.63 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.899 1.28 . . . . 0.0 113.725 175.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.1 m 43.3 54.4 5.14 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.52 1.928 . . . . 0.0 113.528 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.84 154.71 17.59 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -168.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 80.8 t -79.95 90.01 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 128.111 2.565 . . . . 0.0 108.799 -176.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.7 pt -70.11 -23.79 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.698 1.199 . . . . 0.0 112.376 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -155.55 159.66 39.88 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.858 0.863 . . . . 0.0 112.258 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 18.5 p -142.96 139.96 30.89 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 121.342 -0.848 . . . . 0.0 113.069 -173.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -81.82 152.41 26.93 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.724 0.773 . . . . 0.0 112.748 170.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -61.97 -32.26 72.69 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.509 0.724 . . . . 0.0 111.252 175.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.45 -52.55 32.39 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 121.46 -0.775 . . . . 0.0 112.975 172.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.13 -29.73 66.73 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 119.21 1.505 . . . . 0.0 111.136 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.7 t -58.79 -39.82 82.22 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.528 -0.732 . . . . 0.0 110.619 171.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -79.23 -28.31 42.47 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.688 0.795 . . . . 0.0 113.056 174.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.2 tp -57.87 -53.09 62.15 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.051 1.341 . . . . 0.0 110.85 174.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 79.8 m -90.04 -20.01 23.73 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 177.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.71 34.01 40.55 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 124.312 0.958 . . . . 0.0 114.737 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -99.01 -130.18 0.21 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.564 1.146 . . . . 0.0 112.357 -176.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.7 m -159.84 142.88 13.92 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 128.669 2.787 . . . . 0.0 108.143 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -63.98 -40.11 95.65 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 120.922 -1.111 . . . . 0.0 112.934 -169.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.38 -18.04 56.88 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.522 1.129 . . . . 0.0 113.528 174.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -90.21 -20.72 22.7 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.183 1.393 . . . . 0.0 112.179 178.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.7 m -92.7 -14.49 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 CA-C-N 119.31 0.959 . . . . 0.0 113.546 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 35.5 mmt -49.87 114.01 0.98 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.915 1.286 . . . . 0.0 110.467 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 70.15 21.77 5.85 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.88 1.672 . . . . 0.0 113.74 169.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.34 158.84 86.14 Favored Pre-proline 0 N--CA 1.474 0.768 0 O-C-N 121.345 -0.847 . . . . 0.0 111.138 167.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.51 132.99 49.08 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.593 2.196 . . . . 0.0 112.209 171.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 4.6 t -69.99 -23.68 63.19 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.76 1.224 . . . . 0.0 112.548 174.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.0 m -57.04 100.14 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 128.092 2.557 . . . . 0.0 111.792 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 57.7 m -50.04 -21.74 1.35 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -174.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -52.67 -39.19 61.65 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.242 1.017 . . . . 0.0 112.014 171.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -56.14 -24.41 40.85 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.785 1.634 . . . . 0.0 113.4 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 pp -123.08 25.0 8.7 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.048 1.739 . . . . 0.0 113.284 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -63.5 147.26 51.85 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.37 -0.831 . . . . 0.0 112.613 176.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.5 -174.6 13.7 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 125.69 1.615 . . . . 0.0 113.709 -176.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -67.91 -4.38 12.28 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.995 3.13 . . . . 0.0 116.098 -170.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 78.9 mmt-85 -110.26 -10.05 14.64 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 119.609 1.095 . . . . 0.0 113.519 169.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.8 m -73.94 134.98 43.22 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.23 0.923 . . . . 0.0 110.812 -173.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -85.38 137.46 32.92 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.84 0.829 . . . . 0.0 110.029 173.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.0 mmm-85 -67.36 -39.67 85.73 Favored 'General case' 0 C--O 1.219 -0.517 0 O-C-N 121.402 -0.811 . . . . 0.0 111.084 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.1 ptt-85 -53.6 -38.63 64.15 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 169.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.85 -52.15 52.84 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 122.04 0.924 . . . . 0.0 110.079 175.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.42 -33.8 76.8 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.618 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.12 -51.85 28.33 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.783 1.633 . . . . 0.0 112.057 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -50.17 -41.62 49.53 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.456 1.025 . . . . 0.0 112.341 169.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 46.2 mt -62.94 -50.03 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 O-C-N 121.769 -0.582 . . . . 0.0 111.047 172.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.08 -39.79 56.89 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.374 -0.822 . . . . 0.0 112.173 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -69.84 -37.95 76.35 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.589 0.755 . . . . 0.0 111.473 176.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.23 -32.88 74.22 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.536 -0.727 . . . . 0.0 111.075 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mt -81.35 -33.47 32.39 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.452 0.701 . . . . 0.0 111.693 176.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.05 -28.47 69.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.791 2.036 . . . . 0.0 111.28 169.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.09 17.6 9.41 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.007 1.289 . . . . 0.0 114.84 169.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.85 -49.91 75.55 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 118.526 1.163 . . . . 0.0 111.439 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -161.56 151.65 17.14 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.695 1.598 . . . . 0.0 111.926 171.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -72.18 112.98 8.73 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 167.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.5 tpp180 -148.26 135.97 20.78 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.268 1.027 . . . . 0.0 111.431 -176.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -83.87 131.95 34.83 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.403 1.481 . . . . 0.0 110.204 169.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.7 t -134.93 146.12 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.353 1.461 . . . . 0.0 109.074 -176.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -80.05 152.5 29.36 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.773 0.829 . . . . 0.0 110.011 171.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -163.25 148.71 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.42 1.088 . . . . 0.0 110.813 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.8 145.38 25.22 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.665 174.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -117.18 154.14 31.61 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.677 1.191 . . . . 0.0 111.088 172.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -123.9 140.05 53.36 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.535 0.734 . . . . 0.0 110.811 169.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -83.11 162.12 21.42 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.953 1.301 . . . . 0.0 113.28 177.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -50.05 -35.28 24.42 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.469 1.908 . . . . 0.0 113.417 171.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -81.75 -9.91 59.51 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.56 1.144 . . . . 0.0 113.946 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.96 2.07 48.86 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.789 1.661 . . . . 0.0 115.382 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.5 m -74.66 125.11 27.99 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.936 1.368 . . . . 0.0 110.717 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 19.1 t -127.9 132.75 49.28 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.208 1.003 . . . . 0.0 112.589 -170.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -151.06 139.98 20.95 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.57 1.148 . . . . 0.0 113.825 -169.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.419 HD13 ' N ' ' A' ' 108' ' ' CYS . 1.9 tm? -104.81 128.75 53.08 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.405 1.882 . . . . 0.0 109.033 168.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.419 ' N ' HD13 ' A' ' 107' ' ' LEU . 62.3 m -134.99 172.66 12.69 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.422 1.489 . . . . 0.0 110.018 169.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 28.6 tp -79.98 59.88 3.37 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.983 -1.073 . . . . 0.0 110.81 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.7 t -58.42 146.28 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.253 1.421 . . . . 0.0 111.662 -171.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -100.87 69.72 1.35 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 122.608 1.194 . . . . 0.0 111.622 -168.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.7 t -83.32 69.86 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.229 1.011 . . . . 0.0 110.389 -169.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.0 p -119.51 133.47 23.8 Favored Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 124.689 1.195 . . . . 0.0 111.441 -173.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -88.79 -171.34 0.57 Allowed 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 123.761 2.974 . . . . 0.0 113.55 -171.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.7 m -127.81 127.19 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-O 122.811 1.291 . . . . 0.0 113.573 174.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -114.12 165.07 13.02 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 127.273 2.229 . . . . 0.0 112.202 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -94.22 179.99 5.12 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.654 174.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.65 -20.62 63.61 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -71.39 -19.87 62.21 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.546 1.139 . . . . 0.0 114.025 171.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.95 0.96 58.6 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 124.815 1.197 . . . . 0.0 114.127 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.21 126.25 37.21 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.485 1.114 . . . . 0.0 112.025 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.7 p -59.95 99.8 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 128.214 2.605 . . . . 0.0 109.796 171.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.22 -30.06 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.975 177.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.9 mmt -135.46 148.37 49.23 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 124.167 1.937 . . . . 0.0 111.128 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.8 m-30 -104.85 80.39 1.63 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.934 1.694 . . . . 0.0 106.749 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.0 mt -100.05 69.85 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 171.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.87 90.14 4.7 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -59.81 109.05 0.84 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.515 1.126 . . . . 0.0 110.857 -176.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -84.46 49.98 1.79 Allowed 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.233 -1.542 . . . . 0.0 112.515 -177.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -79.84 107.05 12.32 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 123.685 1.707 . . . . 0.0 111.98 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.3 t -57.94 115.82 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 127.166 2.186 . . . . 0.0 109.44 170.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.475 0.801 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 176.757 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo . . . . . 0 CA--C 1.537 0.652 0 CA-C-O 122.708 1.045 . . . . 0.0 113.149 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -68.48 -25.22 64.86 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.485 -0.76 . . . . 0.0 112.855 -169.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -66.7 -49.85 64.74 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.07 0.948 . . . . 0.0 110.384 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 t -75.71 -35.8 60.17 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.829 0.852 . . . . 0.0 112.347 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -57.8 -40.69 80.5 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.138 0.575 . . . . 0.0 110.388 172.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.1 tp -72.54 -43.63 63.25 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 118.607 -0.711 . . . . 0.0 112.289 172.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -48.58 -39.97 25.66 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 120.077 1.308 . . . . 0.0 112.164 175.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 78.9 m -60.12 -42.64 95.21 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 121.607 -0.683 . . . . 0.0 112.732 173.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.1 mm -69.95 -32.74 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.219 1.008 . . . . 0.0 111.011 176.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.7 mm -57.08 -55.8 18.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 170.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -25.33 64.98 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 176.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.1 tptt -68.58 -42.19 78.61 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.087 0.955 . . . . 0.0 112.271 172.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -114.99 16.39 17.14 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 -175.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 -166.914 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -169.78 162.45 9.55 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -172.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 pp -129.25 170.66 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 127.323 2.249 . . . . 0.0 111.347 175.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.1 mm -126.21 114.45 38.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 126.368 1.867 . . . . 0.0 107.388 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.5 150.26 41.85 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 124.325 1.05 . . . . 0.0 111.614 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -81.72 114.03 20.11 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.391 1.076 . . . . 0.0 110.37 176.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.82 4.16 45.55 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 175.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -100.19 -3.38 31.74 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.397 1.479 . . . . 0.0 113.936 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 p -118.15 139.29 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.83 1.652 . . . . 0.0 111.501 -176.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -62.15 -26.39 68.3 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.926 0.89 . . . . 0.0 112.937 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -77.53 -8.88 58.48 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.824 1.25 . . . . 0.0 113.93 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.0 p 43.62 35.4 0.99 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 126.991 2.116 . . . . 0.0 114.877 -176.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.71 154.87 29.73 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -167.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 98.9 t -79.99 89.99 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 129.143 2.977 . . . . 0.0 109.02 -175.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.0 pt -69.94 -24.25 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.462 1.505 . . . . 0.0 112.392 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -153.92 159.66 41.82 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.281 1.033 . . . . 0.0 112.224 171.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 18.6 p -143.77 147.35 34.05 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.817 -1.177 . . . . 0.0 112.798 -177.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -89.74 156.86 18.24 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 176.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -58.81 -27.4 65.04 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.277 0.631 . . . . 0.0 111.626 169.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.7 -56.64 12.84 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 119.218 -0.768 . . . . 0.0 112.465 169.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -53.19 -39.49 63.69 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.4 1.6 . . . . 0.0 111.371 174.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.3 t -60.14 -40.06 88.47 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.901 -0.5 . . . . 0.0 111.308 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -78.56 -25.86 45.49 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.978 0.911 . . . . 0.0 112.979 176.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 36.2 tp -66.26 -55.74 14.66 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.877 1.271 . . . . 0.0 111.213 176.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 78.4 m -93.35 -22.06 19.18 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.638 0.775 . . . . 0.0 113.084 -176.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.22 20.07 79.82 Favored Glycine 0 CA--C 1.539 1.586 0 O-C-N 121.034 -1.041 . . . . 0.0 113.855 -171.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -87.47 -130.02 0.06 Allowed 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 118.493 1.147 . . . . 0.0 110.839 -176.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.0 t -160.66 150.16 17.31 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 127.862 2.465 . . . . 0.0 108.846 176.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.08 -38.87 54.29 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 121.466 -0.771 . . . . 0.0 112.624 172.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.51 -19.99 64.16 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.56 1.144 . . . . 0.0 113.737 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -86.76 -20.73 27.19 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.267 1.427 . . . . 0.0 113.189 174.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -105.41 -18.49 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 176.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.5 mmt -49.84 111.41 0.51 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.491 1.517 . . . . 0.0 111.248 -172.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 66.83 30.67 7.76 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.823 1.649 . . . . 0.0 112.544 170.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -107.21 154.4 40.52 Favored Pre-proline 0 N--CA 1.471 0.61 0 CA-C-O 117.321 -1.323 . . . . 0.0 112.594 176.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -50.59 134.82 40.56 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.267 2.645 . . . . 0.0 113.95 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 52.7 t -66.68 -17.86 65.07 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.727 1.211 . . . . 0.0 112.981 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.2 m -61.88 99.99 0.14 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.211 1.804 . . . . 0.0 111.859 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 27.8 p -54.08 -15.69 1.59 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -175.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -52.85 -38.74 61.85 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.991 0.917 . . . . 0.0 111.523 170.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -64.78 -15.19 61.32 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 pp -123.06 25.38 8.54 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.118 1.767 . . . . 0.0 113.358 172.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -62.34 148.33 45.52 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.197 -0.94 . . . . 0.0 112.62 176.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.96 -179.75 16.04 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 125.126 1.346 . . . . 0.0 114.09 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -63.5 -10.01 20.17 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.572 2.848 . . . . 0.0 116.629 -174.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -110.03 -2.27 17.13 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.412 1.485 . . . . 0.0 114.15 173.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.509 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 3.2 m -80.8 139.99 35.72 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.348 0.976 . . . . 0.0 111.944 -177.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -87.27 135.61 33.25 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 122.493 1.139 . . . . 0.0 111.407 171.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.8 mmm-85 -69.79 -39.74 76.43 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 118.573 -0.727 . . . . 0.0 110.965 176.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.2 ptp85 -54.13 -38.37 65.37 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 169.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.406 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -65.23 -52.81 52.21 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 122.111 0.958 . . . . 0.0 110.05 174.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.24 -32.71 74.52 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.695 -178.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.1 -50.22 43.03 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.17 1.788 . . . . 0.0 112.559 176.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -50.11 -42.61 50.7 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.659 1.118 . . . . 0.0 111.975 169.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 43.0 mt -61.31 -48.83 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.857 -0.527 . . . . 0.0 111.271 173.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.56 -39.88 58.69 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.131 0.572 . . . . 0.0 111.957 174.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -62.63 -40.81 98.18 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.556 0.742 . . . . 0.0 111.284 175.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.01 -29.13 68.05 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 175.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mt -86.55 -32.48 20.67 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.1 pp -71.48 -30.3 65.83 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.618 -0.676 . . . . 0.0 111.227 167.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.83 20.06 7.85 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 118.988 -0.896 . . . . 0.0 113.823 168.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.27 -50.0 68.28 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 118.486 1.143 . . . . 0.0 111.179 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -167.27 150.21 6.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.938 2.095 . . . . 0.0 110.566 169.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -86.84 130.15 34.59 Favored 'General case' 0 C--O 1.238 0.471 0 O-C-N 121.21 -0.931 . . . . 0.0 109.166 -178.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.06 150.54 27.36 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.092 0.957 . . . . 0.0 112.351 174.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -76.77 138.44 39.91 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.275 1.03 . . . . 0.0 109.339 168.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -139.24 144.75 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.332 1.053 . . . . 0.0 109.525 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -80.01 152.62 29.35 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.905 0.882 . . . . 0.0 110.04 171.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.406 HG23 ' HB1' ' A' ' 78' ' ' ALA . 0.6 OUTLIER -163.46 148.05 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.235 1.014 . . . . 0.0 111.028 179.209 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.509 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -90.76 145.37 24.85 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.888 0.475 . . . . 0.0 112.247 177.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -117.51 162.56 17.78 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.767 1.227 . . . . 0.0 111.93 172.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -127.94 136.46 51.36 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.604 0.761 . . . . 0.0 111.531 168.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.7 mmt85 -71.08 152.22 43.72 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.446 1.498 . . . . 0.0 111.624 173.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -54.88 -30.57 58.29 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.788 1.235 . . . . 0.0 112.341 168.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -76.21 -9.95 59.03 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.568 1.547 . . . . 0.0 114.271 175.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.8 10.23 47.16 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.296 1.427 . . . . 0.0 116.313 174.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.3 m -87.61 135.12 33.49 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 119.14 1.47 . . . . 0.0 111.578 176.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 59.3 m -123.24 133.18 54.22 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.467 1.107 . . . . 0.0 112.243 -171.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -150.9 140.47 21.59 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -176.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -102.58 127.46 49.65 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.004 1.722 . . . . 0.0 108.465 168.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 60.9 m -128.45 168.49 15.56 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.435 1.094 . . . . 0.0 110.579 171.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 73.2 mt -79.99 59.85 3.36 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.876 -1.14 . . . . 0.0 110.199 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.3 t -59.06 146.37 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.531 1.532 . . . . 0.0 112.208 -168.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -100.05 69.69 1.53 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 122.56 1.172 . . . . 0.0 112.31 -168.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.9 t -84.67 69.85 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 121.372 -0.83 . . . . 0.0 111.346 -168.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.2 t -111.25 129.2 24.28 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 124.504 1.121 . . . . 0.0 109.464 -178.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -82.96 -168.67 0.61 Allowed 'Trans proline' 0 CA--C 1.553 1.427 0 C-N-CA 123.121 2.548 . . . . 0.0 111.298 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -127.17 128.9 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-O 123.124 1.44 . . . . 0.0 113.945 175.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -111.7 162.2 15.46 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.675 2.39 . . . . 0.0 112.818 -175.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -94.46 -178.95 4.74 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.475 172.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -61.57 -22.18 64.96 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -71.89 -19.98 61.86 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.641 1.177 . . . . 0.0 113.829 170.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.32 -0.03 59.85 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 126.017 1.77 . . . . 0.0 114.372 -176.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.4 140.01 29.94 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.541 1.171 . . . . 0.0 113.146 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.3 p -73.95 98.89 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.668 1.587 . . . . 0.0 109.8 -176.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.96 -30.03 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 118.397 -0.811 . . . . 0.0 111.059 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.7 mmt -135.96 149.91 49.07 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-O 123.455 1.597 . . . . 0.0 110.452 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.2 m-30 -105.61 81.09 1.63 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -175.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.9 mt -99.95 69.99 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 120.206 -1.559 . . . . 0.0 108.295 173.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -73.96 87.64 1.83 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 123.405 1.574 . . . . 0.0 109.398 176.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -59.89 96.54 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 112.845 -1.98 . . . . 0.0 109.862 176.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -83.4 52.76 2.3 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.454 -1.403 . . . . 0.0 111.881 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -79.84 127.08 31.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 122.065 0.936 . . . . 0.0 111.992 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 t -69.36 123.56 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.423 1.089 . . . . 0.0 109.016 172.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 169.25 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo . . . . . 0 CA--C 1.536 0.604 0 CA-C-O 122.3 0.875 . . . . 0.0 112.031 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -63.87 -27.16 68.97 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -168.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -68.45 -50.0 55.72 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.754 0.822 . . . . 0.0 110.371 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 t -75.67 -33.9 60.43 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.835 0.854 . . . . 0.0 112.488 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -59.9 -40.35 88.47 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.454 0.702 . . . . 0.0 110.185 172.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.4 tp -71.6 -45.99 60.55 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-O 118.824 -0.607 . . . . 0.0 112.161 172.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -46.86 -39.75 12.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.587 1.555 . . . . 0.0 113.353 173.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 90.3 m -60.01 -44.77 94.35 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.546 -0.721 . . . . 0.0 112.025 172.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.1 mm -67.3 -35.54 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.881 0.872 . . . . 0.0 110.756 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.4 mm -55.78 -54.95 20.66 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 172.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 -59.96 -28.43 67.65 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.981 0.809 . . . . 0.0 113.038 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.7 tttt -64.27 -41.69 96.79 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 172.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -103.51 1.01 31.76 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 . . . . . 0 N--CA 1.477 0.894 0 C-N-CA 126.872 2.069 . . . . 0.0 114.16 -168.612 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.6 mttp . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -169.72 161.5 9.28 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.392 1.477 . . . . 0.0 113.374 176.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -125.01 167.92 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 126.845 2.058 . . . . 0.0 111.636 170.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.6 mm -125.74 122.43 62.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 125.846 1.658 . . . . 0.0 107.882 173.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.41 152.78 49.43 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 178.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -77.91 106.72 9.95 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 121.561 0.696 . . . . 0.0 111.191 172.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.71 -14.98 61.23 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -94.97 4.14 54.14 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.808 1.243 . . . . 0.0 114.163 -172.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -117.73 140.09 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.482 1.513 . . . . 0.0 110.647 -176.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.34 -26.05 66.28 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -177.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.83 -8.95 59.85 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.223 1.409 . . . . 0.0 114.001 177.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.5 p 35.34 56.12 0.84 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 127.043 2.137 . . . . 0.0 114.214 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.93 153.14 17.92 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -167.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.0 t -79.97 89.97 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 128.64 2.776 . . . . 0.0 108.895 -176.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.5 pt -70.82 -24.64 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.642 1.177 . . . . 0.0 112.2 176.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -154.9 159.77 40.7 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 177.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 25.5 p -142.29 146.8 35.46 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -172.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -92.01 154.1 19.0 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.549 0.69 . . . . 0.0 112.595 167.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -62.9 -33.56 75.57 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.265 0.626 . . . . 0.0 111.14 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.95 -49.95 56.78 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 121.69 -0.631 . . . . 0.0 113.155 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.02 -29.86 67.01 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 119.41 1.605 . . . . 0.0 111.141 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.8 t -59.19 -39.87 83.92 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 120.78 -1.2 . . . . 0.0 110.429 171.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -79.49 -24.79 42.07 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.285 1.034 . . . . 0.0 112.935 173.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.4 tp -59.33 -50.33 74.39 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.438 1.095 . . . . 0.0 110.398 172.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.1 m -86.68 -23.71 25.51 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 175.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.59 31.72 60.37 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 124.481 1.038 . . . . 0.0 114.197 -175.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 17.7 m-30 -95.99 -130.16 0.16 Allowed 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 118.379 1.09 . . . . 0.0 112.146 -175.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.4 t -160.06 149.96 18.19 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 128.026 2.53 . . . . 0.0 108.578 174.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -61.3 -35.35 77.09 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 120.699 -1.251 . . . . 0.0 113.234 -173.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.42 -16.67 48.92 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.436 1.094 . . . . 0.0 113.26 175.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -93.66 -20.86 19.77 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.422 1.889 . . . . 0.0 111.99 178.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 m -95.83 -19.99 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 119.762 1.164 . . . . 0.0 113.296 -174.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 34.3 mmt -50.01 112.97 0.75 Allowed 'General case' 0 C--N 1.342 0.248 0 C-N-CA 124.683 1.193 . . . . 0.0 110.889 -173.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 68.74 21.99 7.56 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.193 1.397 . . . . 0.0 113.549 169.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.3 158.79 86.92 Favored Pre-proline 0 N--CA 1.475 0.785 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.687 167.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.78 140.01 93.23 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.117 1.878 . . . . 0.0 111.481 169.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 3.9 t -69.62 -14.69 62.96 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.043 1.337 . . . . 0.0 112.747 177.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.28 99.8 0.31 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 127.82 2.448 . . . . 0.0 110.544 176.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 30.4 p -55.23 -14.86 1.93 Allowed 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.638 -1.165 . . . . 0.0 113.652 174.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -47.15 -42.82 20.28 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.442 1.497 . . . . 0.0 111.828 167.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -66.81 -12.66 59.77 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 pp -123.05 23.62 9.2 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.282 1.833 . . . . 0.0 113.428 171.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.12 146.85 53.52 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.036 -1.04 . . . . 0.0 112.912 177.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -123.19 -177.43 15.14 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.309 1.433 . . . . 0.0 114.547 -173.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -66.78 -10.15 27.18 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.009 2.473 . . . . 0.0 116.218 -172.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -110.07 -5.34 15.42 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.702 1.201 . . . . 0.0 113.898 170.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.533 HG23 ' H ' ' A' ' 97' ' ' ALA . 3.6 m -71.23 134.1 46.62 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.889 1.222 . . . . 0.0 110.076 177.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -79.88 134.59 36.31 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 122.263 1.03 . . . . 0.0 109.072 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -66.3 -39.71 89.51 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.342 -0.849 . . . . 0.0 110.105 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.8 ptt-85 -55.34 -38.91 69.38 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.559 1.144 . . . . 0.0 113.909 169.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.42 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -63.16 -52.84 60.79 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.987 0.915 . . . . 0.0 110.482 174.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.05 -34.45 78.45 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.181 -178.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.09 -52.81 24.53 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.599 1.16 . . . . 0.0 112.194 176.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -50.18 -40.01 45.59 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.378 0.99 . . . . 0.0 112.921 171.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 46.2 mt -63.62 -49.27 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 121.453 -0.779 . . . . 0.0 111.365 173.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.75 -39.88 59.3 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.777 0.717 . . . . 0.0 111.763 173.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -63.29 -39.76 95.48 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.319 0.648 . . . . 0.0 111.542 175.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.04 -29.7 68.74 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.3 mt -82.79 -34.97 26.87 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.9 pp -70.66 -27.2 63.85 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.976 -0.453 . . . . 0.0 112.056 167.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.93 17.48 9.6 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.315 -0.714 . . . . 0.0 114.2 169.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -51.61 -49.88 61.32 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 118.087 0.944 . . . . 0.0 112.042 173.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -157.01 142.74 17.66 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.52 1.928 . . . . 0.0 110.644 170.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -75.81 118.19 18.35 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.71 -1.244 . . . . 0.0 108.017 169.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -146.23 135.62 22.94 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.851 0.86 . . . . 0.0 112.474 -167.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -86.88 130.0 34.65 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.043 1.337 . . . . 0.0 109.518 168.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.71 144.28 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.21 1.404 . . . . 0.0 109.081 -175.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -79.88 150.62 30.54 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.522 0.729 . . . . 0.0 109.891 171.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.42 HG23 ' HB1' ' A' ' 78' ' ' ALA . 0.7 OUTLIER -160.86 159.98 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.367 1.067 . . . . 0.0 110.32 -177.565 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.533 ' H ' HG23 ' A' ' 74' ' ' THR . . . -102.09 145.31 29.52 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.807 171.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -112.4 152.59 28.47 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.862 1.665 . . . . 0.0 110.645 169.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -127.06 139.56 52.91 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.44 0.638 . . . . 0.0 110.289 167.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -84.9 158.55 20.54 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.786 1.234 . . . . 0.0 112.927 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -54.68 -30.44 55.63 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.574 1.55 . . . . 0.0 112.853 169.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -75.45 -9.94 59.02 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.115 1.366 . . . . 0.0 113.998 175.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.08 3.82 55.6 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.76 1.647 . . . . 0.0 115.763 176.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 54.2 m -84.57 128.24 34.49 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 119.169 1.484 . . . . 0.0 111.347 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 46.9 t -124.43 129.88 51.47 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.065 1.346 . . . . 0.0 112.005 -173.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -150.91 139.96 21.07 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.399 1.079 . . . . 0.0 113.764 -169.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.0 134.87 49.51 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.711 2.404 . . . . 0.0 109.121 172.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 4.5 m -139.04 173.1 11.91 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.66 1.584 . . . . 0.0 110.281 168.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 26.6 tp -76.95 59.84 1.7 Allowed 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.019 -1.051 . . . . 0.0 109.995 173.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.7 t -59.81 146.98 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.955 1.302 . . . . 0.0 110.8 -172.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -100.0 69.72 1.55 Allowed 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 122.802 1.287 . . . . 0.0 112.584 -168.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.1 t -84.19 69.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.343 1.057 . . . . 0.0 110.89 -169.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.2 p -117.88 134.07 23.31 Favored Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 124.038 0.935 . . . . 0.0 111.887 -173.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -86.81 -173.22 1.1 Allowed 'Trans proline' 0 CA--C 1.546 1.089 0 C-N-CA 123.472 2.781 . . . . 0.0 113.445 -172.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.16 127.12 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-O 122.972 1.368 . . . . 0.0 113.483 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -110.62 162.07 15.1 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.634 2.374 . . . . 0.0 112.63 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -92.81 179.97 5.31 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.735 -1.121 . . . . 0.0 112.156 171.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.67 -21.4 65.69 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -70.84 -19.87 62.61 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.481 1.112 . . . . 0.0 113.737 169.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.69 0.09 59.27 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 126.007 1.765 . . . . 0.0 114.406 -176.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.74 139.64 30.36 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.69 1.245 . . . . 0.0 113.292 -178.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.8 p -74.53 100.1 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 125.582 1.553 . . . . 0.0 110.565 -176.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.26 -29.98 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.34 0.656 . . . . 0.0 111.837 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.27 149.99 50.97 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 124.273 1.987 . . . . 0.0 112.732 173.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.3 m-30 -104.45 82.05 1.88 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.155 -1.839 . . . . 0.0 107.048 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.3 mt -102.06 69.88 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 171.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.19 86.56 5.59 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.899 0.857 . . . . 0.0 108.858 -178.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -59.94 104.21 0.28 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.544 1.138 . . . . 0.0 110.94 -175.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -83.85 58.13 4.5 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.277 -1.514 . . . . 0.0 111.729 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -79.79 124.95 29.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 122.626 1.203 . . . . 0.0 110.914 176.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 55.9 t -81.99 113.34 21.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 125.048 1.339 . . . . 0.0 108.27 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.474 0.727 0 CA-C-O 120.836 0.351 . . . . 0.0 111.635 -177.964 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 118.757 -0.639 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -66.88 -27.74 43.3 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.129 2.553 . . . . 0.0 115.196 -175.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.1 p -149.54 156.79 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.771 1.628 . . . . 0.0 110.676 -177.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 30.9 ptt-85 -78.16 52.45 1.1 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.902 1.681 . . . . 0.0 114.401 -176.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -122.92 149.95 43.57 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.794 2.037 . . . . 0.0 111.42 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.29 -54.79 3.98 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.982 1.277 . . . . 0.0 113.351 -177.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 44.0 p-80 -88.17 157.5 18.8 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.535 1.134 . . . . 0.0 112.124 170.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.1 t -130.02 136.09 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.99 1.316 . . . . 0.0 109.246 171.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.43 159.96 69.45 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.091 0.956 . . . . 0.0 111.881 173.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -57.64 105.41 0.2 Allowed 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.678 2.252 . . . . 0.0 110.648 170.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -63.96 -26.98 68.83 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -167.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -70.05 -49.98 45.78 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.67 0.668 . . . . 0.0 110.761 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.5 t -78.25 -33.99 49.36 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.547 1.139 . . . . 0.0 112.357 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -59.78 -42.4 93.24 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.306 0.642 . . . . 0.0 109.947 172.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.9 tp -70.12 -45.43 66.89 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-O 118.708 -0.663 . . . . 0.0 111.868 173.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -48.05 -39.87 21.3 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 120.04 1.291 . . . . 0.0 113.207 174.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.6 m -60.07 -44.98 94.35 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.605 -0.684 . . . . 0.0 112.261 172.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.8 mm -66.34 -36.61 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.762 0.825 . . . . 0.0 110.691 175.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.9 mm -55.96 -53.87 33.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.434 0 CA-C-O 118.445 -0.788 . . . . 0.0 109.05 173.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -59.97 -29.0 68.14 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 118.845 0.748 . . . . 0.0 112.54 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 tptt -63.42 -46.2 87.45 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 118.624 -0.703 . . . . 0.0 112.815 172.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -101.41 11.4 39.22 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.05 -29.09 68.3 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.273 1.429 . . . . 0.0 113.698 -167.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.4 15.04 56.44 Favored Glycine 0 CA--C 1.536 1.391 0 N-CA-C 118.02 1.968 . . . . 0.0 118.02 166.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -121.71 -44.08 2.34 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.358 1.463 . . . . 0.0 111.663 -174.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 71.4 m -113.93 -25.24 8.67 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.085 1.754 . . . . 0.0 111.816 168.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.1 mmt-85 -100.06 156.37 17.21 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.265 1.426 . . . . 0.0 112.63 173.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -134.02 145.35 49.37 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.976 1.71 . . . . 0.0 111.953 -168.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -169.9 161.29 8.86 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -171.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -128.03 172.29 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.884 1.274 . . . . 0.0 111.732 174.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.2 mm -130.28 120.07 48.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 125.988 1.715 . . . . 0.0 108.375 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.02 153.78 51.15 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -81.34 108.49 15.0 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.599 0.714 . . . . 0.0 111.469 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.21 -15.82 62.48 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.239 1.015 . . . . 0.0 113.461 177.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -89.96 -2.13 58.1 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.705 1.602 . . . . 0.0 113.906 -172.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.27 140.14 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.105 1.362 . . . . 0.0 110.567 -174.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -59.46 -28.17 66.74 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -177.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -84.16 -3.55 58.21 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.017 1.327 . . . . 0.0 114.469 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.5 p 37.44 51.29 1.17 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 126.899 2.079 . . . . 0.0 114.417 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.77 150.18 24.33 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -167.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.4 t -79.96 89.96 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 127.843 2.457 . . . . 0.0 108.957 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.8 pt -70.0 -24.86 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.08 1.352 . . . . 0.0 112.446 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -154.78 159.71 40.8 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.151 0.98 . . . . 0.0 112.576 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 5.8 p -148.77 145.29 27.52 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.975 -1.078 . . . . 0.0 113.07 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -86.89 156.64 19.76 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 178.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.58 -27.65 67.87 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.621 0.769 . . . . 0.0 111.913 171.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.41 -50.49 52.6 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.331 -0.856 . . . . 0.0 113.03 170.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.57 -38.16 74.36 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 119.652 1.726 . . . . 0.0 110.593 173.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.6 t -60.22 -40.78 91.35 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.821 -0.55 . . . . 0.0 111.098 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -77.62 -26.31 50.48 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.649 0.78 . . . . 0.0 112.969 175.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.0 tp -63.92 -55.81 19.88 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.951 1.3 . . . . 0.0 111.29 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 77.1 m -95.96 -20.05 19.03 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.934 0.894 . . . . 0.0 113.067 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.4 20.21 76.71 Favored Glycine 0 CA--C 1.538 1.491 0 O-C-N 120.988 -1.07 . . . . 0.0 113.847 -174.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -84.87 -129.64 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.97 1.308 . . . . 0.0 110.313 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 41.6 t -159.87 150.12 18.66 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 127.589 2.356 . . . . 0.0 108.288 173.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.1 mtm180 -58.28 -35.28 71.55 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.124 -0.985 . . . . 0.0 112.328 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.42 -21.71 64.35 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -81.85 -20.79 38.23 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.207 1.403 . . . . 0.0 112.511 175.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -105.3 -17.06 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 7.6 mmt -49.89 108.0 0.19 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 125.519 1.528 . . . . 0.0 111.051 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 70.55 18.86 6.39 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.792 1.637 . . . . 0.0 113.793 171.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.12 159.11 76.29 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 123.843 0.857 . . . . 0.0 110.452 167.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -60.34 140.03 89.74 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.532 2.154 . . . . 0.0 111.857 169.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.7 t -67.47 -9.99 47.26 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.844 1.657 . . . . 0.0 113.469 176.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.7 m -62.81 100.17 0.19 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 127.672 2.389 . . . . 0.0 111.507 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 46.4 m -49.93 -23.48 1.99 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.088 1.755 . . . . 0.0 115.299 -176.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -46.99 -41.81 16.94 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.435 1.494 . . . . 0.0 112.863 169.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -63.1 -16.64 60.63 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.28 1.032 . . . . 0.0 113.551 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 pp -123.11 25.25 8.57 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.74 1.616 . . . . 0.0 113.653 173.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -65.01 151.56 45.67 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.109 -0.995 . . . . 0.0 112.181 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -125.6 -177.81 15.05 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.378 1.466 . . . . 0.0 113.694 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -64.65 -10.13 23.45 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.318 2.679 . . . . 0.0 116.293 -171.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -107.6 -7.39 16.49 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.825 1.65 . . . . 0.0 113.341 175.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.526 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 3.8 m -71.71 132.22 44.23 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.074 -1.016 . . . . 0.0 111.335 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -80.01 135.72 36.44 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.081 0.943 . . . . 0.0 110.105 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.3 mmt-85 -66.33 -39.79 89.47 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.737 -0.602 . . . . 0.0 110.658 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 49.5 ptt85 -53.76 -39.07 65.06 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.385 1.074 . . . . 0.0 113.463 171.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.03 -50.21 43.57 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.593 1.157 . . . . 0.0 110.234 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.23 -33.67 76.55 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.137 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.5 -54.98 11.57 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.478 1.111 . . . . 0.0 111.541 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -50.16 -40.14 45.72 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.862 0.865 . . . . 0.0 112.873 172.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.4 mt -65.48 -50.03 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 118.758 0.708 . . . . 0.0 111.018 174.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.09 -39.89 57.13 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.732 -0.651 . . . . 0.0 111.977 174.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -70.03 -37.71 75.69 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.449 0.7 . . . . 0.0 111.669 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.66 -34.02 76.95 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.328 -0.857 . . . . 0.0 111.317 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mt -83.15 -28.88 29.07 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.509 0.724 . . . . 0.0 111.664 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.19 -27.88 69.01 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.819 2.048 . . . . 0.0 111.016 168.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.0 17.36 9.64 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.245 1.402 . . . . 0.0 114.918 170.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.89 -49.93 74.24 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 118.642 1.221 . . . . 0.0 111.231 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -159.9 139.06 10.93 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.886 1.674 . . . . 0.0 111.392 169.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -74.02 101.45 3.87 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 169.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -144.04 140.05 29.32 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.82 1.248 . . . . 0.0 111.828 -168.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -77.49 135.03 38.2 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.506 1.123 . . . . 0.0 111.123 173.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -136.51 153.2 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.038 1.735 . . . . 0.0 108.553 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -79.93 160.07 26.11 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.857 0.863 . . . . 0.0 110.104 169.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.51 HD13 ' CZ ' ' A' ' 98' ' ' PHE . 0.3 OUTLIER -164.35 149.85 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 119.234 0.925 . . . . 0.0 111.448 169.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.526 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -88.89 145.33 25.61 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.431 0.692 . . . . 0.0 111.548 172.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.51 ' CZ ' HD13 ' A' ' 96' ' ' ILE . 40.9 m-85 -117.29 160.97 20.25 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.374 1.07 . . . . 0.0 110.999 173.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -125.64 140.04 53.06 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.466 0.65 . . . . 0.0 111.441 169.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -83.99 154.78 23.11 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.418 1.087 . . . . 0.0 112.591 175.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -53.95 -27.85 33.64 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.025 1.73 . . . . 0.0 113.089 171.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -71.42 -9.95 58.99 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.188 1.395 . . . . 0.0 114.181 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.76 18.24 33.06 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.249 1.404 . . . . 0.0 115.831 175.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 71.2 m -107.17 136.86 46.29 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 118.634 1.217 . . . . 0.0 111.717 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 29.5 t -126.21 135.0 51.08 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.858 1.263 . . . . 0.0 112.325 -175.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -149.96 139.98 22.01 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.55 1.14 . . . . 0.0 113.422 -168.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -102.54 125.56 49.3 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.408 1.883 . . . . 0.0 109.139 170.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 61.4 m -129.74 173.16 10.9 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.42 1.488 . . . . 0.0 110.082 173.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 30.4 tp -79.31 59.88 2.96 Favored 'General case' 0 CA--C 1.549 0.911 0 O-C-N 120.592 -1.317 . . . . 0.0 111.644 -176.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 45.7 t -63.41 142.9 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 126.062 1.745 . . . . 0.0 111.623 -173.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -108.81 69.98 0.73 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.203 1.001 . . . . 0.0 112.979 -167.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.8 t -81.25 70.02 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.732 1.213 . . . . 0.0 111.045 -168.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.8 p -121.51 126.53 26.45 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 124.133 0.973 . . . . 0.0 112.247 -175.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -88.93 -176.4 1.39 Allowed 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 123.846 3.031 . . . . 0.0 112.293 -173.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -117.03 133.59 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 123.178 1.465 . . . . 0.0 113.677 -175.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.46 160.78 30.43 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.092 2.157 . . . . 0.0 111.947 -173.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -89.92 -176.27 4.87 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.124 0.97 . . . . 0.0 112.092 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -62.48 -19.98 64.11 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -77.29 -19.97 55.71 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.011 1.324 . . . . 0.0 113.862 170.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.75 -0.13 64.74 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.23 1.395 . . . . 0.0 114.447 -176.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.25 131.38 35.29 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.372 1.086 . . . . 0.0 111.669 174.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.7 p -72.56 98.3 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.73 2.012 . . . . 0.0 111.078 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.7 -29.14 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 123.555 0.742 . . . . 0.0 111.731 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.9 148.6 50.12 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 124.115 1.912 . . . . 0.0 112.834 174.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -102.45 83.93 2.37 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 125.815 1.646 . . . . 0.0 106.766 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.6 mt -99.87 79.29 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 170.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.296 34.5 mt -83.0 86.01 7.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 123.226 1.488 . . . . 0.0 108.946 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -59.93 103.13 0.19 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 113.045 -1.889 . . . . 0.0 109.441 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -85.16 55.63 3.58 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 122.584 1.183 . . . . 0.0 110.885 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -79.83 106.75 12.09 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 123.653 1.692 . . . . 0.0 110.507 -176.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.54 120.32 12.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 125.73 1.612 . . . . 0.0 108.691 170.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.2 146.74 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 O-C-N 123.277 0.36 . . . . 0.0 110.076 175.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 87.9 mtp -142.11 152.36 43.18 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.111 1.364 . . . . 0.0 111.145 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -74.46 153.2 39.27 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.241 1.017 . . . . 0.0 112.646 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 C--O 1.253 1.255 0 C-N-CA 125.363 1.465 . . . . 0.0 112.439 177.799 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.8 ttp . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 118.612 -0.709 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -59.32 151.92 64.38 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.459 2.773 . . . . 0.0 113.901 176.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.0 p -148.95 150.86 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.437 1.495 . . . . 0.0 110.878 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -71.91 134.04 45.79 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.76 0.824 . . . . 0.0 110.644 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -153.21 170.09 21.41 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.981 1.712 . . . . 0.0 112.25 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.32 8.27 58.69 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 125.138 1.352 . . . . 0.0 116.38 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -134.71 141.21 46.46 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.319 1.559 . . . . 0.0 112.746 -175.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.2 t -119.33 140.87 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.292 1.437 . . . . 0.0 109.527 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.58 160.76 9.37 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 123.943 0.897 . . . . 0.0 111.786 171.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -42.15 110.09 0.14 Allowed 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 124.57 3.513 . . . . 0.0 112.329 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -60.02 -28.8 68.03 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -165.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -66.65 -49.85 64.85 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.715 0.806 . . . . 0.0 110.53 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 t -79.2 -34.15 43.21 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.177 0.991 . . . . 0.0 112.428 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -58.41 -39.94 81.11 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.07 0.948 . . . . 0.0 110.458 170.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 44.5 tp -70.07 -45.72 66.44 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 118.813 -0.613 . . . . 0.0 111.999 170.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -46.5 -39.93 11.64 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.975 1.31 . . . . 0.0 112.936 174.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.6 m -58.97 -45.1 91.39 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 121.595 -0.691 . . . . 0.0 111.664 173.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.8 mm -66.1 -36.84 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.89 0.876 . . . . 0.0 110.543 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.2 mm -54.51 -55.79 13.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 CA-C-O 117.777 -1.106 . . . . 0.0 108.545 171.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -59.87 -29.99 68.69 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 120.108 1.322 . . . . 0.0 111.922 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.1 tptt -63.6 -40.64 97.46 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.582 1.153 . . . . 0.0 112.235 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -108.16 -0.14 21.19 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 116.034 1.864 . . . . 0.0 116.034 176.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.17 -29.19 68.51 Favored 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -166.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.66 -1.68 69.11 Favored Glycine 0 CA--C 1.54 1.627 0 N-CA-C 117.75 1.86 . . . . 0.0 117.75 169.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -122.13 -32.17 3.74 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.075 1.75 . . . . 0.0 111.492 169.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.4 m -64.2 -29.98 71.06 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.707 0.803 . . . . 0.0 110.478 167.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -76.35 149.93 36.92 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.395 1.478 . . . . 0.0 112.924 169.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -139.95 153.37 46.89 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 128.872 2.869 . . . . 0.0 108.892 170.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -169.72 160.92 9.03 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -121.25 168.93 13.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 126.892 2.077 . . . . 0.0 111.387 170.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.8 mm -119.1 113.85 42.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 126.105 1.762 . . . . 0.0 106.617 170.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -119.09 148.98 42.44 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.922 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -80.87 113.21 18.92 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.946 0.898 . . . . 0.0 110.068 174.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.03 -12.4 60.32 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -100.01 -7.45 25.04 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.022 1.329 . . . . 0.0 114.041 -169.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 p -105.85 140.07 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.887 1.675 . . . . 0.0 111.285 -177.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.76 -30.73 70.19 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -174.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -77.35 -8.96 58.5 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.272 1.029 . . . . 0.0 113.592 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.8 m 48.63 39.01 12.51 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.746 1.618 . . . . 0.0 113.138 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.21 155.16 27.5 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -166.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.9 t -79.96 93.15 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 129.128 2.971 . . . . 0.0 108.192 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.4 pt -73.51 -23.62 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.174 1.39 . . . . 0.0 112.149 177.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -157.57 159.75 37.43 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.659 1.184 . . . . 0.0 112.014 175.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.3 p -141.68 151.12 42.73 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.821 -1.174 . . . . 0.0 114.125 -175.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -89.77 151.45 21.81 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.674 0.75 . . . . 0.0 111.653 166.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -65.92 -27.04 67.89 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.614 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.36 -50.07 48.72 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 121.156 -0.965 . . . . 0.0 112.778 172.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -29.86 66.96 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 118.845 1.323 . . . . 0.0 111.67 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.6 t -59.31 -39.83 84.29 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.597 -0.689 . . . . 0.0 110.466 170.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -77.75 -30.01 51.35 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 118.905 0.775 . . . . 0.0 112.857 174.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.4 tp -55.92 -52.1 65.3 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.15 1.38 . . . . 0.0 110.911 174.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 57.7 m -90.64 -20.85 22.06 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.16 9.98 84.41 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 126.557 2.027 . . . . 0.0 116.69 174.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -87.57 -120.25 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 119.558 1.679 . . . . 0.0 112.728 -175.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.1 t -159.86 138.63 10.68 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.772 1.629 . . . . 0.0 110.313 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -60.57 -32.64 71.72 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.328 1.051 . . . . 0.0 113.459 -175.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.14 -16.58 33.6 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.505 1.122 . . . . 0.0 113.645 174.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -97.1 -20.78 17.76 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.778 1.631 . . . . 0.0 112.46 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 m -89.92 -17.24 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 120.145 1.339 . . . . 0.0 113.134 -172.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 36.3 mmt -49.85 114.93 1.19 Allowed 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.221 1.009 . . . . 0.0 109.698 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 72.66 21.07 3.61 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.036 1.735 . . . . 0.0 114.355 171.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.05 154.03 88.65 Favored Pre-proline 0 N--CA 1.48 1.031 0 O-C-N 120.762 -1.211 . . . . 0.0 111.074 167.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.18 139.99 57.51 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.62 2.213 . . . . 0.0 111.645 173.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.8 t -69.95 -18.96 63.38 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.179 0.992 . . . . 0.0 112.991 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.0 m -61.39 100.1 0.12 Allowed 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 127.143 2.177 . . . . 0.0 111.614 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 68.3 m -50.44 -19.29 0.82 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 116.43 2.011 . . . . 0.0 116.43 -173.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -56.33 -36.31 68.59 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.036 -1.04 . . . . 0.0 111.635 172.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -57.58 -23.49 51.04 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.373 1.469 . . . . 0.0 113.391 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 pp -119.44 22.87 11.53 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.938 1.695 . . . . 0.0 113.162 176.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -63.25 147.1 51.96 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.379 -0.826 . . . . 0.0 111.993 173.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.72 -173.13 12.89 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 125.189 1.376 . . . . 0.0 113.219 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -62.35 -10.07 17.48 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 123.758 2.972 . . . . 0.0 116.406 -172.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -108.18 -9.34 15.57 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.902 1.681 . . . . 0.0 113.562 176.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.438 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 3.1 m -81.29 141.17 34.33 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.928 0.891 . . . . 0.0 112.153 -174.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -89.08 136.78 32.83 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 122.294 1.045 . . . . 0.0 111.512 171.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.4 mmm-85 -69.98 -39.69 75.78 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.363 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -53.23 -39.29 63.68 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 169.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.9 -52.84 54.31 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 122.221 1.01 . . . . 0.0 110.031 175.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.94 -33.86 77.03 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.882 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.02 -50.92 36.53 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.941 1.696 . . . . 0.0 112.271 176.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -50.2 -41.56 49.88 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.42 1.009 . . . . 0.0 112.306 169.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.7 mt -61.78 -49.9 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 O-C-N 121.653 -0.654 . . . . 0.0 111.001 171.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.07 -39.85 56.97 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.385 -0.817 . . . . 0.0 112.171 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -70.11 -34.88 73.67 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.695 0.798 . . . . 0.0 111.888 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.53 -31.45 69.67 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.656 -0.653 . . . . 0.0 111.744 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 mt -82.78 -32.24 27.84 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.537 0.735 . . . . 0.0 111.604 176.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.07 -33.1 74.72 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.868 2.067 . . . . 0.0 110.833 169.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.78 23.67 6.11 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.551 1.072 . . . . 0.0 115.031 168.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.75 -50.63 62.13 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.168 1.484 . . . . 0.0 110.218 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -151.77 143.41 23.6 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.389 2.276 . . . . 0.0 108.63 172.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -77.71 115.56 17.56 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.703 1.138 . . . . 0.0 108.188 169.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -138.96 137.73 36.67 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.592 1.157 . . . . 0.0 111.646 -168.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -87.03 129.63 34.81 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.177 1.791 . . . . 0.0 109.949 169.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.27 145.97 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.102 1.361 . . . . 0.0 109.355 -175.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -79.97 151.44 30.03 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.457 0.703 . . . . 0.0 109.846 170.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -163.0 147.13 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.06 0.944 . . . . 0.0 110.544 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.438 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -87.58 141.42 28.62 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.206 175.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -106.09 155.19 19.67 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.915 1.286 . . . . 0.0 111.231 169.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -121.83 138.29 54.44 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.796 0.838 . . . . 0.0 109.089 166.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -100.04 152.59 20.04 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.944 1.697 . . . . 0.0 110.504 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.92 -15.59 44.27 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 -171.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -78.28 -11.08 59.91 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.227 1.411 . . . . 0.0 113.72 171.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.86 2.53 56.15 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 126.203 1.859 . . . . 0.0 115.126 -174.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 55.3 m -74.77 128.21 35.01 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.866 1.833 . . . . 0.0 111.328 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 67.1 m -124.47 130.62 52.8 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.696 1.198 . . . . 0.0 111.443 -175.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -150.01 139.93 21.9 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.89 0.876 . . . . 0.0 113.013 -171.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.464 HD13 ' N ' ' A' ' 108' ' ' CYS . 2.2 tm? -110.36 134.79 51.96 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.673 1.989 . . . . 0.0 109.3 172.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.464 ' N ' HD13 ' A' ' 107' ' ' LEU . 2.1 m -138.95 171.64 14.02 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.502 1.521 . . . . 0.0 110.457 169.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 29.5 tp -76.88 59.87 1.68 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.199 0.999 . . . . 0.0 110.088 174.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.0 t -58.29 145.36 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.912 1.285 . . . . 0.0 110.516 -172.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -100.0 69.76 1.55 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.693 1.235 . . . . 0.0 111.277 -168.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.4 t -82.43 69.85 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.268 1.027 . . . . 0.0 110.526 -170.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.3 130.76 24.41 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.004 0.922 . . . . 0.0 110.948 -176.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -85.47 -169.72 0.64 Allowed 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 123.199 2.6 . . . . 0.0 111.888 -174.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.92 130.33 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-O 123.133 1.444 . . . . 0.0 113.947 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.4 mttm -112.82 162.4 15.83 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 127.655 2.382 . . . . 0.0 112.801 -175.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -93.17 -179.98 5.25 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.154 171.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.4 -21.69 65.57 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -70.63 -19.88 62.78 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.532 1.133 . . . . 0.0 113.727 169.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.51 0.32 59.44 Favored Glycine 0 CA--C 1.533 1.156 0 C-N-CA 126.112 1.815 . . . . 0.0 114.423 -176.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.75 139.39 30.61 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.64 1.22 . . . . 0.0 113.274 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.6 p -74.67 98.96 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.484 1.513 . . . . 0.0 109.856 -176.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.37 -30.01 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 118.345 -0.836 . . . . 0.0 110.833 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.9 mmt -136.59 150.04 48.37 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-O 123.85 1.786 . . . . 0.0 110.906 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -104.33 81.11 1.78 Allowed 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 125.564 1.545 . . . . 0.0 107.522 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 36.1 mt -100.44 70.74 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 O-C-N 120.481 -1.387 . . . . 0.0 109.211 172.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 127' ' ' LEU . 1.9 mm? -77.25 85.72 3.69 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 123.44 1.591 . . . . 0.0 109.384 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -60.0 103.05 0.19 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 112.877 -1.965 . . . . 0.0 111.007 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -85.54 62.71 7.65 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.518 -1.364 . . . . 0.0 111.799 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -79.71 131.33 35.92 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.185 -0.947 . . . . 0.0 110.372 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 50.5 t -92.95 114.6 30.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 124.58 1.152 . . . . 0.0 108.118 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.34 136.9 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-O 121.331 0.586 . . . . 0.0 112.094 -175.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 28.1 ptm -127.93 164.78 21.55 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.088 1.755 . . . . 0.0 111.329 173.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.07 153.58 43.51 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 45.0 mttm . . . . . 0 C--O 1.253 1.277 0 C-N-CA 126.019 1.728 . . . . 0.0 112.16 176.566 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.3 mtm . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 119.037 -0.506 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -69.11 156.56 64.66 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.439 2.759 . . . . 0.0 112.514 176.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.2 t -134.53 140.87 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.554 1.542 . . . . 0.0 109.875 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -65.52 145.74 55.73 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.351 1.061 . . . . 0.0 111.938 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.26 145.01 24.76 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.813 1.245 . . . . 0.0 109.981 172.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.76 -147.28 46.42 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 123.226 0.441 . . . . 0.0 112.274 -169.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -73.95 158.99 33.4 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.143 0.977 . . . . 0.0 112.843 175.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.0 t -78.97 121.26 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.702 0.801 . . . . 0.0 109.782 174.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.02 159.93 82.4 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.154 0.982 . . . . 0.0 111.489 173.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.61 103.5 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.68 2.253 . . . . 0.0 111.855 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -65.8 -27.08 68.0 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.989 0.915 . . . . 0.0 113.257 -169.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -70.02 -49.99 45.88 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.023 0.529 . . . . 0.0 110.325 -176.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.5 t -74.13 -35.31 64.09 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.724 0.81 . . . . 0.0 112.509 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -58.24 -41.48 84.27 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.318 0.647 . . . . 0.0 109.909 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.1 tp -75.49 -45.04 40.74 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 118.619 -0.705 . . . . 0.0 112.427 174.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -47.66 -39.81 18.18 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.713 1.605 . . . . 0.0 113.151 175.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.7 m -60.02 -45.16 93.71 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.88 -0.513 . . . . 0.0 111.679 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.5 mm -68.95 -34.77 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.941 0.897 . . . . 0.0 110.931 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.8 mm -54.67 -56.5 10.15 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 171.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -60.8 -27.05 67.73 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 176.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -63.2 -43.1 99.12 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.465 0.706 . . . . 0.0 112.228 172.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -104.66 -0.01 27.98 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -59.74 -29.24 68.01 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.504 1.522 . . . . 0.0 113.751 -167.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.29 -0.02 69.88 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 125.276 1.417 . . . . 0.0 115.731 -176.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -114.61 -47.13 2.92 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.2 1.5 . . . . 0.0 112.969 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.9 m -78.98 3.06 18.26 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 175.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 83.3 mmt-85 -120.06 151.07 39.56 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.522 1.529 . . . . 0.0 113.303 -173.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -134.46 143.23 47.39 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.349 1.859 . . . . 0.0 111.567 -167.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -169.81 162.36 9.47 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -169.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -122.93 168.96 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 128.039 2.536 . . . . 0.0 111.217 171.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.0 mm -128.24 124.81 63.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 C-N-CA 126.219 1.807 . . . . 0.0 108.378 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.06 154.46 49.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -177.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -77.77 108.27 10.88 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.402 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.01 -19.52 63.32 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -94.84 2.38 55.45 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.701 1.201 . . . . 0.0 113.989 -169.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.49 140.07 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.32 1.448 . . . . 0.0 110.508 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.97 -23.82 65.63 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -86.55 -7.39 58.41 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.344 1.458 . . . . 0.0 114.23 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.0 p 42.92 43.38 3.51 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 126.945 2.098 . . . . 0.0 115.293 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.53 149.9 32.98 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 -167.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.0 t -80.03 89.98 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 128.584 2.753 . . . . 0.0 109.08 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.7 pt -69.96 -24.54 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.993 1.317 . . . . 0.0 112.453 175.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -153.58 159.62 42.22 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.804 0.842 . . . . 0.0 112.86 173.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.0 p -143.21 143.26 31.69 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.289 -0.882 . . . . 0.0 112.687 -177.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -89.67 155.12 19.44 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 173.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -66.93 -19.92 65.81 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.869 -0.519 . . . . 0.0 112.257 174.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.65 -49.91 55.83 Favored Glycine 0 CA--C 1.535 1.283 0 O-C-N 121.33 -0.856 . . . . 0.0 112.212 169.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -56.75 -39.23 73.62 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 119.04 1.42 . . . . 0.0 110.903 172.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.3 t -60.14 -41.3 92.43 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.922 -0.486 . . . . 0.0 111.321 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -77.1 -30.09 55.2 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.679 0.791 . . . . 0.0 112.663 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.18 -53.8 43.59 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.721 1.609 . . . . 0.0 112.174 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 82.7 m -101.12 -19.97 15.53 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.876 1.271 . . . . 0.0 112.787 -173.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.95 11.87 84.75 Favored Glycine 0 CA--C 1.539 1.541 0 CA-C-O 118.715 -1.047 . . . . 0.0 115.502 176.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -90.71 -122.13 0.07 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.956 1.378 . . . . 0.0 111.401 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.4 t -159.89 150.16 18.67 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.929 1.292 . . . . 0.0 111.095 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.0 mtt-85 -50.04 -43.9 51.16 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.576 1.15 . . . . 0.0 111.189 169.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.81 -19.12 64.78 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.378 1.071 . . . . 0.0 113.824 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -86.48 -20.56 27.91 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.473 1.509 . . . . 0.0 112.81 174.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.7 m -102.11 -18.99 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 174.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 5.4 mmt -49.81 107.47 0.15 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.509 1.523 . . . . 0.0 111.46 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 71.47 18.06 5.56 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.818 1.647 . . . . 0.0 113.85 171.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.55 157.12 72.81 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.039 0.936 . . . . 0.0 111.09 167.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.51 140.17 92.43 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.873 3.049 . . . . 0.0 112.879 169.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.3 m -62.95 -13.79 39.19 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 172.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.3 m -65.98 99.92 0.54 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.396 1.478 . . . . 0.0 110.911 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 32.0 p -53.32 -17.56 1.9 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.878 1.671 . . . . 0.0 115.004 -176.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -48.5 -42.88 34.32 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.925 1.29 . . . . 0.0 111.742 168.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -64.42 -16.19 61.93 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 pp -122.99 23.02 9.45 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.32 1.848 . . . . 0.0 113.432 173.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.27 144.57 57.06 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.224 -0.922 . . . . 0.0 112.568 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.54 173.16 22.67 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.067 1.318 . . . . 0.0 113.479 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.14 -9.99 25.6 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.485 2.79 . . . . 0.0 113.825 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.27 -4.69 25.29 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.192 1.797 . . . . 0.0 113.617 174.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.468 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 5.5 m -80.5 143.19 33.51 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 119.329 0.968 . . . . 0.0 111.889 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.2 mm-40 -92.97 145.24 24.52 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 123.453 1.597 . . . . 0.0 114.097 175.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.486 ' H ' ' HD2' ' A' ' 76' ' ' ARG . 1.2 mpt_? -70.11 -42.45 72.67 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 113.463 -1.699 . . . . 0.0 110.874 -175.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -60.05 -38.85 84.0 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.584 1.154 . . . . 0.0 113.5 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.42 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -63.69 -53.01 57.93 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.044 0.938 . . . . 0.0 109.972 174.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.73 -34.6 78.57 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.551 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.96 -53.29 18.45 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.951 1.301 . . . . 0.0 111.94 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -50.13 -41.6 49.08 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.18 0.9 . . . . 0.0 112.13 171.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 47.7 mt -63.8 -49.79 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 O-C-N 121.834 -0.541 . . . . 0.0 111.493 174.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.87 -39.81 54.77 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.167 0.587 . . . . 0.0 111.912 174.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -67.61 -39.56 84.73 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.553 0.615 . . . . 0.0 111.705 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.45 -27.16 65.01 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.833 -0.542 . . . . 0.0 112.162 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 mt -88.57 -31.53 18.59 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.235 0.614 . . . . 0.0 111.388 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.43 -36.11 79.44 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.31 1.844 . . . . 0.0 109.845 168.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 113.71 22.42 5.39 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.828 1.204 . . . . 0.0 114.821 171.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.24 -50.0 74.84 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 118.374 1.087 . . . . 0.0 111.399 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -159.73 148.6 17.7 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.448 1.499 . . . . 0.0 112.243 170.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -70.97 111.24 6.2 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 167.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -148.07 136.64 21.61 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.41 1.084 . . . . 0.0 111.392 -174.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -84.03 133.59 34.66 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.269 1.428 . . . . 0.0 110.606 171.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.61 146.3 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.434 1.494 . . . . 0.0 109.143 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -80.0 153.9 28.55 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.996 0.918 . . . . 0.0 110.598 172.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.42 HG23 ' HB1' ' A' ' 78' ' ' ALA . 0.6 OUTLIER -163.74 149.5 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.114 0.966 . . . . 0.0 111.428 179.177 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.468 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -90.47 145.32 25.0 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.483 174.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -116.64 162.28 17.89 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.632 1.173 . . . . 0.0 111.394 171.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -126.55 137.89 53.41 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.608 0.718 . . . . 0.0 110.59 167.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -92.83 157.59 16.31 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.288 1.835 . . . . 0.0 111.693 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -55.66 -30.55 61.21 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.103 1.761 . . . . 0.0 113.616 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.4 p30 -77.28 -9.89 59.09 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 175.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.51 -1.15 49.56 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 126.247 1.879 . . . . 0.0 115.298 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.4 m -70.1 130.86 43.25 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.35 1.575 . . . . 0.0 111.483 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 80.5 m -119.91 129.48 54.38 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.748 1.219 . . . . 0.0 110.969 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -151.03 140.01 21.01 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -172.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.436 HD13 ' N ' ' A' ' 108' ' ' CYS . 1.6 tm? -110.83 131.77 54.77 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 127.19 2.196 . . . . 0.0 108.144 168.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.436 ' N ' HD13 ' A' ' 107' ' ' LEU . 5.6 m -138.96 179.17 6.65 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.174 1.39 . . . . 0.0 110.93 170.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 76.9 mt -77.61 60.0 2.07 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.153 0.981 . . . . 0.0 110.763 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.6 t -60.57 142.29 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.739 1.215 . . . . 0.0 110.751 -173.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -102.91 69.72 1.06 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 122.076 0.941 . . . . 0.0 110.769 -168.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.5 t -83.56 69.76 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.835 0.826 . . . . 0.0 109.786 -169.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.47 134.31 24.83 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 124.745 1.218 . . . . 0.0 110.054 -174.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -87.55 -164.65 0.2 Allowed 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 123.083 2.522 . . . . 0.0 112.073 -172.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.7 m -124.93 132.94 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 122.922 1.344 . . . . 0.0 112.941 174.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -118.5 160.95 20.83 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.752 2.021 . . . . 0.0 111.794 -171.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -90.03 179.97 5.82 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.095 0.958 . . . . 0.0 111.976 172.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.72 -21.59 64.63 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -71.24 -19.92 62.31 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.615 1.166 . . . . 0.0 113.866 170.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.7 -1.87 60.12 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.791 1.662 . . . . 0.0 114.307 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -85.99 139.45 31.18 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.57 1.185 . . . . 0.0 113.25 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -74.41 100.02 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 125.828 1.651 . . . . 0.0 110.503 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.86 -30.06 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 118.194 -0.907 . . . . 0.0 111.367 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.8 mmt -136.27 148.33 47.95 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 123.517 1.627 . . . . 0.0 111.077 178.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -103.13 86.84 2.77 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.915 1.686 . . . . 0.0 108.088 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.8 mt -106.49 69.9 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 170.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.02 88.95 2.98 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.259 1.028 . . . . 0.0 108.748 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -59.82 107.03 0.55 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.151 1.381 . . . . 0.0 110.203 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -84.67 52.22 2.34 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 120.617 -1.302 . . . . 0.0 112.169 -176.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -79.89 106.9 12.25 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 123.793 1.759 . . . . 0.0 112.678 -176.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 22.3 t -64.17 112.52 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 125.802 1.641 . . . . 0.0 108.296 169.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.45 140.9 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.832 0.348 . . . . 0.0 111.026 177.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 27.9 ptm -136.33 173.4 11.75 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.645 1.578 . . . . 0.0 112.198 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.91 154.95 32.28 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.808 1.243 . . . . 0.0 113.737 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt . . . . . 0 C--O 1.253 1.283 0 C-N-CA 126.02 1.728 . . . . 0.0 112.517 -175.214 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.0 mtt . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 119.224 -0.417 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -69.44 170.6 15.81 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.371 2.714 . . . . 0.0 111.673 169.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.0 t -63.52 130.03 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.567 0.747 . . . . 0.0 110.182 176.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 -93.57 20.04 7.82 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.268 1.427 . . . . 0.0 113.98 -171.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.18 155.6 46.76 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.705 2.002 . . . . 0.0 111.667 -176.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.81 3.16 83.64 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 125.024 1.297 . . . . 0.0 115.567 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -143.79 173.33 11.78 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.832 1.653 . . . . 0.0 112.058 176.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.7 p -129.97 151.43 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.58 1.552 . . . . 0.0 110.982 175.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.66 159.97 57.03 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 123.83 0.852 . . . . 0.0 111.696 171.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -58.57 107.97 0.37 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.103 2.536 . . . . 0.0 111.197 173.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -64.55 -26.59 68.48 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -168.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -69.97 -49.97 46.4 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.49 0.586 . . . . 0.0 110.585 -176.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.1 t -77.3 -33.41 55.68 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.133 0.973 . . . . 0.0 112.304 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -60.04 -41.02 91.35 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.667 -0.646 . . . . 0.0 110.184 172.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.2 tp -71.03 -45.11 64.5 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-O 118.696 -0.669 . . . . 0.0 112.041 172.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -47.68 -39.75 18.17 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.203 1.365 . . . . 0.0 113.279 173.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 90.2 m -60.16 -43.67 95.62 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.521 -0.737 . . . . 0.0 112.326 172.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.4 mm -68.59 -35.28 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.898 0.879 . . . . 0.0 110.938 175.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 26.2 mm -55.49 -54.5 24.83 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.483 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 171.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 55.5 mtm180 -60.32 -27.36 67.27 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.8 0.727 . . . . 0.0 112.959 176.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.3 tptt -65.09 -40.47 94.64 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 118.631 -0.7 . . . . 0.0 112.757 172.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -106.03 2.4 27.26 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -55.64 -29.0 58.5 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.536 1.935 . . . . 0.0 114.266 -167.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.82 -1.63 68.59 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.695 1.617 . . . . 0.0 116.4 169.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -119.84 -13.14 9.1 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.597 1.559 . . . . 0.0 112.106 168.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.9 p -76.12 8.51 3.19 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 128.016 2.526 . . . . 0.0 115.054 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.82 163.86 4.2 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.335 1.454 . . . . 0.0 113.682 178.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.96 146.1 28.02 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.972 2.109 . . . . 0.0 115.173 -167.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -169.79 163.13 9.76 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -121.71 169.77 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.887 169.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.9 mm -123.2 114.65 42.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 126.069 1.747 . . . . 0.0 107.015 173.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.17 153.16 40.43 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.475 175.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -85.21 120.83 27.13 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.37 -9.62 59.34 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 46.0 mmm-85 -100.1 5.68 44.93 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.886 1.674 . . . . 0.0 114.246 -172.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.4 m -119.61 139.9 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 126.117 1.767 . . . . 0.0 111.73 -174.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.12 -24.4 65.01 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.85 0.86 . . . . 0.0 113.142 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.56 -12.3 59.95 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.169 1.388 . . . . 0.0 112.431 173.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.9 m 46.73 37.95 5.28 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.899 1.68 . . . . 0.0 112.782 -175.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.31 149.86 40.46 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -165.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.4 t -80.66 90.0 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 C-N-CA 128.667 2.787 . . . . 0.0 108.631 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.4 pt -69.95 -24.15 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.162 1.385 . . . . 0.0 112.207 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -155.62 159.82 39.93 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.802 1.241 . . . . 0.0 112.93 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.3 p -143.23 139.96 30.48 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.873 -1.142 . . . . 0.0 112.879 -175.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -83.73 157.98 21.94 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -61.26 -28.22 69.02 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.547 0.739 . . . . 0.0 111.429 171.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.58 -49.97 59.06 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.71 -1.05 . . . . 0.0 113.296 170.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.76 -40.6 69.52 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 120.064 1.932 . . . . 0.0 110.662 172.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.4 t -60.24 -40.65 90.98 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.625 0.37 . . . . 0.0 111.074 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -76.23 -29.62 57.61 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.965 0.906 . . . . 0.0 112.579 176.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.7 tp -64.28 -55.78 19.1 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.935 1.294 . . . . 0.0 111.733 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.1 m -99.59 -20.06 16.54 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.72 0.808 . . . . 0.0 112.794 -172.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.94 14.51 82.55 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-O 118.871 -0.96 . . . . 0.0 115.413 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -89.96 -128.79 0.08 Allowed 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 118.845 1.322 . . . . 0.0 111.762 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.9 t -159.95 150.19 18.6 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.635 1.974 . . . . 0.0 109.789 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.5 mtt85 -50.88 -40.37 56.27 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.329 1.052 . . . . 0.0 112.52 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.7 -21.2 62.63 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.351 1.06 . . . . 0.0 113.537 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -85.38 -20.96 29.08 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.638 1.575 . . . . 0.0 112.296 177.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -105.37 -20.03 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 5.8 mmt -49.97 107.76 0.17 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.845 1.658 . . . . 0.0 111.306 -174.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 70.24 18.4 6.89 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.383 1.473 . . . . 0.0 113.558 170.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.75 161.38 61.37 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 123.882 0.873 . . . . 0.0 110.553 167.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -56.19 140.06 86.79 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.992 2.461 . . . . 0.0 113.165 171.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 34.9 t -67.65 -10.05 48.76 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.128 1.371 . . . . 0.0 113.158 170.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -61.29 100.19 0.12 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 128.01 2.524 . . . . 0.0 110.866 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 33.8 m -50.03 -13.11 0.09 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.461 1.904 . . . . 0.0 115.903 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -52.79 -37.02 59.17 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.844 1.258 . . . . 0.0 111.776 167.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -55.83 -21.78 21.48 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.396 1.479 . . . . 0.0 113.343 171.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.13 20.03 14.6 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 127.611 2.364 . . . . 0.0 111.824 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -72.81 142.2 48.03 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.319 -1.488 . . . . 0.0 111.324 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.68 -170.11 11.99 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.665 1.602 . . . . 0.0 113.123 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -64.6 -10.13 23.29 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.29 2.66 . . . . 0.0 116.26 -170.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -110.07 -2.03 17.22 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.852 1.661 . . . . 0.0 114.415 175.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.503 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 6.0 m -78.53 137.83 38.1 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.704 1.138 . . . . 0.0 112.298 -175.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -82.58 132.22 35.2 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 122.636 1.208 . . . . 0.0 110.59 172.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.7 mmt85 -70.0 -39.9 75.61 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.185 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -56.87 -35.68 69.2 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.682 1.193 . . . . 0.0 113.599 169.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.48 -50.24 53.79 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.648 0.779 . . . . 0.0 110.907 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.32 -34.95 78.81 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.34 -53.01 27.03 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.832 1.253 . . . . 0.0 112.012 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -50.16 -40.8 47.69 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.39 0.996 . . . . 0.0 112.731 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 29.7 mt -63.82 -49.75 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 O-C-N 121.708 -0.62 . . . . 0.0 111.08 174.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.81 -39.94 59.6 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.565 0.621 . . . . 0.0 111.958 173.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -63.51 -39.82 95.43 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.243 0.617 . . . . 0.0 111.635 175.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.16 -28.75 66.7 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mt -84.07 -40.09 18.75 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 pp -66.02 -28.72 69.08 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 118.46 0.573 . . . . 0.0 112.212 169.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.75 18.91 8.55 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 119.031 -0.872 . . . . 0.0 113.965 169.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.27 -50.01 65.73 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 118.372 1.086 . . . . 0.0 110.303 169.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -162.69 129.97 3.68 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.924 1.689 . . . . 0.0 111.648 168.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -68.81 116.55 9.43 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.193 1.397 . . . . 0.0 108.633 172.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -151.73 142.93 23.29 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.851 1.26 . . . . 0.0 111.706 -169.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -83.72 130.69 34.96 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.449 1.5 . . . . 0.0 110.554 169.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.6 153.1 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.508 1.523 . . . . 0.0 109.077 -177.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -79.87 158.83 26.62 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.429 0.691 . . . . 0.0 109.477 170.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -166.71 150.16 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.437 1.095 . . . . 0.0 110.08 175.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.503 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -91.4 145.35 24.7 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.276 172.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -114.61 162.3 16.94 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.76 1.224 . . . . 0.0 111.276 172.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -132.13 140.06 48.65 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.831 0.852 . . . . 0.0 111.495 168.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.2 mtp-105 -88.68 166.66 13.94 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 125.296 1.439 . . . . 0.0 113.393 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -57.81 -33.25 68.39 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.04 2.136 . . . . 0.0 112.88 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -76.99 -9.86 58.98 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.814 1.246 . . . . 0.0 114.235 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.6 -1.3 59.99 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.573 1.559 . . . . 0.0 115.842 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.5 m -72.88 139.66 47.03 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.735 1.767 . . . . 0.0 111.139 176.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 29.3 p -136.01 140.05 43.59 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -178.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -150.89 142.02 23.13 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.378 1.071 . . . . 0.0 113.359 -172.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.499 HD13 ' N ' ' A' ' 108' ' ' CYS . 2.2 tm? -102.61 135.21 44.67 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.419 1.888 . . . . 0.0 109.763 169.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.499 ' N ' HD13 ' A' ' 107' ' ' LEU . 1.9 m -139.83 170.27 16.18 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.319 1.448 . . . . 0.0 110.246 167.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 28.7 tp -77.37 59.92 1.93 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.939 0.896 . . . . 0.0 109.603 172.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.1 t -57.1 147.65 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.959 1.303 . . . . 0.0 110.55 -172.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -99.84 69.68 1.58 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 122.951 1.358 . . . . 0.0 111.177 -169.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.3 t -83.3 69.86 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.571 1.149 . . . . 0.0 110.594 -169.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -121.9 129.03 25.32 Favored Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 123.57 0.748 . . . . 0.0 112.915 -174.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -88.15 -179.49 2.44 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.713 2.942 . . . . 0.0 112.669 -175.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.46 138.43 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 122.925 1.345 . . . . 0.0 114.018 -172.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -118.84 163.08 17.43 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 127.041 2.136 . . . . 0.0 112.38 -169.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -94.31 -179.98 5.1 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.204 1.002 . . . . 0.0 111.937 171.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.77 -21.35 64.49 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -71.41 -19.87 62.2 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.604 1.162 . . . . 0.0 113.893 170.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.12 5.61 60.67 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.6 1.571 . . . . 0.0 114.431 -176.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.89 139.58 30.38 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 118.362 1.081 . . . . 0.0 113.025 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.1 p -73.55 100.05 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.921 1.688 . . . . 0.0 110.641 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.12 -30.0 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.255 177.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 10.3 mmt -135.37 147.36 49.03 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 123.567 1.651 . . . . 0.0 111.347 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -103.95 79.97 1.7 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 126.477 1.911 . . . . 0.0 107.24 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.7 mt -99.96 73.14 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 122.398 1.094 . . . . 0.0 108.999 175.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.281 17.5 mt -77.89 86.62 4.11 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 122.752 1.263 . . . . 0.0 108.934 -178.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -59.84 103.18 0.19 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.094 1.757 . . . . 0.0 109.96 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -84.97 61.31 6.78 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 120.916 -1.115 . . . . 0.0 111.197 -177.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -79.75 128.27 33.21 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 121.949 0.881 . . . . 0.0 110.687 175.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.4 t -88.2 114.06 26.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 124.72 1.208 . . . . 0.0 108.128 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.37 135.8 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 121.084 0.468 . . . . 0.0 111.956 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 94.9 mtp -101.74 149.66 23.93 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.774 1.63 . . . . 0.0 110.97 174.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -69.63 152.19 45.02 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.773 1.229 . . . . 0.0 112.554 175.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? . . . . . 0 C--O 1.253 1.274 0 C-N-CA 125.088 1.355 . . . . 0.0 113.69 177.44 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 118.742 -0.647 . . . . 0.0 110.387 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -70.47 153.81 65.37 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.289 2.659 . . . . 0.0 112.584 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 45.4 t -137.46 139.66 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.552 1.541 . . . . 0.0 109.852 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -81.72 74.73 8.7 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.745 1.218 . . . . 0.0 110.766 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -132.32 163.13 29.34 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 127.148 2.179 . . . . 0.0 112.32 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.51 -26.29 3.11 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 125.31 1.433 . . . . 0.0 114.107 -171.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -143.72 151.19 39.72 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.088 2.155 . . . . 0.0 109.691 169.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.1 p -129.99 136.9 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.477 1.111 . . . . 0.0 111.074 175.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.63 160.95 69.95 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.641 0.776 . . . . 0.0 110.988 169.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -51.57 109.96 0.38 Allowed 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.205 2.603 . . . . 0.0 110.905 169.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -64.74 -28.73 69.79 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -166.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -68.1 -49.82 58.77 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.287 0.635 . . . . 0.0 110.361 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 t -75.82 -35.43 60.02 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.932 0.893 . . . . 0.0 112.345 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -58.04 -41.82 84.08 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.509 0.724 . . . . 0.0 110.024 173.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.7 tp -73.12 -44.47 60.22 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 118.959 -0.543 . . . . 0.0 112.27 173.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -48.61 -39.91 25.61 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.798 1.181 . . . . 0.0 112.424 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.0 m -60.12 -42.89 95.73 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 121.52 -0.737 . . . . 0.0 112.434 173.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.7 mm -69.09 -30.59 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.228 1.011 . . . . 0.0 110.334 176.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.3 mm -60.02 -51.62 70.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 172.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.5 mmp_? -59.9 -30.08 68.78 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.728 1.149 . . . . 0.0 111.812 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -64.48 -45.55 86.89 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.789 0.836 . . . . 0.0 112.519 176.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -100.97 3.14 41.36 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 178.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -57.35 -29.09 63.72 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.149 1.38 . . . . 0.0 113.313 -167.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.05 8.86 85.06 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.667 1.127 . . . . 0.0 115.701 171.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -125.31 -58.09 1.46 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.402 1.101 . . . . 0.0 112.029 174.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 62.2 p -70.84 -30.25 66.6 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.712 -0.618 . . . . 0.0 112.25 174.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.8 mmt85 -117.84 149.95 39.97 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 127.176 2.191 . . . . 0.0 109.39 169.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.12 150.18 51.5 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.354 1.462 . . . . 0.0 112.127 -167.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -169.75 163.32 9.87 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 116.76 2.133 . . . . 0.0 116.76 -170.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -126.66 170.15 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 128.231 2.612 . . . . 0.0 110.682 174.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.6 mm -124.18 117.71 51.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 126.033 1.733 . . . . 0.0 107.727 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.81 153.94 40.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.661 1.219 . . . . 0.0 111.931 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -83.74 110.46 18.33 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.77 1.228 . . . . 0.0 110.292 176.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.84 -12.53 60.4 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -100.17 -5.21 28.11 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.81 1.244 . . . . 0.0 113.812 -169.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 p -109.24 140.0 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.715 1.606 . . . . 0.0 111.339 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.99 -23.95 67.69 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -175.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -85.29 -5.92 59.29 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.153 1.381 . . . . 0.0 113.723 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.0 p 44.27 32.86 0.74 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 128.005 2.522 . . . . 0.0 116.123 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.82 156.3 34.59 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 116.767 2.136 . . . . 0.0 116.767 -167.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.9 t -79.94 91.27 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.15 0 C-N-CA 129.354 3.061 . . . . 0.0 109.148 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.5 pt -69.93 -23.74 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 126.096 1.758 . . . . 0.0 112.991 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -155.9 159.94 39.73 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.768 1.227 . . . . 0.0 112.917 177.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.46 ' SG ' HG23 ' A' ' 59' ' ' VAL . 4.0 m -139.84 140.78 36.63 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.813 -1.179 . . . . 0.0 111.32 -169.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -93.31 153.46 18.55 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 169.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -65.18 -23.96 67.24 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 122.031 -0.418 . . . . 0.0 111.583 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.93 -50.0 46.27 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 119.191 -0.783 . . . . 0.0 112.515 169.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -39.55 83.35 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 119.454 1.627 . . . . 0.0 110.897 175.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 16.1 t -60.19 -40.8 91.27 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 121.665 -0.647 . . . . 0.0 110.758 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -78.67 -28.7 45.34 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.066 0.946 . . . . 0.0 112.473 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 52.8 tp -62.13 -55.78 25.44 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.786 1.234 . . . . 0.0 111.412 175.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 77.7 m -97.43 -20.2 17.94 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 -172.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.27 12.9 83.86 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-O 118.692 -1.06 . . . . 0.0 115.459 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -88.92 -124.3 0.05 Allowed 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 119.172 1.486 . . . . 0.0 111.095 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.9 t -159.97 150.16 18.52 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.312 1.845 . . . . 0.0 109.683 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -52.19 -37.52 55.07 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.429 -0.795 . . . . 0.0 112.432 171.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.0 -20.19 63.63 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -86.17 -20.84 28.0 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.599 1.56 . . . . 0.0 112.55 176.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.46 HG23 ' SG ' ' A' ' 44' ' ' CYS . 15.5 m -105.42 -17.37 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 125.229 1.412 . . . . 0.0 114.377 176.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 3.3 mmt -49.87 113.14 0.78 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.809 1.644 . . . . 0.0 111.223 -175.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 67.07 29.76 7.77 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.766 1.627 . . . . 0.0 112.378 169.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -106.74 154.0 40.38 Favored Pre-proline 0 N--CA 1.471 0.593 0 CA-C-O 117.283 -1.342 . . . . 0.0 112.606 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -48.64 135.25 27.5 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.576 2.85 . . . . 0.0 113.934 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 14.3 t -68.17 -9.79 49.43 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.296 1.038 . . . . 0.0 113.236 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.37 87.26 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.573 1.949 . . . . 0.0 110.848 175.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 26.2 p -54.48 -13.04 0.82 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.611 2.365 . . . . 0.0 114.733 -171.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.554 ' HA ' ' CG ' ' A' ' 70' ' ' HIS . 1.6 p30 -51.15 -22.9 2.81 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 167.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -53.49 -23.55 10.61 Favored 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 169.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.287 2.0 pp -123.14 24.0 9.0 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 170.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.554 ' CG ' ' HA ' ' A' ' 67' ' ' ASP . 1.8 m-70 -67.46 146.45 53.98 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.327 -1.483 . . . . 0.0 112.573 169.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.21 -178.95 23.37 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 124.955 1.264 . . . . 0.0 113.844 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.52 -9.99 24.59 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.591 2.861 . . . . 0.0 114.32 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -89.97 -10.15 46.11 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.009 1.324 . . . . 0.0 113.087 174.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.67 HG23 ' H ' ' A' ' 97' ' ' ALA . 3.0 m -84.16 143.63 29.52 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -168.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -84.55 138.36 32.79 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.651 1.215 . . . . 0.0 112.605 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.9 mmt85 -69.99 -39.99 75.58 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.51 -0.743 . . . . 0.0 111.208 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -57.59 -37.42 73.18 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.221 1.408 . . . . 0.0 113.822 170.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.9 -53.31 52.49 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.005 0.907 . . . . 0.0 110.055 173.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.86 -35.1 79.52 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.423 -0.808 . . . . 0.0 113.009 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.14 -54.1 20.42 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.173 1.389 . . . . 0.0 111.623 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -50.22 -40.83 48.65 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.212 0.914 . . . . 0.0 112.777 171.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.3 mt -63.74 -49.22 83.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 O-C-N 121.495 -0.753 . . . . 0.0 111.433 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.74 -39.99 59.43 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.346 0.521 . . . . 0.0 111.677 173.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -63.43 -39.96 95.88 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.347 0.659 . . . . 0.0 111.796 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.51 -30.3 69.08 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 176.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 mt -83.18 -35.52 25.42 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 pp -70.49 -27.87 64.54 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 118.326 0.512 . . . . 0.0 111.914 168.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.94 16.36 10.75 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.095 -0.836 . . . . 0.0 114.244 168.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.89 -49.82 65.12 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 118.265 1.033 . . . . 0.0 111.99 175.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -155.56 141.66 18.33 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.602 1.561 . . . . 0.0 111.649 171.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -79.31 110.15 14.32 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.199 -0.938 . . . . 0.0 109.164 170.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -155.88 145.27 20.87 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.312 1.045 . . . . 0.0 111.203 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -76.77 143.12 40.08 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.143 1.377 . . . . 0.0 111.638 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -136.49 145.32 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.995 0.918 . . . . 0.0 110.105 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -81.15 147.97 29.8 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.113 0.965 . . . . 0.0 109.99 170.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -158.46 156.93 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 110.27 -176.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.67 ' H ' HG23 ' A' ' 74' ' ' THR . . . -110.12 145.34 37.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.107 0.963 . . . . 0.0 112.41 175.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -130.61 156.14 45.37 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.821 1.248 . . . . 0.0 111.472 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -120.43 138.34 53.84 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.703 0.764 . . . . 0.0 111.913 168.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 28.3 mtp-105 -80.51 166.64 20.99 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.394 1.477 . . . . 0.0 112.847 177.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -56.56 -32.38 65.11 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.616 1.967 . . . . 0.0 113.109 175.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -78.25 -9.89 59.42 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 175.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.75 -1.09 58.04 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.693 1.616 . . . . 0.0 115.826 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 73.3 m -70.15 128.56 36.71 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 119.778 1.789 . . . . 0.0 111.036 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 45.5 t -128.65 125.61 38.43 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.717 1.207 . . . . 0.0 112.201 -170.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -150.96 149.68 29.9 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -171.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.01 125.27 46.04 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.596 1.958 . . . . 0.0 107.177 167.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.406 ' SG ' HG13 ' A' ' 131' ' ' VAL . 81.1 m -125.7 168.47 13.71 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.571 1.148 . . . . 0.0 110.31 169.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.25 59.89 2.93 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.652 -1.28 . . . . 0.0 110.244 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.0 t -63.06 147.48 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.811 1.244 . . . . 0.0 111.206 -172.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -103.58 69.74 1.0 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.724 0.774 . . . . 0.0 111.723 -168.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.4 t -83.22 69.75 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 121.339 -0.851 . . . . 0.0 110.965 -168.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.7 m -112.92 136.47 21.68 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 124.728 1.211 . . . . 0.0 110.368 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -86.13 -161.64 0.13 Allowed 'Trans proline' 0 CA--C 1.552 1.421 0 C-N-CA 123.105 2.536 . . . . 0.0 110.08 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.7 m -127.1 131.13 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-O 122.992 1.377 . . . . 0.0 113.062 172.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.1 pmtp? -122.01 160.04 25.75 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.947 2.099 . . . . 0.0 112.253 -176.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -90.07 -179.41 5.67 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.794 0.838 . . . . 0.0 111.499 178.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.88 -21.7 61.36 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -73.64 -19.91 60.72 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.713 1.205 . . . . 0.0 114.134 171.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.89 -4.28 63.07 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.47 1.51 . . . . 0.0 114.142 -176.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -79.84 129.25 34.32 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 118.26 1.03 . . . . 0.0 112.025 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.7 p -67.86 99.74 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 127.008 2.123 . . . . 0.0 110.509 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.97 -29.63 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.795 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.73 149.96 49.37 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 124.002 1.858 . . . . 0.0 111.713 174.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -103.01 80.03 1.82 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.149 -1.387 . . . . 0.0 107.797 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.0 mt -100.0 71.32 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 O-C-N 120.24 -1.537 . . . . 0.0 108.336 171.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.41 HD22 ' N ' ' A' ' 127' ' ' LEU . 1.8 mm? -74.33 86.86 1.99 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 123.362 1.553 . . . . 0.0 109.453 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -59.85 103.08 0.18 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 112.847 -1.979 . . . . 0.0 110.326 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -87.15 53.35 2.79 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 120.543 -1.348 . . . . 0.0 111.937 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -79.86 106.96 12.27 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 123.569 1.652 . . . . 0.0 111.868 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.406 HG13 ' SG ' ' A' ' 108' ' ' CYS . 3.4 t -59.85 118.91 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.435 1.494 . . . . 0.0 108.89 169.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.38 145.99 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 122.463 0.305 . . . . 0.0 110.603 170.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 78.3 mtm -142.74 155.17 44.82 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.675 1.59 . . . . 0.0 111.012 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -73.06 151.81 41.53 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.163 0.985 . . . . 0.0 112.616 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 C--O 1.252 1.213 0 C-N-CA 125.405 1.482 . . . . 0.0 112.102 178.143 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.287 51.8 tpp . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 116.871 -1.537 . . . . 0.0 113.132 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.51 135.6 54.13 Favored 'Trans proline' 0 C--N 1.356 0.948 0 CA-C-N 122.542 1.943 . . . . 0.0 113.45 -175.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.51 149.43 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.143 0.977 . . . . 0.0 112.652 -174.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -75.32 144.53 42.36 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.213 1.005 . . . . 0.0 111.362 176.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.64 148.73 25.83 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.781 1.633 . . . . 0.0 112.081 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.94 -24.17 60.37 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 124.187 0.899 . . . . 0.0 114.569 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -143.85 154.08 43.01 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.069 1.748 . . . . 0.0 110.781 175.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.57 110.02 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 122.051 0.929 . . . . 0.0 112.175 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.7 160.38 80.03 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.438 1.095 . . . . 0.0 110.163 168.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -44.99 110.11 0.21 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 124.161 3.241 . . . . 0.0 111.817 174.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -63.12 -29.05 70.49 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -164.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -70.02 -49.98 46.0 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.096 0.862 . . . . 0.0 110.72 -176.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 t -77.05 -35.51 56.75 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.685 1.194 . . . . 0.0 112.392 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -57.04 -45.68 82.98 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.284 0.634 . . . . 0.0 110.143 170.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.6 tp -69.95 -42.28 73.43 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 118.549 -0.738 . . . . 0.0 111.237 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -50.01 -39.85 42.69 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.125 1.33 . . . . 0.0 113.073 172.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 58.1 m -60.13 -42.24 94.4 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.348 0.659 . . . . 0.0 112.503 171.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.1 mm -68.49 -35.35 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 O-C-N 121.204 -0.935 . . . . 0.0 110.023 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.5 mm -56.5 -51.14 68.71 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 CA-C-O 117.903 -1.046 . . . . 0.0 108.713 170.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -27.71 66.69 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.145 1.339 . . . . 0.0 112.906 175.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -66.78 -43.92 82.73 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.563 1.145 . . . . 0.0 112.449 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -107.91 7.61 28.11 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -55.49 -29.0 58.01 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.39 1.476 . . . . 0.0 114.504 -167.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.52 33.85 41.92 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 115.605 1.002 . . . . 0.0 115.605 169.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -61.66 -17.78 56.85 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 118.897 1.348 . . . . 0.0 113.895 175.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.6 p -89.3 19.81 4.16 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.177 2.191 . . . . 0.0 113.994 173.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 mmt85 -51.98 149.93 4.67 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.053 1.741 . . . . 0.0 114.644 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.1 151.81 45.63 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 128.171 2.588 . . . . 0.0 110.907 173.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -169.76 163.11 9.83 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 -172.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -121.29 170.83 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.277 1.431 . . . . 0.0 111.512 170.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.0 mm -123.48 116.99 49.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 126.154 1.782 . . . . 0.0 107.428 172.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.5 149.97 50.36 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -76.42 106.67 8.19 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.511 0.672 . . . . 0.0 111.445 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.6 -13.17 60.97 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -91.64 0.91 57.46 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.855 1.662 . . . . 0.0 114.117 -173.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.77 140.12 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.438 1.495 . . . . 0.0 110.943 -173.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -59.78 -26.6 65.85 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.95 -8.65 59.69 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.674 1.19 . . . . 0.0 113.937 177.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 27.1 p 36.46 51.34 0.85 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.241 2.217 . . . . 0.0 115.631 175.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.03 160.2 14.5 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -168.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.2 t -79.85 89.97 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 129.028 2.931 . . . . 0.0 109.071 -171.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.4 pt -69.95 -24.27 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.241 1.416 . . . . 0.0 112.201 175.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -155.35 159.71 40.15 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.197 0.999 . . . . 0.0 111.836 172.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.4 p -142.22 149.07 39.17 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -177.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -86.44 149.99 24.6 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.623 0.725 . . . . 0.0 111.559 168.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -67.87 -24.93 65.29 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.597 176.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.39 -50.0 49.18 Favored Glycine 0 CA--C 1.534 1.239 0 O-C-N 120.903 -1.123 . . . . 0.0 112.941 170.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -29.85 66.79 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 118.965 1.383 . . . . 0.0 111.376 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 23.2 t -60.04 -39.78 87.1 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.186 0.994 . . . . 0.0 110.2 172.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -78.21 -29.99 48.64 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.328 -0.857 . . . . 0.0 112.403 174.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.8 tp -56.44 -53.9 51.99 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.371 1.068 . . . . 0.0 110.602 174.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.8 p -80.01 -27.91 39.5 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.2 12.78 75.59 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 125.531 1.539 . . . . 0.0 115.986 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -89.04 -121.47 0.05 Allowed 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 119.552 1.676 . . . . 0.0 112.899 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.4 t -159.9 144.36 14.78 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.346 1.858 . . . . 0.0 109.981 -176.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.2 ptm85 -64.69 -30.02 71.03 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 120.891 -1.131 . . . . 0.0 113.593 -173.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.47 -16.76 39.7 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.211 1.005 . . . . 0.0 113.361 172.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -89.94 -20.57 23.19 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.532 1.933 . . . . 0.0 112.225 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 m -96.23 -19.98 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-N 119.243 0.928 . . . . 0.0 113.331 -173.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 35.3 mmt -50.01 115.71 1.52 Allowed 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.522 1.129 . . . . 0.0 111.014 -170.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 67.66 29.49 6.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.696 1.598 . . . . 0.0 112.862 169.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -100.81 151.63 37.65 Favored Pre-proline 0 N--CA 1.477 0.882 0 CA-C-O 117.756 -1.116 . . . . 0.0 113.716 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -54.54 135.28 65.82 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.262 2.641 . . . . 0.0 113.171 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 49.6 t -68.73 -12.54 61.56 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 126.349 1.86 . . . . 0.0 112.894 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -63.61 100.11 0.26 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 126.708 2.003 . . . . 0.0 111.046 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 30.2 p -49.89 -19.42 0.68 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.397 1.879 . . . . 0.0 115.614 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -48.13 -43.94 31.62 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.755 1.222 . . . . 0.0 111.939 169.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -67.06 -11.48 57.22 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 pp -123.1 20.04 9.9 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.95 1.7 . . . . 0.0 113.523 172.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -60.8 144.38 52.67 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.312 -0.868 . . . . 0.0 113.241 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.97 172.05 19.51 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 125.216 1.389 . . . . 0.0 113.074 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -65.92 -10.17 25.91 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.448 2.099 . . . . 0.0 116.062 -172.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 77.5 mtm-85 -110.1 0.05 18.18 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.765 1.626 . . . . 0.0 114.91 171.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 6.9 m -67.58 136.68 54.85 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.976 1.262 . . . . 0.0 111.305 175.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -82.64 132.81 35.18 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.581 1.181 . . . . 0.0 110.636 175.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -67.65 -39.79 84.59 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.585 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -41.37 63.5 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.432 1.093 . . . . 0.0 113.397 169.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.403 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -67.78 -49.98 59.52 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 124.44 1.096 . . . . 0.0 110.211 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.25 -33.41 75.75 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.301 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.04 -51.14 34.53 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.302 1.441 . . . . 0.0 112.495 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -49.94 -43.42 49.89 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.779 1.232 . . . . 0.0 111.223 170.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.4 mt -64.06 -49.16 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 121.895 -0.503 . . . . 0.0 111.256 174.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.01 -39.87 56.82 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.575 -0.726 . . . . 0.0 112.175 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -69.06 -38.07 78.86 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.582 0.753 . . . . 0.0 111.379 176.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.6 -33.02 74.73 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.446 -0.784 . . . . 0.0 111.496 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mt -82.62 -29.66 29.98 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.417 0.687 . . . . 0.0 111.9 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.26 -28.75 69.56 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.338 2.255 . . . . 0.0 111.001 169.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.98 18.22 8.99 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.043 1.306 . . . . 0.0 114.799 169.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.55 -49.99 74.45 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.63 1.215 . . . . 0.0 111.024 177.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -163.0 144.35 9.82 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.364 1.865 . . . . 0.0 110.98 169.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -72.07 117.59 13.88 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 167.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.5 tpp180 -149.31 137.23 20.49 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.446 1.098 . . . . 0.0 111.161 -176.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -76.79 127.42 32.72 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.216 1.006 . . . . 0.0 109.958 169.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -129.05 154.46 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.423 1.489 . . . . 0.0 108.863 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -79.9 160.12 26.13 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.221 1.008 . . . . 0.0 110.302 169.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.403 HG23 ' HB1' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -166.59 152.85 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.133 0.973 . . . . 0.0 111.115 169.759 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -85.88 145.32 27.23 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.122 174.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -115.39 163.03 16.31 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.345 1.458 . . . . 0.0 111.506 169.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -135.38 140.09 44.72 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.089 0.471 . . . . 0.0 111.799 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 19.4 mmm-85 -74.19 140.12 44.9 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 168.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -13.8 2.82 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -171.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -72.61 -9.99 59.26 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.198 1.399 . . . . 0.0 113.829 170.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.64 4.43 26.55 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 126.332 1.92 . . . . 0.0 115.467 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 52.6 m -86.5 100.23 12.23 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 118.838 1.319 . . . . 0.0 111.631 -173.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 25.2 t -106.33 137.84 43.59 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.107 1.363 . . . . 0.0 113.924 -172.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -150.99 146.05 25.97 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.439 1.496 . . . . 0.0 113.184 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -100.04 125.45 46.1 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.927 1.691 . . . . 0.0 109.233 170.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 78.2 m -129.6 173.6 10.45 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.048 1.339 . . . . 0.0 110.51 171.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 70.9 mt -79.88 59.84 3.29 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.006 -1.059 . . . . 0.0 111.403 -175.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 47.1 t -62.42 141.83 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.584 1.554 . . . . 0.0 111.426 -172.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -105.26 69.95 0.87 Allowed 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 122.486 1.136 . . . . 0.0 112.554 -168.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.8 t -81.18 70.77 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.071 1.348 . . . . 0.0 111.43 -168.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.8 p -120.5 129.28 25.4 Favored Pre-proline 0 N--CA 1.484 1.249 0 CA-C-O 118.408 -0.806 . . . . 0.0 111.945 -176.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -88.18 -166.61 0.27 Allowed 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.972 3.114 . . . . 0.0 112.435 -173.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -126.29 131.37 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 122.991 1.377 . . . . 0.0 113.415 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -119.01 159.95 22.92 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.081 2.153 . . . . 0.0 111.507 -172.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -89.89 -179.96 5.84 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.02 0.928 . . . . 0.0 111.935 174.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.18 -21.72 64.06 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -72.23 -19.89 61.64 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.698 1.199 . . . . 0.0 113.916 170.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.46 0.9 60.84 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.588 1.566 . . . . 0.0 114.238 -176.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -87.93 139.16 30.8 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.538 1.169 . . . . 0.0 112.937 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.7 p -77.99 98.34 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 125.142 1.377 . . . . 0.0 110.872 -174.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.63 -29.97 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.002 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.8 mmt -136.2 148.04 47.92 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 123.502 1.62 . . . . 0.0 111.122 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.7 m-30 -105.15 87.59 2.67 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 125.767 1.627 . . . . 0.0 106.733 -178.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 43.4 mt -103.83 73.76 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 122.574 1.178 . . . . 0.0 108.471 174.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.312 34.9 mt -80.62 84.06 6.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 123.208 1.48 . . . . 0.0 110.064 -176.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -59.87 104.74 0.32 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.018 2.127 . . . . 0.0 110.825 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -87.41 58.17 4.82 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 120.614 -1.304 . . . . 0.0 112.378 -175.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -79.79 106.89 12.14 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 124.772 2.225 . . . . 0.0 112.46 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 42.8 t -65.63 110.75 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 127.344 2.258 . . . . 0.0 109.218 174.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p -140.37 137.89 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 71.0 mtm -142.87 158.12 43.93 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.001 1.72 . . . . 0.0 110.731 169.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -75.19 147.96 39.96 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.923 -0.486 . . . . 0.0 111.705 169.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.109 0 C-N-CA 126.063 1.745 . . . . 0.0 112.778 -175.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 119.2 -0.429 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.86 -13.9 15.76 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.289 2.659 . . . . 0.0 114.325 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.0 m -73.91 20.0 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 125.696 1.598 . . . . 0.0 114.928 -175.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 54.8 ptt85 -93.81 19.76 8.46 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 126.472 1.909 . . . . 0.0 113.822 176.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 42.4 ptt85 -152.83 60.97 0.79 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 127.916 2.486 . . . . 0.0 109.76 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.39 -171.54 43.38 Favored Glycine 0 CA--C 1.538 1.492 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.044 -168.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -71.82 138.53 48.37 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.506 -0.997 . . . . 0.0 111.938 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.4 t -130.1 142.82 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.711 1.604 . . . . 0.0 109.034 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.43 159.89 28.53 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 123.515 0.726 . . . . 0.0 112.097 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.05 106.34 0.65 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.091 2.528 . . . . 0.0 112.169 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -66.22 -26.52 67.41 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -169.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -69.99 -49.92 46.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.359 0.664 . . . . 0.0 110.39 -176.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.2 t -76.21 -34.53 59.27 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.04 0.936 . . . . 0.0 112.399 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -58.86 -41.77 87.81 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.693 -0.629 . . . . 0.0 110.29 172.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.5 tp -70.71 -45.52 64.8 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-O 118.76 -0.638 . . . . 0.0 112.072 173.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -47.47 -39.81 16.75 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.261 1.424 . . . . 0.0 113.213 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 85.5 m -60.09 -44.6 94.67 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.639 -0.663 . . . . 0.0 112.235 172.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.6 mm -67.31 -35.86 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.952 0.901 . . . . 0.0 110.661 175.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.9 mm -55.79 -54.38 26.98 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 CA-C-O 118.356 -0.83 . . . . 0.0 108.845 172.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 55.4 mtm180 -60.01 -28.44 67.73 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.115 0.871 . . . . 0.0 112.979 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.1 tttt -64.23 -41.16 97.13 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 172.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -105.77 2.99 28.35 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -55.25 -29.02 57.25 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.6 1.96 . . . . 0.0 115.239 -167.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.34 55.44 6.17 Favored Glycine 0 CA--C 1.532 1.127 0 O-C-N 121.558 -0.714 . . . . 0.0 112.9 177.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -65.0 -6.31 8.29 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 -171.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 63.3 p -72.61 -19.08 61.53 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.719 1.208 . . . . 0.0 112.989 168.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 -82.79 153.43 25.23 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.144 1.778 . . . . 0.0 111.177 175.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.27 148.67 33.66 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.739 1.616 . . . . 0.0 112.15 -169.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -169.79 161.31 9.08 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -171.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -120.08 172.15 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.548 1.539 . . . . 0.0 111.248 173.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.5 mm -130.01 117.79 42.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 125.621 1.568 . . . . 0.0 107.92 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.12 148.99 52.03 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -81.79 106.61 13.86 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.688 0.756 . . . . 0.0 110.539 174.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.23 -9.31 58.48 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -95.19 -5.79 43.14 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.639 1.176 . . . . 0.0 114.112 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.79 140.21 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.942 1.297 . . . . 0.0 109.952 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -56.1 -31.07 62.93 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -175.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -83.83 -9.1 59.01 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 73.7 m 45.33 51.18 9.59 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.045 1.738 . . . . 0.0 113.112 -177.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.23 153.08 22.27 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -167.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 67.5 t -80.07 90.04 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 127.957 2.503 . . . . 0.0 108.947 -178.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.7 pt -69.94 -24.21 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.648 1.179 . . . . 0.0 112.141 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -155.38 159.71 40.12 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.475 1.11 . . . . 0.0 112.237 175.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.4 p -139.88 150.94 45.23 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.925 -1.109 . . . . 0.0 112.76 175.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -83.66 156.13 22.81 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 175.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -61.15 -27.77 68.64 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.887 -0.508 . . . . 0.0 111.768 172.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.85 -51.62 44.06 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-O 118.99 -0.894 . . . . 0.0 112.727 169.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.42 -40.11 67.97 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.592 1.696 . . . . 0.0 110.404 174.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.1 t -60.27 -40.91 92.06 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.032 0.533 . . . . 0.0 111.725 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -75.7 -28.93 58.81 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.763 0.825 . . . . 0.0 112.453 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 50.7 tp -66.57 -55.71 14.18 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.206 1.402 . . . . 0.0 111.483 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 33.6 m -93.76 -20.9 19.68 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.092 0.957 . . . . 0.0 112.726 -173.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 72.25 11.57 75.63 Favored Glycine 0 CA--C 1.541 1.706 0 N-CA-C 116.027 1.171 . . . . 0.0 116.027 177.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -90.49 -118.15 0.07 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.239 1.519 . . . . 0.0 111.058 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.3 t -159.91 150.13 18.6 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.945 1.698 . . . . 0.0 110.518 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -55.06 -38.67 68.33 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.947 1.299 . . . . 0.0 112.148 178.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.1 -20.08 63.66 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.352 1.061 . . . . 0.0 113.61 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -82.35 -20.74 36.65 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.212 1.405 . . . . 0.0 112.123 175.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -105.36 -18.59 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 32.2 mmt -49.89 111.77 0.56 Allowed 'General case' 0 C--N 1.344 0.34 0 CA-C-N 119.637 1.108 . . . . 0.0 111.083 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 71.03 18.13 5.99 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.108 1.763 . . . . 0.0 113.652 170.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.49 162.07 70.01 Favored Pre-proline 0 N--CA 1.474 0.727 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.668 167.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -57.67 140.01 92.11 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.961 2.441 . . . . 0.0 112.648 170.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 32.4 t -67.56 -14.3 62.81 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.249 1.019 . . . . 0.0 112.617 171.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.0 m -64.65 100.1 0.36 Allowed 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 126.714 2.005 . . . . 0.0 110.585 176.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 29.6 p -51.58 -18.62 1.19 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.894 1.678 . . . . 0.0 115.402 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -48.71 -41.84 33.11 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.114 1.365 . . . . 0.0 111.375 169.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -56.29 -24.71 44.96 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.716 1.606 . . . . 0.0 113.355 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 pp -123.14 19.98 9.88 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.419 1.887 . . . . 0.0 114.084 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.76 150.46 47.84 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.916 -1.115 . . . . 0.0 113.375 -177.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -130.58 -173.07 13.27 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.799 1.19 . . . . 0.0 115.532 -169.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -68.95 -10.17 28.39 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.383 2.722 . . . . 0.0 115.876 -169.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.4 ttm-85 -109.98 -4.7 15.76 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.086 1.354 . . . . 0.0 113.284 171.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.535 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 3.2 m -75.43 136.64 40.71 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.451 1.023 . . . . 0.0 110.489 -177.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -80.39 132.77 35.81 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 122.738 1.256 . . . . 0.0 109.675 171.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -68.24 -39.75 82.19 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.514 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -53.08 -38.95 62.97 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.488 1.115 . . . . 0.0 113.87 169.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.42 -50.28 53.92 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.357 1.063 . . . . 0.0 110.707 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.48 -33.88 76.91 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.03 -51.47 31.95 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.859 1.264 . . . . 0.0 112.435 177.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -50.07 -41.87 48.87 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.659 1.183 . . . . 0.0 111.916 170.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 34.3 mt -63.65 -49.62 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 O-C-N 121.745 -0.597 . . . . 0.0 111.077 173.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.63 -39.8 51.39 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.208 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -69.43 -36.78 76.99 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.601 0.76 . . . . 0.0 111.685 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.35 -31.09 70.24 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.503 -0.748 . . . . 0.0 111.547 177.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mt -82.59 -31.76 28.79 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.437 0.695 . . . . 0.0 111.342 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.44 -29.75 70.99 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.112 2.165 . . . . 0.0 111.311 169.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.95 20.22 7.71 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.907 1.241 . . . . 0.0 114.929 169.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.23 -50.04 74.69 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 118.857 1.328 . . . . 0.0 110.79 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -163.66 144.98 9.14 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.464 2.306 . . . . 0.0 109.34 168.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -84.9 122.26 28.93 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.984 -1.073 . . . . 0.0 108.728 170.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.8 tpp180 -154.64 150.11 27.32 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.019 1.328 . . . . 0.0 110.537 -169.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -76.73 135.29 39.03 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 171.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -129.42 154.2 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.953 1.301 . . . . 0.0 108.66 172.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -79.83 160.12 26.22 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.084 0.953 . . . . 0.0 109.642 169.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -168.46 150.55 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.362 0.983 . . . . 0.0 110.945 169.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.535 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -89.54 145.36 25.33 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.937 173.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -112.29 159.78 18.3 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.459 1.503 . . . . 0.0 111.771 169.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -132.79 140.01 47.8 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.434 0.694 . . . . 0.0 111.102 169.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -82.47 160.24 22.72 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.938 1.295 . . . . 0.0 113.282 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -54.31 -30.74 52.11 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.613 1.965 . . . . 0.0 113.125 170.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -76.81 -9.95 59.03 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.121 1.368 . . . . 0.0 113.985 175.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.31 4.66 56.24 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 125.755 1.645 . . . . 0.0 115.886 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 58.7 m -87.94 132.26 34.29 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.061 1.431 . . . . 0.0 111.642 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 27.0 p -124.28 140.01 53.36 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.654 1.182 . . . . 0.0 113.529 -174.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -151.0 140.06 21.08 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.306 1.442 . . . . 0.0 113.29 -170.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.476 HD13 ' N ' ' A' ' 108' ' ' CYS . 2.0 tm? -110.16 136.12 49.88 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.916 2.086 . . . . 0.0 109.311 171.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.476 ' N ' HD13 ' A' ' 107' ' ' LEU . 1.6 m -142.28 178.69 7.39 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.318 1.447 . . . . 0.0 111.653 170.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -78.15 59.85 2.32 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.48 1.112 . . . . 0.0 110.192 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.4 t -60.45 146.76 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.975 1.71 . . . . 0.0 111.572 -171.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -102.25 69.71 1.15 Allowed 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 122.437 1.113 . . . . 0.0 112.981 -167.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.0 t -83.44 69.93 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.761 0.824 . . . . 0.0 110.052 -169.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 49.1 t -118.7 123.73 28.91 Favored Pre-proline 0 N--CA 1.484 1.26 0 CA-C-O 118.074 -0.965 . . . . 0.0 111.945 -169.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -81.37 179.91 5.47 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.534 2.823 . . . . 0.0 114.577 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.4 133.05 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.191 1.396 . . . . 0.0 112.928 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -118.74 166.65 12.51 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.421 1.888 . . . . 0.0 112.509 -169.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -96.79 -179.99 4.77 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.995 0.918 . . . . 0.0 112.029 170.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.0 -21.42 64.85 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -71.01 -19.87 62.46 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.574 1.15 . . . . 0.0 113.785 170.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.71 4.29 60.56 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.699 1.619 . . . . 0.0 114.432 -176.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -91.13 138.84 31.29 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.443 1.122 . . . . 0.0 113.014 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.06 100.18 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 126.123 1.769 . . . . 0.0 110.784 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.93 -29.51 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 118.805 -0.616 . . . . 0.0 111.915 173.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.63 147.87 51.5 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 124.248 1.975 . . . . 0.0 113.465 173.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -100.09 84.85 2.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 113.204 -1.816 . . . . 0.0 107.344 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 39.4 mt -100.02 69.99 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 169.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.5 mt -80.5 87.18 5.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.352 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -59.78 104.13 0.26 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.711 -178.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -83.91 49.94 1.72 Allowed 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.406 -1.434 . . . . 0.0 111.778 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -82.26 106.89 14.51 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 123.799 1.761 . . . . 0.0 112.846 -177.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 41.3 t -58.28 113.02 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 127.119 2.168 . . . . 0.0 109.286 170.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p -140.47 141.46 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 123.111 0.564 . . . . 0.0 111.359 176.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 20.5 ptp -139.01 155.43 47.99 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.467 1.507 . . . . 0.0 111.382 172.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -74.09 143.93 45.19 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.887 0.875 . . . . 0.0 111.868 173.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt . . . . . 0 C--O 1.254 1.329 0 C-N-CA 126.28 1.832 . . . . 0.0 111.827 -177.618 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 mmt . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -69.27 159.21 54.64 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.531 2.821 . . . . 0.0 112.641 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.9 m -135.22 158.06 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 125.764 1.625 . . . . 0.0 111.661 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -78.05 58.67 2.03 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.205 1.402 . . . . 0.0 113.795 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 61.4 ttt-85 -58.82 133.81 56.32 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.632 1.173 . . . . 0.0 111.404 176.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.75 9.63 86.76 Favored Glycine 0 CA--C 1.54 1.654 0 N-CA-C 115.592 0.997 . . . . 0.0 115.592 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -64.68 145.6 55.96 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.033 1.416 . . . . 0.0 112.349 175.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -82.01 123.43 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.155 0.982 . . . . 0.0 110.839 -175.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.36 159.89 37.05 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 124.612 1.165 . . . . 0.0 112.316 174.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -58.78 106.8 0.3 Allowed 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.141 2.56 . . . . 0.0 111.682 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -65.47 -26.49 67.96 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.774 1.028 . . . . 0.0 113.774 -168.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -69.98 -50.03 45.74 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.508 0.594 . . . . 0.0 110.493 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 t -77.0 -34.58 57.51 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.17 0.988 . . . . 0.0 112.378 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -59.17 -41.65 88.93 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.073 0.549 . . . . 0.0 110.165 172.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.6 tp -70.95 -45.25 64.48 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-O 118.654 -0.689 . . . . 0.0 112.04 173.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -47.83 -39.81 19.46 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 120.154 1.343 . . . . 0.0 113.146 174.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.6 m -60.01 -44.32 94.66 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.64 -0.663 . . . . 0.0 112.282 172.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.2 mm -67.94 -35.38 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.978 0.911 . . . . 0.0 110.837 175.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.2 mm -55.71 -54.53 25.11 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.462 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 172.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 -60.81 -27.51 68.1 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.125 0.875 . . . . 0.0 113.163 176.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -63.81 -42.14 97.75 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.436 0.694 . . . . 0.0 112.386 172.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -106.09 2.33 27.07 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -55.06 -29.17 56.94 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.352 1.861 . . . . 0.0 114.639 -167.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.64 55.43 11.77 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.159 0.885 . . . . 0.0 113.444 172.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -62.02 -4.21 1.54 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.945 2.098 . . . . 0.0 115.116 -169.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 72.6 p -74.87 15.2 0.41 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.125 1.77 . . . . 0.0 113.072 167.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.8 mtt180 -51.91 155.62 1.73 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.143 1.377 . . . . 0.0 113.216 173.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -113.26 138.43 50.02 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.916 1.287 . . . . 0.0 112.383 -166.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -169.79 162.37 9.51 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -173.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -119.98 172.23 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.337 1.455 . . . . 0.0 111.344 173.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.4 mm -127.08 118.44 50.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 125.764 1.626 . . . . 0.0 107.498 172.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.72 145.36 51.92 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -79.37 106.47 11.42 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.524 0.678 . . . . 0.0 110.684 176.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.52 -7.06 51.82 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -176.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -99.97 -4.68 29.59 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.91 1.284 . . . . 0.0 114.272 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.12 140.26 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.234 1.414 . . . . 0.0 110.243 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -55.06 -26.32 36.81 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -174.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -92.98 -10.32 36.75 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.944 1.298 . . . . 0.0 114.286 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 93.7 m 47.03 55.76 7.62 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.166 1.786 . . . . 0.0 113.259 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.97 157.8 16.61 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 -168.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.6 t -79.95 92.69 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 128.696 2.798 . . . . 0.0 108.728 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.0 pt -72.44 -24.76 22.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.21 1.404 . . . . 0.0 112.228 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -156.84 159.81 38.57 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.272 1.029 . . . . 0.0 112.359 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.4 p -139.94 151.94 45.96 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.094 -1.003 . . . . 0.0 113.368 -175.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -89.2 149.93 22.9 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.711 0.767 . . . . 0.0 111.672 167.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -65.09 -31.15 72.22 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.378 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.22 -50.83 38.6 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 119.451 -0.638 . . . . 0.0 112.812 172.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -29.85 66.9 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 119.258 1.529 . . . . 0.0 111.766 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 13.9 t -60.05 -40.03 88.01 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.542 -0.724 . . . . 0.0 110.962 171.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -80.19 -30.1 38.72 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 121.432 -0.793 . . . . 0.0 112.828 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.4 tp -54.93 -54.35 43.87 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.666 1.586 . . . . 0.0 110.111 172.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.3 m -80.0 -31.12 39.71 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 122.542 0.337 . . . . 0.0 111.624 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.93 17.22 63.67 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 125.438 1.494 . . . . 0.0 115.672 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -98.72 -118.88 0.14 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.073 1.349 . . . . 0.0 112.349 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.1 t -159.84 142.65 13.75 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.863 1.265 . . . . 0.0 111.499 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -59.61 -33.35 71.38 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.637 1.175 . . . . 0.0 113.07 -177.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.76 -16.63 42.24 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.628 1.171 . . . . 0.0 113.211 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -96.67 -20.76 18.04 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.505 1.522 . . . . 0.0 112.561 177.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 m -90.75 -20.04 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 CA-C-N 120.315 1.416 . . . . 0.0 113.378 -175.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 36.1 mmt -51.17 114.47 1.21 Allowed 'General case' 0 C--N 1.339 0.135 0 C-N-CA 124.283 1.033 . . . . 0.0 110.218 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 73.72 20.46 2.99 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.453 1.901 . . . . 0.0 114.769 173.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.98 152.95 95.77 Favored Pre-proline 0 N--CA 1.479 0.982 0 O-C-N 120.6 -1.313 . . . . 0.0 111.304 167.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -62.13 140.02 81.55 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.518 2.146 . . . . 0.0 110.714 170.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 18.9 t -65.19 -11.8 44.52 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.59 0.756 . . . . 0.0 112.879 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.06 87.69 0.11 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.91 1.684 . . . . 0.0 110.152 170.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 22.7 p -50.86 -13.08 0.12 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.229 2.212 . . . . 0.0 114.802 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.483 ' HA ' ' CG ' ' A' ' 70' ' ' HIS . 22.8 t70 -46.45 -31.84 2.93 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.088 1.355 . . . . 0.0 112.505 167.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -55.47 -22.15 19.52 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 174.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 pp -122.96 20.82 9.95 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.528 1.931 . . . . 0.0 114.593 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.561 ' CG ' HG21 ' A' ' 74' ' ' THR . 2.1 m-70 -69.42 151.57 45.95 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 120.753 -1.217 . . . . 0.0 113.652 174.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -124.34 -173.37 13.81 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.715 1.626 . . . . 0.0 114.461 -172.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.71 -10.04 27.93 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.601 2.867 . . . . 0.0 115.24 -171.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.4 tpt85 -94.72 -10.05 32.85 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.68 1.192 . . . . 0.0 113.21 171.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.561 HG21 ' CG ' ' A' ' 70' ' ' HIS . 2.0 m -83.17 138.41 33.66 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -169.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -93.2 138.04 31.97 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.744 1.259 . . . . 0.0 111.71 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.6 mmm-85 -69.26 -39.79 78.2 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.773 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.3 ptt-85 -52.18 -39.47 60.12 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 169.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.41 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -65.22 -51.4 61.15 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 122.053 0.93 . . . . 0.0 109.971 174.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.84 -35.77 79.23 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.02 -52.09 26.94 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 126.171 1.789 . . . . 0.0 111.345 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -50.07 -40.76 46.39 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.589 1.086 . . . . 0.0 112.906 169.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 40.6 mt -63.46 -50.24 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 119.183 -0.437 . . . . 0.0 111.343 173.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.74 -39.89 59.27 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.713 0.688 . . . . 0.0 111.904 174.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -63.46 -39.06 93.45 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.517 0.727 . . . . 0.0 111.716 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.01 -29.5 68.52 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 174.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mt -82.44 -38.9 23.33 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 pp -68.99 -29.65 67.89 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 169.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.85 18.27 9.02 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.927 -0.929 . . . . 0.0 114.042 169.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.6 -49.88 69.38 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 118.77 1.285 . . . . 0.0 110.664 173.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -158.49 134.18 8.9 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.584 1.954 . . . . 0.0 109.777 167.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -74.54 120.47 20.14 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.143 -0.973 . . . . 0.0 108.454 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -143.3 136.78 28.31 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.397 1.079 . . . . 0.0 111.685 -168.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -81.37 130.19 34.93 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.469 1.108 . . . . 0.0 109.384 169.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -136.58 145.63 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.611 1.165 . . . . 0.0 109.333 -174.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.95 150.75 30.39 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.876 0.871 . . . . 0.0 109.714 169.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.41 HG23 ' HB1' ' A' ' 78' ' ' ALA . 0.6 OUTLIER -162.01 146.56 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.614 1.165 . . . . 0.0 110.083 -179.113 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.471 ' H ' HG23 ' A' ' 74' ' ' THR . . . -91.06 145.46 24.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.051 0.541 . . . . 0.0 112.263 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -122.26 157.75 30.99 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.539 1.136 . . . . 0.0 111.633 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -120.9 140.07 52.33 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.31 0.644 . . . . 0.0 110.415 167.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -95.52 162.28 13.71 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.246 1.418 . . . . 0.0 111.656 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -57.78 -29.09 64.57 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.359 1.864 . . . . 0.0 113.189 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -74.24 -9.95 59.12 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.82 1.248 . . . . 0.0 113.859 175.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.93 6.73 56.92 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.602 1.572 . . . . 0.0 115.561 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 63.4 m -87.51 137.99 31.86 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 118.812 1.306 . . . . 0.0 111.247 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 44.0 t -134.13 128.04 33.3 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.176 0.99 . . . . 0.0 112.598 -177.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -151.05 155.52 39.17 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -174.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.413 HD13 ' N ' ' A' ' 108' ' ' CYS . 1.9 tm? -99.91 131.66 45.74 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.668 1.987 . . . . 0.0 109.736 169.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.413 ' N ' HD13 ' A' ' 107' ' ' LEU . 56.8 m -135.13 168.07 19.82 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.643 1.577 . . . . 0.0 110.256 169.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.07 59.94 3.44 Favored 'General case' 0 CA--C 1.548 0.869 0 O-C-N 121.038 -1.039 . . . . 0.0 111.128 -175.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.8 t -59.85 147.88 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.261 1.424 . . . . 0.0 111.716 -171.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -105.19 69.67 0.86 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 122.475 1.131 . . . . 0.0 111.812 -168.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 19.9 t -82.54 69.96 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.213 1.005 . . . . 0.0 110.695 -169.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.6 p -117.26 130.0 24.94 Favored Pre-proline 0 N--CA 1.485 1.285 0 C-N-CA 124.202 1.001 . . . . 0.0 112.973 -171.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -82.21 -177.57 3.57 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 124.828 3.686 . . . . 0.0 114.488 -173.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.425 HG23 ' HB2' ' A' ' 124' ' ' MET . 15.7 m -123.69 124.72 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-O 123.08 1.419 . . . . 0.0 112.802 171.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -109.73 165.61 11.56 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.33 2.252 . . . . 0.0 112.27 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -95.17 179.91 5.03 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 114.781 -1.1 . . . . 0.0 112.244 170.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.65 -21.4 65.67 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -70.19 -19.93 63.15 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.575 1.15 . . . . 0.0 113.677 169.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.36 2.2 59.03 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 126.048 1.785 . . . . 0.0 114.489 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.03 139.59 30.49 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 118.506 1.153 . . . . 0.0 113.324 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.8 p -71.26 100.14 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 125.395 1.478 . . . . 0.0 110.542 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.54 -29.97 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.091 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.037 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.425 ' HB2' HG23 ' A' ' 115' ' ' VAL . 10.1 mmt -136.46 143.63 43.97 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 123.705 1.717 . . . . 0.0 111.081 177.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -100.15 87.69 3.52 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 125.381 1.472 . . . . 0.0 107.756 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 36.4 mt -102.27 69.92 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 169.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.9 mt -79.94 87.72 5.35 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 122.284 1.04 . . . . 0.0 109.55 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -59.84 109.03 0.84 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.002 1.321 . . . . 0.0 110.643 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -87.43 49.98 1.92 Allowed 'General case' 0 CA--C 1.533 0.315 0 O-C-N 120.571 -1.331 . . . . 0.0 111.75 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -79.85 106.97 12.26 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 123.838 1.78 . . . . 0.0 111.536 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 20.1 t -60.13 119.93 5.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 126.718 2.007 . . . . 0.0 109.179 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.34 145.63 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 120.761 0.315 . . . . 0.0 111.078 175.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 91.8 mtp -129.77 153.72 47.93 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.974 1.71 . . . . 0.0 110.801 173.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.9 154.86 40.39 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.092 0.957 . . . . 0.0 113.066 175.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt . . . . . 0 C--O 1.253 1.27 0 C-N-CA 126.388 1.875 . . . . 0.0 111.787 -177.697 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 119.088 -0.482 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.56 169.22 22.8 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 123.973 3.115 . . . . 0.0 113.157 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . 0.288 33.0 m 50.03 33.61 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 127.291 2.236 . . . . 0.0 115.96 170.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 36.0 mtp-105 -70.49 152.64 43.79 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.639 1.176 . . . . 0.0 112.416 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -73.83 165.51 24.99 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.231 1.412 . . . . 0.0 113.079 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -150.47 167.9 30.31 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.264 1.412 . . . . 0.0 112.996 176.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -143.75 149.49 37.19 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.263 1.425 . . . . 0.0 112.202 -175.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.2 t -130.04 135.81 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.704 1.602 . . . . 0.0 109.243 173.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.63 159.83 57.92 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.554 0.742 . . . . 0.0 112.188 177.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.57 104.5 0.79 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.888 2.392 . . . . 0.0 112.107 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -66.57 -26.61 67.2 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.118 0.967 . . . . 0.0 113.208 -170.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -70.05 -49.86 47.0 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.526 0.73 . . . . 0.0 110.419 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 t -75.83 -33.87 60.08 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.954 0.902 . . . . 0.0 112.385 178.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -59.41 -41.17 88.84 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.743 -0.598 . . . . 0.0 110.438 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.6 tp -70.28 -44.84 67.56 Favored 'General case' 0 C--O 1.22 -0.447 0 CA-C-O 118.927 -0.559 . . . . 0.0 111.907 171.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -48.07 -39.7 20.93 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 120.003 1.274 . . . . 0.0 113.556 174.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.2 m -60.03 -42.58 94.68 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 121.704 -0.622 . . . . 0.0 112.289 172.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.5 mm -69.29 -34.15 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 O-C-N 121.113 -0.992 . . . . 0.0 110.857 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.9 mm -55.7 -54.32 27.42 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 169.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.92 -23.96 63.95 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.629 1.104 . . . . 0.0 113.436 175.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -68.62 -43.84 75.52 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.146 0.885 . . . . 0.0 112.495 171.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -102.75 0.26 32.63 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -56.59 -29.12 61.75 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.044 2.137 . . . . 0.0 114.141 -168.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.37 -1.65 60.06 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 125.869 1.7 . . . . 0.0 116.041 176.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -104.16 -25.43 12.93 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.616 1.566 . . . . 0.0 111.407 169.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.5 p -75.6 26.9 0.11 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 129.708 3.203 . . . . 0.0 114.513 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.39 168.84 3.26 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.618 1.167 . . . . 0.0 112.984 176.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -63.89 133.84 54.05 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.882 1.673 . . . . 0.0 113.902 -167.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -169.77 163.38 9.83 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.499 1.519 . . . . 0.0 113.935 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -120.9 170.48 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.849 1.26 . . . . 0.0 112.129 171.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.0 mm -120.66 114.44 43.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 168.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.07 152.82 43.82 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.653 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -85.86 119.39 26.13 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.8 -11.69 59.91 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.538 0.735 . . . . 0.0 112.891 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -100.05 -1.51 36.74 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.186 1.394 . . . . 0.0 114.185 -171.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.8 m -104.27 140.14 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 127.053 2.141 . . . . 0.0 111.58 -177.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -64.59 -27.86 69.24 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.395 1.078 . . . . 0.0 113.11 -174.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -84.47 -6.89 59.42 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.431 1.092 . . . . 0.0 113.28 173.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 46.7 m 49.47 39.89 17.74 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.781 1.632 . . . . 0.0 112.666 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.41 149.93 43.83 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -166.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.4 t -80.01 90.03 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 129.323 3.049 . . . . 0.0 108.511 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.3 pt -69.98 -21.87 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.949 1.3 . . . . 0.0 112.343 178.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -158.99 159.71 35.13 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.051 1.34 . . . . 0.0 111.711 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.4 p -139.98 148.3 41.7 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 120.77 -1.206 . . . . 0.0 113.876 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -82.56 151.33 26.46 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.489 0.662 . . . . 0.0 110.704 166.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -66.48 -28.67 68.76 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.512 175.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.1 -50.79 54.05 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 121.267 -0.896 . . . . 0.0 112.867 173.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -29.85 66.92 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.202 1.501 . . . . 0.0 110.581 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.6 t -60.04 -39.77 87.09 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.555 0.742 . . . . 0.0 110.266 173.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -78.15 -27.92 48.22 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.016 0.926 . . . . 0.0 112.534 173.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.7 tp -60.65 -49.39 77.7 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.471 1.108 . . . . 0.0 111.462 175.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 26.9 p -79.97 -27.4 39.72 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 169.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.2 24.52 61.2 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 125.168 1.366 . . . . 0.0 114.515 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.3 m-30 -90.21 -129.96 0.09 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.154 1.382 . . . . 0.0 111.887 -177.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.7 t -159.9 150.16 18.65 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.604 2.362 . . . . 0.0 109.013 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 67.6 mtp85 -56.27 -43.05 78.4 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 121.059 -1.026 . . . . 0.0 112.112 -171.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.4 -18.12 63.37 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.741 1.216 . . . . 0.0 113.69 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -86.84 -20.72 27.08 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.116 1.766 . . . . 0.0 112.178 176.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.4 m -103.57 -20.2 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -177.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 33.8 mmt -50.0 113.64 0.9 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 124.084 0.954 . . . . 0.0 110.709 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 71.47 20.47 4.84 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.03 1.732 . . . . 0.0 113.744 169.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.52 160.12 75.68 Favored Pre-proline 0 N--CA 1.475 0.808 0 CA-C-O 118.145 -0.931 . . . . 0.0 111.557 167.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.09 140.05 91.63 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.732 2.288 . . . . 0.0 113.073 173.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 37.8 t -63.95 -17.7 63.52 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.592 1.157 . . . . 0.0 112.384 170.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.7 m -64.83 89.45 0.07 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.471 1.908 . . . . 0.0 110.795 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 26.8 p -52.95 -13.29 0.42 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.655 1.982 . . . . 0.0 115.127 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -46.35 -37.79 7.97 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.456 1.502 . . . . 0.0 111.416 166.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.83 -23.08 63.07 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.25 3.0 pp -123.13 28.15 7.28 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.205 1.802 . . . . 0.0 113.729 174.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.43 148.71 47.8 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.913 -1.117 . . . . 0.0 113.27 172.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.85 173.77 22.87 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.714 1.626 . . . . 0.0 114.603 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.56 -10.11 27.24 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.308 2.672 . . . . 0.0 114.152 -174.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -110.04 0.02 18.25 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.165 1.386 . . . . 0.0 113.879 170.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.525 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 18.6 m -71.42 139.0 49.53 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.726 1.148 . . . . 0.0 111.384 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -79.96 129.94 34.89 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 123.099 1.428 . . . . 0.0 109.59 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -70.16 -39.7 75.16 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.398 -176.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -56.63 -36.75 69.85 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 170.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.419 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -66.55 -51.7 53.6 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 122.029 0.919 . . . . 0.0 110.324 174.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.0 -33.27 75.66 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.449 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.01 -50.16 44.3 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.321 1.449 . . . . 0.0 112.18 177.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -49.99 -41.06 46.19 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.563 1.074 . . . . 0.0 112.09 169.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 20.9 mt -64.07 -49.68 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 118.518 0.599 . . . . 0.0 111.937 172.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.12 -39.83 44.27 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.453 0.57 . . . . 0.0 112.022 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -68.43 -39.35 81.56 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.376 0.67 . . . . 0.0 111.764 176.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.15 -27.75 65.83 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.836 -0.54 . . . . 0.0 112.157 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mt -88.02 -34.77 17.9 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.302 0.641 . . . . 0.0 110.538 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.58 -37.63 73.49 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.275 1.83 . . . . 0.0 110.142 168.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 117.46 22.43 4.07 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.691 1.139 . . . . 0.0 114.962 170.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.08 -50.0 75.03 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 118.644 1.222 . . . . 0.0 111.036 174.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -162.74 143.85 9.97 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.173 1.789 . . . . 0.0 111.145 169.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.45 118.4 13.21 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 168.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.9 tpp180 -151.75 138.35 18.73 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.61 1.164 . . . . 0.0 111.685 -173.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -80.63 128.72 33.94 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.693 1.197 . . . . 0.0 110.091 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.34 148.94 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.319 1.447 . . . . 0.0 108.813 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -79.94 157.13 26.96 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.061 0.944 . . . . 0.0 110.399 171.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.579 HD11 HG21 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -164.11 149.13 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.994 0.918 . . . . 0.0 110.629 171.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.525 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -84.36 145.39 28.25 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.726 176.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -117.0 156.2 27.89 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.523 1.129 . . . . 0.0 111.155 175.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -122.75 140.17 53.18 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.173 0.511 . . . . 0.0 110.263 168.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -91.01 146.32 23.95 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.769 1.228 . . . . 0.0 109.687 175.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -49.86 -30.51 10.09 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 126.728 2.011 . . . . 0.0 114.577 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -75.67 -9.82 58.92 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 109.91 28.11 4.32 Favored Glycine 0 CA--C 1.536 1.397 0 N-CA-C 115.905 1.122 . . . . 0.0 115.905 169.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.6 m -119.02 138.54 52.76 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.529 1.132 . . . . 0.0 111.229 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 32.0 p -135.99 140.03 43.61 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -150.93 148.62 28.63 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.837 1.255 . . . . 0.0 113.723 -173.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -99.98 120.94 40.6 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.471 1.509 . . . . 0.0 108.296 167.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 75.3 m -122.74 163.49 20.08 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.465 1.506 . . . . 0.0 109.579 174.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 67.4 mt -79.99 59.85 3.36 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.211 -0.931 . . . . 0.0 111.25 -175.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.555 HG21 HD12 ' A' ' 96' ' ' ILE . 14.5 m -65.2 144.82 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.6 1.96 . . . . 0.0 111.69 -173.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -107.68 69.85 0.76 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 122.42 1.105 . . . . 0.0 112.394 -167.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.579 HG21 HD11 ' A' ' 96' ' ' ILE . 12.8 t -81.37 69.92 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.762 1.225 . . . . 0.0 111.452 -168.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.49 131.99 24.32 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 124.317 1.047 . . . . 0.0 112.364 -175.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -86.18 -170.65 0.71 Allowed 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 123.544 2.83 . . . . 0.0 112.911 -172.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -123.17 129.85 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 122.868 1.318 . . . . 0.0 112.688 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -117.64 159.86 22.23 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.006 2.122 . . . . 0.0 111.277 -174.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -89.88 -179.8 5.81 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.947 0.899 . . . . 0.0 111.923 175.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.17 -21.77 64.09 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -72.45 -19.91 61.49 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.656 1.182 . . . . 0.0 113.884 170.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.54 0.55 60.89 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.622 1.582 . . . . 0.0 114.203 -176.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -87.35 139.39 30.6 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.465 1.132 . . . . 0.0 112.927 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.8 p -77.63 100.0 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 125.449 1.5 . . . . 0.0 111.114 -175.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.25 -30.0 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.71 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.89 150.0 49.19 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 123.997 1.856 . . . . 0.0 113.053 173.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -103.73 84.07 2.22 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 126.166 1.786 . . . . 0.0 107.475 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 44.3 mt -99.97 70.01 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 122.855 1.312 . . . . 0.0 108.697 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.277 22.0 mt -78.74 85.4 4.75 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 122.998 1.38 . . . . 0.0 110.051 -177.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -59.89 105.71 0.42 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.456 1.902 . . . . 0.0 110.143 175.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -86.13 53.97 2.98 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.559 -1.338 . . . . 0.0 110.017 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -79.76 106.66 11.94 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 124.168 1.937 . . . . 0.0 111.241 -168.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.7 t -61.19 112.34 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 113.452 -1.704 . . . . 0.0 108.242 177.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.32 142.05 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 175.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 78.6 mtm -141.35 147.43 38.06 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.01 1.324 . . . . 0.0 111.552 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -70.74 153.55 42.68 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.686 1.194 . . . . 0.0 112.956 176.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 60.9 mttp . . . . . 0 C--O 1.252 1.221 0 C-N-CA 125.939 1.696 . . . . 0.0 112.295 -169.11 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 119.042 -0.504 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -59.81 154.45 49.63 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.634 2.89 . . . . 0.0 113.121 170.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.6 t -72.79 129.37 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.655 0.782 . . . . 0.0 110.622 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 25.1 ptt-85 -135.52 19.9 3.34 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.669 1.588 . . . . 0.0 114.428 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 -49.87 136.75 17.68 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.265 1.826 . . . . 0.0 113.091 -170.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.49 7.85 64.69 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 124.691 1.138 . . . . 0.0 114.403 -170.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -64.93 155.99 32.58 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.115 1.366 . . . . 0.0 112.973 173.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.3 m -79.34 146.81 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.324 1.45 . . . . 0.0 112.638 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.22 159.94 74.1 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 124.065 0.946 . . . . 0.0 111.274 169.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -58.91 108.38 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.283 2.655 . . . . 0.0 111.434 174.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -63.74 -27.5 69.24 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -168.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -70.01 -50.03 45.51 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.614 0.643 . . . . 0.0 110.473 -175.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.4 t -77.27 -34.4 55.72 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.433 1.093 . . . . 0.0 112.373 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -58.82 -41.98 88.11 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.036 0.534 . . . . 0.0 110.161 172.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.45 -44.18 68.32 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 118.82 -0.609 . . . . 0.0 112.07 172.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -48.92 -39.99 28.36 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.865 1.211 . . . . 0.0 112.316 175.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.0 m -60.18 -43.1 96.11 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.399 -0.813 . . . . 0.0 112.718 172.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.8 mm -67.94 -35.76 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 O-C-N 121.306 -0.871 . . . . 0.0 110.389 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.4 mm -55.72 -54.57 24.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 172.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -24.36 64.25 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.568 1.147 . . . . 0.0 113.383 177.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -69.44 -44.65 70.85 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.616 1.166 . . . . 0.0 113.557 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -105.54 4.15 30.12 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -54.37 -29.08 47.23 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.473 1.909 . . . . 0.0 115.169 -167.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.01 -1.62 31.25 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.433 1.492 . . . . 0.0 116.651 170.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -105.66 -5.69 19.82 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.584 1.554 . . . . 0.0 113.181 -174.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 63.6 p -93.73 16.4 14.08 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.01 2.124 . . . . 0.0 113.463 174.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.8 mtt85 -69.19 156.88 37.98 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.074 1.75 . . . . 0.0 114.75 -173.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.1 147.73 40.69 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.308 1.843 . . . . 0.0 113.577 -169.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -169.93 160.18 8.23 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 -172.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 pp -119.92 166.07 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 127.637 2.375 . . . . 0.0 111.052 173.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.8 mm -130.78 118.04 40.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 125.206 1.402 . . . . 0.0 108.206 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.09 156.36 44.66 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -78.88 129.58 34.71 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 169.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.65 -11.87 52.76 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 169.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -94.37 0.4 55.47 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.949 1.7 . . . . 0.0 114.05 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.7 m -109.52 138.89 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 125.692 1.597 . . . . 0.0 111.153 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -63.86 -28.01 69.55 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.822 0.849 . . . . 0.0 112.941 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -81.92 -5.95 58.7 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.49 1.116 . . . . 0.0 113.671 175.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.0 p 45.06 37.41 2.5 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 127.028 2.131 . . . . 0.0 113.709 -175.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.05 150.01 40.86 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -167.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 64.7 t -79.99 90.91 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 129.454 3.102 . . . . 0.0 108.787 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.6 pt -69.99 -23.81 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.116 1.366 . . . . 0.0 112.267 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -156.41 159.72 38.97 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.346 1.058 . . . . 0.0 112.157 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.5 p -143.64 155.79 44.36 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 120.76 -1.212 . . . . 0.0 112.812 172.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -92.29 156.89 16.96 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -58.41 -29.05 65.79 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.708 0.803 . . . . 0.0 111.578 172.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.09 -49.83 41.66 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.416 1.008 . . . . 0.0 113.34 168.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.97 -38.48 76.11 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 119.343 1.572 . . . . 0.0 110.421 174.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.8 t -60.21 -39.86 88.11 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.881 -0.512 . . . . 0.0 111.051 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -74.71 -28.3 60.74 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 121.247 -0.908 . . . . 0.0 112.833 175.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.5 tp -66.85 -55.81 13.15 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.761 1.224 . . . . 0.0 111.594 177.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 64.2 m -98.77 -19.89 17.2 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.526 1.131 . . . . 0.0 113.054 -172.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.78 10.0 83.2 Favored Glycine 0 CA--C 1.541 1.696 0 N-CA-C 116.143 1.217 . . . . 0.0 116.143 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -89.21 -116.86 0.06 Allowed 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 119.072 1.436 . . . . 0.0 111.451 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.7 t -160.02 150.08 18.36 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.229 1.411 . . . . 0.0 110.948 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.9 mtp-105 -55.36 -40.78 71.7 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.402 1.081 . . . . 0.0 111.623 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.52 -19.15 63.33 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.489 1.116 . . . . 0.0 113.766 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -85.67 -20.65 29.1 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.966 1.307 . . . . 0.0 112.712 174.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.7 m -100.97 -20.05 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 174.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 30.2 mmt -49.91 113.24 0.8 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.423 1.089 . . . . 0.0 111.089 -177.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 71.49 15.74 6.08 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.839 1.656 . . . . 0.0 113.977 170.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.83 160.16 74.82 Favored Pre-proline 0 N--CA 1.475 0.803 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.414 167.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.03 140.1 85.92 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.801 2.334 . . . . 0.0 111.834 169.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.4 t -69.39 -12.58 61.77 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.807 0.843 . . . . 0.0 113.091 177.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.7 m -64.76 97.86 0.24 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.373 1.869 . . . . 0.0 110.731 177.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 31.8 p -52.67 -15.05 0.61 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.075 1.75 . . . . 0.0 115.134 -177.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -47.36 -38.98 14.06 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.746 1.219 . . . . 0.0 111.854 168.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.07 -19.76 63.27 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 pp -123.0 24.91 8.78 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.428 1.891 . . . . 0.0 113.045 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.53 145.67 53.69 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.308 -0.87 . . . . 0.0 112.419 174.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -110.8 178.97 19.98 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.532 1.539 . . . . 0.0 113.558 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.05 -10.07 27.73 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.493 2.795 . . . . 0.0 114.208 -177.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.25 -10.09 24.54 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.649 1.579 . . . . 0.0 112.582 172.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 97' ' ' ALA . 2.9 m -80.24 138.37 36.8 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.717 -1.239 . . . . 0.0 111.541 -175.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -87.64 135.26 33.44 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.384 1.088 . . . . 0.0 110.709 174.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.4 mmm-85 -66.26 -39.68 89.62 Favored 'General case' 0 C--O 1.219 -0.536 0 O-C-N 121.43 -0.794 . . . . 0.0 111.074 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -53.68 -38.34 64.1 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 171.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.38 -52.35 47.68 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.942 0.877 . . . . 0.0 110.027 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.55 -33.79 76.73 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.554 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.01 -52.19 26.16 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.859 1.664 . . . . 0.0 112.314 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -50.13 -42.02 49.88 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.455 1.025 . . . . 0.0 112.287 170.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 48.9 mt -62.94 -49.34 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 O-C-N 121.876 -0.515 . . . . 0.0 111.052 173.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.27 -39.93 57.8 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.592 -0.718 . . . . 0.0 112.114 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -68.68 -37.67 79.77 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.636 0.774 . . . . 0.0 111.477 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.37 -33.0 74.73 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.436 -0.79 . . . . 0.0 111.311 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 mt -82.06 -29.83 31.68 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.469 0.707 . . . . 0.0 112.119 177.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.3 -28.75 69.54 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.216 2.206 . . . . 0.0 110.766 168.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.95 17.66 9.44 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.196 1.379 . . . . 0.0 114.905 169.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.4 -50.04 67.01 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.648 1.224 . . . . 0.0 111.182 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -150.59 141.36 22.76 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.658 1.583 . . . . 0.0 111.621 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -79.59 104.02 9.9 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 166.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.7 tpt85 -145.11 136.79 25.43 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.242 1.017 . . . . 0.0 111.433 -171.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -82.02 133.04 35.26 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.572 1.549 . . . . 0.0 109.632 169.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.22 146.42 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.406 1.483 . . . . 0.0 108.9 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.01 153.86 28.57 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.644 0.778 . . . . 0.0 110.404 172.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -161.33 158.57 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.728 1.211 . . . . 0.0 110.537 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.516 ' H ' HG23 ' A' ' 74' ' ' THR . . . -100.09 145.44 27.95 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.671 0.789 . . . . 0.0 112.181 174.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -115.91 158.61 22.75 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.561 1.145 . . . . 0.0 111.041 169.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -127.44 137.46 52.71 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.519 0.728 . . . . 0.0 110.241 168.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -81.26 159.7 24.44 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.191 0.997 . . . . 0.0 112.611 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -55.43 -29.05 57.89 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.786 1.635 . . . . 0.0 112.979 171.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -80.02 -9.9 59.73 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.022 1.329 . . . . 0.0 113.774 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.37 0.69 53.74 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 126.106 1.813 . . . . 0.0 115.822 178.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.0 m -78.23 128.0 33.09 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.108 1.454 . . . . 0.0 111.741 -178.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 61.5 m -115.7 137.93 51.6 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.742 1.217 . . . . 0.0 112.317 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -151.03 139.92 20.92 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.429 ' HB2' ' HB2' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -116.25 121.37 41.83 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 127.091 2.156 . . . . 0.0 108.341 169.123 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 89.0 m -129.37 177.47 7.16 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.429 1.492 . . . . 0.0 110.218 169.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 25.0 tp -78.36 59.92 2.45 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.688 -1.258 . . . . 0.0 110.821 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 49.8 t -55.82 146.06 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.129 1.372 . . . . 0.0 111.194 -172.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -100.03 69.81 1.55 Allowed 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 122.948 1.356 . . . . 0.0 112.047 -167.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.3 t -83.84 69.84 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.37 1.068 . . . . 0.0 110.62 -169.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.77 134.99 23.52 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 124.989 1.316 . . . . 0.0 110.512 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -88.5 -166.41 0.26 Allowed 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 123.517 2.811 . . . . 0.0 113.153 -170.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.65 131.08 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-O 122.927 1.346 . . . . 0.0 113.628 173.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -116.99 160.25 21.23 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.18 2.192 . . . . 0.0 111.744 -173.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -90.02 179.99 5.82 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.065 0.946 . . . . 0.0 112.081 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.99 -21.46 64.87 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -71.2 -19.9 62.34 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.575 1.15 . . . . 0.0 113.819 170.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.08 3.55 60.35 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.599 1.571 . . . . 0.0 114.337 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.06 139.8 30.28 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.585 1.193 . . . . 0.0 113.053 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.2 p -74.34 99.95 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.868 1.667 . . . . 0.0 110.914 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.0 -29.63 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.565 0.746 . . . . 0.0 111.792 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.97 149.14 52.26 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 124.251 1.977 . . . . 0.0 112.626 173.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.2 m-30 -105.01 79.99 1.57 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.27 -1.787 . . . . 0.0 106.886 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 44.3 mt -100.59 70.41 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 169.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.09 89.23 3.6 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.923 0.868 . . . . 0.0 108.822 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -59.86 106.44 0.49 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.663 1.185 . . . . 0.0 110.797 -177.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -84.02 53.21 2.52 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.546 -1.346 . . . . 0.0 112.52 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -79.73 127.2 31.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 122.196 0.998 . . . . 0.0 111.109 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 65.6 t -81.14 117.76 27.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 125.169 1.388 . . . . 0.0 108.327 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.36 140.56 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-O 121.416 0.626 . . . . 0.0 112.642 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 28.5 ptm -133.12 172.48 12.59 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.611 1.964 . . . . 0.0 110.783 174.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.74 135.1 57.48 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.697 0.799 . . . . 0.0 112.043 177.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 86.1 tttt . . . . . 0 C--O 1.253 1.266 0 C-N-CA 125.891 1.676 . . . . 0.0 112.627 -176.456 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -60.05 155.76 43.04 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.735 2.956 . . . . 0.0 114.155 177.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 46.7 t -74.17 136.54 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.277 1.031 . . . . 0.0 110.426 176.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 94.1 mtm-85 -70.63 153.23 43.06 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.484 1.114 . . . . 0.0 112.652 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -137.96 147.96 44.77 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.12 1.768 . . . . 0.0 110.828 173.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.85 9.59 62.96 Favored Glycine 0 CA--C 1.54 1.629 0 C-N-CA 124.499 1.047 . . . . 0.0 115.499 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 -84.18 162.35 20.24 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.258 1.823 . . . . 0.0 113.065 -178.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.4 t -79.46 137.08 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.106 0.962 . . . . 0.0 109.346 172.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.09 159.88 19.15 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.924 0.89 . . . . 0.0 111.997 173.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -52.39 110.01 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.688 2.925 . . . . 0.0 111.858 174.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -65.47 -26.94 68.16 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -167.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -68.76 -49.99 54.15 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.672 0.789 . . . . 0.0 110.299 -178.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 t -74.55 -35.76 63.1 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.716 0.806 . . . . 0.0 112.114 178.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.06 -39.98 83.72 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.498 0.719 . . . . 0.0 110.423 174.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.2 tp -69.99 -45.83 66.46 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.984 0.514 . . . . 0.0 111.869 170.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -47.61 -39.78 17.78 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.974 1.261 . . . . 0.0 113.742 175.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 92.8 m -60.03 -41.69 92.77 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 121.579 -0.701 . . . . 0.0 112.371 172.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.2 mm -68.66 -35.29 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 O-C-N 121.154 -0.966 . . . . 0.0 110.219 174.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.5 mm -56.54 -51.65 62.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 CA-C-O 117.765 -1.112 . . . . 0.0 108.865 170.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -29.02 67.94 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.932 1.242 . . . . 0.0 112.255 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.9 tttp -66.69 -42.79 85.92 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.336 1.054 . . . . 0.0 113.055 174.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -103.65 1.91 32.55 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -56.0 -29.02 59.71 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.183 1.793 . . . . 0.0 114.804 -167.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.42 55.41 3.98 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 121.246 -0.909 . . . . 0.0 111.998 -175.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -71.48 7.07 1.52 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.297 2.239 . . . . 0.0 114.039 -173.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.3 p -73.36 13.85 0.4 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.067 1.747 . . . . 0.0 112.528 167.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -53.27 149.86 6.83 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.789 1.636 . . . . 0.0 112.276 169.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.15 147.68 29.78 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 127.157 2.183 . . . . 0.0 112.241 -172.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -169.79 159.64 8.14 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 -175.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 pp -120.04 172.87 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 126.022 1.729 . . . . 0.0 111.036 174.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.5 mm -131.64 119.72 43.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 125.999 1.72 . . . . 0.0 107.781 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -137.49 152.33 49.41 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -175.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -76.91 107.92 9.58 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.6 174.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.07 -17.42 63.24 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -95.67 2.61 54.14 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.119 1.367 . . . . 0.0 114.034 -169.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.18 140.23 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.797 1.639 . . . . 0.0 110.109 -177.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -57.53 -28.37 63.42 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.18 -14.81 59.31 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.847 1.259 . . . . 0.0 113.982 178.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 82.7 m 43.87 50.67 6.97 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.5 1.52 . . . . 0.0 113.377 -177.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.51 150.02 21.95 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -166.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 98.3 t -79.84 90.0 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 128.011 2.524 . . . . 0.0 109.387 -175.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.5 pt -70.02 -23.75 25.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.837 1.255 . . . . 0.0 112.223 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -155.74 159.83 39.8 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.449 1.099 . . . . 0.0 112.329 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.4 p -140.01 154.69 47.2 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.809 -1.182 . . . . 0.0 113.227 173.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -85.94 153.48 22.16 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 174.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -63.29 -24.1 67.71 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.673 173.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.73 -49.99 45.07 Favored Glycine 0 CA--C 1.532 1.138 0 O-C-N 121.308 -0.87 . . . . 0.0 112.249 168.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -37.25 78.59 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 119.208 1.504 . . . . 0.0 110.852 175.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.2 t -60.09 -39.97 87.97 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.538 -0.726 . . . . 0.0 110.896 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -73.93 -30.04 62.35 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.541 0.736 . . . . 0.0 112.327 175.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.4 tp -64.72 -55.67 18.5 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.274 1.029 . . . . 0.0 112.18 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 78.1 m -97.68 -20.71 17.45 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -172.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.21 15.15 81.3 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-O 118.735 -1.036 . . . . 0.0 115.633 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -88.85 -124.26 0.05 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 119.129 1.465 . . . . 0.0 111.316 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.3 m -159.92 150.09 18.57 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.903 2.081 . . . . 0.0 109.719 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -57.07 -36.19 70.26 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.21 -20.68 59.84 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.886 1.274 . . . . 0.0 113.613 174.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -83.15 -20.89 33.9 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.743 1.617 . . . . 0.0 112.279 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -104.46 -19.29 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 177.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 33.4 mmt -49.99 115.4 1.39 Allowed 'General case' 0 C--N 1.343 0.286 0 CA-C-O 122.172 0.986 . . . . 0.0 110.877 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 72.2 17.67 4.93 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.713 2.005 . . . . 0.0 113.703 169.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.57 154.48 81.38 Favored Pre-proline 0 N--CA 1.473 0.697 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.339 167.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -65.41 140.16 62.42 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.983 3.122 . . . . 0.0 112.043 171.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 96.0 m -62.18 -10.0 9.31 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.4 m -65.24 96.47 0.22 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.198 1.799 . . . . 0.0 110.763 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 61.6 m -50.37 -20.01 0.99 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.629 1.972 . . . . 0.0 115.789 -171.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -46.56 -39.48 11.08 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.059 1.344 . . . . 0.0 112.395 169.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -60.98 -20.17 62.03 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 pp -122.98 23.73 9.21 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.885 1.674 . . . . 0.0 113.229 176.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -64.57 147.18 53.4 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.354 -0.842 . . . . 0.0 112.338 175.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.72 -169.69 11.88 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 125.574 1.559 . . . . 0.0 113.989 -176.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -64.68 -10.13 23.53 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.533 2.822 . . . . 0.0 116.378 -170.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.4 mmm-85 -104.96 -10.1 17.48 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.466 1.506 . . . . 0.0 113.601 174.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.469 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 2.9 m -79.21 133.09 36.69 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.228 0.922 . . . . 0.0 111.608 -169.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -85.2 137.03 33.26 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 122.409 1.1 . . . . 0.0 110.683 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -69.48 -39.69 77.53 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.948 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.9 ptt-85 -53.64 -40.31 65.74 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 169.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.4 -50.66 62.71 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.029 0.931 . . . . 0.0 110.261 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.82 -33.85 76.98 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.457 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.98 -51.89 28.82 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.239 1.416 . . . . 0.0 112.098 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -49.97 -41.91 47.69 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.594 1.158 . . . . 0.0 111.799 170.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.7 mt -64.38 -49.13 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 121.824 -0.547 . . . . 0.0 111.602 173.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.49 -39.94 49.7 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.859 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -70.3 -38.78 75.04 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.758 0.823 . . . . 0.0 111.734 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.42 -32.69 73.74 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.455 -0.778 . . . . 0.0 111.399 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mt -86.94 -27.98 23.01 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.814 0.846 . . . . 0.0 111.521 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.98 -30.19 70.76 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.579 1.952 . . . . 0.0 110.658 168.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.94 22.52 6.56 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.725 1.155 . . . . 0.0 114.319 170.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.33 -49.95 75.36 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.405 1.102 . . . . 0.0 109.81 171.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -166.95 141.36 3.93 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.786 2.435 . . . . 0.0 109.534 167.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -72.67 120.52 18.4 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.897 -1.127 . . . . 0.0 108.485 169.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 26.2 tpp180 -157.56 140.3 14.92 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.542 1.537 . . . . 0.0 110.243 -168.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -81.57 137.36 35.53 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.714 0.806 . . . . 0.0 111.628 175.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.0 t -137.83 150.09 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 126.55 1.94 . . . . 0.0 108.183 177.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -79.97 158.37 26.59 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.073 0.949 . . . . 0.0 110.573 171.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.52 HD11 HG21 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -164.29 152.56 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.526 1.13 . . . . 0.0 110.269 171.637 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.469 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -85.88 145.35 27.21 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.008 176.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.511 ' CE1' HD13 ' A' ' 96' ' ' ILE . 22.2 m-85 -117.31 162.04 18.55 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.822 1.249 . . . . 0.0 111.771 176.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -131.15 140.01 49.88 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.017 0.927 . . . . 0.0 111.5 168.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 24.5 mtp-105 -86.29 166.63 15.5 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.553 1.541 . . . . 0.0 113.088 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -58.15 -30.94 66.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.93 2.092 . . . . 0.0 112.839 174.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -78.06 -9.87 59.35 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.876 1.27 . . . . 0.0 114.047 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.65 -0.8 61.37 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 125.701 1.62 . . . . 0.0 116.003 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.0 t -76.46 140.87 41.43 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.799 1.799 . . . . 0.0 111.39 176.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 23.7 p -137.51 137.25 38.45 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -174.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -151.05 148.4 28.29 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.87 1.268 . . . . 0.0 114.256 -172.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -102.6 125.06 49.2 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.52 1.528 . . . . 0.0 108.337 167.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 67.7 m -128.11 166.27 18.79 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.264 1.426 . . . . 0.0 109.867 172.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 mp -80.05 59.81 3.39 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.071 -1.018 . . . . 0.0 110.238 -176.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.472 HG21 HD12 ' A' ' 96' ' ' ILE . 18.2 m -67.66 148.02 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.294 1.838 . . . . 0.0 111.623 -169.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -109.34 69.72 0.71 Allowed 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 122.545 1.164 . . . . 0.0 113.397 -166.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.52 HG21 HD11 ' A' ' 96' ' ' ILE . 10.8 t -80.62 69.8 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 125.093 1.357 . . . . 0.0 110.003 -171.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.7 p -123.79 130.79 24.31 Favored Pre-proline 0 N--CA 1.484 1.259 0 C-N-CA 124.922 1.289 . . . . 0.0 112.535 -169.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -83.05 179.92 4.85 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.237 1.958 . . . . 0.0 113.34 -174.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -123.18 135.62 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 123.089 1.424 . . . . 0.0 112.334 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.09 165.03 22.03 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.779 2.032 . . . . 0.0 112.152 -169.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -89.99 -177.04 5.09 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.139 1.376 . . . . 0.0 111.958 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.8 -19.96 65.41 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -80.04 -19.85 46.67 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.683 1.193 . . . . 0.0 113.087 170.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.35 8.98 59.52 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.345 1.45 . . . . 0.0 114.147 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -84.59 129.25 34.87 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.347 1.574 . . . . 0.0 110.802 175.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.29 99.99 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 125.82 1.648 . . . . 0.0 110.279 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.8 -29.96 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 118.402 -0.809 . . . . 0.0 111.263 176.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.6 mmt -138.0 148.5 45.22 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 123.835 1.779 . . . . 0.0 111.911 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -101.44 87.07 3.1 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 126.613 1.965 . . . . 0.0 108.307 175.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 40.9 mt -100.72 70.82 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 169.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.3 mt -78.65 84.92 4.72 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.801 0.81 . . . . 0.0 109.672 -174.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -59.9 109.74 1.01 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.072 1.349 . . . . 0.0 110.885 -176.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -85.2 49.86 1.83 Allowed 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.215 -1.553 . . . . 0.0 110.857 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -85.54 106.88 17.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 123.468 1.604 . . . . 0.0 113.412 -168.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.0 t -55.16 114.3 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 113.624 -1.625 . . . . 0.0 109.02 171.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p -140.39 144.58 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 171.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 84.7 mtp -142.79 153.86 43.66 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.602 1.161 . . . . 0.0 111.329 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -73.85 153.43 39.9 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.212 1.005 . . . . 0.0 112.659 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 65.3 pttt . . . . . 0 C--O 1.254 1.299 0 C-N-CA 125.116 1.366 . . . . 0.0 113.732 178.035 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 119.115 -0.469 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.26 168.53 23.91 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.719 2.946 . . . . 0.0 112.812 177.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.3 m -66.63 157.14 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.29 1.036 . . . . 0.0 112.171 172.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -66.69 158.4 30.21 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.738 1.215 . . . . 0.0 113.152 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -123.52 146.48 48.06 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.556 1.942 . . . . 0.0 109.944 169.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.28 24.8 73.59 Favored Glycine 0 CA--C 1.54 1.639 0 C-N-CA 123.411 0.529 . . . . 0.0 113.912 -171.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -117.51 148.2 42.07 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.708 2.003 . . . . 0.0 111.718 -173.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.6 t -126.33 117.77 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.989 1.315 . . . . 0.0 107.624 169.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.06 159.93 52.06 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.401 0.68 . . . . 0.0 111.119 174.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.08 107.5 0.26 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.898 2.398 . . . . 0.0 111.159 174.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -64.36 -26.87 68.66 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -167.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -69.31 -49.86 51.98 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.28 0.632 . . . . 0.0 110.303 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 t -78.69 -32.71 47.16 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.393 1.077 . . . . 0.0 112.883 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -55.26 -44.64 75.77 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.276 1.03 . . . . 0.0 109.594 168.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.7 tp -72.21 -45.22 61.17 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 118.594 -0.717 . . . . 0.0 112.135 175.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -46.73 -39.99 12.62 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.527 1.531 . . . . 0.0 113.349 173.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.4 m -60.0 -45.9 91.22 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.468 173.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.1 mm -68.1 -36.14 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.859 0.864 . . . . 0.0 111.235 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.3 mm -53.28 -57.65 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 172.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -63.43 -24.72 67.96 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.614 0.765 . . . . 0.0 112.946 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.7 tptt -61.63 -45.09 95.56 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 118.347 -0.835 . . . . 0.0 111.974 170.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -103.97 -0.18 29.22 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 116.177 1.918 . . . . 0.0 116.177 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -60.02 -29.12 68.28 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.318 1.847 . . . . 0.0 115.736 -168.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.25 55.46 0.91 Allowed Glycine 0 CA--C 1.539 1.555 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -164.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -84.15 4.48 30.29 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 128.284 2.633 . . . . 0.0 114.615 -168.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.6 m -57.65 -4.1 0.24 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.833 2.053 . . . . 0.0 114.204 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.7 174.36 6.05 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.412 0.685 . . . . 0.0 112.609 168.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 ptpp? -59.35 137.81 57.86 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.71 1.604 . . . . 0.0 114.814 -173.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -169.79 167.22 9.42 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.686 1.594 . . . . 0.0 114.212 -177.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 pp -120.04 169.41 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.722 1.209 . . . . 0.0 111.12 167.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.6 mm -125.54 117.94 50.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 126.058 1.743 . . . . 0.0 107.11 171.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.36 147.66 50.64 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -81.01 106.55 13.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.648 0.737 . . . . 0.0 110.644 175.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.88 -6.48 51.01 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 53.1 mmm-85 -100.05 1.85 42.75 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.798 1.639 . . . . 0.0 114.133 -177.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -108.96 140.22 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.381 1.473 . . . . 0.0 109.974 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -55.7 -29.92 60.22 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -175.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -83.89 -12.67 55.15 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 95.9 m 42.99 58.8 3.13 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.497 1.919 . . . . 0.0 113.518 -177.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.0 156.97 16.12 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -168.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.3 t -79.9 89.94 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 128.272 2.629 . . . . 0.0 108.858 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.7 pt -70.48 -25.39 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.857 1.263 . . . . 0.0 112.185 176.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -156.76 159.79 38.64 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.916 0.886 . . . . 0.0 112.701 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 7.9 p -145.34 147.58 32.46 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.209 -0.932 . . . . 0.0 113.289 -169.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -86.26 152.4 22.81 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.503 0.668 . . . . 0.0 112.537 169.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -61.98 -36.06 80.33 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.215 0.606 . . . . 0.0 111.252 171.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.0 -49.94 53.31 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 121.292 -0.88 . . . . 0.0 112.911 175.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -29.94 66.93 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 118.939 1.37 . . . . 0.0 110.823 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.9 t -60.18 -40.03 88.59 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.007 -1.058 . . . . 0.0 111.181 172.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -78.74 -30.02 45.55 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.977 0.911 . . . . 0.0 112.385 175.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.3 tp -55.17 -52.72 62.4 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.886 1.274 . . . . 0.0 110.244 171.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 57.5 m -80.03 -29.17 39.27 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.15 0.5 . . . . 0.0 112.316 176.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.29 26.07 58.13 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 125.376 1.465 . . . . 0.0 114.143 -173.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 16.1 m-30 -94.7 -130.11 0.14 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.881 1.272 . . . . 0.0 111.865 -173.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.0 t -159.88 140.38 11.98 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 127.117 2.167 . . . . 0.0 108.741 175.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.8 mtm105 -64.75 -31.33 72.51 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 120.92 -1.113 . . . . 0.0 113.246 -171.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.81 -16.66 29.98 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.023 0.929 . . . . 0.0 113.403 172.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -95.6 -20.82 18.67 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.476 1.91 . . . . 0.0 112.14 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.1 m -89.89 -18.12 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-N 119.489 1.04 . . . . 0.0 112.694 -174.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 33.6 mmt -49.73 115.42 1.36 Allowed 'General case' 0 C--N 1.341 0.204 0 C-N-CA 125.041 1.336 . . . . 0.0 110.486 -172.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 69.0 21.03 7.58 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.283 1.433 . . . . 0.0 113.62 169.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.72 155.1 93.87 Favored Pre-proline 0 N--CA 1.475 0.794 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.528 167.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.12 140.04 93.23 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.47 2.113 . . . . 0.0 111.649 169.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 37.4 t -64.36 -17.66 63.93 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.62 1.168 . . . . 0.0 112.914 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.6 m -62.61 99.98 0.17 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 127.09 2.156 . . . . 0.0 111.232 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 28.0 p -55.14 -14.17 1.54 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.446 1.498 . . . . 0.0 114.918 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -49.33 -40.06 33.82 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.778 1.231 . . . . 0.0 111.587 168.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -66.73 -11.0 52.77 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 pp -123.04 20.52 9.92 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.14 1.776 . . . . 0.0 113.744 170.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -63.74 144.38 57.08 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.136 -0.978 . . . . 0.0 113.084 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -109.15 175.87 19.36 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.691 1.615 . . . . 0.0 113.754 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.56 -10.05 27.89 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.445 2.763 . . . . 0.0 114.629 -175.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -103.14 -7.63 21.12 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.206 1.402 . . . . 0.0 113.696 170.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.472 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 5.0 m -70.85 134.58 47.44 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.536 1.062 . . . . 0.0 110.355 178.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -81.97 137.39 35.14 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.643 0.735 . . . . 0.0 110.2 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -66.35 -39.85 89.43 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.697 -0.627 . . . . 0.0 110.855 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.5 ptt-85 -55.59 -41.18 73.04 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.802 0.841 . . . . 0.0 113.008 171.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.429 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -64.56 -51.35 63.23 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.766 0.826 . . . . 0.0 110.364 177.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.44 -33.65 76.19 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.247 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.06 -52.77 21.25 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.762 1.225 . . . . 0.0 111.983 177.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -50.0 -42.18 48.64 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.719 1.208 . . . . 0.0 111.859 171.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 54.3 mt -63.8 -51.04 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 121.878 -0.514 . . . . 0.0 110.897 174.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.37 -39.9 58.1 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 118.604 -0.713 . . . . 0.0 112.116 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -69.09 -36.58 77.73 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.64 0.776 . . . . 0.0 111.601 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.49 -30.11 68.87 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.684 -0.635 . . . . 0.0 111.673 177.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mt -83.59 -31.33 26.36 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.565 0.746 . . . . 0.0 111.445 176.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.77 -30.08 71.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.249 2.22 . . . . 0.0 111.484 169.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.05 19.92 7.83 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.797 1.189 . . . . 0.0 114.953 169.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.89 -50.01 73.93 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 118.868 1.334 . . . . 0.0 110.5 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -162.8 141.47 8.63 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.608 2.363 . . . . 0.0 108.934 168.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -78.73 120.47 23.42 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.987 -1.071 . . . . 0.0 108.654 170.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.9 tpp180 -152.19 136.62 16.79 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.311 1.444 . . . . 0.0 109.857 -169.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -79.61 134.44 36.45 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.302 0.641 . . . . 0.0 110.578 173.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.29 148.2 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.645 1.578 . . . . 0.0 109.126 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -79.87 155.73 27.67 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.108 0.963 . . . . 0.0 110.381 172.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.429 HG23 ' HB1' ' A' ' 78' ' ' ALA . 0.7 OUTLIER -163.39 149.75 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.357 1.063 . . . . 0.0 110.858 179.749 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -87.14 145.37 26.46 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.844 176.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -112.3 145.69 39.55 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.032 1.333 . . . . 0.0 111.675 169.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.66 132.27 53.81 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.535 0.734 . . . . 0.0 109.394 167.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 28.7 mtp-105 -100.04 153.35 19.28 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.738 1.615 . . . . 0.0 112.881 -168.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -58.9 -29.44 67.05 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.688 1.195 . . . . 0.0 112.287 171.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -72.27 -10.03 59.25 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.471 1.508 . . . . 0.0 113.878 175.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.49 0.87 55.53 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.49 1.519 . . . . 0.0 115.397 177.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.51 148.72 47.92 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.85 1.325 . . . . 0.0 111.273 174.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 34.3 t -152.0 110.62 3.79 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.245 0.93 . . . . 0.0 111.421 175.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -151.0 151.75 32.52 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -173.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -102.2 126.43 49.17 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.421 1.889 . . . . 0.0 108.989 168.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 73.5 m -130.29 171.47 12.88 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.94 1.296 . . . . 0.0 110.618 170.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 mp -79.96 59.85 3.34 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 120.947 -1.095 . . . . 0.0 110.921 -175.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.0 t -61.28 140.68 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.179 1.391 . . . . 0.0 111.932 -170.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -101.59 69.78 1.24 Allowed 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 123.109 1.433 . . . . 0.0 112.447 -169.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.8 t -78.18 69.97 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.271 1.828 . . . . 0.0 111.481 -173.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.4 p -120.86 131.19 24.54 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.085 -1.009 . . . . 0.0 113.56 -171.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -85.58 -178.9 3.18 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 125.028 3.819 . . . . 0.0 115.578 -169.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.9 m -123.69 131.36 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-O 122.844 1.307 . . . . 0.0 113.048 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -115.4 163.05 16.29 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.876 2.07 . . . . 0.0 111.82 -171.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -95.64 -179.96 4.92 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.269 1.028 . . . . 0.0 112.009 172.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -61.82 -19.99 63.15 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -177.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -71.37 -21.59 62.0 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.529 1.132 . . . . 0.0 113.57 170.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.75 5.25 57.7 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 125.581 1.562 . . . . 0.0 114.695 -174.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -97.51 142.24 29.59 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.852 1.326 . . . . 0.0 113.581 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.7 p -71.12 100.16 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.955 1.702 . . . . 0.0 111.089 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.45 -29.25 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 118.631 -0.7 . . . . 0.0 111.68 174.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.35 147.59 51.83 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 124.277 1.989 . . . . 0.0 113.236 172.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -99.2 86.03 3.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 112.994 -1.912 . . . . 0.0 107.284 173.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 36.3 mt -101.43 70.0 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 122.834 1.302 . . . . 0.0 108.631 170.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.253 17.7 mt -80.27 83.57 6.09 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.118 -177.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -59.8 103.09 0.18 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.429 1.892 . . . . 0.0 110.443 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -83.32 57.41 3.98 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.679 -1.263 . . . . 0.0 112.593 -174.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -79.74 106.93 12.13 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 124.576 2.132 . . . . 0.0 112.265 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.1 t -61.19 110.39 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 C-N-CA 127.24 2.216 . . . . 0.0 109.051 170.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p -140.43 140.39 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 120.805 0.336 . . . . 0.0 111.699 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 85.2 mtp -139.3 151.67 46.61 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.336 1.454 . . . . 0.0 110.897 169.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -72.53 150.19 43.41 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.037 0.935 . . . . 0.0 112.499 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 C--O 1.252 1.197 0 C-N-CA 126.537 1.935 . . . . 0.0 111.895 -177.531 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 ttp . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 118.433 -0.794 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -63.31 -29.57 72.82 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.127 2.551 . . . . 0.0 115.073 -177.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . 0.322 6.6 p 45.75 40.36 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 127.089 2.156 . . . . 0.0 114.472 172.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 56.68 25.21 9.82 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 127.003 2.121 . . . . 0.0 115.271 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -72.67 155.79 39.63 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.953 1.301 . . . . 0.0 112.082 174.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.17 -164.25 52.18 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.416 1.008 . . . . 0.0 114.178 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -143.84 148.32 35.34 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.267 1.427 . . . . 0.0 111.704 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.6 t -130.1 135.39 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.505 1.522 . . . . 0.0 109.437 174.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.99 159.9 60.54 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 123.677 0.791 . . . . 0.0 112.102 176.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.37 105.15 0.57 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.904 2.403 . . . . 0.0 111.947 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -66.13 -26.65 67.54 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.106 0.962 . . . . 0.0 113.332 -169.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -70.06 -49.9 46.44 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.339 0.656 . . . . 0.0 110.399 -176.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 t -76.13 -33.92 59.42 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.992 0.917 . . . . 0.0 112.32 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -59.96 -40.79 90.23 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.196 0.599 . . . . 0.0 110.328 173.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.3 tp -70.64 -45.68 64.71 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 118.781 -0.628 . . . . 0.0 111.759 171.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -47.9 -39.78 19.95 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.04 1.291 . . . . 0.0 113.475 175.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 86.6 m -60.12 -42.09 94.04 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.701 -0.624 . . . . 0.0 112.434 172.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.1 mm -68.79 -35.18 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 121.112 -0.993 . . . . 0.0 110.454 174.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.9 mm -56.83 -50.89 73.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 CA-C-O 117.673 -1.156 . . . . 0.0 108.668 170.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.79 -27.76 66.85 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.527 1.512 . . . . 0.0 113.15 174.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -65.82 -42.03 91.11 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.832 0.853 . . . . 0.0 112.361 173.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -107.11 2.43 24.9 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -57.27 -29.16 63.62 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.378 1.871 . . . . 0.0 114.311 -168.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.67 -1.7 5.35 Favored Glycine 0 CA--C 1.544 1.858 0 C-N-CA 125.711 1.624 . . . . 0.0 116.257 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -100.79 0.2 38.32 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.978 1.711 . . . . 0.0 112.738 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.5 m -75.1 -10.59 59.62 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.531 1.532 . . . . 0.0 113.094 173.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -63.21 157.75 21.78 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.339 1.456 . . . . 0.0 111.736 170.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.06 132.65 35.89 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.129 0.971 . . . . 0.0 110.515 -174.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -169.84 159.1 7.73 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 122.498 1.142 . . . . 0.0 112.899 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -123.91 171.56 12.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.755 173.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.4 mm -127.06 117.25 47.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 125.99 1.716 . . . . 0.0 106.772 174.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.12 148.83 50.6 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -80.74 106.45 12.76 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.388 0.614 . . . . 0.0 110.829 175.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.26 -6.48 53.27 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -96.1 -1.43 48.63 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.579 1.551 . . . . 0.0 113.797 -178.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -110.42 140.18 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.32 1.448 . . . . 0.0 109.951 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -57.4 -23.45 49.38 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -174.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -90.41 -10.53 43.5 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.381 1.472 . . . . 0.0 114.447 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 80.9 m 44.32 54.0 6.45 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.326 1.85 . . . . 0.0 114.663 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.03 158.52 15.77 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -168.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.8 t -79.93 89.97 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 128.624 2.769 . . . . 0.0 109.592 -172.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.4 pt -70.0 -24.46 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.256 1.422 . . . . 0.0 112.393 176.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -153.6 159.6 42.19 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.046 0.938 . . . . 0.0 112.276 174.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 10.0 p -147.27 142.54 27.3 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.038 -1.039 . . . . 0.0 113.268 -173.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -84.78 153.61 22.89 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -61.86 -29.82 70.44 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.757 0.423 . . . . 0.0 111.399 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.36 -49.92 43.01 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 123.945 0.783 . . . . 0.0 112.747 169.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -38.39 81.43 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 119.52 1.66 . . . . 0.0 110.644 175.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.6 t -60.18 -39.9 88.1 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.594 -0.691 . . . . 0.0 110.566 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -74.81 -30.02 61.28 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.339 0.655 . . . . 0.0 112.238 175.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 66.3 tp -63.83 -55.74 20.69 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.245 1.018 . . . . 0.0 111.83 177.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 59.9 m -95.68 -20.01 19.25 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.291 0.636 . . . . 0.0 112.661 -174.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.53 10.05 86.48 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-O 118.339 -1.256 . . . . 0.0 115.549 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -87.97 -121.73 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 119.46 1.63 . . . . 0.0 111.217 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.1 t -159.98 150.22 18.56 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.535 1.934 . . . . 0.0 109.96 -176.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -50.0 -41.13 46.41 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.259 1.024 . . . . 0.0 112.099 172.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.07 -19.94 63.47 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.321 1.048 . . . . 0.0 113.532 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -84.72 -20.71 30.73 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.635 1.574 . . . . 0.0 112.311 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -105.4 -18.84 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 125.66 1.584 . . . . 0.0 115.127 175.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 7.0 mmt -49.81 112.08 0.6 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.402 1.481 . . . . 0.0 111.647 -174.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 67.3 30.82 6.87 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.358 1.863 . . . . 0.0 112.745 171.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -106.75 154.85 39.87 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-O 117.599 -1.191 . . . . 0.0 112.984 177.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.86 137.59 60.75 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.282 2.654 . . . . 0.0 114.124 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 49.4 t -70.11 -9.94 57.14 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 125.427 1.491 . . . . 0.0 113.616 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.0 m -66.33 100.01 0.6 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 127.044 2.138 . . . . 0.0 111.671 -176.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 32.5 m -50.05 -13.2 0.1 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 127.031 2.132 . . . . 0.0 116.478 -176.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -53.7 -35.18 60.85 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.071 0.948 . . . . 0.0 111.607 168.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.9 -10.39 20.61 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 174.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.02 19.95 10.78 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.936 2.494 . . . . 0.0 111.08 178.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.52 138.43 45.03 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.589 -1.32 . . . . 0.0 111.905 177.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.72 -169.31 11.78 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.518 1.532 . . . . 0.0 113.57 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -61.23 -10.01 14.31 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 124.253 3.302 . . . . 0.0 117.049 -174.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -107.75 -10.01 15.68 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.943 1.297 . . . . 0.0 113.522 174.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.511 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 3.2 m -82.12 138.35 34.78 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.098 0.863 . . . . 0.0 112.109 -170.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -91.47 134.06 34.96 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 122.32 1.057 . . . . 0.0 110.75 176.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.5 mmm-85 -66.9 -39.71 87.51 Favored 'General case' 0 C--O 1.222 -0.394 0 O-C-N 121.65 -0.657 . . . . 0.0 110.593 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 46.7 ptt85 -51.39 -38.62 54.33 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 170.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.07 -50.71 38.32 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.523 1.129 . . . . 0.0 110.294 177.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.37 -33.85 76.43 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.465 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.06 -53.14 18.81 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.663 1.585 . . . . 0.0 112.22 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -50.14 -41.04 48.13 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.323 0.965 . . . . 0.0 112.514 170.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.8 mt -63.0 -49.69 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 121.684 -0.635 . . . . 0.0 111.368 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.3 -39.95 57.95 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.47 0.577 . . . . 0.0 111.944 174.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -62.97 -40.55 98.05 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.423 0.689 . . . . 0.0 111.723 175.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.49 -31.94 72.43 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 176.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 mt -84.16 -35.9 23.25 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -175.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 pp -69.63 -28.19 65.71 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.455 0.57 . . . . 0.0 111.693 168.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.88 14.77 13.02 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 119.078 -0.846 . . . . 0.0 113.986 168.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.69 -49.88 75.05 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 118.333 1.066 . . . . 0.0 111.216 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -160.3 129.99 5.18 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.859 1.264 . . . . 0.0 112.797 169.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -79.77 124.81 28.94 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.233 1.813 . . . . 0.0 109.084 173.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.1 ttp-105 -159.88 165.08 32.93 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.465 1.506 . . . . 0.0 110.999 171.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -76.73 137.07 39.11 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.7 0.8 . . . . 0.0 110.173 170.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.62 152.36 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.958 1.303 . . . . 0.0 108.917 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -79.89 160.04 26.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.325 0.65 . . . . 0.0 109.609 169.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.511 HD13 ' CZ ' ' A' ' 98' ' ' PHE . 0.2 OUTLIER -165.85 147.65 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.156 0.889 . . . . 0.0 110.64 168.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.511 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -90.39 145.43 24.95 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.009 173.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.511 ' CZ ' HD13 ' A' ' 96' ' ' ILE . 54.9 m-85 -118.17 157.2 27.39 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.0 0.92 . . . . 0.0 111.505 173.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -121.14 140.07 52.49 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.467 1.107 . . . . 0.0 110.443 169.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 24.7 mtp-105 -89.81 160.18 16.64 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.573 1.149 . . . . 0.0 111.379 175.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -21.23 65.01 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 172.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -75.24 -10.02 59.08 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.642 1.577 . . . . 0.0 113.61 172.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.81 6.75 67.1 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.384 1.468 . . . . 0.0 115.223 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.8 t -78.94 134.18 36.87 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 118.813 1.306 . . . . 0.0 110.817 175.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 60.8 m -131.61 128.95 40.23 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.635 1.174 . . . . 0.0 111.707 -172.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -151.04 142.72 23.68 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -174.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.429 HD13 ' N ' ' A' ' 108' ' ' CYS . 1.6 tm? -109.57 129.94 55.54 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.06 2.144 . . . . 0.0 108.504 168.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.429 ' N ' HD13 ' A' ' 107' ' ' LEU . 2.2 m -135.84 178.81 6.76 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.368 1.467 . . . . 0.0 111.605 172.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.5 mt -76.69 59.94 1.62 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.416 1.086 . . . . 0.0 111.129 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 36.4 t -61.28 145.16 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.936 1.295 . . . . 0.0 111.406 -173.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -104.16 69.68 0.94 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 122.274 1.035 . . . . 0.0 112.11 -168.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.0 t -83.5 69.91 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.744 0.817 . . . . 0.0 110.476 -169.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 44.8 t -117.12 123.33 30.2 Favored Pre-proline 0 N--CA 1.483 1.213 0 CA-C-O 117.723 -1.132 . . . . 0.0 110.603 -174.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -87.26 -170.36 0.59 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.479 2.786 . . . . 0.0 113.084 -175.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -123.53 126.78 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 123.018 1.39 . . . . 0.0 113.213 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.6 mtmt -112.26 161.12 16.95 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.588 2.355 . . . . 0.0 112.415 -176.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -92.23 179.98 5.41 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.663 -1.153 . . . . 0.0 112.19 172.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.41 -21.69 65.58 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -71.23 -19.89 62.32 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.558 1.143 . . . . 0.0 113.753 170.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.96 4.25 60.23 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.641 1.591 . . . . 0.0 114.322 -176.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -93.19 140.75 29.18 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.462 1.131 . . . . 0.0 113.132 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.14 100.01 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.486 1.514 . . . . 0.0 110.696 -174.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.56 -29.08 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 123.768 0.827 . . . . 0.0 111.795 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.88 148.45 52.29 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 124.111 1.91 . . . . 0.0 112.555 169.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -100.81 85.13 2.83 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.258 -1.792 . . . . 0.0 107.045 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 40.2 mt -99.98 70.04 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 122.86 1.314 . . . . 0.0 108.678 170.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.317 34.7 mt -78.59 88.55 4.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 123.356 1.55 . . . . 0.0 109.843 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -59.88 103.13 0.19 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.501 1.921 . . . . 0.0 110.139 173.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -87.19 50.99 2.12 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 120.683 -1.261 . . . . 0.0 111.85 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -79.97 106.86 12.3 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 124.182 1.944 . . . . 0.0 112.066 -176.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 32.6 t -64.43 114.3 2.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 126.813 2.045 . . . . 0.0 108.694 171.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p -140.39 136.23 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 122.633 0.373 . . . . 0.0 110.637 176.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 97.1 mtp -80.06 165.12 22.84 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 122.725 1.25 . . . . 0.0 112.444 -173.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.79 149.21 50.53 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.459 1.504 . . . . 0.0 112.625 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.7 tptt . . . . . 0 C--O 1.251 1.179 0 C-N-CA 125.886 1.674 . . . . 0.0 111.487 179.872 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 118.91 -0.567 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -70.43 162.23 43.15 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.445 2.763 . . . . 0.0 112.76 176.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.64 155.98 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.328 1.051 . . . . 0.0 112.317 174.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 81.4 mtt85 -129.69 153.94 47.65 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.626 1.571 . . . . 0.0 111.782 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -147.85 163.37 36.96 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.063 1.745 . . . . 0.0 112.537 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.28 -173.37 52.98 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.529 1.061 . . . . 0.0 114.559 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -76.96 159.59 29.83 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.327 1.451 . . . . 0.0 113.271 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.3 p -82.3 146.88 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.494 1.118 . . . . 0.0 111.047 171.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.9 159.96 17.7 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 124.168 0.987 . . . . 0.0 111.403 169.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -43.9 110.05 0.18 Allowed 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 124.503 3.468 . . . . 0.0 112.449 175.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -59.97 -27.25 66.68 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 115.103 1.519 . . . . 0.0 115.103 -165.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -69.99 -49.86 47.34 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.851 0.751 . . . . 0.0 110.407 -176.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 t -76.71 -36.2 57.35 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.1 0.96 . . . . 0.0 112.225 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -57.93 -39.99 79.38 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.951 0.9 . . . . 0.0 110.506 172.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.1 tp -71.49 -44.78 64.09 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.047 0.539 . . . . 0.0 112.266 170.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -47.87 -39.93 20.14 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 120.004 1.275 . . . . 0.0 113.583 176.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.1 m -60.08 -42.6 94.93 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 172.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.1 mm -69.0 -33.96 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.077 0.951 . . . . 0.0 110.436 176.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.5 mm -56.97 -53.7 39.56 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-O 118.202 -0.904 . . . . 0.0 108.714 169.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -25.15 64.9 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.551 1.069 . . . . 0.0 112.924 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.4 tttt -68.8 -45.09 72.17 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.303 1.041 . . . . 0.0 113.443 171.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -100.07 0.28 40.5 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -53.67 -29.02 36.72 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.3 2.24 . . . . 0.0 113.53 -169.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.21 55.52 0.91 Allowed Glycine 0 CA--C 1.531 1.032 0 C-N-CA 125.381 1.467 . . . . 0.0 112.48 -169.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -59.73 -17.17 32.71 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 120.884 -1.363 . . . . 0.0 112.719 174.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.8 p -78.05 -11.31 59.9 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.892 2.077 . . . . 0.0 115.195 178.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . 0.343 0.0 OUTLIER -72.89 167.68 20.49 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 120.753 1.615 . . . . 0.0 112.143 174.132 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.51 144.78 54.49 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.615 1.566 . . . . 0.0 114.868 -167.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -169.72 162.49 9.69 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 123.339 1.542 . . . . 0.0 114.455 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 pp -128.35 170.25 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 127.238 2.215 . . . . 0.0 111.15 172.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.5 mm -127.23 120.05 54.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 126.389 1.876 . . . . 0.0 107.293 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.423 ' HB3' ' HB3' ' A' ' 125' ' ' PHE . . . -125.38 149.16 48.4 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 123.829 0.852 . . . . 0.0 112.553 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -81.14 108.82 15.12 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.519 0.676 . . . . 0.0 110.746 172.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.92 -15.73 63.11 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -100.07 3.02 43.79 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.947 1.299 . . . . 0.0 114.116 -169.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.71 140.13 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.36 1.464 . . . . 0.0 110.726 -176.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -60.09 -27.04 66.67 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -176.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -83.46 -10.22 58.51 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.771 1.229 . . . . 0.0 114.204 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 24.9 m 45.56 47.82 11.18 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.28 1.832 . . . . 0.0 113.449 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.97 152.25 26.81 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -167.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.7 t -79.98 90.0 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 127.914 2.486 . . . . 0.0 108.758 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.8 pt -70.03 -24.78 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.731 1.212 . . . . 0.0 112.462 178.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -153.7 159.62 42.07 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.015 0.926 . . . . 0.0 112.484 174.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.2 p -147.85 145.73 28.82 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.111 -0.993 . . . . 0.0 113.077 -175.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -93.03 159.46 15.3 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -64.01 -23.62 67.4 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.531 -0.731 . . . . 0.0 112.384 175.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.74 -50.03 62.91 Favored Glycine 0 CA--C 1.537 1.413 0 CA-C-O 119.015 -0.881 . . . . 0.0 112.669 169.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -38.33 68.74 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.529 1.665 . . . . 0.0 109.787 172.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.7 t -60.25 -39.98 88.65 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.808 -0.558 . . . . 0.0 111.128 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -74.99 -30.03 61.05 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 175.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.8 tp -64.85 -54.57 28.93 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.683 1.593 . . . . 0.0 112.193 178.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 84.0 m -92.8 -22.58 19.24 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.126 0.971 . . . . 0.0 112.431 -178.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.5 10.04 85.84 Favored Glycine 0 CA--C 1.539 1.573 0 N-CA-C 115.758 1.063 . . . . 0.0 115.758 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -93.94 -116.71 0.1 Allowed 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 118.735 1.267 . . . . 0.0 111.68 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.3 t -159.9 150.12 18.62 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.532 1.533 . . . . 0.0 110.719 -177.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.7 mtm180 -57.63 -36.36 71.72 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.662 1.185 . . . . 0.0 112.426 177.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.32 -20.77 63.32 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.182 0.993 . . . . 0.0 113.503 174.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -84.4 -20.77 31.33 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.118 1.367 . . . . 0.0 112.268 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.5 m -105.39 -11.83 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 10.4 mmt -49.86 107.37 0.15 Allowed 'General case' 0 C--N 1.34 0.191 0 C-N-CA 125.078 1.351 . . . . 0.0 110.427 176.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 68.13 22.43 8.31 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.729 1.612 . . . . 0.0 113.224 172.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.58 161.75 57.98 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 124.887 1.275 . . . . 0.0 110.682 168.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -60.45 137.42 74.04 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.7 2.267 . . . . 0.0 113.032 175.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 23.5 t -70.04 -19.83 63.28 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.509 1.124 . . . . 0.0 112.756 170.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -60.36 100.13 0.09 Allowed 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 127.927 2.491 . . . . 0.0 111.222 178.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 54.7 m -49.98 -13.25 0.1 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.829 2.052 . . . . 0.0 116.35 -176.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -55.11 -39.45 69.39 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.979 1.311 . . . . 0.0 111.26 167.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -58.38 -20.12 41.38 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.57 1.548 . . . . 0.0 113.094 172.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.14 20.0 18.85 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 127.498 2.319 . . . . 0.0 112.169 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -56.37 136.98 53.42 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.657 -1.277 . . . . 0.0 113.482 174.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -130.58 177.2 18.49 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 126.343 1.925 . . . . 0.0 111.687 168.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -64.21 -10.13 22.36 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.524 2.816 . . . . 0.0 115.603 -176.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -104.11 -9.95 18.35 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.739 1.615 . . . . 0.0 113.369 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.571 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 3.4 m -76.63 139.42 40.59 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.297 0.953 . . . . 0.0 111.996 -173.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -84.23 129.91 34.86 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 123.126 1.441 . . . . 0.0 109.847 175.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -70.19 -39.91 74.94 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.14 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -59.53 -35.69 74.68 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.27 1.428 . . . . 0.0 113.919 170.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.27 -50.78 64.45 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.427 0.691 . . . . 0.0 110.604 173.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.03 -33.37 75.89 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.22 -52.3 42.74 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.513 1.125 . . . . 0.0 112.192 176.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -50.16 -42.12 50.38 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.053 0.941 . . . . 0.0 112.66 170.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 35.8 mt -63.61 -48.69 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 O-C-N 121.588 -0.695 . . . . 0.0 111.021 174.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.03 -39.82 56.77 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.526 0.603 . . . . 0.0 111.831 173.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -67.84 -38.24 82.92 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.586 0.63 . . . . 0.0 111.952 175.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.99 -26.85 64.28 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.267 0.627 . . . . 0.0 112.565 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 mt -87.74 -33.63 18.63 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.304 0.642 . . . . 0.0 110.95 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -37.68 81.38 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.197 1.799 . . . . 0.0 110.009 169.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.02 26.37 4.98 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.796 1.189 . . . . 0.0 114.724 171.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.73 -49.93 74.45 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 118.685 1.242 . . . . 0.0 111.204 173.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -159.0 148.85 19.12 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.066 2.146 . . . . 0.0 109.52 169.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -81.31 117.79 22.09 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.998 -1.063 . . . . 0.0 108.567 172.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 -144.85 136.67 25.69 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.355 1.062 . . . . 0.0 111.623 -169.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -83.22 132.06 35.07 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.429 1.492 . . . . 0.0 110.053 171.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -136.41 151.11 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.444 1.498 . . . . 0.0 109.043 -177.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.73 157.09 27.23 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.275 0.63 . . . . 0.0 109.652 170.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -165.71 148.47 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.073 0.949 . . . . 0.0 110.675 176.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.571 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -87.11 145.32 26.49 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.585 175.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -112.65 160.45 17.88 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.213 1.405 . . . . 0.0 110.634 169.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -125.3 140.1 53.12 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.781 0.8 . . . . 0.0 111.079 169.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 17.6 tpp85 -84.39 150.38 25.38 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.147 1.779 . . . . 0.0 109.921 176.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -55.02 -28.98 56.32 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.992 1.717 . . . . 0.0 113.578 175.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -75.71 -9.95 59.02 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.025 1.33 . . . . 0.0 114.1 175.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.81 -0.04 39.21 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 126.205 1.86 . . . . 0.0 115.576 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 45.2 m -78.8 126.44 30.72 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 119.068 1.434 . . . . 0.0 111.566 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 67.4 m -114.83 134.52 55.06 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.244 1.017 . . . . 0.0 111.667 -176.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -149.97 139.95 21.96 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.979 0.912 . . . . 0.0 112.978 -170.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.477 HD13 ' N ' ' A' ' 108' ' ' CYS . 2.2 tm? -115.76 136.23 53.26 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.493 1.917 . . . . 0.0 110.104 176.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.477 ' N ' HD13 ' A' ' 107' ' ' LEU . 1.7 m -139.34 169.54 17.57 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.757 1.623 . . . . 0.0 109.931 168.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.4 tt -78.54 60.01 2.57 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 121.849 0.833 . . . . 0.0 109.31 172.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.1 t -52.99 149.2 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.962 1.705 . . . . 0.0 110.645 -174.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -99.79 69.74 1.6 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 123.172 1.463 . . . . 0.0 110.811 -168.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.8 t -83.2 69.95 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.677 1.191 . . . . 0.0 110.255 -170.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.85 131.24 24.23 Favored Pre-proline 0 N--CA 1.478 0.932 0 C-N-CA 124.05 0.94 . . . . 0.0 110.712 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -85.1 -168.67 0.53 Allowed 'Trans proline' 0 CA--C 1.551 1.348 0 C-N-CA 123.109 2.539 . . . . 0.0 111.481 -174.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.52 129.52 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-O 123.026 1.394 . . . . 0.0 113.656 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -112.1 162.16 15.73 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.666 2.386 . . . . 0.0 112.838 -176.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -92.85 179.96 5.31 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.499 1.12 . . . . 0.0 112.207 171.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.42 -21.69 65.6 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -70.85 -19.92 62.59 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.563 1.145 . . . . 0.0 113.738 169.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.6 -0.02 59.44 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.007 1.765 . . . . 0.0 114.358 -176.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.6 139.98 30.0 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.609 1.204 . . . . 0.0 113.246 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.7 p -75.97 99.96 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 125.515 1.526 . . . . 0.0 110.216 -175.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.04 -28.9 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.641 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.71 149.99 50.55 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 124.012 1.863 . . . . 0.0 111.922 173.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.423 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 2.3 m-30 -104.02 80.22 1.71 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.857 -1.52 . . . . 0.0 107.843 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.6 mt -99.98 71.15 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 120.611 -1.305 . . . . 0.0 108.789 171.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.419 HD22 ' N ' ' A' ' 127' ' ' LEU . 2.0 mm? -76.91 85.19 3.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 123.41 1.576 . . . . 0.0 108.878 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -59.91 103.8 0.24 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 112.958 -1.928 . . . . 0.0 109.931 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -85.81 59.12 5.44 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 120.69 -1.256 . . . . 0.0 111.784 -177.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -79.77 126.58 31.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 122.163 0.983 . . . . 0.0 110.908 175.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.5 t -81.99 113.2 20.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 125.225 1.41 . . . . 0.0 108.403 -178.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p -140.35 137.4 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.092 0.473 . . . . 0.0 112.077 -176.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 21.2 ptp -137.4 158.66 43.92 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.653 1.581 . . . . 0.0 111.306 171.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -72.23 151.74 42.67 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.178 0.991 . . . . 0.0 112.656 177.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 65.4 pttt . . . . . 0 C--O 1.253 1.258 0 C-N-CA 125.183 1.393 . . . . 0.0 113.802 177.91 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 118.771 -0.633 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.98 158.29 55.76 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.219 2.613 . . . . 0.0 112.61 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.8 m -96.08 19.97 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 125.204 1.402 . . . . 0.0 113.653 -178.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -71.97 144.63 48.81 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.14 1.376 . . . . 0.0 111.922 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -150.48 160.11 44.01 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.954 1.702 . . . . 0.0 112.465 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.59 177.91 39.2 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.726 1.155 . . . . 0.0 114.757 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -87.08 161.44 18.13 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.565 1.546 . . . . 0.0 113.0 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.3 t -82.03 138.17 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.268 1.027 . . . . 0.0 109.409 172.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.62 159.93 22.06 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.753 0.821 . . . . 0.0 112.075 173.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -52.97 110.05 0.43 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.629 2.886 . . . . 0.0 111.703 174.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -65.62 -27.13 68.18 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -167.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -69.17 -49.86 52.94 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.519 0.727 . . . . 0.0 110.385 -178.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 t -75.52 -34.02 60.76 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.835 0.854 . . . . 0.0 112.405 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -59.92 -41.07 90.94 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.577 -0.702 . . . . 0.0 110.157 172.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.2 tp -70.85 -45.58 64.22 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.076 172.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -47.43 -39.83 16.55 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.238 1.415 . . . . 0.0 113.217 173.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 90.7 m -60.11 -44.02 95.15 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.615 -0.678 . . . . 0.0 112.205 172.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.5 mm -67.81 -35.7 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.834 0.854 . . . . 0.0 110.868 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.4 mm -55.62 -54.44 25.79 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 52.7 mtm180 -60.16 -29.38 68.63 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 118.981 0.809 . . . . 0.0 112.809 176.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.4 tptt -62.82 -42.42 99.72 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 118.676 -0.678 . . . . 0.0 112.265 173.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -104.51 1.64 30.06 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 178.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -57.77 -29.04 64.51 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.834 1.654 . . . . 0.0 113.894 -167.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.85 55.42 4.49 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -168.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -55.67 -26.88 47.02 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.836 1.654 . . . . 0.0 114.953 -168.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.7 m -67.53 -19.78 65.34 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.2 1.0 . . . . 0.0 113.415 175.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.8 mmt85 -92.55 150.0 21.01 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.368 1.867 . . . . 0.0 110.902 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.19 146.9 38.49 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.845 1.658 . . . . 0.0 111.82 -171.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -169.77 155.4 5.83 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 123.975 1.845 . . . . 0.0 115.074 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -119.9 165.45 15.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 128.025 2.53 . . . . 0.0 110.167 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.8 mm -127.58 113.71 32.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.52 155.91 39.86 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.884 0.85 . . . . 0.0 112.142 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.9 t-20 -85.72 122.3 29.62 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 176.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.46 -9.18 59.77 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -100.03 6.09 45.06 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.974 1.31 . . . . 0.0 113.477 -173.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.8 m -114.08 139.16 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 126.728 2.011 . . . . 0.0 111.378 -177.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.52 -23.26 65.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.133 0.973 . . . . 0.0 113.456 -175.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -90.8 0.56 57.42 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.538 1.535 . . . . 0.0 113.399 174.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 27.8 p 42.08 46.92 3.8 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.969 1.707 . . . . 0.0 113.098 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.1 149.8 31.97 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -167.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.2 t -81.71 92.37 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 128.762 2.825 . . . . 0.0 109.009 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.6 pt -70.43 -23.14 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 126.195 1.798 . . . . 0.0 112.692 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -158.19 159.73 36.42 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.448 1.499 . . . . 0.0 112.592 174.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 27.5 p -147.08 154.4 41.12 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.406 -1.434 . . . . 0.0 113.322 173.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -96.23 157.46 15.89 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -59.36 -28.97 67.34 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.186 0.994 . . . . 0.0 112.006 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.86 -50.04 39.42 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.04 0.828 . . . . 0.0 112.918 169.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.92 -35.54 78.71 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 119.321 1.561 . . . . 0.0 110.706 176.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.0 t -60.04 -39.87 87.43 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.171 -0.956 . . . . 0.0 110.548 176.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -75.85 -25.69 56.46 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 174.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 53.4 tp -64.86 -55.74 17.64 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.089 0.956 . . . . 0.0 111.806 175.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.5 m -94.82 -21.15 18.88 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -174.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.73 22.6 78.14 Favored Glycine 0 CA--C 1.539 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 113.564 -169.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.6 m-30 -91.49 -130.1 0.1 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.288 1.435 . . . . 0.0 110.979 -176.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.5 t -162.11 150.17 14.67 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.794 2.438 . . . . 0.0 109.045 177.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.7 ttp180 -50.14 -40.88 47.69 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.751 0.82 . . . . 0.0 111.907 170.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.77 -20.81 63.98 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -87.41 -20.69 26.3 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.335 1.454 . . . . 0.0 113.069 175.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -104.73 -16.33 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 176.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.4 mmt -49.92 110.34 0.38 Allowed 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.424 1.489 . . . . 0.0 111.388 -177.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 71.13 17.05 6.18 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.472 1.509 . . . . 0.0 113.764 171.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.43 160.81 63.99 Favored Pre-proline 0 N--CA 1.475 0.812 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.397 166.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -58.48 140.08 93.2 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.539 2.159 . . . . 0.0 111.639 169.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.504 ' SG ' HD13 ' A' ' 86' ' ' LEU . 1.4 p -64.69 -10.0 23.92 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 169.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.0 m -64.49 93.42 0.1 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.218 1.807 . . . . 0.0 111.683 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 28.4 p -53.13 -14.27 0.62 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.337 1.855 . . . . 0.0 115.34 -176.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -48.13 -40.04 22.43 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.098 0.959 . . . . 0.0 111.565 167.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.85 -19.96 63.17 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 pp -123.1 23.8 9.1 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.476 1.91 . . . . 0.0 113.052 176.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -60.87 140.01 57.81 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.086 -1.009 . . . . 0.0 112.826 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -95.18 171.45 29.71 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.828 1.204 . . . . 0.0 113.325 175.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.0 -10.05 27.19 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.495 2.797 . . . . 0.0 114.446 -177.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -91.55 -9.27 44.9 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.492 1.917 . . . . 0.0 113.442 174.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.6 m -78.02 139.86 39.13 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.984 0.914 . . . . 0.0 112.428 -173.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -85.34 131.68 34.37 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.743 1.259 . . . . 0.0 109.946 168.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.6 mmm-85 -65.79 -39.66 91.18 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.866 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.22 -41.83 50.52 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 169.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.66 -51.23 61.15 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.311 1.044 . . . . 0.0 110.122 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.26 -33.81 76.66 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.729 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.04 -51.39 32.5 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.022 1.729 . . . . 0.0 112.662 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -50.01 -43.89 50.86 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.686 1.194 . . . . 0.0 111.062 170.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 51.2 mt -62.91 -49.52 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.118 174.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.08 -39.86 57.04 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-O 118.248 -0.882 . . . . 0.0 112.179 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -69.0 -38.51 79.3 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.895 0.77 . . . . 0.0 111.466 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.18 -34.85 78.97 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.557 -0.714 . . . . 0.0 111.949 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.504 HD13 ' SG ' ' A' ' 64' ' ' CYS . 3.0 mt -84.87 -24.66 28.43 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.393 0.677 . . . . 0.0 111.674 177.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.78 -30.04 70.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.788 2.035 . . . . 0.0 110.062 168.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.07 17.93 9.16 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.063 1.316 . . . . 0.0 114.84 169.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.94 -50.13 65.48 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.845 1.323 . . . . 0.0 111.126 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -151.94 141.54 21.75 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.843 1.657 . . . . 0.0 111.312 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -74.61 114.52 13.11 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 166.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -149.28 137.26 20.55 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.951 0.9 . . . . 0.0 111.557 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -84.84 130.44 34.66 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.585 1.554 . . . . 0.0 110.196 169.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.6 153.64 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.525 1.53 . . . . 0.0 108.896 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -79.88 160.04 26.19 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.278 1.031 . . . . 0.0 109.812 169.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -169.75 151.92 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.584 1.154 . . . . 0.0 111.129 173.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.48 145.42 25.31 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 174.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -115.15 162.07 17.54 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.968 1.707 . . . . 0.0 111.722 168.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -136.51 140.18 42.82 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.232 0.613 . . . . 0.0 110.792 168.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -84.69 152.43 23.76 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.332 1.053 . . . . 0.0 112.658 177.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -55.1 -25.14 29.51 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.968 1.707 . . . . 0.0 112.974 169.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.54 -11.12 60.72 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.395 1.478 . . . . 0.0 113.949 174.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.61 41.33 5.11 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.843 1.211 . . . . 0.0 114.833 175.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.0 t -136.71 141.71 43.07 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.499 1.12 . . . . 0.0 111.629 176.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 23.9 p -129.82 139.62 51.19 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.423 1.489 . . . . 0.0 113.508 -171.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -150.23 139.94 21.71 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.899 1.279 . . . . 0.0 113.457 -168.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.462 HD13 ' N ' ' A' ' 108' ' ' CYS . 1.6 tm? -108.44 134.34 51.36 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.918 2.087 . . . . 0.0 108.667 169.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.462 ' N ' HD13 ' A' ' 107' ' ' LEU . 1.9 m -140.0 179.11 6.8 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.292 1.437 . . . . 0.0 111.559 171.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.2 mp -78.23 60.0 2.4 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.652 1.181 . . . . 0.0 109.904 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 16.6 t -63.2 145.58 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.587 1.155 . . . . 0.0 111.261 -171.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -107.63 69.74 0.75 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.615 1.198 . . . . 0.0 112.055 -168.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.6 t -84.05 69.86 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.016 0.927 . . . . 0.0 110.886 -169.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.17 136.12 26.07 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 124.611 1.164 . . . . 0.0 111.253 -174.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -86.88 -169.17 0.48 Allowed 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 123.603 2.869 . . . . 0.0 113.361 -172.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -126.47 132.33 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-O 122.835 1.302 . . . . 0.0 113.689 175.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -111.87 166.62 11.05 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 127.042 2.137 . . . . 0.0 112.389 -174.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -97.23 179.95 4.72 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.272 169.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.78 -21.21 65.7 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -70.11 -19.85 63.21 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.583 1.153 . . . . 0.0 113.68 169.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.6 6.5 59.58 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.811 1.672 . . . . 0.0 114.458 -176.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -97.13 141.76 29.87 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.54 1.17 . . . . 0.0 113.594 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.8 100.01 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 126.0 1.72 . . . . 0.0 110.615 -176.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.02 -29.6 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.113 177.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.53 149.98 51.68 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 124.288 1.994 . . . . 0.0 112.646 173.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -104.52 79.89 1.62 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 113.222 -1.808 . . . . 0.0 107.41 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.1 mt -99.91 69.95 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 170.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.66 88.25 4.57 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.985 0.898 . . . . 0.0 108.828 -178.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -59.85 104.22 0.27 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.767 1.227 . . . . 0.0 111.419 -174.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -82.81 53.61 2.45 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.18 -1.575 . . . . 0.0 112.163 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -79.94 106.84 12.26 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 124.076 1.893 . . . . 0.0 112.782 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.1 t -64.77 111.81 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 127.002 2.121 . . . . 0.0 108.738 170.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p -140.42 137.6 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 122.758 0.423 . . . . 0.0 110.551 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 77.4 mtm -85.6 159.07 19.95 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.83 1.252 . . . . 0.0 111.761 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -70.8 156.77 39.13 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.885 1.274 . . . . 0.0 113.197 175.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 62.0 tttp . . . . . 0 C--O 1.252 1.232 0 C-N-CA 125.95 1.7 . . . . 0.0 111.461 179.838 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.2 mtm . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 119.062 -0.494 . . . . 0.0 110.529 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.06 154.82 71.67 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.369 2.712 . . . . 0.0 112.76 177.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.8 m -74.31 156.15 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.466 1.107 . . . . 0.0 112.619 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -130.68 147.73 52.38 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.499 1.52 . . . . 0.0 110.755 172.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.38 140.64 22.24 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.346 1.459 . . . . 0.0 112.683 177.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.94 -17.95 55.22 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 124.853 1.216 . . . . 0.0 113.754 169.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -71.9 149.75 44.84 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.826 1.25 . . . . 0.0 112.006 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.3 t -79.93 109.86 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.927 0.891 . . . . 0.0 110.947 -176.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.96 170.0 11.32 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 125.444 1.498 . . . . 0.0 109.497 167.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -32.93 110.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 124.851 3.701 . . . . 0.0 112.737 171.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -59.91 -27.41 66.72 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -163.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -67.84 -49.95 59.35 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.731 0.696 . . . . 0.0 110.143 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.6 t -79.77 -35.19 39.02 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.59 1.156 . . . . 0.0 112.679 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -57.97 -39.88 79.25 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.567 1.147 . . . . 0.0 110.243 171.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.8 tp -74.84 -45.49 42.87 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 118.885 -0.579 . . . . 0.0 112.468 170.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -47.8 -39.82 19.31 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.845 1.258 . . . . 0.0 112.628 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 91.3 m -60.07 -42.58 94.84 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.538 -0.726 . . . . 0.0 111.875 175.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.4 mm -68.5 -33.66 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 123.839 0.856 . . . . 0.0 110.194 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.3 mm -59.33 -52.99 54.32 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.517 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 173.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -59.88 -29.21 68.16 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.477 1.111 . . . . 0.0 111.673 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -67.21 -42.11 84.63 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.813 1.245 . . . . 0.0 113.167 175.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -102.84 -0.01 31.96 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -59.88 -29.34 68.26 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.711 1.204 . . . . 0.0 113.391 -166.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.6 -1.72 2.18 Favored Glycine 0 CA--C 1.544 1.849 0 C-N-CA 126.438 1.971 . . . . 0.0 116.794 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -133.61 -10.63 2.77 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.247 1.419 . . . . 0.0 114.451 -172.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.9 p -78.83 -15.8 57.92 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.1 mmt85 -78.8 160.42 27.39 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.71 1.604 . . . . 0.0 113.841 -168.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.15 150.25 44.0 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.494 1.918 . . . . 0.0 112.878 -175.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -169.81 162.99 9.7 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 123.312 1.529 . . . . 0.0 115.094 -171.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pp -126.57 168.93 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 127.951 2.501 . . . . 0.0 111.203 173.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.5 mm -129.99 120.08 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 126.224 1.81 . . . . 0.0 108.165 178.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.5 155.23 48.96 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -78.58 114.68 17.71 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.977 169.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.03 -17.47 58.78 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -178.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 -96.14 5.93 49.96 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.794 1.238 . . . . 0.0 113.831 -170.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.98 140.16 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.744 1.618 . . . . 0.0 110.694 -175.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -58.19 -29.46 65.67 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.054 0.942 . . . . 0.0 113.187 -176.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -82.73 -5.81 59.08 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.5 p 39.08 45.76 1.08 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.678 1.991 . . . . 0.0 114.646 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.02 149.96 26.63 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 -166.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.1 t -79.94 97.22 2.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 128.907 2.883 . . . . 0.0 108.221 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.6 pt -76.67 -24.02 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.556 1.542 . . . . 0.0 111.735 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -153.6 159.44 42.14 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.963 0.905 . . . . 0.0 112.398 171.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 9.1 p -149.29 143.58 25.93 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.971 -1.08 . . . . 0.0 112.901 -174.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -88.79 157.7 18.4 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 -178.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.48 -31.18 67.6 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.533 -0.729 . . . . 0.0 111.706 169.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.91 -49.81 57.21 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.052 0.834 . . . . 0.0 113.249 169.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -58.32 -37.67 75.58 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 119.05 1.425 . . . . 0.0 109.337 176.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.1 t -60.01 -40.28 88.74 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.108 0.563 . . . . 0.0 111.549 177.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -71.06 -30.29 66.4 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.323 -0.86 . . . . 0.0 112.524 173.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.4 tp -70.12 -44.95 67.91 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.103 1.361 . . . . 0.0 114.196 -177.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 2.2 t -99.57 -24.08 14.86 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.634 0.773 . . . . 0.0 111.869 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.11 10.73 86.0 Favored Glycine 0 CA--C 1.541 1.672 0 O-C-N 120.928 -1.107 . . . . 0.0 115.825 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -94.24 -114.71 0.11 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 118.975 1.387 . . . . 0.0 111.911 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.9 t -159.99 148.97 17.49 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.946 1.299 . . . . 0.0 111.818 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 86.7 mtm-85 -53.74 -41.44 67.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.819 1.248 . . . . 0.0 111.811 171.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.79 -19.52 62.6 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.613 1.165 . . . . 0.0 113.355 177.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -88.37 -20.67 25.01 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.037 1.335 . . . . 0.0 112.911 175.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.7 m -103.67 -3.55 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 35.6 mmt -49.93 114.48 1.09 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.136 0.88 . . . . 0.0 109.804 172.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 70.57 23.93 4.61 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.856 1.662 . . . . 0.0 112.885 172.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -101.32 152.06 37.88 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 124.523 1.129 . . . . 0.0 112.342 -176.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.26 140.07 57.4 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.168 2.579 . . . . 0.0 113.227 -174.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.4 m -67.31 -13.25 61.82 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 173.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.7 m -68.17 100.04 0.97 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.416 1.086 . . . . 0.0 110.853 -176.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 30.4 p -54.56 -13.35 0.94 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.607 1.963 . . . . 0.0 116.123 -173.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -55.85 -36.59 67.7 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.877 -1.14 . . . . 0.0 111.267 169.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -54.7 -24.86 23.91 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.272 1.429 . . . . 0.0 113.509 173.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 pp -123.1 27.71 7.49 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.985 1.714 . . . . 0.0 113.029 177.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -62.63 145.79 53.67 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.231 -0.918 . . . . 0.0 111.984 172.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -127.43 -176.72 14.57 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 125.3 1.429 . . . . 0.0 113.157 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -66.51 -10.14 26.71 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.726 2.284 . . . . 0.0 116.512 -169.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.5 ttm105 -110.08 -2.75 16.81 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.768 1.627 . . . . 0.0 113.865 173.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.486 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 3.7 m -78.52 140.35 38.56 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.053 -1.029 . . . . 0.0 112.047 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -90.22 133.05 35.16 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 123.221 1.486 . . . . 0.0 111.65 172.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.7 mmm-85 -69.19 -39.79 78.45 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.302 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -55.57 -38.5 69.44 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.875 0.761 . . . . 0.0 112.956 171.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.412 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -65.8 -51.21 60.91 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 122.119 0.961 . . . . 0.0 109.88 177.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.44 -33.52 76.07 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.837 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.01 -50.01 45.78 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.01 1.724 . . . . 0.0 112.798 177.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -50.17 -42.93 51.99 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.251 1.021 . . . . 0.0 111.372 169.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.4 mt -62.62 -47.71 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 121.798 -0.564 . . . . 0.0 111.605 172.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.28 -39.96 46.9 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.661 -0.685 . . . . 0.0 112.193 174.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -69.01 -38.27 79.14 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.652 0.781 . . . . 0.0 111.551 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.1 -33.17 75.18 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.374 -0.828 . . . . 0.0 111.571 177.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mt -81.59 -29.99 33.15 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.668 0.787 . . . . 0.0 111.987 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.83 -28.72 69.19 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.393 2.277 . . . . 0.0 111.125 169.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.98 17.94 9.21 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.972 1.272 . . . . 0.0 114.873 169.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.36 -49.99 75.39 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.554 1.177 . . . . 0.0 111.495 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -161.39 152.63 18.64 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.517 1.527 . . . . 0.0 112.246 171.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -77.65 110.68 12.69 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 168.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.5 tpp180 -151.0 139.03 20.03 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.461 1.104 . . . . 0.0 110.949 -174.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -76.76 137.19 39.15 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.724 0.81 . . . . 0.0 110.342 170.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.11 148.75 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.772 1.229 . . . . 0.0 109.072 173.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.93 155.48 27.7 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.824 0.85 . . . . 0.0 110.294 171.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.412 HG23 ' HB1' ' A' ' 78' ' ' ALA . 0.3 OUTLIER -164.29 151.21 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 119.228 0.922 . . . . 0.0 111.146 173.169 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.486 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -88.22 145.36 25.92 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.092 176.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -118.04 143.71 46.19 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.504 1.121 . . . . 0.0 112.161 172.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -109.99 140.15 44.32 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.422 0.689 . . . . 0.0 111.336 173.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.6 mmt-85 -81.8 141.16 33.73 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 168.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -49.97 -26.95 4.71 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.994 2.117 . . . . 0.0 113.607 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -64.35 -17.39 63.66 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.316 1.446 . . . . 0.0 114.086 174.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.41 41.26 1.65 Allowed Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.463 1.506 . . . . 0.0 115.453 172.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.3 t -141.97 138.49 31.95 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 118.756 1.278 . . . . 0.0 112.217 175.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 28.9 t -128.9 138.8 52.22 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.483 1.513 . . . . 0.0 113.277 -172.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -150.95 151.33 31.97 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -100.9 127.99 47.13 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 127.917 2.487 . . . . 0.0 109.956 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 41.6 m -132.76 177.92 7.26 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.567 1.547 . . . . 0.0 111.134 171.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -80.05 59.92 3.42 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.415 1.086 . . . . 0.0 110.846 -177.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.5 t -62.16 141.69 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.716 1.606 . . . . 0.0 111.658 -172.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -102.61 69.83 1.11 Allowed 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 122.231 1.015 . . . . 0.0 112.175 -168.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.7 t -83.25 69.84 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 121.391 -0.818 . . . . 0.0 110.726 -168.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.5 t -117.92 127.26 26.74 Favored Pre-proline 0 N--CA 1.473 0.718 0 CA-C-O 117.801 -1.095 . . . . 0.0 109.363 -176.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.488 ' HB3' HD11 ' A' ' 127' ' ' LEU . 60.2 Cg_endo -82.32 -170.09 0.88 Allowed 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.212 2.608 . . . . 0.0 112.434 -177.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -119.89 127.24 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-O 122.865 1.317 . . . . 0.0 112.548 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -121.06 160.02 24.49 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 127.012 2.125 . . . . 0.0 111.909 -176.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -89.87 -179.53 5.75 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.807 0.843 . . . . 0.0 111.556 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -60.02 -21.61 61.55 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -73.68 -19.94 60.69 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.803 1.241 . . . . 0.0 114.156 171.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.92 -4.27 63.0 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.529 1.538 . . . . 0.0 114.073 -176.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -79.77 129.38 34.43 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.308 1.054 . . . . 0.0 111.973 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.67 99.99 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 127.215 2.206 . . . . 0.0 110.536 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.54 -30.04 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 123.397 0.679 . . . . 0.0 111.983 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.52 149.99 50.73 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 124.215 1.96 . . . . 0.0 112.642 174.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.8 m-30 -103.84 80.76 1.8 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.408 -1.724 . . . . 0.0 107.662 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.4 mt -101.18 71.32 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 169.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.488 HD11 ' HB3' ' A' ' 114' ' ' PRO . 0.6 OUTLIER -76.02 90.39 3.03 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 122.32 1.057 . . . . 0.0 108.803 175.519 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -59.97 95.16 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.112 1.365 . . . . 0.0 110.553 176.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -80.99 51.85 1.65 Allowed 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.544 -1.348 . . . . 0.0 112.636 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -79.86 106.81 12.16 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 124.296 1.998 . . . . 0.0 112.681 -176.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 41.2 t -62.49 113.75 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 127.377 2.271 . . . . 0.0 108.917 170.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.35 138.48 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 120.957 0.408 . . . . 0.0 111.316 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 28.6 ptm -92.69 178.55 5.76 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.021 1.728 . . . . 0.0 112.777 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -121.11 152.09 39.11 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.133 1.773 . . . . 0.0 112.44 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 22.5 pttp . . . . . 0 C--O 1.25 1.083 0 C-N-CA 125.252 1.421 . . . . 0.0 113.568 -174.416 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 119.098 -0.477 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -69.1 157.66 60.82 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.479 2.786 . . . . 0.0 112.607 177.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.9 m -135.14 156.78 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.837 1.655 . . . . 0.0 111.899 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -145.35 164.31 31.85 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.628 1.571 . . . . 0.0 113.033 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 21.1 ttp180 -71.73 146.4 48.17 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.147 1.379 . . . . 0.0 111.132 171.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.1 -174.0 26.34 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.368 0.985 . . . . 0.0 114.376 174.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -74.12 142.26 45.56 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.75 -0.853 . . . . 0.0 112.177 175.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.5 t -130.04 135.83 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.643 1.577 . . . . 0.0 109.014 173.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.37 159.86 63.32 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 123.696 0.798 . . . . 0.0 112.139 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.13 103.58 0.77 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.818 2.346 . . . . 0.0 112.233 -178.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -66.34 -27.17 67.68 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.184 0.993 . . . . 0.0 113.095 -171.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -70.09 -49.85 46.79 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.273 0.629 . . . . 0.0 110.415 -177.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 t -75.61 -34.7 60.61 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.028 0.931 . . . . 0.0 112.377 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -57.93 -42.72 85.45 Favored 'General case' 0 C--N 1.341 0.238 0 O-C-N 121.859 -0.526 . . . . 0.0 110.296 171.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.3 tp -70.02 -44.65 68.85 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 118.869 -0.586 . . . . 0.0 112.062 173.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -48.45 -40.01 24.79 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.882 1.219 . . . . 0.0 112.389 175.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.1 m -60.19 -43.09 96.2 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 121.486 -0.759 . . . . 0.0 112.502 172.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.2 mm -67.7 -35.67 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 123.962 0.905 . . . . 0.0 110.783 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.5 mm -56.21 -54.97 21.42 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 172.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -26.75 66.22 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.469 1.108 . . . . 0.0 112.978 176.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -65.31 -46.56 79.88 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 118.155 -0.926 . . . . 0.0 112.193 172.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -104.04 0.0 29.3 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -53.72 -29.16 38.04 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 116.72 2.119 . . . . 0.0 116.72 -165.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.58 -1.8 1.01 Allowed Glycine 0 CA--C 1.544 1.845 0 C-N-CA 126.098 1.809 . . . . 0.0 117.579 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -112.19 -26.01 9.02 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.303 1.551 . . . . 0.0 113.555 -170.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 65.3 m -89.28 16.3 7.62 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.821 1.248 . . . . 0.0 112.651 169.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.7 mmt-85 -89.67 163.58 15.07 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.226 1.81 . . . . 0.0 112.767 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -122.0 145.26 48.3 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.594 1.957 . . . . 0.0 111.419 -169.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -169.69 162.1 9.59 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -171.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.6 pp -123.3 169.13 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 127.754 2.422 . . . . 0.0 111.864 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.7 mm -127.74 119.07 50.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 126.365 1.866 . . . . 0.0 108.06 174.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.32 154.6 46.71 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 -177.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -77.38 106.69 9.3 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.287 172.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.81 -15.87 61.17 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -96.09 5.94 49.97 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.918 1.287 . . . . 0.0 114.057 -171.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.99 140.19 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.087 1.755 . . . . 0.0 110.912 -173.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -59.92 -23.56 63.61 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -176.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -76.03 -20.78 57.5 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.238 1.015 . . . . 0.0 113.578 174.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 15.6 m 45.1 42.85 7.04 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.017 1.727 . . . . 0.0 113.991 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.05 164.12 12.13 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 117.282 2.327 . . . . 0.0 117.282 -166.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 67.6 t -79.78 96.97 2.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 128.633 2.773 . . . . 0.0 108.419 -170.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.7 pt -78.76 -24.44 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.637 1.575 . . . . 0.0 111.47 173.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -153.79 159.68 41.98 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.952 0.901 . . . . 0.0 111.424 171.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 25.0 p -144.21 151.39 39.41 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.167 -0.958 . . . . 0.0 112.84 -173.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -87.8 153.27 21.47 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.721 0.772 . . . . 0.0 112.381 168.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -62.81 -32.87 74.14 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.305 0.642 . . . . 0.0 111.254 173.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.94 -50.04 56.41 Favored Glycine 0 CA--C 1.532 1.113 0 O-C-N 121.346 -0.846 . . . . 0.0 112.794 175.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -29.87 66.97 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 118.857 1.328 . . . . 0.0 111.56 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.7 t -59.97 -39.94 87.36 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.344 -0.848 . . . . 0.0 110.877 171.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -77.05 -30.13 55.46 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.435 -0.791 . . . . 0.0 112.387 174.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.6 tp -57.36 -55.72 31.1 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.277 1.431 . . . . 0.0 110.838 175.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.9 p -79.98 -28.08 39.57 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 175.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.53 9.96 74.42 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.913 1.72 . . . . 0.0 115.919 178.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -86.04 -121.83 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 119.547 1.674 . . . . 0.0 112.603 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.3 t -159.88 142.88 13.87 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.12 1.768 . . . . 0.0 110.036 -176.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -63.7 -33.97 76.82 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 121.168 -0.957 . . . . 0.0 112.178 -173.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.87 -16.65 43.99 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.578 1.151 . . . . 0.0 113.778 173.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -94.04 -20.56 19.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.211 2.204 . . . . 0.0 112.602 177.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 m -89.9 -20.05 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-N 120.254 1.388 . . . . 0.0 112.823 -173.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 35.1 mmt -49.98 118.57 2.98 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.587 1.155 . . . . 0.0 110.263 -174.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 72.56 20.33 3.9 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.825 1.65 . . . . 0.0 114.098 170.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -89.92 150.93 44.64 Favored Pre-proline 0 N--CA 1.484 1.231 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 169.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -64.24 140.02 68.91 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 124.062 3.174 . . . . 0.0 113.165 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 76.9 m -70.08 -12.36 61.55 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 169.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.1 m -59.08 100.09 0.06 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 126.888 2.075 . . . . 0.0 110.304 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 54.4 m -53.64 -13.21 0.61 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 -170.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -54.25 -38.31 65.63 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.399 1.08 . . . . 0.0 111.359 167.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -59.89 -20.36 56.82 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.457 1.503 . . . . 0.0 112.918 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.55 20.03 14.98 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 127.377 2.271 . . . . 0.0 111.52 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.05 149.2 45.09 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.629 -1.294 . . . . 0.0 112.826 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.7 -172.41 12.66 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.573 1.559 . . . . 0.0 112.45 172.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.35 -9.99 24.28 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.412 2.741 . . . . 0.0 114.781 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -96.46 -10.1 28.23 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.14 1.376 . . . . 0.0 113.555 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.3 m -82.83 139.72 33.33 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 119.237 0.926 . . . . 0.0 112.181 -170.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -95.74 143.65 26.81 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 122.684 1.23 . . . . 0.0 112.139 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.4 ' HD2' ' H ' ' A' ' 76' ' ' ARG . 0.4 OUTLIER -68.79 -39.88 79.92 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.93 -176.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -57.94 -40.71 81.16 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.259 1.024 . . . . 0.0 112.912 174.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.424 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -64.73 -52.19 58.38 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.368 1.067 . . . . 0.0 110.039 176.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.88 -34.79 79.23 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.07 -54.82 11.42 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.69 1.196 . . . . 0.0 111.563 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -50.15 -40.06 45.29 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.243 1.017 . . . . 0.0 112.405 172.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 49.6 mt -64.42 -50.61 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 O-C-N 121.704 -0.623 . . . . 0.0 111.442 173.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.1 -39.93 57.26 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 118.481 -0.771 . . . . 0.0 111.806 175.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -70.63 -37.16 73.76 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.617 0.767 . . . . 0.0 111.852 176.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.34 -33.41 74.25 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.484 -0.76 . . . . 0.0 111.243 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 mt -81.67 -31.96 32.01 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.287 0.635 . . . . 0.0 111.571 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.94 -29.25 70.65 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.494 1.918 . . . . 0.0 111.518 169.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.99 18.44 8.81 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.912 1.244 . . . . 0.0 114.929 169.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.95 -49.9 75.57 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 118.623 1.211 . . . . 0.0 111.424 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -156.75 146.2 20.56 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.535 1.934 . . . . 0.0 110.232 171.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -74.83 113.63 12.33 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 169.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -143.31 136.28 27.79 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.331 -167.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -87.72 129.86 35.01 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.424 1.49 . . . . 0.0 109.535 169.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.1 t -136.09 142.88 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.348 1.459 . . . . 0.0 108.705 -175.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -80.03 150.43 30.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.635 0.774 . . . . 0.0 110.093 172.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.424 HG23 ' HB1' ' A' ' 78' ' ' ALA . 0.6 OUTLIER -161.57 148.88 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.255 1.022 . . . . 0.0 110.843 -179.031 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.04 145.36 25.53 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.3 173.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -119.48 157.55 28.06 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.373 1.069 . . . . 0.0 111.165 175.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -113.93 140.06 48.7 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.834 0.854 . . . . 0.0 109.836 167.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -93.94 150.33 20.46 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.154 1.381 . . . . 0.0 109.585 170.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -17.64 60.73 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -171.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -73.1 -10.03 59.36 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.036 1.334 . . . . 0.0 113.659 172.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.0 9.31 37.34 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.693 1.616 . . . . 0.0 115.442 176.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 63.8 m -91.44 133.16 35.72 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.851 1.326 . . . . 0.0 111.198 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 49.6 t -134.44 129.37 35.17 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.827 0.851 . . . . 0.0 112.86 -176.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -151.01 153.35 34.98 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -173.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.443 HD13 ' N ' ' A' ' 108' ' ' CYS . 2.5 tm? -100.04 135.35 41.61 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.772 2.029 . . . . 0.0 110.435 173.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.443 ' N ' HD13 ' A' ' 107' ' ' LEU . 2.1 m -139.24 170.0 16.75 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.524 1.529 . . . . 0.0 110.706 168.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 31.1 tp -78.33 60.79 2.63 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.796 1.238 . . . . 0.0 110.69 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.7 t -60.79 145.23 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.691 1.196 . . . . 0.0 111.206 -174.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -104.1 69.69 0.95 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 122.493 1.139 . . . . 0.0 111.195 -169.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.1 t -82.76 69.81 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.022 0.929 . . . . 0.0 110.228 -169.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.89 132.46 23.91 Favored Pre-proline 0 N--CA 1.483 1.183 0 C-N-CA 124.26 1.024 . . . . 0.0 111.88 -171.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -88.54 -174.28 1.04 Allowed 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 123.595 2.863 . . . . 0.0 113.797 -171.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.85 129.26 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-O 122.854 1.311 . . . . 0.0 113.658 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -107.72 170.56 7.91 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 127.001 2.12 . . . . 0.0 112.31 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -104.13 179.91 4.14 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 113.666 -1.606 . . . . 0.0 112.346 169.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.25 -19.95 65.01 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -69.34 -19.96 63.86 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.458 1.103 . . . . 0.0 113.681 170.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.95 18.69 49.94 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.468 1.032 . . . . 0.0 113.842 -173.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -110.86 142.4 42.95 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.317 1.047 . . . . 0.0 113.448 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.6 p -74.99 100.06 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.946 1.698 . . . . 0.0 110.814 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.13 -28.94 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 123.303 0.641 . . . . 0.0 111.993 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.33 149.88 50.9 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-O 124.24 1.971 . . . . 0.0 112.654 174.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.8 m-30 -104.87 82.62 1.9 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.222 -1.808 . . . . 0.0 107.337 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.8 mt -100.83 69.88 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 170.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.49 88.93 5.61 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.99 0.9 . . . . 0.0 108.696 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -59.89 108.86 0.82 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.637 1.175 . . . . 0.0 110.712 -176.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -84.17 52.53 2.35 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 120.407 -1.433 . . . . 0.0 112.196 -176.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -79.93 106.89 12.29 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 123.998 1.856 . . . . 0.0 112.294 -178.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 37.0 t -64.74 112.42 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 C-N-CA 126.308 1.843 . . . . 0.0 108.633 171.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.8 p -140.36 138.79 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 122.842 0.457 . . . . 0.0 110.041 175.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.2 ptp -83.99 178.77 7.73 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.73 1.212 . . . . 0.0 112.47 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -59.67 157.7 11.41 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.893 1.277 . . . . 0.0 112.498 175.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 86.3 tttt . . . . . 0 C--O 1.254 1.307 0 C-N-CA 125.626 1.57 . . . . 0.0 113.731 -172.127 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.955 -0.545 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.64 -17.81 7.1 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 123.341 2.694 . . . . 0.0 115.199 -174.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.8 t -130.48 152.92 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 125.663 1.585 . . . . 0.0 111.086 -169.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 57.45 43.46 22.97 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.576 1.95 . . . . 0.0 114.007 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.8 ppt_? -139.94 154.13 47.12 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.033 1.733 . . . . 0.0 111.969 169.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.21 5.72 59.58 Favored Glycine 0 CA--C 1.541 1.71 0 C-N-CA 124.514 1.055 . . . . 0.0 115.419 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 55.1 p-80 -84.91 162.47 19.44 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.282 1.833 . . . . 0.0 112.79 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.2 t -75.1 130.89 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.707 0.803 . . . . 0.0 109.335 172.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.03 159.92 24.64 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 123.62 0.768 . . . . 0.0 111.942 174.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -52.97 110.0 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.525 2.816 . . . . 0.0 111.774 174.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -66.38 -26.79 67.43 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -168.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -68.32 -49.92 57.04 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.719 0.808 . . . . 0.0 110.272 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 t -74.35 -36.43 63.61 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.751 0.821 . . . . 0.0 112.307 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -57.9 -40.02 79.31 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.27 0.628 . . . . 0.0 110.541 173.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.5 tp -71.19 -44.28 65.77 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 118.957 -0.544 . . . . 0.0 112.4 171.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -47.51 -39.9 17.33 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.951 1.3 . . . . 0.0 112.743 175.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 57.0 m -60.14 -42.27 94.47 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 121.193 -0.942 . . . . 0.0 112.549 172.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.8 mm -70.09 -33.31 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.311 1.045 . . . . 0.0 110.785 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.9 mm -56.43 -55.62 18.14 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.426 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 169.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -23.74 63.71 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.303 1.041 . . . . 0.0 113.354 177.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.2 tptp -68.96 -45.49 70.58 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.166 0.986 . . . . 0.0 112.989 171.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -102.45 -0.08 32.98 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -51.57 -28.97 15.51 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 127.256 2.222 . . . . 0.0 116.544 -167.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.5 55.53 6.7 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 118.951 0.796 . . . . 0.0 112.449 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -63.6 9.34 0.06 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.606 2.362 . . . . 0.0 116.521 -169.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.2 p -75.56 5.87 5.45 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.241 1.416 . . . . 0.0 111.695 165.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.8 mtt180 -53.62 158.47 1.85 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.154 1.782 . . . . 0.0 112.518 170.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -114.38 145.14 42.19 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.515 1.126 . . . . 0.0 112.601 -168.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -169.78 159.25 7.92 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 123.189 1.471 . . . . 0.0 114.916 -175.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -120.03 169.01 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 127.574 2.35 . . . . 0.0 111.208 172.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.0 mm -125.25 120.07 57.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 125.957 1.703 . . . . 0.0 107.365 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.0 152.56 48.48 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 178.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -77.31 110.72 12.27 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.301 0.572 . . . . 0.0 111.53 173.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.21 -15.51 61.94 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -99.92 4.63 45.1 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.536 1.309 . . . . 0.0 114.536 -169.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -119.73 140.05 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.422 1.489 . . . . 0.0 110.882 -175.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.4 -23.17 65.62 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -175.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -83.37 -14.52 52.63 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.899 1.28 . . . . 0.0 113.725 175.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.1 m 43.3 54.4 5.14 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.52 1.928 . . . . 0.0 113.528 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.84 154.71 17.59 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -168.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 80.8 t -79.95 90.01 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 128.111 2.565 . . . . 0.0 108.799 -176.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.7 pt -70.11 -23.79 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.698 1.199 . . . . 0.0 112.376 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -155.55 159.66 39.88 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.858 0.863 . . . . 0.0 112.258 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 18.5 p -142.96 139.96 30.89 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 121.342 -0.848 . . . . 0.0 113.069 -173.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -81.82 152.41 26.93 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.724 0.773 . . . . 0.0 112.748 170.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -61.97 -32.26 72.69 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.509 0.724 . . . . 0.0 111.252 175.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.45 -52.55 32.39 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 121.46 -0.775 . . . . 0.0 112.975 172.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.13 -29.73 66.73 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 119.21 1.505 . . . . 0.0 111.136 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.7 t -58.79 -39.82 82.22 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.528 -0.732 . . . . 0.0 110.619 171.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -79.23 -28.31 42.47 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.688 0.795 . . . . 0.0 113.056 174.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.2 tp -57.87 -53.09 62.15 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.051 1.341 . . . . 0.0 110.85 174.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 79.8 m -90.04 -20.01 23.73 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 177.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.71 34.01 40.55 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 124.312 0.958 . . . . 0.0 114.737 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -99.01 -130.18 0.21 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.564 1.146 . . . . 0.0 112.357 -176.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.7 m -159.84 142.88 13.92 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 128.669 2.787 . . . . 0.0 108.143 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -63.98 -40.11 95.65 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 120.922 -1.111 . . . . 0.0 112.934 -169.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.38 -18.04 56.88 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.522 1.129 . . . . 0.0 113.528 174.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -90.21 -20.72 22.7 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.183 1.393 . . . . 0.0 112.179 178.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.7 m -92.7 -14.49 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 CA-C-N 119.31 0.959 . . . . 0.0 113.546 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 35.5 mmt -49.87 114.01 0.98 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.915 1.286 . . . . 0.0 110.467 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 70.15 21.77 5.85 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.88 1.672 . . . . 0.0 113.74 169.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.34 158.84 86.14 Favored Pre-proline 0 N--CA 1.474 0.768 0 O-C-N 121.345 -0.847 . . . . 0.0 111.138 167.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.51 132.99 49.08 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.593 2.196 . . . . 0.0 112.209 171.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 4.6 t -69.99 -23.68 63.19 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.76 1.224 . . . . 0.0 112.548 174.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.0 m -57.04 100.14 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 128.092 2.557 . . . . 0.0 111.792 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 57.7 m -50.04 -21.74 1.35 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -174.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -52.67 -39.19 61.65 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.242 1.017 . . . . 0.0 112.014 171.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -56.14 -24.41 40.85 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.785 1.634 . . . . 0.0 113.4 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 pp -123.08 25.0 8.7 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.048 1.739 . . . . 0.0 113.284 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -63.5 147.26 51.85 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.37 -0.831 . . . . 0.0 112.613 176.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.5 -174.6 13.7 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 125.69 1.615 . . . . 0.0 113.709 -176.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -67.91 -4.38 12.28 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.995 3.13 . . . . 0.0 116.098 -170.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 78.9 mmt-85 -110.26 -10.05 14.64 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 119.609 1.095 . . . . 0.0 113.519 169.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.8 m -73.94 134.98 43.22 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.23 0.923 . . . . 0.0 110.812 -173.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -85.38 137.46 32.92 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.84 0.829 . . . . 0.0 110.029 173.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.0 mmm-85 -67.36 -39.67 85.73 Favored 'General case' 0 C--O 1.219 -0.517 0 O-C-N 121.402 -0.811 . . . . 0.0 111.084 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.1 ptt-85 -53.6 -38.63 64.15 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 169.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.85 -52.15 52.84 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 122.04 0.924 . . . . 0.0 110.079 175.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.42 -33.8 76.8 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.618 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.12 -51.85 28.33 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.783 1.633 . . . . 0.0 112.057 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -50.17 -41.62 49.53 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.456 1.025 . . . . 0.0 112.341 169.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 46.2 mt -62.94 -50.03 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 O-C-N 121.769 -0.582 . . . . 0.0 111.047 172.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.08 -39.79 56.89 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.374 -0.822 . . . . 0.0 112.173 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -69.84 -37.95 76.35 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.589 0.755 . . . . 0.0 111.473 176.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.23 -32.88 74.22 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.536 -0.727 . . . . 0.0 111.075 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mt -81.35 -33.47 32.39 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.452 0.701 . . . . 0.0 111.693 176.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.05 -28.47 69.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.791 2.036 . . . . 0.0 111.28 169.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 110.09 17.6 9.41 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.007 1.289 . . . . 0.0 114.84 169.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.85 -49.91 75.55 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 118.526 1.163 . . . . 0.0 111.439 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -161.56 151.65 17.14 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.695 1.598 . . . . 0.0 111.926 171.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -72.18 112.98 8.73 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 167.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.5 tpp180 -148.26 135.97 20.78 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.268 1.027 . . . . 0.0 111.431 -176.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -83.87 131.95 34.83 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.403 1.481 . . . . 0.0 110.204 169.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.7 t -134.93 146.12 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.353 1.461 . . . . 0.0 109.074 -176.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -80.05 152.5 29.36 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.773 0.829 . . . . 0.0 110.011 171.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -163.25 148.71 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.42 1.088 . . . . 0.0 110.813 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.8 145.38 25.22 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.665 174.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -117.18 154.14 31.61 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.677 1.191 . . . . 0.0 111.088 172.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -123.9 140.05 53.36 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.535 0.734 . . . . 0.0 110.811 169.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -83.11 162.12 21.42 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.953 1.301 . . . . 0.0 113.28 177.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -50.05 -35.28 24.42 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.469 1.908 . . . . 0.0 113.417 171.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -81.75 -9.91 59.51 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.56 1.144 . . . . 0.0 113.946 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.96 2.07 48.86 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.789 1.661 . . . . 0.0 115.382 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.5 m -74.66 125.11 27.99 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.936 1.368 . . . . 0.0 110.717 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 19.1 t -127.9 132.75 49.28 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.208 1.003 . . . . 0.0 112.589 -170.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -151.06 139.98 20.95 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.57 1.148 . . . . 0.0 113.825 -169.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.419 HD13 ' N ' ' A' ' 108' ' ' CYS . 1.9 tm? -104.81 128.75 53.08 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.405 1.882 . . . . 0.0 109.033 168.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.419 ' N ' HD13 ' A' ' 107' ' ' LEU . 62.3 m -134.99 172.66 12.69 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.422 1.489 . . . . 0.0 110.018 169.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 28.6 tp -79.98 59.88 3.37 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.983 -1.073 . . . . 0.0 110.81 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.7 t -58.42 146.28 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.253 1.421 . . . . 0.0 111.662 -171.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -100.87 69.72 1.35 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 122.608 1.194 . . . . 0.0 111.622 -168.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.7 t -83.32 69.86 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.229 1.011 . . . . 0.0 110.389 -169.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.0 p -119.51 133.47 23.8 Favored Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 124.689 1.195 . . . . 0.0 111.441 -173.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -88.79 -171.34 0.57 Allowed 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 123.761 2.974 . . . . 0.0 113.55 -171.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.7 m -127.81 127.19 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-O 122.811 1.291 . . . . 0.0 113.573 174.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -114.12 165.07 13.02 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 127.273 2.229 . . . . 0.0 112.202 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -94.22 179.99 5.12 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.654 174.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.65 -20.62 63.61 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -71.39 -19.87 62.21 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.546 1.139 . . . . 0.0 114.025 171.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.95 0.96 58.6 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 124.815 1.197 . . . . 0.0 114.127 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -92.21 126.25 37.21 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.485 1.114 . . . . 0.0 112.025 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.7 p -59.95 99.8 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 128.214 2.605 . . . . 0.0 109.796 171.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.22 -30.06 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.975 177.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.9 mmt -135.46 148.37 49.23 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 124.167 1.937 . . . . 0.0 111.128 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.8 m-30 -104.85 80.39 1.63 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.934 1.694 . . . . 0.0 106.749 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.0 mt -100.05 69.85 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 171.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.87 90.14 4.7 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -59.81 109.05 0.84 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.515 1.126 . . . . 0.0 110.857 -176.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -84.46 49.98 1.79 Allowed 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.233 -1.542 . . . . 0.0 112.515 -177.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -79.84 107.05 12.32 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 123.685 1.707 . . . . 0.0 111.98 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.3 t -57.94 115.82 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 127.166 2.186 . . . . 0.0 109.44 170.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.47 144.12 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 176.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 78.5 mtm -137.0 154.87 50.3 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.062 1.745 . . . . 0.0 110.834 169.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -73.77 157.06 37.13 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.133 0.973 . . . . 0.0 113.28 176.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.8 tptt . . . . . 0 C--O 1.252 1.211 0 C-N-CA 125.912 1.685 . . . . 0.0 111.381 179.773 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.3 mtm . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -69.14 157.67 60.7 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.435 2.757 . . . . 0.0 112.634 177.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.8 t -133.06 137.96 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.609 1.563 . . . . 0.0 109.847 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -88.82 19.93 3.8 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -173.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.8 161.65 42.24 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 127.098 2.159 . . . . 0.0 112.385 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.74 143.32 9.0 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.35 1.452 . . . . 0.0 111.986 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -143.9 162.65 35.58 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.505 1.522 . . . . 0.0 112.705 -170.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.75 142.47 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.649 1.18 . . . . 0.0 109.476 171.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.19 159.87 13.77 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 123.813 0.845 . . . . 0.0 112.193 174.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -54.46 110.1 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.671 2.914 . . . . 0.0 113.149 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -68.48 -25.22 64.86 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.485 -0.76 . . . . 0.0 112.855 -169.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -66.7 -49.85 64.74 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.07 0.948 . . . . 0.0 110.384 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 t -75.71 -35.8 60.17 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.829 0.852 . . . . 0.0 112.347 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -57.8 -40.69 80.5 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.138 0.575 . . . . 0.0 110.388 172.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.1 tp -72.54 -43.63 63.25 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 118.607 -0.711 . . . . 0.0 112.289 172.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -48.58 -39.97 25.66 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 120.077 1.308 . . . . 0.0 112.164 175.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 78.9 m -60.12 -42.64 95.21 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 121.607 -0.683 . . . . 0.0 112.732 173.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.1 mm -69.95 -32.74 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.219 1.008 . . . . 0.0 111.011 176.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.7 mm -57.08 -55.8 18.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 170.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -25.33 64.98 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 176.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.1 tptt -68.58 -42.19 78.61 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.087 0.955 . . . . 0.0 112.271 172.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -114.99 16.39 17.14 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 -175.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -60.08 -29.05 68.31 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 -166.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.54 55.47 28.68 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 119.019 0.827 . . . . 0.0 113.188 172.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -58.07 -6.71 0.64 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 116.858 2.17 . . . . 0.0 116.858 -168.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.8 m -69.88 -18.76 63.43 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 120.927 -1.108 . . . . 0.0 112.323 167.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -78.1 154.58 31.18 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.787 2.035 . . . . 0.0 110.904 172.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -111.82 149.08 32.27 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.482 1.513 . . . . 0.0 113.496 -168.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -169.78 162.45 9.55 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -172.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 pp -129.25 170.66 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 127.323 2.249 . . . . 0.0 111.347 175.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.1 mm -126.21 114.45 38.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 126.368 1.867 . . . . 0.0 107.388 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.5 150.26 41.85 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 124.325 1.05 . . . . 0.0 111.614 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -81.72 114.03 20.11 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.391 1.076 . . . . 0.0 110.37 176.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.82 4.16 45.55 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 175.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -100.19 -3.38 31.74 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.397 1.479 . . . . 0.0 113.936 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 p -118.15 139.29 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.83 1.652 . . . . 0.0 111.501 -176.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -62.15 -26.39 68.3 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.926 0.89 . . . . 0.0 112.937 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -77.53 -8.88 58.48 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.824 1.25 . . . . 0.0 113.93 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.0 p 43.62 35.4 0.99 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 126.991 2.116 . . . . 0.0 114.877 -176.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.71 154.87 29.73 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -167.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 98.9 t -79.99 89.99 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 129.143 2.977 . . . . 0.0 109.02 -175.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.0 pt -69.94 -24.25 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.462 1.505 . . . . 0.0 112.392 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -153.92 159.66 41.82 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.281 1.033 . . . . 0.0 112.224 171.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 18.6 p -143.77 147.35 34.05 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.817 -1.177 . . . . 0.0 112.798 -177.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -89.74 156.86 18.24 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 176.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -58.81 -27.4 65.04 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.277 0.631 . . . . 0.0 111.626 169.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.7 -56.64 12.84 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 119.218 -0.768 . . . . 0.0 112.465 169.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -53.19 -39.49 63.69 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.4 1.6 . . . . 0.0 111.371 174.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.3 t -60.14 -40.06 88.47 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.901 -0.5 . . . . 0.0 111.308 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -78.56 -25.86 45.49 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.978 0.911 . . . . 0.0 112.979 176.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 36.2 tp -66.26 -55.74 14.66 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.877 1.271 . . . . 0.0 111.213 176.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 78.4 m -93.35 -22.06 19.18 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.638 0.775 . . . . 0.0 113.084 -176.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.22 20.07 79.82 Favored Glycine 0 CA--C 1.539 1.586 0 O-C-N 121.034 -1.041 . . . . 0.0 113.855 -171.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -87.47 -130.02 0.06 Allowed 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 118.493 1.147 . . . . 0.0 110.839 -176.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.0 t -160.66 150.16 17.31 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 127.862 2.465 . . . . 0.0 108.846 176.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.08 -38.87 54.29 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 121.466 -0.771 . . . . 0.0 112.624 172.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.51 -19.99 64.16 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.56 1.144 . . . . 0.0 113.737 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -86.76 -20.73 27.19 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.267 1.427 . . . . 0.0 113.189 174.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -105.41 -18.49 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 176.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.5 mmt -49.84 111.41 0.51 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.491 1.517 . . . . 0.0 111.248 -172.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 66.83 30.67 7.76 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.823 1.649 . . . . 0.0 112.544 170.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -107.21 154.4 40.52 Favored Pre-proline 0 N--CA 1.471 0.61 0 CA-C-O 117.321 -1.323 . . . . 0.0 112.594 176.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -50.59 134.82 40.56 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.267 2.645 . . . . 0.0 113.95 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 52.7 t -66.68 -17.86 65.07 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.727 1.211 . . . . 0.0 112.981 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.2 m -61.88 99.99 0.14 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.211 1.804 . . . . 0.0 111.859 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 27.8 p -54.08 -15.69 1.59 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -175.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -52.85 -38.74 61.85 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.991 0.917 . . . . 0.0 111.523 170.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -64.78 -15.19 61.32 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 pp -123.06 25.38 8.54 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.118 1.767 . . . . 0.0 113.358 172.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -62.34 148.33 45.52 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.197 -0.94 . . . . 0.0 112.62 176.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.96 -179.75 16.04 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 125.126 1.346 . . . . 0.0 114.09 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -63.5 -10.01 20.17 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.572 2.848 . . . . 0.0 116.629 -174.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -110.03 -2.27 17.13 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.412 1.485 . . . . 0.0 114.15 173.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.509 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . 3.2 m -80.8 139.99 35.72 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.348 0.976 . . . . 0.0 111.944 -177.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -87.27 135.61 33.25 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 122.493 1.139 . . . . 0.0 111.407 171.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.8 mmm-85 -69.79 -39.74 76.43 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 118.573 -0.727 . . . . 0.0 110.965 176.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.2 ptp85 -54.13 -38.37 65.37 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 169.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.406 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -65.23 -52.81 52.21 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 122.111 0.958 . . . . 0.0 110.05 174.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.24 -32.71 74.52 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.695 -178.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.1 -50.22 43.03 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.17 1.788 . . . . 0.0 112.559 176.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -50.11 -42.61 50.7 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.659 1.118 . . . . 0.0 111.975 169.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 43.0 mt -61.31 -48.83 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.857 -0.527 . . . . 0.0 111.271 173.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.56 -39.88 58.69 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.131 0.572 . . . . 0.0 111.957 174.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -62.63 -40.81 98.18 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.556 0.742 . . . . 0.0 111.284 175.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.01 -29.13 68.05 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 175.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mt -86.55 -32.48 20.67 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.1 pp -71.48 -30.3 65.83 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.618 -0.676 . . . . 0.0 111.227 167.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.83 20.06 7.85 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 118.988 -0.896 . . . . 0.0 113.823 168.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.27 -50.0 68.28 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 118.486 1.143 . . . . 0.0 111.179 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -167.27 150.21 6.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.938 2.095 . . . . 0.0 110.566 169.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -86.84 130.15 34.59 Favored 'General case' 0 C--O 1.238 0.471 0 O-C-N 121.21 -0.931 . . . . 0.0 109.166 -178.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.06 150.54 27.36 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.092 0.957 . . . . 0.0 112.351 174.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -76.77 138.44 39.91 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.275 1.03 . . . . 0.0 109.339 168.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -139.24 144.75 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.332 1.053 . . . . 0.0 109.525 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -80.01 152.62 29.35 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.905 0.882 . . . . 0.0 110.04 171.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.406 HG23 ' HB1' ' A' ' 78' ' ' ALA . 0.6 OUTLIER -163.46 148.05 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.235 1.014 . . . . 0.0 111.028 179.209 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.509 ' HB3' ' HA ' ' A' ' 74' ' ' THR . . . -90.76 145.37 24.85 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.888 0.475 . . . . 0.0 112.247 177.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -117.51 162.56 17.78 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.767 1.227 . . . . 0.0 111.93 172.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -127.94 136.46 51.36 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.604 0.761 . . . . 0.0 111.531 168.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.7 mmt85 -71.08 152.22 43.72 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.446 1.498 . . . . 0.0 111.624 173.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -54.88 -30.57 58.29 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.788 1.235 . . . . 0.0 112.341 168.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -76.21 -9.95 59.03 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.568 1.547 . . . . 0.0 114.271 175.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.8 10.23 47.16 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.296 1.427 . . . . 0.0 116.313 174.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.3 m -87.61 135.12 33.49 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 119.14 1.47 . . . . 0.0 111.578 176.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 59.3 m -123.24 133.18 54.22 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.467 1.107 . . . . 0.0 112.243 -171.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -150.9 140.47 21.59 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -176.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -102.58 127.46 49.65 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.004 1.722 . . . . 0.0 108.465 168.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 60.9 m -128.45 168.49 15.56 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.435 1.094 . . . . 0.0 110.579 171.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 73.2 mt -79.99 59.85 3.36 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.876 -1.14 . . . . 0.0 110.199 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.3 t -59.06 146.37 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.531 1.532 . . . . 0.0 112.208 -168.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -100.05 69.69 1.53 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 122.56 1.172 . . . . 0.0 112.31 -168.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.9 t -84.67 69.85 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 121.372 -0.83 . . . . 0.0 111.346 -168.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.2 t -111.25 129.2 24.28 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 124.504 1.121 . . . . 0.0 109.464 -178.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -82.96 -168.67 0.61 Allowed 'Trans proline' 0 CA--C 1.553 1.427 0 C-N-CA 123.121 2.548 . . . . 0.0 111.298 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -127.17 128.9 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-O 123.124 1.44 . . . . 0.0 113.945 175.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -111.7 162.2 15.46 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.675 2.39 . . . . 0.0 112.818 -175.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -94.46 -178.95 4.74 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.475 172.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -61.57 -22.18 64.96 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -71.89 -19.98 61.86 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.641 1.177 . . . . 0.0 113.829 170.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.32 -0.03 59.85 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 126.017 1.77 . . . . 0.0 114.372 -176.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.4 140.01 29.94 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.541 1.171 . . . . 0.0 113.146 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.3 p -73.95 98.89 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.668 1.587 . . . . 0.0 109.8 -176.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.96 -30.03 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 118.397 -0.811 . . . . 0.0 111.059 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.7 mmt -135.96 149.91 49.07 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-O 123.455 1.597 . . . . 0.0 110.452 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.2 m-30 -105.61 81.09 1.63 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -175.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.9 mt -99.95 69.99 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 120.206 -1.559 . . . . 0.0 108.295 173.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -73.96 87.64 1.83 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 123.405 1.574 . . . . 0.0 109.398 176.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -59.89 96.54 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 112.845 -1.98 . . . . 0.0 109.862 176.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -83.4 52.76 2.3 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.454 -1.403 . . . . 0.0 111.881 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -79.84 127.08 31.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 122.065 0.936 . . . . 0.0 111.992 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 t -69.36 123.56 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.423 1.089 . . . . 0.0 109.016 172.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p -140.46 145.24 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 169.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.2 ptp -142.87 157.66 44.38 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.858 1.263 . . . . 0.0 111.865 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -76.18 145.93 39.5 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.374 0.67 . . . . 0.0 111.68 169.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt . . . . . 0 C--O 1.253 1.278 0 C-N-CA 125.973 1.709 . . . . 0.0 111.784 -174.494 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.4 ttm . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 118.775 -0.631 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -71.07 -22.92 25.54 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.27 2.647 . . . . 0.0 114.098 -175.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.0 m -119.56 154.4 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 126.321 1.848 . . . . 0.0 111.308 173.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.9 ptp85 -157.13 162.95 39.39 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.327 1.451 . . . . 0.0 112.776 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -81.59 146.92 29.86 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.335 1.054 . . . . 0.0 110.941 168.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.97 -155.97 48.02 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 123.612 0.625 . . . . 0.0 113.725 -175.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -77.85 162.43 26.87 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.13 1.372 . . . . 0.0 113.462 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.9 p -90.15 148.69 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.874 1.269 . . . . 0.0 110.956 170.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.36 159.93 27.55 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 123.531 0.732 . . . . 0.0 111.561 169.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -51.6 110.16 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.803 3.002 . . . . 0.0 112.031 174.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -63.87 -27.16 68.97 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -168.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -68.45 -50.0 55.72 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.754 0.822 . . . . 0.0 110.371 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 t -75.67 -33.9 60.43 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.835 0.854 . . . . 0.0 112.488 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -59.9 -40.35 88.47 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.454 0.702 . . . . 0.0 110.185 172.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.4 tp -71.6 -45.99 60.55 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-O 118.824 -0.607 . . . . 0.0 112.161 172.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -46.86 -39.75 12.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.587 1.555 . . . . 0.0 113.353 173.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 90.3 m -60.01 -44.77 94.35 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.546 -0.721 . . . . 0.0 112.025 172.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.1 mm -67.3 -35.54 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.881 0.872 . . . . 0.0 110.756 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.4 mm -55.78 -54.95 20.66 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 172.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 -59.96 -28.43 67.65 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.981 0.809 . . . . 0.0 113.038 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.7 tttt -64.27 -41.69 96.79 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 172.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -103.51 1.01 31.76 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -57.43 -26.96 61.96 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.872 2.069 . . . . 0.0 114.16 -168.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.71 42.9 30.49 Favored Glycine 0 CA--C 1.532 1.147 0 O-C-N 121.284 -0.885 . . . . 0.0 113.066 -178.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -63.39 -10.18 15.69 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.875 1.67 . . . . 0.0 113.421 -173.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 51.1 p -61.66 -8.56 4.69 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.938 1.695 . . . . 0.0 114.774 171.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . 0.369 0.0 OUTLIER -69.21 -175.24 0.74 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 119.777 1.171 . . . . 0.0 113.591 169.287 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -62.1 130.5 45.76 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.764 1.626 . . . . 0.0 113.181 -167.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -169.72 161.5 9.28 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.392 1.477 . . . . 0.0 113.374 176.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 pp -125.01 167.92 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 126.845 2.058 . . . . 0.0 111.636 170.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.6 mm -125.74 122.43 62.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 125.846 1.658 . . . . 0.0 107.882 173.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.41 152.78 49.43 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 178.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -77.91 106.72 9.95 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 121.561 0.696 . . . . 0.0 111.191 172.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.71 -14.98 61.23 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -94.97 4.14 54.14 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.808 1.243 . . . . 0.0 114.163 -172.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -117.73 140.09 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.482 1.513 . . . . 0.0 110.647 -176.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.34 -26.05 66.28 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -177.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.83 -8.95 59.85 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.223 1.409 . . . . 0.0 114.001 177.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.5 p 35.34 56.12 0.84 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 127.043 2.137 . . . . 0.0 114.214 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.93 153.14 17.92 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -167.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.0 t -79.97 89.97 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 128.64 2.776 . . . . 0.0 108.895 -176.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.5 pt -70.82 -24.64 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.642 1.177 . . . . 0.0 112.2 176.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -154.9 159.77 40.7 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 177.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 25.5 p -142.29 146.8 35.46 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -172.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -92.01 154.1 19.0 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.549 0.69 . . . . 0.0 112.595 167.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -62.9 -33.56 75.57 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.265 0.626 . . . . 0.0 111.14 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.95 -49.95 56.78 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 121.69 -0.631 . . . . 0.0 113.155 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.02 -29.86 67.01 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 119.41 1.605 . . . . 0.0 111.141 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.8 t -59.19 -39.87 83.92 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 120.78 -1.2 . . . . 0.0 110.429 171.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -79.49 -24.79 42.07 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.285 1.034 . . . . 0.0 112.935 173.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.4 tp -59.33 -50.33 74.39 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.438 1.095 . . . . 0.0 110.398 172.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.1 m -86.68 -23.71 25.51 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 175.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.59 31.72 60.37 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 124.481 1.038 . . . . 0.0 114.197 -175.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 17.7 m-30 -95.99 -130.16 0.16 Allowed 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 118.379 1.09 . . . . 0.0 112.146 -175.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.4 t -160.06 149.96 18.19 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 128.026 2.53 . . . . 0.0 108.578 174.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -61.3 -35.35 77.09 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 120.699 -1.251 . . . . 0.0 113.234 -173.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.42 -16.67 48.92 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.436 1.094 . . . . 0.0 113.26 175.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -93.66 -20.86 19.77 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.422 1.889 . . . . 0.0 111.99 178.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 m -95.83 -19.99 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 119.762 1.164 . . . . 0.0 113.296 -174.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 34.3 mmt -50.01 112.97 0.75 Allowed 'General case' 0 C--N 1.342 0.248 0 C-N-CA 124.683 1.193 . . . . 0.0 110.889 -173.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 68.74 21.99 7.56 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.193 1.397 . . . . 0.0 113.549 169.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.3 158.79 86.92 Favored Pre-proline 0 N--CA 1.475 0.785 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.687 167.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.78 140.01 93.23 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.117 1.878 . . . . 0.0 111.481 169.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 3.9 t -69.62 -14.69 62.96 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.043 1.337 . . . . 0.0 112.747 177.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.28 99.8 0.31 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 127.82 2.448 . . . . 0.0 110.544 176.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 30.4 p -55.23 -14.86 1.93 Allowed 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.638 -1.165 . . . . 0.0 113.652 174.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -47.15 -42.82 20.28 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.442 1.497 . . . . 0.0 111.828 167.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -66.81 -12.66 59.77 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 pp -123.05 23.62 9.2 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.282 1.833 . . . . 0.0 113.428 171.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.12 146.85 53.52 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.036 -1.04 . . . . 0.0 112.912 177.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -123.19 -177.43 15.14 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.309 1.433 . . . . 0.0 114.547 -173.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -66.78 -10.15 27.18 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.009 2.473 . . . . 0.0 116.218 -172.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -110.07 -5.34 15.42 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.702 1.201 . . . . 0.0 113.898 170.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.533 HG23 ' H ' ' A' ' 97' ' ' ALA . 3.6 m -71.23 134.1 46.62 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.889 1.222 . . . . 0.0 110.076 177.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -79.88 134.59 36.31 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 122.263 1.03 . . . . 0.0 109.072 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -66.3 -39.71 89.51 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.342 -0.849 . . . . 0.0 110.105 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.8 ptt-85 -55.34 -38.91 69.38 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.559 1.144 . . . . 0.0 113.909 169.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.42 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -63.16 -52.84 60.79 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.987 0.915 . . . . 0.0 110.482 174.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.05 -34.45 78.45 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.181 -178.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.09 -52.81 24.53 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.599 1.16 . . . . 0.0 112.194 176.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -50.18 -40.01 45.59 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.378 0.99 . . . . 0.0 112.921 171.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 46.2 mt -63.62 -49.27 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 121.453 -0.779 . . . . 0.0 111.365 173.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.75 -39.88 59.3 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.777 0.717 . . . . 0.0 111.763 173.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -63.29 -39.76 95.48 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.319 0.648 . . . . 0.0 111.542 175.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.04 -29.7 68.74 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.3 mt -82.79 -34.97 26.87 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.9 pp -70.66 -27.2 63.85 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.976 -0.453 . . . . 0.0 112.056 167.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.93 17.48 9.6 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.315 -0.714 . . . . 0.0 114.2 169.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -51.61 -49.88 61.32 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 118.087 0.944 . . . . 0.0 112.042 173.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -157.01 142.74 17.66 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.52 1.928 . . . . 0.0 110.644 170.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -75.81 118.19 18.35 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.71 -1.244 . . . . 0.0 108.017 169.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -146.23 135.62 22.94 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.851 0.86 . . . . 0.0 112.474 -167.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -86.88 130.0 34.65 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.043 1.337 . . . . 0.0 109.518 168.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.71 144.28 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.21 1.404 . . . . 0.0 109.081 -175.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -79.88 150.62 30.54 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.522 0.729 . . . . 0.0 109.891 171.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.42 HG23 ' HB1' ' A' ' 78' ' ' ALA . 0.7 OUTLIER -160.86 159.98 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.367 1.067 . . . . 0.0 110.32 -177.565 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.533 ' H ' HG23 ' A' ' 74' ' ' THR . . . -102.09 145.31 29.52 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.807 171.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -112.4 152.59 28.47 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.862 1.665 . . . . 0.0 110.645 169.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -127.06 139.56 52.91 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.44 0.638 . . . . 0.0 110.289 167.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -84.9 158.55 20.54 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.786 1.234 . . . . 0.0 112.927 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -54.68 -30.44 55.63 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.574 1.55 . . . . 0.0 112.853 169.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -75.45 -9.94 59.02 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.115 1.366 . . . . 0.0 113.998 175.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.08 3.82 55.6 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.76 1.647 . . . . 0.0 115.763 176.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 54.2 m -84.57 128.24 34.49 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 119.169 1.484 . . . . 0.0 111.347 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 46.9 t -124.43 129.88 51.47 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.065 1.346 . . . . 0.0 112.005 -173.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -150.91 139.96 21.07 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.399 1.079 . . . . 0.0 113.764 -169.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.0 134.87 49.51 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.711 2.404 . . . . 0.0 109.121 172.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 4.5 m -139.04 173.1 11.91 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.66 1.584 . . . . 0.0 110.281 168.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 26.6 tp -76.95 59.84 1.7 Allowed 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.019 -1.051 . . . . 0.0 109.995 173.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.7 t -59.81 146.98 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.955 1.302 . . . . 0.0 110.8 -172.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -100.0 69.72 1.55 Allowed 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 122.802 1.287 . . . . 0.0 112.584 -168.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.1 t -84.19 69.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.343 1.057 . . . . 0.0 110.89 -169.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.2 p -117.88 134.07 23.31 Favored Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 124.038 0.935 . . . . 0.0 111.887 -173.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -86.81 -173.22 1.1 Allowed 'Trans proline' 0 CA--C 1.546 1.089 0 C-N-CA 123.472 2.781 . . . . 0.0 113.445 -172.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.16 127.12 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-O 122.972 1.368 . . . . 0.0 113.483 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -110.62 162.07 15.1 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.634 2.374 . . . . 0.0 112.63 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -92.81 179.97 5.31 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.735 -1.121 . . . . 0.0 112.156 171.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.67 -21.4 65.69 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -70.84 -19.87 62.61 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.481 1.112 . . . . 0.0 113.737 169.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.69 0.09 59.27 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 126.007 1.765 . . . . 0.0 114.406 -176.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.74 139.64 30.36 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.69 1.245 . . . . 0.0 113.292 -178.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.8 p -74.53 100.1 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 125.582 1.553 . . . . 0.0 110.565 -176.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.26 -29.98 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.34 0.656 . . . . 0.0 111.837 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.27 149.99 50.97 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 124.273 1.987 . . . . 0.0 112.732 173.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.3 m-30 -104.45 82.05 1.88 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.155 -1.839 . . . . 0.0 107.048 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.3 mt -102.06 69.88 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 171.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.19 86.56 5.59 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.899 0.857 . . . . 0.0 108.858 -178.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -59.94 104.21 0.28 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.544 1.138 . . . . 0.0 110.94 -175.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -83.85 58.13 4.5 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.277 -1.514 . . . . 0.0 111.729 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -79.79 124.95 29.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 122.626 1.203 . . . . 0.0 110.914 176.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 55.9 t -81.99 113.34 21.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 125.048 1.339 . . . . 0.0 108.27 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.6 p -140.38 135.99 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 120.836 0.351 . . . . 0.0 111.635 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 27.8 ptm -142.82 158.74 43.33 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.34 1.456 . . . . 0.0 111.722 173.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -72.54 149.63 43.89 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.951 0.9 . . . . 0.0 112.202 173.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 87.1 tttt . . . . . 0 C--O 1.252 1.204 0 C-N-CA 125.792 1.637 . . . . 0.0 111.505 179.86 . . . . . . . . 0 0 . 1 stop_ save_